Final Programme - World Heart Federation

Final Programme 

World Congress of Cardiology 

Buenos Aires, Argentina 

18 - 21 May, 2008

Congress FLoor PLAn

Content 

WeLCoMe Address 3 

CoMMittees 4 

Hosting orgAnizAtions 6 

World Heart Federation 

Argentine Society of Cardiology 

Argentine Federation of Cardiology 

Congress sCHeduLe 21 

Congress inForMAtion 24 

How to get to the congress venue 

About the congress venue La Rural 

Registration 

Media and press 

Visual reproduction policy 

Congress material 

WCC on-site services 

soCiAL ProgrAMMe 34 

WCC 2008 CoMMunity ACtivities 35 

ABout ArgentinA 36 

Argentina 

Buenos Aires 

Climate 

Language 

Time difference 

Banks, currency, credit cards and VAT 

Electrical power 

Security 

Making phone calls 

Useful phone numbers 

Opening hours 

Leaving Argentina 

tours 38 

sPonsorsHiP And exHiBition 41 

Acknowledgements 

Exhibition opening hours 

List of exhibitors 

Exhibition map 

Sponsors’ and Exhibitors’ editorial listing 

sCientiFiC ProgrAMMe 60 

Formats 

CME Accreditation 

Technical information for sessions 

Posters & abstracts 


Programme-at-a-glance 

By day and by time 

AutHor And FACuLty index 290 

Content / 1

? 

? 

Do they know their risk? 

Join the global effort to prevent and control cardiovascular disease, the world’s number one killer. 

Support World Heart Day by giving heart health checks to your patients and their families to make 

them aware of their risk of cardiovascular disease. Help spread the message: ‘Know Your Risk!’ and 

have a heart for life. www.world-heart-federation.org 

World Heart Day 

Sunday, 28 September, 2008 

? 

? 

? 

? 

? 

? 

? 

? ? 

? 

? 

? ? 

? 

? 

?

WeLCoMe Address 

A warm welcome to the World Congress of Cardiology 2008. 

It is our pleasure, speaking on behalf of the joint organizers 

of the World Heart Federation, the Argentine Society of 

Cardiology and the Argentine Federation of Cardiology, to 

welcome delegates from the furthest corners of the globe 

to Buenos Aires. 

We strongly believe that it is only with each and every 

one of us working together that we will make a significant 

difference – and that is what the World Congress of 

Cardiology seeks to achieve. Our joint focus is on individual, 

community and patient care interventions and the growing 

epidemic of cardiovascular disease that could and can be 

prevented and managed more effectively. 

We all know the statistics, or a version of it – that 

cardiovascular disease, primarily heart disease and stroke, is 

known to be responsible for a staggering 17.5 million deaths 

a year. A total, 80% of these deaths are in low- and middleincome 

countries, and we all have a role to play in changing 

this trend, be it through prevention, education or the sharing 

of knowledge. These are three key themes that unite the 

approach of your World Congress Organizers, not to mention 

many thousands of our participants. 

And for now – WCC 2008 welcomes world class speakers 

with topical and wide-ranging sessions under the theme of 

“From patients to populations” – a theme that offers a rich, 

diverse and rewarding opportunity to share new and exciting 

advances in the fields of prevention and management of 

heart disease and all its inter-related factors. Whether it 

be part of the official scientific programme, a commercial 

satellite symposium or a workshop or taking the time to 

discover the wealth of new devices and pharmaceutical 

products present in the exhibition hall – the World Congress 

of Cardiology offers a wide and rich breadth of educational 

material to enhance your personal learning and career. You 

will see that the WCC 2008 also offers Continuing Medical 

Education Credits (CME) – be sure to benefit from this 

internationally recognized programme. Full details may be 

found on page 60 of this WCC Final Programme. 

As previously communicated, one key objective of 

the scientific programme is to feature globally relevant 

topics in the diagnosis, management and treatment 

of cardiovascular disease, which includes basic clinical 

and population research and another is to address public 

policy and advocacy topics related to cardiovascular 

disease. Whilst these objectives are shared by all three 

joint organizers, it is of particular importance for the 

World Heart Federation in its continuing relationships 

with changing partners to construct your future World 

Congresses of Cardiology. It is your participation that 

makes the World Congress of Cardiology what it is and 

it is your input and feedback that creates an environment 

in which to exchange science and build stronger and better 

working practices and procedures for the future. 

The World Congress of Cardiology, the official congress 

of the World Heart Federation, is delighted to be back in 

Argentina for a second time. We encourage you to take 

the opportunity post congress to visit this beautiful country 

and experience the famous warmth of the Argentine people. 

Welcome – we look forward to meeting you over the next 

few days. Enjoy your World Congress of Cardiology and 

Buenos Aires. 

Horacio Faella, MD Shahryar Sheikh, MD 

President of the WCC 2008 President of the World Heart Federation 

Welcome address / 3

Congress MAnAgeMent CoMMittee (CMC) 

Presidents: 

Horacio Faella (Argentina) – Shahryar Sheikh (Pakistan) 

Vice-Presidents: 

Néstor Vita (Argentina) – Trevor Hassell (Barbados) 

Valentin Fuster (US) 

Pekka Puska (Finland) 

National Organizing Committee President: 

Jorge Lerman (Argentina) 

National Organizing Committee Vice-President: 

Juan Carlos Linares-Casas (Argentina) 

Scientific Committee: 

Arturo Cagide (Argentina) 

Felipe Martínez (Argentina) 

Sidney C. Smith (US) 

sCientiFiC ProgrAMMe CoMMittee (sPC) 

Co-Chairmen: 

Arturo Cagide (Argentina) 

Felipe Martínez (Argentina) 

Sidney C. Smith (US) 

Scientific Advisory Board Council Chairs / Advisers: 

Jonathan Carapetis (Australia) 

Edgardo Escobar (Chile) 

Dong Zhao (People’s Republic of China) 

National Advisers: (Argentina) 

Luis Alday 

Hugo Grancelli 

Liliana Grinfeld 

Néstor Pérez Baliño 

Juan A. Plastino 

Ricardo Ronderos 

International Advisers: 

Mónica Acevedo (Chile) 

Ayrton Brandão (Brazil) 

Günter Breithardt (Germany) 

Valentin Fuster (US) 

sPonsorsHiP CoMMittee 

Horacio Faella (Argentina) 

Shahryar Sheikh (Pakistan) 


Press CoMMittee 

Hugo Lastiri (Argentina) 

Álvaro Sosa-Liprandi (Argentina) 

Janet Voûte (Switzerland) 

International Relationships: 

Luis María Amuchástegui (Argentina) 

General Secretary: 

Juan Krauss (Argentina) 

Chief Executive Officer, World Heart Federation: 


Director Congress Division, World Heart Federation: 

Adrian Ott (Switzerland) 

Managing Director, ICS Congresos Internacionales: 

Mariano Castex (Argentina) 

Runlin Gao (China) 

Trevor Hassell (Barbados) 

José López-Sendón (Spain) 

Mário Maranhão (Brazil) 

Marco Martínez-Ríos (Mexico) 

Akira Matsumori (Japan) 

Bongani Mayosi (South Africa) 

Sania Nishtar (Pakistan) 

Churchill Onen (Botswana) 

Dev Pahlajani (India) 

Pekka Puska (Finland) 

Srinath Reddy (India) 

Carlos Romero (Uruguay) 

Nizal Sarraf-Zadegan (Iran) 

Sergio Timerman (Brazil) 

Tak Fu Tse (China) 

Andrew Tonkin (Australia) 

William Wijns (Belgium) 

Salim Yusuf (Canada) 

Director Science Operations, World Heart Federation: 

Marilyn Hunn (US) 


Helen Alderson (Switzerland) 

Adrian Ott (Switzerland) 

Mariano Castex (Argentina) 

Victoria Dix (Switzerland) 

Patricia Blanco (Argentina) 

Laura Torres (Argentina) 

Eugenia De la Fuente (Argentina)

IT’S A RED ALERT 

Heart disease & stroke is the No.1 killer of women worldwide. Most 

heart disease & stroke is preventable. Spread the word. Go Red today. 

www.worldheart.org/grfw

Hosting orgAnizAtions 


IMPROVING lIVES By PREVENtING HEARt DISEASE AND StROkE 

The World Heart Federation is a non-governmental 

organization committed to helping the global population 

achieve a longer and better life through prevention and 

control of heart disease and stroke, with a focus on low- 

and middle-income countries. 

AWARENESS BUIlDING 

To raise public awareness of heart disease and stroke, 

the World Heart Federation develops campaigns and 

events. With its members and other partners, it encourages 

individuals and institutions to adopt heart-healthy habits 

and plays a major role in ensuring that governments 

implement policies for cardiovascular disease prevention. 

The World Heart Federation is comprised of 196 medical 

societies and heart foundations from more than 100 

countries, as well as continental members covering the 

regions of Africa, the Americas, Asia-Pacific and Europe. 

Recognized by the World Health Organization, the World 

Heart Federation is its leading non-governmental partner 

in cardiovascular disease prevention and control. 

Our four pillars of activity include: awareness building, 

advocacy, demonstration projects and sharing science/ 

building capacity. Together with its members, the World 

Heart Federation raises awareness of heart disease and 

stroke, advocates for policy changes, develops projects to 

educate communities and patients about reducing the risk 

of cardiovascular disease and shares medical and population 

health science to build sustainable capabilities at national 

and regional levels. 

www.worldheart.org 

World Heart Day is our most important awareness building 

event. It promotes preventive measures to reduce the 

incidence of cardiovascular disease worldwide. Today, 

World Heart Day is actively celebrated in more than 100 

countries and on all continents. This global event, which 

takes place on the last Sunday of September and focuses 

on a specific theme each year, involves a wide range of 

activities, including physical exercise sessions, lectures, 

shows, walking tours, healthy cooking competitions, 

and health risk assessments including the testing of 

cholesterol, blood pressure and glucose levels, along 

with BMI and waist circumference measurement. 

The Go Red for Women campaign raises awareness 

of heart disease and stroke as the number one cause of 

death of women worldwide. It encourages the medical 

profession to include heart disease and stroke prevention 

as a core component of women’s health and urges women 

to recognize their risks and to reduce them by adopting 

appropriate lifestyle changes.



ADVOCACy 

Tobacco use kills 5.4 million people a year - an average of 

one person every six seconds - and accounts for one in 

10 adult deaths worldwide. The World Heart Federation 

and its member organizations are intensively involved in 

advocating for tobacco control and, notably, the ratification 

and implementation at the national level of the Framework 

Convention on Tobacco Control, which has been signed by 

168 countries and entered into force in 2005. 153 countries 

have ratified the FCTC and thus become Parties. Our specific 

focus includes active involvement in the Global Smokefree 

Partnership and the development of a Youth Advocacy 

DEMONStRAtION PROJECtS 

The World Heart Federation aims to measurably impact 

cardiovascular disease risk, using resource-appropriate 

demonstration projects implemented at both population 

and high-risk individual levels. 

Demonstration projects are a part of the World Heart 

Federation’s efforts to achieve measurable impact on 

cardiovascular disease risk levels in low-income countries. 

Projects are specifically geared towards demonstrating best 

practice in areas of cardiovascular disease prevention and 

Network in Latin America. The World Heart Federation also 

focuses on the current overweight/obesity epidemic. It 

is playing a lead role in campaigning for the need to protect 

public health against the hazards associated with unhealthy 

nutrition habits and physical inactivity. 

In partnership with the World Economic Forum and the 

World Health Organization, the World Heart Federation is 

also leading the movement to improve employee health 

through working toward wellness in the workplace. 

control and span several continents. For example, the World 

Heart Federation is leading the field of secondary prevention 

for children with rheumatic fever/rheumatic heart disease in 

Africa and the Asia-Pacific region. A partnership with Sesame 

Workshop in Colombia is working to instill healthy habits 

in young viewers and their families. The Grenada Heart 

Project, implemented in collaboration with the Government 

of Grenada, uses the World Health Organization STEPwise 

approach to surveillance of CVD risk factors in order to help 

communities to tailor prevention programmes to their needs. 

Hosting organizations / 7



SHARING SCIENCE/BUIlDING CAPACIty 

World Congresses of Cardiology are held every two years 

during which thousands of cardiologists and other healthcare 

professionals from all over the world gather to share the 

latest science on the treatment of patients and the latest 

thinking in population-based prevention. 

World Heart Federation Scientific Councils, composed 

of experts from around the world, carry out international 

training seminars, research and demonstration projects. 

Through its Twin Centres programme, the organization 

sponsors fellowships for young cardiologists and scientists 

from less advantaged countries to undergo postgraduate 

training in world-class cardiology centres. 

WorLd HeArt FederAtion BoArd 

President 

Shahryar SHEIKH (Pakistan) 

Vice-President 

Trevor HASSELL (Barbados) 

President Elect 

Pekka PUSKA (Finland) 

Vice-President Elect 

Lyn ROBERTS (Australia) 

Past President 

Valentin FUSTER (United States) 

Past Vice-President 

Laksmiati A. HANAFIAH (Indonesia) 

Continental representatives 

Asia-Pacific 

Tsui-Lieh HSU (Taiwan) 

Anil KUMAR D.M. (India) 

Europe 

Peter HOLLINS (United Kingdom) 

William WIJNS (Belgium) 

CVD Prevention and Control is a quarterly journal of 

the World Heart Federation, which focuses especially 

on cardiovascular disease prevention in low- and middleincome 

countries. Nature Clinical Practice Cardiovascular 

Medicine is a monthly publication of the World Heart 

Federation, which provides physicians with the latest 

science of patient care. Further information on the World 

Heart Federation Journals can be found on page 16. 

For more information about the World Heart Federation, 

please visit www.worldheart.org 

Secretary 

Akira MATSUMORI (Japan) 

treasurer 

Craig T BEAM (United States) 

Chief Executive Officer 

Janet VOÛTE (Switzerland) 

Chairman, Foundations' Advisory Board 

Srinath REDDY (India) 

Chairman, Scientific Advisory Board 

Sidney SMITH Jr. (USA) 

Editor-in-Chief, CVD Prevention & Control Journal 

Andy WIELGOSZ (Canada) 

Africa 

Robert de SOUZA (South Africa) 

Albert AMOAH (Ghana) 

Inter-America 

Oscar ALVARADO (Peru) 

Rafael SHUCHLEIB (Mexico)

WorLd HeArt FederAtion Meetings 

World Heart Federation Foundations’ Advisory Board (FAB) Meeting 

Saturday, 17 May, 2008 08.30 –12.30 Room Martin Fierro, Sheraton San Martin, Buenos-Aires 

World Heart Federation Board Meeting 

Saturday, 17 May, 2008 13.30 –18.00 Room Martin Fierro, Sheraton San Martin, Buenos-Aires 

World Heart Federation Members' Workshop 

Monday, 19 May, 2008 08.30 - 17.30 Sheraton, San Martin, Buenos-Aires 

World Heart Federation Writers’ Workshop 

Monday, 19 May, 2008 09.30 –12.30 WHF Meeting Room, La Rural Congress Centre 

OTHER MEETINGS 

ISACCD (International Society Adults Congenital Heart Disease) Meeting 

Wednesday, 21 May, 2008 12.30 - 13.30 Ganges Room, La Rural Congress Centre 

Argentine Foundation of Cardiology Meeting 

Wednesday, 21 May, 2008 12.30 - 13.30 Tiber Room, La Rural Congress Centre 

Workshop: Medical and social issues about women's CV health. 

Chairperson: Salvatti Ana (ARGENTINA) 

Speakers: Nanette Wenger (UNITED STATES), Grinfeld Liliana (ARGENTINA) 

Book Presentation - "Fisiopatología Cardiovascular, bases racionales para la terapéutica" 

Wednesday, 21 May, 2008 12.30 - 13.30 Tigris Room, La Rural Congress Centre 

WorLd HeArt FederAtion 10tH generAL AsseMBLy 

Sunday, 18 May, 2008 11.30 –13.30 Room Piso 24, Sheraton San Martin, Buenos-Aires 

AGENDA 

1. Introduction of Members of Board Shahryar Sheikh 

2*. Adoption of Minutes of last General Assembly Shahryar Sheikh 

3. President’s Report Shahryar Sheikh 

4*. Report of the Treasurer Craig T BEAM 

(including approval by General Assembly 

of 2006 & 2007 audited reports) 

5. Report of the Foundations’ Advisory Board Trevor Hassell (for Srinath Reddy) 

6. Report of the Scientific Advisory Board/Demonstration Sidney Smith 

Project Reviews 

7. Report of the Secretary Akira Matsumori 

8*. Report of the Nominating Committee & Elections Valentin Fuster 

9. Awards Shahryar Sheikh 

10. Future Priorities for Action Pekka Puska 

11. Any Other Business 

*Requires approval by General Assembly 


Accepted abstracts 

are published in the 

Circulation supplement. 

Circulation – the journal of choice in 

the cardiology community, 

with an impact factor of 10.940. 

Over 450 media attend; their articles 

create 200 million impressions. 

Featured research can have an immediate global impact. 

The American Heart Association’s Scientific Sessions is the world’s premier cardiovascular conference, 

with unmatched scientific scope, authority and prestige. 

Abstract submissions 

April 15 to June 6 

Late-breaking abstract 

submission deadline 

June 30 

scientificsessions.org 

Submitting 

Your Research 

To The 

American 

Heart 

Association 

Is The Right 

Choice. 

Global leaders in 

cardiovascular research 

and instruction will see 

your science. 

Discuss your work with the world’s 

foremost leaders in your field. 

Opportunities exist for Early Career 

Awards and Travel Stipends. 

Awards are available for qualified healthcare professionals. 

Submit Your Best Science Today For Sessions 

In New Orleans, November 8 – 12 

ONE WORLD. ONE MISSION. YOUR SPECIALTY. 

©2008, American Heart Association. 4/08LS1704

World Heart Federation Members 

CONtINENtAl MEMBERS 

A continental society or foundation which is a group of societies or foundations from one of the continental groupings 

of countries comprising Europe, North/Central/South America, Asia Pacific, and Africa. 

ORGANIzATION NAME PRESIDENT/CHAIRMAN COuNTRy 

African Heart Network (AHN) Robert de Souza South Africa 

Asia Pacific Heart Network (APHN) Hsu Tsui-Lieh China, Taiwan 

Asian-Pacific Society of Cardiology (APSC) Anil Kumar India 

European Heart Network (EHN) Peter Hollins United Kingdom 

European Society of Cardiology (ESC) Kim Fox United Kingdom 

InterAmerican Heart Foundation (IAHF) Rafael Shuchleib Mexico 

Interamerican Society of Cardiology (IASC) Oscar Alvarado Peru 

Pan-African Society of Cardiology (PASCAR) Albert Amoah Ghana 

NAtIONAl MEMBERS 

A national society of cardiology or a national heart foundation. 


Algerian Society of Cardiology Djamaleddine Nibouche Algeria 

Argentine Heart Foundation Liliana Grinfeld Argentina 

Argentine Society of Cardiology Eduardio Mele Argentina 

National Heart Foundation of Australia Bruce Carter Australia 

The Cardiac Society of Australia & New zealand Michael Feneley Australia 

Austrian Heart Foundation Konrad Steinbach Austria 

Austrian Society of Cardiology Kurt Huber Austria 

Bangladesh Cardiac Society Sirajul Haque Bangladesh 

National Heart Foundation of Bangladesh Justice Chowdury ATM Masud Bangladesh 

Heart and Stroke Foundation of Barbados Inc Dru Symmonds Barbados 

Belarusian Scientific Society of Cardiologists N. Manak Belarus 

Belgian Heart League Jean-Pierre Willaert Belgium 

Belgian Society of Cardiology Guy Berkenboom Belgium 

Bolivian Society of Cardiology Edgar Pozo Valdivia Bolivia 

Association of Cardiologists of Bosnia and Herzegovina Enver Raljevíc Bosnia and Herzegovina 

Foundation of Health and Heart Slobodan Cvjetic Bosnia and Herzegovina 

Brazilian Society of Cardiology Antonio Palandri Chagas Brazil 

Funcor – Brazilian Heart Foundation Alvaro Avezum Brazil 

Bulgarian Society of Cardiology Tzvetana Katova Bulgaria 

Canadian Cardiovascular Society Denis Roy Canada 

Heart and Stroke Foundation of Canada Carol Jillings Canada 

Chilean Heart Foundation Mario Alvo Chile 

Chilean Society of Cardiology & Cardiovascular Surgery René Asenjo González Chile 

Hong Kong College of Cardiology Chu-Pak Lau China, Hong Kong 

The Hong Kong Heart Foundation, Ltd. Patrick Wu China, Hong Kong 

Macau Association of Cardiology Mario Lima Evora China, Macao 

Macau Heart Foundation Jimmy Chac Lam Chu China, Macao 

Chinese Society of Cardiology Runlin Gao People’s Republic of China 

Taiwan Heart Foundation Hung-Chi Lue China, Taiwan 

Taiwan Society of Cardiology Fui-Tien Chiang China, Taiwan 

Colombian Society of Cardiology Fernando Manzur Jattin Colombia 

World Heart Federation members / 11



A Heart for Life Nathalie Kaky-Ndembe Congo 

Croatian Cardiac Society Davor Milicic Croatia 

Cuban Society of Cardiology Lorenzo Llerena Rojas Cuba 

Cyprus Heart Foundation Christos Mavrellis Cyprus 

Cyprus Society of Cardiology Pambis Nicolaides Cyprus 

Czech Society of Cardiology Michael Aschermann Czech Republic 

Healthy Nutrition Forum Rudolf Poledne Czech Republic 

Danish Heart Foundation Henrik Sillesen Denmark 

Danish Society of Cardiology Henrik Steen Hansen Denmark 

Dominican Heart Foundation Hector Mateo Dominican Republic 

Dominican Society of Cardiology Frank Valdez Báez Dominican Republic 

Ecuadorian Foundation of Cardiology Ernesto Fuentes Ecuador 

Ecuadorian Society of Cardiology Santiago García Eguez Ecuador 

Egyptian Society of Cardiology Aly Ramsy Egypt 

Society of Cardiology of El Salvador Dagoberto Pereira El Salvador 

Estonian Heart Association Maarit Vaikmaa Estonia 

Finnish Cardiac Society Saila Vikman Finland 

Finnish Heart Association Pekka Puska Finland 

French Society of Cardiology Nicolas Danchin France 

Georgian Association of Cardiology V. B. Tchumburidze Georgia 

Georgian Heart Foundation Merab Mamatsashvili Georgia 

German Cardiac Society Gerd Heusch Germany 

German Heart Foundation Hans-Jürgen Becker Germany 

Ghana Heart Foundation Kwabena Frimpong-Boateng Ghana 

Ghana Society of Hypertension and Cardiology Albert Amoah Ghana 

Hellenic Cardiological Society Dimitris Kremastinos Greece 

Hellenic Heart Foundation Metropolitan of Thebes and Levadia Ieronymos Greece 

Guatemala Association of Cardiology Pablo Montenegro Valdovinos Guatemala 

Honduras Society of Cardiology Mauricio Varela Honduras 

Hungarian National Heart Foundation András Nagy Hungary 

Hungarian Society of Cardiology Tamás Forster Hungary 

Icelandic Heart Association Gunnar Sigurdsson Iceland 

All India Heart Foundation Sivaramakrishna Padmavati India 

Cardiological Society of India S. S. Chatterje India 

Heart Foundation of Indonesia Firdanerry A. Sani Indonesia 

Indonesian Heart Association Muhammad Munawar Indonesia 

Iranian Heart Association Feridoun Noohi Islamic Republic of Iran 

Iraqi Cardio-Thoracic Society Adil S. Abdul-Ghafour Iraq 

Irish Cardiac Society David Higginson Ireland 

Irish Heart Foundation Eoin O'Brien Ireland 

Israel Heart Society Basil Lewis Israel 

Italian Federation of Cardiology Giuseppe Di Pasquale Italy 

Italian Heart Foundation Rodolfo Paoletti Italy 

The Heart Foundation of Jamaica Knox Hagley Jamaica 

Japan Heart Foundation Takuji Shidachi Japan 

Japanese Circulation Society Tetsu Yamaguchi Japan 

Jordan Cardiac Society M. Al-Naser Jordan 

Association of Cardiologists of Kazakhstan Alikham K. Jussipov Kazakhstan



Kenya Cardiac Society Stephen Ogendo Kenya 

Kenyan-Heart National Foundation David Githii Kenya 

The Korean Society of Cardiology Woo Hyung Lee Republic of Korea 

Kuwait Heart Foundation Jassim M Al-Bahar Kuwait 

Scientific Society of Cardiologists of the Kyrgyz Republic Mirrachimov Mirhamidovich Kyrgyzstan 

Latvian Society of Cardiology Andrejs Erglis Latvia 

Lebanese Society of Cardiology Fouad Farhat Lebanon 

Libyan Cardiac Society Omar Msalam Libya 

Lithuanian Heart Association Pranas Serpytis Lithuania 

Lithuanian Society of Cardiology Remigijus Zaliunas Lithuania 

Macedonia Society of Cardiology Sasko Kedev Macedonia 

National Heart Association of Malaysia Hendrick Chia Malaysia 

The Heart Foundation of Malaysia Tun Omar Ong Yoke Lin Malaysia 

The Heart Foundation T. K. Gunness Mauritius 

Mexican Society of Cardiology Jorge Gaspar Hernandez Mexico 

Moldavian Society of Cardiology Mihai Popovici Republic of Moldavia 

Moroccan Society of Cardiology Mohamed Saadaoui Morocco 

Cardiac Society of Myanmar Medical Association May San Khin Myanmar 

Cardiac Society of Nepal Abani Upadhyaya Nepal 

Nepal Heart Foundation Abani Upadhyaya Nepal 

Netherlands Heart Foundation L. E. H. Vredevoogd The Netherlands 

The Netherlands Society of Cardiology H. J. G. M. Crijns The Netherlands 

Cardiac Society of Australia and New zealand Robert Donaldson New Zealand 

The National Heart Foundation of New zealand Robert Donaldson New Zealand 

Nicaraguan Society of Cardiology Daniel Rivas Nicaragua 

Nigerian Cardiac Society Martin Aghaji Nigeria 

Nigerian Heart Foundation A. V. M. Mouktar Mohammed Nigeria 

Norwegian Council On Cardiovascular Disease Mons Lie Norway 

Norwegian Society of Cardiology Cecilie Risøe Norway 

Pakistan Cardiac Society Azhar Masood Faruqui Pakistan 

Pakistan Heart Foundation Muhammad Ilyas Pakistan 

Cardiological Foundation of Panama Alfredo L. Maduro Panama 

Society of Cardiology of Panama Baldomero González Panama 

National Heart Foundation of Papua New Guinea Inc. David Guinn Papua New Guinea 

Paraguayan Heart Foundation Abdón Villamayor Paraguay 

Paraguayan Society of Cardiology Maria Paniagua de Decoud Paraguay 

Peruvian Society of Cardiology Jaime Espinoza S. Peru 

Heart Foundation of the Philippines Francisco G. Dizon Philippines 

Philippine Heart Association Inc. Efren Vicaldo Philippines 

Polish Cardiac Society Andrzej Rynkiewicz Poland 

Portuguese Heart Foundation Manuel Oliveira Carrageta Portugal 

Portuguese Society of Cardiology Hugo Madeira Portugal 

Puerto Rican Society of Cardiology Luis Molinary Puerto Rico 

Foundation for Cardiac Assistance (Ascar) Costin Carp Romania 

Romanian Society of Cardiology Radu Capalneanu Romania 

Society of Cardiology of Russian Federation Rafael G. Oganov Russian Federation 

San Marino Society of Cardiology Liano Marinelli San Marino 

Saudi Heart Association Mohammed Arafah Saudi Arabia 




Serbian Heart Foundation Miodrag Ostojic Republic of Serbia 

Society of Cardiology of Serbia and Montenegro Miodrag Ostijic Republic of Serbia 

Seychelles Heart and Stroke Foundation Dolores Pool Seychelles 

Singapore Cardiac Society Richard Ng Singapore 

Singapore Heart Foundation Lip-Ping Low Singapore 

Slovak League Heart to Heart Ján Slezák Slovak Republic 

Slovak Society of Cardiology Róbert Hatala Slovak Republic 

Slovenian Heart Foundation Danica Rotar Pavlic Slovenia 

Slovenian Society of Cardiology Miran Kenda Slovenia 

Heart and Stroke Foundation South Africa Richard Cramer South Africa 

The South African Heart Association Bongani Mayosi South Africa 

Spanish Heart Foundation Eduardo de Teresa Galván Spain 

Spanish Society of Cardiology Maria Jesús Salvador Taboada Spain 

Sri Lanka Heart Association S. J. Stephan Sri Lanka 

Swedish Heart Lung Foundation Anna-Karin Lundin Sweden 

Swedish Society of Cardiology Anna Engström-Laurent Sweden 

Swiss Heart Foundation Ludwig von Segesser Switzerland 

Swiss Society of Cardiology Andres Jaussi Switzerland 

Syrian Cardiovascular Association Moufid Jokhadar Syria 

The Heart Association of Thailand Pradistchai Chaiseri Thailand 

The Heart Foundation of Thailand HRH Princess Maha Chakri Sirindhorn Thailand 

Turkish Heart Foundation Cetin Yildirimakin Turkey 

Turkish Society of Cardiology Cetin Erol Turkey 

ukrainian Society of Cardiology Volodymir Kovalenko Ukraine 

Emirates Cardiac Society Wael Almahmeed United Arab Emirates 

British Cardiovascular Society Nicholas Boon United Kingdom 

British Heart Foundation Sir Peter Morris United Kingdom 

American College of Cardiology James T. Dove United States 

American Heart Association Daniel W. Jones United States 

uruguayan Society of Cardiology Alvaro Báez Uruguay 

Venezuelan Heart Foundation Igor Morr García Venezuela 

Venezuelan Society of Cardiology Bartolomé Finizola Celli Venezuela 

Vietnam National Heart Association Pham Gia Khai Vietnam


ASSOCIAtE INtERNAtIONAl MEMBER 

An independent incorporated organization active in some aspect of the prevention and control of heart disease and stroke. 


Association of Black Cardiologists, Inc Gerald DeVaughn United States 

Association of Thoracic and Cardiovascular Surgeons of Asia (ATCSA) Avenilo P. Aventura Philippines 

Children's HeartLink Elizabeth Bickel United States 

Eastern Mediterranean Network on Heart Health Nizal Sarraf-Zadegan Islamic Republic of Iran 

Heart Friends Around the World Alessandro Scalzini Italy 

Heartfile Sania Nishtar Pakistan 

International Chinese Heart Health Network Tan-Hoong Chu Eng China, Hong Kong 

International Council of Nurses Hiroko Minami Japan 

International Forum for Hypertension Control and CVD Prevention in Africa Daniel Lemogoum Cameroon 

International Heart Health Society (IHHS) David MacLean Canada 

International Self-Monitoring Association of Oral Anticoagulated Patients (ISMAAP) Christian Schaefer Germany 

International Society for Heart Research J. M. Downey United States 

International Society for Holter & Non-Invasive Electrocardiology Sergio Dubner Argentina 

International Society of Cardiomyopathy and Heart Failure Akira Matsumori Japan 

International Society of Cardiovascular Pharmacotherapy Antonio Bayés de Luna Spain 

International Society of Cardiovascular ultrasound Navin Nanda United States 

International Stroke Society Geoffrey A. Donnan Switzerland 

Latin Society of Pediatric Cardiology and Cardiovascular Surgery Pedro L. Ferrer Panama 

ProCOR/Lown Cardiovascular Research Foundation Bernard Lown United States 

The International Society on Hypertension in Blacks (ISHIB) Charles L. Curry United States 

The Society of Chest Pain Centers and Providers J. Lee Garvey United States 

The World Heart Failure Society Willem J. Remme The Netherland 

ASSOCIAtE NAtIONAl 

A national society devoted to aspects of the prevention and control of heart disease and stroke or with aims similar 

to those of the World Heart Federation. 


Academy of Cardiology at Mumbai Dev. B. Phalajani India 

Cardiovascular Society of India A. B. Mehta India 

Foundation for Lay Education on Heart Diseases Adolfo B. Bellosillo Philippines 

Heart Care Foundation Comilla Abu Hamid Bangladesh 

Heart Research uK David Watson United Kingdom 

Indonesian Cardiocerebrovascular Society Lukman Makmun Indonesia 

Norwegian Heart and Lung Patient Organization (LHL) Svein Erik Myrseth Norway 


WorLd HeArt FederAtion JournALs 

Nature Clinical Practice Cardiovascular Medicine, a peerreviewed 

journal for cardiologists, is an official publication of 

the World Heart Federation. It delivers timely interpretations 

of key research developments, translating the latest findings 

into clinical practice. Our Editor-in-Chief, Valentin Fuster, 

MD, PhD, and the journal’s international Advisory Board 

ensure comprehensive coverage of topical issues throughout 

the year, with the highest standards of editorial quality and 

integrity that are hallmarks of the Nature Publishing Group. 

Published monthly in print and online, Nature Clinical 

Practice Cardiovascular Medicine features unique content 

designed to be of real, practical value in making diagnosis 

and treatment decisions. Content includes editorial and 

opinion pieces, highlights from the current literature, 

commentaries on the application of recent research to 

practical patient care, comprehensive reviews, original 

clinical research and in-depth case studies. Content is 

subject to rigorous peer-review. 

For more information about the journal, its Advisory Board 

and its aims and scope, visit www.nature.com/ncpcardio 

Visit the World Heart Federation booth to collect your free 

copy of Nature Clinical Practice Cardiovascular Medicine. 

Valentin Fuster, MD, PhD 

Editor-in-Chief 

As the official journal of the World Heart Federation, CVD 

Prevention and Control (formerly “Prevention and Control”, 

now re-launched under a new title) continues to provide 

a forum for dialogue and education on matters relating to 

the prevention and control of cardiovascular diseases 

worldwide, with a special focus on countries with middle 

and lower economies. 

Now in its fourth year of publication, the response to this 

new niche journal has been very encouraging. In line with 

the mission of the World Heart Federation, CVD Prevention 

and Control has become a priority journal for all who 

wish to contribute to the advancement of knowledge 

in cardiovascular diseases CVDand 

to help halt the spread 

of this epidemic worldwide. Prevention 

and 

CVD Prevention and Control Control 

is organizing a Writers’ 

Workshop during the World Congress of Cardiology 2008 in 

Buenos Aires, Argentina. This half day workshop is primarily 

intended for those from developing countries who want 

to publish in scientific journals. Participants will receive 

information on how to organize and write a manuscript for 

publication as well as information on how manuscripts are 

processed through the Elsevier Electronic system. The aim 

and scope of the journal will be discussed and a part of the 

session will be focused on interactions with a successful 

writer. This workshop is being held on Monday, May 19, 

2008 from 9.30 –12.30. The number of participants is 

limited to 40. 

On Monday, 19 May at 13.30, Andy Wielgosz, the Editorin-Chief 

of CVD Prevention and Control will be holding a 

“Meet the Editor” session at the World Heart Federation 

booth. This is an opportunity for you to discuss the journal 

and find out how you can submit a paper to the journal. 

Andy Wielgosz, MSC, MD, PhD 

Editor-in-Chief 

For further details, please visit: www.precon-journal.com

CLINICAL PRACTICE 

Calling now for original research submissions 

Maximise the visibility and impact of your research by submitting to 

Nature Clinical Practice Cardiovascular Medicine and be one of the fi rst to be 

published in our new Clinical Research section. 

www.nature.com/ncpcardio/originalresearch 

13409-12_WCC final programme ad.indd 1 18/3/08 17:09:55

the Argentine society of Cardiology (sAC) 

GENERAl INFORMAtION 

The Argentine Society of Cardiology (SAC), founded in 

1937, is a member of the World Heart Federation, the 

Interamerican Society of Cardiology, the South American 

Society of Cardiology and is affiliated to the European Society 

of Cardiology. It is one of the world's oldest cardiology 

societies. Its members include many prestigious historical 

figures internationally recognized for their contributions 

to science, such as the Nobel Prize winner Dr. Bernardo 

Houssay and Drs Eduardo Braun Menéndez, Pedro Cossio, 

Alberto Taquini, Mauricio Rosenbaum and Rene Favaloro. 

Over its 70-year history, it has been responsible for a rich 

history of scientific achievements – both educational and 

within the community. Each year, the Argentine Society of 

Cardiology organizes the Argentine Congress of Cardiology. 

10,500 participants attended the 34th meeting in October 

2007, including some of the most important international 

figures in the world of cardiology. In 1974 the SAC jointly 

hosted the 7th World Congress of Cardiology and in 1999 

the 17th International Congress of Cardiology – setting the 

scene for the partnership this May, once again playing an 

active role in the World Congress of Cardiology. 

ARGENtINE SOCIEty OF CARDIOlOGy BOARD 

President Eduardo Mele, MD 

1st Vice-President Ricardo Iglesias, MD 

2nd Vice-President Walter Santander, MD 

Secretary Fernando Sokn, MD 

Vice Secretary Antonio Pocoví, MD 

treasurer Víctor Mauro, MD 

Vice treasurer Rodolfo La Greca, MD 

Members at large Horacio Pomés Iparraguirre, MD 

C. Sara Berensztein, MD 

María Inés Sosa Liprandi, MD 

Carlos Farinelli, MD 

Andrés Mulassi, MD 

Héctor Sequeira, MD 

Mirta Diez, MD 

Enrique Pautasso, MD 

Past President Osvaldo Masoli, MD 

ARGENtINE SOCIEty OF CARDIOlOGy PROJECtS 

Medical continuous education and investigation are the 

chief advocacies of the Argentine Society of Cardiology. 

Current projects include: the organization of the next 

Argentine Congress of Cardiology and Meeting of the 

Regional Districts in 2009, the interactive programme for 

continuous training, PROSAC, and the promotion of clinical 

investigation, teaching and counselling on different aspects 

of methodology and biostatistics, among others. 

The Argentine Society of Cardiology has more than 6,500 

members in various categories including doctors, nurses and 

technicians. It has 36 Regional Districts spread over the entire 

national territory and 17 scientific councils representing all 

the subspecialties of cardiology. It conducts continuous 

and intensive teaching with courses in all subspecialties, 

grants the certification of “University of Cardiology“ 

with various universities and conducts a programme 

of recertification training. 

Other important areas of its role include research, with 

epidemiological surveys, clinical research studies and 

the Consensus which sets standards for diagnosis and 

treatment of major cardiovascular diseases. The society 

acts as advisor to both legislative chambers of the national 

parliament and also established a community programme 

for the general population, the Argentine Foundation 

of Cardiology, to educate and prevent cardiovascular 

disease as well as running and dictating courses on 

cardiopulmonary resuscitation. 

REVIStA ARGENtINA DE CARDIOlOGíA (RAC) 

(ARGENtINE JOURNAl OF CARDIOlOGy) 

The journal was created in 1934, and as of 1937, when 

the Argentine Society of Cardiology was founded, it became 

its official publication. 

Many original scientific papers from different specialities, 

editorials, clinical cases, review articles, controversies, 

articles of opinion and images in cardiology are published 

in the Journal. There is also a section devoted to letters 

from the readers. 

In the RAC´s web page (www.revista.sac.org.ar ) all editions 

from 1993 onwards can be found, with all articles available at 

full free access. It includes English versions of original papers 

and the English version of the whole Journal will be available 

soon. It is indexed in SciELO, LILACS, Latindex and DOAJ. 

For more information about the Argentine Society 

of Cardiology, please visit www.sac.org.ar

the Argentine Federation of Cardiology (FAC) 

The Argentine Federation of Cardiology (FAC) is a scientific 

institution comprised of 37 cardiology organizations and 

11 delegations from the Republic of Argentina and currently 

reaches more than 6’000 members. Its mission is to 

promote the harmonious and integrated development of 

Argentine cardiology to promote cardiovascular health. 

The FAC was founded in 1965 by a group of prominent 

cardiologists from the following Argentine northeast 

provinces representing the six cardiology organizations 

existing at the time: Córdoba, Rosario, Mendoza, San 

Juan, Tucumán and La Plata. A Society of Societies was 

formed, structured as a federation, in which every federate 

society kept their autonomy and independence, with equal 

representation and decision among the Federal National 

Council, its leadership body. 

Its first president and "alma mater" was Prof, Dr, Ricardo 

Podio from Cordoba, who was then succeeded by members 

of the Society of Cardiology from Rosario, Mendoza, 

Córdoba, La Plata, Tucumán, Salta, Buenos Aires and 

Neuquén. In over 40 years, the organization has carried out 

intensive work to accomplish its goals in the development 

and progress of cardiology throughout the country. Since 

its foundation, many prestigious scientists such as Dr. René 

Favaloro and others, have joined FAC, thus contributing 

to its mission. 

Currently FAC has a total of 22 scientific committees with 

subspecialties devoted to research and scientific output. 

It publishes a hierarchical Scientific Magazine, in which 

prestigious national and foreign authors contribute. Through 

its educational programmes, it develops regular activity 

focusing on immediate postgraduate education. 

ARGENtINE FEDERAtION OF CARDIOlOGy BOARD 

President Luis Alberto Guzmán, MD 

1st Vice-President Héctor Luciardi, MD 

2nd Vice-President Domingo Pozzer, MD 

Secretary Guillermo Azize, MD 

treasurer Miguel Chiappe, MD 

Vice Secretary Juan Muntaner, MD 

Vice treasurer Sergio Chain, MD 

Members at large Carlos Volonté, MD 

Eduardo Conci, MD 

Rodolfo Sarjanovich, MD 

Graciela Scaro, MD 

Horacio Sismondi, MD 

In this field, FAC has signed several arrangements 

with different universities and ministers of health across 

the country, in order to develop a proper process of 

specialty certification. 

Annually, FAC organizes the National Cardiology Congress 

in different provinces, through a predefined rotation system, 

and the mentioned congress has become one of the most 

important cardiology events. The next FAC Congress will 

take place in May 2009, and the usual attendance is about 

to 7’000 cardiologists, technicians and nurses. 

Its Center for Teleinformática (CETIFAC) was established in 

1995 to develop communication between different federate 

societies, as well as with several cardiologic centers from 

abroad. Its achievements include the 5th Congress of Virtual 

Cardiology, a pioneer activity on the Internet. It also works 

closely with the CARDIO Foundation dealing with subjects 

related to the prevention of cardiovascular diseases and 

health education in the community. 

Recognized in several worldwide scientific fora, with many 

of its members participating in international scientific 

meetings, FAC continues working in pursuit of a range 

of goals and always under the ideals set by its founders. 

For more information about the Argentine Federation 

of Cardiology, please visit www.fac.org.ar 


World 

The World Heart Federation is committed to helping the global population achieve 

Heart 

a longer and better life through prevention and control of heart disease and stroke, 

Federation 


with a particular focus on low and middle-income countries. 

Come and visit us at our booth

Congress sCHeduLe 

tiMe sAt. 17 MAy, 2008 sun. 18 MAy, 2008 Mon. 19 MAy, 2008 tues. 20 MAy, 2008 Wed. 21 MAy, 2008 tiMe 

6:30 6:30 

6:45 6:45 

7:00 7:00 

7:15 ClOSED 

ClOSED 

ClOSED 7:15 

7:30 INDUStRy 

INDUStRy 

INDUStRy 7:30 

7:45 7:45 

8:00 8:00 

8:15 8:15 

8:30 8:30 

8:45 

9:00 

9:15 

9:30 

ORAl 

ABStRACt 

SESSIONS 

ORAl 

ABStRACt 

SESSIONS 

ORAl 

ABStRACt 

SESSIONS 

8:45 

9:00 

9:15 

9:30 

9:45 9:45 

10:15 

10:30 

10:45 

R 

E 

G 

I 

S 

PuBLIC 

EVENT 

10KM RuN & 

R 

E 

G 

I 

S 

E 

X 

H 

I 

B 

P 

O 

S 

t 

E 

R 

E 

G 

I 

S 

E 

X 

H 

I 

B 

P 

O 

S 

t 

E 

P 

U 

B 

l 

I 

R 

E 

G 

I 

S 

E 

X 

H 

I 

B 

P 

O 

S 

t 

E 

10:15 

10:30 

10:45 

11:15 

11:30 

11:45 

t 

R 

A 

t 

3KM WALK t 

R 

A 

t 

I 

t 

I 

O 

R 

S 

SESSIONS t 

R 

A 

t 

I 

t 

I 

O 

R 

S 

C 

E 

V 

SESSIONS t 

R 

A 

t 

I 

t 

I 

O 

R 

S 

SESSIONS 

11:15 

11:30 

11:45 

12:15 

12:30 

12:45 

13:15 

13:30 

PuBLIC 

EVENT 

CPR 

I 

O 

N 

I 

O 

N 

N 

SAtEllItE 

SCIENtIFIC 

ACtIVItIES 

(INtER- 

SESSIONS) 

I 

O 

N 

N E 

N 

t 

t 

H 

E 

SAtEllItE 

SCIENtIFIC 

ACtIVItIES 

(INtER- 

SESSIONS) 

I 

O 

N 

N 

SAtEllItE 

SCIENtIFIC 

ACtIVItIES 

(INtER- 

SESSIONS) 

12:15 

12:30 

12:45 

13:15 

13:30 

13:45 COuRSES 

M 

A 

13:45 

14:15 

14:30 

14:45 

SESSIONS 

t 

I 

C SESSIONS 

SESSIONS 

14:15 

14:30 

14:45 

15:15 

15:30 

15:45 

16:15 

16:30 

16:45 

R 

E 

G 

I 

S 

t 

R 

A 

t 

SESSIONS 

E 

V 

E 

N 

t 

SESSIONS 

SESSIONS 

15:15 

15:30 

15:45 

16:15 

16:30 

16:45 

17:15 

17:30 

17:45 

I 

O 

N 

17:15 

17:30 

17:45 

18:15 

18:30 

18:45 

E 

X 

H 

I 

B 

I 

EXHIBItION 

OPENING 

OPENING 

CEREMONy SAtEllItE SCIENtIFIC 

ACtIVItIES 

(EVENING SESSIONS) 

SAtEllItE SCIENtIFIC 

ACtIVItIES 

(EVENING SESSIONS) 

18:15 

18:30 

18:45 

19:15 

19:30 

19:45 

t 

I 

O 

N 

19:15 

19:30 

19:45 

10:00 10:00 

11:00 11:00 

12:00 12:00 

13:00 13:00 

14:00 14:00 

15:00 15:00 

16:00 16:00 

17:00 17:00 

18:00 18:00 

19:00 19:00 

20:00 

20:15 

20:00 

20:15 

20:30 20:30 

20:45 20:45 

21:00 21:00 

21:15 GAlA DINNER 

21:15 

21:30 (By PAyMENt OR 

21:30 

21:45 INVItAtION ONly) 

OFF-SItE 

21:45 

22:00 

22:15 

22:00 

22:15 

22:30 22:30 

22:45 22:45 

23:00 23:00 

Congress schedule / 21

Building New Strategies in Acute 

Tuesday, May 20, 2008 

17:30 – 18:00 Reception 

18:00 – 19:30 Symposium 

Ganges Room 

La Rural Convention & 

Exhibition Centre 

Av. Sarmiento 2704 

Palermo 

Buenos Aires, 

Argentina

Decompensated Heart Failure 

Faculty 

Nadine Clausell, MD, PhD (Co-Chair) 

Associate Professor of Medicine 

Federal University of Rio Grande do Sul 

Porto Alegre, RS, Brazil 

Sergio V. Perrone, MD (Co-Chair) 

Medical Director — 

Intrathoracic Transplant & Heart Failure Division 

FLENI Institute 


Uri Elkayam, MD 

Professor of Medicine 

University of Southern California, 

Keck School of Medicine 

Los Angeles, California 

J. Thomas Heywood, MD, FACC 

Clinical Professor of Medicine 

Loma Linda University School of Medicine 

Loma Linda, California 

Fábio Vilas-Boas, MD, PhD 

Chief Cardiology Division 

Hospital Espanhol 

Salvador, BA, Brazil 

Agenda 

17:30 – 18:00 Reception 

18:00 – 18:05 Introduction (Co-chairs) 

Nadine Clausell, MD, PhD 

Sergio Perrone, MD 

Programme Overview 

Organized by 

Acute decompensated heart failure (ADHF) is associated with 

prolonged in-hospital lengths of stay, high rates of hospital 

readmission, and substantial rates of inpatient and outpatient 

morbidity and mortality. In Latin American countries, the incidence of 

heart failure is rising, and ADHF has not been as well characterized as 

chronic heart failure. An awareness of unmet needs in ADHF 

management is therefore useful to improve the process of care in this 

patient population. Goals of therapy for ADHF include relieving 

symptoms, reversing acute hemodynamic abnormalities, initiating 

evidence-based therapy, reducing length of stay, and preventing 

rehospitalization. Treatment recommendations are generally based on 

the patient’s fluid volume status and cardiac output. It is therefore 

critical for cardiologists to be aware of when to use various intravenous 

therapies for improving hemodynamics and acute heart failure signs 

and symptoms. One such agent is the vasodilator nesiritide, a purified 

preparation of human B-type natriuretic peptide (hBNP), which 

reduces pulmonary capillary wedge pressure and improves dyspnea in 

patients with ADHF who have dyspnea at rest or with minimal activity. 

This program will help Latin American cardiologists understand the 

challenges in managing ADHF and effective therapeutic strategies for 

treating patients with different hemodynamic and clinical profiles. In 

addition, faculty members will describe and demonstrate through case 

presentation the appropriate use of nesiritide in patients with ADHF. 

18:05 – 18:15 Focus on Latin America: 

Unmet Needs in Acute Decompensated Heart Failure Management 

Nadine Clausell, MD, PhD 

18:15 – 18:35 Current Treatment Options for Acute Decompensated Heart Failure 

Uri Elkayam, MD 

18:35 – 18:55 Nesiritide Therapy for the ADHF Patient 

J. Thomas Heywood, MD 

18:55 – 19:15 Case Presentation and Panel Discussion 

Moderator: Uri Elkayam, MD 

Panelists: Nadine Clausell, MD, PhD, Sergio Perrone, MD, Fábio Vilas-Boas, MD, PhD, 

J. Thomas Heywood, MD 

19:15 – 19:30 Question and Answer

Congress inForMAtion 


By SHUttlE SERVICE 

A shuttle service running every 15 minutes, will be available between 

the congress venue and the main hotel area at key times. 

DATE HOuRS OF SERVICE 

Sunday, 18 May 16.30 – 21.30 

Monday, 19 May 07.00 – 10.00 

17.00 – 20.00 

Tuesday, 20 May 07.00 – 10.00 

17.00 – 20.00 

Wednesday, 21 May 07.00 – 10.00 

16.00 – 18.00 

There are four different routes. Please see below the shuttle bus map 

and the schedule for each route. 

PlEASE BE AWARE OF 

tHE FOllOWING: 

• When returning from the La Rural 

Convention Centre buses will stop 

on the opposite side of the Avenue 

due to traffic regulations 

• Frequency may vary during 

rush hour


ROuTE 1 – yELLOW 

SHuTTLE SERVICE STARTS 

SuNDAy MON, TuE & WED 

34 Hotel InterContiental ** 16.30 7.00 

35 Reino Del Plata Hotel 

37 NH City 

38 562 Nogaró Hotel 

44 Gran Boulevard Hotel 

45 Hotel de las Luces 

72 Argentino Hotel ** 16.35 – 16.40 07.05 – 07.10 

36 Imperial Park 

39 Tribeca 

40 Amerian Congreso 

41 Apart Hotel & Spa Congreso 

42 Castelar 

43 Golden Tulip Savoy 

48 Sarmiento Palace 

67 Hotel Salles 

12 Pestana ** 16.45 – 16.50 07.15 – 07.20 

7 Sheraton Libertador 

8 Regente Palace Hotel 

13 El Conquistador 

14 Presidente 

27 Loi Suites Esmeralda 

Arrival at La Rural Congress Centre 17.30 7.40 

** Indicates official shuttle pick-up and drop-off location 

ROuTE 2 – ORANGE 



15 Panamericano ** 16.30 7.00 

10 Hostería Posta Carretas 

16 Argentina Tango Hotel 

17 Art Deco Suites 

18 725 Continental Hotel 

19 Broadway All Suites 

20 NH Latino 

21 Obelisco Center 

22 Park Central Kempinski 

23 Mayflower Suites 

46 Intersur Suites 

24 Hotel Embajador ** 16.35 – 16.40 07.05 – 07.10 

25 Bel Air 

26 Carlton 

30 Argenta Tower 

31 Loi Suites Arenales 

33 Impala 

47 Design Suites 

Lenguas Vivas School – Carlos Pellegrini 1515 ** 16.45 – 16.50 07.15 – 07.20 

29 Four Seasons 

62 Emperador 



Congress information / 25


ROuTE 3 – BLuE 



51 Madero By Sofitel ** 16.30 07.00 

52 Faena Hotel 

50 Hilton Buenos Aires ** 16.35 – 16.40 07.05 – 07.10 

Plaza Roma – Leandro N Alem & Lavalle ** 16.45 – 16.50 07.15 – 07.20 

3 Meliá Buenos Aires 

4 Holiday Inn Express Puerto Madero 

9 Regal Pacific 

53 NH Jousten 

54 Lafayette 

55 Liberty 

56 Claridge 

57 Amerian Buenos Aires Park 

58 NH Lancaster 

60 Tryp Buenos Aires 

61 Gran Hotel Buenos Aires 



ROuTE 4 – RED 



1 Sheraton Buenos Aires ** 16.30 07.00 

2 Marriott Plaza 

5 Howard Johnson Plaza 

6 Waldorf 

11 Sheltown 

28 NH Crillon 

59 NH Florida 

68 Hotel Promenade 

74 Meliá Buenos Aires Hotel 

71 Caesar Park ** 16.40 – 16.45 07.10 – 07.15 

32 Howard Johnson Recoleta 

63 Plaza Francia 

64 Alvear Palace 

65 Melia Recoleta 

66 Ulises Recoleta 

70 Temporary Apartments 


** Indicates official shuttle pick-up and drop-off location


By SUBWAy 

There are five “subtes” lines (abbreviated name for 

subterraneo/subway). Subway lines are connected with 

the main avenues, railway and bus stations. Each ticket 

may be used on all the subway lines. 

By tAXI 

Taxis can be called by phone or hailed directly in the street. 

Radio taxis are considered the best option. Taxis can be 

easily recognized by their colours, black and yellow, and a 

red light on the taximeter indicates that they are available. 

The main subway line from the hotel area to La Rural 

Convention & Exhibition Centre is the “Subte Linea D” 

with “Plaza Italia” as the stop. Delegates can buy discounted 

metro tickets (MONEDERO) at the registration area. 

Please see below the recommended radio taxi companies 

that major hotels work with: 

EL PORTEÑO: +54 11 4566 5777 

PREMIUM: +54 11 4374 6666 

SU TAXI: +54 11 4635 6089 

It is highly recommended that you use only black and yellow taxis or taxi companies that work with leading hotels. 


About the congress Centre La rural 

ADDRESS 

La Rural Convention & Exhibition Centre 


Palermo 


EXHIBItION OPENING HOURS 

Sunday, 18 May, 2008 18.00 – 20.00 

Monday, 19 May, 2008 09.00 – 18.00 

Tuesday, 20 May, 2008 09.00 – 18.00 

Wednesday, 21 May, 2008 09.00 – 18.00 

SESSION ROOMS 

To highlight the international nature of the World Congress 

of Cardiology all session rooms have been named after 

rivers. Session rooms are shown on the WCC 2008 Floor 

Plan on the inside front cover. Please note that seating in 

the session rooms is on a first-come, first-served basis. 

We recommend therefore that you go to the session room 

well before your session begins. Due to safety policies of 

La Rural, the access to the session rooms will be denied 

once the room is filled to its maximum capacity. 

lANGUAGE 

English is the official language of the congress. However, 

a track line presented during the South American Congress 

of Cardiology will be held in Spanish. Simultaneous 

translation (English-Spanish and Spanish-English) will, 

however, be provided in the following rooms: Main 

Auditorium “Rio de la Plata”, Danube and Thames. 

tOBACCO FREE POlICy 

Tobacco smoking is a major cause of preventable early death 

throughout the world. Cigarette smokers have almost double 

the risk of dying from coronary heart disease compared with 

non-smokers. Exposure of non-smokers to environmental 

tobacco smoke is increasingly suspected as being a cause 

of coronary heart disease. 

The World Heart Federation aims to promote the reduction in 

the prevalence of smoking globally. Workplaces, community, 

health care, educational institutions, food industry, health 

professionals and governments are important settings for 

implementing this policy. 

All premises occupied by the World Heart Federation, 

including those that are used temporarily by the World 

Heart Federation, shall be smoke-free. 

The WCC Congress Committees thank all participants and 

exhibitors for not smoking in the Congress Centre “La Rural” 

and its immediate surroundings at all times. 

DISClAIMER 

The Congress organizers will accept no liability for personal 

injuries sustained by, or for loss or damage to property 

belonging to Congress participants, or other unforeseen 

circumstances either during or as a result of the Congress or 

during all tours and activities. It is therefore recommended 

that participants, as well as companies, arrange their own 

personal health, accident and travel insurance property loss, 

damage insurance or any other necessary insurance. ICS 

Congresos Internacionales S.A. and Bounty Travel Service 

act as agents and cannot be held responsible for any loss, 

injury or damage to any person or property whatever the 

cause may be. The liability of persons and companies 

providing means of transportation or other services, 

however, remains unaffected.

egistration 

REGIStRAtION OPENING HOURS 

To collect your badge in the registration area, please bring 

a copy of your letter of confirmation, in order to facilitate the 

process. Participants can register on-site during the following 

opening hours: 

ON-SItE REGIStRAtION OPENING HOURS: 

Saturday, May 17, 2008 15.00 – 18.00 

Sunday, May 18, 2008 09.00 – 18.00 

Monday, May 19, 2008 08.00 – 18.00 

Tuesday, May 20, 2008 08.00 – 18.00 

Wednesday, May 21, 2008 08.00 – 18.00 

FEES 

Registration fees are payable in US Dollars and are inclusive of VAT. 

FEE CATEGORy ON-SITE REGISTRATION FEE 

Standard Fee USD 790 

Technician/Nurse/Trainee a USD 400 

Latin-American and Caribbean Delegate USD 790 

Latin-American and Caribbean Technician/Nurse/Trainee a USD 400 

Argentine Delegate USD 790 

Argentine Technician/Nurse/Trainee a USD 400 

Heart Foundation Professional b USD 400 

Accompanying Person’s Programmme USD 345 c 

a. With a letter of approval from your university or hospital. IMPORTANT 

FOR TRAINEES: Registration will be processed only upon presentation 

of a copy of your degree/licence sent with the registration form 

(5 years maximum since graduation) 

b. With a letter of approval from the World Heart Federation 

c. According to availability 

DElEGAtE REGIStRAtION FEES INClUDE: 

• Congress badge 

• Congress bag with the WCC 2008 Final Programme 

• Full access to the exhibition and scientific sessions 

• Access to the opening ceremony (limited seats available) 

ACCOMPANyING PERSON FEES INClUDE: 

• Access to the exhibition 

• Access to the opening ceremony (limited seats available) 

• Half day city tour, Tigre Delta Cruise and Cultural tour 

• Scientific sessions are not open to accompanying persons. 

AttENtION ItAlIAN DElEGAtES 

Please note that Alijet & Fargo International has been 

authorized to collect and deliver to the department 

of Public Health in Rome, Italy, all application forms 

from these delegates who will attend the WCC 2008. 

Contact: Alijet & Fargo International S.r.l. 

Via Petro Maroncelli 44/46 

50137 Firenze – Italy 

Tel. +39 055 600555 

Fax +39 055 609078 

Contact person: Fawn Sarkisian 

f.sarkisian@fargointernational.it 

registration / 29

egistration 

BADGES 

Participants and accompanying persons are kindly asked to 

wear their badge during all congress activities. Entry will not 

be permitted without a badge. Replacement of lost badges 

incurs an administrative charge of USD 100 (+VAT). 

NAME CHANGES 

Participant names may be changed with a handling fee of 

USD 50 (+VAT) along with a newly completed registration 

form for the replacement participant and with a written 

permission from the original participant that the name 

change has been approved. 

Colour code of badges: Delegate – White 

Accompanying person – Grey 

WCC Exhibitor – Green 

WCC Staff – Red 

WCC Faculty – Orange 

Press – Purple 

VISItOR tRACkING SyStEM 

All active delegate badges contain a bar code, which 

acts as an electronic business card. Participants are 

therefore able to leave their contact details for exhibitors 

very quickly and easily. Please note that group registration 

data is subject to corporate companies completing the 

details of their delegates and whilst WCC encourage this, 

we cannot guarantee the quality of group registrations 

provided by industry. 

Media and press 

The WCC Press Centre is located in the Ocre Pavillion. It will 

be open from 15.00 – 18.00 on 17 May, 08.00 – 20.00 on 

18 May and on the 19, 20 and 21 May, from 08.00 – 18.00, 

or later. A press badge is required to enter this facility. This 

badge also gives access to the scientific sessions. In order to 

be granted a complimentary press badge for the WCC 2008, 

journalists have to register beforehand. Your press badge will 

be available for you to collect on-site at the press registration 

area. To collect your badge you will be asked to show photo 

identification such as a passport, so please have this with you. 

During the Congress you will have the opportunity to learn 

about the latest science advances on the management of 

cardiovascular diseases and to review effective approaches 

to tackling the rising burden of cardiovascular disease 

CANCEllAtION AND REFUNDS 

For cancellations received in writing prior to 15 April, 

2008 the paid registration fee will be reimbursed, less 

a 25% administration fee. No refunds will be issued after 

that date. Reimbursements will be forwarded 60 days 

after the Congress ends. 

CHOICE OF JOURNAlS 

All delegates of the World Congress of Cardiology 2008 are 

eligible to receive a special subscription rate to the following 

journals. Fees stated in USD (US Dollars). 

• Nature Clinical Practice Cardiovascular Medicine Journal 

at USD 50 for a one-year subscription 

• CVD Prevention and Control Journal at USD 50 for 

a one-year subscription 

• Revista Argentina de Cardiologia Journal at USD 50 for 

a one-year subscription 

• Revista de la Federacion Cardiologica Argentina Journal 

at USD 50 for a one-year subscription 

Please find more information on Nature Clinical Practice 

Cardiovascular Medicine and CVD Prevention and Control 

on page 16. 

CERtIFICAtE OF AttENDANCE 

Attendance certificates for delegates can be found in 

each congress bag. 

globally. These include, for example public policy and 

advocacy, the development of the polypill, a focus 

on women and CVD and youth tobacco advocacy. 

The scientific programme will feature globally relevant 

topics in the diagnosis, management and treatment of 

cardiovascular disease, including basic clinical and population 

research. The Scientific Programme includes Symposia, 

Debates How to & Workshop Sessions and Clinical 

Seminars. Around 250 scientific sessions will be presented in 

the main programme, abstract based programme, or 

in one of the special sessions. Another important feature 

of the WCC programme is the Spanish Sessions track. 

Press enquiries should be directed to Victoria Dix 

(victoria.dix@cohnwolfe.com)

visual reproduction policy 

The WCC organizers reserve the right to film all 

presentations during the WCC 2008. Photographing or 

videotaping scientific sessions is not allowed on the WCC 

Congress material 

WCC FINAl PROGRAMME 

Each delegate will receive one copy of the WCC Final 

Programme with their congress bag. Additional copies can 

be purchased in the registration area on the final day of the 

congress, subject to availability, for USD 10 per copy. The 

WCC Final Programme is also available on the WCC 2008 

Website www.worldcardiocongress.org 

WCC PROGRAMME At A GlANCE 

Your copy of the WCC Programme at a Glance is given 

to you with your congress badge. It is your easy instant 

summary of the key scientific programme activities. Once 

you have located a session in the WCC Programme at 

a Glance, refer to the WCC Final Programme for more 

detailed information. 

WCC ABStRACtS 

All abstracts have been published in the online version of 

the official American Heart Association Journal “Circulation”. 

For more information, please visit www.circ.ahajournals.org. 

In addition, all delegates may collect their personal electronic 

copy of these abstracts on CD Rom from the Boehringer 

Ingelheim booth in the exhibition hall. To collect your free 

copy, please go to their booth with your voucher which you 

will find in your congress bag. 

The WCC would like to thank Boehringer Ingelheim for their 

financial support towards the production and distribution of 

the abstract CD Rom. 

Farbe/colour: 

PANTONE 288 CV 

congress site, except with specific prior permission 

of the WCC organizers. 

WEBCAStS 

Certain official WCC 2008 Scientific Sessions will 

be webcasted by Prous Science. These sessions 

will be accessible on the WCC Congress website 

www.worldcardiocongress.org approximately one 

week after the congress. 

WCC 2010 FIRSt ANNOUNCEMENt 

Please come and see the World Heart Federation booth 

on Wednesday, 21 May in order to retrieve the First 

Announcement for the next WCC in 2010. 


WCC on-site services 

CyBER CORNER 

Internet access will be provided at selected locations 

throughout the congress venue. They can be used by all 

delegates free of charge for a limited time period to access 

the internet. 

BUSINESS CENtRE 

Printing, copying and other office requirements can be handled 

at the business centre located within the exhibition area. 

MOBIlE PHONES 

For mobile phone rentals, please visit www.phonerental.com.ar 

or refer to page 33. 

FIRSt AID 

Delegates in need of medical treatment should contact 

the First Aid Point located near the registration area. 

ClOAkROOMS 

Cloakroom service for clothing and reasonable-sized items 

is available during the opening hours of the congress in the 

exhibition hall. There will be a daily charge of ARS 5 or USD 

2 for each item left in the cloakroom. Valuable items should 

not be left in the cloakroom. Please ensure to collect all your 

belongings at the end of the day. 

FOOD AND BEVERAGE OUtlEtS 

Please refer to the map to locate different food and beverage 

points throughout the congress venue. All food and beverage 

facilities will be open during the day to serve drinks, snacks 

and lunch. Payments can be made by cash (in ARS and USD) 

or credit card. 

lOSt AND FOUND 

A lost and found office will be available for delegates. 

ContACt inForMAtion 

REGIStRAtION, ACCOMMODAtION, SPONSORSHIP 

(lOCAl AND lOGIStICS), tOURISM AND SOCIAl EVENtS 

ICS Congresos Internacionales S.A. 

C. C. (P. O. Box) 73, C1084ZAA, Buenos Aires, Argentina 

Phone: +54 11 4812 3444 

Fax: +54 11 4813 0073 

E-mail: wcc2008@congresosint.com.ar 

Registration 

wcc2008registration@congresosint.com.ar 

Accommodation 

wcc2008accommodation@congresosint.com.ar 

HOtEl INFORMAtION DESk/GAlA DINNER 

AND tOURS DESk 

Desks for information about hotels, Gala dinner ticket sales 

and tours will be located in the registration area. 

MESSAGE CENtRE 

A message centre will be located behind the Amazon Room. 

It can be used by all delegates free of charge for leaving 

messages for other delegates. 

INFO POINtS 

WCC info points are located throughout the congress 

centre. Please refer to the WCC 2008 Floor Plan on the 

inside front cover for their exact location. 

PARkING 

Underground parking can be accessed 24 hours from two 

different entrances: via the Sarmiento Avenue and via the 

Cerviño Street. Approximately 1,000 cars can be parked 

at the La Rural Congress Venue. 

The following rates will apply: 1 hour – USD 2.50, 

12 hours – USD 12, 24 hours – USD 15. 

FUtURE EVENtS BOOtH 

In order to share knowledge and make you aware of other 

national and international cardiology congresses, please 

make sure to drop by the future events booth in the 

exhibition hall. 

tRANSPORt FOR DISABlED PERSONS 

Special transport facilities within La Rural will be provided 

for disabled persons. 

SCIENtIFIC PROGRAMME 


7 Rue des Battoirs, CP 155 

1211 Geneva 4, Switzerland 

Phone: + 41 22 807 0320 

Fax: + 41 22 807 0337 

science@worldheart.org 

www.worldcardiocongress.org

soCiAL ProgrAMMe 

WCC 2008 opening Ceremony 

Sunday, 18 May, 2008 – 18.00 – 20.00 – Rio de la Plata, 

Red Pavillion, La Rural Congress – Exhibition Centre 

(Overflow in meeting rooms of the Yellow Pavillion) 

Opening speeches by: 

Horacio Faella, Shahryar Sheikh, Sidney Smith, 

Felipe Martínez, Arturo Cagide, Eduardo Mele, Luiz Guzman 

and Argentine authorities 

WCC 2008 opening reception 

Sunday, 18 May, 2008 at 20.30 – Room Libertador, 

Sheraton Buenos Aires Hotel, San Martin 1225/1275, 

Retiro, Buenos Aires 

Entrance by invitation only 

WCC 2008 gala dinner 

Tuesday, 20 May, 2008 at 20.00 – Hilton Buenos Aires, 

Macacha Guemes 351, Puerto Madero, Buenos Aires 

Access to the WCC 2008 Gala Dinner requires an invitation 

or a pre-purchased ticket. Your tickets can be collected from 

the registration area from Sunday, 18 May, 2008 from 10.00. 

Also enjoy a unique Argentine tango performance! 

Buses will depart from the La Rural main entrance 

(Sarmiento Avenue) immediately after the 

Opening Ceremony 

Dress code: Smart casual, please wear something red 

Buses will depart from the Sheraton Buenos Aires Hotel 

(San Martin Avenue) as of 19.00 up to 19.30 

Dress code: Business attire

WCC 2008 CoMMunity ACtivities 

In celebration of the World Congress of Cardiology, 

there are several public events that will run in parallel 

to the Congress. 

These will be coordinated by the Argentine Foundation of 

Cardiology and the CARDIO Foundation who are pleased 

to propose the following activity programme. All of the 

activities are intended for the community and you are 

invited to join in. 

On Saturday, May 17, 2008 between 9.00 and 18.00 

mass group CPR courses are planned in the park located 

on Av. Sarmiento and Av. Del Libertador, close to 

“Monumento a los Españoles”. 

There will be 40-minute courses running throughout the day 

– allowing attendees to be trained in Basic Cardiopulmonary 

Resuscitation procedures. The activity will be carried out in 

a 200m 2 tent and the aim is to make people aware of the 

importance of knowing the proper basic Cardiopulmonary 

Resuscitation procedures in case of an emergency situation. 

(Registration: Argentine Foundation of Cardiology 

info@fundacioncariologica.org - +54 11 4961 6520/9388) 

On Sunday, May 18, 2008 the Argentine Foundation of 

Cardiology and the Cardio Foundation are organizing a 10 km 

competitive run and 3 km aerobic walk at the Bosques de 

Palermo. These activities will take place from 9.00 – 13.00. 

The run is expected to gather approximately 3,000 

professional runners and the walk about 7,000 people. 

The aim is to promote the importance of physical exercise 

in order to prevent cardiovascular disease and to improve 

the quality of life whilst developing healthy habits from an 

early age and maintaining them throughout your life. 

The general goal of these activities is to spread the 

importance of preventing cardiovascular diseases to 

the Argentine community, as prevention is one of the 

major topics being discussed during the World Congress 

of Cardiology. 

On Tuesday, May 20, 2008 visit the Thematic tent at Plaza 

de la República (Obelisco) from 09.00 – 18.00. There will 

be arterial pressure, waistline, cholesterol and glycemia 

measurements, with leaflets and brochures containing 

general tips. 

There will also be a press area, with armchairs and a backpanel 

with logos of the societies involved. The media 

are invited to cover the activity so as to get a strong 

understanding of the themed agenda. 

Material for this activity has included donations from 

laboratories: lancets and reagents for cholesterol control, 

stethoscopes, tape measure and scales for determining BMI. 

Media: Press releases, information and invitations for all 

means of communication: press, radio and television. 

Publicity, promotional material and flyers have been sent 

by e-mail to both foundations’ data bases. 

WCC 2008 Community Activities / 35

ABout ArgentinA & Buenos Aires 

ABOUt ARGENtINA 

Argentina has a wealth of natural beauty and immensely 

varied scenery. It covers an area of over 1 million square 

miles and is the second largest country in South America. 

In the north there are the hot Chaco grasslands and tropical 

jungle and in the south the Antarctic ice of Tierra del Fuego. 

A visit to Iguazu Falls, the largest and most extensive in 

the world, can be combined with a horseback ride on 

the Pampas, whale watching in the south, a visit to the 

amazing Moreno glacier and the capital, Buenos Aires. 

VISItING BUENOS AIRES 

The cultural capital of South America, Buenos Aires, is 

located on the eastern banks of the River Plate, the largest 

river in the world. The city has a cosmopolitan atmosphere, 

although being a modern city; it includes turn-of-thetwentieth-century 

European style buildings. It also has 

some well preserved districts of typical colonial architecture. 

Buenos Aires inhabitants are called “porteños” which 

makes reference to the fact that the city is a port. 

Buenos Aires has everything to transform your visit 

into a wonderful experience. 

We strongly recommend that you make reservations 

in advance with Bounty Travel, as availability for tours is 

limited. Further information about Bounty Travel Tours 

and reservations can be found either at www.bts.com.ar 

or at the tours information desk in the registration area. 

ClIMAtE 

The climate of Buenos Aires is mild all year round. 

The mean annual temperature is 18ºC. Visitors can enjoy 

walking around the city in any season. On a sunny day 

in autumn, mornings are chilly; the temperature rises at 

mid-day and drops again at night. The average temperature 

for May is 12°C. 

lANGUAGE 

The official language in Argentina is Spanish and many locals 

also easily understand Italian and Portuguese. However, 

most people involved in tourist activities speak English. 

tIME DIFFERENCE 

The time zone corresponds to GMT-3. 

BANkS, CURRENCy AND CREDIt CARDS 

Banks open at 10.00 and close at 15.00 (some banks 

extend their closing time to 16.00). Cash withdrawals and 

other transactions may be made at ATMs, 24 hours a day. 

The tourist subsidiary of Banco Ciudad offers this service 

to visitors. You can buy and sell US dollars, Euros and 

travellers’ cheques: 

Tuesdays to Fridays from 10.00 – 17.00; 

Saturdays and Sundays from 11.00 – 16.00; 

Mondays from 10.00 – 18.00. 

Cashiers are tourist exclusive. 

The Argentine currency is the peso ($). There are $ 100, 

$ 50, $ 20, $ 10, $ 5 and $ 2 notes, and 1 peso, 50, 25, 

10 and 5 cent coins. 

The U.S. dollar (USD) is the most common foreign currency. 

Banks and currency exchange offices (casas de cambio), 

where you must present your passport, exchange foreign 

currency. Most of the shops accept credit cards and 

dollars but it is more convenient to pay by cash with pesos 

exchanged in casas de cambio or banks. 

ElECtRICAl POWER 

Electric power in Argentina is 220 volt, 50-cycle alternating 

current. Power outlets have two cylindrical holes or two flat 

holes with ground connection. 

SECURIty 

Buenos Aires has the reputation of being a safe city but, 

as in any other large cities in the world, tourists should 

take sensible precautions. 

tOURISM POlICE DEPARtMENt 

In case of an emergency please call 0800 999 5000 or 

+54 11 4346 5748 or contact turista@policiafederal.gov.ar 

English, Italian, French, Portuguese, Ukrainian, Japanese 

and Spanish are the available languages.

ABout ArgentinA & Buenos Aires 

MAkING PHONES CAllS 

Buenos Aires has many public telephone booths. Public 

phones operate with 5, 10, 25, 50-cent and 1-peso coins. 

Phone cards can be bought at any sweet or tobacco 

stalls (quiosco). These phones allow local, national and 

international calls. 

For international calls, dial 00 + country code + area code 

+ local number. 

The country code for Argentina is 54, and the area code for 

Buenos Aires is 11. For example, to call to 4333-6666 from 

outside the country, you should dial +54 11 4333 6666. 

USEFUl PHONE NUMBERS 

• Police: 101 

• Fire: 100 

• Medical assistance/Emergencies: 107 

• Telephone enquiries: 110 

• Ezeiza International Airport and Jorge Newbery Airport: 

+54 11 5480 6111 

OPENING HOURS 

Shops are open from Monday through Fridays from 9.00 – 

20.00, and Saturdays from 9.00 –13.00; however, shops in 

main locations are also open on Saturday afternoons. 

In shopping centres, hours usually extend until 20.00, 

including Saturdays and Sundays. 

lEAVING ARGENtINA 

The VAT rate in Argentina is 21%. As a foreign visitor, you 

have the right to a refund of the value-added tax included in 

the price of the articles you export to your country. At the 

airport you may obtain a VAT reimbursement corresponding 

to any purchases made within the country for an amount 

over $70 (per invoice) and in shops operating with the Global 

Refund system. 

Please note that your airport tax which is often 

included in your booking fee may not be included 

because of Argentinean regulations. you may be 

asked to pay this in cash at the airport as you are 

passing through security. 

About Argentina & Buenos Aires / 37

tours 

HAlF DAy CIty tOUR 

Half day tour around South America’s most elegant capital, 

Buenos Aires. On the way you will see Plaza de Mayo and 

the buildings that surround it: Casa Rosada (Government 

House), Cabildo Old City Hall, the bustling banking and 

business district. Then on to see the monumental Congress 

Building and its square and along 9 de Julio Ave., the widest 

in the world, the Colon Theatre, the famous Opera House 

where the most important artists and musicians from all over 

the world perform. You will also visit San Telmo, la Boca, and 

its picturesque street “Caminito”, Puerto Madero, Palermo 

Park with Jacaranda and Palo borracho trees which flower in 

spring and late summer, the polo field and the race track and 

the historical Recoleta Cementery with its ornate memorials. 

Price per person USD 22* 

tIGRE & DEltA CRUISE 

Drive through the fashionable riverside suburbs of Olivos, 

San Isidro, San Fernando to the Tigre district, with its 

gracious homes, weeping willows, open air restaurants and 

cafes. With its assorted food vendors and soap-box politics, 

this is the preferred “playground of the porteños”. Board 

the ‘Tren de la Costa’ – the Coastal Train – modern train on 

the old suburban railway line which runs along the coast of 

the Rio de la Plata towards the delta of the river. All stations 

have been renovated, keeping the original buildings built 

by the British. Drive then to San Isidro where a stop will be 

arranged. Cruise along the waterways and islands of the 

delta and past "turn-of-the century" stone mansions, English 

cottages, Italian villas, little wooden shacks painted bright 

blue and green, ferries, crews practicing in outriggers, lonely 

canoeists, rowing and yacht clubs. You will enjoy a cruise 

along innumerable channels before returning to town. 


CUltURAl tOUR – MUSEUMS 

The cultural heritage in Buenos Aires is ever increasing. This 

tour is a selection of the best art collections of the city. First 

you will go to the institutional centre, the Fine Arts National 

Museum. Once you have visited the new and magnificent 

museum of Latin American modern and contemporary art 

(MALBA, Costantini Collection), you will go to the tiny and 

excellent Xul Solar Museum that holds the best works 

of some of the most prestigious Argentinean artists. 


FUll DAy FIEStA GAUCHA 

This tour is the ideal opportunity to absorb the atmosphere 

of country life at a really colourful Argentine feast in the 

Pampas. Lunch with renowned Argentine beef and live 

entertainment by “Gauchos” in their typical dress, dancing 

to folklore music, will make this a memorable day. 

Price per person USD 112 

*The accompanying person’s programme includes the 

following local tours: 

– Half day City Tour 

– Tigre & Delta Cruise 

– Cultural Tour 

Please note that the Fiesta Gaucha Tour is not included. 

People not participating in the accompanying persons programme 

will have to pay for all tours. 

Tour schedule for Monday, Tuesday and Wednesday 

tOUR tIME COSt PER 

PERSON 

Half day city tour 10.30 – 14.30 USD 22 

Tigre and Delta Cruise 10.30 – 15.30 USD 45 

Cultural tour 10.30 – 14.30 USD 55 

Fiesta Gaucha (Full Day) 09.00 – 17.00 USD 112 

We strongly recommend that you make reservations in 

advance as availability for tours is limited. Further information 

about the Bounty Travel Tours and their reservation can be 

found either at www.bts.com.ar or at the tours information 

desk in the registration area.

SIZING UP THE 

HEART-HEALTHY FACTS 

WE’RE THE SNACK THAT 

LOVES HEARTS BACK 

It may be news to some, but we’ve known 

for a long time what a huge 

difference a handful of 

California Almonds can 

make. From being 

good for your heart 

to staving off hunger 

to getting a nutrientrich 

boost, eating 

23 almonds every 

day (an ounce to 

be exact) is a hearthealthy 

habit everyone 

should develop. 

WE’RE 

CHOLESTEROL- 

F IGHTING DYNAM OS 

All nine clinical studies conducted 

to date indicate that almonds lower 

cholesterol. These groundbreaking 

studies show how a handful of almonds a day 

consistently lowered LDL cholesterol levels.* 

And because people love eating them, almonds 

are an ideal way for cholesterol-conscious patients to 

maintain healthy numbers. If you’ve got time, these 

clinical studies make fascinating reading. In fact, 

when the FDA read the research, 

it influenced their first Qualified 

Health Claim for nuts: 

“Scientific evidence suggests but does not prove 

that eating 1.5 ounces per day of most nuts, such 

as almonds, as part of a diet low in saturated fat 

and cholesterol may reduce the 

risk of heart disease.” 

The case for 23 almonds a day. 

width: 10mm 

height: 20mm 

{ Fig. 1a: Prunus dulcis } 

weight: 1/23 oz 

AlmondsAreIn.com 

OUR GOOD FATS 

RUN D EEP 

Good things happen when you get 

good fats. And with 9 grams of 

monounsaturated fat per 

serving, we’re full 

of it. In fact, nearly 

70 percent of the 

fat in almonds is 

monounsaturated, 

making us one of 

the leading sources 

among nuts. 

NUTRIENT 

R I C H & E X T R A 

CRUNCHY: 

A TEM PTING 

COM BINATION 

Ounce for ounce almonds are one 

of the most nutrient-rich nuts around. 

We’d list them all if we had more room. 

But if you’re looking for a tasty snack 

that’s an excellent source of three dietary 

nutrients, a good source of three and has 

3 grams of fiber, 6 grams of protein per serving while 

packing a heck of a crunch, then we’re your nut. 

COM E VISIT 

To learn more about almond 

nutrition research and taste the appeal 

of almonds, visit the Almond Board 

of California at booth number 271. 

*Find more information at 

www.AlmondsAreIn.com/9studies

�� 

�� 

Workshop Sess�on 

Objectives 

To understand today’s role of catheter ablation in 

patients with atrial fi brillation 

To realize the benefi t of continuous remote monitoring 

in these patients 

To be familiar with the design of the CASTLE-AF trial 

for heart failure patients with atrial fi brillation 

Date 

Tuesday, May 20th, 12:45 – 13:30 

Speakers 

Sergio Dubner, MD Professor 


Johannes Brachmann, MD Professor 

Coburg, Germany 

Location 

Room Niger 

La Rural Convention Center 


Buenos Aires

sPonsorsHiP And exHiBition 

ACkNOWlEDGEMENtS 

The World Congress of Cardiology Buenos Aires 2008 

organizers, the World Heart Federation, the Argentine 

Society of Cardiology and the Argentine Federation of 

Cardiology, would like to thank all participating organizations 

for their commitment to the World Congress of Cardiology 

2008. This summary overview is correct at time of going to 

press (17 April, 2008). 

EXHIBItION OPENING HOURS 

Please come and visit the WCC Exhibition in the Blue/Green 

Pavillion during the following opening hours and discover the 

wealth of new devices and pharmaceutical products present: 

Sunday, 18 May, 2008 18.00 – 20.00 

Monday, 19 May, 2008 09.00 – 18.00 

Tuesday, 20 May, 2008 09.00 – 18.00 

Wednesday, 21 May, 2008 09.00 – 18.00 

sponsorship and exhibition information / 41

List of exhibitors in alphabetical order 

3M 221 

Abbott Laboratories 229 

Aché Laboratorios Farmaceuticos S.A 210 

Almond Board of California 271 

Aloka Co. Ltda. (represented in Argentina by 

Hittec) 

270 

American College of Cardiology 121 

American Heart Association 

ANMAT (Dirección Nacional de 

Medicamentos, Alimentos y Tecnología 

Médica) 

123A+123B+ 

124A 

138B 

Aplicaciones Médicas 113 

Argentine Federation of Cardiology (FAC) 313A 

Argentine Society of Cardiology (SAC) 315A 

Astra zeneca 309 and 181 

Baptist Health International Center of Miami 108B 

Bayer Schering Pharma AG 302 

Biolab Farmaceutica Ltda 254 

Biosite - an Inverness Medical Company 257 

Biotronik 301 

Boehringer Ingelheim GmbH 306 

Bolivian Society of Cardiology 136B 

Bonus Comunicaciones S.R.L 177 

Boston Scientific 212+214+252 

Brazilian Society of Cardiology 128 

C2C -The eHealth Company 102 

Cambridge Theranostics Ltd. 137B 

Cardiology Management 164 

Cardiotek Bv. 255 

Chinese Society of Cardiology 114B 

Colegio Argentino de Cardiologos 

Intervencionistas 

140 

Colgate 194B 

Colombian Society of Cardiology 138A 

Congreso Internacional de Medicina Interna 

del Hospital de Clínicas 

106 

Content Ed Net Communications 139A 

Cortex Biophysik GmbH 206 

CSL Behring S.A. 183 

CVD Prevention and Control Journal 

(Elsevier) 

186+188 + 215 

Daichii Sankyo Brazil Farmaceutica Ltda 307 

Dasani 217 

Diagnóstico Maipú por Imágenes S.A. 101 

Digimed S.A. 105 

Distribuna Editorial y Libreria Medica 162 

Driplan 103 

Ecuadorian Foundation of Cardiology 108A 

Ecuadorian Society of Cardiology 108A 

Edan Instruments, Inc. 236 

Ediciones Journal 194A 

Editorial Médica Panamericana 142A 

Editorial Mediterráneo Argentina 195B 

Ekosur S.A. 200 

Esaote Latinoamérica S.A. 211 

European Society of Cardiology 119 

Feas Electrónica 160 

Fundación Favaloro 134B 

Fundación Rusculleda / DAMIC SRL 163 

Future events 199 

Galix Biomedical Instrumentation 204 

GE Healthcare 219+243+244 

Gedic - Grupo de Estudio, Docencia e 

Investigacion Clinica 

205 

GlaxoSmithKline 230 

Granix 110 

Griensu S.A. 207 

Hittec Medical S.A. 270 

Hospital Alemán 238 

Instramed 161 

InterAmerican Society of Cardiology 124B 

International Federation of Pharmaceutical 

Manufacturers & Associations (IFPMA) 

141A 

Iroko Cardio, LLC 179 

ISCP (International Society on Cardiovascular 

Pharmacotherapy) 

ISHNE (International Society of Holter and 

Noninvasive Electrocardiology) 

107B 

126

List of exhibitors in alphabetical order 

IVAX Argentina 201 

Janssen-Cilag Farmaceutica 197 

Japanese Circulation Society 130B 

Jota Tec S.A. 262 

Karger AG 141B 

Laboratorio Baliarda S.A. 265 

Laboratorios Bagó S.A. 316 

Laboratorios Bernabó S.A. 272 

Laboratorios Casasco S.A.I.C. 269 

Laboratorios Elea S.A. 242 

Laboratorios Gador S.A. 317 

Laboratorios Lazar 237 

Laboratorios Phoenix S.A.I.C.F. 203 

Laboratorios Roemmers S.A.I.C.F. 318 

Latin American Society of Interventional 

Cardiology (SOLACI) 

114A 

Libreria AKADIA Editorial 143A 

Libyan Cardiac Society 134A 

Lilis S.A. 259 

McGraw-Hill Education 143B 

Medispec 104 

Medley S.A Ind. Farmaceutica 250 

Menarini International Operations 

Luxembourg S.A. 

216+249 

Merck KGaA 247+248 

Merck Sharp & Dohme 245+246 

Methabolic Syndrome Institute 264 

Mexican Society of Cardiology 112A 

Microlife uSA 232 

Micromed 206 

Ministerio de Turismo de la Prov. de Salta 167 

Molinos Rio de la Plata S.A. 175 

Nature Clinical Practice Cardiovascular 

Medicine (Nature publishing Group) 

186+188+ 215 

Novartis Pharma 303 

Numed (Omnimédica Argentina) 202 

Omron Healthcare, Inc 222 

Oxford Journals | Oxford university Press 142B 

Paraguay Society of Cardiology 136A 

PCNA (Preventive Cardiovascular Nurses 

Association) 

107A 

Pfizer 148+189 

Pfm Medical 159 

Philips Healthcare 266+267+268 

Polymer Technology Systems, Inc 263 

Productos Roche S.A. 180 

Prous Science 260 

Quaker – a PepsiCo Group Company 145 

Raffo S.A. 253 

Rozinn by Scottcare 116 

Sanofi-aventis 157+182 

Schiller 218+220 

Siemens 198 

Slovenian Society of Cardiology 112B 

Solvay Pharmaceuticals GmbH 

153+ 185+ 151+ 

187 

South American Society of Cardiology 130A 

Spacelabs Healthcare 103 

Spanish Society of Cardiology 118+115 

St Jude Medical 310 

Taiwan Society of Cardiology 132 

Tecnoimagen-Sonosite 233+239 

unilever 150 

upTo Date 144 

Veccsa 231 

Vitaphone GmbH 184 

V-Patch Medical Systems 195A 

Welch Allyn, Inc. 117 

Wiley-Blackwell 137A 

Wolters Kluwer 139B 

World Heart Federation 186+188+ 215 

World Point 111 

youth for Smoke Free Environments 258 


List of exhibitors by booth number 

101 Diagnóstico Maipú por Imágenes S.A. 

102 C2C -The eHealth Company 

103 Driplan 

103 Spacelabs Healthcare 

104 Medispec 

105 Digimed S.A. 

106 

110 Granix 

Congreso Internacional de Medicina Interna del Hospital 

de Clínicas 

111 World Point 

113 Aplicaciones Médicas 

115 Spanish Society of Cardiology 

116 Rozinn by Scottcare 

117 Welch Allyn, Inc. 

118 Spanish Society of Cardiology 

119 European Society of Cardiology 

121 American College of Cardiology 

126 

ISHNE (International Society of Holter and Noninvasive 

Electrocardiology) 

128 Brazilian Society of Cardiology 

132 Taiwan Society of Cardiology 

140 Colegio Argentino de Cardiologos Intervencionistas 

144 UpTo Date 

145 Quaker – a PepsiCo Group Company 

148 Pfizer 

150 Unilever 

151 Solvay Pharmaceuticals GmbH 


157 Sanofi-aventis 

159 Pfm Medical 

160 Feas Electrónica 

161 Instramed 

162 Distribuna Editorial y Libreria Medica 

163 Fundación Rusculleda / DAMIC SRL 

164 Cardiology Management 

167 Ministerio de Turismo de la Prov. de Salta 

175 Molinos Rio de la Plata S.A. 

177 Bonus Comunicaciones S.R.L 

179 Iroko Cardio, LLC 

180 Productos Roche S.A. 

181 Astra Zeneca 

182 Sanofi-aventis 

183 CSL Behring S.A. 

184 Vitaphone GmbH 


186 CVD Prevention and Control Journal (Elsevier) 

186 

Nature Clinical Practice Cardiovascular Medicine 

(Nature publishing Group) 

186 World Heart Federation 


188 CVD Prevention and Control Journal (Elsevier) 

188 




189 Pfizer 

197 Janssen-Cilag Farmaceutica 

198 Siemens 

199 Future Events 

200 Ekosur S.A. 

201 IVAX Argentina 

202 Numed (Omnimédica Argentina) 

203 Laboratorios Phoenix S.A.I.C.F. 

204 Galix Biomedical Instrumentation 

205 

Gedic - Grupo de Estudio, Docencia e Investigacion 

Clinica 

206 Cortex Biophysik GmbH 

206 Micromed 

207 Griensu S.A. 

210 Aché Laboratorios Farmaceuticos S.A 

211 Esaote Latinoamérica S.A. 

212 Boston Scientific 


215 CVD Prevention and Control Journal (Elsevier)


215 




216 Menarini International Operations Luxembourg S.A. 

217 Dasani 

218 Schiller 

219 GE Healthcare 

220 Schiller 

221 3M 

222 Omron Healthcare, Inc 

229 Abbott Laboratories 

230 GlaxoSmithKline 

231 Veccsa 

232 Microlife USA 

233 Tecnoimagen-Sonosite 

236 Edan Instruments, Inc. 

237 Laboratorios Lazar 

238 Hospital Alemán 

239 Tecnoimagen-Sonosite 

242 Laboratorios Elea S.A. 



245 Merck Sharp & Dohme 

246 Merck Sharp & Dohme 

247 Merck KGaA 

248 Merck KGaA 

249 Menarini International Operations Luxembourg S.A. 

250 Medley S.A Ind. Farmaceutica 


253 Raffo S.A. 

254 Biolab Farmaceutica Ltda 

255 Cardiotek Bv. 

257 Biosite - an Inverness Medical Company 

258 Youth for Smoke Free Environments 

259 Lilis S.A. 

260 Prous Science 

262 Jota Tec S.A. 

263 Polymer Technology Systems, Inc 

264 Methabolic Syndrome Institute 

265 Laboratorio Baliarda S.A. 

266 Philips Healthcare 



269 Laboratorios Casasco S.A.I.C. 

270 Aloka Co. Ltda. (represented in Argentina by Hittec) 

270 Hittec Medical S.A. 

271 Almond Board of California 

272 Laboratorios Bernabó S.A. 

301 Biotronik 

302 Bayer Schering Pharma AG 

303 Novartis Pharma 

306 Boehringer Ingelheim GmbH 

307 Daichii Sankyo Brazil Farmaceutica Ltda 

309 Astra Zeneca 

310 St Jude Medical 

316 Laboratorios Bagó S.A. 

317 Laboratorios Gador S.A. 

318 Laboratorios Roemmers S.A.I.C.F. 

107A PCNA (Preventive Cardiovascular Nurses Association) 

107B 



108A Ecuadorian Foundation of Cardiology 

108A Ecuadorian Society of Cardiology 

108B Baptist Health International Center of Miami 

112A Mexican Society of Cardiology 

112B Slovenian Society of Cardiology 

114A 

Latin American Society of Interventional Cardiology 

(SOLACI) 

114B Chinese Society of Cardiology 

123A American Heart Association 

123B American Heart Association 



124A American Heart Association 

124B InterAmerican Society of Cardiology 

130A South American Society of Cardiology 

130B Japanese Circulation Society 

134A Libyan Cardiac Society 

134B Fundación Favaloro 

136A Paraguay Society of Cardiology 

136B Bolivian Society of Cardiology 

137A Wiley-Blackwell 

137B Cambridge Theranostics Ltd. 

138A Colombian Society of Cardiology 

138B 

ANMAT (Dirección Nacional de Medicamentos, 

Alimentos y Tecnología Médica) 

139A Content Ed Net Communications 

139B Wolters Kluwer 

141A 



141B Karger AG 

142A Editorial Médica Panamericana 

142B Oxford Journals | Oxford University Press 

143A Libreria AKADIA Editorial 

143B McGraw-Hill Education 

313A Argentine Federation of Cardiology 

315A Argentine Society of Cardiology

exHiBition FLoor PLAn 

B 

C 

MAIN ENTRANCE FROM 

PUBLIC TRANSPORT AND SHUTTLE BUS 

A 

SUITES 

D 

104 

106 

107 

A 

107 

B 

108 

A 

108 

B 

112 

A 

112 

B 

114 

A 

114 

B 

115 

118 

POSTER HELP DESK 

119 

121 

123 

A 

123 

B 

124 

A 

124 

B 

126 

128 

130 

A 

130 

B 

POSTER AREA HOSPITALITY 

132 

134 

A 

134 

B 

136 

A 

136 

B 

138 

A 

138 

B 

140 

103 102 101 

105 

110 167 

111 165 

113 163 

164 175 

164 177 

B B 

162 177 

160 179 

159 

157 182 

155 184 

229 230 

@ 

161 116 

117 

180 222 

181 220 

183 218 

153 185 186 

151 187 

150 

148 189 

145 

141 

137 

A 

A 

137 

B 

139 

B 

139 

A 

141 

B 

142 

B 

144 

142 143 

A A 

143 

B 

188 215 

192 210 

206 197 

CLOAK 

ROOMS 

194 195 

A A 

194 195 

B B 

231 

228 232 

225 236 

238 237 

219 

217 

221 

216 249 

214 

212 

252 

243 

248 

207 257 

205 

244 

247 

FUTURE 

EVENTS 

LOST 

AND 

FOUND 

233 239 

242 

211 215 

198 

204 

203 

250 

245 

246 

255 260 

258 

253 

202 

262 

259 

200 

201 

263 

264 

265 266 267 268 269 270 271 272 

@ 

306 

315 

A 

316 

REGISTRATION 

303 302 301 

307 

313 

A 

BUSINESS CENTER 

MAIN ENTRANCE FROM THE PARKING 

309 310 

MEETING POINT 

317 318 

ENTRANCE FROM SESSIONS, WORKSHOPS 

AND SYMPOSIA ROOMS 

exhibition floorplan / 47

exHiBitors’ And sPonsors’ editoriAL Listing 

3M 

Olga Cossettini 1031 

Buenos Aires C1107CEA 

ARGENTINA 

www.3m.com 

Booth 221 

Abbott Laboratories 

200 Abbott Park Road 

Abbott Park, IL 60064 

UNITED STATES 

Abbott is a global, broad-based healthcare company devoted 

to the discovery, development, manufacture and marketing 

of pharmaceuticals and medical products. 

www.abbott.com 

Booth 229 

Aché Laboratorios Farmaceuticos S.A 

BRAZIL 

www.ache.com.br 

Booth 210 

Almond Board of California 

1150 9th Street 

Suite 1500 

Modesto, CA 95354 

UNITED STATES 

www.almondsarein.com 

The Almond Board of California, a Federal Marketing 

Order under the United States Department of Agriculture, 

promotes the best quality almonds. 

Booth 271 

Aloka Co. Ltda. (represented in Argentina by Hittec) 

JAPAN 

www.aloka.com 

See Hittec 

Booth 270 

American College of Cardiology 

2400 N Street NW 

Washington DC, VA 

UNITED STATES 

www.acc.org 

ACC will launch Cardiosource en Espanol, an 

online cardiovascular information resource, and offer 

information about ACC membership opportunities and 

educational products. 

Booth 121 


7272 Greenville Avenue 

Dallas, TX 75231-4596 

UNITED STATES 

www.heart.org 

The American Heart Association offers the latest information 

on cardiovascular and stroke research. Pick up free 

CD-ROMs: Core Collection 2008 & Scientific Sessions 

Abstracts. Receive information on Emergency Cardiovascular 

Care, Professional Membership, Scientific Publications, 

Get With the Guidelines, Patient Education and more. 

Booth 123A+123B+124A 

ANMAT (Dirección Nacional de Medicamentos, 

Alimentos y Tecnología Médica) 

ARGENTINA 

www.anmat.gov.ar 

Booth 138B 

Aplicaciones Médicas 

Cnel Rosetti 2264 

Olivos 

Buenos Aires 

ARGENTINA 

www.aplimed.com.ar 

Booth 113 

Argentine Federation of Cardiology (FAC) 

Bulnes 1004 

C1176ABT 

Buenos Aires 

ARGENTINA 

www.fac.org.ar 

Booth 313 A 

Argentine Society of Cardiology (SAC) 

Azcuenaga 980 (C1115AAD) 

Buenos Aires 

ARGENTINA 

www.sac.org.ar 

Booth 315 A 

Astra zeneca 

R&D MöIndal 

SE 43183 MöIndal 

SWEDEN 

www.astrazeneca.com 

Tel: +46 31 7761000 - Fax: +46 31 7763806 

Web sites: www.incirculation.net www.astrazeneca.com 

AstraZeneca is one of the world’s leading research-based 

pharmaceutical companies. Our mission is to develop 

innovative and effective new medicines that fulfil unmet 

medical needs in important areas of healthcare. 

Booth 309 and 181


Baptist Health International Center of Miami 

Miami, FL 

UNITED STATES 

Booth 108B 

Bayer Schering Pharma AG 

BU Primary Care 

S101,9,120 

Muellerstrasse 179 

13353 Berlin 

GERMANY 

www.bayerhealthcare.com 

Booth 302 

Biolab Farmaceutica Ltda 

Av Do cafe, 277 

7 Andar 

Torre B (04311-900) 

Sao Paolo 

BRAZIL 

www.biolabfarma.com 

Booth 254 

Biosite - an Inverness Medical Company 

21 Rue Albert Calmette 

78350 Jouy en Josas 

FRANCE 

www.biosite.com 

Inverness Medical is a world leader in diagnostic products 

to assist laboratory and healthcare professionals in both 

preventative and interventional medicine, providing 

qualitative and quantitative results. Our focus is in the broad 

clinical fields of Women’s Health, Blood Born Pathogens, 

Oncology, Drugs of Abuse, Respiratory-Infectious Disease 

and Cardiology. Visit us Booth 257 to discover our product 

portfolio. 

Booth 257 

Biotronik 

Woermannkehre 1 

12359 Berlin 

GERMANY 

www.biotronik.com 

BIOTRONIK® is a leading European company in the 

field of biomedical technology. We focus on devices for 

electrotherapy of the heart and for vascular intervention. 

Our products help physicians to save lives and to improve 

their patients’ quality of life. For further information, please 

visit our booth 301 in the main exhibition hall. 

Booth 301 

Boehringer Ingelheim GmbH 

Binger Strasse 173 

55216 Ingelheim am Rhein 

GERMANY 

www.boehringeringelheim.com 

Booth 306 

Bolivian Society of Cardiology 

Avenida Saavedra 1983 

edificio Italia (Mezaninne) 

Barrio Miraflores 

La Paz 

BOLIVIA 

www.bago.com.bo 

Booth 136B 

Bonus Comunicaciones S.R.L 

Fonrouge 1561 

c1440CYO 

Buenos Aires 

ARGENTINA 

Booth 177 

Boston Scientific 

One Boston Scientific Place 

Natick, MA 1760 

UNITED STATES 

www.bsci.com 

Taxus Liberté, the only one that has CE mark for use 

in Diabetic Patients. The proven one. 

Booth 212+214+252 

Brazilian Society of Cardiology 

Booth 128 

C2C -The eHealth Company 

Republica dominicana 3, bajos local 1 

07014 Palma de Mallorca 

SPAIN 

www.c2ctsis.com 

Company specialized in developing Healthcare IT integration 

solutions, focused mainly on imaging integration solutions. 

Booth 102 

Cambridge Theranostics Ltd. 

7 Hills Avenue 

Cambridge CB1 7UY 

UNITED KINGDOM 

CTL has developed AterononR/T, the first clinically proven 

neutraceutical product able to inhibit the process responsible 

for atherosclerotic plaque growth. 

Booth 137B 

exhibitors’ and sponsors’ editorial listing / 49


Cardiology Management 

28 Rue de la Loi 

1040 Brussels 

BELGIUM 

www.cardiologymanagement.eu 

Booth 164 

Cardiotek Bv. 

Amerikalaan 70 (6199AE) 

Maastricht Airport 

Maastricht 

THE NETHERLANDS 

www.cardiotek.com 

Amplifier /Stimulator for Electrophysiologic Procedures 

Booth 255 

Chinese Society of Cardiology 

www.heart.org.cn 

Booth 114B 

Colegio Argentino de Cardiologos Intervencionistas 

Booth 140 

Colgate 

300 Park Avenue 

PK 12 

New York, NY 10022 

UNITED STATES 

Colgate Total 

Booth 194B 

Colombian Society of Cardiology 

www.scc.org.co 

Booth 138A 

Congreso Internacional de Medicina Interna del Hospital 

de Clínicas 

Booth 106 

Content Ed Net Communications 

Maetro Lasalle 36 

28016 Madrid 

SPAIN 

Content Ed Net is a Global Medical Publishing Specialist with 

10 offices in Argentina, Brazil, France, Italy, Japan, Mexico, 

New Zealand, Spain & UK. 

Booth 139 A 

Cortex Biophysik GmbH 

Nonnenstrabe 39 

04229 Leipzig 

GERMANY 

www.cortex-medical.com 

See Micromed 

Booth 206 

CSL Behring S.A. 

Fray Justo Sarmiento 2350 

Olivos (B1036AKJ) 

Buenos Aires 

ARGENTINA 

www.cslbehring.com 

Booth 183 

CVD Prevention and Control Journal (Elsevier) 

Radarweg 29 

Amsterdam NX 1043 


www.elsevier.com 

Elsevier publishes leading international medical journals, 

including Prevention and Control, the official journal of 

the World Heart Federation. Visit us and collect your free 

sample copy. 

Booth 186+188+215 

Daichii Sankyo Brazil Farmaceutica LTDA 

Almeda Xingu, 766 

Barueri 

Sao Paul 

BRAZIL 

www.daiichisankyo.com 

Booth 307 

Dasani 

www.dasani.com 

Booth 217 

Diagnóstico Maipú por Imágenes S.A. 

Av Maipu 1668 (1602) 

Buenos Aires 

ARGENTINA 

Booth 101 

Digimed S.A 

Giribone 1002 (C1427CAN) 

Buenos Aires 

ARGENTINA 

www.digimed.com 

Booth 105


Distribuna Editorial y Libreria Medica 

Booth 162 

Driplan 

Catalina de Boyle 3340 (calle 28) 

Gral. San Martin (B1650IMD) 

Buenos Aires 

ARGENTINA 

www.driplan.com 

Booth 103 

Ecuadorian Foundation of Cardiology 

Booth 108A 

Ecuadorian Society of Cardiology 

www.sec-np.org 

Booth 108A 

Edan Instruments, Inc. 

3/F-B Nanshan Medical Equipments Park,Nanhai Rd.1019# 

Shekou, Nanshan Shenzhen 

Guangdong Province 518067 

CHINA 

www.edaninstruments.com 

Edan Instruments, Inc. is one of the leading medical 

equipments manufacturers in China. 

Booth 236 

Ediciones Journal 

Junin 873 - Piso 4 

Depto H 

Buenos Aires 

ARGENTINA 

www.journal.com.ar 

Publisher and distributor of medical books in both Spanish 

and English language. Great exhibition and sale of books in 

the field of cardiology of main US and European publishers: 

Elsevier, Lippincott Williams & Wilkins and Springer Verlag. 

Booth 194A 

Editorial Médica Panamericana 

Booth 142A 

Editorial Mediterráneo Argentina 

Paraguay 2028 4 Piso ofc. 21 

Buenos Aires 

ARGENTINA 

Booth 195B 

Ekosur S.A. 

Buenos Aires 

ARGENTINA 

Booth 200 

Eli Lilly 

www.lilly.com 

Esaote Latinoamérica S.A. 

Buenos Aires 

ARGENTINA 

Booth 211 

European Society of Cardiology 

2035 Route des Colles 

Les Templiers 

BP 179 

06903 Sophia Antipolis 

FRANCE 

www.escardio.org 

Booth 119 

Feas Electrónica 

Colon 5760 

(X5003DFP) 

Cordoba 

ARGENTINA 

Booth 160 

Fundación Favaloro 

Booth 134B 

Fundación Rusculleda / DAMIC SRL 

Asistencia, docencia e investigación en Medicina. 

Independencia 387. Cordoba Argentina 

Booth 163 

Future Events 

Learn what's happening world wide in the field of cardiology 

and heart disease. 

Booth 199 

Galix Biomedical Instrumentation 

Rocamora 4029 

Buenos Aires 

ARGENTINA 

www.galix-gbi.com 

Cardiac External Pacemaker, Computerized ECG and 

Stress Test Systems, ECG Holter Recorders and Analyzers. 

Simulators for Polygraph and Electrophysiology. 

Booth 204 

GE Healthcare 

Bouchard 710 

3 piso 

Buenos Aires 

ARGENTINA 

Booth 219+243+244 



Gedic - Grupo de Estudio, Docencia e Investigacion 

Clinica 

Av Rivadavia 2358 PB4 

Buenos Aires 

ARGENTINA 

Booth 205 

GlaxoSmithKline 

980 Great West Road 

Brentford, Middlesex, TW8 9GS 


www.gsk.com 

GlaxoSmithKline – one of the world’s leading research-based 

pharmaceutical and healthcare companies, committed to 

improve the quality of human life.ww.gsk.com 

Booth 230 

Granix 

Buenos Aires 

ARGENTINA 

Booth 110 

Griensu S.A. 

Av.Julio A.Roca 636, Pisos 10O. 

Buenos Aires 

ARGENTINA 

www.griensu.com 

Booth 207 

Hittec Medical S.A. 

Mexico 3100 

C1223ABL 

Buenos Aires 

ARGENTINA 

Booth 270 

Hospital Alemán 

Buenos Aires 

ARGENTINA 

Booth 238 

Instramed 

Av. Protásio Alves, 3371 

Porto Alegre 90410-003 

BRAZIL 

www.instramed.com.br 

Booth 161 

InterAmerican Society of Cardiology 

Juan Badiano No. 1, Edificio Galas, P. B 

Mexico D.F. 

MEXICO 

www.soinca.org 

Booth 124B 



Ch Louis-Dunant 15 

PO Box 195 

1211 Geneva 20 

SWITZERLAND 

www.ifpma.org 

IFPMA is the global non-profit NGO representing the 

research-based pharmaceutical, biotech and vaccine sectors. 

Its members comprise 26 leading international companies 

and 46 national and regional industry associations covering 

developed and developing countries. The IFPMA Clinical 

Trials Portal (www.ifpma.org/clinicaltrials), the IFPMA’s 

Ethical Promotion and its Health Partnerships information 

help make the industry’s activities more transparent. 

Booth 141 A 

Iroko Cardio, LLC 

Philadelphia 

UNITED STATES 

Booth 179 



A. Bayés de Luna 

ICCC - Hospital Sant Pau 

Avda. Sant Antoni Mª Claret, 167 

08025 Barcelona 

SPAIN 

www.iscpcardio.org 

Booth 107B 

ISHNE (International Society of Holter and Noninvasive 

Electrocardiology) 

Monroe County 

Rochester, NY 

UNITED STATES 

www.ishne.org 

Booth 126 

IVAX Argentina 

JJ Castelli 6701 

Munro prov 

Buenos Aires 

ARGENTINA 

www.ivax.com 

Cardiovascular line of pharmaceutical products, 

antihypertensives, lipid regulators, platelet 

aggregation inhibitors. 

Booth 201


Janssen-Cilag Farmaceutica 

1900 Charleston Road 

M10-3111 

Mountain View, CA 94043 

UNITED STATES 

NATRECOR® (nesiritide): A recombinant version of human 

B-type natriuretic peptide, for I.V. treatment of acute 

congestive heart failure. 

Booth 197 

Japanese Circulation Society 

8th Floor, CUBE OIKE Bldg. 

599 Bano-cho Karasuma Aneyakoji 

Nakagyo-ku 

Kyoto 604-8172 

JAPAN 

www.j-circ.or.jp 

Booth 130B 

Jota Tec S.A. 

Maipu 231 3p of 40 

Buenos Aires 1084 

ARGENTINA 

www.jotatec.com 

We are leaders producing ABPM, Holter, ECG and 

ergometry equipment. We are certified under ISO 13485, 

CE mark and ANVISA. 

Booth 262 

Karger AG 

Allschwilerstrasse 10 

4009 Basel 

SWITZERLAND 

www.karger.com 

We are pleased to present the latest publications in 

Cardiology at the Karger booth including the book 

‘Cardiovascular Diabetology’. Pick up a sample copy 

of the journal CARDIOLOGY. 

Booth 141B 

Laboratorio Baliarda S.A. 

Alberti 1283 

Buenos Aires 

ARGENTINA 

Booth 265 

Laboratorios Bagó S.A. 

Bernardo de Irigoyen 248 

Buenos Aires 

ARGENTINA 

www.bago.com.ar 

Booth 316 

Laboratorios Bernabó S.A. 

Terrada 2346 

Buenos Aires 

ARGENTINA 

www.laboratoriosbernabo.com 

Booth 272 

Laboratorios Casasco S.A.I.C. 

Av. Carabobo 22 

Buenos Aires 

ARGENTINA 

www.casasco.com.ar 

Booth 269 

Laboratorios Elea S.A. 

Sanabria 2353 - C1417AZE 

Buenos Aires 

ARGENTINA 

www.laboratorioelea.com.ar 

Booth 242 

Laboratorios Gador S.A. 

Darwin 429 

Buenos Aires 

ARGENTINA 

www.gador.com.ar 

Booth 317 

Laboratorios Lazar 

Av. Vélez Sársfield 5855 - B1606ARI 

Buenos Aires 

ARGENTINA 

www.lazar.com.ar 

Since 1934 manufactoring top quality pharmaceutical 

products under strict CMP standards. 

LAZAR, a trustful symbol in the Medical Field. 

Booth 237 

Laboratorios Phoenix S.A.I.C.F. 

Humahuaca 4065 

Buenos Aires 

ARGENTINA 

www.phoenix.com.ar 

Booth 203 

Laboratorios Roemmers S.A.I.C.F. 

Fray Justo Sarmiento 2350 

Buenos Aires 

ARGENTINA 

www.roemmers.com.ar 

Booth 318 



Latin American Society of Interventional Cardiology 

(SOLACI) 

Adolfo Alsina 2653 piso 2 departamento H 

Buenos Aires 

ARGENTINA 

www.solaci.org 

Booth 114A 

Libreria AKADIA Editorial 

Paraguay 2078 

Buenos Aires 

ARGENTINA 

www.editorialakadia.com.ar 

Software and medical books in Spanish 

Booth 143A 

Libyan Cardiac Society 

Tajura Cardiac Center 

P.O.Box: 82251 

Tripoli 

LIBYA 

www.lcs.org.ly 

Booth 134A 

Lilis S.A. 

Pasteur 798 

Buenos Aires 

ARGENTINA 

www.lilis.com.ar 

Littmann - Stethocopes - Medical supplies - ECG - 

Electrocardiographs - Patient monitoring - Diagnostic 

imaging - Blood pressure monitors - Oximeters - Head lights 

- Binocular loupes heine - Accessories 

Booth 259 

McGraw-Hill Education 

148 Princeton-Hightstown Road, N-1 

Hightstown, NJ 08520 

UNITED STATES 

www.mheducation.com 

Booth 143B 

Medispec 

2041 Observation Drive 

Suite # 102 

Germantown, MD 20876 

UNITED STATES 

www.medispec.com 

Booth 104 

Medley S.A Ind. Farmaceutica 

Rua Macedo Costa 55 

13080-180 Campinas 

Sao Paulo 

BRAZIL 

www.medley.com.br 

Booth 250 

Menarini International Operations Luxembourg S.A. 

Via Sette Santi 1 

50131 Firenze 

ITALY 

www.menarini.com 

Booth 216+249 

Merck KGaA 

Frankfurter Strasse 250 

64293 Darmstadt 

GERMANY 

www.merck.de 

Booth 247+248 

Merck Sharp & Dohme 

One Merck Drive, WS2C-36A 

Whitehouse Station, NJ 08889 

UNITED STATES 

www.msd.com 

Merck Sharp & Dohme is a global reseach-driven 

pharmaceutical company dedicated to putting patients 

first. Established in 1891, MSD discovers, develops, 

manufactures and markets vaccines and medicines to 

address unmet medical needs. The company also devotes 

extensive efforts to increase access to medicines through 

far-reaching programs that not only donate MSD medicines 

but help deliver them to the people who need them. 

MSD also publishes unbiased health information as a 

not-for-profit service. 

Booth 245+246 

Methabolic Syndrome Institute 

Booth 264 

Mexican Society of Cardiology 

Juan Badiano #1 

Col. Sección XVI, Tlalpan C.P. 14080 

C.P. 14080 

Mexico D.F. 

MEXICO 

www.smcardiologia.org.mx 

Booth 112A


Microlife uS 

424 Skinner Boulevard 

Suite B 

Dunedin, FL 34698 

UNITED STATES 

www.microlifeusa.com 

Booth 232 

Micromed 

Rua 3 Lotes 15/17 - Polo de Modas 

Guara II 

Brasilia DF 71070503 

BRAZIL 

Booth 206 

Ministerio de Turismo de la Prov.de Salta 

Booth 167 

Molinos Rio de la Plata S.A 

Booth 175 

Nature Clinical Practice Cariovascular Medicine (Nature 

publishing Group) 

The Macmillan Building 

4 Crinan Street 

London N19XW 


www.nature.com 

Booth 186+188+215 

Novartis Pharma 

5200 Blue Lagoon Drive 

Suite 690 

Miami, FL 33126 

UNITED STATES 

www.novartis.com 

The Pharmaceuticals Division of Novartis is recognized 

worldwide for the innovative medicines provided to patients, 

physicians and healthcare organizations. Our current product 

portfolio includes more than 45 key marketed products, 

many of which are leaders in their respective therapeutic 

areas. The product development pipeline involves nearly 

140 projects – including potential new products as well 

as potential new indications or formulations for existing 

products in various stages of clinical development. 

Booth 303 

Numed (Omnimédica Argentina) 

Buenos Aires 

ARGENTINA 

Booth 202 

Omron Healthcare, Inc 

1200 Lakeside Drive 

Bannockburn, IL 60015 1243 

UNITED STATES 

www.omronhealthcare.com 

Booth 222 

Oxford Journals | Oxford university Press 

Great Clarendon Street 

Oxford OX2 6DP 


www.oup.co.uk 

Booth 142B 

Paraguay Society of Cardiology 

www.spc.org.py 

Booth 136A 

PCNA (Preventive Cardiovascular Nurses Association) 

613 Williamson Street 

Suite 205 

Madison, WI 53703 

UNITED STATES 

www.pcna.net 

PCNA is the leading nursing organization dedicated to 

preventing cardiovascular disease through assessing risk, 

facilitating lifestyle changes, and guiding individuals to 

achieve treatment goals. 

Booth 107A 

Pfizer 

235 East 42nd Street 

New York, NY 10017 

UNITED STATES 

www.pfizer.com 

Booth 148+189 

Pfm Medical 

2605 Temple Heights Drive 

Suite A 

Oceanside, CA 92056 

UNITED STATES 

www.pfm-ag.com 

Pfm Ag, Cologne, Germany and it affiliates world wide 

provide innovative products to the medical community. 

The Nit-Occlud® spiral coil system is designed for 

transcatheter occlusion of Patent Ductus Arteriosus (PDA) 

of all shapes. Safety and reliability of this system are the 

result of a continuous further improvement of the proven 

Duct-Occlud® system. 

Booth 159 



Philips Healthcare 

Vedia 3892 

Buenos Aires 

ARGENTINA 

www.medical.philips.com 

Royal Philips Electronics of the Netherlands is a global leader 

in healthcare, lighting and consumer lifestyle, delivering 

people-centric, innovative products, services and solutions 

through the brand promise of “sense and simplicity”. 

With sales of EUR 2007, the company is a market leader in 

medical diagnostic imaging and patient monitoring systems, 

energy efficient lighting solutions, as well as lifestyle 

solutions for personal wellbeing. 

Booth 266+267+268 

Polymer Technology Systems, Inc 

7736 Zionsville Road 

Indianapolis, IN 46268 

UNITED STATES 

www.cardiochek.com 

Booth 263 

Productos Roche S.A. 

Productos Roche S.A.Q.e I., Rawson 3150 

B1610BAL Ricard Rojas, Tigre 

Buenos Aires 

ARGENTINA 

Booth 180 

Prous Science 

Provenza 388 

08025 Barcelona 

SPAIN 

www.prous.com 

Prous Science, a Thomson Scientific business, provides 

information and communication services on drug R&D, 

pharmacology, medicine and medicinal chemistry. 

Booth 260 

Quaker – a PepsiCo Group Company 

R&D Quaker Lar 

Poneiente 116 No 659 

Col. Industrial Vallejo 

Mexico D.F 02300 

MEXICO 

www.pepsico.com 

Booth 145 

Raffo S.A. 

Av. Cabildo 86 

Buenos Aires 

ARGENTINA 

www.raffo.com.ar 

Leaders in the treament of dsylipemias and cholesterol 

lowering drugs. 

Booth 253 

Rozinn by Scottcare 

4791 West 150th Street 

Cleveland, OH 44135 

UNITED STATES 

www.scottcare.com 

Rozinn by Scottcare offers holter, pacemaker follow-up, 

cardiac evnt, ambulatory BP and Telerehab monitoring 

systems, plus external counterpulsation (ECP)beds. 

Booth 116 

Sanofi-aventis 

174, avenue de France 

75013 Paris 

FRANCE 

www.sanofi-aventis.com 

Sanofi-aventis is one of the leading pharmaceutical company 

in the world, ranking number one in Europe. Backed by a 

world-class R&D organization, sanofi-aventis is developing 

leading positions in seven major therapeutic areas: 

cardiovascular, thrombosis, oncology, metabolic diseases, 

central nervous system, internal medicine and vaccines. 

The Group is inspired by a powerful vision: 

- to find new compounds to prevent, combat and eradicate 

diseases around the world, 

- to provide therapeutic and preventive solutions geared to 

populations in both industrialized and developing countries, 

- to support innovative medicines and vaccines, mature 

products, OTC medicines and generics. 

Every day, everywhere sanofi-aventis is working for what 

really matters: Patients HEALTH. 

Booth 157+182 

Schiller 

Altgasse 68 

6341 Baar 

SWITZERLAND 

www.schiller.ch 

SCHILLER specailizes in cardio-therapy equipment, focusing 

on resting & exercise ECG, spirometry, patient monitoring 

and cardiac defibrillation. 

Booth 218+220


Servier 

192 Avenue Charles de Gaulle 

92578 Neuilly-sur-Seine Cedex 

FRANCE 

www.servier.com 

Siemens 

Wittelsbacherplatz 2 

80333 Munich 

GERMANY 

www.siemens.com 

Booth 198 

Slovenian Society of Cardiology 

Slovenska hiša srca 

Ulica stare pravde 6 

1000 Ljubljana 

SLOVENIA 

www.sicardio.org 

Booth 112B 


Global Product Strategy Department 

PO Box 220 

30002 Hannover 

GERMANY 

Solvay Pharmaceuticals Cardiometabolic portfolio includes: 

Lipanthyl®/Tricor® indicated for the treatment of lipid 

disorders, Teveten® controlling high blood pressure 

and Omacor® for the adjuvant treatment in secondary 

prevention after myocardial infarction. 

Booth 153+ 185+ 151+ 187 

South American Society of Cardiology 

Booth 130A 

Spacelabs Healthcare 

5150 220th AVE SE 

Issaquah, WA 

UNITED STATES 

Booth 103 

Spanish Society of Cardiology 

Booth 118+115 

St Jude Medical 

One Lillehei Plaza 

St. Paul, MN 55117 

UNITED STATES 

www.sjm.com 

Booth 310 

Taiwan Scociety of Cardiology 

7, Chung-Shan S. Road 

National Taiwan University Hospital 

Taipei 100 

TAIWAN, ROC 

www.tsoc.org.tw 

Booth 132 

Tecnoimagen-Sonosite 

Buenos Aires 

ARGENTINA 

Booth 233+239 

unilever 

Olivier van Noortlaan 120 

P.O.Box 114 

Vlaardingen 3130 AC 


www.unilever.com 

Unilever is the global food industry leader in heart health 

nutrition via its products and education services. 

Booth 150 

upTo Date 

Boerhaavelaan 24 

Zoetermeer 2713 HX 


www.uptodate.com 

Booth 144 

Veccsa 

Juramento 5841 

Buenos Aires C1431CLA 

ARGENTINA 

Booth 231 

Vifor International Inc. 

P.O.Box, Rechenstrasse 37 

9001 St. Gallen 

SWITZERLAND 

Vitaphone GmbH 

Markirchener Strasse 22 

68229 Mannheim 

GERMANY 

With advanced telemedicine monitoring and care systems, 

Vitaphone not only provides comprehensive patient care 

solutions to care suppliers but also to healthcare insurers. 

Booth 184 



V-Patch Medical Systems 

Chemin Long 259 

1310 La Hulpe 

BELGIUM 

Wireless, waterproof, body worn EVENT/HOLTER device 

& patch, program to continuously monitor critical events, 

data automatically sent to WWW. 

Booth 195A 

Welch Allyn, Inc. 

4341 State Street Rd. 

PO Box 220 

Skaneateles Falls, NY 13153- 0220 

UNITED STATES 

www.welchallyn.com 

Booth 117 

Wiley-Blackwell 

350 Main Street 

Malden, MA 02148 

UNITED STATES 

www.wiley.com 

Booth 137A 

Wolters Kluwer 

Philadelphia, PA 60090 

UNITED STATES 

www.wolterskluwer.com 

Booth 139B 

unrestriCted eduCAtionAL grAnts 

In addition to the welcome participation and support from all 

exhibitors and sponsors listed elsewhere in this programme, 

the WCC 2008 would like to thank the following companies 

for their contribution to WCC 2008 with an unrestricted 

educational grant. 

• Otsuka Pharmaceuticals 

• St. Jude Medical 

A special thanks also to the following societies for their support of 

the WCC 2008: 

Lawyers Bustamante, Cavallero, Bolo, Tomeo y Asociados 

25 de Mayo 267 5º 512 (C 1002 ABE) - Buenos Aires - Argentina 

Tel./Fax: +54 11 4343 4861 - bcbt@bcbt.com.ar - www.bcbt.com.ar 

Counter Santiago Sáenz Valiente SSV 

Paraná 754 Piso 8 Capital (Entre Córdoba y Viamonte) . 4816-6996 


7 Rue des Battoirs 

Case postale 155 

1211 Geneva 4 

SWITZERLAND 

The World Heart Federation is committed to helping the 

global population achieve a longer and better life through 

prevention and control of heart disease and stroke, with 

a particular focus on low and middle-income countries. 


Booth 186+188+215 

World Point 

1326 S. Wolf Rd. 

Wheeling, IL 60090 

UNITED STATES 

www.worldpoint-ecc.com 

Booth 111 

youth for Smoke Free Environments 

A display on youth-led activities promoting smoke-free 

environments, supported by networks linked to the World 

Heart Federation and its members. 

Booth 258

Session: 

Rheumatic Fever/Rheumatic Heart Disease 

Tuesday, 20 May, 2008 – 16.00-17.30 - Pilcomayo 

Demonstration: 

World Heart Federation booth 

Wednesday, 21 May, 2008 – 10.00-10.30

sCientiFiC ProgrAMMe 

Formats 

Over 250 sessions will be presented in the following formats: 

Symposia (SyMP) include a maximum of five presentations 

on the latest developments in fields such as basic science, 

clinical cardiology and epidemiology. 

Debates (DEB) provide a discussion on controversial issues 

with two statements that will be debated, each with a pro 

and contra presentation followed by a discussion at the end 

of each statement. 

How-to & Workshop Sessions (HTS) will give the 

opportunity to interact between a limited audience and 

experts in various fields of clinical cardiology. 

Continuing Medical education (CMe) 

The World Congress of Cardiology is 

accredited by the European Board for 

Accreditation in Cardiology (EBAC) for 

18 hours of External CME credits. 

Each participant should claim only 

those hours of credit that have actually 

been spent in the educational activity. 

One credit may be claimed for each hour of participation in 

WCC scientific sessions. 

EBAC works according to the quality standards of the 

European Accreditation Council for Continuing Medical 

Education (EACCME), which is an institution of the European 

Union of Medical Specialists (UEMS). 

In compliance with the EBAC guidelines, all speakers 

and chair persons who are participating in this scientific 

programme have disclosed or indicated potential conflicts of 

interest which might case a bias in the presentations. 

The Organizers are responsible for ensuring that all potential 

conflicts of interest relevant to the congress are declared to 

the audience prior to the CME activities. 

Clinical Seminars (CS) will highlight various specific 

subspecialty topics. The sessions do not target exclusively 

specialists but also a general audience. 

The South American Congress of Cardiology (SACC) 

will be held in conjunction with the World Congress of 

Cardiology and presented in a series of eleven sessions in 

Spanish. (Session rooms: Amazon, Tigris). 

Special Featured Joint Sessions (SP) are held by 

cardiology societies and organizations. 

The American Medical Association (AMA) has an 

agreement of mutual recognition of continuing medical 

education (CME) credit with the European Union of Medical 

Specialties (UEMS). Under the terms of this agreement, 

the AMA will convert CME credit certified by the European 

Accreditation Council for Continuing Medical Education 

(EACCME), the accrediting arm of the UEMS, to AMA PRA 

Category 1 Credit. 

How do I receive credits? 

Credits can be received after the congress via our online 

system. Please make sure to keep a record of the session 

titles / numbers and save your registration confirmation 

number and/or access code. After completing the EBAC 

evaluation you will be taken to the website to input your 

information for EBAC CME credits. The site is accessible via 

a direct link you will be provided within due course. 

ATTENTION: It will take approximately 6-8 weeks to process 

your enquiry and before you receive confirmation of your 

accreditation. Please note that no certificates will be given 

on-site.

technical information for sessions 

SPEAkERS PREVIEW CENtRE 

The speakers preview centre is located in the Green Pavilion 

behind the Seine and the Niger rooms. 

OPENING HOURS: 

Saturday, 17 May, 2008: 15.00 – 18.00 

Sunday, 18 May, 2008: 09.00 – 19.00 

Monday, 19 May, 2008 07.00 – 19.00 

Tuesday, 20 May, 2008: 07.00 – 19.00 

Wednesday, 21 May, 2008: 07.00 – 16.00 

IMPORtANt NOtE: 

CHECK-IN TO THE SPEAKERS PREVIEW CENTRE IS 

MANDATORY FOR ALL PRESENTERS! 

Plan to check-in the day before or no later than 4 hours 

before your presentation time. Presenters who do not checkin 

sufficiently in advance of their presentation may give the 

scheduled talk, but may not have visuals. Speakers who 

have submitted their presentations in advance via the online 

website are advised to visit the speakers preview room for a 

final check. 


The Scientific Programme Committee (SPC) gratefully 

acknowledges the submission of over 2000 abstracts from 

all over the world. All abstracts have been graded and 

reviewed by the Scientific Programme Committee. 

All accepted abstracts have been published in the online 

version of the official American Heart Association Journal 

“Circulation” For more information, please visit 

www.circ.ahajournals.org. 

In addition to that, all delegates may collect their personal 

abstract CD Rom from the Boehringer Ingelheim booth in 

the exhibition hall. To collect your free copy, please go to 

their booth with your voucher which you will find in your 

congress bag. 

The WCC would like to thank Boehringer Ingelheim for their 

financial support towards the production and distribution of 

the abstract CD Rom. 

Abstracts will be presented in the following formats: 

• Poster 

• Oral abstract presentation 

Farbe/colour: 

PANTONE 288 CV 

POWERPOINt PRESENtAtIONS 

All presentations are downloaded on to a single server 

before the session and sent through a network to the correct 

session room. 

Only MS-PowerPoint (2003 and XP) presentations with 

video formats should be used for this conference. However, 

technical assistance will be provided in case you are using a 

MAC computer. 

You will have NO possibility to upload/change your presentation(s) 

to/on the computer in the session room. Therefore you must go 

to the speakers preview room before your presentation starts. 

Technicians will be available in case you may need assistance. 

tIME lIMIt 

All speakers are requested to adhere strictly to the time limit 

indicated in the programme. The indicated lecture times include 

time for discussions. Overrunning by even a few minutes may 

impact on the smooth running of the following sessions, so 

please respect your colleagues and the time slots. All session 

rooms will be equipped with video projection. Overhead 

projection and standard 35mm slide projection is not available. 

POStER PRESENtAtIONS 

• Dimensions: 1.8 meters (max) to 1.5 meters (min) high by 

0.9 meters wide (70.80 inches by 35.40 inches). 

• The title, authors’ detail(s) and affiliation(s) should be 

printed at the top of the poster. The chosen font should not 

be smaller than 5 cm (1.95 inches). 

• Even at a distance of 1 meter from the poster board, the 

poster should be easily readable. 

• Posters must be placed on the boards (provided by the 

organizers) with double sided tape (not provided by the 

organizers). 

• Regarding the content structure of the poster, the sections 

outlined below should be observed: 

– Introduction 

– Materials and Methods 

– Results 

– Conclusion(s) 

– Wherever possible, results can be illustrated with 

picture(s) and chart(s) 

• Posters must be put up and dismantled according to the 

time slots given by the organizers. 

• Should you not dismantle your poster at the appropriate 

time the staff will take the liberty to remove it. The 

Congress Organizers will accept no liability for your 

material and poster. 

Authors will be present at their posters during the coffee 

breaks either from 10:00-10:30 or 15:30-16:00. 

scientific Programme / 61


A poster help-desk is located within the poster area. Please 

do not hesitate to contact one of the staff members at the 

poster help desk for any further assistance. 

POStER tOPICS 

Posters will be presented in the following scientific topics: 

• Arrhythmias 

• Heart Failure/Left Ventricular Function 

• Valvular Disease/Pulmonary Circulation/Myocardialpericardial 

• Ischemia/Coronary Artery Disease 

• Interventions/Peripheral Circulation/Stroke 

• Hypertension 

• Exercise/Epidemiology/Prevention 

special featured joint sessions 

The World Congress of Cardiology 2008 organizers; the 

World Heart Federation, the Argentine Society of Cardiology 

and the Argentine Federation of Cardiology, would like to 

thank the following societies and organizations that have 

committed to the World Congress of Cardiology 2008. 

• American College of Cardiology (ACC) 

• American Heart Association (AHA) 

• American Society of Echocardiography (ASE) and 

International Society for Cardiovascular Ultrasound (ISCU) 

• American Society of Nuclear Cardiology (ASNC) 

• Argentine Ministry of Health 

• Asian-Pacific Society of Cardiology (APSC) 

• Brazilian Society of Cardiology (SBC) 

• Heart Rhythm Society (HRS) and International Society for 

Holter and Noninvasive Electrocardiology (ISHNE) 

• Pharmacology 

• Basic Science 

• Cardiac Imaging/Computers 

• Acute Cardiac Care 

• Paediatric/Congenital Heart Disease 

• Nursing/Technician/Miscellaneous 

• Public Policy / Advocacy initiatives 

ORAl ABStRACt PRESENtAtIONS 

Oral abstract sessions have a dedicated time slot from 8.30 

to 10.00 in the morning. All details for oral abstract session 

can be found in the detailed scientific programme. 

• Interamerican Society of Cardiology (IASC) 

• International Society of Hypertension (ISH) 

• Latin American Society of Interventional Cardiology 

(SOLACI) and Society for Cardiovascular Angiography and 

Interventions (SCAI) 

• Metabolic Syndrome Institute (MSI) 

• Mexican Society of Cardiology (SMC) 

• Pan African Society of Cardiology (PASCAR) 

• Preventive Cardiovascular Nurses Association (PCNA) 

• World Heart Failure Society (WHFS) 

• International Society of Cardiovascular & Pharmacotherapy 

(ISCP) 

For further information about these Special Featured Joint 

Sessions, kindly refer to the detailed scientific programme 

which follows.

south American Congress of Cardiology 

The South American Congress of Cardiology will be held 

in conjunction with the World Congress of Cardiology and 

presented in Spanish in a series of eleven sessions 

(Session rooms: Amazon, Tigris). 

• Opening Ceremony-XXIII Congreso Sudamericano 

de Cardiología 

• Desafíos actuales de la cardiología sudamericana 

• Cómo optimizar el tratamiento de la insuficiencia 

cardiaca crónica 

• Manejo del paciente con síndrome coronario agudo 

• Conferencias : 

- De los ensayos clínicos a la práctica asistencial 

- Avances en el manejo de la enfermedad aórtica 

Webcasts 

Certain official WCC 2008 Scientific Sessions will 

be webcasted by Prous Science. These sessions 

will be accessible on the WCC Congress website 

www.worldcardiocongress.org after the congress. 

industry satellite symposia and workshop activities 

Industry Satellite Symposia and Workshop activities as well as 

Non-commercial symposia have dedicated time slots: 

• before the congress opens in the afternoons 

(Pre-Congress activities) 

• in the middle of the day during the congress (Inter-Sessions) 

• at the end of the afternoon (Evening Sessions) 

These sessions include: 

• Symposia specifically designed for any company active in 

the field of cardiology as an opportunity to showcase the 

latest developments and scientific information. 

• Workshops designed for medical device companies, 

biotechnology companies and the distribution sector 

related to cardiovascular medicine. 

• Tratamiento actual de la enfermedad coronaria crónica 

• Factores de riesgo y aterosclerosis subclínica 

• Toma de decisiones en valvulopatías 

• Fibrilación auricular. Lo viejo y lo nuevo. 

• Avances en la insuficiencia cardiaca aguda descompensada 

• Nuevas fronteras en la hipertensión arterial 

For further detailed information about the Spanish 

sessions, please refer to the detailed scientific programme 

which follows. 

• Non-commercial Symposia tailor-made for institutions 

such as hospitals, universities and not-for-profit 

organizations. 

For further information about these Industry satellite symposia 

and workshop activities, kindly refer to the detailed scientific 

programme which follows. 



The scientific programme has been prepared in close 

collaboration with the Scientific Programme Committee 

(SPC), local advisers and topic group leaders. 

The WCC 2008 organizers would like to thank everybody 

for their commitment and contribution to the WCC 2008 

Scientific Programme. 

tOPIC GROUP lEADERS: 

Arrhythmias 

Günter Breithardt (Germany) 

Alvaro Sosa Liprandi (Argentina) 

Heart failure/Left ventricular function 

Hugo Grancelli (Argentina) 

Akira Matsumori (Japan) 

Valvular disease/Pulmonary circulation/Myocardialpericardial 

Edgardo Escobar (Chile) 

Ricardo Ronderos (Argentina) 

Ischemia/Coronary artery disease 

Juan Krauss (Argentina) 

Dev Pahlajani (India) 

Interventions/Peripheral circulation/Stroke 

Liliana Grinfeld (Argentina) 

William Wijns (Belgium) 

Hypertension 

Luis Maria Amuchástegui (Argentina) 

Ayrton Brandão (Brazil) 

Churchill Onen (Botswana) 

Exercise/Epidemiology/Prevention 

Nizal Sarrafzadegan (Iran) 

Néstor Vita (Argentina) 

Pharmacology 


Andrew Tonkin (Australia) 

Basic science 

Luis Alday (Argentina) 

Valentin Fuster (United States) 

Cardiac imaging/Computers 

Moníca Acevedo (Chile) 

Néstor Pérez Baliño (Argentina) 

Acute cardiac care 

Juan Carlos Linares-Casas (Argentina) 

Marco Martínez-Ríos (Mexico) 

Paediatric/Congenital heart disease 

Horacio Faella (Argentina) 

Trevor Hassell (Barbados) 

Nursing/Technician 

Sania Nishtar (Pakistan) 

Juan Plastino (Argentina) 

Local advisers (Argentina) 

Carla Agatiello 

Carlos Barrero 

Horacio Capelli 

Sergio Dubner 

Irene Ennis 

Guillermo Fábregues 

Mariano Falconi 

Paola Kuschnir 

Emilio Kuschnir 

Pedro Lylyk 

Osvaldo Masoli 

Eduardo Mele 

José Moltedo 

Oscar Oseroff 

Diego Pérez de Arenaza 

Daniel Piñeiro 

María Laura Plastino 

Fernán Quiroz 

José Luis Ramos 

Rodolfo Rothlin

sCientiFiC ProgrAMMe At A gLAnCe 

Monday, 19 May 2008 

PAVILLION ROOM 8.30-10.00 10.30-12.00 14.00-15.30 16.00-17.30 

RED 

yELLOW 

GREEN 

OCHRE 

Rio de la Plata 

Thames 

Danube 

Amazon 

South American 

Congress of Cardiology 

Arrhythmias 

Heart failure / Left ventricular function 

Valvular disease / Pulmonary circulation / Myocardial-pericardial 

Ischemia/ Coronary artery disease 

Interventions / Peripheral circulation / Stroke 

Hypertension 

ORAL ABSTRACT SESSIONS 

Exercise / Epidemiology / Prevention 

Vulnerable plaque 

and registries 

Coronary and non-coronary 

endovascular treatment I 

Acute and chronic 

Heart Failure 

Opening Ceremony - 

XXIII Congreso 

Sudamericano de Cardiología 

Rhine Arrhythmias I 

SCIENTIFIC SESSIONS 

HTS 

CS 

SyMP 

SACC 

SP 

Interpretation of the difficult 

ECG: Practical approach 

Novel concepts in 

hypertension treatment 

Cardiac resynchronisation 

therapy (CRT) - Part One 

Desafíos actuales de la 

cardiología sudamericana 

ACC: Regional challenges to 

the prevention and treatment 

of CVD in the U.S. 

Missouri Research in Heart Failure DEB Treatment of Chagas disease 

Huang He 3D Echocardiography CS 

Nile 

Pilcomayo 

Tiber 

Lipids, obesity and 

metabolic syndrome 

Diet, drugs and 

cardiovascular disease 

Clinical and experimental 

atherosclerosis 

SyMP 

CS 

SP 

Common challenges in the 

everyday practice of nuclear 

cardiology 

Cardiac rehabilitation 

programmes 

Pharmacotherapy in heart 

failure: New drugs or new 

benefits? 

PASCAR - Health Transitions 

and CVD in Africa: Implications 

for the 21st Century 

Pharmacology 

Basic science 

Cardiac imaging / Computers 


Paediatric / Congenital heart disease 

Nursing / Technician 

Public policy / Advocacy initiatives 

DEB Drugs vs. electrical devices SyMP The polypill 

SP 

SCAI-SOLACI: 

What we know and what we 

don’t know about DES 

SP 

SyMP Electrical therapy in heart failure SyMP 

SACC 

CS 

SP 

CS 

SyMP 

SyMP 

Cómo optimizar el tratamiento 

de la insuficiencia cardiaca 

crónica 

Non-invasive risk stratification 

for sudden cardiac death 

APSC: Global burden of heart 

failure 

All a cardiologist needs to know 

about cardiac MSCT & MRI 

Are comorbidities a limit 

to cardiovascular prevention in 

the elderly? 

Use of 3D echo in clinical 

day-to-day practice 

Mississippi General Cardiology I SyMP Advances in genetics HTS 

New trends in the management 

of cardiovascular risk: The role of SyMP 

heart rate 

Volga 

Tigris 

Niger 

Ganges 

Pediatric cardiology: From 

neonates to grown-ups 

Experience with ST and 

non ST elevation infarction 

Hypertrophy and dysfunction 

of cardiac cells 

Stroke and carotid artery 

stenting 

SyMP 

Seine Myocardial infarction SyMP 

yang Tze 

Paraná 

Euphrates 

Cardiovascular risk factors 

in different populations 

Diabetes and 

cardiovascular risk 

Innovations in surgical 

and percutaneous valvular 

treatments 

CS 

CS 

CS 

SyMP 

Orinoco Research in hypertension SyMP 

Mekong 

Coronary and non-coronary 

interventions 

SP 

SyMP 

Severe pulmonary 

insufficiency after 

congenital heart surgery 

Advances in cardiopulmonary 

resuscitation 

Acute coronary syndrome in 

the elderly 

Unresolved issues on coronary 

interventions 

Acute decompensated heart 

failure 

Atrial fibrillation: Nonpharmacologic 

treatment 

MSI: The Metabolic 

Syndrome: Growing 

prevalence in Latin America 

and treatment needs 

Treatment of hypertension in 

special situations 

Current treatment of 

myocardial infarction: From 

evidence to clinical practice 

SACC 

SyMP 

SyMP 

WHFS: The failing heart 

around the world 

Cardiac resynchronisation therapy 

(CRT) - Part Two 

Manejo del paciente con 

síndrome coronario agudo 

Management of arrhythmias in 

genetically based diseases 

Heart failure with normal ejection 

fraction 

SyMP Delayed enhancement imaging for 

evaluation of cardiomyopathies 

SyMP 

HTS 

SyMP Fetal cardiology SyMP 

Primary and secondary prevention 

in atherosclerosis: From theory 

to daily practice 

Optimum treatment 

for heart failure 

Cellular regenerative therapy 

in cardiology 

Interventional cardiology in 

congenital heart disease 

DEB Cardiopulmonary resuscitation SyMP Resuscitation science and survival 

CS 

Endovascular heart valve 

interventions: The end of valvular 

open-heart surgery? - Part One 

SP 

CS 

SyMP Advanced heart failure CS 

DEB 

The polypill is an effective 

strategy for reduction of 

cardiovascular diseases 

ISCU: Update in 3D 

echocardiography 

All you need to know about 

carotid stenting 

Surgical treatment for 

congestive heart failure 

SyMP Health promotion for children 

SyMP 

CS Anemia and heart failure SyMP 

SyMP 

SyMP 

Update of treatment of 

hypertension 

Antithrombotic treatment 

in non-ST-acute coronary 

syndrome 

SP 

SyMP 

SyMP Symposium 

DEB Debate 

Cardiovascular risk and human 

immunodeficiency virus (HIV) 

infection in Africa 

Management of asymptomatic 

valve disease 

ISH: Hot topics in hypertension: 

An update 

Revascularization of patients with 

stable coronary artery disease 

HTS How-to and Workshop session 

CS Clinical seminar 

SP Special featured joint session 

SACC South American Congress of Cardiology 



tuesday, 20 May 2008 


RED 

yELLOW 

GREEN 

OCHRE 


Thames 

Arrhythmias 





Hypertension 



Atrial flutter and fibrilation 

Experiences with high risk 

patients I 


DEB 

Danube Chronic heart failure CS 

Amazon 



Rhine 

ECG, atrial fibrilation 

and ablation 

SP 

SACC 

Missouri Cardiac transplantation SyMP 

CS 

Controversial issues regarding 

management and treatment 

of systolic heart failure 

IASC: Heart failure with 

preserved systolic function 

Late results in cardiovascular 

interventions 

Conferencias 

Management of patients 

with syncope 

What is new in heart failure? 

Pharmacology 

Basic science 






DEB 

SyMP 

SyMP 

Guiding and optimizing 

treatment of heart failure 

Promoting smoke-free 

environments 

Mitral valve repair: What is 

the best option? 


DEB Debate 

SyMP Go Red for Women: Going global 

SP 

DEB 

Tratamiento actual de la 

SACC enfermedad coronaria crónica SACC 

CS 

SP 

Risk stratification in genetic 

disorders: ICD or not? 

AHA: Critical issues and new 

strategies to manage patients SyMP 

with cardiovascular disease 



PCNA: The role of the nurse 

in preventive cardiology: 

An area of leadership 

Coronary bypass surgery: 

Contemporary issues 

Factores de riesgo y 

aterosclerosis subclínica 

Health from a gender perspective: 

SyMP 

Implications for CVD 

Adequate management of 

chronic heart failure 

Huang He Echo stress II SyMP Nuclear cardiology 2008 

Endothelial dysfunction 

SyMP detection with cold pressor SyMP 

test and myocardial perfusion 

Viability imaging 

Nile 

Pilcomayo 

Tiber 

Exercise, lifestyle and 

ischemic heart disease 

Primary and secondary 

prevention II 

Novel treatments for 

lipids disorders 

Mississippi Echo stress I 

SyMP 

SyMP 

Volga Fetal cardiology SyMP 

Tigris Acute myocardial infarction SyMP 

Niger Research on pharmacology SyMP 

Ganges 

Drug eluting stent: 

Early and late outcomes 

Seine Acute coronary events CS 

yang Tze 

Paraná 

Euphrates 

Orinoco 

Primary and secondary 

prevention I 

Long QT syndrome, 

heart failure and diabetes 

Mitral valve disease and 

pulmonary hypertension 

Drugs, diabetes and 

hypertension 

SP 

CS 

SP 

SyMP 

Women and coronary heart 

disease 

The class effect dilemma - 

are all drugs within a class 

created equal? 

The global nutrition challenge 

Percutaneous pulmonary valve 

replacement 

Acute heart failure in the 

emergency department 

Acute coronary syndrome in 

diabetes 

Percutaneous heart valve 

interventions:The end of valvular 

open heart surgery? - Part two 

BMS and DES restenosis: How 

do we treat them in 2008? 

HRS & ISHNE: 

Sudden cardiac death 

Cardiovascular disease 

prevention in children 

SyMP 

SP 

SP 

SyMP 

SyMP 

SyMP 

CS 

CS 

SP 

DEB 

SyMP Update on mitral regurgitation SyMP 

SyMP 

Mekong Markers in acute syndromes CS 

Hypertension and target 

organ damage 

Interventional treatment of 

acute myocardial infarction 

SyMP 

SyMP 

Cardiovascular drug therapy 

in women 

Inflammation and 

Cardiovascular Disease: 

Multi-marker approach 

Políticas de Salud 

Congenital heart disease 

in countries with limited 

resources 

Acute coronary syndrome 

from pre-hospital to the 

emergency room 

SyMP 

SP 

SyMP 

SyMP 

Acute coronary events during 

SyMP 

non-cardiac surgery 

Complex patients and 

complex decisions - Part one CS 

Lower limb interventions: 

Stand up and walk 

ASNC: The big trials on 

nuclear cardiology 

Why are we not better in 

preventing cardiovascular 

diseases? 

Current topics in infective 

endocarditis 

What are the strategies in 

the management of mild 

hypertension? 

Non-invasive imaging for 

the diagnosis of myocardial 

ischemia: Which method? 

Stress and depression: New risk 

factors for coronary heart disease 

Rheumatic Fever/Rheumatic 

Heart Disease 

Prevention of cardiac disease 

in childhood 

Reperfusion in the elderly: 

Evidence vs. real life 

An international look at care for 

patients with acute coronary 

syndrome 

How to deal with PCI 

complications? 

SyMP Stroke above the carotids 

CS 

Understanding hypertrophic 

cardiomyopathy 

SyMP Diabetes prevention 

CS Exercise in valvular heart disease 

SyMP 

Management of patients with 

hypertension and comorbidities 

SyMP 

What should be the antithrombotic 

therapy in acute coronary 

syndrome? 


SACC South American Congress of Cardiology


Wednesday, 21 May 2008 


RED 

yELLOW 

GREEN 

OCHRE 


Thames 

Danube 

Amazon 



Arrhythmias 






Hypertension 


Prognosis, myocardial 

infarction and stents 

Experiences with high 

risk patients II 

Experimental and clinical 

interventions with 

cardiovascular cells 

Prevention of cardiovascular 

disease 


SyMP 

SyMP 

SACC 

Rhine ICD and pacemakers SyMP 

Advanced concepts in 

critical care nursing 

Cardiology in middle- and 

low-income countries 

Toma de decisiones en 

valvulopatías 

Atrial fibrillation: From 

pathogenesis to practice 

Pharmacology 

Basic science 






SyMP 

Post-graduate cardiology 

training and recertification 

SyMP Relevant nursing topics SyMP Nursing in cardiovascular disease 

SyMP 

SACC 

Missouri Kidney and heart failure SyMP Sudden death in heart failure SyMP 

Huang He MRI and CT scan SyMP 

Nile 

Pilcomayo 

Hypertension and subclinical 

atherosclerosis 

Interventions and cardiac 

ultrasound 

Tiber Cell therapy 

Mississippi 

Volga 

Tigris 

Niger 

Ganges 

Seine 

yang Tze 

Exercise and autonomic 

nervous system 

Coronary and non coronary 

endovascular treatment II 

Acute coronary syndromes 

and PTCA 

TC Scan, arrhytmias and 

orthostatic hypotension 

Inside the artery, 

inside the plaque 

Women and 

coronary disease 

Social and emotional factors 

in heart disease 

SyMP 

SyMP 

SyMP 

SyMP 

SyMP 

SP 

DEB 

How to use CT multislice 

and magnetic resonance 

in clinical practice? 

Global risk factors for the 

development of coronary artery 

disease and stroke 

Cardiovascular safety of 

non-cardiovascular drugs 

Novel cellular mechanisms in 

cardiac hypertrophy and ischemia 

Adult congenital heart 

disease: Hot issues 

The chest pain centre: 

Evolving concept 

Cardiovascular disease in diabetes: 

Controversies and opportunities 

PCI in chronic CHD has no proven 

long-term safety and benefit 

To ablate or not to ablate? 

Controversial issues 

Fibrilación auricular. 

Lo viejo y lo nuevo. 

SyMP Sudden death 

SyMP 

HTS 

SyMP 

SP 

CS 

SyMP 

SACC 

CS 

The cardiorenal syndrome 

in heart failure 

Tissue doppler imaging: 

Present and future 

CS 

SACC 

CS 

SyMP 

How to reach and 

maintain LDL below 70 in very SyMP 

high risk patients 

Medical informatics: 

Applications in cardiology 

MSC: Interventional cardiology 

in adults with congenital 

heart disease 

Contemporary factors 

in cardiology 

Management of 

obesity today 

Avances en la insuficiencia 

cardiaca aguda 

descompensada 

Women and 

cardiovascular disease 

HTS 

SP 

Update in ablation of 

ventricular arrhythmias 

Nuevas fronteras en la 

hipertensión arterial 

Prognostic factors for heart failure 

in the betablocker era: Who must 

be listed for heart transplant? 

Echo doppler in r 

esynchronisation era 

Nutrition, diet and C 

VD prevention 

ISCP: Update on current 

cardiovascular research in USA 

and Europe 

BSC: Coronary artery 

disease 2008 

Prevention of cardiovascular 

SyMP 

disease in asymptomatic patients 

CS 

CS 

CS New Strategies for PCI CS 

Metabolic syndrome in youth: Is it 

SyMP the beginning of the cardiovascular SyMP 

disease continuum? 

Haemodynamics, 

heart and hypertension 

SyMP 

Paraná Advances in nursing topics HTS 

Euphrates Cardiomyopathies SyMP 

Orinoco 

Hypertension and other risk 

factors 

DEB 

Mekong Antiplatelets in PTCA CS 

Endothelial function and 

dysfunction: Assessment, 

therapy and outcome 

How to assess ventricular 

dysynchrony for RCT? 

Management of acute pulmonary 

embolism and pulmonary 

hypertension 

Management of pre-hypertension 

and metabolic syndrome 

Management of acute myocardial 

infarction in the 21st century 

SyMP 

CS 

Stress echocardiography in 

difficult patients 

Echodoppler as the main tool 

in assessing left ventricular 

function 

SyMP 

SyMP Chagas disease CS 

The cardiovascular hazards 

of air pollution 

The high-risk asymptomatic 

patient with coronary 

artery disease 

Complex patients and complex 

decisions - Part two 

Growing practice of nonpharmacological 

treatment in 

congestive heart failure 

Myocarditis and dilated 

cardiomyopathies: How are 

they related? 

SyMP Management of hypertension SyMP Hot topics in hypertension 

SyMP 

Scaling-up secondary 

prevention 

CS 


DEB Debate 

Hyperglycemia, inflammation 

and coronary artery disease: 

New relationships? 




SACC South American Congress of Cardiology 


sCientiFiC ProgrAMMe By dAy And By tiMe 

sunday, 18 May 2008 

oPening CeRemony 

WoRld CongRess of CaRdiology 2008 

WelCome addRess 

by Argentinean Authorities 

oPening addRess 

Horacio Faella (ARGENTINA) 

President of the World Congress of Cardiology 2008 

Shahryar Sheikh (PAKISTAN) 

President of the World Heart Federation 

Rio de la Plata - Red Pavillion - 18.00 - 20.00 

Overflow in meeting rooms of the Yellow Pavillion 

Sidney Smith (UNITED STATES), Felipe Martínez (ARGENTINA), Arturo Cagide (ARGENTINA) 

Co-Chairmen of Scientific Programme Committee of the World Congress of Cardiology 2008 

Eduardo Mele (ARGENTINA) 

President of the Argentine Society of Cardiology 

Luíz Guzman (ARGENTINA) 

President of the Argentine Federation of Cardiology 

Hugo Grancelli (ARGENTINA) 

President of the XXIII Congress of the South American Society of Cardiology 

The Opening Address is followed by 

the ignaCio Chávez leCtuRe 

Fuster Valentin (UNITED STATES) 

Simultaneous translation Spanish-English / English-Spanish provided in Rio de la Plata – Thames – Danube


seine - gReen Pavillion - 08:30-10:00 

Oral abstract session 

myoCaRdial infaRCtion 

Chairs: Eduardo Morales Briceño (VENEZUELA), Carlos Boissonet (ARGENTINA) 

08:30 Are clinical characteristics, therapeutic interventions and in hospital outcome different in women with 

non ST-segment elevation acute coronary syndromes? 

H. Pomés Iparraguirre, P. Santander, G. Calderón, W. Santander, G. Andersen, O. Paredes, L. Ferrer, R. Aguero, 

G. Guthman, J. C. Olmos 

08:43 Early and late cardiogenic shock during acute myocardial infarction 

A. Charask, V. Mauro, L. Rodriguez, J. Zimmermann, M. Ferrer, E. Fairman, Y. Castillo Costa, H. Gomez Santamaria, 

J. Leguizamon, C. Barrero 

08:56 Role of embolic protection devices in acute myocardial infarction. Is their routine use of clinical benefit 

at 6 months? 

M. Masotti, H. Salazar, X. Freixa, N. Bellera, R. Kiamco, C. Fernández, M. Jiménez, S. Argiró, A. Betriu 

09:09 Late Recovery of Myocardial Blush 24 Hours After a Primary PCI Predicts Long Term Left Ventricular Function 

(LVF) Improvement. 

M.A. Riccitelli, J. Szarfer, P. Arce, A. García Escudero, G. Gigena, F. Blanco, R. Neme, R. Sarmiento, M. Gaito, L. Vidal 

09:22 Genetic Variability Of Platelet Glycoprotein Ia Regulates The Release Of Soluble CD40-Ligand And P Selectin 

During Acute ST-Elevated Myocardial Infarction 

C. Antoniades, D. Tousoulis, C. Vasiliadou, K. Marinou, N. Koumallos, E. Stefanadi, A. Antonopoulos, C. Tentolouris, 

K. Bakoyiannis, C. Stefanadis 

09:35 ST-T Elevation Myocardial Infarction Called By The Emergency Department: How Often Is It True? 

T. Vagaonescu, A. Hussain, A. Mehra, J. Plate, G. Batsides, A. Wilson, A. Moreyra 

09:48 Are women at risk for poor outcomes after percutaneous coronary intervention for acute myocardial infarction? 

M. Masotti, X. Freixa, N. Bellera, M. Jiménez, R. Kiamco, S. Argiró, C. Fernández, A. Betriu. 



Rio de la Plata - Red Pavillion - 08:30-10:00 


vulneRable Plaque and RegistRies 

Chairs: Conci Eduardo (ARGENTINA), Romero Carlos (URUGUAY) 

08:30 Managing ACS patients in 2004 and 2007: does practice makes perfection? 

C. Lourenço, R. Teixeira, S. Monteiro, N. António, S. Costa, F. Goncalves, P. Monteiro, L. Gonçalves, M. Freitas, 

L. Providência 

08:43 Vulnerable Plaque: Presence and characteristics in patients who died because of an acute stroke 

or cerebral trauma 

M. J. Vera Janavel, C. Vigliano, E. Gurfinkel 

08:56 Multicentric inflammation in coronary arteries in ischemic acute syndromes 

R. A. Sarmiento, C. Parisi, F. Blanco, R. Blanco, L. Romeo, S. Fandiño, E. Bit Chacock, M. Riccitelli, L. Vidal 

09:09 High Molecular Weight Adiponectin Is a Good Predictor for the Coronary Artery Soft Plaque 

R. Nakazato, M. Moroi, T. Furuhashi, H. Fukuda, K. Sugi 

09:22 Importance of the magnitude of cardiac troponin T and natriuretic peptide release for long-term riskstratification 

in decompensated heart failure. A report from the CIAST-HF (Collaborative Italo 

- Argentinean Study On Troponin-T In Heart Failure) Studies 

E. Perna, N. Aspromonte, J. P. Cimbaro Canella, G. Di Tano, S. M. Macin, L. Milani, M. L. Coronel, M. Milli, 

J. Parra Moreno, R. Valle 

09:35 Computed discharge report (Epi-Cardio) as a tool for a prospective multicenter registry of in-hospital 

cardiology activity. A GEDIC-ARIAM collaboration 

M. De Abreu, Horacio Pomes Iparraguirre, J. Benitez, S. Salzberg, A. Reina, I. Slimobich, P. Gitelman, J. Gagliardi, 

H. Doval, C. Tajer 

09:48 Clinical profiles and outcomes of Acute Aortic Dissection from 2000 to 2006, “Instituto Nacional del Corazón” 

ESSALuD, Lima – Peru. 

Gálvez Caballero, David Germán, Rosales Vidal, Maritza, Franco Escobar, David Lenin, Rodriguez Villegas, 

Jorge Morales Azcona, Rosa Maria, Zelaya Castro, Pio Daniel, Chacon Diaz, Manuel


mekong - oChRe Pavillion - 08:30-10:00 


CoRonaRy and non CoRonaRy inteRventions 

Chairs: Raúl Bretal (ARGENTINA), Roxana Mehran (UNITED STATES ) 

08:30 Which is the best strategy to treat patients with concomitant hypertrophic obstructive cardiomyopathy 

and coronary artery disease? 

SILVIA Judith Fortunato De Cano, MANUEL Nicolas Cano, ADRIANA C. Moreira, JAIRO Alves Pinheiro Jr., 

RICARDO Pavanello, VERA Marcia Lopes Gimenes, AMANDA Moraes R. Sousa, JOSE Eduardo Mr Sousa, 

ADIB Domingos Jatene 

08:43 The microvascular rheology of ultrasound contrast in ischemia-reperfusion injury, diabetes and sepsis 

A. Camarozano, F. Cyrino, E. Bouskela, A. Siqueira-Filho, K. Camarozano, R. Noe 

08:56 Multiple Coronary-Left Ventricle Communications: angiographic and clinical characteristics in 20 patients 

A. Dini, G. Tamashiro, C. Rando, M. Villegas, J. Diaz, J. Gomez, A. E. Ballestrini, A. Tamashiro 

09:09 A retrospective analysis of Contrast Induced Nephropathy (CIN) in 501 consecutive patients undergoing 

coronary angiograms done in a secondary centre 

I. Ternouth, C. Tibbatts, J. Sleigh 

09:22 StentBoost-A Novel Angiographic Technique to Evaluate Stent Expansion: Validation with Caliper Measurement 

M. Albertal, A. Candiello, F. Cura, L. T. Padilla, P. Perez Balino, S. Jozami, J. A. Belardi 

09:35 Extent and Patterns of Neointimal Hyperplasia Distribution after Drug-Eluting Stent Implantation in Diabetic 

Patients assessed by Intravascular ultrasound 

L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, 

L. Thuesen 

09:48 Evaluation of Collateral Circulation by Fractional Flow Reserve in Patients with Previous Myocardial 

Infarction: Relation to Chest Pain and ECG Changes 

B. Beleslin, M. Ostojic, S. Stojkovic, V. Vukcevic, G. Stankovic, D. Orlic, M. Nedeljkovic, A. Arandjelovic, J. Kostic, 

M. Dikic 



tigRis - yelloW Pavillion - 08:30-10:00 


exPeRienCe With st and non st elevation infaRCtion 

Chairs: Mònica Masotti (SPAIN), Juan Gagliardi (ARGENTINA) 

08:30 Significant decline in the age adjusted mortality rate from acute ST elevation myocardial infarction (STEMI) 

in the united States 

M. R. Movahed, M. Hashemzadeh, M. M. Jamal 

08:43 Impact of Combination Evidence-Based Medical Therapy used at Admission on In-Hospital Mortality in 

Patients With Non-ST-Elevation Myocardial Infarction 

z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky 

08:56 HDL-Cholesterol Improves Prediction of In-hospital Events in Individuals with unstable Angina or 

Non-ST-Elevation Acute Myocardial Infarction 

L. C. L. Correia, M. S. Rocha, J. P. Esteves 

09:09 Correlation between serum markers of inflammation, myocardial injury and thrombosis with coronary 

angiographic findings in patients with non-ST elevation acute coronary syndromes. 

Cyntia Karla Magalhães, Jose Geraldo Castro Amino, Aristarco Gonçalves Siqueira, Bernardo Rangel Tura, 

Vitor Manuel Pereira Azevedo, Marco Aurelio Santos, Rogerio Brant Martins Chaves, Regina Maria Aquino Xavier 

09:22 Nationwide trends in the incidence of non ST elevation myocardial infarction (NSTEMI) in the united States 


09:35 Heart-kidney connection: Renal fibrosis and activation of renal molecular remodeling after myocardial 

infarction in the absence of heart failure 

F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett 

09:48 Bisoprolol and standard therapy combination in patients with ischemic cardiomyopathy on long-term outcome 

K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan 

aRRhytmias i 

Chairs: Ivan Mendoza (VENEZUELA), Alberto Giniger (ARGENTINA) 

Rhine - yelloW Pavillion - 08:30-10:00 


08:30 Reperfusion arrhythmias: Are they only a marker of epicardial reperfusion or continuing myocardial ischemia 

after acute myocardial infarction? 

G. Heper, M. E. Korkmaz 

08:43 Cardiac palpitations in menopausal women due to non-sustained right atrial tachycardia (NSRAT) 

E. Sclarovsky 

08:56 The left-middle (septal) fascicular block 

P. Sanches, P. Moffa, A. Riera 

09:09 Clinical use of microvolt T wave alternans test in risk stratification of dilated cardiomyopathy 

G. Molon, A. Costa, T. De Santo, G. Ligorio, E. Barbieri 

09:22 NT-Pro-BNP decreases rapidly following cardioversion in patients with persistent atrial fibrillation and 

preserved ventricular function. 

C. Higa, J. Gambarte, G. Ciambrone, S. Donato, A. Escobar, P. D. Comignani, F. Novo, A. Macchia 

09:35 Therapeutic limitations conducts in octogenarians in Intensive Care unit 

J. Silva, M. Fervenza, T. Asmann, R. Azevedo, R. Della Pasqua, L. Peixoto, A. Tors, E. Marques, J. Freitas, A. Macedo 

09:48 Intravenous digoxin for the cardioversion of recent-onset atrial fibrillation: meta-analysis of randomized studies 

H. H. Veloso, A. V. De Paola


euPhRates - oChRe Pavillion - 08:30-10:00 


innovations in suRgiCal and PeRCutaneous valvulaR tReatments 

Chairs: Agatiello Carla (ARGENTINA), Borracci Raúl (ARGENTINA) 

08:30 Repair of anomalous left coronary artery from pulmonary artery. Early survival, outcomes and follow up. 

M. Pilan 

08:43 First uK experience of percutaneous aortic valve replacement 

H. Jilaihawi, T. Spyt, E. Logtens, J. C. Laborde, D. Chin, J. Kovac 

08:56 Percutaneous aortic valve replacement for severe aortic stenosis by core valve bioprosthesis 

G. Schuler, A. Linke, S. Möbius-Winkler, F. Mohr, T. Walther, J. Fassl 

09:09 Minimally invasive mitral valve surgery without aortic cross-clamping: An excellent solution for re-operative 

cardiac surgery 

S. S. Eagle, R. Umakanthan, M. Leacche, M. R. Petracek, R. M. Ahmad, J. M. Balaguer, J. P. Greelish, S. K. Ball, 

S. J. Hoff, J. G. Byrne 

09:22 Aortic root surgery: Ten-year experience at the Favaloro Foundation 

R. Favaloro, P. Roura, C. Salvatori, J. Diaz, H. Raffaelli, E. Dulbecco, J. Abud, C. Lopez, H. Casabe, E. Guevara 

09:35 The Ross procedure for the treatment of aortic valve disease in adult patients: mid and long term results 

at a single referral surgical center 

R. Favaloro, P. Roura, C. Salvatori, J. Diaz, E. Guevara, F. Vaisbuj, C. Rodriguez Correa, F. Salmo, C. Gomez, 

M. Bustamante Labarta 

09:48 Atherosclerotic burden among patients with acute aortic artery syndrome 

M. J. Fosco, M. P. Marturano, G. Procopio, R. Merbilháa, L. Cicco, R. Favaloro, F. Klein 

yangtze - oChRe Pavillion - 08:30-10:00 


CaRdiovasCulaR Risk faCtoRs in diffeRent PoPulations 

Chairs: Jorge Vilarino (ARGENTINA), Fernando Manzur Jattin (COLOMBIA) 

08:30 An assessment of cardiovascular disease risk factors and behavior in Pakistani adolescents 

S. I. Hassan, K. Kazmi, F. Jahan, S. H. Badruddin, S. Ahmed 

08:43 Impact of cardiovascular risk factors on the relationship between education and mortality. 

A Chilean prospective cohort study: the San Francisco Project. 

E. Koch, T. Romero, C. Akel, C. Diaz, L. Manriquez, M. Paredes, A. Taylor, C. Roman 

08:56 Factors associated with the cord blood lipid profile: Baseline data of a birth cohort study 

R. Kelishadi, Z Badiei 

09:09 EuROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and 

rehabilitation programme share the same risk factors? Do they change together? 

C. Jennings, T. Collier, A. Mead, J. Jones, A. Holden, S. Connolly, K. Kotseva, D. De Bacquer, G. De Backer, D. Wood 

09:22 Development of a valid cardiovascular risk model that aims to stimulate lifestyle changes in the population 

M.R. Cobain, P. Murray, J. Massaro, R. B. D'Agostino 

09:35 National Keshan Disease Surveillance 2007 

T. Wang, J. Hou, L. Zhang, J. Pei, H. Feng, Q. Li, B. Xu 

09:48 Prevalence and distribution of sub-clinical atherosclerosis by screening vascular ultrasound in a low and 

intermediate Framingham risk cohort 

J. Postley, A. Perez, N. D. Wong, M. Chan, J. Gardin 



missouRi - yelloW Pavillion - 08:30-10:00 


ReseaRCh in heaRt failuRe 

Chairs: Marcelo Montera (BRAZIL), Gimeno Graciela (ARGENTINA) 

08:30 Assessment of contractility and afterload mismatch as determinants of reduced ejection fraction in severe 

aortic stenosis with heart failure 

R. Migliore, M. Adaniya, M. Bruzzece, F. Saliva, M. Barranco, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi 

08:43 Invasive and non-invasive evidences of cardiac function and morphology improvement in trained infarcted rats 

L. Jorge, B. Rodrigues, J. Paulini, K. Rosa, K. De Angelis, M. C. Irigoyen 

08:56 Inspiratory muscle training improves distribution of blood flow to resting and exercising limbs in heart failure 

(WITHDRAWN) 

G. R. Chiappa, B. T. Roseguini, P. J. C. Vieira, C. N. Alves, A. Tavares, E. R. Winkelmann, E. L. Ferlin, R. Stein, J. P. Ribeiro 

09:09 Physical training improves haemodynamic function, muscle oxidative stress and plasmatic levels 

of IL-10 in chronic heart failure rats 

P. Dall'Ago, R. B. Nunes, M. Tonetto, N. McHado, M. Chazan, T. G. Heck, A. B. G. Veiga 

09:22 Association of oxygen uptake efficiency slope with other prognostic variables in heart failure 

S. Miriuka, D. Delgado, M. Walker, S. Carson, H. Ross 

09:35 Changes of endogenic intoxication during ivabradin and beta blockers therapy at patients with 

decompensated CHF 

N. A. Bylova, G. P. Arutyunov, A. G. Arutyunov, A. L. Volkova 

09:48 Assessment of cardiotoxicity of imatinib mesylate in chronic myeloid leukemia patients - a cross-sectional study 

M. S. Marcolino, H. N. S. Bittencourt, N. C. D. Clementino, M. M. Barbosa, M. C. P. Nunes, V. F. Xavier, A. L. P. Ribeiro 

aCute and ChRoniC heaRt failuRe 

Chairs: Roberto Ricca (URUGUAY), Eduardo Sampo (ARGENTINA) 

danube - gReen Pavillion - 08:30-10:00 


08:30 Immediate reversion of myocardial ischemic dysfunction after coronary angioplasty. 

Jose Geraldo Castro Amino, Aristarco Gonçalves Siqueira, Bernardo Rangel Tura, Vitor Manuel Pereira Azevedo, 

Marco Aurelio Santos, Rogerio Brant Martins Chaves, Regina Maria Aquino Xavier 

08:43 Metabolic syndrome does not imply worse prognosis in systolic heart failure (WITHDRAWN) 

J. Thierer, N. Vainstein, A. Acosta, J. Marino, D. Ametrano, A. Francesia, V. Mezzalira, M. Trivi, M. Sutton, F. Brites 

08:56 Acute myocardial infarction in patients with prior coronary artery bypass surgery; 19-year experience 

P. Mitrovic, B. Stefanovic, V. Vukcevic, N. Radovanovic, M. Radovanovic, D. Rajic, G. Matic, P. Erceg, Z. Vasiljevic, 

M. Ostojic 

09:09 Safety and efficacy of the utilization of continuous I.V. infusion of Levosimendan out of the Coronary 

Care unit setting. 

L. A. Guzman, G. Moré, R. Sarjanovich, G. B. Scaro, A. Vanella 

09:22 Comparison of the effects on plasma neutrophils count of two ARBs in hypertensive patients 

J. Said Nisi, M. Benderski, J. Martinez, F. Martinez 

09:35 Thrombolysis in patients with myocardial infarction after previous coronary artery bypass surgery; 

19-year experience 


M. Ostojic 

09:48 Structural alterations of large intestinal wall role in development of chronic heart failure 

N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya, N. A. Savelov, Y. A. Pokrovskiy, N. V. Kokosadze, A. V. Risnenko, 

Z. A. Chernaya, T. K. Chernyavskaya, M. I. Korsunskaya


liPids, obesity and metaboliC syndRome 

Chairs: Carlos Cuneo (ARGENTINA), Masao Sano (PARAGUAY) 

nile - yelloW Pavillion - 08:30-10:00 


08:30 Significant differential metabolic effects of lipophilic and hydrophilic statins in hypercholesterolemic patients 

K. Koh, M. Quon, S. Han, W. J. Chung, B. Oh, E. Shin 

08:43 Prevalence of metabolic syndrome and associated risk factors and the impact of acculturation among 

multiethnic u.S adolescents 

S. L. Bassin, A. Perez, V. Lopez, N. D. Wong 

08:56 Relationship between race/ethnicity, education and household income, and the prevalence of metabolic 

syndrome: impact of education in the burden of cardiovascular disease in women 

S. yala, E. Fleck, R. Sciacca, D. Castro, E. Giardina 

09:09 Spleen derived vascular progenitor cell transfer restores metabolic and vascular insulin sensitivity in high-fat 

diet insulin resistant mice 

J. Bloch, M. Schwab, P. Dessen, C. Mathieu, A. Monney, H. Duplain, P. Nicod, C. Sartori, U. Scherrer 

09:22 Waist circumference and its association with classic cardiovascular risk factors in healthy women. 

Maria Teresa Lira, S. Kunstmann, E. Caballero, D. Gainza, J. C. Molina 

09:35 Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition 

(WITHDRAWN) 

A. Pouta, J. Pirkola, T. Tammelin, A. Bloigu, J. Laitinen, A. Ruokonen, P. Tapanainen, M. R. Järvelin, M. Vääräsmäki 

09:48 Accuracy of anthropometric measures of adiposity to predict cardiovascular risk factors in Chilean men and 

women. The San Francisco Project. 

E. Koch, T. Romero, C. Diaz, L. Manriquez, M. Paredes, C. Roman, A. Taylor 

PilComayo - yelloW Pavillion - 08:30-10:00 


diet, dRugs and CaRdiovasCulaR disease 

Chairs: J Fernandes (BRAZIL), Ricardo Esper (ARGENTINA) 

08:30 Lipid-altering efficacy and safety profile of co-administered extended release Niacin/Laropiprant and 

Simvastatin in patients with dyslipidemia 

L. Ose, M. Farnier, G. Gleim, N. Liu, S. Thompson-Bell, K. Beckey, A. O. Johnson-Levonas, C. Ballantyne, J. F. Paolini 

08:43 A two-year study to assess the efficacy, safety, and tolerability of Taranabant in obese patients: 52 week results 

M. Moreno, I. Gantz, N. Erondu, S. Suryawanshi, B. Musser, J. Nayee, A. O. Johnson-Levonas, S. Heymsfield, J. Amatruda 

08:56 Comparison of the omega-3 index in the acute coronary syndromes in a beef-eating population in Argentina 

as compared to a fish-eating population in Norway. 

R. Leòn De La Fuente, H. Aarsetoey, S. Kiserud, H. Grundt, E. Lovaglio, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, 

D. W. T. Nilsen 

09:09 Plant sterol-enriched spread enhances the cholesterol-lowering potential of ezetimibe in coronary patients 

already taking statins but not reaching lipid goals 

G. B. Gomes, A. D. Zazula, L. S. Shigueoka, R. A. Fedato, J. R. Faria Neto 

09:22 Low levels of antibodies against phosphorylcholine predict development of atherosclerosis 

J. Frostegård, B. Sjöberg, J. Su, H. Grönlund, I. Dahlbom, B. Hedblad, G. Berglund, U. De Faire 

09:35 Green and black tea are equally potent stimuli of NO production and vasodilation: New insights into tea 

ingredients involved 

V. Stangl, N. Jochmann, M. Lorenz, J. Urban, G. Baumann, M. Laule, K. Stangl 

09:48 Development of atherosclerosis: role of systemic inflammation and endotoxin 

N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya 



ReseaRCh in hyPeRtension 

Chairs: Brandão Ayrton (BRAZIL), Cristina Arranz(ARGENTINA) 

oRinoCo - oChRe Pavillion - 08:30-10:00 


08:30 Comparison of abdominal obesity and total obesity in predicting risk of prehypertension status 

with reference to economic development in the south-west of Congo Kinshasa 

B. Longo-Mbenza, J. B. Kasiam Lasi On’kin, A. Nge Okwe, D. Vangu Ngoma, S. Mbungu Fuele, G. Milongo Dipa 

08:43 Left ventricular mass and diastolic function in patients undergoing renal artery stenting 

T. Przewlocki, D. Rzeznik, A. Kablak-Ziembicka, M. Kostkiewicz, A. Roslawiecka, A. Kozanecki, W. Tracz 

08:56 Baroreflex dysfunction by sinoaortic denervation increases cardiac damage in hypertension 

K. Flues, I. C. M. Silva, J. Paulini, R. N. De La Fuente, E. D. Moreira, C. Mostarda, K. De Angelis, M. C. Irigoyen 

09:09 Cholinergic stimulation with Pyridostigmine improves the chronotropic response during exercise 

and heart rate recovery in heart failure patients 

A. Nobrega, S. Serra, R. Vivacqua, S. Xavier 

09:22 Association between Consumption of a DASH-type diet and blood pressure in adults from southern Brazil 

S. C. Fuchs, A. Celestini, L. B. Moreira, R. L. Henn, F. C. Fuchs, F. D. Fuchs 

09:35 Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs 


09:48 The presence of nitric oxide synthase genetic polymorphism decreases arterial baroreflex sensitivity 

after maximal exercise 

F. Neves, B. Silva, A. Sales, N. Rocha, T. Barbosa, V. Stelet, R. Gonçalves, P. Soares, A. Nobrega 

volga - yelloW Pavillion - 08:30-10:00 


PediatRiC CaRdiology: fRom neonates to gRoWn-uP 

Chairs: Alberto Sciegata (ARGENTINA), John Cheatham (UNITED STATES ) 

08:30 Levosimendan for cardiac failure in postoperative management of cardiac surgery for congenital 

heart disease in neonates 

C. R. Ferreiro, M. A. O. Barbosa, M. B. Jatene, I. Jatene, L. C. B. Souza, E. R. Romano, E. T. Egito, S. F. Pedra, 

V. Fontes, J. E. Sousa 

08:43 Outcomes of 124 consecutive congenital heart surgical procedures. Analysis through a variable 

life adjusted display. 

E. Juaneda, B. Vega, R. De Rossi, O. Lazzarín, E. Banille, I. Azar, L. Alday 

08:56 Anomalous origin of left coronary artery from pulmonary artery: outcome after surgical repair. 

I. Lugones, M. Cazalas, A. Sardella, M. I. Roman, C. Kreutzer, J. L. Simon, A.J. Schlichter 

09:09 Spectrum of conotruncal congenital heart malformations in patients with 22q11.2 chromosome microdeletion 

E. Juaneda, N. Rossi, A. Sturich, C. Montes, R. Schumiachkin, A. Chávez, B. Vega, L. Alday 

09:22 Stenting coarctation of the aorta with Cheatham platinum stent: initial results 

R. Gamboa, F. P. Mollon, R. E. Rios Mendez, D. Antoni, G. M. Arro 

09:35 Optimal programming of the ICD in children and young adults on the basis of long term follow-up. 

M. Lewandowski, A. Przybylski, P. Syska, M. Sterlinski, A. Maciag, H. Szwed 

09:48 Grown-up congenital heart disease treated in pediatric catheterization laboratory 

R. E. Rios Mendez, R. Gamboa, F. P. Mollon, G. M. Arroyo, D. F. Gutierrez, H. Mon, H. E. Montero Monar, 

L. R. Valdivieso Cedeño, O. A. Mendiz, A. Fogel


nigeR - gReen Pavillion - 08:30-10:00 


hyPeRtRoPhy and dysfunCtion of CaRdiaC Cells 

Chairs: Horacio F. Cingolani F (ARGENTINA), Kelly David T (AUSTRALIA) 

08:30 Ovarian hormones deprivation induces cardiovascular autonomic dysfunction associated with cholesterol 

levels in LDL knockout mice 

J. Paulini, K. Flues, M. Heeren, C. Mostarda, E. D. Moreira, K. De Angelis, M. C. Irigoyen 

08:43 Endothelial function in healthy subjects exposes to hypobaric hypoxia 

D. Iglesias, N. Vainstein, F. Brites, L. Rosso, C. Pesce, C. Lezon 

08:56 Functional role of the arginase II in modulating cardiac contractility in mice with and without pressure overload 

C. H. M. Azevedo, D. Gonzales, G. Joseph, A. M. Benjo, H. C. Champion, D. Nyhan, A. A. Shoukas, J. M Hare, D. Berkowitz 

09:09 Diagnosis of acute cellular cardiac allograft rejection by endomyocardial biopsy performed in a teaching 

hospital from 1984 to 2007 

S. Bordignon, E. Horowitz, M. Barra, L. Lima, J. Vieira, P. Ruschell, P. Cordeiro, V. Porto, S. Fonseca, I. Nesralla 

09:22 Angiotensin AT2 receptor mediates cardiac c-kit+ cell proliferation and supports survival of cardiomyocyte 

W. Altarche-Xifró, C. Birka, E. Kaschina, M. Timm, A. Grzesiak, C. Curato, M. Brinckmann, T. Unger, J. Li 

09:35 Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy 

in families with hypertension 

B. M. Mayosi, P. J. Avery, M. Farrall, B. Keavney, H. Watkins 

09:48 Echocardiographic study of left ventricular geometry in spontaneously hypertensive rats 

O. A. Pinilla, V. B. Carranza, E. M. Escudero 

tibeR - yelloW Pavillion - 08:30-10:00 


CliniCal and exPeRimental atheRosCleRosis 

Chairs: Luis De La Fuente (ARGENTINA), Zeljko Reiner (CROATIA) 

08:30 Simvastatin improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity 

in overweight hypercholesterolemic patients independent of doses 


08:43 Effects of Peroxisome Proliferator Activated Receptor gamma (PPAR gamma) stimulation 

in hypercholesterolemic rabbits with induced vascular lesion 

A. Alessi, L. Baroncini, O. França, C. Prim, D. Précoma 

08:56 Is hereditary thrombophilia a contributing factor in premature myocard infarction? 

M. Kayikcioglu, C. Hasdemir, M. Ildizli, L. Can, S. Payzin, Z. Eroglu, E. Y. Sozmen, B. Saygi, H. Kultursay 

09:09 EP2300 compounds, novel squalene synthase inhibitors, reduce atherosclerosis in vivo 

A. Tavridou, L. Kaklamanis, A. P. Kourounakis, P. N. Kourounakis, A. Charalambous, V. G. Manolopoulos 

09:22 Aatorvastatin inhibits the RHO A/RHO kinase pathway and, reduces blood pressure and the expression 

of vascular remodeling genes in rats with genetically high levels of angiotensin II 

P. Rivera, M. Ocaranza, J. Jalil 

09:35 Overall atherosclerosis burden in patients with end-stage renal disease who are receiving hemodialysis. 

W. Masson Juarez, I. Bluro, R. Ricardo, G. Rosadiez, V. Aliperti, A. Elizalde, J. Krauss, A. Cagide 

09:48 Rosiglitazone effects on counterlateral iliac artery after vascular injury in hypercholesterolemic rabbits 

O. R. França Neto, A. Alessi, C.R. Prim, R. F. K. Caetano Da Silva, L. De Noronha, A. Caporal, L. A. V. Baroncini, 

D. B. Precoma 



ganges - gReen Pavillion - 08:30-10:00 


stRoke and CaRotid aRteRy stenting 

Chairs: Fernando Vinuela (UNITED STATES ), Jorge Bluguerman (ARGENTINA) 

08:30 ENERI experience in carotid artery stenting. Lesson learned and current practice in 1013 patients. 

P. Lylyk, A. Musacchio, A. Ferrario, C. Miranda, R. Ceratto, J. Vila, P. Angelani, J. Manterola, C. Ingino 

08:43 Siriraj subtypes stroke and validation study in Kinshasa 

B. Longo-Mbenza, J. C. Mbete Tsasa, M. Lelo Tshikwela, P. Mbuilu, D. Vangu Ngoma, S. Mbungu Fuele 

08:56 Long-term survival after ‘tailored’ carotid artery stenting: Results from an academic registry 

of 555 consecutive procedures 

P. Pieniazek, L. Tekieli, P. Musialek, A. Kablak-Ziembicka, T. Przewlocki, A. Lesniak-Sobelga, B. Biernacka, K. Zmudka, 

W. Tracz 

09:09 Initial experience and mid term follow up with intracranial endovascular reconstruction aneurysm treatment 

with a new stent pipeline 

P. Lylyk, C. Miranda, A. Berez, K. Nelson, E. Scrivano, R. Romero, C. Ingino 

09:22 Percutaneous closure of patent foramen ovale with Amplatzer® device for secondary cryptogenic stroke 

prevention. immediate results and middle term follow-up analysis 

M. Borges, P. Machado, E. Horowitz, L. François, J. Silva, R. Rossi 

09:35 Risk factors of stroke among Congolese black hypertensive diabetics 

B. Longo-Mbenza, R. Mombo Ngimbi, D. Vangu Ngoma, S. Mbungu Fuele, B. Buassa-Bu-Tsumbu 

09:48 Quality of stroke care in Argentina. Insights from The Argentinian National Stroke Registry (ReNACer) 

L. A. Sposato, M. M. Esnaola, M. C. Zurru, R. Zamora, O. Fustoni, G. Saposnik 

thames - yelloW Pavillion - 08:30-10:00 


CoRonaRy and non CoRonaRy endovasCulaR tReatment i 

Chairs: Deborah Nercolini (BRAZIL), Fernando Cura (ARGENTINA) 

08:30 Revival of percutaneous balloon aortic valvuloplasty in non surgical patients with degenerative aortic 

stenosis as bridge for percutaneous aortic valve replacement 

C. Agatiello, H. Eltchaninoff, C .Tron, D. Nercolini, C. Rojas Matas, D. Berrocal, A. Cribier, L. Grinfeld 

08:43 Abdominal Aortic Aneurysm Evolution after Endovascular Repair. 

G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, J. Scaglia, P. Mollon 

08:56 Descending aorta endovascular repair: Dissection vs. non dissection disease 

G. Lev, O. Mendiz, L. Valdivieso, C. Fava, L. Villagra, J. Scaglia, P. Mollon 

09:09 Contribution to the clinical recognition of severe coronary disease in women 

C. Serra MD, P. H. M. Del Sueldo, MD, S. Joekes, Magister, G. Pacheco, MD, J. Floridia, MD, H. Cuezo, MD, 

P. Grosse, MD, A. Righetti, Magister, J. Sala, MD, C. Balestrini, MD 

09:22 Therapeutic interventions based on findings in stored electrographs of patients with definitive pacemakers. 

G. M. M. Pellegrino, D. F. Ortega, L. D. Barja, N. Mangani, L. Mari 

09:35 Effects of the late reperfusion of the infarct-related artery on mortality, morbidity and left ventricular 

remodelling. A metaanalysis of randomised controlled trials. 

J. Mariani, H. Cohen Arazi, C. Tajer 

09:48 Are we treating the right non-ST acute coronary syndrome patients with an invasive strategy? 

R. Teixeira, C. Lourenço, S. Monteiro, N. Antonio, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, 

L. A. Providencia


huang he - yelloW Pavillion - 08:30-10:00 


3d eChoCaRdiogRaPhy 

Chairs: Eduardo Guevara (ARGENTINA), Jose Fernando Guadalajara (MEXICO) 

08:30 utility of the real time 3D echocardiography for assessment of left ventricular mass in patients with 

hypertrophic cardiomyopathy. Comparison with cardiac magnetic resonance 

G. Avegliano, M. Huguet, P. Kuschnir, J. Thierer, C. Tobon, D. Capdeferro, C. Burnikoff, A. Frangi, M. Petit, 

R. Ronderos 

08:43 Non invasive estimation of end-diastolic pressure in patients with preserved and reduced ejection fraction. 

A new single method using stroke volume and deceleration time. 

R. Migliore, M. Adaniya, D. Duarte, M. Barranco, J. Poch, J. Lloveras, A. Greco, D Pisano, H. Tamagusuku, A. Sinisi 

08:56 Left ventricular systolic performance, function and contractility in patients with severe sepsis or septic shock 

D. Chejtman, A. Hita, S. Baratta, P. Pratesi, J. Bilbao, H. Fernandez, D. Bernardez, D. Turri 

09:09 Real-time three dimensional echocardiographic left ventricular systolic evaluation: comparison between 

dyssynchrony indexes and ejection fraction 

M. L. C. Vieira, V. M. L. Gimenes, W. A. Oliveira, G. Naccarato, A. Cury, J. Pinheiro Jr, M. M. Andrade, S. F. P Pedra, 

C. H. Fischer, S. S. Morhy 

09:22 Epicardial fat as a contributing factor to diastolic dysfunction 

S. B. yoon, S. J. Eum, E. J. Lee, P. K. Min, Y. W. Yoon, B. K. Hong, H. M. Kwon, H. S. Kim, S. J. Rim 

09:35 Systolic aortic regurgitation: Pathogenesis, doppler hemodynamic mechanisms and natural history 

J. Mohan, D. Tomar, C. Shekhar 

09:48 Value of contrast echocardiography for the diagnosis of hepatopulmonary syndrome: prevalence in patients 

with liver transplantation indication 

F. L. Weich Glogier, T. F. Cianciulli, J. Vilkas Anzorena, F. Spernanzoni, M. C. Saccheri, J. A. Lax, A. N. Dorelle, 

H. A. Prezioso, L. A . Vidal, O. C. Imventarza 

diabetes and CaRdiovasCulaR Risk 

Chairs: Guzman L (ARGENTINA), Raul Pisabarro (URUGUAY) 

08:30 Type 2 Diabetes mellitus is strongly associated with third degree AV-block 


08:48 Relationship between Acute Myocardial Infarction and Glycemic Status 

L. Ribeiro, P. Nogueira, R. Berber, R. Ramos, A. Timerman, C. Gun, L. Piegas 

PaRaná - oChRe Pavillion - 08:30-10:00 


09:06 The impact of diabetes mellitus on outcomes in patients undergoing primary percutaneous coronary 

intervention for ST segment elevation myocardial infarction. 

L. O. Jensen, M. Maeng, P. Thayssen, A. Kaltoft, H. Tilsted, M. Bottcher, J. F. Lassen, L. Pedersen, S. P. Johnsen, 

L. Thuesen 

09:24 Are all forms of pre-diabetes born equal regarding acute coronary syndromes outcome? 

N. Antonio, C. Lourenco, P. Monteiro, S. Monteiro, S. Costa, R. Teixeira, F. Goncalves, L. Goncalves, M. Freitas, 

L. A. Providencia 

09:42 Multiethnic prevalence of abdominal obesity and associated cardiometabolic risk factor burden 

in u.S. adults 2003-2004 

H. Ghandehari, V. Le, S. Kamal-Bahl, S. L. Bassin, N. D. Wong 



mississiPPi - yelloW Pavillion - 08:30-10:00 


geneRal CaRdiology i 

Chairs: Victor Sinisi (ARGENTINA), Eduardo Roura (ECUADOR) 

08:30 Fuzzy logic. A new internet tool for heart rhythm classification. 

M. Lewandowski, A. Przybylski, W. Kuzmicz, J. Ollitrault, A. Blinowska, H. Szwed 

08:43 Different methods for mechanical dyssynchrony assessment and prognosis in heart failure 

M. Trivi, J. Thierer, R. Ronderos, P. Kuschnir, R. Guglielmone, A. Acosta, A. Hirshon Prado, V. Mezzalira, M. Sultán, J. Marino 

08:56 Preliminary evaluation of the safety and effect of pancreatic adult stem cell implantation 

in Diabetes Mellitus type 1 patients. 

A. Mesples, B. Pertiné, R. Bellomo 

09:09 Is fibrinogen a predictive factor for albuminuria in type 2 diabetes ? 

A. C. Cordeiro, C. C. Gonzaga, M. G. Sousa, F. O. Borelli, O. Passarelli Jr, L. Lotaif, L. S. Piegas, C. Amodeo 

09:22 Left and right atrial appendage function after percutaneous mitral valvuloplasty in mitral stenosis 

and sinus rhythm. 

T. F. Cianciulli, M. C. Saccheri, J. A. Lax, R. A. Sarmiento, A. M. Bermann, J. E. Guerra, J. A. Gagliardi, A. N. Dorelle, 

H. A. Prezioso, L. A. Vidal 

09:35 Carotid intima-media thickness predicts cardiovascular events in patients with atherosclerosis 

A. Kablak-ziembicka, T. Przewlocki, W. Tracz, I. Stopa, P. Pieniazek, P. Musialek, A. Kozanecki 

09:48 Age evaluation with cardiac doppler of the heart in young sportsmen category amateur soccer 

D. Avayu, D. Morisse, J. Goral, J. Fuse, C. Seidler, C. Froimovich, L. Rodas, I. Diaz, L. Cimerman 

amazon - yelloW Pavillion - 08:30-10:00 

South American Congress of Cardiology 

oPening CeRemony 

xxiii CongReso sudameRiCano de CaRdiología 

08:30 Opening Ceremony - XXIII Congreso Sudamericano de Cardiología 

ConfeRenCia: 

Presidente: Sergio Varini (ARGENTINA) 

09:00 Imagen y genoma como estrategias de prevención en el futuro. The HRP Study. 

Fuster Valentin (UNITED STATES ) 


How-to & Workshop Session 

inteRPRetation of the diffiCult eCg: PRaCtiCal aPPRoaCh 

Chairs: Alberto Giniger (ARGENTINA), Dario Sobral (BRAZIL) 

10:30 Supraventricular tachycardia 

Ivan Mendoza (VENEZUELA) 

11:15 Ventricular tachycardia 

Günter Breithardt (GERMANY)



Symposium 

atRial fibRillation: non-PhaRmaCologiCal tReatment 

Chairs: Carlos Labadet (ARGENTINA), Galvao Silas (BRAZIL) 

10:30 Management of atrial fibrillation in patients with heart failure: From drug therapy to ablation 

Shih-Ann Chen (CHINA, TAIWAN) 

10:52 Catheter ablation of atrial fibrillation in brady-tachy syndrome 

Yunlong Xia (CHINA, PEOPLE'S REPUBLIC OF) 

11:14 Strategies and results of catheter ablation of atrial fibrillation 

Andrea Natale (UNITED STATES ) 

11:36 Where are we going with management of atrial fibrillation 

Adrian Baranchuk(CANADA) 


Symposium 

CaRdiaC ResynChRonisation theRaPy (CRt) - PaRt one 

Chairs: Ramos José Luis (ARGENTINA), Ricardo Miglino (BRAZIL) 

10:30 Left ventricular dyssynchrony: Impact on function and structure 

John Gorcsan III (UNITED STATES ) 

10:52 Right ventricular pacing: The unwanted model of dyssynchrony? 

Jose Carlos Pachon Mateos (BRAZIL) 

11:14 How to assess left ventricular dyssynchrony? 

Cheuk-Man Yu (CHINA, PEOPLE'S REPUBLIC OF) 

11:36 Impact of CRT on atrial fibrillation and atrial function 

Michael Gold (UNITED STATES ) 

aCute deComPensated heaRt failuRe 

Chairs: John Cleland (UNITED KINGDOM), Carlos García (COLOMBIA) 

10:30 Neurohumoral aspect of acute heart failure 

Mihai Gheorghiade (UNITED STATES ) 

10:52 Clinical aspect of acute heart failure: The ADHERE registry 

Guillermo Torre Amione (UNITED STATES ) 

11:14 When to use inotropic therapy 

Fabio Vilas-Boas (BRAZIL) 

11:36 New perspectives in the treatment of acute heart failure 

Faiez Zannad (FRANCE) 


Symposium 




Symposium 

advanCes in genetiCs 

Chairs: Alicia MattiazzI (ARGENTINA), Walter Reyes Caorsi (URUGUAY) 

10:30 The genetics of atrial fibrillation 

Johannes Brachmann (GERMANY) 

11:00 Clinical correlates of long QT syndrome mutations 

Christian Wolpert (GERMANY) 

11:30 Role of obesity and adiponectin in heart disease 

Kwang Koh (KOREA, REPUBLIC OF) 


Symposium 

seveRe PulmonaRy insuffiCienCy afteR Congenital heaRt suRgeRy 

Chairs: Ademar Atik(BRAZIL), Pilar Arnaiz (CHILE) 

10:30 The impact of pulmonary insufficiency on GuCHS patients 

Alex Javois (UNITED STATES ) 

10:48 Evaluation of right ventricular function 

David Sahn (UNITED STATES ) 

11:06 Timing of pulmonary valve replacement 

Miguel L Barbero Marcial (BRAZIL) 

11:24 Transcatheter pulmonary valve insertion 

Ziyad Hijazi (UNITED STATES ) 

11:42 Surgeon's perpsective 

Christian Kreutzer (ARGENTINA) 


Clinical Seminar 

novel ConCePts in hyPeRtension tReatment 

Chairs: Carlos Ferrario (UNITED STATES ), Oscar Carretero (UNITED STATES ) 

10:30 The Renin Inhibition in hypertension? 

Alberto Villamil (ARGENTINA) 

10:52 Betablockers in Hypertension today 

Lars Lindholm (SWEDEN) 

11:14 Which combination of anti-hypertensive drugs is the most effective to reduce blood pressure? 

Marcelo Orias (ARGENTINA) 

11:36 Gap between patients and physicians attitudes and awareness toward hypertension and its complication 

in cardiovascular diseases 

Luis Ruilope (SPAIN)


CaRdiaC Rehabilitation PRogRammes 

Chairs: Erika S Froelicher (UNITED STATES ), Puska Pekka (FINLAND) 

10:30 Cardiac Rehabilitation in Latin America: Survey results 

Hermes Ilarraza-Lomeli(MEXICO) 

10:48 Simplified Methods of cardiac rehabilitation programs 

Marian Worcester (AUSTRALIA) 

11:06 Risk benefits of exercise 

Alan Goble (AUSTRALIA) 

11:24 Models of cardiac rehabilitation programs for low and middel income countries 

Sarraf-Zadegan Nizal (IRAN, ISLAMIC REPUBLIC OF) 

11:42 Cardiac Rehabilitation: the Cuban Model 

Eduardo Rivas Estany (CUBA) 


Symposium 



PhaRmaCotheRaPy in heaRt failuRe: neW dRugs oR neW benefits? 

Chairs: Kelly David T (AUSTRALIA), Cesare Orlandi (UNITED STATES ) 

10:30 What is new in aldosterone blockage? 

Willem Remme (NETHERLANDS) 

10:52 Vasopressin receptor antagonists in heart failure 

Marvin Konstam (UNITED STATES ) 

11:14 New beta blockers: New actions? 

Juan Gonzalez Juanatey (SPAIN) 

11:36 New drugs in heart failure: What is really new? 

Philip A Poole-Wilson (UNITED KINGDOM) 



Common Challenges in the eveRyday PRaCtiCe of nuCleaR CaRdiology 

Chairs: Claudio Meneghetti (BRAZIL), Adel Allam (EGYPT) 

10:30 How to study obese patients? 

Joao Vitola (BRAZIL) 

10:48 Patients referred for viability assessment 

Erick Alexanderson (MEXICO) 

11:06 Patients with 50% stenosis in multi-slide computed tomography studies 

Marcelo Goldstein (BELGIUM) 

11:24 Patients with chest pain and negative ECG 

Anibal Mele (ARGENTINA) 

11:42 Clinical use of cardiac PET 

Barry Zaret (UNITED STATES ) 




Debate 

tReatment of Chagas disease 

Chairs: Roberto Blandon Calderon (PANAMA), Fernando Aguirre (ECUADOR) 

Statement 1: 

10:30 Treatment of chronic Chagas disease with current anti-parasitic drugs 

Pro: Rosalia Morais Torres (BRAZIL) 

Contra: Jose Milei (ARGENTINA) 

Statement 2: 

11:15 Treatment of asymptomatic ventricular arrhythmias 

Pro: Jorge Mitelman (ARGENTINA) 

Contra: Juan Justiniano Encina (BOLIVIA) 


Symposium 

CuRRent tReatment of myoCaRdial infaRCtion: 

fRom evidenCe to CliniCal PRaCtiCe 

Chair: Fuster Valentin (UNITED STATES ) 

10:30 un-treated patients: How to reduce lost opportunities? 


10:52 Reperfusion strategies in the emergency treatment of ST-segment elevation myocardial infarction 

Oscar Bazzino (ARGENTINA) 

11:14 Predictors of one year mortality in high risk patients 

Frans Van De Werf (BELGIUM) 

11:36 Guidelines revised 

Rafael Diaz (ARGENTINA) 



unResolved issues on CoRonaRy inteRventions 

Chairs: Raúl Bretal (ARGENTINA), Gao Runlin (CHINA, PEOPLE'S REPUBLIC OF) 

10:30 Late and very late stent thrombosis: New classification and outcomes 

Donald Cutlip (UNITED STATES ) 

10:52 Clinical trials: Long-term follow-up regarding DES safety 

Bonnie Weiner (UNITED STATES ) 

11:14 LIMA showed 30 years effectiveness: What happened with stent PCI in the last 30 years? 

Julio Palmaz (UNITED STATES ) 

11:36 Which benefits does DES have shown in comparison with BMS at long-term follow-up? 

Carlos Macaya (SPAIN)




aCute CoRonaRy syndRome in the eldeRly 

Chairs: Jose Antonio Francisco Ramires (BRAZIL), Eduardo Roura (ECUADOR) 

10:30 Risk stratification and management strategy in the elderly with non-ST ACS 

Mauricio Cohen (UNITED STATES ) 

10:52 Is the aggressive medical treatment beneficial in the elderly? 

Rodolfo Pizarro (ARGENTINA) 

11:14 Antithrombotic treatment in St. miocardial infarction 

Acevedo Monica (CHILE) 

11:36 Prognosis and presictors of survival in St. miocardial infarction 

Satyavan Sharma (INDIA) 



advanCes in CaRdioPulmonaRy ResusCitation 

Chairs: Alejandro Barbagelata (UNITED STATES ), Eduardo Hasbani (ARGENTINA) 

10:30 Pathophysiology evolution of the RCP in the last 10 years 

Kern Karl B (UNITED STATES ) 

10:52 Vasopressin: Is it an alternative or a better option than ephinefrine? 

Ari Timerman (BRAZIL) 

11:14 Post-resuscitation care: Induced hypothermia to whom, how and when? 

Jorge Neira (ARGENTINA) 

11:36 In hospital resuscitation: Outcomes and prediction of survival 

Timerman Sergio (BRAZIL) 


Symposium 

tReatment of hyPeRtension in sPeCial situations 

Chairs: Hugo Baglivo (ARGENTINA), Sokn Fernando (ARGENTINA) 

10:30 Hypertension in pregnancy 

Gloria S. Valdes (CHILE) 

10:52 Pediatric and adolescent hypertension 

Andrea Brandão (BRAZIL) 

11:14 In elderly, 80 years and above 

Kjeldsen Sverre E (NORWAY) 

11:36 In resistant hypertension 

Antonio Coca (SPAIN) 




Special Featured Joint Session 

msi: the metaboliC syndRome: 

gRoWing PRevalenCe in latin ameRiCa and tReatment needs 

Chairs: Romero Carlos (URUGUAY), Piñeiro Daniel (ARGENTINA) 

10:30 The emerging obesity problem in Latin America 

Ada Cuevas (CHILE) 

10:52 Drug therapy for the dyslipidemia of the Metabolic Syndrome 

Jean Charles Fruchart (FRANCE) 

11:14 The Metabolic Syndrome as a risk factor for diabetes 

Pablo Aschner (COLOMBIA) 

11:36 The Metabolic Syndrome as a risk factor for cardiovascular disease 

Scott Grundy (UNITED STATES ) 



aCC: Regional Challenges to 

the PRevention and tReatment of Cvd in the u.s. 

Chairs: W. Douglas Weaver (UNITED STATES ), Mele Eduardo (ARGENTINA) 

10:30 Cardiovascular imaging for prevention and treatment of CV disease in the u.S.: Challenges and opportunities 

George Beller (UNITED STATES ) 

10:52 The quality - first vision: building a learning health care system 

Jack Lewin (UNITED STATES ) 

11:14 Challenges in maximizing functional capacity in elderly patients with valvular heart disease 

Navin Nanda (UNITED STATES ) 

11:36 State of the art perspectives in heart failure: A Fantastic Voyage 

Hector Ventura (UNITED STATES ) 



PasCaR - health tRansitions and Cvd in afRiCa: 

imPliCations foR the 21st CentuRy 

Chairs: Robert Fagard (BELGIUM), Amoah Albert (GHANA) 

10:30 Epidemiologic and Nutritional Transitions in Africa - The Evidence from Obesity, Diabetes, 

and the Metabolic Syndrome. 

Krisela Steyn (SOUTH AFRICA) 

10:52 Spectrum of CVD and risk factors in Africa today - The Heart of Soweto Study 

Karen Sliwa (SOUTH AFRICA) 

11:14 Addressing Rheumatic Fever and CVD in children and young adults - beyond the Drakensberg Declaration 

Mayosi Bongani (SOUTH AFRICA) 

11:36 Health Transitions in Africa: Policy and Resource Implications for International Health Organizations 

George A. Mensah (UNITED STATES )




desafíos aCtuales de la CaRdiología sudameRiCana 

Coordinadores: Gilson Feitosa(BRAZIL), Grancelli Hugo (ARGENTINA) 

10:30 Epidemiología de las enfermedades cardiovasculares en sudamérica 

Bartolome Finizola (VENEZUELA) 

10:45 ¿ Las guías internacionales son aplicables en nuestra realidad sanitaria? 

Edgardo Sandoya (URUGUAY) 

11:00 Tecnología y alta complejidad cardiovascular. Limitaciones e inequidades en la región 

Jaime Goich (CHILE) 

11:15 ¿Cómo desarrollar investigación independiente en nuestros países? 

Hernan Doval (ARGENTINA) 



non-invasive Risk stRatifiCation foR sudden CaRdiaC death 

Chairs: Luis Alcocer (MEXICO), Martinelli Martino (BRAZIL) 

14:00 Microvolt t-wave alternants 

Gioia Turitto (UNITED STATES ) 

14:22 ECG and heart rate variability and turbulence 

Dubner Sergio (ARGENTINA) 

14:44 Signal average electrocardiogram 

Nabil El-Sheriff(UNITED STATES ) 

15:06 Putting this all together: Is an individualized decision possible? 

John Camm (UNITED KINGDOM) 


Debate 

dRugs vs. eleCtRiCal deviCes 

Chairs: Günter Breithardt (GERMANY), Oseroff Oscar (ARGENTINA) 

Statement 1: 

14:00 Atrial fibrillation: Catheter ablation as first line treatment? 

Pro: Andrea Natale ( UNITED STATES ) 

Contra: Shih-Ann Chen (CHINA, TAIWAN) 

Statement 2: 

14:45 All patients with cardiomyopathy and an ejection fraction below 35% should receive an ICD 

Pro: Sergio Pinski (UNITED STATES ) 

Contra: José Luis López-Sendón (SPAIN) 




Symposium 

eleCtRiCal theRaPy in heaRt failuRe 

Chairs: Aleksandras Laucevicius (LITHUANIA), Diego Vanegas (COLOMBIA) 

14:00 Cardiac contractility modulation to improve left ventricular function 

María José Sancho Tello (SPAIN) 

14:30 How to prevent pacing in pacemakers: Role of new algorithms 

Jorge Gonzalez ZUelgaray (ARGENTINA) 

15:00 Monitoring of heart failure by implanted devices 


anemia and heaRt failuRe 

Chairs: Miguel Adorno (PARAGUAY), Bocchi E.A (BRAZIL) 

14:00 Heart failure and anemia: Mechanisms and pathophysiology 

Alejandro Macchia (ARGENTINA) 

14:30 Prevalence of anemia in heart failure and its effects on prognosis 

Cesar Belziti (ARGENTINA) 

15:00 use of EPO and Iron in the Treatment of Anemia in Heart Failure 

Philip A Poole-Wilson (UNITED KINGDOM) 




Symposium 

advanCed heaRt failuRe 

Chairs: Norberto Vulcano (ARGENTINA), Ricardo Levin (UNITED STATES ) 

14:00 Advanced dysfunction without advanced symptoms: Pathophysiology and clinical profile 

Santiago Miriuka (ARGENTINA) 

14:18 The time for assistance: Clinical decisions for VAD implantation 

Hector Ventura (UNITED STATES ) 

14:36 The future is here: New devices for the failing heart 

Diego Delgado (CANADA) 

14:54 Heart transplantation in 2008 

Guillermo Torre Amione (UNITED STATES )




endovasCulaR heaRt valve inteRventions: 

the end of valvulaR oPen heaRt suRgeRy? - PaRt one 

Chairs: Rubén Piraino (ARGENTINA), Ramón Quesada (UNITED STATES ) 

14:00 Results with a new valve 

Alexander Abizaid (BRAZIL) 

14:18 How to select patients for endovascular balloon expandable aortic bioprosthesis? 

Agatiello Carla (ARGENTINA) 

14:36 Innnovative approaches in surgical valve replacement 

Timothy Gardner (UNITED STATES ) 

14:54 Further applications for percutaneous aortic valve biosprosthesisr: For all patients? 

Deborah Nercolini (BRAZIL) 

15:12 South American experience 

Jose Condado (VENEZUELA) 


Debate 

the PolyPill is an effeCtive stRategy 

foR ReduCtion of CaRdiovasCulaR diseases 

Chairs: Fuster Valentin (UNITED STATES ), Ricardo Esper (ARGENTINA) 

Statement 1: 

14:00 The polypill is an effective strategy for reduction of cardiovascular diseases 

Pro: Gines Sanz (SPAIN) 

Contra: Satyavan Sharma (INDIA) 

Statement 2: 

14:45 The statin pleotrophic effect is very important 

Pro: Nanette Wenger (UNITED STATES ) 

Contra: TBD 



neW tRends in the management of CaRdiovasCulaR Risk: 

the Role of heaRt Rate 

Chairs: Kumar Anil (INDIA), Jose Luis Vukasovic (CHILE) 

14:00 Heart rate and prognosis in cardiovascular diseases 

José Luis López-Sendón (SPAIN) 

14:30 Heart rate reduction: Evidence of clinical benefit 

Sheikh Shahryar A (PAKISTAN) 

15:00 Heart rate and heart failure: Partners or enemies? 

Willem Remme (NETHERLANDS) 



fetal CaRdiology 

Chairs: Miguel Granja (ARGENTINA), Loreta Jara (CHILE) 

14:00 Interventional cardiology in newborns 

John Cheatham (UNITED STATES ) 

14:22 Management outcome of congenital AV block 

Paulo Zielinsky (BRAZIL) 

14:44 Advances in fetal diagnosis, including MRI 

David Sahn (UNITED STATES ) 

15:06 Aortic valvuloplasty in HLHS 

Pablo Marantz (ARGENTINA) 


Symposium 


Symposium 

antithRombotiC tReatment in non-st-aCute CoRonaRy syndRome 

Chairs: Mònica Masotti (SPAIN), Barrero Carlos (ARGENTINA) 

14:00 usefulness of antithrombin agents in non-ST-acute coronary syndrome 

Jose Nicolau (BRAZIL) 

14:22 Contemporary issues in clopidogreltherapy for non-ST segment elevation infarction: 

New evidence for clinical practice 

I. Coma-Canella (SPAIN) 

14:44 Optimal pharmacological treatment of non-ST -elevation acute coronary syndrome without PTCA 

Radke P (GERMANY) 

15:06 Rate of complications and management of antithrombotic treatment in non-ST -acute coronary syndrome 

Jose Navarro Estrada (ARGENTINA) 


Symposium 

uP-date of tReatment of hyPeRtension 

Chairs: Alberto Re (ARGENTINA), Oscar Carretero (UNITED STATES ) 

14:00 Polypill: Which component and to whom? 

Nicholas Wald (UNITED KINGDOM) 

14:22 Meta-analysis in hypertension 

Carlos Ferrario (UNITED STATES ) 

14:44 Clinical trials for hypertension: Expectation fulfilled and unfulfilled 

Alberto Zanchetti (ITALY) 

15:06 How strong is the evidence for the use of beta-blockers as a first-line therapy for hypertension? 

Systematic review and meta-analysis 

Giuseppe Mancia (ITALY)




all a CaRdiologist needs to knoW about CaRdiaC msCt& mRi 

Chairs: Horacio Dinunzio (ARGENTINA), David Vetcher (ARGENTINA) 

14:00 Actual role of cardiac MSCT: Where are we? 


14:22 Coronary calcium score: Applications in clinical practice 

(UNITED STATES ) 

14:44 Non-invasive coronary computed tomographic angiography for patients with low and high pre-test 

probability for having coronary artery disease: Is it still an indication? 

Anibal Damonte (ARGENTINA) 

15:06 Dual source computed tomography: Is it the real advantage in MSCT? 

Ernest Garcia (UNITED STATES ) 


Symposium 

aRe ComoRbidities a limit to CaRdiovasCulaR PRevention in the eldeRly? 

Chairs: Pasquale Abete (ITALY), Mariano Giorgi (ARGENTINA) 

14:00 Cardiovascular Prevention in the Elderly 

Mario Garcia-Palmieri (PUERTO RICO) 

14:22 Acute coronary syndromes/myocardial infarction at advanced age 


14:44 Polypharmacy in the elderly 

Nedina Mendez (VENEZUELA) 

15:06 Cardiac rehabilitation and its limits 

Mauricio Wajngarten (BRAZIL) 


Debate 

CaRdioPulmonaRy ResusCitation 

Chairs: T. P. Aufderheide (UNITED STATES ), Ari Timerman (BRAZIL) 

Statement 1: 

14:00 Cardiocerebral resuscitation: Is ventilation not necessary in cardiac arrest? 

Pro: Karl B. Kern (UNITED STATES ) 

Contra: Timerman Sergio (BRAZIL) 

Statement 2: 

14:45 Metabolic Resuscitation: Hibernation or hypothermia in CPR? 

Pro: Soon Joo Wang(Seoul, KOREA, REPUBLIC OF) 

Contra: Flavio Marques (BRAZIL) 




Symposium 

use of 3d eCho in CliniCal day-to-day PRaCtiCe 

Chairs: Mario Garcia (UNITED STATES ), Fernando Manzur Jattin (COLOMBIA) 

14:00 Quantitation of valvar heart disease 


14:22 Differentiation of cardiac masses 

Juan Carlos Plana (UNITED STATES ) 

14:44 Assessment of adult congenital heart disease 

Mani Vannan (UNITED STATES ) 

15:06 Assesment of LV ejection fraction, volume and mass 

Marcelo Trivi (ARGENTINA) 



sCai-solaCi: 

What We knoW and What We don't knoW about des 

Chairs: Carlos Mendiz (ARGENTINA), Ziyad Hijazi (UNITED STATES ) 

14:00 Interventional cardiologist institute 

Manish Parikh (UNITED STATES ) 

14:14 Worldwide impact of DES and worldwide impact of late sten thrombosis 

Christopher Cates (UNITED STATES ) 

14:28 Is late stent thrombosis a main concern? 

Bonnie Weiner (UNITED STATES ) 

14:42 What do we know and what we don't know about DES in off label indications 

Daniel Berrocal(ARGENTINA) 

14:56 The future of DES 


15:10 Panel: 

D. Echeverri (COLUMBIA), F. Brito (BRAZIL), C. Cates (UNITED STATES), B. Weiner (UNITED STATES), 

A. Abizaid (BRAZIL) 

aPsC: global buRden of heaRt failuRe 

Chairs: Hisayoshi Suma (JAPAN), Takeshi Nakatani (JAPAN) 



14:00 Idiopathic Heart Failure: Contribution of cardiomyopathy and the global alert and response network 

Matsumori Akira (JAPAN) 

14:22 Etiological diagnosis of Heart Failure 

Cheuk-Man Yu (CHINA, PEOPLE'S REPUBLIC OF) 

14:44 Heart Failure: Epidemiology, pathophysiology and treatment worldwide 

David T. Kelly(AUSTRALIA) 

15:06 Valvular heart diseases in developed and undeveloped countries 

Robert Bonow (UNITED STATES )




Cómo oPtimizaR el tRatamiento de la insufiCienCia CaRdiaCa CRóniCa 

Coordinadores: Graciela González Bogado (PARAGUAY), José Luis Barisani (ARGENTINA) 

14:00 Tratamiento farmacológico actual. Interrogantes no resueltos 

Miguel Gonzalez (ARGENTINA) 

14:15 ¿Cómo adecuar el tratamiento en el paciente con comorbilidades? 

Waldo Fernández Durand (PERU) 

14:30 ¿Cómo seleccionar a los candidatos para resincronización ventricular? 

Walter Reyes Caorsi (URUGUAY) 

14:45 Estrategias de manejo en el paciente chagásico. ¿Son diferentes? 

Harry Acquatella (VENEZUELA) 

15:00 Alternativas terapéuticas en la IC refractaria 

Fernando Bacal (BRAZIL) 


Symposium 

management of aRRhythmias in genetiCally based diseases 

Chairs: Walter Reyes Caorsi (URUGUAY), Pablo ChiAle (ARGENTINA) 

16:00 Brugada syndrome 

Marcelo Elizari (ARGENTINA) 

16:22 Short and long QT syndrome 

Christian Wolpert (GERMANY) 

16:49 Right ventricular dysplasia 

Nestor Galizio (ARGENTINA) 

17:11 Catecholamine-induced polymorphic ventricular tachycardia 

Riccardo Cappato (ITALY) 


Symposium 

CaRdiaC ResynChRonisation theRaPy (CRt) - PaRt tWo 

Chair: Saúl Drajer (ARGENTINA) 

16:00 Reasons for failure of CRT 

Luis Molina (MEXICO) 

16:22 Emerging indications for CRT 


16:44 Should all patients with an indication for CRT also receive an ICD? 


17:06 Cost-effectiveness of CRT: Implications for developing countries 

John Gorcsan III (UNITED STATES ) 





oPtimum tReatment foR heaRt failuRe 

Chairs: Krauss Juan (ARGENTINA), Roberto Ricca (URUGUAY) 

16:00 How to prevent heart failure? 

Jay Cohn (UNITED STATES ) 

16:45 How to achieve guidelines recommendations in patients with heart failure? 

Philip A Poole-Wilson. (UNITED KINGDOM) 



suRgiCal tReatment foR Congestive heaRt failuRe 

Chairs: Hector Ventura (UNITED STATES ), Ernesto Weinschelbaum (ARGENTINA) 

16:00 Surgical correction of mitral regurgitation in end stage cardiomyopathy 

Enio Buffolo (BRAZIL) 

16:22 Surgical strategy for non-ischaemic cardiomyopathy 

Hisayoshi Suma (JAPAN) 

16:44 Ventricular restoration for ischaemic heart failure 

Noedir Groppo Stolf (BRAZIL) 

17:06 Left ventricular assist device 

José Luis Navia (UNITED STATES ) 


Symposium 

heaRt failuRe With noRmal ejeCtion fRaCtion 

Chairs: Mihai Gheorghiade (UNITED STATES ), Miguel Gonzalez(ARGENTINA) 

16:00 Diastolic heart failure: Is it a disease? 

Marvin Konstam (UNITED STATES ) 

16:22 Prevalence and etiologies 

16:44 How to diagnose in clinical practice 

Jorge Thierer (ARGENTINA) 

17:06 How to treat 

John Cleland (UNITED KINGDOM) 



Whfs: the failing heaRt aRound the WoRld 

Chairs: Shahryar A. Sheikh (PAKISTAN), Grancelli Hugo (ARGENTINA) 

16:00 Chagas' disease, or hypertension and IHD: Which are the driving factors of heart failure in Latin America? 

Bocchi E. A. (BRAZIL) 

16:22 HIV-related heart failure in Africa 


16:44 Heart failure due to virus infection in Asia 


17:06 What we have learned from heart failure registries in Europe 

Willem Remme (NETHERLANDS)



Symposium 

delayed enhanCement imaging foR evaluation of CaRdiomyoPathies 

Chairs: Wilson Mathias (BRAZIL), Lorenzo Montserrat (SPAIN) 

16:00 Currents status, indications and limitations of MSCT angiography 


16:18 Myocardial perfusion imaging by MSCT: Is it possible to use in clinical practice? 

Joanne D. Schuijf (NETHERLANDS) 

16:36 MSCT and molecular imaging: New advances 

Milind Desai (UNITED STATES ) 

16:54 Non-invasive diagnostic of vulnerable plaque: the eternal challenge 

Mario Garcia (UNITED STATES ) 

17:12 Relationships between CT, PET, SPECT and MR 

Daniel Berman (UNITED STATES ) 



ish: hot toPiCs in hyPeRtension: an uPdate 

Chairs: Gilson Feitosa(BRAZIL) 

16:00 Is time to say good-bye to beta-blockers as first line treatment for primary hypertension? 

Lars Lindholm (SWEDEN) 

16:22 Ambulatory blood pressure and prediction of risk: do we need the night? 

Robert Fagard (BELGIUM) 

16:44 Heart remodelling in hypertension 

Daniel Piskorz (ARGENTINA) 

17:06 Salt sensitive hypertension: genetics pathophysiology and management 

Ramiro Sánchez (ARGENTINA) 


Symposium 

management of asymPtomatiC valve disease 

Chairs: Jose Antonio Francisco Ramires (BRAZIL), Jorge Lopez Sosa (ARGENTINA) 

16:00 Aortic regurgitation 

Escobar Edgardo (CHILE) 

16:22 Aortic stenosis 

Jeffrey Borer (UNITED STATES ) 

16:44 Mitral valve prolapse 

Tomás Cianciulli (ARGENTINA) 

17:06 Criteria for early intervention in asymptomatic patients 

Robert Bonow (UNITED STATES ) 




Symposium 

RevasCulaRization of Patients With stable CoRonaRy aRteRy disease 

Chairs: Cossio Pedro (ARGENTINA), Shirish Hiremath (INDIA) 

16:00 Optimal medical treatment in patients with stable coronary artery disease 

Karina Rey García (CUBA) 

16:22 Is ischemia enough to select patients for PCI? 

Gao Runlin (CHINA, PEOPLE'S REPUBLIC OF) 

16:44 PCI outcomes with drug eluting stents 

Jose Alejandro Martinez Sepulveda (CHILE) 

17:06 How to select the best strategy for managing patients with stable coronary artery disease? 


Symposium 

inteRventional CaRdiology in Congenital heaRt disease 

Chairs: Zabal Carlos (MEXICO), Mariano Ithuralde (ARGENTINA) 

16:00 ASD Closure 

Ziyad Hijazi (UNITED STATES ) 

16:18 VSD Closure new developments 

Trong Phi Le (GERMANY) 

16:36 Hybrid procedures 

John Cheatham (UNITED STATES ) 

16:54 use of stents 

Carlos Pedra (BRAZIL) 

17:12 Cutting balloon results 

Neil Wilson (UNITED KINGDOM) 


Symposium 

CellulaR RegeneRative theRaPy in CaRdiology 

Chairs: Jorge Trainini (ARGENTINA), David T. Kelly(AUSTRALIA) 

16:00 Role of stem- and progenitor cells in coronary artery disease 

Luis De La Fuente (ARGENTINA) 

16:22 Which cells and which route of administration? 

Julio Argentieri(ARGENTINA) 

16:44 For which patients? 

Juan Carlos Chachques (FRANCE)



Symposium 

CaRdiovasCulaR Risk and human immunodefiCienCy viRus (hiv) infeCtion in afRiCa 

Chairs: Jean-Rene M’buyamba (CONGO, THE DEMOCRATIC REPUBLIC OF THE), Karen Sliwa (SOUTH AFRICA) 

16:00 Cardiovascular risk in HIV-infected patients: Global overview and implication for action 

Sergio Lupo (ARGENTINA) 

16:22 Cardiovascular risk in African HIV patients: Situation analysis and implication for action 

Onen Churchill (BOTSWANA) 

16:44 Cost-effective approaches for management and prevention of HIV infection induced cardiomyopathie in Africa 

Amoah Albert (GHANA) 

17:06 Mechanisms of cardiovascular diseases in HIV-infected patients: Is there an ethnic difference? 

Daniel Lemogoum (CAMEROON) 


Symposium 

health PRomotion foR ChildRen 

Chair: Diego Esandi (ARGENTINA), Volqvartz Susanne (DENMARK) 

16:00 Relation between CVD risk factors in children and their parents: Smoking and Rayuela Project 

Maria Ines Sosa Liprandi (ARGENTINA) 

16:22 The role of the paediatrician in school-based health education programmes 

Soon Joo Wang Ernesto Juaneda (ARGENTINA) 

16:44 Protecting children from marketing 

Anita Saxena (INDIA) 

17:06 The Colombia experience 

Beatriz Londoño (COLOMBIA) 


Symposium 

the PolyPill 

Chairs: Angeles Alonso Garcia (SPAIN), Alfonso Perez (UNITED STATES ) 

16:00 Why a polypill? 

Nicholas Wald (UNITED KINGDOM) 

16:22 Clinical considerations 

Fuster Valentin (UNITED STATES ) 

16:44 Regulatory issues 

Martin Seoane (ARGENTINA) 

17:06 Cost benefit considerations 

Gianni Tognoni (ITALY) 



ResusCitation sCienCe and suRvival 

Chairs: Timerman Sergio (BRAZIL), Ana Salvati (ARGENTINA) 

16:00 International collaboration on resuscitation guidelines 

Soon Joo Wang (KOREA, REPUBLIC OF) 

16:22 Quality CPR 

Manoel Fernandes Canesin (BRAZIL) 

16:44 The history of how resuscitation techniques have been developed 

Fabián Gelpi (ARGENTINA) 

17:06 Public access to defibrillation: Why, when and where? 

Alessandro Capucci (ITALY) 


Symposium 


Symposium 

PRimaRy and seCondaRy PRevention in atheRosCleRosis: 

fRom theoRy to daily PRaCtiCe 

Chairs: Masao Sano (PARAGUAY), Guzman L. (ARGENTINA) 

16:00 International guidelines: Can they be extrapolated and implemented in our countries? 

Gianni Tognoni (ITALY) 

16:22 Control and prevention of cardiovascular disease around the world 

Ponte N Carlos I. (VENEZUELA) 

16:44 Statins and other cardiovascular drugs in developing countries: Are the usual doses useful? 

Carlos Cuneo (ARGENTINA) 

17:06 Cardio-protection through promotion of physical activity in mega cities 

Mario Garcia-Palmieri (PUERTO RICO) 



all you need to knoW about CaRotid stenting 

Chairs: Martínez Rios Marco A (MEXICO), Roxana Mehran (UNITED STATES ) 

16:00 Current practice and multicentric trial with the "TwinOne" cerebral protection system 

Jacques Theron (FRANCE) 

16:22 Protection devices: Are all the same? 

José Gabay (ARGENTINA) 

16:44 Why should we treat asymptomatic patients with severe carotid stenosis? 

Lylyk Pedro (ARGENTINA) 

17:06 Carotid stenting: Level of evidence: Where are we? Where are we going? 

Hugo Londero (ARGENTINA)




isCu: uPdate in 3d eChoCaRdiogRaPhy 

Chairs: Nelson Pizzano (URUGUAY), Amuchástegui Luis Maria (ARGENTINA) 

16:00 Basics of 3-D echocardiography 

Ronderos Ricardo (ARGENTINA) 

16:22 3-D TTE /TEE in the evaluation of valvular heart disease 

Juan Carlos Plana (UNITED STATES ) 

16:44 3-D transesophageal echocardiography 

Mani Vannan (UNITED STATES ) 

17:06 3-D echocardiography in the assessment of intracardiac masses and adult congenital heart disease 




manejo del PaCiente Con síndRome CoRonaRio agudo 

Coordinadores: Gabriel D’empaire Yanes (VENEZUELA), Daniel Isaza (COLOMBIA) 

16:00 SCA sin supra ST: ¿Cómo identificar al paciente de alto riesgo clínico? 

Miguel Quintana (PARAGUAY) 

16:15 SCA sin supra ST: Estrategia invasiva ¿Sistemática o electiva? 

Carlos Tajer (ARGENTINA) 

16:30 SCA con supra ST: ¿Cómo lograr la reperfusión óptima? 

Francisco Benítez (ECUADOR) 

16:45 Terapia antiplaquetaria combinada post SCA ¿A quién, cómo y durante cuánto tiempo? 





aCute CoRonaRy events 

Chairs: Manuel IrarrazAbal (CHILE), Ernesto Ferreiro (ARGENTINA) 


Oral abstract Session 

08:30 Differences in mobilization of mesenchymal and endothelial progenitors cells by early ischemic 

preconditioning in porcine myocardial ischemia-reperfusion 

M. Gyongyosi, N. Pavo, A. Posa, R. Hemetsberger, S. Steiner-Boker, C. Kopp, I. Pavo Jr., Z. Petrasi, Ö. Petnehazy, 

D. Glogar 

08:43 Effect of dietary restriction in the mitochondrial function in an EX-VIVO animal model of diabetes submitted 

to global myocardial ischemia-reperfusion 

P. Monteiro, P. Matafome, A. Reis, S. Monteiro, R. Seiça, L. Goncalves, L. A. Providencia 

08:56 Recurrent angina after admission may partially explain some discrepancies between initial risk stratification 

and the selection for invasive evaluation in Non ST elevation Acute Coronary Syndromes. Results of the 

multicentre registry Epi-Cardio 

M. De Abreu, J. Mariani, A. Charask, E. Zuanich, C. Pellegrini, M. Trevisan, E. Forte, J. Gagliardi, C. Tajer, H. Doval 

09:09 Long-term prognosis of patients with acute chest pain, normal electrocardiogram, and non detectable 

cardiac troponin 

R. Merbilháa, M. P. Marturano, G. F. Procopio, L. Pfister, M. Piraino, G. A. Ontiveros, M. J. Fosco 

09:22 utility of the Global Registry of Acute Coronary Events Risk Score in Mild or Severe Obstructive Coronary 

Artery Disease in Non-ST-segment Elevation Acute Coronary Syndromes 

E. Gurfinkel, E. Duronto, F. Guerloy, B. M. Kennelly, J. López-Sendón, Á. Avezum, E. Beck, K. A. Eagle, G. Fitzgerald, 

J. M. Gore 

09:35 White Blood Cell Subtypes Predicting Diagnosis in a Chest Pain unit: Diagnostic Value of an Elevated 

Neutrophil to Lymphocyte Ratio in Patients with Suspected Acute Coronary Syndrome 

D. Precoma Neto, A. D. Zazula, G. F. Barbieri, A. M. Gomes, H. Kruklis, M. Conforto, G. Facin, R. Y. Forte, J.R. Faria Neto 

09:48 Distinguishing Features of Mild vs Severe Coronary Artery Disease in Patients With Acute Coronary 

Syndromes. The Global Registry of Acute Coronary Events 

E. Duronto, E. P. Gurfinkel, K. A. Eagle, R. J. Goldberg, D. Brieger, B. Freedman, M. Jelinek, G. Fitzgerald, J. M. Gore




maRkeRs in aCute syndRomes 

Chairs: Sokn Fernando (ARGENTINA), Luis Molinary (PUERTO RICO) 

08:30 Clinical correlates of acute myocardial infarction recurrence in patients presenting at a tertiary care 

hospital in the uS. 

I. Singla, A. Sunil, H. Hreybe, S. Samir 

08:43 Creatinine Level or Estimated Creatinine Clearance as Predictors of Cardiovascular Mortality in Patients 

undergoing CABG – Do We Really Need the Math? 

L. H. W. Gowdak, J. J. G. De Lima, J. A. F. Ramires, L. A. M. Cesar 

08:56 Cystatin c plasma concentration in patients with multivessel coronary artery disease and hypertension 

predicts cardiovascular events during the follow-up observation 

z. Dzielinska, A. Januszewicz, A. Prejbisz, J. Chudek, M. Makowiecka-Ciesla, M. Demkow, P. Tyczynski, A. Wiecek, 

W. Ruzyllo 

09:09 Reviewing the American Society of Transplantation Guidelines for Cardiovascular Risk Stratification in Renal 

Transplant Candidates 

L. H. W. Gowdak, R. L. Arantes, F.J. De Paula, L. A. M. Cesar, L. E. Ianhez, E. M. Krieger, J. J. G. De Lima 

09:22 Prognostic value of the QTc prolongation in patients with Acute Coronary Syndrome 

J. Siccha Martinez, M. Carrion Chambilla 

09:35 Can the creatinine clearance predict bleeding complications in acute coronary syndrome patients? 

N. Antonio, S. Monteiro, C. Lourenco, R. Teixeira, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, 


09:48 Prediction of renal artery stenosis in patients with coronary and supraaortic artery atherosclerotic disease 

T. Przewlocki, A. Kablak-Ziembicka, W. Tracz, G. Kopec, P. Rubis, A. Kozanecki, T. Stompor, M. Kostkiewicz, 

A. Sokolowski, M. Pasowicz 





aCute myoCaRdial infaRCtion 

Chairs: Jorge Leguizamon (ARGENTINA), Sismondi Horacio (ARGENTINA) 

08:30 Direct Transport of MI Patients to Interventional Cardiology Centre Following ECG Teletransmission Increases 

Percentage of Patients Treated within the Timeframe Set by Guidelines 

M. Karcz, P. Bekta, M. Skwarek, M. Dabrowski, K. Kukula, J. Kadziela, M. Ciszewski, A. Debski, M. Demkow, W. Ruzyllo 

08:43 Outcomes in ST Elevation Acute Myocardial Infarction patients poorly included in randomized controlled 

clinical trials 

C. Higa, F. Botto, J. Fuselli, P. Blanco, E. Fairman, A. Fernandez, H. Cohen Arazi, R. Merbilhaa, R. Sarmiento, J. Gagliardi 

08:56 The Chilean Health Reform and its impact in the Management and Mortality of ST Segment Elevation 

Myocardial Infarction (STEMI) in Chilean Hospitals. 

C. N. Carolina Nazzal, P. C. Pabla Campos, R. C. Ramon Corbalan, J. B. Jorge Bartolucci, P. S. Patricio Sanhueza, 

J. C. P. Juan Carlos Prieto, F. L. Fernando Lanas 

09:09 Nationwide trends in the incidence of acute ST elevation myocardial infarction (STEMI) in the united States 


09:22 Acute Myocardial Infarction With ST-Segment Elevation 

W. Quiroga Castro, E. Conci, F. Zelaya, M. Isa, J. Sala, G. Pacheco, C. Balestrini, C. Serra, C. Quiroga, A. Bossi 

09:35 Contribution of each subinterval to door-to-balloon time in primary angioplasty. 

I. Gomes, A. Correa, M. Makdisse, M. Perin, S. F. Brito Jr., A. Abizaid, B. Almeida, M. A. Magalhães, T. C. Nascimento 

09:48 Women with acute myocardial infarction are more likely than men to have delayed door-to-ECG time 

M. Makdisse, A. G. Correa, A. Pfeferman, L. M. A. Forlenza, M. Knobel, V. Oliveira, S. Ellovitch, C. O. Berlowitz Fo, 

M. Vaidotas, E. Knobel 

eCg, atRial fibRilation and ablation 

Chairs: Carlos Labadet (ARGENTINA), Adrian Baranchuk(CANADA) 



08:30 Isolated areas of electrical remodeling: electrocardiographic characteristics and clinical aspects. 

S. Sclarovsky 

08:43 Electro-vectorcardiographic patterns in patients with severely symptomatic hypertrophic obstructive 

cardiomyopathy submitted to percutaneous ethanol septal ablation: immediate and late follow up 

Silvia Judith Fortunato De Cano, Manuel Nicolas Cano, Andrés Ricardo Pérez Riera, Jairo Alves Pinheiro Jr., 

Ricardo Pavanello, Amanda Moraes R. Sousa, Jose Eduardo Mr Sousa, Adib Domingos Jatene 

08:56 Symptomatic repetitive monomorphic premature ventricular ectopy. Results of radiofrequency ablation. 

A. Bochoeyer, R. Rabinovich, L. Enciso, R. Costello, R. Ferreyra 

09:09 Radiofrequency catheter ablation of incessant ventricular tachycardia in a patient with isolated noncompaction 

of the left ventricle. 

L. Citta, E. Sosa, M. Scanavacca, N. Citta 

09:22 Findings of sustained ventricular tachycardia in stored electrograms and their correlation with syncope in 

patients with definitive pacemakers 

G. M. M. Pellegrino, D. Ortega, L. Barja, N. Mangani, L. Mari 

09:35 MuSAFTA : Multicenter Study Atrial Fibrillation Transcatheter Ablation ) – Ablation Characteristics. Follow-up 

L. Barja, D. Ortega, N. Mangani, M. Kenar, A. Hita, F. Ditomaso, S. Baratta, J. Bilbao, H. Fernadez, D. Turri 

09:48 Advantages of the catheter ablation of nodal slow pathway during atrioventricular nodal tachycardia 

R. Speranza, G. Costa, O. Perez Mayo, A. Stefani, D. Deluso, A. Alfie, A. Balestrini, C. De Zuloaga




atRial flutteR and fibRilation 

Chairs: Oseroff Oscar (ARGENTINA), Jose Carlos Pachon Mateos (BRAZIL) 

08:30 Does Timing of Atrial Fibrillation Onset or Ventricular Rate Relate to the Development of In-Hospital 

Ventricular Fibrillation in Patients with Acute Myocardial Infarction 

R. Sankaranarayanan, H. Gonna, B. Nuta, S. Burtchaell, R. Holloway, M. A. James 

08:43 Feasibility of Common Atrial Flutter Radiofrequency Catheter Ablation in Outpatients 

E. Marijon, S. Boveda, N. Combes, A. Bortone, J. Najjar, J. P. Donzeau, S. Jacob, J. P. Albenque 

08:56 Omega 3 Fatty Acid Supplementation reduces One-year Risk of Atrial Fibrillation in Patients Hospitalized with 

Myocardial Infarction 

A. Macchia, S. Monte, M. Romero, F. Pellegrini, A. P. Maggioni, A. Dettorre, G. Tognoni 

09:09 Different medical pretreatment strategies in persistent atrial fibrillation after successful cardioversion. 

From Bisoprolol to Ivabradin? 

K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan 

09:22 New insights of segmental pulmonary vein isolation by irrigated catheter ablation and the mesh 

mapper technique 

A. Meissner, M. Christ, M. Von Bracht, P. Maagh, C. A. Perings, H. J. Trappe, G. Plehn 

09:35 CaMKII-dependent phosphorylation of defective RyR2 predisposes to atrial fibrillation (WITHDRAWN) 

X. H. Wehrens, M.G. Chelu, S. Sood, R. Van Oort, D. Skapura, D. Dobrev 

09:48 Predictive factors of atrial systole recovery after left MAzE III surgery by radiofrequency ablation 

MD Tinetti Matias, MD Lescano Adrian, MD Costello Ramiro, MD Daru Victor, MD Cardenas Cesar, 

MD Piazza Antonio, MD Iglesias Ricardo 



mitRal valve disease and PulmonaRy hyPeRtension 

Chairs: Ricardo Migliore (ARGENTINA), Jane Somerville (UNITED KINGDOM) 

08:30 Changes of myocardial function after mitral valve downsizing in patients with ischemic mitral regurgitation 

J. Ostermeyer, S. Geidel, M. Lass, K. H. Kuck 

08:43 Mechanisms underlying dyspnea in patients with Rheumatic Mitral Stenosis 

C. Palaniswamy, R. Guleria, R. Narang, S. Ramamurthy, A. Mohan 

08:56 Rheumatic heart disease prevalence in Fiji 

A. C. Steer, J. Kado, N. Wilson, L. Waqatakirewa, T. Tuiketei, E. K. Mulholland, M. Good, A. J. W. Jenney, J. R. Carapetis 

09:09 Pulmonary hypertension in patients with ankylosing spondylitis 

D. A. Poddubnyy, N. A. Karoli, A. P. Rebrov 

09:22 Oxidative stress-induced fetal programming of hypoxic pulmonary hypertension 

J. Bloch, P. Y. Jayet, C. Mathieu, P. Dessen, A. Monney, M. Schwab, H. Duplain, J. F. Tolsa, C. Sartori, U. Scherrer 

09:35 Demographic, clinical and functional characteristics of outpatients with different stages of Chagas´disease 

in a prospective registry 

R. Agüero, L. Ferrer, V. Volberg, M. Leonardi, M. Sancineti, A. Sancineti, Horacio Pomes Iparraguirre, G. Calderon 

09:48 Exercise-induced abnormal pulmonary arterial pressure response in adolescents and adults with atrial 

or ventricular septal defect 

T. Möller, E. Pettersen, K. Peersen, P. M. Fredriksen, H. Holmstrøm, E. Thaulow 





CaRdiaC tRansPlantation 

Chairs: Diez Mirta (ARGENTINA), Hector Ventura (UNITED STATES) 

08:30 Influence of regeneration of heart muscle on mobilization of BM-CPCs by intracoronary autologous bone 

marrow cell transplantation in patients with AMI as well as with Chronic Myocardial Infarction 

R. G. Turan, M. Brehm, S. Yokus, M. Koestering, S. Steiner, T. Zeus, T. Bartsch, C. M. Schannwell, B. E. Strauer 

08:43 Phenotype Characterization Through Cellular Network Reconstruction. A Systems Biology Approach to the 

Discovery of Candidate Molecular Targets for Phenotype Characterization and Compound Discovery in Heart 

Transplantation 

M. Cadeiras, A. Sinha, M. Bayern, F. Latiff, W. K. Lim, R. Dedrick, T. Palomero, C. C. Marboe, A. Califano, M. C. Deng 

08:56 NT-proBNP is not useful in early follow up of heart transplant patients 

D. Milicic, J. Ljubas, B. Pezo-Nikolic, B. Skoric 

09:09 Improving Diagnostic Accuracy of Acute Cellular Cardiac Allograft Rejection Applying Non-Linear Algorithms 

to Whole Genome Microarrays in Peripheral Blood Mononuclear Cells of Heart Transplant Recipients 

E. Tabak, M. Cadeiras, C. Turner, F. Latif, P. Lal, C. C. Marboe, A. Califano, M. C. Deng 

09:22 Temporal trends of sex disparity in the referral of patients to heart function clinic, transplant listing, and 

cardiac transplantation. 

V. Micevski, F. Gustafsson, D. H. Delgado, H. J. Ross 

09:35 Role of probiotics in multimodality therapy of chronic heart failure 

N. A. Bylova, G.P. Arutyunov, L. I. Kafarskaya, T. K. Chernyavskaya, Z. A. Chernaya 

09:48 Outcomes in Patients with Advanced Heart Failure and Left Ventricular Ejection Fraction 30% or Less Referred 

for Orthotopic Heart Transplantation: The Gender Paradox. 

S. M. yala, M. Cadeiras, R. Henquin, D. M. Mancini, Y. Naka, E. V. Giardina, M. C. Deng


ChRoniC heaRt failuRe 

Chairs: Rafael Porcile (ARGENTINA), Ileana Piña (UNITED STATES) 



08:30 Location of Wall Motion Abnormality as a Determinant of Rapid Diastolic Filling: Role of Left Ventricular 

Ejection Fraction 

I. P. Clements, D. O. Hodge, C. G. Scott 

08:43 Progression of chronic heart failure possible role of gram-negative flora 

N. A. Bylova, G. P. Arutyunov, L. I. Kafarskaya, Y. A. Pocrovskiy, T. K. Chernyavskaya, Z. A. Chernaya 

08:56 Do Cholesterol Levels Influence Long-Term Heart Failure Outcome in Post-Infarct Patients with Moderate 

to Severe Left Ventricular Systolic Dysfunction? 

R. Sankaranarayanan, M. A. James, H. Gonna, S. Burtchaell, R. Holloway 

09:09 The Heart Failure Survival Score is a useful Method in Predicting Cardiovascular Mortality in Severe Heart 

Failure Patients 

E. Acarturk, M. Koc, T. Yildiran, O. Sen, D. Y. Sahin 

09:22 Influence of cardiologist and non-cardiologist in the management of outpatients with chronic heart failure 

in Argentina. Preliminary results from Argentinean HOSPICAL II Registry 

E. Perna, J. P. Cimbaro Canella, C. Poy, F. Diez, R. Colque, L. Lobo Marquez, M. L. Coronel, P. Barrios, S. Perrone 

09:35 In-hospital and Long-Term Prognosis of Women Compared with Men with Heart Failure and Acute Myocardial 

Infarction after Previous Coronary Artery Bypass Surgery; 19-year Experience 


M. Ostojic 

09:48 Non-transplant surgical treatment of primary dilated cardiomyopathy and congestive heart failure - 

RADO operation 

N. Radovanovic, S. Popovic, M. Radovanovic, M. Cenanovic, M. Ignjatovic, S. Potic, N. Pejcic, S. Grujic, M. Zorc 





dRugs, diabetes and hyPeRtension 

Chairs: Dagnovar Aristizabal (COLOMBIA), Jorge Resk (ARGENTINA) 

08:30 Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled 

blood pressure receiving hydrochlorothiazide: a double-blinded randomized trial with ambulatory blood 

pressure measurement 

P. Guerrero, F. D. Fuchs, L. B. Moreira, V. M. Martins, C. Bertoluci, S. C. Fuchs, M. Gus 

08:43 The combination of Amlodipine 5 mg and Valsartan 160 mg lowers blood pressure effectively and safely in 

hypertensive patients not controlled by monotherapy with calcium channel blockers 

J. Brachmann, R. Handrock, S. Klebs 

08:56 Anti-hypertensive drug treatment and the effect over different variability indexes of systolic blood pressure 

measured by 24-hour Ambulatory Blood Pressure Monitoring 

M. Gus, F. F. Vianna, A. L. Ferreira, F. C. Fuchs, J. L. Neyeloff, C. Schneider, M. B. Moreira, L. B. Moreira, S. C. Fuchs, 

F. D. Fuchs 

09:09 Inverse association between ankle-brachial index and blood pressure variability estimated by the rate of 

systolic blood pressure variation derived from 24-hour Ambulatory Blood Pressure Monitoring (ABPM) 

L. B. Moreira, E. Wittke, F. T. Cichelero, C. M. Moreira, R. Picon, J. S. Varela, T. Bassani, S. C. Fuchs, F. D. Fuchs, M. Gus 

09:22 Depressive syndrome prevalence in hypertensives patients and its association with higher pulse pressure and 

nondipping pattern 

S. Obregon, C. Kotliar, P. Forcada, G. Iacometti, D. Chejtman, G. Vallejos, C. Bellido, A. Hita, D. Turri 

09:35 Type 1 Diabetes mellitus is strongly and independently associated with essential hypertension 


09:48 Cardiovascular risk assessment by SCORE System in Romania and Poland. Data from two National studies: 

SEPHAR and NATPOL III PLuS 

M. Dorobantu, T. Zdrojewski, E. Badila, S. Ghiorghe, P. Bandosz, R. O. Darabont, M. Olteanu, P. Flondor 



long qt syndRome, heaRt failuRe and diabetes 

Chairs: Manuel Vazquez-Blanco (ARGENTINA), Miguel Adorno (PARAGUAY) 

08:30 The Long QT syndrome in pediatric age: prognosis and risk factor 

G. Fazio, S. Pipitone, L. D'Angelo, P. Palazzolo, G. Di Gesaro, L. Sutera, G. Novo, S. Novo 

08:43 Exercise training in patients with left ventricular systolic dysfunction 

G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, L. Favaloro, M. Diez, R. Favaloro 

08:56 A Single Submaximal Exercise Session Enhances Systemic Endothelial Function Independently of 

Changes in Blood Flow in Patients with Chronic Heart Failure 

D. umpierre, J. P. Ribeiro, P. J. C. Vieira, R. S. Moraes, E. L. Ferlin, R. Stein 

09:09 Heart failure mortality in three Brazilian states from 1999 to 2004: an analyis of death certification 

E. Gaui, G. Oliveira, C. Klein 

09:22 Age related renine and aldosterone status in 430 essential hypertensives 

C. Kotliar, P. Forcada, S. Obregon, E. Arcani, J. Bustamante, A. Hita, S. Baratta, D. Turri 

09:35 Early detection of right ventricular systolic dysfunction by tissue Doppler derived isovolumic myocardial 

acceleration (IVA) in Type II diabetes mellitus 

y. Tayyareci, Z. Bugra, Y. Nisanci, B. Umman, A. Oncul, I. Altun, S. Yurdakul, N. Polat, K. Adalet 

09:48 Pancreatic islets xenotransplantation in dogs with diabetes type 1 

A. Abalovich, M. A. Müller, V. Castillo, A. Pisarevsky, G. Ottaviano, R. Gomez Figueroa, D. R. Grana, J. Milei




PRimaRy and seCondaRy PRevention i 

Chairs: Rodolfo Daniel La Greca (ARGENTINA), Mario Bey Lombana (PANAMA) 

08:30 Cardiovascular rehabilitation in patients with peripheral artery disease 

G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, C. Capano, M. Cisterna, R. Favaloro 

08:43 EuROACTION: Changes in smoking, diet and physical activity over one-year in a family based preventive 

cardiology programme in hospital and general practice. 

J. L. Jones, A. Mead, C. S. Jennings, A. Holden, S. B. Connolly, K. Kotseva, T. Collier, D. De Bacquer, G. De Backer, 

D. A. Wood 

08:56 EuROACTION: Achieving Blood Pressure, Lipid and Glucose targets in a 16 week Multidisciplinary 

Cardiovascular Prevention and Rehabilitation Hospital Programme – One year Results 

K. Kotseva, S. Connolly, C. Jennings, A. Mead, J. Jones, A. Holden, D. De Bacquer, G. De Backer, T. Collier, D Wood 

09:09 EuROACTION: The Achievement of Blood Pressure, Lipid and Glucose Targets in a Cardiovascular Prevention 

Programme in General Practice – One year Results 

S. Connolly, K. Kotseva, C. Jennings, A. Mead, J. Jones, A. Holden, T. Collier, D. De Backer, G. De Bacquer, D. Wood 

09:22 Cardiovascular Risk in Women: The Link Between Framingham Risk Score and Education Inequalities 

S. yala, E. Fleck, R. Sciacca, D. Castro, E. Giardina 

09:35 Follow up of patients undergoing cardiovascular surgery, compliance with secondary prevention measures 

S. Kerbage, E. Gallucci, G. Giunta, R. Bianco, J. Figal, J. Abud, E. Dulbecco, H. Raffaelli, R. Favaloro, B. Mautner 

09:48 Lack of Cardiac Rehabilitation Programs in Latin America and the Caribbean 

A. Montero-Gómez, C. Terzic, C. Mendoza, L. Saavedra, F. Kuniyoshi, R. Thomas, S. Kopecky, R. Squires, J. Vallejos, 

F. López-Jiménez 



PRimaRy and seCondaRy PRevention ii 

Chairs: Palmira Pramparo (ARGENTINA), Mauricio Wajngarten (BRAZIL) 

08:30 Dance-Hall dancing in patients with cardiovascular disease: Experience of 2 years 

P. Quiroga, MD Rius Suárez, Hermes Ilarraza-Lomel, Y. Prior, MA Viveros, I. Montero, M. Chen, A. Halabe, A. López, 

D. Flores 

08:43 EuROACTION: Achieving lifestyle targets in a hospital and primary care multidisiplinary cardiovascular 

prevention and rehabilitation programme. Results at 1 year. 

A. Mead, J. Jones, C. Jennings, A. Holden, S. Connolly, K. Kotseva, T. Collier, D. De Bacquer, G. De Backer, D. Wood 

08:56 Global mortality and relationship with cardiovascular risk factors in a cohort of public employees medical 

service mendoza argentina. Optimal Systematic Evaluation Program (OSEP STuDy) in Cardiovascular Risk 

O. Arrieta, S. Mortaloni, S. Zizzias, A. Añó, J. Alvarez, L. Cammi, S. Depine, S. Gimenez 

09:09 Clinical reality of coronary prevention in Europe: a comparison of Euroaspire I, II and III surveys 

K. Kotseva, C. Jennings, D. De Bacquer, G. De Backer, D. Wood 

09:22 Profile and High Prevalence of Cardiovascular Risk Factors in an urban Black African Population 

K. Tibazarwa, L. Ntyintyane, K. Sliwa, T. Gerntholtz, D. Wilkinson, S. Stewart 

09:35 High Prevalence of Cardiovascular Risk Factors Among Brazilian Cardiologists 

M. S. Rocha, L. C. L. Correia, J. P. Esteves 

09:48 Cardiovascular disease prevention and risk factors control: Evaluation of educational community level 

intervention and communicational strategies for primary prevention 

S. Kunstmann, Maria Teresa Lira, D. Gainza, J. A. Degrazia, J. C. Molina 



ReseaRCh on PhaRmaCology 

Chairs: Lerman Jorge (ARGENTINA), Angeles Alonso Garcia (SPAIN) 



08:30 A novel orally active BNP possesses chronic natriuretic actions and decreases mean arterial pressure and 

activates cGMP in a model of acute hypertension 

A. Cataliotti, H. H. Chen, J. A. Schirger, F. L. Martin, G. Boerrigter, L. C. Costello-Boerrigter, K. D. James, J. C. Burnett 

08:48 Clinical utility of Single-Pill Amlodipine Besylate/Atorvastatin Calcium to Reduce Predicted 10-year Coronary 

Heart Disease Risk by Lowering Blood Pressure and Lipids to Meet Therapeutic Goals in Latin American 

Patients with Hypertension/Dyslipidemia 

H. Chaves, Y. Ro, H. F. Tse, L. Howes, C. Aguilar-Salinas, S. Erdine, R. Guindy, P. Chopra, R. A. Moller, I. M. Schou 

09:06 Enoxaparin and unfractionated heparin for inpatient initial treatment of venous thromboembolism: an 

utilization study and cost-minimization analysis 

L. Moreira, C. Argenta, M. A. P. Ferreira 

09:24 Correlation Between Plasma Concentration Of Aldosterone And Neutrophils And The Effect With Aldosterone 

Blockade In Patients With Heart Failure Following Ami 

J. Martinez, J. Said Nisi, F. Martinez, M. Bendersky, F. Zaanad, B. Pitt 

09:42 Correlation of highly sensitive C reactive protein with Acute Coronary Syndromes and effects of Statin therapy 

y. Varma, R. Gupta, A. Kuchwaha, B. S. Yadav, G. Singh, R. K. Shrivastava, V. K. Sharma, T. N. Dube, R. K. Jain, R. S. Meena 



exeRCise, lifestyle and isChemiC heaRt disease 

Chairs: Hermes Ilarraza-Lomeli(MEXICO), Roberto Peidro (ARGENTINA) 

08:30 Subacute effects of maximal exercise on heart rate variability in patients with chronic heart failure 

P. Soares, P. Moreira, F. Neves, N. Rocha, A. Nobrega 

08:45 Invasive exercise testing improves the early diagnosis of pulmonary arterial hypertension 

R. Fowler, A. Maiorana, S. Jenkins, M. Thomas, E. Gabbay, G. O'Driscoll 

09:00 Relationship of Exercise Heart Rate Responses to 10-year Mortality in CHD 

T. G. Allison, R. W. Squires, B. J. Johnson, F. H. Kuniyoshi, R. J. Thomas 

09:15 Circulatory responses to walking test of 50 m in coronary unit in unstable angina and acute myocardial 

infarction of acute phase 

C. Dias, A. Maiato, K. Baqueiro, A. Figueiredo, F. Rosa, J. Pitanga, L. Catão, A. Guimarães 

09:30 Monitoring myocardial infarction (diagnostic combination, prodromal period, behavioral characteristics) 

using the WHO program "Registry of Acute Myocardial Infarction", “MONICA” during the period of 22 years 

in Russia 

V. Gafarov, A. Gafarova 

09:45 EuROASPIRE III: Lifestyle and risk factor management and use of drug therapies in coronary patients 

from 22 countries in Europe. 

K. Kotseva, C. Jennings, D. De Bacquer, G. De Backer, D. Wood


fetal CaRdiology 

Chairs: Pablo Marantz (ARGENTINA), Areias Carlos (PORTUGAL) 



08:30 Histology of umbilical Blood Vessels 

J. Milei, H. Ruda Vega, R. Guerri Guttenberg, D. R. Grana, F. Azzato, M. Vazquez Blanco 

08:43 The severity of pulmonary regurgitation - what impact it may have on regional right ventricular function in 

patients after Tetralogy of Fallot repair 

E. Kowalik, M. Kowalski, M. Kusmierczyk, J. Rozanski, P. Hoffman 

08:56 Fetal ductal arteriosus flow velocities and right ventricular size are influenced by maternal ingestion of 

polyphenol-rich common beverages 

P. zielinsky, J. Manica, A. Piccoli Jr., L. Nicoloso, R. Frajndlich, H. Menezes, A. Busato, T. Behrens, J. Huber, M. Silva 

09:09 Maternal ingestion of herbal teas and grape juice during pregnancy may cause fetal ductal constriction 

P. zielinsky, A. Piccoli Jr., J. Manica, L. Nicoloso, H. Menezes, R. Frajndlich, A. Busato, L. Hagemann, M. Moraes 

J. Silva 

09:22 An experimental study of the role of maternal ingestion of green tea, mate tea and grape juice as cause of 

fetal ductal constriction 

P. zielinsky, J. Areias, A. Piccoli Jr., J. Manica, L. Nicoloso, H. Menezes, R. Frajndlich, M. Moraes, J. Silva, M. Allievi 

09:35 Pulmonary venous flow and its relation with fetal respiratory movements 

P. zielinsky, K. Chemello, L. Nicoloso, M. Morais 

09:48 Study of left atrium shortening fraction in fetuses of diabetic mothers 

P. zielinsky, S. Luchese, J. Manica, A. Piccoli Jr., L. Nicoloso, M. Leite, L. Hagemann, A. Busato, M. Moraes 

novel tReatments foR liPids disoRdeRs 

Chairs: Mele Eduardo (ARGENTINA), Zampelas A (GREECE) 



08:30 Effectiveness of Trimetazidine treatment and Mediterranean-type diet in postinfarction overweight patients 

with borderline serum cholesterol 

K. G. Adamyan, A. V. Astvatsatryan, A. L. Chiningaryan 

08:43 A treatment algorithm for statin dose selection enables the majority of Latin-American patients with a range 

of cardiovascular-risk profiles to reach LDL-C targets. 

A. M. Valderrama, R. Vinueza, and The La-Atgoal Study Group 

08:56 Transfer of lipids to High Density Lipoprotein (HDL) in age groups and the effect of Coronary Artery Disease: 

a study using an artificial nanoemulsion. 

C. H. M Azevedo, A. C. Lo Prete, C. G. Puk, T. M. Seydell, F. Maniero, M. Wajngarten, J. Diament, R. C. Maranhao 

09:09 Simultaneous transfer of lipids from an artificial model lipoprotein (LDE) to high-density lipoprotein. 

A. C. Lo Prete, C. H. M. Azevedo, C. G. Puk, R. C. Maranhao 

09:22 Paradoxical and curvilinear relationship between components of metabolic syndrome, atherosclerosis, and 

HDL-cholesterol in africans with type 2 diabetes mellitus: Proposition of metabolic syndrome definition for 

B. Longo-Mbenza, J. B. Kasiam Lasi On’ki, A. Kasiam Lasi On’ki, N. Kangola Kabangu 

09:35 Lipid transfer to the HDL fraction in patients with type 2 diabetes 

T. M. Seydell, G. S. Feitosa-Filho, A. C. Lo Prete, F. Maniero, C. H. Azevedo, C. Alberto Silva, R. Cavalcante Maranhão 

09:48 Increased P-Selectin and Fibrinogen Levels After Maximal Stress Test Are Not Modified by a 

High Dose Atorvastatin 

D. Lindefjeld, M. Acevedo, G. Chamorro, E. Riedemann, D. Mezzano, C. Aranis, J. Oporto, O. Panes 





dRug eluting stent: eaRly and late outComes 

Chairs: Omar Santaera (ARGENTINA), Costantino Costantini (BRAZIL) 

08:30 Novel Drug Eluting Stent System with a Polymer Free, On-Site Stent Coating: Single Centre Experience 

N. Sinha, S. Kumar, A. Kapoor, S. Tewari, H. Rai, N. Singh 

08:43 Long term Follow-up of Bare Metal and Drug Eluting Stents in Coronary Angioplasty. 

G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, P. Mollon, J. Scaglia 

08:56 The Fate Of Coronary Artery Aneurysm Developed After Drug-eluting Stent Implantation 

B. Hong, C. Ahn, Y. Yoon, P. Min, S. Rim, H. Kwon, D. Choi, Y. Jang, D. Jeon, J. Yang 

09:09 Long-term Outcome Following Primary Percutaneous Coronary Intervention with Drug-Eluting and 

Bare Metal Stent in Patients with ST-Segment Elevation Myocardial Infarction 

P. Thayssen, L. O. Jensen, M. Maeng, A. Kaltoft, H. Tilsted, M. Bottcher, K. E. Pedersen, L. Pedersen, S. O. Johnsen, 

L. Thuesen 

09:22 Can Disproportionality Analysis Play a Role in Monitoring Drug-Eluting Stent Safety? 

H. Duggirala, X. Yang, R. Van Manen 

09:35 Treatment of bifurcation lesions with two drug eluted stents: Clinical follow up of "Crush" versus "T" 

stenting techniques 

I. Teplitsky, A. R. Assali, H. Vaknin Assa, E. Lev, D. Brosh, I. Ben-Dor, S. Fuchs, N. Shor, A. Battler, R. Kornowski 

09:48 Cost-effectiveness of the percutaneous treatment strategy of multivessel disease with Taxus stents in 

comparison with bypass surgery 3 years after treatment 

M. Gyongyosi, F. Leisch, R. Karnik, S. Harb, P. Siostrzonek, M. Heigert, G. Zenker, I. Lang, G. Christ, D. Glogar 

eCho stRess i 

Chairs: Jorge Lax(ARGENTINA) 



08:30 Prognostic Value of Exercise Stress Test and Pharmacological Myocardial Scintigraphy in Diabetic Women 

Without Cardiac Symptom 

P. Smanio, A. Thom, A. Carvalho, L. Mastrocolla, R. Meneghelo, S. Tebexreni, A. De Paola, L. Piegas 

08:43 Risk stratification of patients with chest pain suspected to be due to acute cardiac ischemia in the emergency 

department: can rest myocardial perfusion imaging add value to the traditional risk stratification tools? 

M. Ferreira, A. Ferrer-Antunes, V. Rodrigues, F. Santos, J. Lima, M. D. Cerqueira, L. A. Providência 

08:56 Prevalence of myocardial ischemia in patients with syncope. 

P. Smanio, J. Poeys, G. Monteiro, G. Moscardi, R. Teixeira, D. Moreira, A. Thom, L. Piegas 

09:09 Determinants of dipyridamole-induced hypotension in patients undergoing gated myocardial perfusion 

single-photon emission computed tomography 

A. De Lorenzo, R. S. L. Lima, M. P. Pellini, J. B. Pereira, L. M. B. Fonseca 

09:22 Aortic stiffness is related to the extent of aortic structural damage detected by hybrid PET/CT 

L. Joly, W. Djaballah, A. Kearney-Schwartz, A. Zervoudaki, P. Olivier, P. Jolivet, P. Y. Marie, A. Benetos 

09:35 Imaging of coronary artery fistulas by multidetector computed tomography: Is Multidetector computed 

tomography sensitive? 

F. Kacmaz, N. Isiksalan Ozbulbul, O. Alyan, O. Maden, A. D. Demir, R. Atak, A. R. Erbay, Y. Balbay, T. Olcer, E. Ilkay 

09:48 Parameters associated with development of myocardial ischemia during mental stress test 

J. Stepanovic, M. Ostojic, D. Lecic-Tosevski, O. Vukovic, A. Djordjevic-Dikic, I. Nedeljkovic, B. Beleslin, V. Giga, 

I. Nedeljkovic, M. Nedeljkovic


eCho stRess ii 

Chair: Shay Livschiz (ISRAEL) 



08:30 Prevalence of ischemia in diabetic women with multiple risk factors. Comparison between myocardial 

perfusion scintigraphy, exercise stress test and cardiopulmonary test in the assessment of severe coronary 

artery disease 

P. Smanio, C. Carvalho, A. Tebexreni, A. Thom, L. Mastrocolla, R. Meneghelo, A. Alves, L. Piegas 

08:43 Incremental Prognostic Value of Left Atrial Volume over Dobutamine Stress Echocardiography Results in 

Patients with Known or Suspected Coronary Artery Disease 

J. Tsutsui, P. Dourado, A. Elhendy, S. Falcão, A. Chagas, P. Daluz, J. Ramires, W. Mathias Jr. 

08:56 New and faster protocol of stress echocardiography with dobutamine and atropine 

L. Rocha Lopes, P. Cordeiro, O. Simoes, M. J. Loureiro, S. Almeida, C. Cotrim, M. Carrageta 

09:09 Prognostic value of exercise echocardiography in diabetic patients 

T. S. Aragão, J. L. M. Oliveira, F. D. Anjos-Andrade, E. O. Alves, A. C. Nascimento-Junior, T. J. S. Goes, A. D'Oliveira-Junior, 

J. A. S. Barreto-Filho, A. C. S. Sousa 

09:22 Which is the target heart rate to achieve with dobutamine to consider sufficient an assessment of coronary 

flow reserve. Is it a feasible test? 

J. Lowenstein, E. Forte, A. Garcia, G. Peñaloza, A. Lescano, M. Amor, A. Panaro, C. Quiroz, O. Montaña, V. Darú 

09:35 Effects of myocardial viability assessed by strain stress echocardiography on diastolic function in Acute 

Myocardial Infarction 

W. J. Chung, M. S. Shin, E. O. Shim, W. C. Kang, S. H. Han, C. I. Moon, K. K. Koh, T. H. Ahn, I. S. Choi, E. K. Shin 

09:48 Mitral regurgitation and exercise capacity in heart failure patients with left ventricular systolic dysfunction 

M. Trivi, J. Thierer, R. Guglielmone, A. Adriana, P. Huschnir, J. Marino, M. Sultán, V. Mezzalira, A. Hirshon Prado, R. Ronderos 



exPeRienCes With high Risk Patients i 

Chairs: José Gabay (ARGENTINA), Luis Guzman (UNITED STATES) 

08:30 Nationwide Trends in the utilization Of Percutaneous Coronary Intervention (Pci) in the united States. 


08:43 "Deep" Plasma Proteomic Assessment Reveals Increased Amyloidogenic Proteins in Patients With 

Extensive Atherosclerosis 

A. Wilson, A. Rafie, K. Beck, N. Balasubramanian, E. Fung, J. Olin, J. Cooke 

08:56 In-Hospital Mortality after Acute Ischemic Stroke in an Emerging Country. The Argentinian National Stroke 

Registry (ReNACer) 

L. A. Sposato, M. M. Esnaola, M. C. Zurru, J. J. Cirio, R. Zamora, O. Fustinoni, G. Saposnik 

09:09 Are there any Gender Differences in First-Ever Ischemic Strokes in Emerging Countries?. The Argentinian 

National Stroke Registry (ReNACer) Experience 

L. A. Sposato, M. M. Esnaola, M. C. Zurru, R. Zamora, O. Fustinoni, G. Saposnik 

09:22 Effects of Carbamazepine on Spinal Cord Ischemia 

M. Sirlak, S. Eryilmaz, B. Inan, L. Yazicioglu, E. Ozcinar, R. Akar, B. Kaya, Z. Egileten, R. Tasoz, U. Ozyurda 

09:35 Early experience in mechanical cardiac support with Berlin heart as bridge to transplant in pediatrics 

H. Vogelfang, G. Naiman, A. Villa, A. Charroqui, G. Moreno, L. Quiroga, G. Burlli, E. Carmona, D. Haag, M. De La Riba 

09:48 Intraaortic Balloon Pump in High-Risk Cardiac Patients undergoing Non-Cardiac Surgery 

R. Levin, M. Degrange, R. Porcile, F. Salvagio, C. Del Mazo, A. Botbol, N. Blanco, E. Tanus 



management of Patients With synCoPe 

Chairs: Dario Sobral (BRAZIL), Riccardo Cappato (ITALY) 

10:30 Inappropriate sinus node tachycardia 

Carlos A. Morillo (CANADA) 

10:52 Management strategies 

Rafael Rabinovich (ARGENTINA) 

11:14 Syncope and falls in the elderly 

Antonio Gonzalez Hermosillo(MEXICO) 




Symposium 

What’s neW in heaRt failuRe? 

Chairs: Jay Cohn (UNITED STATES), Shigetake Sasayama (JAPAN) 

10:30 New pharmacotherapies for chronic heart failure 

Philip A Poole-Wilson. (UNITED KINGDOM) 

10:52 What is new with currents agents 

Henry Krum (AUSTRALIA) 

11:14 Cardiac resynchronization therapy 

John Cleland (UNITED KINGDOM) 

11:36 New pharmacotherapies for decompensated heart failure 

Mihai Gheorghiade (UNITED STATES) 


Debate 

ContRoveRsial issues RegaRding management and tReatment 

of systoliC heaRt failuRe 

Chairs: Sergio Varini (ARGENTINA), Hori Masatsugu (JAPAN) 

Statement 1: 

10:30 Patients with systolic heart failure in the New york Heart Class Association II should be treated 

with aldosterone antagonist 

Pro: Willem Remme (NETHERLANDS) 

Contra: José Luis López-Sendón (SPAIN) 

Statement 2: 

11:15 Patients with heart failure and LV ejection fraction < 25% and sinus rhythm should receive 

anticoagulant therapy 

Pro: Guillermo Torre Amione (UNITED STATES) 

Contra: Barry Massie (UNITED STATES)



Symposium 

nuCleaR CaRdiology 2008 

Chairs: Alia Abdelfattah (EGYPT), Angel Sandrin (ARGENTINA) 

10:30 Molecular imaging 

Barry Zaret (UNITED STATES) 

10:48 utility of images of the evaluation of vulnerable asymptomatic patients 

George Beller (UNITED STATES) 

11:06 Pharmacological stress: New agents 

Manuel Cerqueira (UNITED STATES) 

11:24 Complementary techniques: Computed tomography and nuclear medicine 

Ernest Garcia (UNITED STATES) 

11:42 Coronary artery disease: Do women constitute a special group? 

Joao Vitola (BRAZIL) 

uPdate on mitRal ReguRgitation 

Chairs: Marcia Barbosa(BRAZIL), Carlos Nojek (ARGENTINA) 

10:30 Asymptomatic mitral regurgitation, intervene or wait? 

TBD 

10:52 Mitral valve reconstruction: What have we learned during the past 40 years? 

David Adams(UNITED STATES) 

11:14 Percutaneous repair of mitral regurgitation 

William E. Cohn E. (UNITED STATES) 

11:36 Three-dimensional echo evaluation of mitral regurgitation 

Bernhard Mumm (GERMANY) 


Symposium 



PeRCutaneous heaRt valve inteRventions: 

the end of valvulaR oPen heaRt suRgeRy? - PaRt tWo 

Chairs: Alejandro Palacios (ARGENTINA), Felipe Heusser Risopatró (CHILE) 

10:30 Innovation in percutaneous mitral valve repair and replacement 


10:52 Percutaneous pulmonary valve replacement: An update 


11:14 Balloon mitral valve dilation for mitral stenosis disease from low income countries: 

Has it replaced surgery forever? 

Deborah Nercolini (BRAZIL) 

11:36 Surgery vs. percutaneous procedures 

A. A. Shafi Majumder (BANGLADESH) 





inteRventional tReatment of aCute myoCaRdial infaRCtion 

Chairs: Fabio Sandoli De Brito (BRAZIL), Riccitelli Miguel (ARGENTINA) 

10:30 Strategies to reduce door-to-balloon times 


10:52 Adjunctive drug treatment for primary PCI Dudek 

Ricardo Lluberas (URUGUAY) 

11:14 Multivessel disease management in ST-segment elevation myocardial infarction 


11:36 Transfer for PCI: Controlled studies and the real world 

P. Radke (GERMANY) 


Symposium 

Women and CoRonaRy heaRt disease 

Chairs: Juan Justiniano Encina (BOLIVIA), Angeles Alonso Garcia (SPAIN) 

10:30 Cardiovascular risk factors in women: Is there a real gender difference? 

Nanette Wenger (UNITED STATES) 

10:52 Diagnostic assessment of IHD in women 

Noel Bairey Merz (UNITED STATES) 

11:14 Therapeutic interventions in women: How can we improve outcomes? 

Rose Marie Robertson (UNITED STATES) 

11:36 Gender differences in angina and acute coronary 




late Results in CaRdiovasCulaR inteRventions 

Chairs: Luis Guzman (UNITED STATES), Ramón Quesada (UNITED STATES) 

10:30 Internal thoracic artery over 30 years of experience 

Sabik III Joseph F (UNITED STATES) 

11:00 Composite graph: Radial, gastroepiploic artery and SVG 

Roque Cordoba (ARGENTINA) 

11:30 Preservative surgery of the aortic valve: In hospital and long-term outcomes 

Daniel Navia (ARGENTINA)



Symposium 

the Class effeCt dilemma: aRe all dRugs Within a Class CReated equal? 

Chairs: Lerman Jorge (ARGENTINA), Luis Vidal (ARGENTINA) 

10:30 Beta blockers 

Corbalan Ramon (CHILE) 

11:00 Nonsteroidal anti-inflammatory drugs 

Frank Thomas Ruschitzka (SWITZERLAND) 

11:30 Statins 

Antonio Chagas (BRAZIL) 


Symposium 

PeRCutaneous PulmonaRy valve RePlaCement 

Chairs: Guillermo Kreutzer (ARGENTINA), Valmir Fontes (BRAZIL) 

10:30 Opportunity of pulmonary valve replacement 

Michael Landzberg (UNITED STATES) 

10:52 Point of view of a surgeon 

Andrés Schlichter (ARGENTINA) 

11:14 Experience with Edwards valve 

Ziyad Hijazi (UNITED STATES) 

11:36 Results with Bonhoffer valve 



Symposium 

hyPeRtension and taRget oRgan damage 

Chairs: Luis Alcocer (MEXICO), Luis Molinary (PUERTO RICO) 

10:30 Cognitive dysfunction and hypertension 


10:52 Specific cardiac complications 

Richard Devereux (UNITED STATES) 

11:14 The kidney’s role in hypertension 

Luis Juncos (ARGENTINA) 

11:36 Hypertension, inflammation and organ target damage 

Oscar Carretero (UNITED STATES) 




Symposium 

aCute CoRonaRy syndRome in diabetes 

Chairs: Mehta A. B (INDIA), Pomes Iparraguirre Horacio (ARGENTINA) 

10:30 Diabetes and acute coronary syndromes: An overview 


10:52 Management of ACS in diabetics: An European perspective and lessons from the MIDAS registry 

Marco Roffi (SWITZERLAND) 

11:14 Diabetes and ACS in India: Magnitude of the disease burden and optimal pharmacotherapy 

Shirish Hiremath (INDIA) 

11:36 When perform surgical revascularization in patients with stable coronary artery disease? 

Robert Califf (UNITED STATES) 


Symposium 

CaRdiovasCulaR disease PRevention in ChildRen 

Chairs: Pilar Arnaiz (CHILE), Veronica Ines Volberg (ARGENTINA) 

10:30 Prevention of cardiovascular diseases from childhood: The EDuCANDO Project 

Rodolfo Daniel La Greca (ARGENTINA) 

10:52 Excercise as a tool in prevention for children 

Patricia Sangenis (ARGENTINA) 

11:14 Pharmacologic treatment of hypertension in adolescents 

Giuseppe Ambrosio (ITALY) 

11:36 Cardiovascular risk factors in childhood: A growing international problem 

Roya Kelishadi (ISLAMIC REPUBLIC OF IRAN) 


Symposium 

aCute heaRt failuRe in the emeRgenCy dePaRtment 

Chairs: Gines Sanz (SPAIN), Victor Mauro (ARGENTINA) 

10:30 Biochemical diagnosis: How much better than clinical diagnosis? 

Carlos Martinez-Sanchez (MEXICO) 

10:52 Echocardiogram in acute heart failure: When to indicate it in the emergency department? 

Pablo Oberti (ARGENTINA) 

11:14 Heart failure units: Rationale for their implementation 

Juan José Fuselli (ARGENTINA) 

11:36 Nesiritide and levosimedan: Do they have any role in the emergency department? 

Fernando Bacal (BRAZIL)




bms and des Restenosis: hoW do We tReat them in 2008? 

Chairs: Christopher Cates (UNITED STATES), Antonio Pocovi (ARGENTINA) 

10:30 Critical assessment of the outcomes of in-stent restenosis 

Expedito Ribeiro (BRAZIL) 

10:52 High risk lesions for restenosis: Bifurcations, long lesions, small vessels, etc. 

Spencer King III (UNITED STATES) 

11:14 Different paterns and solutions for in-segment/stent restenosis for BMS and DES 

Carlos Mendiz (ARGENTINA) 

11:36 Are there any new devices for avoiding in-stent restenosis? 

Mario Pieroni (ARGENTINA) 



isCP the global nutRition Challenge 

Chairs: Scott Grundy (UNITED STATES), Palmira Pramparo (ARGENTINA) 

10:30 Nutrition transition in the developing world 

Barry Popkin (UNITED STATES) 

10:52 Nutrition and health status in China 

Zhao Dong (CHINA, PEOPLE’S REPUBLIC OF) 

11:14 Nutrition and health status in Brazil 

11:36 Nutrition and health status in Mexico 



iasC: heaRt failuRe With PReseRved systoliC funCtion 

Chairs: Oscar Alvarado C (PERU), Maria Paniagua (PARAGUAY) 

10:30 A new worldwide epidemic? 

Wistremundo Dones (PUERTO RICO) 

10:52 Pathophysiological mechanisms 

Piñeiro Daniel (ARGENTINA) 

11:14 How to make the diagnosis? 

Miguel Quiñones (UNITED STATES) 

11:36 How to treat it? 






hRs & ishne: sudden CaRdiaC death 

Chairs: Oseroff Oscar (ARGENTINA), Branco Mautner (ARGENTINA) 

10:30 High risk stratification for ICD implantation - clinical approach 

Gioia Turitto (UNITED STATES) 

10:52 High risk stratification for ICD implantation - non-invasive assessment 

Nabil El-Sheriff(UNITED STATES) 

11:14 ICD - primary prevention of SD 


11:36 ICD indication for secondary prevention and genetic arrhytmic disorders 

Carlos A. Morillo (CANADA) 



ConfeRenCias 

Pesidentes: Javier Bustamante (BOLIVIA), Eduardo Roura (ECUADOR) 

10:30 De los ensayos clínicos a la práctica asistencial 

Cagide Arturo (ARGENTINA) 

11:15 Avances en el manejo de la enfermedad aórtica 

Noedir Groppo Stolf (BRAZIL) 


Symposium 

Congenital heaRt disease in CountRies With limited ResouRCes 

Chairs: Alberto Sciegata (ARGENTINA), Rodolfo Neirotti (SWITZERLAND) 

14:00 Epidemiology and cost-effective practices for congenital heart disease in the developing world 

Masood Sadiq (PAKISTAN) 

14:22 Reality of Chagas Disease in 2008 

Ademar Atik(BRAZIL) 

14:44 Congenital cardiac surgery in the less privileged regions of the world 


15:06 Congenital cardiac survey in Central America 

Joaquín Barnoya (GUATEMALA)




Risk stRatifiCation in genetiC disoRdeRs: iCd oR not? 

Chairs: Branco Mautner (ARGENTINA), Yunlong Xia (CHINA, PEOPLE’S REPUBLIC OF) 

14:00 Genomic of sudden death: A new approach to risk stratification? 

Peter Spooner (UNITED STATES) 

14:22 Long QT Syndrome pathophysiological background 

Gabriel Vanerio (URUGUAY) 

14:44 ARVCs 

Guy Fontaine (FRANCE) 

15:06 Polymorphic ventricular tachycardia 

Víctor Arregui (ARGENTINA) 


Debate 

guiding and oPtimizing tReatment of heaRt failuRe 

Chairs: José Luis Barisani (ARGENTINA), V. Mareev (RUSSIAN FEDERATION) 

Statement 1: 

14:00 The medical treatment of heart failure should be guided and optimized with measurement of BNP levels 

Pro: Henry Krum (AUSTRALIA) 

Contra: Jay Cohn (UNITED STATES) 

Statement 2: 

14:45 The medical treatment of heart failure should be guided and optimize with echocardiogram parameters 

Pro: Miguel Quiñones (UNITED STATES) 

Contra: Marvin Konstam (UNITED STATES) 


Symposium 

aCute CoRonaRy events duRing non-CaRdiaC suRgeRy 

Chairs: Hernán Cohen Arazi (ARGENTINA), Edgar Pozo Valdivia (BOLIVIA) 

14:00 Epidemiology of acute coronary events in non-cardiac surgery 

Falconi Mariano (ARGENTINA) 

14:22 How should we stratify patients before non-cardiac surgery? 

Victor Sinisi (ARGENTINA) 

14:44 Are scores really useful in cardiac risk assessment before non-cardiac surgery? 

15:06 Prevention of acute coronary events in non-cardiac surgery: Revascularization or betablocker therapy? 

Don Poldermans (NETHERLANDS) 





ComPlex Patients and ComPlex deCisions - PaRt one 

Chairs: Martínez Rios Marco A. (MEXICO), Miguel Rubio (ARGENTINA) 

14:00 The left main trunk PCI, anatomy related strategies and outcomes 

TBD 

14:22 Elderly patients PCI: Clinical and anatomical risk factors 

Christopher Cates (UNITED STATES) 

14:44 Outcomes in sapheneous vein graft’s interventions: DES and BRS with/without distal protection 

Roxana Mehran (UNITED STATES) 

15:06 The patient with very low ejection fraction 

Costantino Costantini (BRAZIL) 


Symposium 

CuRRent toPiCs in infeCtive endoCaRditis 

Chairs: Hector Delgado Osorio (PUERTO RICO), Peter Liu (CANADA) 

14:00 World epidemiology of infective endocarditis/experience of ICE study 

Adam Torbicki (POLAND) 

14:22 Epidemiology, clinical characteristics and evolution of infective endocarditis in under-developed countries: 

Results of the Latino-American registries (EIRA) 

José Horacio Casabé (ARGENTINA) 

14:44 New advances in prognostics stratification of patients with infective endocarditis 

Miguel Gomez Sanchez (SPAIN) 

15:06 Which should be the therapeutic approach of the multi-disciplinarian health team of a patient 

with infective endocarditis in the new millennium? 

Francisco Nacinovich (ARGENTINA) 


Symposium 

endothelial dysfunCtion deteCtion With Cold PRessoR test 

and myoCaRdial PeRfusion 

Chairs: Plastino Juan A. (ARGENTINA), Acevedo Monica (CHILE) 

14:00 Prognostic impact of coronary vasodilator dysfunction 

Dimitri Tousoulis (UNITED STATES) 

14:22 Endothelial dysfunction on moderate risk patients 

Perez Baliño Nestor (ARGENTINA) 

14:44 PET utility on the analyses of the coronary vasomotion 

Heinrich Schelbert (UNITED STATES) 

15:06 Endothelia dysfuction treatment 

Giuseppe Ambrosio (ITALY)



Symposium 

mitRal valve RePaiR: What is the best oPtion? 

Chairs: Julio Palmaz (UNITED STATES), Alberto Domenech (ARGENTINA) 

14:00 How to select patients for surgical mitral valve repair 

Jaime Calderón Herrer (COLOMBIA) 

14:22 In-hospital and long-term follow-up on surgical valve repair 

David Adams(UNITED STATES) 

14:44 When mitral valve repair is not possible: What prosthetic valve should be preferred and for which patient? 

José Luis Navia (UNITED STATES) 

15:06 up-date on percutaneous mitral valve repair 

Igor Palacios (UNITED STATES) 


Debate 

Why aRe We not betteR in PReventing CaRdiovasCulaR diseases? 

Chairs: Shanthi Mendis (SWITZERLAND), Hernán Delmonte (ARGENTINA) 

Statement 1: 

14:00 It is the fault of the doctors that we are not better in preventing cardiovascular disease 

Pro: Hassell Trevor (BARBADOS) 

Contra: Zeljko Reiner (CROATIA) 

Statement 2: 

14:45 Is the general publics’ erroneous perception the reason why we are not better in preventing 

cardiovascular disease? 

Pro: Daniel W. Jones (UNITED STATES) 

Contra: Ulrich Keil(GERMANY) 


Symposium 

PRomoting smoke-fRee enviRonments 

Chairs: Ana Tambussi (ARGENTINA), Federico Giachello (ARGENTINA) 

14:00 Health impact of passive tobacco smoke: New evidence 

Joaquín Barnoya (GUATEMALA) 

14:22 Policy change for smoke-free environments in Latin America and the Caribbean 

Beatriz Champagne (UNITED STATES) 

14:44 Implementation of the framework convention on tobacco control 

Eduardo Bianco (URUGUAY) 

15:06 Counteracting the tobacco industry’s strategies 

Ernesto Sebrie (UNITED STATES) 




Symposium 

non-invasive imaging foR the diagnosis of myoCaRdial isChemia: 

WhiCh method? 

Chairs: Kuschnir Paola (ARGENTINA), Wielgosz Andy (CANADA) 

14:00 Nuclear medicine 

Francisco Benítez (UNITED STATES) 

14:22 Echocardiography 

Walter Stoermann (ARGENTINA) 

14:44 MRI and CT multi-slice 

Mario Garcia (UNITED STATES) 

15:06 Looking at the images: Why, when and which one? 

Pérez De Arenaza Diego (ARGENTINA) 


Symposium 

CaRdiovasCulaR dRug theRaPy in Women 

Chairs: César Serra (ARGENTINA), Pedro Lipszyc (ARGENTINA) 

14:00 Treatement during pregnancy and post-partum 

Manuel Vazquez-Blanco (ARGENTINA) 

14:22 Reperfusion therapy 

Jose Antonio Francisco Ramires (BRAZIL) 

14:44 Hormone replacement therapy 

Nanette Wenger (UNITED STATES) 

15:06 Primary and secondary recommendations for Aspirin therapy in women 

Smith Sidney (UNITED STATES) 


Symposium 

aCute CoRonaRy syndRome fRom PRe-hosPital to the emeRgenCy Room 

Chairs: Karl B. Kern (UNITED STATES), Alfredo Piombo (ARGENTINA) 

14:00 Right ventricular myocardial infarction 


14:22 Reducing the door-to-balloon time for myocardial infarction 

Alia Abdelfattah (EGYPT) 

14:44 Pre-hospital 12-lead EKG 

Mario Lado (URUGUAY) 

15:06 Antithrombotic therapy in pre-hospital and emergency room 

Ernesto Paolasso (ARGENTINA)



Symposium 

What aRe the stRategies in the management of mild hyPeRtension? 

Chairs: Luis Acosta (VENEZUELA), Pablo Rodriguez (ARGENTINA) 

14:00 Lifestyle modifications? 

Celso Amodeo (ARGENTINA) 

14:22 Anti-hypertensive drugs? 


14:44 Anti-platelets agents? 

Luis Ruilope (SPAIN) 

15:06 Lipid lowering agents? 




loWeR limb inteRventions: stand uP and Walk 

Chairs: Miguel Chiape (ARGENTINA), Joseph F. Sabik III (UNITED STATES) 

14:00 Patency vs clinical outcomes in complex infrapopliteal interventions: Does use of DES change the story? 

Mariano Ferreira (ARGENTINA) 

14:22 Percutaneuous treatment of total oclussions of SFA and iliac arteries: Long term follow-up 

Fernando Cura (ARGENTINA) 

14:44 Critical overview of endovascular treatment of aortic aneurysms 

Patricio Zaefferer (ARGENTINA) 

15:06 Long term results in superficial Femoral arteries stenting 

Jorge Bluguerman (ARGENTINA) 



aha: CRitiCal issues and neW stRategies to manage 

Patients With CaRdiovasCulaR disease 

Chairs: Gao Runlin (CHINA, PEOPLE’S REPUBLIC OF), Kumar Anil (INDIA) 

14:00 New imaging strategies to assess cardiovascular risk 

Fuster Valentin (UNITED STATES) 

14:22 Critical issues in the new secondary prevention guidelines 


14:44 Evolving strategies for the treatment of hypertension - is it time to change the guidelines? 

Daniel W. Jones (UNITED STATES) 

15:06 New guidelines for the management of patients with valvular heart disease 

Robert Bonow (UNITED STATES) 





inflammation and CaRdiovasCulaR disease: multi-maRkeR aPPRoaCh 

Chair: Conci Eduardo (ARGENTINA) 

14:00 From inflammation biology to cardiovascular Biomarkers 

Peter Libby (UNITED STATES) 

14:22 Dyslipidemic risk factors which are clinically important 

Tonkin Andrew (AUSTRALIA) 

14:44 Adiponectin and Coronary Heart Disease 

15:06 Brain natriurectic peptide as a marker of cardiovascular risk 




asnC: the big tRials on nuCleaR CaRdiology 

Chairs: Barry Zaret (UNITED STATES), Néstor Alejandro Vita (ARGENTINA) 

14:00 COuRAGE Trial 

Leslee Shaw (UNITED STATES) 

14:22 INSPIRE Trial 

John Mahmarian (UNITED STATES) 

14:44 DIAD Trial 


15:06 ADVANCE MPI 

Manuel Cerqueira (UNITED STATES) 



PolítiCas de salud 

Chairs: Graciela Ocaña (ARGENTINA), Perez Baliño Néstor Abel (ARGENTINA) 

14:00 Políticas públicas en prevencíon cardiovascular: rol de los gobiernos provinciales 

Oscar González (ARGENTINA) 

14:22 Prevencíon cardiovascular en un sistema de atencíon primaria de la salud 

Claudio Zin (ARGENTINA) 

14:44 Políticas Públicas de Salud en la ciudad de Buenos Aires 

Jorge Lemus(ARGENTINA) 

15:06 Promocíon y programas de salud en la Argentina 

Juan Carlos Nadalich (ARGENTINA)




tRatamiento aCtual de la enfeRmedad CoRonaRia CRóniCa 

Coordinadores: Patricia Rebaza (PERU), Edgar Pozo Valdivia (BOLIVIA) 

14:00 Impacto del tratamiento médico en la enfermedad coronaria crónica 

Sanhueza Patricio (CHILE) 

14:15 ¿Cuándo y cómo evaluar isquemia y viabilidad miocárdica? 

Masoli Osvaldo (ARGENTINA) 

14:30 ¿Qué pacientes deben ser revascularizados? 

Protasio Da Luz (BRAZIL) 

14:45 Seleción de la estrategia de revascularización ¿Cuándo utilizar stent con drogas? 

Ricardo Lluberas (URUGUAY) 


Symposium 

adequate management of ChRoniC heaRt failuRe 

Chairs: Miguel Quintana (PARAGUAY), Cuesta Silva Manuel (ARGENTINA) 

16:00 Optimizing diuretic treatment in ambulatory patients 

Barry Massie (UNITED STATES) 

16:18 Frequent difficulties and mistakes with ACEI and beta blockers therapy 


16:36 Careful Manage in patents with high comorbidity 

Gilson Feitosa(BRAZIL) 

16:54 Prevention of thromboembolic events 

Ileana Piña (UNITED STATES) 

17:12 How to implement a simple and effective disease programme in heart failure? 

Grancelli Hugo (ARGENTINA) 


Symposium 

viability imaging 

Chairs: Victor Balestrini (ARGENTINA), Gustavo Acosta (PARAGUAY) 

16:00 Is dobutamine echo the best test? 

Milind Desai (UNITED STATES) 

16:18 Recent outcomes in Nuclear Cardiology 

Francisco Benítez (UNITED STATES) 

16:36 Is Pet the gold standard? 

Heinrich Schelbert (UNITED STATES) 

16:54 New kids on the block: Magnetic resonance 

Masoli Osvaldo (ARGENTINA) 

17:12 Is there room for spect nowadays? 





Symposium 

management of Patients With hyPeRtension and ComoRbidities 

Chairs: Sverre E. Kjeldsen (NORWAY), Jaime Espinosa (PERU) 

16:00 Heart failure and hypertension: Just an overload? 

Jay Cohn (UNITED STATES) 

16:22 Diabetes and hypertension 


16:44 Hypertension in the very elderly 


17:06 Microalbuminuria 

Luis Ruilope (SPAIN) 



exeRCise in valvulaR heaRt disease 

Chairs: Mario Bey Lombana (PANAMA), Harry Acquatella (VENEZUELA) 

16:00 Aortic stenosis 

Roberto Peidro (ARGENTINA) 

16:22 Aortic regurgitation 

Daniel Areco (URUGUAY) 

16:44 Mitral regurgitation 

Jairo Pedraza (COLOMBIA) 

17:06 Mitral stenosis 

Pedro Gutierrez Fajardo (MEXICO) 



RheumatiC feveR/RheumatiC heaRt disease 

Chairs: Amoah Albert (GHANA), Aloyzio Achutti (BRAZIL) 

16:00 It is still around? 

Edward L. Kaplan (UNITED STATES) 

16:18 Primary prevention and the ASAP Program in Africa 


16:36 Pathogenesis of rheumatic heart disease 

Luiza Guilherme (BRAZIL) 

16:54 Rheumatic fever vaccines 

Carapetis Jonathan (AUSTRALIA) 

17:12 Rheumatic heart disease and its control in the Pacific 

Andrew Steer (AUSTRALIA)




undeRstanding hyPeRtRoPhiC CaRdiomyoPathy 

Chairs: Lastiri Hugo (ARGENTINA), Eduardo Moreyra (ARGENTINA) 

16:00 HCM in children 

Alday Luis (ARGENTINA) 

16:22 Pathogenesis beyond gene mutations 


16:44 Missense mutations and prognosis of hypertrophic cardiomyopathy 

Lorenzo Montserrat (SPAIN) 

17:06 Treatment approach 

Peter Liu (CANADA) 


Symposium 

an inteRnational look at CaRe foR Patients With aCute CoRonaRy syndRome 

Chairs: Mauricio Cohen (UNITED STATES), Ricardo López Santi (ARGENTINA) 

16:00 EuROPE 

Juan Kaski (UNITED KINGDOM) 

16:18 ASIA 

16:36 LATIN AMERICA 

Andres Orlandini (ARGENTINA) 

16:54 uSA 


17:12 What did we learn from international registries? 

P. Gabriel Steg (FRANCE) 


Symposium 

What should be the antithRombotiC theRaPy in aCute CoRonaRy syndRome? 

Chairs: Luis Mercado (BOLIVIA), P. Radke (GERMANY) 

16:00 Should fondaparinux be the first choice in ACS? 

Yusuf Salim (CANADA) 

16:22 PCI in ACS: When to indicate and which antithrombotic agent should be used? 

Enrique Fairman (ARGENTINA) 

16:44 Low molecular heparin is the first choice 




diabetes PRevention 

Chairs: Isaac Sinay (ARGENTINA), Shirish Hiremath (INDIA) 


Symposium 

16:00 Interventions in diabetes prevention in Europe: Experiences from development of European guidelines 

Marco Roffi (SWITZERLAND) 

16:22 Diabetes prevention in uruguay 

Raul Pisabarro (URUGUAY) 

16:44 Diabetes prevention programmes in China 

Qing Qiao (FINLAND) 

17:06 Diabetes prevention: A global strategy 

Mehta A. B (INDIA) 


Symposium 

stRess and dePRession: neW Risk faCtoRs foR CoRonaRy heaRt disease 

Chairs: Bernardo Boskis (ARGENTINA), Adel Allam (EGYPT) 

16:00 Psychosocial interventions in coronary heart disease 

Matthew Burg (UNITED STATES) 

16:18 Depression and cardiovascular disease 


16:36 Work stress and its impact on coronary artery disease 


16:54 Myocardial ischaemia detection during mental stress: Is it prognostic? 

Néstor Alejandro Vita (ARGENTINA) 

17:12 Type D personality: a chronic risk factor in heart disease 

Angelique Schiffer (NETHERLANDS) 


Symposium 

health fRom a gendeR PeRsPeCtive: imPliCations foR Cvd 

Chairs: Fernando De La Serna (ARGENTINA), Robert J. De Souza (SOUTH AFRICA) 

16:00 A focus in gender 

Nishtar Sania (PAKISTAN) 

16:22 The implications for the PHC sector: Strengthening core competencies of PHC workers to deal 

with CVD among women 

Denise Eldemire Shearer (JAMAICA) 

16:44 Policies that work: Examples from Canada 

Wielgosz Andy (CANADA) 

17:06 The WHO response 

Shanthi Mendis (SWITZERLAND)



Symposium 

PRevention of CaRdiaC disease in Childhood 

Chairs: Alfonso Buendia-Hernandez (MEXICO), Alex Javois (UNITED STATES) 

16:00 Childhood origins of vascular disease: New insights and future developments 

Horacio Zylbersztejn (ARGENTINA) 

16:22 Cardiovascular implications of childhood obesity 


16:44 Metabolic Syndrome as risk factor in children 

Irina Kovalskys(ARGENTINA) 

17:06 Epidemiology of rheumatic fever 



Debate 

CoRonaRy byPass suRgeRy: ContemPoRaRy issues 

Chairs: Daniel Bracco (ARGENTINA), Expedito Ribeiro (BRAZIL) 

Statement 1: 

16:00 Extra-corporeal circulation in coronary surgery is preferred 

Pro: Roberto Favaloro (ARGENTINA) 

Contra: Enio Buffolo (BRAZIL) 

Statement 2: 

16:45 Patients with multiple vessel disease should have surgery 

Pro: Manuel IrarrazAbal (CHILE) 

Contra: Alfredo Rodriguez (ARGENTINA) 


Symposium 

RePeRfusion in the eldeRly: evidenCe vs. Real life 

Chairs: Fernando Botto (ARGENTINA), M. Nahir (ISRAEL) 

16:00 Reperfusion in developed countries 

Xavier Bosch (SPAIN) 

16:22 Reperfusion in the rest of the world 

Álvaro Avezum (BRAZIL) 

16:44 Comorbidity and reperfusion strategies 

John Field (UNITED STATES) 

17:06 Cardiac care after myocardial infarction 

Mauricio Wajngarten (BRAZIL) 





hoW to deal With PCi ComPliCations? 

Chairs: Gao Runlin (CHINA, PEOPLE’S REPUBLIC OF), Jorge Leguizamon (ARGENTINA) 

16:00 PCI: Lethal or near lethal complications: Predictions and solutions 

Grinfeld Liliana (ARGENTINA) 

16:22 New antithrombotic strategies for avoiding stent thrombosis 

Marcelo Casey (ARGENTINA) 

16:44 Bleeding in PCI: How much of a problem? 

Carlos Macaya (SPAIN) 

17:06 Post-procedural renal failure: An unnecessary complication 

Roxana Mehran (UNITED STATES) 


Symposium 

go Red foR Women: going global 

Chairs: Zhao Dong (CHINA, PEOPLE’S REPUBLIC OF), Volqvartz Susanne (DENMARK) 

16:00 Women and heart disease in Argentina 

Florencia Rolandi (ARGENTINA) 

16:18 Africa: The data gaps 

Krisela Steyn (SOUTH AFRICA) 

16:36 Go Red for Women in the uSA 

Nancy Brown (UNITED STATES) 

16:54 Go Red for Women Singapore style 

Sun Yee Ho (SINGAPORE) 

17:12 Women & heart disease in low- and middle-income countries 


stRoke above the CaRotids 

Chairs: Omar Santaera (ARGENTINA), Chain Sergio (ARGENTINA) 


Symposium 

16:00 Incidence, prevalence of ischemic and hemorrhagic strokes: Demographic and geographic differences 

Sebastián Ameriso (ARGENTINA) 

16:22 Therapeutic window: Diagnosis and management based on neuro-imaging, CT vs. MRI 

Gilberto Gonzalez (UNITED STATES) 

16:44 Medical treatment beyond aspirin and IV rtpa 

Tonkin Andrew (AUSTRALIA) 

17:06 Endovascular treatment in intracranial ischemic stroke 

Fernando Vinuela (UNITED STATES)




PCna: the Role of the nuRse in PReventive CaRdiology: 

an aRea of leadeRshiP 

Chairs: Joanna Sikkema (UNITED STATES), Lira Maria Teresa (CHILE) 

16:00 The role of the nurse on cardiovascular prevention programmes 

Veronica Kramer (CHILE) 

16:22 Secondary Prevention: Are we able to improve the results? 

Catriona Jennings (UNITED KINGDOM) 

16:44 Role of nursing in cardiac rehabilitation 

Nancy Houston Miller (UNITED STATES) 

17:06 Behavioral changes in cardiovascular diseases: Tools for success 

Laura Hayman (UNITED STATES) 



faCtoRes de Riesgo y ateRosCleRosis subClíniCa 

Coordinadores: Mario Lado (URUGUAY), Santiago García Egüez (ECUADOR) 

16:00 ¿Es suficiente el score de Framinghan para establecer el riesgo cardiovascular? 

Hernández Edson (VENEZUELA) 

16:15 Aterosclerosis subclínica y riesgo cardiovascular. ¿Cómo evaluarla y como tratarla? 

Antonio Chagas (BRAZIL) 

16:30 Cambios en el estilo de vida: Beneficios clínicos y fallas en su implimentación 

Victoria Chaparro Cristaldo (PARAGUAY) 

16:45 ¿Cómo detectar y como tratar el metabolismo anormal de la glucosa? 

José Drago Silva (PERU) 

17:00 Objetivos terapéuticos de los trastornos lipídicos en prevención primaria y secundaria 

Rey Ricardo (ARGENTINA) 






antiPlatelets in PtCa 

Chairs: Ricardo Lluberas (URUGUAY), Barrero Carlos (ARGENTINA) 

08:30 Prognostic value of myocardial perfusion Gated SPECT after myocardial infarction 

P. Pujol, G. Cuberas, G. De León, R. Falú, S. Aguadé-Bruix, J. Castell-Conesa, J. Candell-Riera 

08:43 Can haemoglobin at admission predict short-term prognosis in acute coronary syndrome patients? 

N. Antonio, S. Monteiro, C. Lourenco, S. Costa, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, 


08:56 Efficacy and Safety of Abciximab in Conjunction with Aspirin, Heparin and Clopidogrel in High Risk Indian 

Patients undergoing Percutaneous Coronary Intervention 

N. Sinha, S. Kumar, K. Parikh, P. Chandra, A. Srinivas 

09:09 Safety and Efficacy of Bivalirudin in High-Risk Indian Patients undergoing Percutaneous Coronary 

Intervention: The Bivaflo® Registry 

A. Seth, N. Sinha, K. Parikh, T. Patel, M. S. Hiremath, A. B. Mehta, P. Chandra, B. Pinto, K. K. Sethi, S. Kumar 

09:22 Bleeding during warfarin therapy: an alert to concomitant diseases 

P. L. Lavitola, G. Spina, F. Tarasoutchi, R. O. Sampaio, M. Grinberg 

09:35 Traditional cardiovascular risk factors in unselected patients with acute myocardial infarction – impact on 

short-term mortality 

z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky 

09:48 Interaction between inflammation, glucose plasma levels and left ventricular function in postmenopausal 

women with coronary arterial disease 

u. Rushentsova, Y. Ekimova 

aCute CoRonaRy syndRomes and PtCa 

Chairs: P. Gabriel Steg (FRANCE), Hita Alejandro (ARGENTINA) 



08:30 Time to reperfusion and myocardial salvage achievement in Primary PCI 

J. Szarfer, M. A. Riccitelli, A. Garcia Escudero, G. Gigena, B. Federico, A. Alonso, R. Sarmiento, R. Blanco, R. Neme, 

L. Vidal 

08:43 Brazilian Registry of Acute Coronary Syndromes 

L. Piegas, H. Guimarães, A. Avezum, H. Reis, A. Muniz, E. Santos, M. Knobel, I. Santos, L. Ritt, J. Braga 

08:56 Factors That Impact The Door-To-Electrocardiogram Time In Patients With Acute Myocardial Infarction 

A. Correa, M. Makdisse, V. F. Oliveira, L. M. A. Forlenza, R. B. Magaldi, L. F. Lisboa, M. Vaidotas, M. Knobel, E. Knobel 

09:09 Patients undergoing rescue PCI with selective drug-eluting stent use can achieve similar mortalities to 

primary PCI, and low rates of target vessel revascularisation 

Q. Lo, V. Hsieh, N. Wouters, R. Van Der Vijver, D. Tobing, A. Hopkins, S. Lo, D. Leung, C. Juergens, J. French 

09:22 ST segment resolution after a successful PTCA: clinical and angiographic associated factors 

R. Blanco, J. Szarfer, M. A. Riccitelli, A. Garcia Escudero, S. Affatato, G. Gigena, F. Blanco, R. Sarmiento, 

A. Rodriguez, L. Vidal 

09:35 Predictors for lack of reperfusion after primary angioplasty in ST-elevation acute myocardial infarction 

F. Cura, A. Garcia Escudero, M. Trivi, M. Albertal, J. Thierer, P. Perez Baliño, L. Padilla, J. Belardi 

09:48 Prognosis of acute myocardial infarction in the elderly in Chile from 1993 to 2006 

F. Lanas, J. C. Prieto, C. Nazzal, P. Seron, P. Campos, J. Bartolucci, R. Corvalan, Gemi Group


Women and CoRonaRy disease 

Chairs: Masotti Mónica (SPAIN), Rodolfo Pizarro (ARGENTINA) 



08:30 Homocysteine lowering B-vitamin therapy improves coronary flow in patients with stable coronary artery 

disease, a WENBIT substudy 

Ø. Bleie, E. Strand, P. M. Ueland, S. E. Vollset, H. Refsum, J. Igland, J. E. Nordrehaug, O. Nygård 

08:43 Prognostic Value Of Myocardial Perfusion Defects With Cold Pressor Testing As An Indicator Of Endothelial 

Dysfunction In Asymptomatic Moderate Risk Patients.Paradigma Multicenter Study 

N. Perez Baliño, S. Traverso, L. Grynberg, M. Redruello, N. Maciel, C. Rapallo, D. Rosa, L. Vidal, J. Gagliardi, O. Masoli 

08:56 Atorvastatin Improved Endothelial Dysfunction To Supranormal Level After 9 Months Of Treatment In 

Familial Hypercholesterolaemia Patients 

A. Rapaee, H. Nawawi, K. Yusoff 

09:09 Flow mediated vasodilation in women at risk for preeclampsia 

F. A. Casas, H. A. Avaca, C. R. Majul, B. Lopez Ledesma, O. D. Manuale, G. M. Ferrari 

09:22 Effects of Long-Term Estrogen Replacement Therapy in Postmenopausal Women with Coronary Risk Factors 

R. Campisi, T. H. Schindler, J. O. Prior, X. L. Zhang, D. Dorsey, H. R. Schelbert 

09:35 Endothelial Dysfunction in dyslipidemia: pre and post-treatment assessment using 64-multislice PET/CT, C 

Reactive Protein and Lipid Profile 

E. Alexanderson, G. Alexanderson, L. García-Rojas, M. Rodríguez, P. A. Lamothe, J. A. Talayero, J. G. Juárez-Rojas, 

H. Rodríguez-Zanella, J. Almada, A. Meave 

09:48 ultrafiltration To Remove Inflammatory Mediators During Cardiopulmonary Bypass In Coronary Artery 

Bypass Graft Surgery 

O. Petrucci, N. Antunes, P. P. M. Oliveira, C. Kosour, M. H. S. L. Blotta, D. M. Braile, R. W. Vieira 





tC sCan, aRRhytmias and oRthostatiC hyPotension 

Chairs: Dubner Sergio (ARGENTINA), Nabil El-Sheriff(UNITED STATES) 

08:30 Mutation screening of PKP2 gene in severe form of arrhythmogenic right ventricular cardiomyopathy in 

Polish population 

E.K. Wlodarska, G. Beffagna, O. Wozniak, E. Czarnowska, C. Basso, K. Pilichou, P. Hoffman, G. Thiene, G. A. Danieli, 

A. Rampazzo 

08:43 Noncalcified Coronary Plaques Evaluated by 64 Slice Computed Tomography in Patients With Low Risk for 

Coronary Artery Disease 

A. Bayol, J. Vallejos, R. Peloso, J. Mazucco, R. Obregon, M. Romero, W. Harvey, R. Gonzalez, A. Zarza, J. Parras 

08:56 Diagnostic Accuracy of 64-Slice Computed Tomography To Identify Coronary Artery Disease. A Single Center 

Comparison with Invasive Coronary Angiography 

L. Lasave, E. Picabea, F. Kozak, A. Damonte, M. Rossi, C. Bonini, E. Arias, M. Gamen, A. Dauria, R. Villavicencio 

09:09 Influence of paroxysm of atrial fibrillation on the left atrial and left ventricular functional parameters 

L. Tunyan 

09:22 The significance of short time Poincare plot analysis in assessment of sudden cardiac death risk in patients 

with alcoholic liver disease 

B. M. Branislav Milovanovic, N. M. Nikola Milinic, M. K Mirjana Krotin, B. F. Branka Filipovic, V. B Vesna Bisenic 

09:35 Association Between Orthostatic Hypotension And Results Of The Head-up Tilt Table Testing 

L. Smidt, M. Morais, J. Barbisan, C. Nicoletti, L. Biason, J. Paiva 

09:48 Circulatory variables related to the clinical syndrome of Postural Orthostatic Hypotension 

C. Podoleanu, R. Maggi, M. Brignole, D. Podoleanu, E. Carasca, K. Orban, I. Craciunescu, C. Ginghina




iCd and PaCemakeRs 

Chairs: Luis Alcocer (MEXICO), Jorge Gonzalez ZUelgaray (ARGENTINA) 

08:30 Clinical value of a simple RR interval holter monitoring as a predictor of life-threatening arrhythmias in 

patients with defibrillator discharge. 

M. Lewandowski, H. Szwed, I. Kowalik. 

08:41 Identification of patients who benefit from implantable cardioverter defibrillators (ICDs) by combining the 

genotypes for Angiotensinogen (AGT), Angiotensin-converting enzyme (ACE) and Angiotensin II type1 

receptor (AT1R) 

L. Woie, L. Wee, H. Vefring, J. T. Kvaløy, D. W. T. Nilsen. 

08:52 Non-pharmacological prevention of atrial fibrillation after off-pump CABG: temporary atrial external stimulation 

F. Silva, P. Brofman, R. Milani, D. Précoma, M. Guimarães, L. Barbosa, A. Sartori, J. Augusto Souza. 

09:03 The Successful use of Extracorporeal Membrane Oxygenation and Drotrecogin alfa in Patients with Acute Life 

Threatening Myocarditis 

T. Tsai, S. Tsao, Y. Wu, J. Yu, K. Chan, K. Ueng, H. Wong, Y. Sun, S. Huang. 

09:14 Effectiveness and Feasibility of a Transtelephonic Monitoring Program 

A. Baranchuk, D. Campbell, K. Stuart, W. Hopman, J. McMillan, K. Aldworth-Gaumond, R. Witjes, D. Clark, 

D. P. Redfearn, C. S. Simpson. 

09:25 Biventricular Pacing using Conventional Dual-Chamber Pacemakers in Patients with Permanent Atrial 

Fibrillation and Heart Block 

S. Pinski, B. Kuo, F. Arnaldo, M. Helguera. 

09:36 Where Are The Left Ventricular Leads Really Implanted? A Study of 90 Consecutive Patients 

C. D'Ivernois, J. Lesage, A. Lagrange, P. Blanc. 

09:47 Antiarrhythmic effect of H1-histamine receptors blocker – Phencarol 

O. N. uchevatkina, L. M. Makarov, L. A. Balykova, V. N. Komolyatova, V. P. Balashov. 





CaRdiomyoPathies 

Chairs: Eduardo Moreyra (ARGENTINA), Hector Delgado Osorio (PUERTO RICO) 

08:30 Surgical treatment of primary dilated cardiomyopathy (the role of endomyocardial biopsy analysis) 

M. zorc, D. Petroviè, R. Zorc-Pleskoviè, A. Pleskoviè, N. Radovanoviæ 

08:43 New insight into the pathogenesis of the hypertrophic cardiomyopathy: benign tumour secreting 

inappropriately high amount of BNP during stress 

N. Nranyan 

08:56 Short and long term follow-up of patients with hypertrophic cardiomyopathy treated with percutaneous 

alcohol septal myocardial ablation 

L. A. Malek, M. Klopotowski, L. Chojnowska, M. Demkow, A. Witkowski, M. Dabrowski, B. Kusmierczyk, M. Konka, 

R. Maczynska, W. Ruzyllo 

09:09 Seven years follow-up of metoprolol for treatment of dilated cardiomyopathy 

S. Xue 

09:22 Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: ultra-Low Dose of Alcohol (1 ml) is 

Still Effective 

J. Veselka, D. Zemánek, P. Tomašov, R. Duchoňová, K. Linhartová 

09:35 Echocardiographic And Pathological Assessment Of Cardiac Myxomas: A 14-year Retrospective Review. 

T. F. Cianciulli, L. A. Cosarinsky, J. A. Lax, M. C. Saccheri, J. A. Gagliardi, H. J. Redruello, S. D. Llanos Dethinne, 

S. Fandiño Lound, C. E. Parisi, L. A. Vidal 

09:48 Value of real-time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy. 

Comparison with two-dimensional echocardiography and magnetic resonance imaging. 

L. Bicudo, J. Tsutsui, A. Shiozaki, C. Rochitte, E. Arteaga, C. Mady, W. Mathias 



kidney and heaRt failuRe 

Chairs: Daniel Nul (ARGENTINA), Barry Massie (UNITED STATES) 

08:30 Kidney-Heart Connection: Cardiac Fibrosis and Differential Ventricular Gene Profiles after One Kidney 

Nephrectomy in the Absence of Heart Failure 

F. L. Martin, A. Cataliotti, B. K. Huntley, G. E. Harders, H. H. Chen, J. C. Burnett. 

08:45 Experimental Diabetic State Attenuated Left Ventricular Dysfunction after Myocardial Infarction 

B. Rodrigues, A. Medeiros, G. Orsi Candido, K. Teodoro Rosa, R. Nitrosi De La Fuente, P. Chakur Brum, 

K. De Angelis, M. C. Irigoyen. 

09:00 Influence of glomerular filtration rate and age in the accuracy of Brain Natriuretic Peptide 

B. Fabricio, L. Armini, J. Kezen, S. Gomes Jr., F. Alvim, P. P. Sampaio, I. Gotlib, J. Mansur. 

09:15 High serum adiponectin as a marker of severity and bad prognosis in systolic heart failure 

J. Thierer, A. Acosta, N. Vainstein, J. Marino, A. Hirchson Prado, M. Sultan, A. Francesia, M. Sutton, L. Boero, F. Brites. 

09:30 Left atrial size and prognosis in patients with heart failure. An individual patient meta-analysis study of 

longitudinal data (MeRGE Heart Failure) 

A. Rossi, M. Quintana, P. L. Temporelli, G. Hillis, N. A. Marsan, D. Prior, C. Yu, K. Poppe, R. Doughty, G. Whalley. 

09:45 Comparison of prognostic value of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide 

levels in patients with different functional classes of chronic systolic heart failure 

A. B. Nargizyan, L. R. Tumasyan, K. G. Adamyan.


hyPeRtension and otheR Risk faCtoRs 

Chairs: Wistremundo Dones (PUERTO RICO) 



08:30 Cardiovascular autonomic control improvement induced by exercise training in an experimental model of 

menopause associated with Dyslipidemia 

M. Heeren, C. Mostarda, J. Paulini, K. Flues, L. De Souza, E. Moreira, M. C. Irigoyen, K. De Angelis 

08:43 Impact of Age-related Elongation of the Aorta on Pulse Wave Velocity Measurement 

J. Sugawara, K. Hayashi, T. Yokoi, H. Tanaka 

08:56 Atrial Fibrillation And Isolated Systolic Hypertension: The Shep And Shep-X Study 

T. Vagaonescu, A. C. Wilson, J. B. Kostis 

09:09 The use of oscillometric blood pressure devices in children for fieldwork in resource poor settings 

J. J. Miranda, S. Stanojevic, A. Bernabe-Ortiz, R. H. Gilman, L. Smeeth 

09:22 Rho Kinase Inhibition Reduces Blood Pressure And Activates The Vasodilator Pathway Of The Renin 

Angiotensin System In The Aortic Wall Of Hypertensive Rats. 

M. Ocaranza Jeraldino, P. Rivera, J. Jalil Milad 

09:35 Impact of combined hypertension and dyslipidemia on risk of coronary heart disease events in the elderly: 

the Cardiovascular Health Study 

N. D. Wong, V. A. Lopez, R. Tracy, D. Yanez, L. Kuller, G. Burke, C. Roberts, H. Solomon, B. Psaty 

09:48 Heart Rate Recovery After Mental Stress Test Is Impaired In Healthy Relatives Of Hypertensive Patients 

A. Nobrega, A. Coimbra, M. Magalhaes, R. Castro, P. Silva, S. Pedrosa 



hyPeRtension and subCliniCal atheRosCleRosis 

Chairs: Alberto Lorenzatti (ARGENTINA), Protasio Da Luz (BRAZIL) 

08:30 Cardiovascular Morbimortality in End Stage Renal Disease patients: Effect of Spironolactone 

D. Gainza, S. Kunstmann, E. Marusic, A. Vukusich, L. Michea, C. Varela, D. Sepulveda, S. Bravo 

08:43 Salt reduction in processed foods to reduce population sodium consumption 

D. Ferrante, B. Linetzky, M. Virgolini, N. Apro 

08:56 Prevalence, and smoking behaviour among university students, and the impact of medical education in their 

attitudes, towards tobacco control in Chile. 

J. A. De Grazia, D. Faivovich, F. Falcón, R. Díaz, G. Yentzen, Maria Teresa Lira, S. Kunstmann 

09:09 Is there an association between impaired clock drawing test and hypertension in ambulatory communitydwelling 

elderly? 

M. Schapira, M. Bellomo, J. Benchimol, M. Bechelli, S. Maggi, J. Pollan, M. Perazzoli, D. Seinhart, L. Cámera 

09:22 Impact of obesity and overweight on left ventricle mass, systolic and diastolic function in children and adolescents 

I. Schusterova, J. Saligova, L. Potocnakova, M. Kuchta, I. Riecansky 

09:35 The Relationship of Adiponectin to C-Reactive Protein Levels, Anthropometric Parameters of Obesity and 

Subclinical Atherosclerosis in Children 

P. Arnaiz, M. Acevedo, S. Barja, M. Aglony, B. Guzman, B. Cassis, J. Carvajal, M. Moreno, X. Berrios 

09:48 The Impact of Age on the Identification of Pre-clinical Atherosclerosis by Screening Vascular ultrasound 

(WITHDRAWN) 

J. Postley 





exeRCise and autonomiC neRvous system 

Chairs: José Spolidoro (ARGENTINA), Eduardo Rivas Estany (CUBA) 

08:30 Strength And Flexibility Measurement In Patients In Phase II Cardiovascular Rehabilitation 

S. Kerbage Soraya, Gallucci Emilce, Angelino Arnaldo, Brion Graciela, Morozovsky Veronica, Burgos Sebastian, 

Diaz Lidia, Castañeda Luis, Roberto Peidro, Lirio Carlos 

08:43 Exercise-induced cardiopulmonary reflex increase is related to autonomic improvement in spontaneously 

hypertensive rats 

I. C. M. Silva, R. N. De La Fuente, K. Flues, C. Mostarda, K. De Angelis, M. C. Irigoyen 

08:56 Carotid Chemoreceptors And Antihypertensive Agents 

D. R. Grana, R. Guerri Guttenberg, N. Paglia, F. Azzato, J. E. Toblli, J. Milei 

09:09 An Integrative Evaluation Of Vascular Structure And Function In Patients With Essential Hypertension. Early 

Detection Of Subclinical Vascular Disease. 

P. Forcada, C. Kotliar, C. Dámico, J. Guerrieri, G. Millet, S. Obregon, O. Montaña, C. Schulte, A. Hita, D. Turri 

09:22 Resistance arm exercise with vascular occlusion acutely improves recovery calf blood flow in older subjects 

P. J. C. Vieira, G. R. Chiappa, C. N. Alves, R.S. Moraes, R. Stein, J. P. Ribeiro 

09:35 Effects of an acute inspiratory muscle training session on haemodynamic control of patients with heart failure 

and inspiratory muscle weakness. 

P. Mello, S. Borile, M. C. Irigoyen, G. M. Guerra, C. E. Negrão, MU P.B.Rondon, P. Dallágo, E. Moacyr Krieger, 

F. M. Consolim-Colombo 

09:48 Recovery Of Heart Rate Variability And Baroreflex Sensitivity After Maximal Exercise Is Correlated 

To Exercise Capacity 

A. Nobrega, P. Soares, K. Bousquet-Santos, L. Protasio, J. Figueiredo, E. Silva Junior, M. Souza 



soCial and emotional faCtoRs in heaRt disease 

Chairs: Carlos Tajer (ARGENTINA), Angelique Schiffer (NETHERLANDS) 

08:30 Substantial Gaps in Myocardial Infarction Care and Outcomes Across Socioeconomic Groups 

in the Contemporary Era of Evidence-Based Medicine 

M. G. Cohen, G. M. Holmes, T. S. Carey, S. B. Greene, K. A. Selzman, C. Patterson 

08:43 Burnout syndrome, perceived stress and depression in cardiology residents 

S. Waldman, J. C. Lopez Diez, B. Linetzky, H. Cohen Arazi, S. Guinjoan, H. Grancelli 

08:56 10 years investigation of influence of depression on myocardial infarction risk in the population 

of men of 25-64 years old in Russia: epidemiological views 

V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova 

09:09 Association between Depression, Anxiety and Quality of Life In Post Acute Myocardial Infarction Patients 

C. Lemos, C. Gottschall, L. Smidt 

09:22 High Rates of Depression and Cardiovascular Risk Factors in Rural Mexico 

L. A. Temming, K. A. Olson, C. R. Clover, B. D. Skinner, S. C. Clark, A. Krishnarao, S. M. Skinner, M. G. Cohen 

09:35 Effects of geographical area of residence & deprivation on access to coronary angiography and on mortality 

after acute myocardial infarction in Quebec, Canada 

C. B. Claudia Blais, D. H. Denis Hamel 

09:48 Alarming Prevalence of Metabolic Risk for Cardiovascular Diseases in a Physician Population of 

Southern India 

A. Mathavan, A. Chockalingam, S. Chockalingam, B. Bilchik, V. Saini


Cell theRaPy 

Chairs: Jorge Trainini (ARGENTINA) 



08:30 Mononuclear Stem Cells Implant In Chronic Ischemic Cardiomyopathy 

J. C. Trainini, N. Lago, J. Bordone, J. C. Chachques, J. De Paz, O. Masoli, C. Collaud, A. Christen, J. C. Barisani, 

J. Mouras 

08:43 Sustained clinical improvement after Autologous Bone Marrow Mononuclear Cell Transplantation (ABMMC) 

in Humans With Severe Ischemic Heart Failure- Four years follow up 

H. Dohmann, A. Haddad, R. C. Moreira, S. A. Silva, F. A. Tuche, J. A. Assad, R. Verney, C. M. Rutherford, A. S. Souza, 

R. Borojevick 

08:56 Mesothelial Cells Transplantation For Myocardial Vascularization And Regeneration 

M. Cortes Morichetti, B. Bourahla, O. Meilhac, I. Elmadbouh, E. Chachques, A. Carpentier, J. B. Michel, 

J. C. Chachques 

09:09 Cellular Therapy In Cardiology: Analysis of Research at the Last 10 years 

G. Carvalho, A. Silva, P. Mota, P. Silva, L. Campos, D. Santoro, T. Guimarães, A. Câmara, R. Barreiro Filho, V. Lima 

09:22 Bioartificial matrix and bone marrow stem cells in ischemic cardiomyopathy 

J. Trainini, N. Lago, J. L. Barisani, A. Christen, J. Mouras, G. Ruiz Deza, M. Redruello, O. Masoli, S. Chada, J. Bordone 

09:35 Combining Granulocyte Colony-Stimulating Factor Treatment With Cellular Cardiomyoplasty induces 

Myocardial Regeneration In Patients With Acute Or Chronic Ischaemic Heart Disease 

J. Senior Sanchez, C. Saldarriaga, F. Cuellar, O. Velásquez, J. Gomez, J. Delgado, G. Blanco, C. Navas, F. Jaimes 

09:48 Intracoronary Bone Marrow Stem Cell Transplantation: Feasibility, Safety, And Effect On Ventricular Function 

And Myocardial Perfusion In Chronic Myocardial Infarction Patients. Recuperar Study. 

L. Grynberg, N. Perez Baliño, M. Riccitelli, J. Dupont, R. Caccione, S. Traverso, M. Redruello, J. Szarfer, O. Masoli, 

L. Vidal 





exPeRimental and CliniCal inteRventions With CaRdiovasCulaR Cells 

Chairs: Juan Carlos Chachques (FRANCE), Kwang Koh (KOREA, REPUBLIC OF) 

08:30 Suppression of Cardiomyocyte Hypertrophy by Inhibition of the ubiquitin-Proteasome System 

K. Stangl, H. Dreger, M. Fechner, G. Baumann, V. Stangl, S. Meiners 

08:43 Progressive Ventricular Remodeling Occurring After Alcohol Septal Ablation In Severely Symptomatic 

Patients With Hypertrophic Obstructive Cardiomyopathy 

Silvia Judith Fortunato De Cano, Manuel Nicolas Cano, Jairo Alves Pinheiro Jr., Vera Marcia Lopes Gimenes, 

Creso Benedito Conceição Oliveira, Mercedes Maldonado Andrade, Amanda Moraes R. Sousa, 

Jose Eduardo Mr Sousa, Adib Domingos Jatene 

08:56 Physiologic cardiac hypertrophy : impact of its development upon a model of pathologic hypertrophy 

I. Ennis, M. B. Nolly, O. A. Pinilla, C. D. Garciarena, V. B. Carranza, M. R. Piaggio, E. M. Escudero, H. E. Cingolani 

09:09 Time Course of Angiogenesis, Arteriogenesis and Peripheral Conductance After Plasmid VEGF Delivery in Rat 

Model of Hind Limb Ischemia 

S. Mishra, S. S. Chauhan, S. K. Maulik, R. Ray, S. Sharma, S. C. Manchanda, V. K. Bahl 

09:22 Transendocardial Autologous Bone Marrow in Chronic Myocardial Infarction using a Helical Needle Catheter, 

Two year Follow-up in an Open-Label, Non-Randomized, Pilot Study (the TABMMI study) 

L. M. De La Fuente, S. H. Stertzer, E. Peñaloza, J. Argentieri, J. Miano, B. Koziner, C. Bilos, L. Battaglia, J. Stertzer, 

P. A. Altman 

09:35 Reduction of cardiac output: diagnosis of nursing in patients with cardiomyopathy wide undergone cell 

therapy 

A. Camara, A. Silva, D. Santoro, G. Carvalho, L. Campos, P. Silva, P. Mota, T. Guimarães, V. Lima, R. Barreiro Filho 

09:48 Cardiac 123I-MIBG Scintigraphy in a Chagasic Patient: Alterations induced by intracoronary injection of 

autologous bone marrow mononuclear cells 

L. M. B. Fonseca, S. S. Xavier, R. S. L. Lima, P. H. C. Castro, R. C. S. Goldenberg, M. C. Landermann, B. Gutfilen, 

R. C. Pedrosa, A. Hasslocher-Moreno, A. C. Campos De Carvalho




mRi and Ct sCan 

Chairs: Marcelo Goldstein (BELGIUM), Campanelli Hugo (ARGENTINA) 

08:30 Evaluation of Pulmonary Vein anomalies by Cardiovascular Magnetic Resonance 

A. Ithuralde, J. P. Gallo, J. Moltedo, C. Seara, P. Garcia De Lucis, C. Nojec, M. Ithuralde 

08:43 Detection of Myocardial Fibrosis by Cardiovascular Magnetic Resonance Imaging in Patients with Chagas’ 

Disease: Correlation with Clinical Presentation and Risk Stratification 

M. uellendahl, D. Sobral Filho, C. Ribeiro, S. Martins, W. Oliveira Jr., C. Medeiros, C. Rochitte 

08:56 Diagnostic accuracy of 64-row Gadolinium-enhanced CT coronary angiography 

P. Carrascosa, A. Deviggiano, C. Capuñay, M. Bettinotti, A. Goldsmit, J. Carrascosa, M. Garcia 

09:09 Steep learning curve of exclusion significant coronary stenosis with DSCT coronary angiography assessment 

T. Adla, J. Neuwirth, J. Veselka, R. Duchonova, L. Martinkovicova, V. Suchanek 

09:22 The ACTIVE Trial: Comparison of the Effects on Renal Function of Iomeprol-400 and Iodixanol-320 in Patients 

with Chronic Kidney Disease undergoing Abdominal Computed Tomography 

C. M. Erley, H. S. Henrik S., S. K. Morcos, L. Grazioli, Z. Ni, L. Romano 

09:35 Multidetector CT coronary angiography: Importance of the previous appointment for the management of the 

heart rate in our daily practice. 

P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa 

09:48 Clinical Characteristics and stress tests results of the patients derived to our centre for a CT coronary 

angiography: The real world. 

P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa 



inteRventions and CaRdiaC ultRasound 

Chairs: Roxana Campisi (ARGENTINA), Sharaf Abd El Rahman Abd El Gawad Sharaf (EGYPT) 

08:30 Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events 

N. D. Wong, H. Gransar, J. Narula, L. J. Shaw, D. Polk, J. Moon, L. Miranda-Peats, D. S. Berman 

08:43 Long-term results and factors influencing outcome of subclavian and innominate artery angioplasty 

T. Przewlocki, A. Kablak-Ziembicka, P. Pieniazek, P. Musialek, A. Kozanecki, I. Stopa, A. Roslawiecka, D. Rzeznik, 

K. Zmudka, W. Tracz 

08:56 Anomalies In The Origin Of Coronary Artery In Chile. Frequency In 10.000 Consecutive Angiographies. 

H. Ugalde, A. Ramirez, D. Ugalde, F. Ayala, S. Garcia, G. Dussaillant, A. Silva, E. Farias 

09:09 Color Doppler Echocardiography Guided Transradial Coronary Interventions 

S. Chugh, R. Kasliwal, N. Trehan 

09:22 Relationship between carotid intima-media thickness and atherosclerotic renal artery stenosis in 

hypertensive patients. 

S. Chain, H. Luciardi, G. Feldman, A. Breitgand, S. Berman, J. Ochoa, E. Escudero 

09:35 Endothelium dysfunction assessment with high-resolution ultrasound in patients with impaired left 

ventricle function 

O. Savenko, V. Vikentyev 

09:48 Kinking and coiling of the carotid arteries: Embryiogenic or acquired? A study by color Doppler 

ultrasonography. 

R. Beigelman, A. Izaguirre, M. Robles, D. R. Grana, G. Ambrosio, J. Milei 





inside the aRteRy, inside the Plaque 

Chairs: Daniel Berrocal(ARGENTINA), Igor Palacios (UNITED STATES) 

08:30 Intravascular ultrasound Assessment of Sirolimus-eluting or Paclitaxel-eluting Stent Expansion in 

Diabetic Patients. 

L. O. Jensen, M. Maeng, G. S. Mintz, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, 

L. Thuesen, P. Thayssen 

08:43 Safety and feasibility of same day discharge after Percutaneous Coronary Intervention using left radial access 

S. Chugh, S. Chugh, R. Kasliwal, N. Trehan 

08:56 Contrast-Induced Nephropathy (CIN) During PCI or Angiography in Patients at the Highest Risk 

A. E. Moreyra, J. Reiner, C. Staniloae, S. K. Sharma, R. E. Katholi, R. J. Solomon 

09:09 Are drug eluting stents an attractive strategy to treat the diffuse in-stent restenosis? 

O. Carlevaro, S. Centeno, L. De Candido, H. Maffeo, R. Kevorkian 

09:22 Effect of the Stent Design Properties on Restenosis in Stented Human Coronary Artery 

V. Dehlaghi, S. Najarian, M. Tafazzoli-Shadpour, A. Rai 

09:35 The value of invasive functional parameters in prediction of restenosis in patients with previous 

myocardial infarction 

B. Beleslin, M. Ostojic, A. Djordjevic-Dikic, V. Vukcevic, S. Stojkovic, M. Nedeljkovic, D. Orlic, G Stankovic, V. Giga, 

J. Stepanovic 

09:48 Homocysteine lowering B-vitamin therapy and in-stent restenosis. A WENBIT sub study 

Ø. Bleie, E. Strand, K. H. Løland, P. M. Ueland, S. E. Vollset, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. Nygård 



CoRonaRy and non CoRonaRy endovasCulaR tReatment ii 

Chairs: Carlos Mendiz (ARGENTINA), Alexander Abizaid (BRAZIL) 

08:30 Biodegradable Synthetic Small Calibre Vascular Prostheses: Potential as Coronary Bypass Grafts (WITHDRAWN) 

B. Walpoth, M. Cikirikcioglu, D. Mugnai, J. C. Tille, E. Pektok, A. Kalangos, G. Bowlin 

08:43 Impact of glycemic control on postoperative complications in type II diabetic patients undergoing elective 

coronary bypass surgery. 

M. Santos, D. Lowenstein, H. Sanabria, A. Ciccale Smit, R. Favaloro, E. Gabe 

08:56 Expiratory positive airway pressure associated with incentive spirometry reduces pulmonary complications 

and improves functional capacity in patients undergoing coronary artery bypass graft surgery 

P. Dall'Ago, M. P. Haefner, G. M. Ferreira, S. S. M. Barreto 

09:09 Prognostic impact of early asymptomatic coronary graft stenosis or occlusion 

A. De Lorenzo, M. S. Felix, C. C. Zeno, F. J. M. Pittela, A. S. C. Rocha 

09:22 Early and late clinical outcomes after off pump are better than after on pump coronary surgery? 

J. M. Vrancic, J. Thierer, F. Piccinini, G. Vaccarino, H. Raich, S. Florit, D. Navia 

09:35 New Technology: Valvuloplasties with Biodegradable Rings 

R. Neirotti, M. Cikirikcioglu, A. Kalangos 

09:48 Midterm Outcomes After Aortic Valve Replacement With Homograft Implantation. 

H. J. Redruello, T. F. Cianciulli, M. L. Talavera, J. A. Lax, M. C. Saccheri, R. Blanco, H. A. Prezioso, V. P. Picone, 

O. A. Schwint, H. Vogelfang


exPeRienCes With high Risk Patients ii 

Chairs: Carlos Macaya (SPAIN), Alejandro Palacios (ARGENTINA) 

08:30 Percutaneous Left Ventricular Assist in Ischaemic Cardiac Arrest 

V. Tuseth, M. Salem, R. Pettersen, S. Rotevatn, K. Grong, J. E. Nordrehaug 

08:52 Open vs. Close Cells Stent Designs in Carotid Angioplasty. 

G. Lev, O. Mendiz, L. Valdivieso, F. Carlos, L. Villagra, P. Mollon, J. Scaglia 


09:14 Percutaneous Mitral Valvuloplasty during Pregnancy 

H. M. Pham, H. L. Nguyen, Q. N. Nguyen, O. N. Pham, L. D. Do, V. L. Nguyen, K. G. Pham 

09:36 Carotid artery stenting with neuroembolic cerebral protection filter vs endarterectomy . Long term follow-up. 

B. Tedeschi, A. Tedeschi, B. Gonçalves, M. De Sena, R. Peixoto 

advanCes in nuRsing toPiCs 

Chairs: Amparo Peiró (SPAIN), José Antonio Boggiano (ARGENTINA) 

08:30 Early transfer preparation for discharge patient from ICCu to a general ward. 

Anna Lider, Sigalit Dayan, Miroslava Yardenova, Tatyana Gopshtein, Yafim Irgo 

09:00 Six minute walking test in cardiac rehabilitation: factors related to performance. 

M. Bustamante, V. Krämer, D. Guidi, A. Guajardo, F. Marques, F. Yañez, M. Acevedo 


09:30 “Does he live to take his medications or to fish?” Values, identity, and context as determinants of compliance 

during heart failure 

A. M. Clark, N. Freyberg, L. Strain, M. Chan, R. Tsuyuki, P. Armstrong, F. A. McAlister 

PRevention of CaRdiovasCulaR disease 

Chairs: Herman Schargrodsky (ARGENTINA), Denise Eldemire Shearer (JAMAICA) 

amazon - 08:30-10:00 


08:30 Regional demonstration for sustained community based prevention of CVD: From North Karelia Project to 

North Karelia Center of Public Health 

V. Korpelainen, P. Puska 

08:52 Consumption of fruits and vegetables in adolescents of Porto Alegre, Southern Brazil: Association with age, 

gender, and education 

S. C. Fuchs, M. A. Rieth, L. B. Moreira, R. L. Henn, M. B. Moreira, P. Stoll, F. Ghizzoni, F. D. Fuchs 

09:14 EuROACTION: Do couples attending a hospital based multidisciplinary family cardiovascular prevention and 

rehabilitation programme share the same smoking habits? Do they stop smoking together? 

C. Jennings, T. Collier, A. Mead, J. Jones, A. Holden, S. Connolly, K. Kotseva, D. De Bacquer, G. De Backer, D. Wood 

09:36 Palpitations in menopausal women without structural heart disease: a cross sectional prospective study with 

12 leads holter system recording 

E. Sclarovsky 





PRognosis, myoCaRdial infaRCtion and stents 

Chairs: Riccitelli Miguel (Argentina), Karina Rey García (Cuba) 

08:30 Long-term prognosis in Mexican patients with silent myocardial ischemia: results of a cohort study with 

10 years of follow-up 

A. unzueta, M. A. Villasis, G. Ordoñez, N. Zamorano, F. David 

08:43 Prognostic significance of N-terminal pro B-type natriuretic peptide in asymptomatic severe aortic 

regurgitation: Incremental value over clinical and echocardiographic variables 

R. Pizarro, P. Oberti, M. Falconi, F. Achilli, A. Arias, S. Tewell, J. Krauss, A. Cagide 

08:56 Pseudo-aneurysm of VE - a complication of myocardial infarction 

E. Marum, A. Soares, M. Amoedo, M. Patricio, M. Socorro, V. Cordeiro, R. Fitaroni, R. Russo, J. Buono, H. Abensur 

09:09 Patients with acute myocardial infarction receiving drug eluting stents have better survival compared 

to patients receiving bare metal stents. A new jersey statewide database study 

T. Vagaonescu, A. E. Moreyra, A. C. Wilson, N. M. Cosgrove, J. B. Kostis 

09:22 Significant differential metabolic effects of atorvastatin, atorvastatin combined with amlodipine, and 

amlodipine therapy in hypertensive patients 


09:35 Low body mass index and body surface area are independently associated with aortic regurgitation 

M. R. Movahed, A. Martinez, R. Ebrahimi 

09:48 Diagnostic usefulness and prognostic implications of tissue Doppler imaging and E/Vp ratio in patients 

with aortic stenosis 

P. Oberti, R. Pizarro, M. Falconi, F. Achilli, A. Arias, F. Sosa, L. Lucas, J. Krauss, A. Cagide 


Symposium 

atRial fibRillation: fRom Pathogenesis to PRaCtiCe 

Chairs: Rene Asenjo (CHILE), Enrique Retyk (ARGENTINA) 

10:30 Mechanism of atrial fibrillation: From electrical to structural remodeling. 


10:52 Rate versus rhythm control: Still a matter of discussion? 

Martinelli Martino (BRAZIL) 

11:14 Old and new anti-arrhythmic drugs: Revised concepts 

Ricardo Pesce (ARGENTINA) 

11:36 Antithrombotic therapy: Revised guidelines 

Ali Oto (TURKEY)


sudden death in heaRt failuRe 

Chairs: Iglesias Ricardo (ARGENTINA), Luis Molina (MEXICO) 

10:30 Epidemiology of sudden death in heart failure 

V. Mareev. (RUSSIAN FEDERATION) 

10:52 Risk stratification for sudden death in heart failure 


11:14 ICD indications in primary prevention: The arrhythmia specialists’ vision 

Sergio Pinski (UNITED STATES) 

11:36 ICD indications in primary prevention: The clinical cardiologist specialists’ vision 

Hernan Doval (ARGENTINA) 

missouR - yelloW Pavillion - 10:30-12:00 

Symposium 


Symposium 

endothelial funCtion and dysfunCtion: assessment, theRaPy and outCome 

Chairs: Roberto César Esper (ARGENTINA), Luis Mercado (BOLIVIA) 

10:30 Biomarkers in detection of endothelial function 


10:48 Methods for the non-invasive evaluation of endothelial function in humans. 

Jorge Vilarino (ARGENTINA) 

11:06 Detection of vulnerable plaque by coronary angioscopy 

Kyoichi Mizuno (JAPAN) 

11:24 Does correcting endothelialdysfunction make a difference? 


11:42 Are inflammatory markers good cardiovascular risk 



Debate 

management of PRe-hyPeRtension and metaboliC syndRome 

Chairs: Leonardo Ribeiro (BRAZIL), Onen Churchill (BOTSWANA) 

Statement 1: 

10:30 Pre-hypertension should be treated with anti-hypertensive drugs 

Pro: Gianfranco Parati (Milano, ITALY) 

Contra: Dagnovar Aristizabal (COLOMBIA) 

Statement 2: 

11:15 Metabolic syndrome: A collection of risk factors or a true syndrome? 

Pro: Wahida Karmally (New York, UNITED STATES) 

Contra: Ricardo Horacio Rey (ARGENTINA) 



euPhRates - oChRe Pavillion - 10:30-12:00| 

Symposium 

management of aCute PulmonaRy embolism and PulmonaRy hyPeRtension 

Chairs: Piñeiro Daniel (ARGENTINA), Corbalan Ramon (CHILE) 

10:30 Current classification and diagnostic strategies 


10:52 Imaging and monitoring right ventricle function 

Miguel Gomez Sanchez (SPAIN) 

11:14 Present and future in the pulmonary hypertension treatment 

Sergio Perrone (ARGENTINA) 

11:36 Diagnostic strategy in acute pulmonary embolism 

Jorge Ubaldini (ARGENTINA) 

PaRana - oChRe Pavillion - 10:30-12:00 


hoW to assess ventRiCulaR dysynChRony foR RCt? 

Chairs: Heinrich Schelbert (UNITED STATES), Ricardo Martellotto (ARGENTINA) 

10:30 How to assess ventricular-dysynchrony? 

Ronderos Ricardo (ARGENTINA) 

11:15 How to optimise CRT? 

John Gorcsan III (UNITED STATES) 


Symposium 

global Risk faCtoRs foR the develoPment of CoRonaRy aRteRy disease and stRoke 

Chairs: Santiago García Egüez (ECUADOR), Maranhão Mario (BRAZIL) 

10:30 International prevalence, recognition and treatment of CV risk factors in out-patients with atherothrombosis 

Deepak Bhatt (UNITED STATES) 

11:00 Risk factors for the development of strokes in multiple populations 

Gilberto Gonzalez (UNITED STATES) 

11:30 Risk factors for heart disease globally: An up-date from the Inter-Heart Study 


the Chest Pain CentRe: evolving ConCePt 

Chairs: M. Nahir (ISRAEL), Sergio Hauad (ARGENTINA) 

10:30 New injury markers 


10:52 The chest pain centre concept: Scientific rationale and clinical results 

Hugo Ramos (ARGENTINA) 

11:14 Exercise testing vs. images tests 

Ezra Amsterdam (UNITED STATES) 


Symposium 

11:36 What happens to patients who are descharged from the chest pain centre in the follow-up? 

Muntaner Juan (ARGENTINA)



Debate 

PCi in ChRoniC Chd has no PRoven long-teRm safety and benefit 

Chairs: Roxana Mehran (UNITED STATES), José Antonio Rodríguez (CHILE) 

Statement 1: 

10:30 PCI in chronic CHD has no proven long-term safety and benefit 

Pro: Yusuf Salim (CANADA 

Contra: Igor Palacios (UNITED STATES) 

Statement 2: 

11:15 Conventional risk factors control is sufficient to prevent past intervention CVD progression 

Pro: Spencer King III (UNITED STATES) 

Contra: Robert Superko 


Symposium 

hoW to use Ct multisliCe and magnetiC ResonanCe in CliniCal PRaCtiCe? 

Chairs: James Moon (UNITED KINGDOM), Ricardo Baeza (CHILE) 

10:30 How to implement CT multislice in the emergency department to assess patients with chest pain? 

Enrique Gurfinkel (ARGENTINA) 

10:52 How to estimate cardiovascular risk using coronary CT multislice? 

Andre Ricardo Valle (BRAZIL) 

11:14 Cardiovascular magnetic resonance for assessing myocardial ischaemia and viability 

Gustavo Avegliano (ARGENTINA) 

11:36 Delayed enhancement imaging for evaluation of cardiomyopathy 

Scott Flamm(UNITED STATES) 


Symposium 

CaRdiovasCulaR safety of non-CaRdiovasCulaR dRugs 

Chairs: Rothlin Rodolfo (ARGENTINA), Jeffrey Borer (UNITED STATES) 

10:30 Anti-cancer therapies 

Diego Rosso (ARGENTINA) 

10:52 Erythropoietin 

Henry Krum (AUSTRALIA) 

11:14 Antipsychotics 

Silvia Wikinski (ARGENTINA) 

11:36 NSAIDs/Coxibs 

Frank Thomas Ruschitzka (SWITZERLAND) 




Symposium 

novel CellulaR meChanisms in CaRdiaC hyPeRtRoPhy and isChaemia 

Chairs: Kwang Koh (KOREA, REPUBLIC OF) 

10:30 NHE-I and myocardial hypertrophy 

Ennis Irene (ARGENTINA) 

10:52 Regulation of pHi in the heart 

Richard Vaughan-Jones (UNITED KINGDOM) 

11:14 PDE-5 inhibition and NHE-I 

Néstor Gustavo Pérez (ARGENTINA) 

11:36 uNREP effect 

Paolo Tucci (BRAZIL) 


Symposium 

adult Congenital heaRt disease: hot issues 

Chairs: Patricia Frangini (CHILE), Capelli Horacio (ARGENTINA) 

10:30 Asymtomatic Patients with ASD and Moderated/ Severe Pulmonary Hypertension 

Alfonso Buendia-Hernandez (MEXICO) 

10:52 Serious arrhythmia and sudden death after surgery 

Jose Moltedo (ARGENTINA) 

11:14 Mistakes and Disasters in Medical Care GuCH Patients 

Jane Somerville (UNITED KINGDOM) 

11:36 The perspective of patients 



Symposium 

advanCed ConCePts in CRitiCal CaRe nuRsing 

Chairs: Nancy Houston Miller (UNITED STATES), Marcelo Alvarez (ARGENTINA) 

10:30 Advantages and disadvantages of open critical care units 

Nancy Bravo (ARGENTINA) 

10:52 Prevalence of infections in patients post-cardiovascular surgery 

Stella Maimone (ARGENTINA) 

11:14 Contrapulsation balloon 

Amparo Peiró (SPAIN) 

11:36 Hemodynamic monitoring 

Marcela Ferrada (CHILE)




management of aCute myoCaRdial infaRCtion in the 21st CentuRy 

Chairs: Conci Eduardo (ARGENTINA), Eduardo Rivas Estany (CUBA) 

10:30 Epidemiology of acute myocardial infarction in the 21st century: Is it changing? 

Carlos Tajer (ARGENTINA) 

10:52 Management of AMI in developing countries 

Eduardo Morales Briceño (VENEZUELA) 

11:14 Significance of Q-wave in myocardial infarction in the era of cardiac magnetic resonance imaging 

Antoni Bayés De Luna (SPAIN) 

11:36 Multi-slice computed tomography after acute myocardial infarction: Can we use this technique to 

establish prognosis? 

Michael Lim (SINGAPORE) 


Symposium 

metaboliC syndRome in youth: is it the beginning of the CaRdiovasCulaR 

disease Continuum? 

Chairs: Gabriel D. Waisman (ARGENTINA) 

10:30 Bogalusa heart study 

10:52 The Rio de Janeiro study 

Brandao Ayrton (BRAZIL) 

11:14 Risk score predictions of atherosclerotic lesions in young people: The PDAy study 

Wistremundo Dones (PUERTO RICO) 

11:36 How early does the cardiovascular disease continuum begin? 

Mario Bey Lombana (PANAMA) 


Symposium 

CaRdiology in middle- and loW-inCome CountRies 

Chairs: Antonio Chagas (BRAZIL), Hassell Trevor (BARBADOS) 

10:30 Prevention is better than cure 


10:52 The research perspective 

Reddy Srinath (INDIA) 

11:14 Models of service delivery 

Howard Spencer (BAHAMAS) 

11:36 Economic impact of cardiology services 

George A. Mensah (UNITED STATES) 





toma de deCisiones en valvuloPatías 

Coordinadores: Plastino Juan A (ARGENTINA), Luis Moya (COLOMBIA) 

10:30 ¿Cirugía de la insuficiencia aórtica ¿Cuándo es demasiado precoz y cuándo demasiado tarde? 

Juan Gonzalez Moreno (URUGUAY) 

10:45 ¿Cuándo intervenir la estenosis aórtica asintomática? 

Octavio Aparicio (BOLIVIA) 

11:00 La insuficiencia mitral severa con factibilidad de reparación. ¿Siempre es quirúrgica? 

Gustavo Restrepo (COLOMBIA) 

11:15 ¿Cuándo operar la insuficiencia mitral funcional? 

Zalaquett Ricardo (CHILE) 

11:30 Procedimientos percutáneos de reparación y remplazo valvular 



Symposium 

sudden death 

Chairs: Ladislao Endrei (ARGENTINA), María José Sancho Tello (SPAIN) 

14:00 Sudden cardiac death, a changing problem 

Ali Oto (TURKEY) 

14:22 Role of pharmacological therapy to prevent sudden death 

Jorge Garguichevich (ARGENTINA) 

14:44 Role of ICD in primary prevention of sudden cardiac death 


15:06 Role of the ICD in rare disorders 

Andres Caeiro (ARGENTINA) 


Symposium 

to ablate oR not to ablate? ContRoveRsial issues 

Chairs: Pozzer Domingo (ARGENTINA), Sabine Ernst (UNITED KINGDOM) 

14:00 To ablate or not to ablate in asymptomatic WPW 

Riccardo Cappato (ITALY) 

14:22 Should atrial flutter always be ablated? 

Rolando Gonzalez (CHILE) 

14:44 To ablate or not to ablate idiopathic ventricular tachycardia 

Mauricio Scanavacca (BRAZIL) 

15:06 Atrial tachycardia 

Teruhisa Tanabe (JAPAN)



Symposium 

the CaRdioRenal syndRome in heaRt failuRe 

Chairs: Roberto Colque (ARGENTINA), Barry Massie (UNITED STATES) 

14:00 The cardiorenal syndrome: Pathophysiology of the crosstalk 

Daniel Nul (ARGENTINA) 

14:22 Prognosis in patients with chronic renal failure 


14:44 Emerging therapies in acute heart failure 

Mihai Gheorghiade (UNITED STATES) 

15:06 Continuous ambulatory ultrafiltrations in chronic heart disease 

Victor Gura (UNITED STATES) 


Symposium 

haemodynamiCs, heaRt and hyPeRtension 

Chairs: Kuschnir Emilio (ARGENTINA), Eduardo Moreyra (ARGENTINA) 

14:00 The role of collagen in the development of left ventricular dysfunction 


14:30 Hypertensive cardiopathy and coronary reserve. Is it always diminished? 


15:00 Pulse wave velocity and prognosis 

Gianfranco Parati (ITALY) 



ContemPoRaRy faCtoRs in CaRdiology 

Chairs: Horacio F. Cingolani F (ARGENTINA), Maranhão Mario (BRAZIL) 

14:00 up-date in the functions of natriuretic peptides 

Adolfo De Bold (CANADA) 

14:18 Vascular NADPH oxidases as drug targets for novel antioxidant strategies 

Tj. Guzik (POLAND) 

14:36 The growing role of inflammatory markers 


14:54 The cellular pathophysiology of oxidative stress 

Carlos Ferrario (UNITED STATES) 

15:12 Apoptosis in myocardial ischaemia 

Ricardo Gelpi (ARGENTINA) 



Women and CaRdiovasCulaR disease 

Chairs: Romero Carlos (URUGUAY), Susana Zeffiro (ARGENTINA) 

14:00 Explanation for the higher mortality in women 


14:22 Clinical presentation and differences in pathophysiology of CAD in women 

Judith Zilberman (ARGENTINA) 



14:44 What is the best method for the non invasive investigation of CAD in my female patients? 

Roxana Campisi (ARGENTINA) 

15:06 Are there any differences in results from revascularization between genders? 



Symposium 

Chagas disease 

Chairs: Antonio Chagas (BRAZIL), Javier Bustamante (BOLIVIA) 

14:00 Pathogenesis of chagas disease: Is there now a consensus? 

José Antônio Marin-Neto (BRAZIL) 

14:18 Chagas heart disease: Clinical work up at initial presentation and prognosis 

Anis Rassi Jr. (BRAZIL) 

14:36 Echocardiography approach for diagnosis and prognosis 

Ricardo Migliore (ARGENTINA) 

14:54 Periodic parasitemias in the development of Chagas’ cardiomyopathy 

Oscar Salomone (ARGENTINA) 

15:12 Antiparasitic treatments of chagas disease: An update 

Arturo Arribada (CHILE) 


Symposium 

management of obesity today 

Chairs: Norberto Pallavicini (ARGENTINA), Gerardo Uceda (ARGENTINA) 

14:00 Obesity in the Americas 

Luis Molinary (PUERTO RICO) 

14:18 Which Diet Is Best for Obesity? 

Jorge Braguinsky (ARGENTINA) 

14:36 Exercise for the Management of Obesity 

Palmira Pramparo (ARGENTINA) 

14:54 Gastric bypass: patient selection and perioperative management 

Claudio Zin (ARGENTINA) 

15:12 Central obesity or viceral obesity? 

Scott Grundy (UNITED STATES)



Symposium 

sCaling-uP seCondaRy PRevention 

Chairs: Eduardo Rivas Estany (CUBA), Álvaro Sosa Liprandi (ARGENTINA) 

14:00 Lessons from prevention programs in Europe 

David Wood (UNITED KINGDOM) 

14:22 Secondary prevention in stroke 

J. Fernandes (BRAZIL) 

14:44 Field testing of fixed dose combinations 

TBD 

15:06 Gaps in secondary prevention and access to essential medicines 


Relevant nuRsing toPiCs 

Chairs: Veronica Kramer (CHILE), Imelda Perdomo (ARGENTINA) 

14:00 Evidences of nursing cares in cardiovascular surgery 

Aina Lauga (ARGENTINA) 


Symposium 

14:22 Advances in pre-hospitalization treatment of acute coronary syndromes with ST segment elevation 

José Luis Araya (ARGENTINA) 

14:44 Reaches and competences of nursing in catheter handling 

Martín Toranzo (ARGENTINA) 

15:06 Handling of cardiogenic shock in a public hospital emergency ward 

Mabel Medina (ARGENTINA) 

hoW to ReaCh and maintain ldl beloW 70 

in veRy high Risk Patients 

Chairs: Francisco Fonseca(BRAZIL), Alberto Lorenzatti (ARGENTINA) 

14:00 With mixed dyslipidemia 

George Steiner (CANADA) 

14:45 With severe hypercholesterolemia 







Symposium 

stRess eChoCaRdiogRaPhy in diffiCult Patients 

Chairs: Eduardo Escudero (ARGENTINA), Horacio Vazquez (URUGUAY) 

14:00 Stress echo in patients with LBBB, atrial fibrillation or left ventricular hypertrophy 

Manuel Pinto (CHILE) 

14:22 Stress echo after heart transplant 

Wilson Mathias (BRAZIL) 

14:44 Stress echo for aortic valvulopathy 

Gustavo Restrepo (COLOMBIA) 

15:06 Assessment of coronary flow reserve during stress echo 

Jorge A. Lowenstein (ARGENTINA) 



eChodoPPleR as the main tool in assessing left ventRiCulaR funCtion 

Chairs: Susan Acosta Castillo (BOLIVIA), Takeshi Nakatani (JAPAN) 

14:00 Global and regional systolic function: The classic and the new 

Miguel Quiñones (UNITED STATES) 

14:22 Dyastolic ventricular function at rest and during exercise 

Nelson Pizzano (URUGUAY) 

14:44 Role of echodoppler in the diagnosis of heart failure 

Mani Vannan (UNITED STATES) 

15:06 Heart failure treatment based on the echocardiography findings 

Bjoy Khandheria (UNITED STATES) 



neW stRategies foR PCi 

Chairs: Ricardo Sarmiento (ARGENTINA), Jose Alejandro Martinez Sepulveda (CHILE) 

14:00 Stents platforms, polymers and gene therapies: Where are we? 

Igor Palacios (UNITED STATES) 

14:22 New drugs for drug eluting stents 


14:44 New approached for bifurcation lesions: One, two or dedicated stents? 

Expedito Ribeiro (BRAZIL) 

15:06 New non-stent devices 

Jorge Belardi (ARGENTINA)



Symposium 

Post-gRaduate CaRdiology tRaining and ReCeRtifiCation 

Chairs: Hector Luciardi (ARGENTINA), Abel Moreyra (UNITED STATES) 

14:00 The training of cardiology in developing countries 


14:22 Sub-specialty training in cardiology 

Günter Breithardt (GERMANY) 

14:44 Promoting international medical education 

Tudor Vagaonescu (UNITED STATES) 

15:06 The training of a cardiac surgeon 

Radu Deac (ROMANIA) 


Symposium 

management of hyPeRtension 

Chairs: Fernando Manzur Jattin (COLOMBIA), Mayosi Bongani (SOUTH AFRICA) 

14:00 ACE inhibition and ARB, mechanisms of cardiovascular and renal protection: Are they the same? 

Oscar Carretero (UNITED STATES) 

14:22 Benefits of hypertensive therapy beyond lowering blood pressure 

Jorge Jalil (CHILE) 

14:44 Diuretics: Are they the same? 

Daniel Piskorz (ARGENTINA) 

15:06 Choosing the right drug for the right patient or socio ethnic considerations in selection of hypertensive therapy 

GuilleRmo Fabregues (ARGENTINA) 


Symposium 

tissue doPPleR imaging: PResent and futuRe 

Chairs: Jorge Cachero (ARGENTINA), Ricardo Castro (ARGENTINA) 

14:00 Strain 2D non-doppler for quantifying regional ventricular function 

Bjoy Khandheria (UNITED STATES) 

14:22 Speckle tracking: A toy or a tool? 

Carlos Eduardo Suaide Silva (BRAZIL) 

14:44 Tissue doppler imaging: A new diagnostic and prognostic tool 

Juan Carlos Plana (UNITED STATES) 

15:06 Tissue doppler and strain rate during stress echo 

Miguel Bustamante-Labarta (ARGENTINA) 




Symposium 

mediCal infoRmatiCs: aPPliCations in CaRdiology 

Chairs: Ortego Raul (ARGENTINA), Fernán Quirós (ARGENTINA) 

14:00 Clinical decision support to improve cost and quality: Valve and practical use 


14:18 Medical Informatics at Distance: Continuing Learning in Cardiology 

Armando Pacher (ARGENTINA) 

14:36 Tele electrocardiography in Chile: Impact on the national care system 

Escobar Edgardo (CHILE) 

14:54 Ambulatory blood pressure monitoring: Teletransmission: The Latin American experience 

Jose Andres Octavio (VENEZUELA) 

15:12 Knowledge Translation: from data to clinical practice 

Alvaro Margoglis (URUGUAY) 



smC: inteRventional CaRdiology in adults With Congenital heaRt disease 

Chairs: J. C. Linares-Casas (ARGENTINA), Carlos Zabal (MEXICO) 

14:00 Patent ductus arteriosus in the adult. Interventional treatment versus surgical repair 

Zabal Carlos (MEXICO) 

14:22 Interventioan treatment of the coarctation of the aorta in adults 

Alejandro Peirone (ARGENTINA) 

14:44 Percutaneous closure with amplatzer device of atrial septal defects with pulmonary hypertension in adults 

more than 40 years old 

Alfonso Buendia-Hernandez (MEXICO) 

15:06 Interventional cardiology in adults: State of the Art 

Faella Horacio (ARGENTINA) 



fibRilaCión auRiCulaR. lo viejo y lo nuevo. 

Coordinadores: Dario Sobral (BRAZIL), Ronald Cuellar (BOLIVIA) 

14:00 Activación neurohormonal e inflamación en la FA 


14:15 ¿Cómo diagnosticar y cómo tratar la FA intermitente? 

Alberto Giniger (ARGENTINA) 

14:30 ¿Cómo optimizar el control del ritmo y la frecuencia? 

Javier Galeano (PARAGUAY) 

14:45 Prevención de la complicación embólica: ¿Cuándo y cómo? 

René Vicuña Mariño (ECUADOR) 

15:00 Ablación con radiofrecuencia como terapia de la FA 

Rene Asenjo (CHILE)




avanCes en la insufiCienCia CaRdiaCa aguda-desComPensada 

Coordinadores: Enrique Oropeza (BOLIVIA), Fernando Aguirre (ECUADOR) 

14:00 Impacto de la descompensación en la evolución de la enfermedad 

Juan Cimbaro Canella (ARGENTINA) 

14:15 Asistencia respiratoria no invasiva en el manejo inicial 

Solon Navarrete (COLOMBIA) 

14:30 Estrategia actual del manejo farmacológico 


14:45 ¿Cómo proteger la función renal? 

Alberto Fernández (ARGENTINA) 


Symposium 

nuRsing in CaRdiovasCulaR disease 

Chairs: - Daniel Maggio (ARGENTINA), Virginia Argibay Pitlyk(SPAIN) 

16:00 How can the Nursing Team work in the Prevent Coronary Risk Factors 

Monica Soto Vertchert (ARGENTINA) 

16:22 Academical Formation In Cardiovascular Nursing. What is the laboral status around the world? 

Rosana Andreoli (ARGENTINA) 

16:44 Cardiovascular Emergency: Importance of the Interrelation Doctor-Nurse in reducing Patients Morbimortality 

Boggiano José Antonio (ARGENTINA) 

17:06 Participation of Nurses in Bioethical Committees 

Nancy Houston Miller (UNITED STATES) 



uP-date in ablation of ventRiCulaR aRRhythmias 

Chairs: Ivan Mendoza (VENEZUELA), José Luis Serra (ARGENTINA) 

16:00 Ventricular tachycardia: Epi- and endocardial approach 


16:22 Ventricular tachycardia ablation results 

Teruhisa Tanabe (JAPAN) 

16:44 Right & left ventricular outflow tract tachycardia 

Sabine Ernst (UNITED KINGDOM) 

17:06 Hemodynamically stable VT 

Guy Fontaine (FRANCE) 




Symposium 

gRoWing PRaCtiCe of non-PhaRmaCologiCal tReatment in Congestive heaRt failuRe 

Chairs: Barry Massie (UNITED STATES), Javier Marino (ARGENTINA) 

16:00 Exercise I therapy: Application to mild to severe heart failure 


16:22 Treatment of heart failure patients with central sleep apnea syndrome by nasal oxygen 

Shigetake Sasayama (JAPAN) 

16:44 Waon Therapy : soothing warmth therapy 

Chuwa Tei (JAPAN) 

17:06 Device monitoring of heart failure 

Cheuk-Man Yu (CHINA, PEOPLE’S REPUBLIC OF) 



PRognostiC faCtoRs foR heaRt failuRe in the betabloCkeR eRa: 

Who must be listed foR heaRt tRansPlant 

Chairs: Marcos Amuchastegui (ARGENTINA), Marcelo Montera (BRAZIL) 

16:00 How to predict sudden death? 

Guillermo Bortman (ARGENTINA) 

16:22 Are scores useful in advance heart failure? 

Nadine Clausell (BRAZIL) 

16:44 Biomarkers for risk stratification 

Eduardo Perna (ARGENTINA) 

17:06 State of the art of VO2 max exercise test 




myoCaRditis and dilated CaRdiomyoPathies: hoW aRe they Related? 

Chairs: Hector Delgado Osorio (PUERTO RICO), Mitsuaki Isobe (JAPAN) 

16:00 Difference in presentation timing of pregnancy-related heart failure 

Karen Sliwa (SOUTH AFRICA) 

16:30 Characterization of post part time cardiomyopathy 

Carlos Dumont (ARGENTINA) 

17:00 Pathogenesis of myocarditis 

Peter Liu (CANADA)




the high-Risk asymPtomatiC Patient With CoRonaRy aRteRy disease 

Chairs: Tak-Fu Tse (CHINA, PEOPLE’S REPUBLIC OF), Zeljko Reiner (CROATIA) 

16:00 Clinical characteristics of high-risk asymptomatic patients with coronary artery disease 

Mele Eduardo (ARGENTINA) 

16:22 Non-classical markers of risk in patients with asymptomatic coronary artery disease 

T. Omland (NORWAY) 

16:44 Optimal treatment of coronary heart disease to prevent heart failure 


17:06 Dietary Lipids and Coronary Heart Disease 

A. Zampelas (GREECE) 



the CaRdiovasCulaR hazaRds of aiR Pollution 

Chairs: Ali Oto (TURKEY), Rose Marie Robertson (UNITED STATES) 

16:00 The cardiovascular effect of air pollution: the AHA scientific statement 


16:22 The acute cardiovascular effects of air pollution 

Hermes Ilarraza-Lomeli(MEXICO) 

16:44 Mechanisms of cardiovascular disease induced by air pollution: Basic science studies 

Shuchleib Rafael (MEXICO) 

17:06 Mechanisms of cardiovascular disease induced by air pollution: Clinical science studies 

David Newby (UNITED KINGDOM) 

nutRition, diet and Cvd PRevention 

Chairs: Maranhão Mario (BRAZIL), Maria Inés Somoza (ARGENTINA) 

16:00 Risk factors in the developing world 

16:18 Healthy life style vs. medications in CVD prevention 


16:36 Portofolio eating plan and antioxidants 

Wahida Karmally (UNITED STATES) 

16:54 Red wine: Experimental and clinical basis for its recomendations 



Symposium 





hyPeRglyCemia, inflammation and CoRonaRy aRteRy disease: 

neW RelationshiPs? 

Chairs: Jose Sala (ARGENTINA), Corbalan Ramon (CHILE) 

16:00 Hyperglycemia as a risk factor in AMI: New insights 


16:30 Do biomarkers change pharmacological interventions in Stable Coronary Artery Disease? 


17:00 The role of lipids in chronic coronary disease 



Symposium 

PRevention of CaRdiovasCulaR disease in asymPtomatiC Patients 

Chairs: Carlos Nijensohn (ARGENTINA), Alejandro Gómez Monroy (ARGENTINA) 

16:00 The impact of policies to reduce salt consumption on cardiovascular health 

Hassell Trevor (BARBADOS) 

16:30 Experience in developing national policy frameworks for prevention and control of CVD 

Herman Schargrodsky (ARGENTINA) 

17:00 Cost effectiveness of cardiovascular prevention programmes 

Shah Ebrahim (UNITED KINGDOM) 



ComPlex Patients and ComPlex deCisions - PaRt tWo 

Chairs:C. Vozzi (ARGENTINA), Miguel Ballarino(ARGENTINA) 

16:00 When do gender differences exist in patients undergoing planned PCI? 

Spencer King III (UNITED STATES) 

16:22 When does a bifurcation lesion require more than one stent? 

Costantino Costantini (BRAZIL) 

16:44 An old concept a new approach. Autoretroperfusion of the coronary sinus in no-option patients 

Jose Navia (ARGENTINA) 

17:06 PCI in the diabetic patient: Outcomes for focal and diffuse disease 

Alexander Abizaid (BRAZIL)



Symposium 

eCho doPPleR in ResynChRonisation eRa 

Chairs: Jesus Vargas Baron (MEXICO), Amuchastegui Luis Maria (ARGENTINA) 

16:00 Left ventricular dynamics in heart failure 

Jeffrey Borer (UNITED STATES) 

16:22 Myocardial? 

Cheuk-Man Yu (CHINA, PEOPLE’S REPUBLIC OF) 

16:44 Role of tissue doppler imaging in RCT 

Eduardo Guevara (ARGENTINA) 

17:06 Myocardial syndrome assessment by 3D 

Bernhard Mumm (GERMANY) 

hot toPiCs in hyPeRtension 

Chairs: Jorge Jalil (CHILE), Fernando Peliche (ARGENTINA) 

16:00 Home measurement of blood pressure: Does it work? 

Gianfranco Parati (ITALY) 

16:18 Obstructive sleep apnea: Where are we? 

Luciano Drager (BRAZIL) 


Symposium 

16:54 Silent white matter lesions, blood pressure variability and cognitive deterioration in elderly 

hypertensive patients 

Ramiro Sánchez (ARGENTINA) 

17:12 Ambulatory blood pressure for all? 

Mario Bendersky (ARGENTINA) 

sbC: CoRonaRy aRteRy disease 2008 

Chairs: Antonio Chagas (BRAZIL), Faella Horacio (ARGENTINA) 

16:00 Clinical approaches for treatment: drugs vs lifestyle 


16:22 The utility of inflammatory markers in the management of the disease 

Enrique Gurfinkel (ARGENTINA) 

16:44 Current views in PCI 

Luiz Piva Mattos (BRAZIL) 

17:06 The roll of surgical management 

Kalil Renato Ak (BRAZIL) 







isCP: uPdate on CuRRent CaRdiovasCulaR ReseaRCh in usa and euRoPe 

Chairs: Jay Cohn (UNITED STATES), Antoni Bayés De Luna (SPAIN) 

16:00 Strategies toward advances in research: Perspective from the uS National Heart Lung and Blood Institute 

Marvin Konstam (UNITED STATES) 

16:45 Most important clinical cardiovascular research in Europe 

Angeles Alonso Garcia (SPAIN) 



nuevas fRonteRas en la hiPeRtensión aRteRial 

Coordinadores: Claudia Anchique (COLOMBIA), Masao Sano (PARAGUAY) 

16:00 La reducción de la presión arterial ¿es suficiente? 

Felix Medina (PERU) 

16:15 Hipertensión arterial en el anciano ¿Son distintos los objetivos y el tratamiento? 

Fernando Manzur Jattin (COLOMBIA) 

16:30 ¿Cómo prevenir y tratar el daño de órgano blanco? 

GuilleRmo Fabregues (ARGENTINA) 

16:45 Objetivos terapéuticos en el paciente diabético 

Espinoza Jaime (PERU) 

17:00 Manejo de la hipertensión arterial en el paciente con insuficiencia renal 

Hilton Chaves (BRAZIL)

Posters And ABstrACts 

Poster Listing 

P1 CHANGING OF MONOCytE CHEMOAttRACtANt PROtEIN-1 (MCP-1) IN PAtIENtS WItH tyPE 

2 DIABEtES MEllItUS AND ACUtE CORONARy SyNDROME 

T. Golitsyna, T. Chazova, K. Zykov. 

P3 tHE PRESENCE OF C AllElE FOR -765G>C COMMON VARIANt OF COX-2 GENE CONStItUtES 

A PROtECtOR FACtOR AGAINSt CORONARy DISEASE IN CHIlEAN INDIVIDUAlS 

L. A. Salazar, A. Hernandez, A. Cuevas, P. Jaramillo, C. Lanas, F. Lanas. 

P4 tRICUSPID INSUFFICIENCy DOES NOt INCREASE EARly AFtER PERMANENt IMPlANtAtION 

OF PACEMAkER lEADS 

N. Kucukarslan, A. Kirilmaz, E. Ulusoy, M. Yokusoglu, N. Gramatnikovski, E. Ozal, H. Tatar . 

P5 IS AllEN tESt SAFE FOR RADIAl ARtERy GRAFt IN CABG SURGERy? 

N. Kucukarslan, E. Ozal, E. Kuralay, M. Arslan, H. Tatar . 

P6 tWO FACtORS EFFECtING tHE MORBIDIty AND MORtAlIty IN SURGERy OF VASCUlAR 

INJURIES DUE tO GUNSHOt: MISSED ARtERIAl INJURy, IGNORED VEIN REPAIR 

N. Kucukarslan, B. Oz, E. Ozal, V. Yildirim, M Sahin, H. Tatar . 

P7 AtHEROtHROMBOtIC RISk FACtORS CORRESPOND tO tHE APPEARANCE OF 

INtERNAl INFlAMMAtION AND ERytHROCytE ADHESIVENESS/AGGREGAtION 

IN tHE PERIPHERAl BlOOD 

I. Shapira, O. Rogowski, D. Zeltser, S. Berliner . 

P8 lOW GRADE INFlAMMAtION IN INDIVIDUAlS WItH tHE HyPERtRIGlyCERIDEMIC WAISt 

PHENOtyPE. ANOtHER FEAtURE OF tHIS AtHEROGENIC DySMEtABOlISM 

I. Shapira, O. Rogowski, S. Toker, S. Melamed, A. Shirom, S. Berliner . 

P9 lIVER ENzyMES AND INFlAMMAtION - SENSItIVE BIOMARkERS. RElEVANCE FOR 

APPARENtly HEAltHy INDIVIDUAlS AND tHOSE WItH AtHEROtHROMBOtIC RISk 

I. Shapira, O. Rogowski, R. Oren, S. Berliner . 

P10 EFFECtS OF EFFERENt SyMPAtHEtIC NERVE StIMUlAtION ON ISCHEMIA-INDUCED 

VENtRICUlAR ARRHytHMIAS By MODUlAtING CONNEXIN43 PROtEIN IN RAtS 

X. R. Hu, H. Jiang, Z. B. Lu, H. Z. Wen, M. Ghias, D. D. Zhao, Q. Z. Tang, C. X. Huang. 

P11 COMMUNICAtION DEVICES PRODUCE ElECtROMAGNEtIC INtERFERENCE ON ECG 

MACHINES: DOES It REAlly MAttER? 

A. Baranchuk, J. Kang, C. Shaw, D. Campbell, H. Alanazi, W. Hopman, D. P. Redfearn, C. S. Simpson. 


Posters And ABstrACts 


P12 PROGNOSIS OF HEARt RAtE CONtROl ON DECOMPENSAtED HEARt FAIlURE PAtIENtS. 

G. P. Aroutunov, Professor, A. G. Aroutunov, A. L. Volkova, N. A. Bylova. 

P15 DEtERMINAtION OF VASCUlAR WAll SHEAR StRESS By HIGH-RESOlUtION UltRASOUND 

AS A MEtHOD OF ASSESSMENt OF ENDOtHElIUM-DEPENDENt VASODIlAtAtION IN 

PAtIENtS WItH ARtERIAl HyPERtENSION 

A. Rekhviashvili, B. Tsinamdzgvrishvili, A. Tsiskaridze, M. Chkhetia, N. Archvadze, G. Labakhua . 

P16 MEASUREMENtS IN IMAGING: ARE INtERNAl OR EXtERNAl REFERENCE SyStEMS BEttER 

IN DEtECtING EARy StAGE HEARt FAIlURE? 

R. Asbot. 

P17 QUANtItAtIVE ElECtROCARDIAC PARAMEtERS CAN PREDICt IMPAIRED SyStOlIC HEARt 

FUNCtION 

G. Simonyi, E. Szûcs, T. Bauernfeind, K. Szakolczai, J. R. Bedros, I. Préda, M. Medvegy. 

P18 ENDOVASCUlAR tHERAPy OF CHRONIC MESENtERIC ISCHAEMIA 

A. Silva, R. Barros Wanderley, L. Carvalho Pereira, I. Kury Nunes, R. Luis Favero, L. Henrique Kanashiro. 

P19 ClINICAl FEASIBIlIty AND ANGIOGRAPHIC FOllOW-UP OF ENDOVASCUlAR StENt-GRAFt 

FOR tyPE B DISSECtION (StANtFORD). EXPERIENCE OF A SINGlE CENtER 

A. Silva, R. Barros Wanderley, L. Carvalho Pereira, L. Henrique Kanashiro, R. Luis Favero, I. Abilio Kury Nunes. 

P20 PREVAlENCE OF CHANGES IN UNDIAGNOSED GlUCOSE INtOlERANCE ACCORDING tO AGE 

AND GENDER IN JAPANESE MIDDlE AGED WORkING PEOPlE 

H. Kawano, H. Soejima, H. Fujii, Y. Nagayoshi, Y. Tanaka, S. Nakayama, Y. Kinoshita, H. Ogawa. 

P21 DEHyDROEPIANDROStERONE lEVElS VARy ACCORDING AS HEARt FAIlURE CONDItION IN 

PAtIENtS WItH IDIOPAtHIC DIlAtED CARDIOMyOPAtHy 

H. Kawano, Y. Nagayoshi, H. Soejima, Y. Tanaka, H. Yamabe, Y. Kinoshita, H. Ogawa. 

P22 INtERMEDIAtE OUtCOME OF PERCUtANEOUS CORONARy INtERVENtIONS FOR SINGlE 

REMAINING CORONARy ARtERy 

S. Mishra, V. K. Bahl . 

P23 FREQUENCy OF DIARRHOEA AS A PREDICtOR OF ElEVAtED BlOOD PRESSURE 

IN CHIlDREN 

J. J. Miranda, A. R. Davies, G. Davey Smith, L. Smeeth, L. Cabrera, R. H. Gilman, H. H. Garcia, Y. R. Ortega, 

V. A. Cama. 

P24 IS BEING AN IMMIGRANt A RISk FACtOR FOR CVD IN AUStRAlIA? 

J. Dassanayake, L. Gurrin, W. R. Payne, V. Sundararajan, S. C. Dharmage .


P25 PERCUtANEOUS FEMORAl ClOSURE FOllOWING tHORACIC AORtA StENt GRAFt 

PlACEMENt: PRElIMINARy RESUltS AND 6 MONtH FOllOW UP 

P. Avanzas, M. Martin, I. Lozano, J. M. Llaneza, F. Vega, F. Fernandez, J. M. De La Hera, J. M. Vegas, J. M. Valle, C. Moris. 

P26 PREDICtIVE VAlUE OF CORONARy ARtERy StENOSES AND C-REACtIVE PROtEIN lEVElS IN 

PAtIENtS WItH StABlE CORONARy ARtERy DISEASE 

P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski. 

P27 A/A’: A NEW CORRElAtE OF lEFt VENtRICUlAR END DIAStOlIC PRESSURE? 

R. A. Lawrance, I. Jadavji, W. T. Emery, J. B. Choy. 

P28 UNIVARIABlE AND MUltIVARIABlE CORRElAtES OF E/E’: CAN WE GEt ClOSER tO NON- 

INVASIVE lEFt VENtRICUlAR END-DIAStOlIC PRESSURE EStIMAtION? 

R. A. Lawrance, I. Jadavji, W. T. Emery, J. B. Choy. 

P29 INVEStIGAtING tHE EUROPEAN SOCIEty OF CARDIOlOGy DIAStOlOGy GUIDElINES IN A 

PRACtICAl SCENARIO 

W. T. Emery, I. Jadavji, J. B. Choy, R. A. Lawrance . 

P30 E/E’ RAtIO DERIVED FROM SEPtAl AND lAtERAl ANNUlI AND ItS CORRElAtION WItH lEFt 

AtRIAl VOlUME INDEX 

W. T. Emery, I. Jadavji, R. A. Lawrance, J. B. Choy. 

P31 ECHOCARDIOGRAPHIC CORRElAtES OF lEFt AtRIAl SIzE: INtER-RElAtIONSHIPS WItH 

OtHER DIAStOlIC MEASURES. 

I. Jadavji, W. T. Emery, R. A. Lawrance, I. Vondermuhl, J. B. Choy. 

P32 DISCREPANt MItRAl ANNUlAR DOPPlER VElOCItIES: IMPlICAtIONS FOR tHE ASSESSMENt 

OF DIAStOlIC FUNCtION 

W. T. Emery, I. Jadavji, R. A. Lawrance, J. B. Choy. 

P33 C-REACtIVE PROtEIN CORRElAtES WItH lEFt VENtRICUlAR EJECtION FRACtION AND 

PREDICtS FUNCtIONAl StAtUS IN PAtIENtS WItH CHRONIC StABlE ANGINA 

P. Avanzas, R. Arroyo-Espliguero, J. Quiles, J. C. Kaski. 

P34 tHE INCIDENCE OF ACUtE RHEUMAtIC FEVER IN tHE WORlD: A SyStEMAtIC REVIEW OF 

POPUlAtION-BASED StUDIES 

K. B. Tibazarwa, J. A. Volmink, B. M. Mayosi. 

P35 PAtENt DUCtUS ARtERIOSUS ClOSED WItH NIt-OCClUD SyStEM: MID tERM FOllOW-UP. 

R. E. Rios Mendez, R. Gamboa, F. P. Mollon, G. M. Arroyo, D. F. Gutierrez, D. M. Villa. 



P39 EFFECtS OF tARANABANt, A NOVEl CANNABINOID 1 RECEPtOR (CB-1R) INVERSE AGONISt, 

ON WEIGHt REDUCtION IN OBESE PAtIENtS OVER 12 WEEkS 

C. D. Gonzalez, N. Erondu, B. Gumbiner, B. Musser, K. Lu, R. A. Capece, S. Klein, E. Ravussin, J. M. Amatruda, 

S. B. Heymsfield. 

P40 tHE PROGNOStIC VAlUE OF Nt-PROBNP IN PAtIENtS WItH CHRONIC CORONARy HEARt 

DISEASE BUt WItHOUt ClINICAlly MANIFESt HEARt FAIlURE. 

O. Mayer Jr., J. Šimon, M. Galovcová, J. Bruthans, R. Cífková. 

P41 CARDIAC PERFORMANCE IN HyPERtENSIVE VERSUS PHySIOlOGICAl lEFt VENtRICUlAR 

HyPERtROPHy. 

M. Deljanin Ilic, S. Ilic, V. Stoickov, L. Nikolic. 

P42 CHANGES OF WHItE BlOOD CEll COUNt DURING StRESS ECHOCARDIOGRAPHy MAy 

PREDICt FUtURE CORONARy EVENtS. 

S. Ilic, M. Deljanin Ilic, P. Milosavljevic, L. Nikolic. 

P43 USE OF (All-BlOOD) MINIPlEGIA VERSUS CRyStAllOID CARDIOPlEGIA IN AN 

EXPERIMENtAl MODEl OF ACUtE MyOCARDIAl ISCHEMIA. 

O. Petrucci, R. W. Vieira, M. R. Carmo, N. Antunes, P. P. M. Oliveira, D. M. Braile. 

P45 ECHOCARDIOGRAPHy AND ADENOSINE tESt: NON INVASIVE MEtHOD tO DEtECt PAtIENtS 

WItH REACtIVE PUlMONARy HyPERtENSION. 

R. Reinoso, H. Badiola Villa, R. Artigas Garcia, C. Lozano Girol. 

P46 HOW OFtEN DOES PRESSURE RECOVERy AFFECt MEASUREMENt OF AORtIC VAlVE 

GRADIENtS By DOPPlER ECHOCARDIOGRAPHy IN PAtIENtS WItH AORtIC StENOSIS IN 

REAl-WORlD ClINICAl PRACtICE? 

A. C. Parameswaran, D. Reisner, A. Amanullah. 

P47 EFFECt OF BEtA BlOCkER tREAtMENt ON PlAtElEt NItRIC OXIDE SyNtHASE, CyClIC 

GUANOSINE MONOPHOSPHAtE AND OXIDAtIVE StRESS, IN PAtIENtS WItH HEARt FAIlURE 

A. Shah, E. Gkaliagkousi, J. Decourcey, R. Buckley, J. Ritter, A. Ferro. 

P48 tHE HUMAN SEROtONIN 5-Ht4A RECEPtOR 

J. Neumann. 

P49 EFFECtS OF RESIStANCE StRESS ON CARDIAC BIOCHEMICAl MARkERS IN POWER lIFtERS 

V. Pönitz, S. P. H. Hjortshoj, G. Espersen, J. Ravkilde.


P50 ClINICAl FEAtURES OF StEMI-PAtIENtS WItH MUltIVESSEl DISEASE WHO DEVElOP 

CARDIOGENIC SHOCk AFtER PRIMARy PERCUtANEOUS CORONARy INtERVENtION. 

A. Dominguez-Rodriguez, M. J. Garcia-Gonzalez, S. Samimi-Fard, A. Sanchez-Grande, G. Yanes-Bowden, 

I. Hernandez-Baldomero, P. Abreu-Gonzalez, F. Marrero-Rodriguez. 

P51 tHE CORRElAtION BEtWEEN AUGMENtAtION INDEX AND MyOCARDIAl ISCHEMIA OF 

ADENOSINE StRESS MyOCARDIAl SCINtIGRAPHy 

T. Morishima, T. Hatano, M. Aiga, M. Odaira, M. Nakayama, K. Takeishi, S. Fuse, T. Chikamori, K. Takazawa, 

A. Yamashina. 

P52 A PROSPECtIVE RANDOMIzED tRIAl OF A RAPID FIBRINOlytIC PROtOCOl FOR lEFt-SIDED 

PROStHEtIC VAlVE tHROMBOSIS (RAFt-PVt) 

G. Karthikeyan, N. Mathew, R. S. Math, P. R. Bhimashankar, S. Singh, M. Kalaivani, V. K. Bahl. 

P53 SIGNIFICANCE OF BRAIN NAtRIUREtIC PEPtIDE IN tHE PREDICtION OF SECONDARy 

MORBIDIty AND MORtAlIty IN POSt-MI PAtIENtS 

A. Boskovic, L. Music. 

P54 IS tHERE DIFFERENCE BEtWEEN DAIly AND NIGHtly HEARt RAtE VARIABIlty 

IN PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION 


P55 ClINICAl EFFICACy OF StAtINS IN SMOkERS WItH CORONARy ARtERy DISEASE 

A. Boskovic, L. Music, S. Dragnic. 

P56 ClINICAl EFFICACy OF StAtINS IN SECONDARy PREVENtION IN PAtIENtS WItH CORONARy 

ARtERy DISEASE DEPENDING ON GENDER 


P57 CARDIOPROtECtIVE EFFECt OF RED WINE 

A. Novakovic, L. J. Gojkovic Bukarica, D. Nezic, M. Peric. 

P58 GENDER, AGE AND ClINICAl DIFFERENCES OF IDIOPAtHIC, HyPERtROPHIC AND AtyPICAl 

COMPlEtE lEFt BUNDlE BRANCH BlOCk 

S. Sclarovsky. 

P59 ElECtRICAl REMODElING (ER) AS IS EXPRESSED IN tHE ElECtROCARDIOGRAM (ECG), 

ElECtRICAl REMODElING PHENOtyPES FROM NEONAtAl tO SEXUAl MAtURAtION, 

GENDER DIFFERENCES. 




P60 tHE ACCURACy OF FACtORS USED IN ASSESSING tHE PROGRESSION OF EXPRESSED HEARt 

FAIlURE SyMPtOMS 

A. Chaitoff, H. Kominsky, V. Sumodi, K. Fagnilli, M. Hanna. 

P62 IMPACt OF DIABEtES ON MORtAlIty OF PAtIENtS WItH HEARt FAIlURE WItH REDUCED 

lEFt VENtRICUlAR FUNCtION 

A. Innasimuthu, G. Rao, B. Naronha, K. Ckarke. 

P64 PROGNOStIC VAlUE OF CORRECtED Qt INtERVAl AND ItS CORRElAtION WItH CARDIAC 

tROPONIN t IN NON - St- ElEVAtION ACUtE CORONARy SyNDROME 

S. C. L. Llois Susana Claudia, F. L. G. Gadaleta Francisco Leonardo, V. A. S. Sinisi Víctor Alfredo, P. A. Avanzas Pablo, 

J. C. K. Kaski, Juan Carlos. 

P65 CHIlDREN WHO FUlFIl CURRENt RECOMMENDAtION FOR PHySICAl ACtIVIty 

ARE SlIMMER AND HAVE HIGHER FItNESS lEVEl 

M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen. 

P66 BODy FAt, ABDOMINAl FAt AND BODy FAt DIStRIBUtION RElAtED tO RISk FACtORS FOR 

CARDIOVASCUlAR DISEASE IN yOUNG CHIlDREN 

M. Dencker, O. Thorsson, M. K. Karlsson, C. Linden, P. Wollmer, L. B. Andersen. 

P68 EPIDEMIOlOGICAl ASPECtS OF tHE BURNOUt SyNDROME IN PROFESSIONAl 

CARDIOVASCUlAR NURSING 

J. Boggiano, R. Miret, D. Maggio, A. Bantar, I. Perdomo, M. Medina, M. Lavalle, E. Moya, N. Bravo, 

H. Macazana Trucios. 

P69 EFFECt OF EARly EDUCAtION ON PAtIENt ANXIEty WHIlE WAItING FOR CARDIAC 

CAtHEtERIzAtION 

J. Boggiano, A. Zichert, D. Maggio, H. Macazana Trucios, A. Incarbone, R. Dágosto, R. Dominguez, G. Bulacio, 

N. Crozzoli, M. Bertoli. 

P70 WORkPlACE StRESS FACtORS PERCEIVED By tHE NURSES, WHO WORk IN tHOSE AREAS OF 

tHE HOSPItAl CONCERNED WItH HEARt-lUNG tRANSPlANtS 

J. Boggiano, R. Miret, D. Maggio, M. Medina, M. E. De La Antonia, N. Acuña, F. Rotemberg, D. Chaparro, C. Ortiz, 

S. Castelar. 

P71 CORRECtED Qt INtERVAl MEASUREMENt IN PAtIENtS WItH NON-St ElEVAtION ACUtE 

CORONARy SyNDROME AND t-WAVE ABNORMAlItIES: ANy ADDItIONAl ClINICAl VAlUE? 

F. L. Gadaleta, S. C. Llois, VA Sinisi, P. Avanzas, J. C. Kaski. 

P72 SCIENtIFIC PRODUCtION SPIlt IN SyMPOSIUMS OF CARDIOVASCUlAR NURSING IN 

ARGENtINA 

J. Boggiano, R. Miret.


P73 tHE VIRtUAl HEARt: ARt AND SCIENCE 

J. Reynolds, C. Salazar, J. Vega, A. Castellanos. 

P74 DEtERMINANtS OF HOSPItAl lENGtH OF StAy IN PAtIENtS ADMIttED WItH ACUtE HEARt 

FAIlURE. 

R. Bagnati, P. Ledesma, N. Vulcano, S. Fernandez, C. Belziti . 

P75 PREDICtORS OF ACUtE IMPAIRMENt IN RENAl FUNCtION IN PAtIENtS ADMIttED WItH 

ACUtE DECOMPENSAtED HEARt FAIlURE. 

P. Ledesma, R. Bagnati, N. Vulcano, S. Fernandez, C. Belziti . 

P76 INFlUENCE OF AtRIAl NAtRIUREtIC PEPtIDE tREAtMENt ON CARDIOVASCUlAR AND RENAl 

NItRIC OXIDE SyStEM IN SPONtANEOUSly HyPERtENSIVE RAtS 

M. A. Costa, D. Rodríguez Ierace, R. Elesgaray, M. F. Visintini Jaime, C. Caniffi, A. M. Balaszczuk, C. Arranz. 

P77 MOSt FREQUENt SyMPtOMS AND EXtENSION OF CORONARy ARtERy DISEASE IN WOMEN 

WItH ACUtE CORONARy SyNDROMES 

C. N. Crudo Norma, P. A. Alfredo Piombo, V. L. Luis Vidal. 

P78 CORONARy ARtERy CAlCIFICAtION IN ElDERly ADUltS OVER 80 yEARS OlD: DOES It HAVE 

ANy ROlE IN tHE PRE-OPERAtION DEtERMINAtION OF ISCHEMIC HEARt DISEASE? 

Masahiro Tamashiro, Yuu Nomura, Toshiya Chinen, Atsushi Kakazu, Kageyuki Ohba, Naoya Maehira, Akira Kakazu, 

Masanori Kakazu, Osamu Arasaki, Tetsuji Shinjo. 

P81 EARly OUtCOMES OF DIRECt CAROtID ARtERy StENtING WItHOUt PREDIlAtION IN HIGH- 

RISk PAtIENtS: ANAlySIS OF A SINGlE-CENtER REGIStRy 

J. Veselka, D. Erná, P. Zimolová, M. Šramko, A. Tomek, M. Šrámek. 

P84 RElAtION OF ISCHEMIA-MODIFIED AlBUMIN tO St-SEGMENt RESOlUtION AFtER 

REPERFUSION OF ACUtE MyOCARDIAl INFARCtION 

A. Dominguez-Rodriguez, S. Samimi-Fard, P. Abreu-Gonzalez, M. J. Garcia-Gonzalez, J. C. Kaski. 

P85 DO DIABEtIC PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION tREAtED WItH 

tHROMBOlytIC tHERAPy HAVE A WORSE PROGNOSIS DURING lONG-tERM FOllOW-UP 

B. Stefanovic, P. Mitrovic, Z. Vasiljevic, G. Matic, M. Radovanovic, N. Radovanovic, A. Karadzic, A. Milosevic, 

G. Krljanac, M. Dragovic. 

P86 RISk StRAtIFICAtION IN CARDIAC SURGERy: OUR EXPERIENCE 

M. Silvero, G. Solari, L. Browne, D. Bergerot, R. Vallejo, E. Badino . 



P87 lOW RISk CARDIOVASCUlAR PROFIlE PAtIENtS SEEMS tO HAVE HIGH RISk 

AtHEROSClEROtIC PlAQUES. IDENtIFICAtION OF AtHEROSClEROtIC PlAQUES IN 

ASyMPtOMAtIC PAtIENtS WItH 64 CHANNEl MSCt. 

A. Bayol, J. Vallejos, R. Obregon, M. Romero, R. Peloso, R. Gonzalez, W. Harvey, A. Zarza, J. Mazucco, J. Parras. 

P88 ANtEROGRADE UtIlIzAtION OF INtRAAORtIC BAllOON PUMP 

R. Levin, M. Degrange, R. Porcile, F. Salvagio, N. Blanco, A. Botbol, C. Del Mazo, E. Tanus. 

P89 RElAtION BEtWEEN tHE VEGF lEVEl AND MyOCARD ISCHEMIA IN PAtIENtS WItH 

COllAtERAl VESSElS AND SINGlE-VESSEl CHRONIC tOtAl OCClUSION 

F. Arican Ozluk, O. Badak, A. Sýsman, G. Capa Kaya, H. Bozkurt, S. Guneri . 

P90 MEtABOlIC SyNDROME PREDICtS NON-ElDERly ONSEt IN PAtIENtS WItH ACUtE 

MyOCARDIAl INFARCtION 

T. Saikawa, M. Hara, T. Takakura, T. Ooie, T. Iwao, S. Shigematsu. 

P91 PREDICtORS OF SUCCESSFUl ASA REIStANCE SUPPRESSION USING DOSE ESCAlAtION 

REGIMEN IN StABlE CORONARy ARtERy DISEASE PAtIENtS. 

M. Dominiak, T. Wcislo, A. Rozga, L. Figiel, J. Drozdz, M. Krzeminska - Pakula, J. Kasprzak. 

P92 ACCURACy OF MyOCARDIAl CONtRASt ECHOCARDIOGRAPHy IN PREDICtING EARly AND 

lONG-tERM OUtCOME IN PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION 

M. Olszowska, M. Kostkiewicz, P. Podolec, M. Hlawaty, T. Przewlocki, W. Tracz. 

P93 Nt-PROBNP MEASURED ON ADMISSION IS WEll PREDICtOR EARly AND lONG-tERM 

OUtCOME IN PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION AFtER PRIMARy CORONARy 

ANGIOPlASty. 

M. Olszowska, M. Kostkiewicz, P. Podolec, M. Hlawaty, W. Tracz. 

P94 tHE IMPACt OF SOCIOECONOMIC CONDItIONS ON tHE EVOlUtION OF CHRONIC CHAGAS 

DISEASE. 

R. Viotti, C. Vigliano, M. G. Alvarez, B. Lococo, M. Petti, G. Bertocchi, A. Armenti. 

P95 tHE EFFECt OF CONCOMItANt USE OF MONOPRIl AND SPIRONOlACtONE IN PAtIENtS 

WItH MIlD tO MODERAtE CONGEStIVE HEARt FAIlURE 

N. Krstic, M. Pavlovic, Z. Perisic, L. J. Radevic, M. Lazovic, S. Salinger, A. Stojkovic, D. Milic. 

P96 CARNEy’S SyNDROME: REVIEW AND REPORt OF A CASE WItH FIVE INtRACARDIAC 

MyXOMAS 

M. Silvero, J Boullosa.


P97 GAtED SPECt MyOCARDIAl IMAGING IN PAtIENtS WItH lEFt BUNDlE BRANCH BlOCk: 

COMPARISON WItH StRESS ECHO CORONARy FlOW RESERVE 

D. Sobic-Saranovic, S. Pavlovic, A. Djordjevic-Dikic, Z. Petrasinovic, N. Kozarevic, D. J. Saranovic, 

M. Todorovic-Tirnanic, V. Artiko, V. Obradovic, M. Ostojic. 

P99 VAlUE OF GAtED SPECt PERFUSION IMAGING IN PAtIENtS WItH PREVIOUS MyOCARDIAl 

INFARCtION AND SINGlE VESSEl DISEASE 

D. Sobic-Saranovic, S. Pavlovic, B. Beleslin, M. Todorovic-Tirnanic, D. J. Saranovic, Z. Petrasinovic, V. Artiko, 

V. Obradovic, B. Vujisic-Tesic, M. Ostojic. 

P101 ISCHEMIC PRECONDItIONING IN ElDERly PAtIENtS WItH FIRSt StEMI. 

M. Giorgi, R. Ahuad Guerrero, P. Schygiel, F. Sokn, H. Farras, M. Voos, J. Tronge . 

P102 CAN WE PREDICt ClOPIDOGREl RESIStANCE AFtER PERCUtANEOUS INtERVENtION? 

M. Dominiak, A. Rózga, T. Wcis£o, M. Krzemiñska- Paku£a, J. Kasprzak. 

P103 AN INCREASED RIGHt VENtRICUlAR OVERlOAD - HOW DOES It INFlUENCE tHE tISSUE? 

M. Kowalski, E. Kowalik, P. Hoffman. 

P104 ABO BlOOD GROUP DIStRIBUtION AND MAJOR CARDIOVASCUlAR RISk FACtORS IN 

PAtIENtS WItH MyOCARDIAl INFARCtION 

I. Sari, O. Ozer, M. Sucu, V. Davutoglu, S. Gorgulu, M. Eren, M. Aksoy. 

P105 ClINICAl VAlUE OF lEAD AVR IN ACUtE CORONARy SyNDROMES WItH NON-St SEGMENt 

ElEVAtION 

H. Juan Gallinari, H. Alviso De Vargas, E. Gonzalez Gonzalez, G. Boccuzzi, S. Colangelo, M. Minelli. 

P106 MORNING PEAk IN tHE CIRCADIAN VARIAtION OF MyOCARDIAl INFARCtION IS NOt VAlID 

FOR All NAtIONS: AFtERNOON PREDOMINANCE IN tURkISH POPUlAtION 

I. Sari, V. Davutoglu, B. Erer, E. Tekbas, E. Ucer, O. Ozer, H. Uyarel, M. Eren, M. Sucu, M. Aksoy. 

P107 ANAlySIS OF tIMING EVENtS IN DOPPlER UltRASOUND SIGNAlS FROM tHE FEtAl HEARt 

RAtE 

J. zietek, J. Jezewski, K. Horoba, A. Gacek, J. Wrobel. 

P108 SEPtADIAN VARIAtION IN tHE OCCURRANCE OF St ElEVAtION MyOCARDIAl INFARCtION IN 

tURkISH POPUlAtION: MONDAy SyNDROME 

I. Sari, B. Erer, E. Tekbas, E. Ucer, H. Uyarel, V. Davutoglu, O. Ozer, M. Sucu, S. Soydinc, M. Aksoy. 

P109 ANtEPARtUM EVAlUAtION OF FEtAl CARDIAC PERFORMANCE 

J. Zietek, A. Matonia, J. Sikora, K. Horoba, A. Gacek, J. Jezewski. 

P110 lEFt VENtRICUlAR REGIONAl FUNCtION IN ADUltS AFtER AORtIC COARCtAtION REPAIR 

M. Kowalski, E. Kowalik, K. Kotlinski, J. Rozanski, P. Hoffman. 



P112 RElAtIONSHIP BEtWEEN tOtAl AND DIFFERENtIAl lEUkOCytE COUNtS AND ISOlAtED 

CORONARy ARtERy ECtASIA 

S. A. Kocaman, G. Taçoy, A. Sahinarslan, T. Timurkaynak, A. Çengel. 

P113 SHORt-tERM PREOPERAtIVE tREAtMENt WItH AtORVAStAtIN REDUCES 

PROINFlAMMAtORy RESPONSE AND tHE RISk OF RENAl FAIlURE AFtER 

CARDIOPUlMONARy ByPASS IN PAtIENtS WItH DIABEtES tyPE 2 OPERAtED DUE tO 

AORtIC VAlVE DISEASE-RANDOMIzED, PlACEBO CONtROllED StUDy 

D. zakrzewski, J. Janas, J. Stepinska. 

P114 PEAk OXyGEN UPtAkE IS BEttER tHAN OXyGEN UPtAkE EFFICIENCy SlOPE IN 

QUANtIFyING CARDIOPUlMONARy FUNCtIONAl RESERVE IN PAtIENtS WItH MEtABOlIC 

SyNDROME 

A. Casella-Filho, B. C. G. Nascimento, C. B. Casella, I. C. Trombetta, M. U. Rondon, F. Y. Cesena, D. Favaratto, 

C. E. Negrao, P. L. Daluz, A. C. P. Chagas. 

P115 URBANIzAtION OF CHAGAS DISEASE – A 17-yEAR FOllOW-UP 

F. Sosa. 

P116 PHARMACOlOGICAl EFFECt At lOW DOSIS OF EzEtIMIBE/SIMVAStAtIN COMBINAtION 

A. Kavata, B. Martire. 

P117 ASSOCIAtION BEtWEEN A CEll-SEEDED COllAGEN MAtRIX AND CEllUlAR 

CARDIOMyOPlASty FOR MyOCARDIAl SUPPORt AND REGENERAtION 

M. Cortes Morichetti, J. A. Genovese, E. Chachques, A. F. Carpentier, J. C. Chachques. 

P118 “UNOPERAtED UNIVENtRICUlAR HEARt WItH NORMAlly RElAtED ARtERIES AND 

PUlMONARy StENOSIS IN A 47 yEAR OlD WOMAN” 

J. V. G. N. Juvenal Vaz Guimarães Neto, T. M. G.Q. Tânia Maria Gonçalves Quintão, H. F. M. Helena Furtado 

Martino, B. M. F. N. Betania De Freitas Nogueira, R. C. A. Roberta Chaves Araújo, G. P. T. Glenda Pataro Teixeira, 

G. M. R. Gabriela Mendonça Rabello. 

P119 CARDIAC tISSUE-REACtIVE AUtOANtIBODIES. PREVAlENCE OF ANtI-CARDIAC tROPONIN-I 

IGG IN A BNP POSItIVE POPUlAtION. 

M. Adamczyk, R. J. Brashear, P. G. Mattingly. 

P120 DEPRESSION AND HEARt DISEASE - A CROSS CUltURAl VIEW 

A. Nanhay, L. Villano. 

P121 VElOCIty VECtOR IMAGING FOR ASSESSMENt OF MECHANICAl DySSyNCHRONy AND ItS 

COMPARISON tO COlOR CODED tISSUE DOPPlER IMAGING. 

A. C. Parameswaran, T. P. Shah, A. Amanullah.


P122 INtRAOPERAtIVE CORONARy ANGIOGRAPHy – AN APPROACH tO QUAlIty CONtROl 

AND lOGIStIC BACkGROUND FOR EMERGENCy SIMUltANEOUS CAtHEtER-BASED 

INtERVENtIONS DURING MINIMAl INVASIVE CORONARy ByPASS SURGERy 

G. Friedrich, C. Kolbitsch, T. Schachner, N. Bonaros, S. Abbrederis, G. Laufer, O. Pachinger, J. Bonatti . 

P123 MEtABOlIC SyNDROM By NEW IDF DEFINItION AND MORtAlIty OUtCOMES IN PAtIENtS 

WItH MANIFESt CORONARy HEARt DISEASE. 

O. Mayer, J. Šimon, M. Plášková, R. Cífková. 

P124 INtRAOPERAtIVE DEtECtION OF PORCElAIN AORtA REMAINS A CHAllENGING DIlEMMA IN 

CORONARy ARtERy ByPASS SURGERy 

H. B. Bittner, R. R. Battellini, A. J. Rastan, F. W. Mohr. 

P125 MUltISlICE COMPUtER tOMOGRAPHIC CORONARy ANGIOGRAPHy FOR PREOPERAtIVE RISk 

StRAtIFICAtION IN PAtIENtS UNDERGOING lIVER tRANSPlANtAtION 

S. Abbrederis, G. Feuchtner, O. Pachinger, W. Vogel, E. Gassner, I. Graziadei, A. Mallouhi, G. Friedrich. 

P126 AN EIGHt-WEEk, MUltI-CENtER, RANDOMIzED, DOUBlE-BlIND, PARAllEl GROUP StUDy 

COMPARING tHE EFFICACy AND SAFEty OF AMlODIPINE/VAlSARtAN COMBINAtION 

tHERAPy VERSUS AMlODIPINE MONOtHERAPy IN tHE tREAtMENt OF StAGE 2 

HyPERtENSION 

M. Destro, L. Satlin, A. Kandra, P. Brunel. 

P127 VAlUE OF FIRSt-lINE HyPERtENSION tREAtMENt WItH AN AMlODIPINE/VAlSARtAN 

REGIMEN FOR SyStOlIC BlOOD PRESSURE CONtROl: ANAlySES IN DIFFICUlt-tO-tREAt 

POPUlAtIONS 


P128 EFFICACy AND SAFEty OF AMlODIPINE/VAlSARtAN IN HISPANIC SUBJECtS WItH StAGE 2 

HyPERtENSION 


P129 tISSUE DOPPlER IMAGING AND CONtRASt ECHOCARDIOGRAPHy: NEW MEtHODS IN 

DIAGNOSING INtRACARDIAC StRUCtURES. 

M. Hlawaty, W. Tracz, M. Olszowska, M. Kostkiewicz, M. Pasowicz, P. Podolec. 

P130 tRANSIENt MyOCARDIAl StUNNING SyNDROME: PREVAlENCE AND ClINICAl FEAtURES IN 

A POPUlAtION OF A GENERAl HOSPItAl 

L. Hamity, F. Ramello, A. Moyano, L. Marani, E. Moreyra, L. Alday. 

P131 lENGtHENING OF tHE AORtA WItH ADVANCING AGE: MRI StUDy 

H. Tanaka, K. Hayashi, T. Yokoi, J. Sugawara. 

P132 ISCHEMIC CARDIOPAtHOlOGy IN CUBAN WOMEN 

S. Luis Mario Sollet Lopez, Laura Principe. 



P133 ANOMAlOUS ORIGIN OF tHE lEFt CORONARy ARtERy FROM tHE PUlMONARy ARtERy 

(AlCAPA). PRESENtAtION OF tWO CASES. 

L. M. Sollet Lopez, E. Selman Houssein, A. Naranjo, L. Principe, A. E. Gonzalez Morejon. 

P134 ASSESSMENt OF PAtIENtS OPERAtED ON COMPlEtE ANOMAlOUS DRAINAGE OF 

PUlMONARy VEINS ACCORDING tO tHE CUBAN PROGRAM FOR CHIlDREN’S CARDIAC 

REHABIlItAtION 

S. Luis Mario Sollet Lopez, Francisco Carballes Garcia, Adel Glez Morejon, Laura Principe . 

P135 tHE ROlE OF ABNORMAl Q WAVES AND St-SEGMENt ElEVAtION AS A MARkER FOR 

DISEASE PROGRESSION IN HyPERtROPHIC CARDIOMyOPAtHy 

Maky Fabiola Furuki K., Hiroya Kawai, Katsuko Norisada, Mariko Okada, Kazuhiro Tatsumi, Toshiya Kataoka, 

Tetsuari Onishi, Hidekazu Tanaka, Kenichi Hirata. 

P136 HEARt RAtE, RISk FACtORS, MEtABOlIC SyNDROME AND GlOBAl CARDIOVASCUlAR RISk 

IN A WORkING POPUlAtION 

M. A. Sánchez Chaparro, J. Román García, E. Calvo Bonacho, M. Cabrera Sierra, A. Fernández Meseguer, 

M. Ruiz Moraga, J. C. Saínz Gutiérrez, C. Fernández-Labandera, A. García García, A. Gálvez Moraleda. 

P137 EVAlUAtION OF HEARt PUMPING FUNCtION By DyNAMICS OF OXyGEN DEPt IN 

CARDIOPUlMONARy EXERCISE tESt IN PAtIENtS WItH CORONARy ARtERy DISEASE. 

S. V. Ivanov, Y. U. A. Izachik, A. B. Pestova, S. S. Ivanov, N. A. Grablina . 

P138 Ct CORNARy ANGIOGRAPHy - NEW PERSPECtIVES OF DIAGNOStIC OF CORONARy ARtERy 

DISEASE. PERSONAl EXPERIENCES 

B. Cveticanin, M. Zorc. 

P139 ISOlAtED NONCOMPACtION IS A BIVENtRICUlAR DISEASE 

E. K. Wlodarska, O. Wozniak, B. Lubiszewska, M. Konka, D. Piotrowska-Kownacka, E. Walczak, K. Baranska, 

W. Ruzyllo, P. Hoffman. 

P140 PRESENCE AND SEVERIty OF CEREBRAl WHItE MAttER lESIONS ASSOCIAtED WItH AN 

ARtERIAl HyPERtENSION 

M. Tundybaeva, A. Jussipov. 

P141 PREGNANCy IN PAtIENtS WItH PROStHEtIC AND HOMOGRAFt HEARt 

VAlVES - MAtERNAl AND FEtAl OUtCOME. 

A. Lesniak-Sobelga, M. Kostkiewicz, W. Tracz. 

P144 tISSUE DOPPlER POSt-SyStOlIC MOtION IN PAtIENtS WItH HyPERtENSIVE HEARt 

DISEASE 

A. Stevanovic, B. Vujisic-Tesic, M. Dekleva, L. J. Sevic.


P145 INFlUENzA VACCINAtION REDUCES tHE FREQUENCy OF CORONARy EVENtS IN PAtIENtS 

AFtER PRIMARy PCI 

A. Ciszewski, Z. T. Bilinska, L. B. Brydak, M. Romanowska, C. Kepka, M. Kruk, W. Piotrowski, W. Ruzyllo. 

P146 EFFECt OF FIXED ANtIHyPERtENSIVE COMBINAtIONS ON BlOOD PRESSURE, PUlSE WAVE 

VElOñIty AND GlUCOSE MEtABOlISM IN HyPERtENSIVE PAtIENtS WItH MEtABOlIC 

SyNDROME 

S. Nedogoda, T. Chalabi, U. Brel, E. Podolskaya, G. Mazina, V. Tzoma, D. Zaremba. 

P147 tREAtMENt OF ARtERIAl HyPERtENSION WItH VERy-SMAll DOSES OF ANtIBODIES tO 

C-END FRAGMENt OF àò1 RECEPtORS OF ANGIOtENSIN II. 

S. Nedogoda, V. Petrov, O. Epstein, T. Chaliabi, U. Brel, N. Chepurina, G. Masina, A. Sabanov, S. Tarasov, 

A. Kolosova . 

P148 EFFECt OF INDAPAMIDE SR VS HyDROCHlOROtHIAzIDE ON BlOOD PRESSURE, PUlSE WAVE 

VElOSIty AND GlUCOSE MEtABOlISM IN OBESE HyPERtENSIVE PAtIENtS 

S. Nedogoda, T. Chaliabi, U. Brel, E. Podolskaya, G. Mazina . 

P149 EFFICACy OF AtORVAStAtIN At PAtIENtS WItH MEtABOlIC SyNDROME 

S. Nedogoda, V. Tsoma, T. Chaliabi, U. Brel, E. Podolskaya, G. Mazina . 

P150 tHE EFFECt OF AN EDUCAtIONAl INtERVENtION ON CARDIOVASCUlAR RISk FACtORS IN 

AN OVERWEIGHt ElDERly POPUlAtION. 

F. Santos, A. Neujahr, E. Veitenheimer, N. Schimidt, B. Santos, R. El-Kik, A. Gustavo. 

P152 NORMAl E/EA RAtIO VAlUES IN HEAltHy INDIVIDUAlS ACCORDING tO AGE. 

H. Deschle, G. Allende, A. Miranda, A. Lakowsky, D. Sanchez Luceros, J. Carbajales, R. Calviño. 

P153 PEDIAtRIC CARDIOVASCUlAR REHABIlItAtION PROGRAM: ROll OF tHE AQUAtIC PHySICAl 

tHERAPy. 

J. Bleiz, C. Serra, M. Venere, G. Guarraccino, G. Rocca, V. Assinnato, I. Souto, P. Campana, J. Rodriguez, S. Prates. 

P154 SyStOlIC AND DIAStOlIC lEFt VENtRICUlAR WAll MOtION DySSyNCHRONy ASSESSED By 

99MtC-SEStAMIBI-GAtED-SPECt IN PAtIENt WItH HyPERtENSION 

M. Ishikawa, A. Yamamoto, N. Takahashi, T. Shingo, J. Abe, K. Amitani, T. Yamaguchi, N. Kawaguchi, T. Uchida, 

K. Munakata. 

P155 IMPACt OF ANGIOtENSIN II RECEPtOR BROCkADE ON lEFt VENtRICUlAR DySSyNCHRONy 

IN HyPERtENSION 

N. Takahashi, A. Yamamoto, M. Ishikawa, S. Tezuka, J. Abe, K. Amitani, T. Yamaguchi, N. Kawaguchi, T. Uchida, 

K. Munakata. 

P156 ADHERENCE OF PAtIENtS tO tHE ANtIHyPERtENSIVE tREAtMENt IN GEORGIAN 

POPUlAtION 

D. Trapaidze, B. Tsinamdzgvrishvili, R. Tataradze, T. Abesadze, A. Rekhviashvili. 



P157 EARly AND lAtE RESUltS OF tOtAl CORRECtION OF tEtRAlOGy OF FAllOt 

K. H. Hashemzadeh, S. H. Hashemzadeh, M. J. Dehdilani, M. Z. Dehdilani. 

P158 ACUtE EFFECtS OF PEROXISOME PROlIFERAtOR ACtIVAtED RECEPtOR GAMMA (PPAR 

GAMMA) StIMUlAtION IN MACROPHAGE CEllS AND HIGHly SENSItIVIty 

CREACtIVE PROtEIN OF HyPERCHOlEStEROlEMIC RABBItS 

A. Alessi, O. França Neto, C. Prim, P. R. Brofman, L. Noronha, L. Baroncini, D. B. Précoma. 

P159 HyPERtENSION DEtECtION IN CHIlDREN IN SCHOOlARSHIP AGE 

S. Lopez Cross, L. Dumas, D. Peroni, G. Valenzuela . 

P160 RISk FACtORS FOR INADEQUAtE tRANSESOPHAGEAl ECHOCARDIOGRAPHy 

B. Flynn, J. Stanley, S. Wang, S. Lam, J. Meltzer, V. Moitra. 

P161 RElEASE OF CAlCItONIN GENE-RElAtED PEPtIDE FROM tHE JUGUlAR-NODOSE GANGlION 

COMPlEX IN RAtS 

T. Strecker, A. Dieterle, K. Messlinger, W. Neuhuber, M. Weyand, S. Koulchitsky. 

P162 StENtING OF tHE VENA CAVA SUPERIOR IN A PAtIENt WItH A tOtAl ARtIFICIAl HEARt 

T. Strecker, M. Uder, R. Tandler, M. Weyand, M. Kondruweit. 

P163 CARDIAC tUMORS – 37-yEAR RESUltS, SURGICAl EXPERINENCE AND OUtCOME IN OUR 

HEARt SURGERy CENtER 

T. Strecker, J. Roesch, M. Weyand, M. Kondruweit. 

P164 INCIDENCE OF CORONARy ARtERy DISEASE IN PAtIENtS WItH tRICUSPID VERSUS BICUSPID 

AORtIC StENOSIS 

L. Cook, S. Burger, C. Harden. 

P165 ONE-yEAR CARDIOVASCUlAR EVENt RAtES IN OUtPAtIENtS WItH SlOW UPSlOPING St 

DEPRESSION VS. HORIzONtAl OR DOWNSlOPING St DEPRESSION IN tREADMIll EXERCISE 

tEStING 

L. Ferro, A. Contreras, P. Pogonza, E. Brenna, F. Urinovsky, R. Bagur, D. Morillo, L. M. Amuchastegui. 

P166 ASyNCHRONOUS HEMIDISC ClOSURE IN MECHANICAl BIlEAFlEt PROStHESES WItH 

NORMAl FUNCtION. 

T. F. Cianciulli, M. A. Beck, J. A. Lax, M. C. Saccheri, G. E. Gigena, A. N. Dorelle, E. H. Fernandez, J. H. Leguizamon, 

H. A. Prezioso, L. A. Vidal. 

P167 DEtECtION OF AtHEROSClEROSIS IN tHE BRACHIOCEPHAlIC tRUNk: tHE MISSING PIECE OF 

tHE PUzzlE? 

N. Moraes, R. Dias, J. Tsutsui, A. Uchida, M. Vieira, S. Oliveira, P. Da Luz, W. Mathias. 

P168 IS EASy-ACCESS PREVENtIVE MEDICINE NECESSARy IN A SOCIAl HEAltHCARE SyStEM 

A. Bader, M. Hochleitner.


P169 PRONE IMAGING IS AN EFFECtIVE MEtHOD OF AttENUAtION CORRECtION IN 

A. Salacata, J. Mills, S. Keavey . 

P170 DIABEtIC PAtIENtS UNDERGOING PERCUtANEOUS CORONARy INtERVENtION USING 

DRUG-ElUtING StENtS: INCIDENCE AND PREDICtORS OF VERy lAtE 

(> 12 MONtHS) StENt tHROMBOSIS 

V. Voudris, P. Karyofillis, S. Thomopoulou, S. Patsilinakos, A. Manginas, C. Spargias, G. Pavlides, D. V. Cokkinos. 

P171 lONG-tERM ClINICAl OUtCOME OF PAtIENtS WItH SAPHENOUS VEIN GRAFt lESIONS 

tREAtED WItH DRUG-ElUtING StENtS ; COMPARISON WItH PAtIENtS tREAtED WItH BARE 

MEtAl StENtS 

V. Voudris, S. Thomopoulou, P. Karyofillis, C. Kalianos, A. Manginas, G. Pavlides, C. Spargias, D. V. Cokkinos. 

P172 SEEkING MEDICAl ADVICE OF PAtIENtS WItH MyOCARDIAl INFARCtION IN RUSSIA 

V. Gafarov, A. Gafarova. 

P173 MONItORING MyOCARDIAl INFARCtION (DIAGNOStIC COMBINAtION, PRODROMAl PERIOD, 

BEHAVIORAl CHARACtERIStICS) USING tHE WHO 

PROGRAM “REGIStRy OF ACUtE MyOCARDIAl INFARCtION”, “MONICA” 

DURING tHE PERIOD OF 22 yEARS IN RUSSIA 

V. Gafarov, A. Gafarova. 

P175 ECO-CARDIOGRAPHIC ERGOMEtRIC CORRElAtION OF PAtIENtS 

L. Sollet Lopez, A. Gonzalez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arsola, 

C. Garcia Morejon, E. Fleitas. 

P176 ECO-CARDIOGRAPHIC ERGOMEtRIC CORRElAtION OF PAtIENtS 

L. Sollet Lopez, A. Gonzalez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arsola, 

C. Garcia Morejon, J. C. Ramiro Novoa, J. Ozores, E. Fleitas. 

P177 CORRElACIóN ECO CARDIOGRáFICA-ERGO MétRICA DE PACIENtES OPERADOS 

DE tGV A tRAVéS DE lA téCNICA DE MUStARD. 

L. Sollet Lopez, A. Glez Morejon, J. Ponce Vitar, E. Selman Houssein Sosa, R. Casanova Arzola, C. Garcia Morejon, 

J. C. Ramiro Novoa, E. Fleitas. 

P178 RISk FACtORS OF AtHEROSClEROSIS IN CHIlDREN 

H. Valdes Pino, L. Sollet Lopez, F. Carballes Garcia, E. Aguilera. 

P179 FACtORES DE RIESGOS DE AtEROSClEROSIS EN POBlACION INFANtIl, AREA DE SAlUD 

REPARtO JESUS MENENDEz, 2006 

H. Valdes Pino, L. Sollet Lopez, F. Carballes Garcia, E. Aguilera. 



P180 OBESIty, PlASMA lIPID PROFIlES AND MEtABOlIC SyNDROME AMONG APPARENtly 

HEAltHy ADUlt NIGERIANS 

M. Sani, K. Wahab, B. Yusuf, O. Johnson. 

P181 CORRElAtION OF ISCHEMIC WAll MOtION ABNORMAlItIES IN StRESS ECHO WItH 

OBSERVED MORPHOlOGIC PAttERN IN tWElVE lEAD EXERCISE ElECtROCARDIOGRAPHy. 

N. G. Allende, R. Perez De La Hoz, E. Carrasco, G. Marambio, S. Carabajal, C. Vazquez, M. Russo. 

P182 VAlVE REPlACEMENt WItH BIlEAFlEt HP-BIPlUS MECHANICAl PROStHESES VERSUS 

StANDARD PROStHESES: lONG-tERM RESUltS. 

T. F. Cianciulli, M. A. Beck, J. A. Lax, M. C. Saccheri, L. A. Cozarinsky, F. J. Gadea, A. N. Dorelle, R Guidoin, 


P184 OUtCOMES OF PRIMARy PERCUtANEOUS CORONARy INtERVENtION FOR ACUtE 

St-ElEVAtION MyOCARDIAl INFARCtION IN PAtIENtS AGED OVER 80 yEARS 

I. Teplitsky, A. R. Assali, H. Vaknin Assa, E. Lev, D. Brosh, I. Ben-Dor, S. Fuchs, N. Shor, A. Battler, R. Kornowski. 

P185 tHE ElECtRICAl REMODElING IN tHE SENESCENt OVER 90 yEARS OlD - GENDER 

DIFFERENCES AND ClINICAl ASPECtS 


P186 lEVEl OF kNOWlEDGE OF tHE IMPACt OF CARDIOVASCUlAR DISEASE IN WOMEN’S 

MORtAlIty, IN tHREE POPUlAtION GROUPS: ORDINARy WOMEN, NURSES AND MEDICAl 

DOCtORS IN SANtIAGO, CHIlE. 

M. Fernandez, P. Arellano, V. Vera, P. Uriarte, M. Tobar, A. Abufhele. 

P187 NONCOMPACtION OF tHE VENtRICUlAR MyOCARDIUM (NCVM) 

A. De Dios, E. Flores, A. Olive, M. Pasquale, M. Vaccari, M. Vidal, M. Zampach, B. Zarlenga, R. Cayre. 

P189 ACtIVAtED FACtOR XII AND B-tyPE NAtRIUREtIC PEPtIDE, BUt NOt C-REACtIVE PROtEIN, 

ARE INDEPENDENt PREDICtORS OF MORtAlIty FOllOWING ADMISSION WItH SUSPECtED 

MyOCARDIAl INFARCtION. 

V. Pönitz, T. Brügger-Andersen, D. Pritchard, H. Grundt, H. Staines, D. T. W. Nilsen. 

P190 ACtIVAtED FACtOR XII tyPE A IS AN INDEPENDENt PREDICtOR OF CARDIOVASCUlAR 

OUtCOME IN CORONARy PAtIENtS ADMIttED WItH tROPONIN t NEGAtIVE CHESt PAIN 

V. Pönitz, T. Brugger-Andersen, D. Pritchard, H. Grundt, H. Staines, D. T. W. Nilsen. 

P191 MItRAl VAlVE REPAIR SURGERy 

V. Bichara, J. Tazar, A. Araujo, R. De Rosa. 

P192 BODy COMPOSItION ANAlySIS WItH COMBINAtED PHySICAl tRAINING IN CORONARy 

PAtIENtS 

M. Resnik, M. Ruffa, S. Taurozzi, L. Maggio, M. Perez Ruffa, E. Abad Monetti.


P193 HEAD tO HEAD COMPARISON OF PROGNOStIC VAlUE OF DOBUtAMINE AND ADENOSINE 

REAl-tIME MyOCARDIAl CONtRASt ECHOCARDIOGRAPHy- PRElIMINARy RESUltS 

A. Alves, I. Kowatsch, J. Tsutsui, A. Osório, L. César, J. Ramires, W. Mathias Jr. 

P194 tHE IMPACt OF PREOPERAtIVE AtRIAl FIBRIllAtION IN PAtIENtS UNDERGOING MItRAl 

VAlVE SURGERy: 15 yEARS OF EXPERIENCE OF A CARDIAC SURGERy SERVICE 

R. Santa Ritta, M. Coutinho, E. Varella, F. Di Giovanni, K. Da Correggio, G. Longo, C. Fontana, S. Fadel. 

P195 NURSE lED HEARt FAIlURE ClINIC IS COSt EFFECtIVE IN NEW zEAlAND 

I. Ternouth, B. Lindsay. 

P196 IS MUltI SlICE Ct ANGIOGRAPHy ADEQUAtE AS tHE SOlE DIAGNOStIC 

CRItERIA tO PROCEED FOR CABG ? 

H. Bedi, J. Gill, S. Bakshi. 

P197 SURGICAl tREAtMENt OF CHRONIC SEVERE RIGHt VENtRICUlAR CARDIOMyOPAtHIES 

M. Cortes Morichetti, J. L. Hebert, T. Lavergne, R. Frank, G. Fontaine, F. Hidden-Lucet, Y. Lecarpentier, 

A. Carpentier, J. N. Fabiani, J. C. Chachques. 

P198 lAtE COMPlICAtIONS AFtER DRUG-ElUtING StENt IMPlANtAtION IN 

“REAl-WORlD” ClINICAl PRACtICE 

D. R. Ramsdale, A. Rao, O. Asghar, K. A. Ramsdale, E. McKay. 

P200 PREVAlENCE AND PREDICtORS OF CAROtID VERSUS FEMORAl PlAQUE By SCREENING 

VASCUlAR UltRASOUND IN ASyMPtOMAtIC ADUltS 

J. Postley, J. Gardin, A. Perez, M. Chan, N. D. Wong. 

P201 ROlE OF PAtIENt EDUCAtION IN EXERCISE ADHERENCE IN PAtIENtS UNDERGOING 

MyOCARDIAl REVASCUlARIzAtION 

G. Giunta, D. Comtesse, H. Sanabria, A. Hershon, R. Mayer, L. Brandani, R. Romero, S. Di Yelsi, C. Commes, 

S. Kerbage. 

P202 REtRIEVAl, REPOSItIONING, UNkNOttING, AND StRIPPING OF INtRACARDIAC CAtHEtERS 

AND FOREIGN BODIES 

J. Tisnado, D. J. Komorowski, M. K. Sydnor, D. A. Leung, J. Tisnado. 

P206 RENAl FUNCtION AND EVOlUtION OF ACUtE CORONARy SINDROME. NAtIONAl HOSPItAl 

ARzOBISPO lOAyzA lIMA-PERU 

M. Carrion Chambilla, A. Hurtado Arestegui, C. Gutierrez Villafuerte, J. Pinto Concha. 

P207 SURVIVIN EXPRESSION IN CARDIAC MyXOMA 

P. H. Chu, S. M. Jung. 



P209 EFFECt OF lEVOSIMENDAN ON DIAStOlIC FUNCtIONS IN PAtIENtS WItH HEARt FAIlURE 

AND COEXIStING AtRIAl FIBRIllAtION 

O. C. yontar, M. B. Yilmaz. 

P210 ElEVAtED tRIGlyCERIDES/HDl RAtIO PREDICtS EXtENSIVE CORONARy ARtERy DISEASE IN 

CyPRUS 

C. Conkbayir, S. Kenan. 

P211 SHORt-tERM EXERCISE tRAINING IMPROVES HDl FUNCtIONAl CHARACtERIStICS IN 

PAtIENtS WItH MEtABOlIC SyNDROME 

A. Casella-Filho, V. M. Silva, C. B. Casella, I.C. Trombetta, F. Y. Cesena, B. C. G. Nascimento, C. E. Negrao, 

R. C. Maranhao, P. L. Daluz, A. C. P. Chagas. 

P213 PREVAlENCE OF RHEUMAtIC HEARt DISEASE ACCORDING tO WORlD HEAltH 

ORGANIzAtION CRItERIA FOR SUB-ClINICAl VAlVE lESIONS 

E. Marijon, D. S. Celermajer, B. Ferreira, A. O. Mocumbi, D. Sidi, X. Jouven. 

P214 ASSESSMENt OF QUAlIty OF lIFE IN PAtIENtS WItH DEPENDENt CAVOtRICUSPID IStHMUS 

FlUttER 

J. García-Seara, L. Martinez-Sande, F. Gude Sampedro, B. Cid Alvarez, R. Vidal Perez, F. Soto Loureiro, 

J. Gonzalez Juanatey . 

P216 tHE EFFECtS OF GENERAl DEMOGRAPHIC DAtA ON tHE INItAtION AND tIMING OF 

tHROMBOlytIC tHERAPy AMONG OF StEMI PAtIENtS 

O. C. yontar, A. Erdem, K. Yalta, M. B. Yilmaz, I. Tandogan. 

P217 IS tHERE A PREDICtIVE PAttERN OF P-WAVE SIGNAl AVERAGED ElECtROCARDIOGRAM FOR 

ARRHytHMIA RECURRENCE AFtER CARDIOVERSION OF PERSIStENt AtRIAl FIBRIllAtION 

C. Militaru, A. Giuca, O. Istratoaie, D. D. Ionescu. 

P218 CARDIOPROtECtIVE EFFECtS OF zOFENOPRIl, ENAlAPRIl AND VAlSARtAN ON 

DOXORUBICIN CARDIOtOXICIty 

E. Bozçali, D. B. Dedeoglu, O. Süzer, H. Karpuz. 

P219 PlASMA HOMOCyStEINE lEVEl IN CARDIAC SyNDROME X AND ItS RElAtION WItH DUkE 

tREADMIll SCORE 

T. Timurkaynak, S. Balcioglu, U. Arslan, S. A. Kocaman, A. Çengel. 

P220 INFlAMMAtION AND FIBRINOlytIC DySFUNCtION IN IMPAIRED GlUCOSE tOlERANCE. 

H. L. Luciardi, S. Chain, S. G. Berman, G. Feldman, J. Muntaner, R. N, Herrera.


P221 AtP-BINDING CASSEttE tRANSPORtER G1 PROMOtER VARIANt INFlUENCES 

tO A SEVERIty OF CORONARy ARtERy DISEASE 

y. uehara, S. Furuyama, S. Abe, S. I. Miura, B. Zhang, K. Saku. 

P222 lAyPERSON tRAINEES IMPROVE tHEIR kNOWlEDGE OF RESUSCItAtION IN BlS/AED 

COURSES AND tHEIR CONFIDENCE IN PROVIDING ByStANDER CPR. 

P. Cokkinos, N. Nikolaou, T. Papafanis, P. Strebelas, C. Hasikidis, A. Tasouli, D. Kontogianni, G. Gavrielatos, 

T. Kapadohos, D. Chrysos. 

P223 DIStRIBUtION, AWARENESS, CONtROl AND BENEFItS OF REDUCtION OF BlOOD PRESSURE 

IN yEREVAN, ARMENIA 

P. zelveian, G. Podosyan, S. Barsamyan, A. Potosyan. 

P224 PROGNOStIC VAlUE OF SURFACE ElECtROCARDIOGRAM (ECG) ONE-MINUtE HEARt RAtE 

VARIABIlIty (HRV) 

J. Visperas, O. Bugarin, M. Somera, M. Ramirez, E. Caguioa, M. Yamamoto. 

P225 IS tHE COlD PRESSOR tESt USEFUl IN tHE PRE-ClINICAl StAGE OF CORONARy HEARt 

DISEASE tO PREDICt EVENtS? 

E. Pautasso, M. Koretzky, J. Aiub, C. Borrego, R. Foye, M. Boscaro, M. Battiston, F. De Cecco, J. Panini, 

A. Marcon Del Point. 

P226 EXERCISE ECHOCARDIOGRAPHy WItH CONtRASt FOR tHE EVAlUAtION OF PUlMONARy 

ARtERy SyStOlIC PRESSURE. NEW MEtHOD. 

L. Rocha Lopes, S. Almeida, R. Miranda, M. J. Loureiro, O. Simoes, P. Cordeiro, C. Cotrim, M. Carrageta. 

P227 INFECtIOUS ENDOCARDItIS ASSOCIAtED WItH PERMANENt IMPlANtABlE ElECtRONIC 

DEVICES (PIED): A PROSPECtIVE StUDy. 18 MONtHS FOllOW-UP. 

G. Pérez Baztarrica, F. Salvaggio, L. Gariglio, M. Cerón, F. Gonzalez, D. Calcines Huerta, H. Massetti, N. Blanco, 

A. Botbol, R. Porcile. 

P228 PUlMONARy EMBOlISM IN INFECtIOUS ENDOCARDItIS ASSOCIAtED WItH PERMANENt 

IMPlANtABlE ElECtRONIC DEVICES PIED: INCIDENCE AND OUtCOMES AFtER 

PERCUtANEOUS EXtRACtION OF CAtHEtERS. 

G. Pérez Baztarrica, F. Salvaggio, L. Gariglio, M. Nordaby, T. Soria, H. Cruz, F. Sanchez, N. Blanco, A. Botbol, 

R. Porcile. 

P229 PREDICtORS OF HIGH HOSPItAl COStS FOR ElDERly PAtIENtS WItH HEARt FAIlURE 

M. Giorgi, M. Voos, R. Borracci, R. Ahuad, H. Farras, S. Balmaceda, M. Fanuele, J. Insua. 

P230 PERCUtANEOUS CORONARy INtERVENtION IN PAtIENtS OVER 80 yEARS OlD tHROUGH 

tHE tRANSRADIAl ACCESS 

G. Samaja, A. Rodriguez Saavedra, M. Koretzky, R. Costello. 



P231 tRANSAPICAl MINIMAlly INVASIVE AORtIC VAlVE IMPlANtAtION 

T. Walther, R. Battellini, V. Falk, M. Borger, J. Kempfert, J. Fassl, Y. Rückert, A. Linke, G. Schuler, F. W. Mohr. 

P232 CARDIAC lEAD VEGEtAtIONS IN RHytHM DEVICES - tRANSVENOUS EXtRACtION 

R. Battellini, A. Rastan, M. Uhlemann, N. Lachmann, M. Luduena, T. Walther, N. Doll, F. W. Mohr. 

P233 SURVIVAl FROM CARDIAC ARRESt IN A SPECIAlIzED HOSPItAl. 

P. Cokkinos, E. Papadopoulou, A. Gkouziouta, V. Voudris, D. V. Cokkinos. 

P234 NON INVASIVE ASSESMENt OF CORONARy ARtERy By PASS GRAFtS By VCt 64 MUltISlICE. 

COMPARISON WItH CONVENtIONAl CORONARy ANGIOGRAPHy. 

J. Bonelli, C. Cigalini. 

P235 DOES CARVEDIlOl tHERAPy REDUCE Qt DISPERSION IN PAtIENtS WItH HEARt FAIlURE ? 

E. Tatli, T. Kurum, M. Aktoz, C. Gul, M. Buyuklu. 

P236 EFFECt OF CARVEDIlOl ON P-WAVE DURAtION AND P-WAVE DISPERSION IN PAtIENtS WItH 

SyStOlIC HEARt FAIlURE 

E. Tatli, T. Kurum, M. Aktoz, M. Buyuklu, C. Gul, A. Barutcu. 

P237 NON INVASIVE CORONARy ANGIOGRAPHy WItH MSCt 64 SlICE 

J. Bonelli, C. Cigalini, P. Pollono. 

P238 ClINICAl AND ECHOCARDIOGRAPHIC ASSESSMENt OF PAtIENtS WItH AORtIC VAlVE 

DISEASE - MAtERNAl AND FEtAl OUtCOME 

A. Lesniak-Sobelga, W. Tracz, M. Kostkiewicz. 

P239 INFORMAtION POVERty AS A RISk FACtOR FOR CARDIOVASCUlAR DISEASE: ASHANtI- 

PROCOR PROJECt tO INCREASE CVD kNOWlEDGE AND PRACtICE AMONG HEAltH WORkERS 

C. Coleman, B. Bilchik. 

P240 IMPlEMENtAtION MEASURES SECUNDARy PREVENtION CHD IN BANJA lUkA 

REGION,REPUBlIC OF SRPSkA,B&H 

D. Vulic, S. Loncar, B. Vulic, D. Roganovic, M. Ostojic, J. Marinkovic. 

P241 AWARENESS, tREAtMENt AND CONtROl OF tHE COMBINAtION OF HyPERtENSION AND 

HyPERCHOlEStEROlEMIA IN A PRIMARy PREVENtION POPUlAtION IN CHIlE 

M. Acevedo, V. Krämer, R. Tagle, G. Chamorro, M. Fernandez, L. Orellana. 

P243 DOES GENDER INFlUENCE POStPRANDIAl lIPAEMIA IN HEtEROzyGOtES OF FAMIlIAl 

HyPERCHOlEStEROlAEMIA? 

G. Kolovou, P. Cokkinos, S. Mavrogeni, G. Hatzigeorgiou, D. V. Cokkinos.


P244 CORONARy AtHEROSClEROSIS IN WEStERN SIBERIA: NORtH-SOUtH DIFFERENCES 

V. Kuznetsov, I. Zyrianov, G. Kolunin, D. Krinochkin, L. Evlampieva, M. Bessonova, E. Gorbatenko. 

P245 ASyMPtOMAtIC CAROtID AtHEROSClEROSIS IN PAtIENtS WItH CORONARIOPAtHy: 

PREVAlENCE, PREDICtORS AND DIAGNOSIS 

R. Marelli, J. Lopez Camelo, C. Geronés, C. Viscuso, A. Gomez Monroy, G. Godoy, M. Portis, F. Bourdin, I. Rifourcat, 

R. Sanchez. 

P246 AtHEROSClEROSIS OF CAROtID ARtERIES AND CORONARy ARtERy DISEASE 

P. Meszaros, N. Cemerlic-Adjic, K. Pavlovic, M. Maletin. 

P247 INtERlEUkIN-6 (Il-6): IS A MARkER FOR CARDIOVASCUlAR DISEASE IN PAtIENtS WItH 

DIABEtIC NEPHROPAtHy 

A. Silva, A. Baptista, P. Neves. 

P248 PREVAlENCE OF CARDIOVASCUlAR RISk FACtORS AND MEtABOlIC SyNDROME IN A 

HOSPItAl HyPERtENSION UNIt 

M. Irurita, C. Culebras, E. Bosch, R. Chirino, J. Irurita, L. Sanchez, L. Lopez Y Juan, B. Saiz, P. Rosique, R. Guerra. 

P249 NON-ISCHEMIC BENEFItS MAy BE INDEPENDENt OF tHE lDl-lOWERING PROPERtIES OF 

AtORVAStAtIN 

J. C. Larosa, J. Shepherd, D. D. Waters, A. Breazna, D. Demicco. 

P250 UNRAVEllING HIDDEN RENAl DySFUNCtION. AN UNRECOGNIzED MAJOR PROBlEM. 

M. Irurita, C. Culebras, E. Bosch, R. Chirino, J. Irurita, L. Suarez, B. Saiz, P. Rosique, R. Guerra, V. Nieto. 

P251 PItUItARy-ADRENAl AXIS HORMONE ADJUStMENt FOllOWING CARDIAC SURGERy 

M. Irurita, C. Culebras, J. Velayo, J. Irurita, R. Chirino, L. Suarez, H. Marrero, B. Saiz, L. Lopez Y Juan, V. Nieto. 

P252 DEtERMINANt FACtORS FOR tEMPORARy HORMONE CHANGES IN CARDIAC SURGERy 

M. Irurita, C. Culebras, J. Velayo, J. Irurita, R. Chirino, L. Suarez, H. Marrero, B. Saiz, L. Lopez Y Juan, V. Nieto. 

P253 PlASMAtIC lEVElS OF APOlIPOPROtEIN IN yOUNG SUBJECtS WItHOUt CARDIOVASCUlAR 

DISEASE. EFFECtS OF AGE, GENDER AND BODy MASS INDEX. 

D. A. Siniawski, W. M. Masson, P. Sorroche, J. Krauss, A. M. Cagide . 

P254 ACHIEVEMENt OF tREAtMENt tARGEtS OF CARDIOVASCUlAR RISk FACtORS IN A PIlOt 

SECONDARy PREVENtION PROGRAM IN CHIlE 

M. Acevedo, V. Krämer, G. Chamorro, G. Krogh, A. Muñoz, R. Corbalan. 

P255 ANtIPHOSPHOlIPID SyNDROME AND HyPERtENSIVE DISORDERS OF PREGNANCy 

(PRElIMINARy RESUltS). 

L. S. Voto, M. J. Mattioli, R. Zarate, G. N. Voto, B. E. Grand. 



P256 ElEVAtED AUGMENtAtION INDEX BUt NOt HSCRP COUlD BE RElAtED tO ARtERIAl 

DAMAGE IN PAtIENtS WItH RHEUMAtOID ARtHRItIS 

A. Cypiene, A. Laucevicius, J. Dadoniene, A. Venalis, Z. Petrulioniene, M. Kovaite, J. Badariene, V. Dzenkeviciute, 

L. Ryliskyte. 

P257 AUtOlOGOUS BONE-MARROW MONONUClEAR CEll tRANSPlANtAtION AFtER ACUtE 

MyOCARDIAl INFARCtION:COMPARISON OF tWO DElIVERy tECHNIQUES 

H. Dohmann, S. A. Silva, R. C. Moreira, A. Haddad, F. A. Tuche, A. S. Souza, C. Peixoto, R. Verney, M. Amorin, 

R. Borojevick . 

P258 IMPlEMENtAtION OF EMERGENCy-BASED tHROMBOlySIS; AN ACHIEVABlE OPtION FOR 

RURAl HOSPItAlS IN DEVElOPING COUNtRIES. 

S. Azarisman, H. Ngow, P. Melor, A. Jamalludin, A. Fauzi, S. Sapari, K. Khairi, S. Noorfaizan, M. Oteh. 

P259 COMPlIANCE WItH tHE MAlAySIAN NAtIONAl ClINICAl PRACtICE GUIDElINES ON tHE 

ADMINIStRAtION OF tHROMBOlytIC AGENtS IN ACUtE St-ElEVAtION MyOCARDIAl 

INFARCtION 


P260 RISk FACtOR PROFIlE OF PAtIENtS PRESENtING WItH ACUtE St-ElEVAtION MyOCARDIAl 

INFARCtION tO A RURAl HOSPItAl IN MAlAySIA 


P266 SURGICAl tHERAPy FOR ISCHEMIC HEARt FAIlURE: PREDICtORS OF MORtAlIty At lAtE 

FOllOW-UP 

I. Butkuviene, L. Ivaskeviciene, G. Nogiene, J. Zidanaviciute. 

P267 ARtERIAl HyPERtENSION MUltICENtRIC StUDy IN tyPE 2 DIABEtIC PAtIENtS 

M. L. Ruiz Morosini, E. Lopez Gonzalez, A. Garcia, A. Luongo, C. Gonzalez, G. Burlando, M. Ruiz . 

P269 MyOCARDIAl PERFUSION SPECt WItH DOUBlE DRUG NEED. 

V. Martire, D. Portillo, J. M. Dominguez, E. Pis Diez. 

P270 SPECt USEFUlNESS IN PAtIENtS WItH DOUBtFUl ERGOMEtRy DUE tO 

St-t DEPRESSION 

V. Martire, M. Cantos, M. Pilato, S. Pilato, C. Vietti, S. Vogogna. 

P271 INFlUENCE OF tHE COllAtERAl CORONARy CIRCUlAtION IN tHE MODEl 

OF DOUBlE ERGOMEtRIC StRESS tESt 

V. Martire, A. Arrastia, S. Gonzalez, D. Portillo, J. M. Dominguez.


P272 ClINICAl OUtCOMES IN PAtIENt WItH IDIOPAtHIC DIlAtED CARDIOMyOPAtHy OR 

CORONARy CARDIOMyOPAtHy AND AN IMPlANtABlE CARDOVERtER DEFIBRIllAtOR. 

ARE tHEy DIFFERENt? 

R. Aguayo, S. Diangelo, W. De Andrade, E. Costa, L. Azocar, O. Macz, R. Ferreyra, I. Romero, J. Maloney, C. Muratore 

P273 PHARMACOlOGICAl EFFECtS OF INAMRINONE lACtAtE IN PAtIENtS WItH REVERSIBlE 

PERFUSION DEFECtS INDUCED By DIPyRIDAMOlE 

V. Martire, D. Portillo, J. M. Dominguez, A. Kavata. 

P274 IMPlANtABlE CARDIOVERtER DEFIBRIllAtOR tHERAPy IN PAtIENtS WItH CHRONIC 

CHAGAS’ CARDIOMyOPAtHy: COMPARISON WItH ISCHEMIC CARDIOMyOPAtHy. 

L. Aguinaga, C. Muratore, A. Malan, L. Batista, G. Maid, J. Escudero, M. Lanzotti, P. Chiale, J. Maloney . 

P275 IMPORtANCE OF BlOOD FlOW AND CAlCIFICAtION DEGREE IN RESUltS OF CAROtID 

ARtERy StENtING 

L. Martinez Riera, E. Trucco, M. J. Cabrera Ferreyra, F. Paoletti, H. Londero. 

P276 CARDIAC MyOCytE INJURy CAN RESUlt IN ElEVAtED lEVElS OF CHOlINE IN PlASMA. 

M. Adamczyk, R. J. Brashear, P. G. Mattingly. 

P277 CHESt SyMPtOM ClASSIFICAtION IS USEFUl FOR IDENtIFyING CARDIAC RISk IN DIABEtIC 

PAtIENtS 

H. Fukuda, M. Moroi, R. Nakazato, T. Furuhashi, K. Sugi. 

P278 DES, lIkE BMS, DO NOt INFlUENCE SyStEMIC INFlAMMAtORy StAtUS RElAtED WItH 

INFlAMMAtORy CEllS AFtER PCI IN StABlE ANGINA PECtORIS 

T. Timurkaynak, S. A. Kocaman, A. Sahinarslan, A. Cengel. 

P279 HOSPItAlIzAtION OF PAtIENtS WItH HEARt FAIlURE. ROlE OF tHE PRECIPItAtING 

FACtORS. 

T. Livieratos, A. Tziovas, A. L. Patsilinakos, P. A. Koustas, F. O. Kontari, G. E. Fagogenis, G. E. Kordosis, A. T. Germanos. 

P280 CHARACtERIStICS, MANAGEMENt AND IN-HOSPItAl OUtCOMES OF PAtIENtS WItH ACUtE 

CORONARy SyNDROMES. 

T. H. Livieratos, A. R. Tziovas, A. L. Patsilinakos, G. E. Fagogenis, F. O. Kontari, P. A. Koustas, G. E. Kordosis, A. T. Germanos. 

P281 tHE EFFECtS OF NOCtURNAl DIPPING ON CARDIOVASCUlAR OUtCOME AND PROtEINURIA 

IN ESSENtIAl HyPERtENSIVE PAtIENtS 

y. Selcoki, B. Uz, N. Baybek, A. Akcay, B. Eryonucu. 

P282 ASSESSMENt OF MyOCARDIAl VIABIlIty IN CHRONIC ISCHEMIC HEARt DISEASE 

EVAlUAtED By StRESS ECHOCARDIOGRAPHy WItH DOBUtAMINE AND GAtED SINGlE 

PHOtON EMISSION COMPUtED tOMOGRAPHy (GSPECt) 

M. Kostkiewicz, A. Lesniak-Sobelga, M. Olszowska, M. Hlawaty, P. Podolec, W. Tracz. 



P283 CARDIOPUlMONARy EXERCISE tEStING IN tHE EStIMAtION OF tHE CARDIO RESPIRAtORy 

EFFICIENCy AFtER CARDIAC REHABIlItAtION IN CORONARy PAtIENtS 

A. Stuto, G. Cosentino, A. Ambu, F. Raineri, G. Bottaro, G. Basile, B. Armaro. 

P284 PREVAlENCE OF CARDIAC EVENtS IN PAtIENtS WItH NORMAl PERFUSION 

AND ABNORMAl St-t SEGMENt DURING DIPyRIDAMOlE INFUSION 

P. Smanio, L. Freitas, A. Feldman, A. Mota, C. Collet, F. Penhalves, R. Lopes, M. Oliveira, A. Thom, L. Piegas. 

P285 FIVE yEAR RESUltS OF tHE tREAtMENt StRAtEGy BASED UPON tHE FRACtIONAl FlOW 

RESERVE MEASUREMENtS IN PAtIENtS WItH BORDERlINE CORONARy ARtERy lESIONS 

u. Arslan, S. Balcioglu, S. A. Kocaman, T. Timurkaynak. 

P286 AORtIC SClEROSIS AND MItRAl ANNUlAR CAlCIFICAtION ARE RElAtED WItH INCREASED 

RISk FACtORS AND MARkERS IN ACUtE CORONARy SyNDROME 

S. A. Kocaman, G. Taçoy, S. Türkoglu, S. Akinci, M. Erden, S. K. Açikgöz, A. Çengel. 

P287 PREVAlENCE AND ClINICAl COURSE OF tHE END StAGE PHASE OF HyPERtROPHIC 

CARDIOMyOPAtHy IN PAtIENtS REFERRED tO A tERtIARy CARE CENtER 

A. Fernández, J. H. Casabé, R. R. Favaloro, M. Diez, L. Favaloro, C. Vigliano, E. Guevara, F. Landeta, J. Diaz, R. Laguens. 

P288 RElAtIONSHIP BEtWEEN FREQUENCy OF VENtRICUlAR tACHyARRHytHMIA EPISODES 

AND FUNCtIONAl CAPACIty IN PAtIENtS tREAtED WItH IMPlANtABlE CARDIOVERtER 

DEFIBRIllAtOR 

A. Eksik, A. Akyol, T. Norgaz, S. Sakalli, N. Cakmak, H. Hasdemýr, A. Alper, O. Soylu, D. Oz, I. Erdinler . 

P289 ROlE OF A FAMIly PHySICIAN SERVICE IN lIPID CONtROl IN PAtIENtS 

WItH CORONARy ARtERy DISEASE 

O. Korzh, G. Kotchuev, S. Krasnokutskiy. 

P290 tORSADE DE POINtES: A CAUSE OF MORGAGNI-ADAM-StOkES AttACkS 

IN PAtIENtS WItH AtRIOVENtRICUlAR BlOCk. 

D. Antonelli, E. Rosner, A. Shurman, N. A. Freedberg, Y. Turgeman. 

P291 PROGNOSItC VAlUE OF ANEMIA IN PAtIENtS HOSPItAlIzED FOR ACUtE CORONARy 

SyNDROME 

A. B. Cid Alvarez, E. Gonzalez Babarro, J. M. Garcia Acuña, A. Varela Román, P. Rigueiro Veloso, F. J. García Seara, 

A. Virgos Lamela, R. Vidal Perez, A. Díaz Redondo, J. R. Gonzalez Juanatey. 

P292 ClINIC FEAtURES AND PROGNOSIS OF ACUtE CORONARy SyNDROME IN 

tHE ElDERly 

A. B. Cid Alvarez, E. Gonzalez Babarro, J. M. Garcia Acuña, A. Varela Román, J. Garcia Seara, M. Gutierrez Feijoo, 

R. Vidal Perez, J. L. Martinez Sande, A. Díaz Redondo, J. R. Gonzalez Juanatey.


P293 ClINICAl PRESENtAtION AND PROGNOSIS OF ACUtE CORONARy SyNDROME 

IN WOMEN 

A. B. Cid Alvarez, E. Gonzalez Babarro, M. Pedreira Perez, J. M. Garcia Acuña, M. Bastos Fernandez, 

P. Mazon Ramos, I. Gomez Otero, R. Vidal Perez, A. Diaz Redondo, J. R. Gonzalez Juanatey. 

P294 APPlICAtION OF DEVEREUX’S GEOMEtRIC MODEl FOR tHE ANAlySIS OF StRUCtURE AND 

FUNCtION IN HyPERtENSIVE PAtIENtS. 

D. Chejtman, S. Baratta, A. Hita, F. Tramontini, H. Fernandez, C. Kotliar, P. Forcada, D. Turri . 

P296 SERUM MyElOPEROXIDASE lEVEl IS ASSOCIAtED WItH RISk OF MAJOR CARDIOVASCUlAR 

EVENtS DURING HOSPItAlIzAtION AND EXtENt OF CORONARy ARtERy DISEASE IN 

PAtIENtS WItH ACUtE CORONARy SyNDROMES 

B. Karadag, B. Vatan, N. Karadag, I. Keles, Z. Ongen, V. A. Vural. 

P297 tHE PROGNOStICS SIGNIFICANCE OF IMPAIRED GlUCOSE REGUlAtION IN NON-DIABEtIC 

PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION 

M. Ilic, I. Mrdovic, T. Jozic, R. Lasica, J. Perunicic, M. Asanin, M. Srdic, S. Stankovic, M. Matic, Z. Vasiljevic . 

P298 lEAD INtOXICAtION IN CHIlDREN: MARkERS OF ENDOtHElIAl DAMAGE. 

G. Feldman, S. Chain, H. Luciardi, S. Berman, R. Feldman, N. Martínez Riera. 

P299 A SIMPlIFIED StRAtEGy FOR tHE EStIMAtION OF tHE VENtIlAtORy tHRESHOlDS DURING 

RAMP-INCREMENtAl EXERCISE 

R. Stein, J. A. Neder. 

P300 BRACHIAl-ANklE PUlSE WAVE VElOCIty IS A MARkER OF CORONARy HEARt DISEASE IN 

SUBJECtS WItHOUt, BUt NOt WItH, MEtABOlIC SyNDROME 

H. Tomiyama, A. yamashina . 

P301 INCIDENCE OF PAtIENtS WItH ISOlAtED NONCOMPACtION OF lEFt VENtRIClE - SINGlE 

CENtER EXPERIENCES 

A. Nikolic, L. J. Jovovic, S. Tomic, M. Vukovic, D. Nikolic. 

P302 ACHIEVING lIPID GOAlS WItH ROSUVAStAtIN COMPARED tO SIMVAStAtIN: DISCOVERy 

BEtA StUDy 

T. Laks, E. Keba, M. Leiner, E. Merilind, M. Peterson, S. Reinmets, S. Väli, T. Sööt, K. Otter. 

P303 tHE DISEASE OF VASA VASORUM IN ENDARtERECtOMy SEQUEStERS OF CORONARy 

ARtERIES IN PAtIENt WItH CHlAMyDIA PNEUMONIAE INFECtION 

M. zorc, R. Zorc Pleskovic, A. Pleskovic, O. Vraspir Porenta, D. Petrovic, N. Radovanovic. 



P304 CHRONIC CHlAMyDIA PNEUMONIAE INFECtION AND MORPHOlOGy OF AtHEROSClEROtIC 

PROCESS IN DIFFUSE AND DIStAl CORONARy ARtERy DISEASE 

A. Pleskovic, R. Zorc Pleskovic, M. Zorc, O. Vraspir Porenta, D. Petrovic, N. Radovanovic. 

P305 PREDICtORS OF BlOOD PRESSURE NON-DIPPING PAttERN IN ACUtE CORONARy SyNDROME 

A. zamora, G. Vazquez, M. Vilaseca, J. M. Fernandez-Real, M. Crespo, A. Gibert, G. Paluzuie, S. Corali, D. Bron, J. Massa. 

P306 INtRACORONARy AUtOlOGOUS BONE MARROW MONONUClEAR CEll tRANSFER AFtER 

lARGE ANtERIOR ACUtE MyOCARDIAl INFARCtION (AMI 

M. A. Riccitelli, N. Perez Baliño, J. C. Dupont, J. Szarfer, F. Blanco, L. Grynberg, R. Cacchione, L. A. Vidal, 

A. García Escudero, O. Masoli. 

P307 CORONARy ENDOtHElIAl DySFUNCtION IS DIStINCt IN POStMENOPAUSAl WOMEN WItH 

CHESt PAIN IN tHE ABSENCE OF CORONARy ARtERy DISEASE 

T. Ashikaga, H. Fujii, S. Niki, K. Ihara, N. Murai, S. Maeda, N. Yamawake, M. Nishizaki, Y. Kishi, M. Isobe. 

P308 PROGNOStIC VAlUE OF PUlSE PRESSURE REGIStERED By 24 HOURS AMBUlAtORy BlOOD 

PRESSURE MONItORING IN ACUtE CORONARy SyNDROME 

G. Vazquez, A. Zamora, M. Vilaseca, M. Crespo, A. Gibert, G. Paluzie, I. Caballe, V. Fernández, C. Campoamor, S. Coralli. 

P309 CORRElAtION BEtWEEN ACCESS tO INVASIVE CORONARy APPROACH AND COMORBIDIty 

StAtUS IN PAtIENtS ADMIttED WItH ACUtE CORONARy SyNDROME IN A COMMUNIty 

HOSPItAl 

M. Vilaseca, G. Vazquez, A. Zamora, M. Crespo, A. Gibert, G. Paluzie, R. Cuenca, D. Bron, A. Rivera, R. Massa. 

P310 BlOOD PRESSURE VARIAtION ACtIVIty/RESt IS ASSOCIAtED tO A POOR CARDIOVASCUlAR 

PROGNOSIS IN PAtIENtS WItH ACUtE CORONARy SyNDROME 

A. zamora, G. Vazquez, M. Vilaseca, M. Crespo, A. Gibert, G. Paluzie, C. Campoamor, S. Coralli, D. Bron, A. Garcia-Flores. 

P311 DEPRESSION AND QUAlIty OF lIFE IN PAtIENtS WItH HEARt FAIlURE. 

M. Kowman, T. Sobow, I. Kloszewska, M. Dominiak, M. Klosinska, J. Drozdz. 

P312 SyNCRONOUS CAROtID ARtERy StENtING AND CARDIOVASCUlAR SURGERy. lONG tERM 

EVOlUtION 

C. Fava, L. Valdivieso, G. Lev, L. Villagra, J. Scaglia, A. Mollon, O. Mendiz. 

P313 EFFECt OF MEAN PlAtElEt VOlUME ON POSt-INtERVENtION CORONARy BlOOD FlOW IN 

PAtIENtS WItH CHRONIC StABlE ANGINA PECtORIS 

H. Duygu, F. Ozerkan, U. Turk, B. Kirilmaz. 

P314 StAtINS MIGHt IMPROVE CORONARy BlOOD FlOW AFtER PERCUtANEOUS CORONARy 

INtERVENtION 

H. Duygu, F. Ozerkan, U. Turk, C. Turkoglu.


P315 lAtENCy NON INVASIVE EVAlUAtION IN IMPlANtABlE PACEMAkER PAtIENtS POtENtIAl 

USE AS BIOSENSOR FOR AUtOMAtIC RAtE RESPONSIVE PACEMAkER 

D. Ortega, L. Barja, N. Mangani, F. Di Tomaso, A. Hita, D. Turri, M. Kenar. 

P316 PARAHISIAN SEPtAl StIMUlAtION. INDICAtION ANAlySIS. RESUltS 

D. Ortega, L. Barja, N. Mangani, E. V. Segura, A. Hita, C. Paladino, N. Paz, M. Kenar, D. Turri. 

P317 CARDIAC ElECtROtONIC MEMORy INDUCtION AFtER QRS NORMAlIzAtION By PARAHISIAN 

PACING. 

D. Ortega, L. Barja, N. Mangani, D. Turri, G. M. M Pellegrino, A. Hita, M. Kenar, C. Paladino, V. Kotowicz. 

P318 EFFECt OF DIFFERENt RIGHt VENtRICUlAR PACING PlACES ON lEFt VENtRICUlAR 

ElECtRO-MECHANICAl tIME. 

D. Ortega, L. Barja, M. Amor, G. M. M. Pellegrino, N. Mangani, A. Hita, D. Turri, M. Kenar. 

P319 USES OF tISSUE DOPPlER IMAGING FOR DEtECtION OF SUBClINICAl lEFt VENtRICUlAR 

DySFUNCtION IN PRE- tRANSPlANt RENAl HEMODIAlySED PAtIENtS 

C. Dizeo, M. Brito, G. Rey, P. Rossi. 

P321 PREDICtORS FOR SIlENt MyOCARDIAl ISCHEMIA IN DIABEtIC PAtIENtS WItH MyOCARDIAl 

PERFUSION ISCHEMIA 

H. Fukuda, M. Moroi, R. Nakazato, T. Furuhashi, N. Joki, H. Hase. 

P322 PREOPERAtIVE USE OF CAlCIUM SENSItIzER lEVOSIMENDAN REDUCES MORtAlIty 

AND lOW CARDIAC OUtPUt SyNDROME IN PAtIENtS WItH AORtIC StENOSIS AND lEFt 

VENtRICUlAR DySFUNCtION 

R. Levin, M. Degrange, R. Porcile, F. Salvagio, C. Del Mazo, E. Tanus, N. Blanco, L. Botbol. 

P323 SCREENING FOR PRIMARy HyPERAlDOStERONISM IN ESSENtIAl HyPERtENSIVE PAtIENtS: 

A MUltICENtRIC StUDy* 

S. Lupi, S. Belli, D. Cornalo, S. Damilano, R. Gomez, M. Leal, M. Martinez, M. Nofal, G. Ruibal, E. Pardes. 

P324 ASyMPtOMAtIC CAROtID AtHEROSClEROSIS IN PAtIENtS WItH SEVERE AORtIC VAlVUlAR 

StENOSIS. 

R. Marelli, L. Godoy, L. Geronés, N. Napoli, O. Pisano, C. Echeverria, M. Giacomo, V. Marasa, M. Geronés, O. Rastelli. 

P325 DEtERMINAtION OF tHE AlDOStERONE/PlASMA RENIN ACtIVIty RAtIO IN A 

NORMOtENSIVE POPUlAtION: A MUltICENtRIC StUDy* 

E. Pardes, S. Belli, L. Contreras, L. Costa, R. Chervin, S. Damilano, C. Fenili, R. Gomez, M. Leal, S. Lupi. 

P326 kEy ROlE OF REACtIVE OXyGEN SPECIES IN tHE ANREP’S PHENOMENON. 

N. G. Pérez, L. P. Novaretto, H. E. Cingolani. 



P327 IN tHE tREAtMENt OF tHE ACUtE MyOCARDIAl INFARCtION, tHE PRIMARy 

PERCUtANEOUS CORONARy INtERVENtION SHOW US BEttER IN-HOSPItAl RESUltS tHAN 

tHE RESCUE PERCUtANEOUS CORONARy INtERVENtION AFtER tHROMBOlISIS. 

M. Cantarelli, S. Gioppato, J. B. Guimarães, E. P. Ribeiro, J. Nardi, R. Gomes, T. Conforti, F. Pereda, R. Gonçalves, 

H. Castello . 

P328 ARE tHERE DIFFERENCES IN IMMEDIAtE RESUltS OF PERCUtANEOUS CORONARy 

INtERVENtION BEtWEEN ElDERly POPUlAtION ABOVE AND UNDER 80 yEARS OlD? 

M. Cantarelli, S. Gioppato, J.B. Guimarães, E.P. Ribeiro, J. Nardi, R. Gomes, T. Conforti, F. Pereda, R. Gonçalves, 

H. Castello . 

P329 DOUBlE CHAMBER RIGHt VENtRIClE: DIAGNOSIS AND tREAtMENt. PRESENtAtION OF tWO 

CASES 

C. Viscuso, M. Giacomo, C. Echeverria, L. Cali, M. Antonetti, J. Como Birche, G. Basso, D. Herrera, O. Pisano, 

R. Marelli . 

P330 QUAlIty CONtROl ( QC ) IN ANtICOAGUlAtION ClINIC 

M. G Gonzalez Achaval, M. Hadad, A. Del Val, S. Ghione, S. Gomez, J. P. Sala. 

P331 tHERAPEUtIC HyPOtHERMIA AFtER CARDIAC ARRESt 

M. Petrovic, G. Panic, I. Srdanovic, T. Canji, A. Jovelic . 

P332 tEtRAlOGy OF FAllOt: A 1 yEAR OF EXPERIENCE At tHE HOSPItAl CARDIOlOGICO 

INFANtIl lAtINOAMERICANO “DR GIlBERtO RODRIGUEz OCHOA” CARACAS, VENEzUElA. 

A. Galindo, J. Rengel, J. Figueira, S. Sanchez, A. Sanchez, J. Figueredo, N. Ysturiz, J. Iribarren, E. Parra, H. Mejias . 

P333 HOSPItAl CARDIOlOGICO INFANtIl lAtINOAMERICANO “DR GIlBERtO RODRIGUEz OCHOA” 

CARACAS; VENEzUElA. POSt OPERAtIVE EXPERIENCE OF VENtRICUAlR SEPtAl DEFECt. 

J. Figueira, J. Rengel, A. Galindo, S. Sanchez, J. Iribarren, A. Sanchez, C. Febres, M. Flores, H. Contreras, F. Emperador 

P334 ANOMAlOUS ORIGIN OF tHE lEFt CORONARy ARtERy FROM tHE PUlMONARy ARtERy 

(AlCAPA) IN ADOlESCENt: PRESENtAtION OF ClINICAl CASE. 

J. Rengel, J. Figueira, A. Galindo, S. Sanchez, I. Donis, J. Figueredo, J. Gonzalez, F. Guerra, Y. Acosta, I. Tolj . 

P335 lONG tERM tIROFIBAN INFUSION BEFORE PCI IN PAtIENtS WItH ANGIOGRAPHICAlly 

MASSIVE INtRACORONARy tHROMBUS 

T. Timurkaynak, U. Arslan, S. Balcioglu, S. A. Kocaman, S. Türkoglu. 

P336 C- REACtIVE PROtEIN AND ItS RElAtION WItH tHE VENtRICUlAR MASS, 

IN PAtIENtS WItH CHRONIC HEMODIAlySIS 

I. Masuda.


P339 C- REACtIVE PROtEIN AND ItS RElAtION WItH tHE VENtRICUlAR MASS, IN PAtIENtS WItH 

CHRONIC HEMODIAlySIS 

Masuda Isabel, Ferrero Mónica, Hecker Susana, Ziella Juan Carlos, Marcozzi Amalia, Hansen Ana, Aguirre Gustavo, 

Eduardo Escudero, Ciprés Miriam . 

P341 EARly DEtECtION OF RIGHt VENtRICUlAR SyStOlIC DySFUNCtION At tISSUE lEVEl By 

ISOVOlUMIC MyOCARDIAl ACCElERAtION IN PAtIENtS WItH COPD 

y. Tayyareci, C. P. Tastan, P. Bayazit, Y. Nisanci, A. Oncul, B. Umman, T. Goren, S. Umman, K. Adalet, Z. Bugra. 

P342 MANAGEMENt AND IMMEDIAtE OUtCOME OF ElDERly PAtIENtS WItH ACUtE CORONARy: 

A SINGlE CENtER EXPERIENCE 

V. Dias, S. Cabral, F. Soares, A. Luz, C. Gomes, F. Oliveira, L. Gomes . 

P343 INVASIVE AND ANtICOAGUlANt tHREAtMENt OF CORONARy ECtASIA 

V. Grigorov. 

P344 tHE ASSOCIAtION BEtWEEN MEtABOlIC SyNDROME AND ItS COMPONENtS AND HEARt 

FAIlURE IN PAtIENtS REFERRED tO A PRIMARy CARE FACIlIty 

F. Coelho, M. Moutinho, M. Rosa, V. Miranda, L. Tavares, E. Mesquita . 

P345 EFFECtS OF SIMVAStAtIN ON tHE tRANSFER OF lIPIDS tO HIGH DENSIty lIPOPROtEIN IN 

CORONARy ARtERy DISEASE PAtIENtS. 

A. C. Lo Prete, C. H. Dina, C. H. M. Azevedo, T. M. Seydell, W. Hueb, R. C. Maranhao. 

P346 BRADykININ RElEASED DURING INtENSE EXERCISE INHIBItS tHE EXPRESSION OF GAP 

JUNCtION PROtEIN IN tRAINED MOUSE HEARtS. 

G. C. Tiscornia, E. A. Garcia Gras. 

P348 tHE EFFECtS OF tHE CONtROllED RESPIRAtION ON tHE AUtONOMIC MODUlAtION OF tHE 

HEARt IN RESIStENt HIPERtENSION: tHE IMPACt OF RENIN-ANGIOtENSIN-AlDOStERONE 

SyStEM ON CARDIAC AUtONOMIC MODUlAtION (tHE CURUMIM StUDy) 

G. N. Gobbi, P. R. Benchimol-Barbosa, C. S. Miranda, A. F. P. Gondar, F. D. Vilela, F. V. Campos, J. Barbosa-Filho, 

M. V. Barros, A. B. R. Lima, I. Cordovil. 

P349 HDl SIzE AND ABIlIty OF ACCEPtANCE CHOlEStEROl AND OtHER lIPIDS IN HEARt 

tRANSPlANtAtION PAtIENtS WItH tREAtMENt 

C. G. Puk, A. C. Lo Prete, E. A. Bocchi, C. H. Azevedo, S. Ayub, R. C. Maranhão. 

P351 UtIlIty OF A lOW-RISk SPECt tESt IN UNStABlE ANGINA 

y. Castillo Costa, V. Mauro, A. Charask, R. Pérez, E. Fairman, L. Rodríguez, E. Barrionuevo, C. Barrero. 



P352 CARDIAC MIXOMAS: ClINICAl PRESENtAtION, SURGICAl RESUltS AND lONG-tERM 

FOllOW UP OF 60 CASES. 

E. Gonzalez, N. Pizzi, G. Caponi, J. Shiraishi, M. Varela Otero, Y. Arzani, L. Helman, R. Favaloro. 

P353 COMPlIACAtION OF CARDIOtHORACIC SURGERy IN tHE PERUVIAN NAtIONAl HEARt 

INStItUtE 

M. Condori. 

P354 SURGICAl tREAtMENt OF ACUtE tyPE A AORtIC DISSECtIONS. IMMEDIAtE AND lONGtERM 

RESUltS. 

R. Spampinato Torcivia, H. Cohen Arazi, H. Grancelli, W. Rodriguez, S. Waldman, M. Cáceres, M. Sellanes, 

C. Pensa, C. Nojek. 

P355 EVAlUAtION ON tHE RISk OF tARGEt ORGAN DAMAGE BASED ON tHE GENEtIC PROFIlE 

OF AGt 235Mt, MINERAlOCORtICOID RECEPtOR GCC5GG4C AND ACE I/D IN SUBJECtS WItH 

RESIStANt HyPERtENSION 

F. V. Campos, P. R. Benchimol-Barbosa, F. D. Vilela, C. S. Miranda, G. N. Gobbi, J. Barbosa-Filho, A. F. P. Gondar, 

M. V. Barros, A. B. R. Lima, I. Cordovil. 

P356 VENtRICUlAR-VASCUlAR COUPlING RESPONSE AND lEFt VENtRICUlAR FUNCtION 

PARAMEtERS WItH tHE ERGO-MEtRIC StRESS 

J. Tripolone, G. Santiago, M. Garcia. 

P357 RIGHt-SIDED INFECtIVE ENDOCARDItIS IN SINGAPORE 

y. Goh, P. Goh, H. Oh. 

P358 tHE EFFECt OF lONG-tERM BEtA-BlOCkER tREAtMENt ON ENDOtHElIUM-DEPENDENt 

HEMOStASIS IN PAtIENtS WItH CHRONIC HEARt FAIlURE 

E. V. Shlyakhto, K. A. Khmelnitskaya, M. Y. U. Sitnikova. 

P359 NAtURAl HIStORy OF RHEUMAtIC MItRAl StENOSIS 

M. Kilickap, B. Candemir, A. O. Ozdemir, S. Turhan, H. Ede, T. Altin, T. Sayin, G. Akgun, C. Erol. 

P360 EXERCISE DIAStOlIC lEFt VENtRICUlAR FUNCtION IN PAtIENtS WItH CORONARy ARtERy 

DISEASE 

Y. U. A. Izachik, S. V. Ivanov, A. B. Pestova, N. A. Grablina, S. S. Ivanov. 

P361 IMPROVEMENt IN ENDOtHElIAl FUNCtION WItH SHORt-tERM EXERCISE tRAINING AND 

WItHOUt SPECIFIC DIEt IN PAtIENtS WItH MEtABOlIC SyNDROME 

A. Casella-Filho, S. R. Coimbra, C. B. Casella, I. C. Trombetta, F. Y Cesena, E. Cerqueira, D. Favarato, C. E. Negrao, 

P. L. Daluz, A. C. P. Chagas.


P363 MItRAl AND AORtIC VAlVE DySFUNCtION IN MAINtENANCE HAEMODIAlySIS PAtIENtS - 

ECHOCARDIOGRAPHIC FINDINGS. 

M. Hlawaty, M. Olszowska, W. Tracz, P. Podolec, M. Kostkiewicz, A. Liœniak-Sobelga, M. Pasowicz. 

P364 MEDICAl ADVICE tO QUIt tOBACCO SMOkING AS A CORNERStONE IN CARDIOVASCUlAR 

PREVENtION. REAlIty OR FICtION. 

G. Pérez Baztarrica, R. Alonso, H. Cruz, F. Sanchez, F. Ganzalez, M. Cerón, L. Gariglio, F. Salvaggio, R. Cherhousky, 

R. Porcile. 

P365 tHE POlARISING SOlUtION IN tHE tREAtMENt OF ACUtE CORONARy SyNDROM 

R. Matunovic, S. Rafajlovski, M. Rabrenovic, J. Samardzic, R. Spasic. 

P367 IMPORtANCE OF CARDIOSURGERy tREAtEMENt IN PAtIENtS WItH INFECtIVE 

ENDOCARDItIS AND HEARt FAIlURE 

R. Matunovic, Z. Mijailovic, D. Tavciovski, Z. Vucinic, Z. Davicevic, Z. Jovic, V. Begovic, J. Samardzic. 

P368 REStING ElECtROCARDIOGRAPHIC VARIABlES OF PAtIENtS WItH SEVERE CORONARy 

ARtERy DISEASE UNDERGOING CORONARy ARtERy ByPASS GRAFt SURGERy PlUS 

INtRAMyOCARDIAl BONE MARROW CEll INJECtION: AN ONE-yEAR FOllOW UP StUDy 

M. S. Bittencourt, I. T. Schettert, C. J. Grupi, L. A. M. Cesar, J. E. Krieger, L. A. O. Dallan, S. A. Oliveira, 

L. H. W. Gowdak. 

P369 OUtCOMES At FOllOW-UP OF PAtIENtS WHO HAD CAROtID StENtING PERIPROCEDURAl 

tIA OR MINOR StROkE COMPlICAtIONS. 

C. Fava, G. Lev, L. Valdivieso, L. Villagra, J. Scaglia, A. Mollon, O. Mendiz. 

P370 ONE yEAR FOllOW UP OF AMBUlAtORy ElECtROCARDIOGRAPHIC VARIABlES OF PAtIENtS 

WItH SEVERE CORONARy ARtERy DISEASE UNDERGOING CORONARy ARtERy ByPASS 

GRAFt SURGERy PlUS INtRAMyOCARDIAl BONE MARROW CEll INJECtION 

M. S. Bittencourt, I. T. Schettert, C. J. Grupi, L. A. M. Cesar, J. E. Krieger, L. A. O. Dallan, S. A. Oliveira, 

L. H. W. Gowdak. 

P371 lEFt MAIN CORONARy ARtERy DISEASE IS CORRElAtED tO tHE ClINICAl 

CHARACtERIStICS OF StABlE CORONARy ARtERy DISEASE PAtIENtS. A StUDy AJUStED 

tO tHE CORONARy AtHEROSClEROtIC BURDEN 

A. L. V. Oliveira, M. S. Bittencourt, A. C. Pereira, L. A. M. Cesar, L. H. W. Gowdak. 

P373 BISOPROlOl AND PERINDOPRIl COMBINAtION IN POSt INFARCtION lEFt VENtRIClE 

REMODEllING 

K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan . 

P374 CARDIAC REStING MEtABOlISM: ENERGEtIC COSt OF CAlCIUM WItHDRAWAl 

P. Bonazzola, D. Takara. 



P375 tISSUE DOPPlER tRICUSPID ANNUlAR StUDy WItH lOADING VARIAtIONS: ClINICAl AND 

PRONOStICAl INtERESt 

G. Robles, M. Feissel, R. Khalaky, J. Badie, O. Ruyer, A. Grentzinger, J. P. Faller. 

P376 CAN WE USE tHE QRS COMPlEX AXIS AS A ElECtROCARDIOGRAPHIC PREDICtOR OF 

EFFICACy OF CARDIAC RESyNCHRONIzAtION tHERAPy? 

J. García-Seara, B. Cid Alvarez, J. L. Martinez Sande, M. Bastos Fernandez, A. Varela Roman, 

L. Grigorian Shamagian, P. Rigueiro Veloso, E. Gonzalez Babarro, J. R. Gonzalez-Juanatey. 

P377 INVERSE REMODElING AFtER DEPENDENt CAVOtRICUSPID IStHMUS FlUttER ABlAtION 

J. García-Seara, L. Martinez-Sande, B. Cid Alvarez, F. Soto Loureiro, R. Vidal Perez, M. Bastos Fernandez, 

M. Gutierrez Feijoo, M. Vega Fernandez, J. R. Gonzalez Juanatey. 

P378 ECHOCARDIOGRAPHIC ASSESSMENt OF EARly lEFt DIAStOlIC DySFUNCtION AND 

CORRElAtION WItH BNP SERUM lEVElS EStIMAtION IN PAtIENtS WItHOUt ClINICAl 

HEARt FAIlURE 

K. Hristova, S. Milanov, I. Filibev. 

P379 ECHOCARDIOGRAPHIC REGIONAl RIGHt VENtRICUlAR DySFUNCtION IN PAtIENtS WItH 

ACUtE PUlMONARy EMBOlISM 

K. Hristova, S. Milanov, I. Filibev, D. Petrov. 

P380 tHE RElAtIONSHIP BEtWEEN SERUM HBA1C lEVElS AND SEVERIty OF CORONARy 

ARtERIAl DISEASE IN DIABEtIC PAtIENtS 

O. C. yontar, A. Erdem, M. B. Yilmaz, K. Yalta, I. Tandogan. 

P381 ENtRy – AND EXItBlOCk AS ENDPOINtS IN SEGMENtAl PUlMONARy VEIN ISOlAtION By 

IRRIGAtED CAtHEtER ABlAtION AND tHE MESH MAPPER tECHNIQUE 

A. Meissner, M. Von Bracht, M. Christ, P. Maagh, C. A. Perings, H. J. Trappe, G. Plehn. 

P382 SCREENING PAtIENtS FOR HyPERtENSION IN EMERGENCy DEPARtMENt 


P383 PREVENtION ON MORtAlIty AND SUDDEN CARDIAC DEAtH IN PAtIENtS WItH 

CARDIOVASCUlAR DISEASES: EFFECt OF HIGHly PURIFIED OMEGA – 3 FAtty ACID 

(OMACOR). 


P384 NON-INVASIVE ASSESSMENt OF ARtERIAl PUlSE PRESSURE By USING AUtOMAtIC 

ANAlySIS OF B-MODE ECHOGRAPHIC IMAGES 

S. Graf, R. Armentano.


P385 lONG - tERM EVOlUtION OF R WAVE AMPlItUDE IN PAtIENtS WItH IMPlANtABlE 

CARDIOVERtER DEFIBRIllAtORS 

MD Di Toro Dario, RCT Lopez Carlos, MD Hadid Claudio, MD Luis Vidal, MD Carlos Labadet. 

P387 StUDy OF tHE DEGREE OF kNOWlEDGE tHAt tHE CARDIOlOGIStS IN tHE CIty OF SÃO 

PAUlO BRAzIl HAVE ABOUt AN ENtIty WItH lOW PREVAlENCE ASSOCIAtED tO SUDDEN 

CARDIAC DEAtH: BRUGADA SyNDROME 

A. R. Perez Riera, C. Ferreira, C. Ferreira Filho, E. Schapachnik, S. Dubner, A. H. Uchida, L. Zhang. 

P388 “SHARP-SUVED”… PROVED INtEGRAtED MANAGEMENt WItH INDIAN SyStEMS OF 

MEDICINE FOR CAD (CORONARy ARtERy DISEASE) 

V. Marathe, S. Vaidya. 

P389 RIGHt VENtRICUlAR MECHANIC ANAlySIS AND PUlMONARy DIStENSIBIlIty DURING tHE 

ERGO-MEtRIC EFFORt 

J. Tripolone, G. Santiago, C. Rollan. 

P390 NEW lEFt VENtRICUlAR FUNCtION INDEX. ¨MIOCARDIC ACCElERAtION CONCEPt 

J. Tripolone, G. Santiago, M. Salguero. 

P391 ASyMPtOMAtIC PAROXIStIC AtRIAl FIBRIllAtION.“tHE IMPORtANCE OF 

BEING SIlENt” 

J. Gant Lopez, F. Meiller, F. Deketele, A. Garcia Aguirre, A. Morales Lezica, M. Passauer, M. Cabo Fustaret, 

G. Maid, C. Rivas. 

P393 EVAlUAtION OF CORONARy ARtERIAl IllNESS RISk FACtORS IN AMAzONIANS 

INHABItANtS OF tHE MUtUCAl ISlAND, CIty OF CURUçá-PARá. 

L. Freire, R. Freire, B. Faillace, M. Palmeira, M. Lemes, I. Faillace, H. Azevedo. 

P394 PRESENCE OF tHE CARDIOVASCUlAR RISk FACtORS IN PAtIENtS AttENDED IN tHE 

CARDIOlOGy ClINIC OF tHE UNIVERSIty OF tHE StAtE OF PARá. 

L. Freire, R. Freire, B. Faillace, M. Palmeira, I. Faillace, M. Lemes, H. Azevedo. 

P396 RISk FACtORS FOR CORONARy EVENtS AND BASElINE DEMOGRAPHICS IN JAPANESE MEN. 

J. Sasaki, K. Fukuyo, K. Shimomura. 

P397 CARDIOPROtECtIVE EFFECtS OF NIGEllA SAtIVA ON CyClOSPORINE A-INDUCED 

CARDIOtOXICIty IN RAtS 

y. Selcoki, E. Uz, B. Uz, R. Bayrak, A. Kaya, F. H. Turgut, A. Karanfýl, S. Sahýn, N. Baybek, A. Akcay. 

P398 tHE INFlUENCE OF tHE BEtA-ADRENERGIC AGONIStS AND ANtAGONIStS ON t-WAVE 

AltERNANS AND lAtE POtENtIAl IN PAtIENtS WItH VENtRICUlAR tACHyARRHytHMIA 

N. Komiya, S. Fukae, S. Seto. 



P399 EFFECt OF CARVEDIlOl AND BISOPROlOl ON PARAMEtERS OF QUAlIty OF lIFE IN 

PAtIENtS WItH CHRONIC HEARt FAIlURE 

u. Kamilova, S. Shukurjanova, S. H. Jurayeva, R. Rahmonov, A. Kevorkov. 

P400 EFFECt OF BISOPROlOl AND CARVEDIlOl ON PARAMEtERS OF lEFt VENtRIClE 

REMODEllING IN PAtIENtS WItH POStINFARCtION CARDIOSClEROSIS 

Z. Shoalimova, u. Kamilova, S. H. Jurayeva, A. Kevorkov, T. Aliyeva. 

P401 SUPERIORIty OF lEVOSIMENDAN OVER DOBUtAMINE IN lOW CARDIAC OUtPUt SyNDROME 

AFtER AORtIC VAlVE REPlACEMENt 

R. Levin, M. Degrange, C. Del Mazo, R. Porcile, E. Tanus, N. Blanco, F. Salvagio, L. Botbol, V. Milman. 

P402 lONG tIME PROGNOStIC VAlUE OF Ck-MB MASS IN lOW-RISk PAtIENtS WItH StABlE 

ANGINA SCHEDUlED FOR CARDIAC SURGERy 

Kjell Vikenes, Knut S. Andersen, Tor Mellberg, Mikael Farstad, Jan Erik Nordrehaug. 

P403 EFFECt OF CARVEDIlOl ON MyOCARDIAl PERFUSION IN PAtIENtS WItH CHRONIC HEARt 

FAIlURE 

u. Kamilova, S. H. Jurayeva, T. Aliyeva, A. Kevorkov, B. Myasnik. 

P405 tHE COMBINAtION OF AMlODIPINE 10MG AND VAlSARtAN 160MG lOWERS BlOOD 

PRESSURE EFFECtIVEly AND SAFEly IN ElDERly HyPERtENSIVE PAtIENtS NOt 

CONtROllED By COMBINAtION tHERAPy WItH AN ACE INHIBItOR AND A CAlCIUM 

CHANNEl BlOCkER 

P. Trenkwalder, R. Schaetzl, E. Borbas, R. Handrock, S. Klebs. 

P406 EVAlUAtION OF HEAltHCARE PROVIDER INERtIA IN tHE MANAGEMENt OF 

CARDIOVASCUlAR DISEASE (CVD) RISk FACtORS IN PRIMARy CARE SEttINGS IN CAPE 

tOWN 

K. Steyn, N. Levitt, M. N. Hill, C. Dennison, N. Peer, J. Fourie . 

P407 SHORt AND lONG-tERM OUtCOMES OF PERCUtANEOUS CORONARy INtERVENtION IN 

PAtIENtS WItHOUt kNOWN DIABEtES AND ABNORMAl GlUCOSE REGUlAtION: ClINICAl 

IMPlICAtIONS 

J. De La Hera, E. Hernández, J. Vegas, J. García-Ruiz, R. Suarez-Arias, I. Lozano, C. Fernández-Cimadevilla, 

P. Avanzas, F. Alvarez, C Morís. 

P408 IMPACt OF UNkNOWN DIABEtES DIAGNOSIS WItH ORAl GlUCOSE tOlERANCE tESt IN 

CORONARy PAtIENtS: IDENtIFICAtION OF POSSIBlE IMPROVEMENtS IN SECONDARy 

PREVENtION MEASURES 

J. De La Hera, E. Hernández, J. Vegas, P. Avanzas, J. García-Ruiz, R. Suarez-Arias, F. Torres, D. Calvo, E. Delgado, 

C. Morís.


P409 ORAl GlUCOSE tOlERANCE tESt PERFORMANCE AND MUltIDISCIPlINARy tEAM 

APPROACH IMPROVE SECONDARy PREVENtION MEASURES IN NON-DIABEtIC CORONARy 

PAtIENtS 

J. De La Hera, E. Hernández, J. Vegas, R. Suarez-Arias, P. Avanzas, J. García-Ruiz, I. Lozano, A. Carro, E. Delgado, 

C. Morís. 

P410 POly(ADP-RIBOSE) POlyMERASE (PARP) INHIBItOR HO3089 ENHANCED POSt ISCHEMIC 

MyOCARDIAl GlUCOSE UPtAkE MOStly By ACtIVAtION OF AMP-ACtIVAtED PROtEIN 

kINASE (AMPk) 

E. Bognar, G. Y. N. Kiss, Z. S. Sarszegi, E. Bartha, I. Solti, B. Sumegi, Z. Berente . 

P412 SURGERy DEAtH RAtE PREDICtORS IN PAtIENtS WItH SEVERE AORtIC StENOSIS 

L. Gerones, L. Godoy, F. Bourdin, J. Como Birche, M. D’Aglio, F. Bravo, J. Aringoli, R. Martinez, P. Flaherty, R. Marelli. 

P413 BASElINE CHARACtERIStICS IN PAtIENtS WItH CHAGAS HEARt DISEASE IMPlANtED 

WItH A DEFIBRIllAtOR. DOES tHE PRESENCE OF A VENtRICUlAR ANEURySM MAkE ANy 

DIFFERENCE? 

C. Hadid, C. Lopez, D. Di Toro, L. Vidal, C. Labadet. 

P414 PREVENtION OF RADIAl ARtERy SPASM IN CORONARy SURGERy WItH IN VItRO 

OVER-DIlAtION 

D. Guastavino, M. Nahin, G. Vizcarra, G. Cozzarin, S. Budelli, A. Zillo, D.R. Grana, J. Milei. 

P415 tIME-COURSE OF REGRESSION OF tHE PROtECtION CONFERRED By SIMUlAtED 

HIGH AltItUDE ON RAt MyOCARDIUM. I. RESPONSE tO CAlCIUM AND tO HyPOXIA/ 

REOXyGENAtION. 

P. La Padula, L. Costa. 

P416 ClINICAl 2-yEAR FOllOW-UP RESUltS IN BIFURCAtION lESIONS WItH SIROlIMUS-ElUtING 

StENtS AND BARE-MEtAl StENtS. 

T. Ashikaga, S. Niki, H. Fujii, K. Ihara, N. Murai, S. Maeda, N. Yamawake, M. Nishizaki, M. Isobe. 

P417 tIME-COURSE OF REGRESSION OF tHE PROtECtION CONFERRED By SIMUlAtED HIGH 

AltItUDE ON RAt MyOCARDIUM. II. MItOCHONDRIAl NOS ACtIVIty AND EXPRESSION. 

P. La Padula, J. Bustamante, A. Czerniczyniec, L. Costa. 

P418 SElF-REPORtED lEISURE-tIME PHySICAl ACtIVIty PREDICtS lONG-tERM SURVIVAl IN 

PAtIENtS WItH CORONARy HEARt DISEASE 

F. Apullan, M. Bourassa, J. C. Tardif, A. Fortier, M. Gayda, A. Nigam. 

P419 tHE tIME OF CARDIOVERSION IN PAtIENtS WItH HyPERtHyROIDISM AND 

AtRIAl FIBRIllAtION 

H. Arý, E. Erdogan, V. Koca, T. Bozat . 



P420 lONG-tERM OUtCOME OF tHE OFF-lABEl USE OF PAClItAXEl-ElUtING StENtS: INSIGHtS 

FROM A COHORt OF 604 PAtIENtS 

X. Flores-Ríos, J. P. Abugattás-De Torres, R. Marzoa-Rivas, R. Campo-Pérez, G. Aldama-López, J. Salgado-Fernández, 

R. Calviño-Santos, J. M. Vázquez-Rodríguez, N. Vázquez-González, A. Castro-Beiras. 

P421 tHE COMBINAtION OF AMlODIPINE 10 MG AND VAlSARtAN 160 MG lOWERS BlOOD 

PRESSURE EFFECtIVEly AND SAFEly IN HyPERtENSIVE PAtIENtS NOt CONtROllED By 

COMBINAtION tHERAPy WItH AN ACE INHIBItOR AND A CAlCIUM CHANNEl BlOCkER 



PRESSURE EFFECtIVEly AND SAFEly IN OVERWEIGHt AND OBESE HyPERtENSIVE PAtIENtS 

NOt CONtROllED By COMBINAtION tHERAPy WItH AN ACE INHIBItOR AND A CAlCIUM 

CHANNEl BlOCkER 



PRESSURE EFFECtIVEly AND SAFEly IN HyPERtENSIVE PAtIENtS WItH MEtABOlIC RISk 

FACtORS NOt CONtROllED By COMBINAtION tHERAPy WItH AN ACE INHIBItOR AND A 

CAlCIUM CHANNEl BlOCkER 


P424 PERCUtANEOUS CORONARy INtERVENtIONS IN OCtOGENARIANS: IMMEDIAtE AND 

MIDDlE-tERM RESUltS 

M. Centemero, O. Belzares, C. E. Soares, F. Maia, R. Staico, F. Feres, I. Pinto, L. A. Mattos, A. G. M. R. Sousa, 

J. E. Sousa. 

P426 tyPE 2 DIABEtES AND MEtABOlIC SyNDROME: lIPID tRANSFER FROM AN ARtIFICIAl 

lIPIDIC NANOEMUlSION tO HIGH DENSIty lIPOPROtEIN 

V. M. Silva, C. G. C. Vinagre, M. P. Bertato, C. P. Oliveira, A. P. M. Chacra, R. C. Maranhão. 

P427 ROSUVAStAtIN AND AORtIC REMODElING IN NItRIC OXIDE DEFICIENt RAtS 

R. Neto-Ferreira, V. N. Rocha, L. S. R Reis, A. L. R Nascimento, C. A. Mandarim-De-Lacerda, J. J. Carvalho. 

P428 ROlE OF SIlDENAFIl IN EISENMENGER SyNDROME: A PIlOt StUDy 

N. Garg, U. Agrawal, N. Sinha . 

P429 EXERCISE tRAINING lEFt VENtRICUlAR REMODElING IN MAlES AND FEMAlES RAtS 

V. B. Carranza, O. A. Pinilla, E. M. Escudero. 

P430 SHORt AND lONG tERM RESUltS OF PERCUtANEOUS CORONARy INtERVENtION IN 

PAtIENtS OlDER tHAN 80 yEARS OlD 

S. Bulur, S. Ordu, E. S. Albayrak, A. Kaya, S. Bulur, H. Ozhan, M. Yazici.


P431 EPIDEMIOlOGy IN RHEUMAtIC VAlVUlAR DISEASE SURGICAl REPlACEMENt IN A 

DEVElOPING COUNtRy. 

Rogerio Brant Martins Chaves, Regina Maria De Aquino Xavier, Maria Cristina C. Kuschinir, Bernardo Rangel Tura, 

Monica Moura De Vasconcellos, Vitor Manuel Pereira Azevedo, Carlos Alberto M. Magalhães, José Oscar Reis Brito, 

Márcia Cristina C. M. Pinheiro, Clara Weksler. 

P432 SHORt AND lONG tERM FOllOW-UP RESUltS OF PAtIENtS WHO ARE IMPlANtED WItH 

R-StENt: A SINGlE CENtER EXPERIENCE 

S. Bulur, A. Kaya, S. Bulur, S. Ordu, H. Özhan, M. Yazici. 

P433 MORtAlIty AMONG PAtIENtS SUBMIttED tO VAlVUlAR SURGICAl PROCEDURES. IS tHERE 

ANy DIFFERENCE BEtWEEN RHEUMAtIC AND DEGENERAtIVE VAlVUlAR DISEASE GROUPS? 


Monica Moura De Vasconcellos, Carlos Alberto M. Magalhães, Arn Migowski Rocha Dos Santos, Clara Weskler, 

Vitor Manuel Pereira Azevedo, José Oscar Reis Brito. 

P434 SyStEMIC VASCUlAR RESIStANCE MEASUREMENt By ECHOCARDIOGRAPHy IN 

CHRONIC CONGEStIVE HEARt FAIlURE: A tOOl tO OPtIMIzE MEDICAl PRESCRIPtION 

OF ANGIOtENSIN-CONVERtING ENzyME INHIBItORS AND ANGIOtENSIN II RECEPtOR 

BlOCkERS. 

L. Florio, G. Vignolo, R. Centurión, J. Pouso. 

P435 EFFECt OF CARDIAC ARRESt INDUCED By CARDIOVERtER DEFIBRIllAtOR (ICD) tEStING ON 

ISCHEMIA MODIFIED AlBUMIN (IMA). 

L. Woie, Ø. Hetland, J. T. Kvaløy, D. W. T. Nilsen. 

P436 EPIDEMIOlOGICAl PROFIlE OF tHE SURGICAl INtERVENtIONS IN VAlVUlAR DISEASES 

IN A DEVElOPING COUNtRy. 


Mônica Moura De Vasconcellos, Vitor Manuel Pereira Azevedo, Arn Migowki Rocha Dos Santos, Clara Weskler, 

Márcia Cristina C. M. Pinheiro, José Oscar Reis Brito. 

P437 INtRACARDIAC ElECtROCARDIOGRAPHIC (EGM) MORPHOlOGy CHANGES IN PAtIENtS WItH 

IMPlANtABlE CARDIOVERtER DEFIBRIllAtOR (ICD). 

L. Woie, T. Eftestøl, J. T. Kvaløy, T. Aarsland, K. Tjelta, D. T. W. Nilsen. 

P438 tHE PREVAlENCE OF HyPERtENSION AND ItS ASSOCIAtION WItH BODy WEIGHt INDEX IN 

HUNGARIAN POlICEMEN 

G. Simonyi, J. R. Bedros, K. Szakolczai, M. Medvegy, T. Csatay, L. Halmy. 

P439 tHE EFFECtS OF VEGEtARIAN DIEtS ON CHylOMICRON MEtABOlISM 

J. C. M. Vinagre, C. G. Vinagre, F. S. Pozzi, E. Slywitch, R. C. Maranhão. 



P440 CORtICAl RENAl VOlUME MEASUREMENtS By USING MUltI-DEtECtOR ROW Ct AND ItS 

RElAtIONSHIP WItH PRIMARy HyPERtENSION 

J. Vallejos, P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa. 

P441 lEFt VENtRIClE EVAlUAtION WItH 64-ROW GADOlINIUM ENHANCED CARDIAC Ct. 

P. Carrascosa, A. Deviggiano, C. Capuñay, J. Carrascosa, M. Garcia. 

P442 MUltI-DEtECtOR COMPUtED tOMOGRAPHy FEASIBIlIty´S IN CAlCUlAtING tHE CORtICAl 

RENAl VOlUME 

J. Vallejos, P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa. 

P443 PREVAlENCE OF MyOCARDIAl BRIDGING IN 64-ROW MDCt CORONARy ANGIOGRAPHIC 

StUDIES. 

P. Carrascosa, C. Capuñay, A. Deviggiano, J. Carrascosa, M. Garcia. 

P444 RISk StRAtIFICAtION IN NON-St SEGMENt ACUtE CORONARy SyNDROMES BASED ON 

ACUtE AND CHRONIC RISk SCORES DERIVED FROM tHE EUROPEAN GUIDElINES 

M. Dorobantu, A. G. Fruntelata, M. Stefuriac, M. Chiru, L. Platica, A. Crusitu, A. Scafa-Udriste. 

P445 RElAtIONSHIP BEtWEEN DIEtARy INtAkE OF AlCOHOl AND SOME MEtABOlIC AND 

CARDIOVASCUlAR RISk FACtORS IN HEAltHy MEN 

L. Vitek, M. Kalousova, B. Stankova, L. Novotny, P. Schreib, T. Zima, A. Zak. 

P446 ElDERly PAtIENtS WItH StEMI ARE SUBOPtIMAlly tREAtED WItH REPERFUSION tHERAPy 

z. Monhart, V. Faltus, H. Grunfeldova, P. Jansky. 

P447 USE OF NOt EVIDENCE BASED tREAtMENtS AMONG ElDERly REAl WORlD PAtIENtS 

HOSPItAlIzED WItH ACUtE HEARt FAIlURE. 

A. Macchia, G. Ciambrone, N. Laffaye, J. Gambarte, S. Donato, N. Rizzo, F. Novo, C. Higa, P. Comignani. 

P448 ASSESSMENt OF CAROtID-RADIAl PUlSE WAVE VElOCIty CHANGES AFtER INDUCED 

ISCHEMIA 

E. Rusak, O. Iavicoli, S. Vazquez, S. Robert, M. Duarte, J. Lerman, C. Bellido. 

P449 BRAIN NAtRIUREtIC PEPtIDE INCREASES 24 HOURS AFtER ACUtE MyOCARDIAl INFARCtION 

IRRESPECtIVE OF REPERFUSION AND IS A MARkER OF EARly lEFt VENtRICUlAR 

REMODElING 

M. Dorobantu, R. Onut, A. Scafa-Udriste, D. Constantinescu, A. Alexandrescu, A. Vasile, E. Gainoiu, A. G. Fruntelata. 

P450 EFFECt OF REPEAtED CORONARy ANGIOPlASty ON Qt DISPERSION 

E. z. Soliman, M. Abdel-Salam .


P451 DISCREPANCy BEtWEEN tROPONINS t AND I IN CHRONIC HEMODIAlySIS PAtIENtS 

H. Trimarchi, M. Dicugno, M. Mongitore, M. Forrester, A. Toscano, F. Lombi, M. Vera, M. Alonso, H. Pereyra, 

A. Muryan. 

P452 CORRElAtION BEtWEEN CHESt PAIN AND ACUtE CORONARy SyNDROME DIAGNOSIS 

M. Assad, A. Volschan, M. Diniz, LH. Fonseca, M. Santos, C. Stipp, A. Sa, E. Mesquita. 

P453 AGE-RElAtED CHANGES IN MyOCARDIAl OXIDAtIVE StRESS AND tHE INtERVENtIONAl 

EFFECt OF DHEA 

M. H. V .M. Jacob, D. R. Janner, A. Belló-Klein, M. F. M. Ribeiro. 

P454 MORPHOlOGIC PAttERN OF lAtE GADOlINIUM ENHANCEMENt IN tAkO-tSUBO SyNDROME. 

“ANOtHER ClUE tO SOlVE tHE ENIGMA”. 

G. Avegliano, M. Huguet, P. Kuschnir, A. Panaro, F. Botto, G. Oller, D. Capdeferro, A. Frangi, R. Ronderos, M. Petit. 

P455 DElAyMENt FACtORS FOR MEDICAl ASSIStANCE SEARCH IN PAtIENtS WItH CHESt PAIN 

M. Assad, A. Volschan, M. Diniz, L. H. Fonseca, M. Santos, C. Stipp, A. K. Sá, E. Mesquita. 

P456 ACUtE EFFECt OF SIlDENAFIl CItRAtE ON PUlSE WAVE VElOCIty IN MIDDlE-AGED 

PAtIENtS 

M. Assad, A. Brandão, R. Pozzan, E. Magalhães, A. P. Brandão. 

P457 BAROREFlEX FUNCtION ASSESStMENt By A NON-INVASIVE PRESSOR tESt 

M. Duarte, D. R. Grana, C. A. Bellido, J. Milei. 

P458 EXERCISE VENtIlAtORy RESPONSE IN DIABEtIC PAtIENtS 

R. Peidro, D. Motta, A. Angelino, G. Brión, E. Navia, P. Diaz Uberti, R. Favaloro . 

P459 DEMOGRAPHIC CHARACtERIStICS OF OVER SIX HUNDRED RENAl ARtERIES INtERVENtIONS. 

N. Schechtmann, Md. Facc, E. Polanco Md, S. Karas, Md. Facc. 

P460 CARDIAC MAGNEtIC RESONANCE HAS ADVANtAGES OVER 2D ECHOCARDIOGRAPHy IN 

ASSESSMENt OF MItRAl StENOSIS PAtIENtS. 

A. Rapaee, C. K. Liew, A. Y. Y. Fong, C. K Ang, H. B Liew, W. M Chin, B. S. P Chin, T. K Ong, K. H Sim. 

P461 IMPAIRMENt OF ENDOtHElIAl FUNCtION IN NEWly DIAGNOSED HyPERtENSIVE AND 

PREHyPERtENSIVES PAtIENtS 

A. Rapaee, H. Nawawi, K. Yusoff. 

P462 DIAGNOStIC AND tREAtMENt AlGORItHM FOR SUStAINED VENtRICUlAR tACHyCARDIA IN 

CHRONIC CHAGAS DISEASE 

R. Viotti, C. Vigliano, M. G. Alvarez, B. Lococo, M. Petti, G. Bertocchi, A. Armenti, A. Sinisi. 



P463 FUROSEMIDE INDUCED CARDIAC AltERAtIONS IN tHIAMINE-DEPRIVED RAtS 

S. Cunha, J. C. Bastos, J. B. Salles, M. C. C. Silva, V. L. F. C. Bastos, C. A. Mandarim-De-Lacerda. 

P464 RISk StRAtIFICAtION IN ASyMPtOMAtIC SEVERE MItRAl REGURGItAtION: ClINICAl, 

BIOCHEMICAl AND ECHOCARDIOGRAPHIC VARIABlES. IS It POSSIBlE tO DEtERMINE 

ADVERSE ClINICAl OUtCOME? 

R. Pizarro, P. Oberti, M. Falconi, F. Achilli, A. Arias, J. Krauss, A. Cagide. 

P465 ISOlAtED CORONARy ARtERy DISEASE OF tHE DIAGONAl BRANCH OF tHE lEFt ANtERIOR 

DESCENDING ARtERy 

V. Kuznetsov, I. Bessonov, I. Zyrianov, G. Kolunin, D. Krinochkin, M. Semukhin, M. Bessonova, L. Frazin. 

P466 ASSOCIAtION BEtWEEN POlyMORPHISMS OF tHE RENIN-ANGIOtENSIN SyStEM GENES 

AND ESSENtIAl HyPERtENSION: A COMMUNIty-BASED StUDy IN SOUtHERN CHINA 

y. zhan, X. Jiang, H. Sheng, J. Li, P. Xun, Y. Cheng, J. Huang, H. Xiao. 

P467 IMPlEMENtAtION AND RESUltS OF A COMPREHENSIVE CARDIAC REHABIlItAtION 

PROGRAM IN A DEVElOPING COUNtRy. 

E Rivas Estany, J. Alvarez Gomez, J. Barrera Sarduy, S. Sixto Fernandez, L. Rodriguez Nande, C. Kesser Garcia. 

P468 EFFECt OF PARP INHIBItION ON yOUNG SPONtANEOUSly HyPERtENSIVE RAt (SHR) 

HEARtS 

E. Bartha, R. Halmosi, I. Solti, E. Bognar, K. Kovacs, T. Habon, T. Kálai, B. Sumegi, K. Hideg, K. Toth. 

P469 SIGNIFICANCE OF DEtERMINING tROPONIN I lEVElS IN tHE EVAlUAtION OF PAtIENtS WItH 

ISOlAtED FORM OF AORtIC StENOSIS BEFORE AND AFtER AORtIC VAlVE REPlACEMENt 

A. Nikolic, L. J. Jovovic, M. Vukovic, T. Babic, M. Balevic, V. Maravic, D. Brunner . 

P470 tHE EFFECt OF AORtIC VAlVE REPlACEMENt ON B tyPE BNP IN PAtIENtS WItH ISOlAtED 

FORM OF SEVERE AORtIC StENOSIS AND NOt IMPAIRED SyStOlIC FUNCtION 

A. Nikolic, L. J. Jovovic, M. Vukovic, T. Babic, M. Balevic, S. Tomic, D. Brunner. 

P471 USING OF ARtERIAl GRAFt (lIMA) IN PREDICtION OF FREQUENt OCCURRENCES OF 

PERICARDIAl EFFUSION AFtER CABG 

A. Nikolic, S. Tomic, L. J. Jovovic, M. Vukovic, L. J. Trkulja, M. Zlatanovic, B. Djukanovic . 

P472 PROlACtIN INHIBItION IMPROVES ClINICAl OUtCOME IN PERIPARtUM CARDIOMyOPAtHy 

PAtIENtS PRESENtING WItH SUBSEQUENt PREGNANCy 

O. Forster, D. Hilfiker-Kleiner, A. A. Ansari, J. B. Sundstrom, W. Tshani, A. Yip, A. Becker, K. Sliwa. 

P473 t-CEll MEDIAtED AUtOIMMUNE REACtION IN PERIPARtUM CARDIOMyOPAtHy MIGHt BE 

REFlECtED By ACtIVIty OF PRO-INFlAMMAtORy CytOkINES 

O. Forster, A. A. Ansari, J. B. Sundstrom, W. Tshani, A. Becker, K. Sliwa.


P478 tIME COURSE PAttERN OF IMMUNOGlOBUlIN M IN HIV POSItIVE AND HIV NEGAtIVE 

PERIPARtUM CARDIOMyOPAtHy PAtIENtS 

O. Forster, A. A. Ansari, J. B. Sundstrom, W. Tshani, M. J. Nel, A. Becker, K. Sliwa. 

P479 ACUtE CORONARy SyNDROMES IN BlACk SOUtH AFRICAN PAtIENtS WItH HUMAN 

IMMUNODEFICIENCy VIRUS INFECtION: tHE ClINICAl AND ANGIOGRAPHIC FEAtURES 

A. C. Becker, K. Sliwa, S. Stewart, E. Libhaber, A. R. Essop, M. R. Essop. 

P480 HEAt SHOCk PROtEINS ANtIBODy lEVEl AND ASSOCIAtED DISEASE IN PAtIENtS 

UNDERGOING CARDIAC OPERAtION. 

V. Kecskemeti, A. Szebeni, Z. Prohaszka, I. Matko, Z. Szabolcs . 

P481 CIRCADIAN RHytHM AND RISk FACtORS IN ISOlAtED NOCtURNAl HyPERtENSION 

G. Simonyi, R. J Bedros, M. Medvegy. 

P482 PREVAlENCE OF SlEEP RElAtED BREAtHING DISORDERS IN PAtIENtS WItH CHRONIC HEARt 

FAIlURE AND tHEIR IMPROVEMENt WItH CARDIAC RESyNCHRONISAtION tHERAPy 

K. Seidl, M. Strauß, T. Kleemann, T. Becker. 

P483 PREVAlENCE OF COMPlEtE ElECtRICAl PUlMONARy VEIN ISOlAtION USING 

AN ANAtOMICAlly GUIDED APPROACH ASSESSED By A NOVEl HIGH DENSIty 

CIRCUMFERENtIAl MAPPING CAtHEtER 

K. Seidl, T. Becker, T. Kleemann, M. Strauß. 

P484 INtERRACtION IN CHANGES OF AN ENDOtHElIUM StAtUS AND ClINICAl CURRENt IN 

PAtIENtS WItH CHF ON A BACkGROUND OF tHERAPy ACE INHIBItORS 

M. Sitnikova, T. Maximova, C. Kchmelnitskaya. 

P485 lOCAlly DElIVERED tEtRADECyltHIOACEtIC ACID (ttA) REDUCES INFlAMMAtION AND 

COllAGEN FORMAtION AFtER CORONARy BAllOON INJURy IN A PORCINE MODEl 

R. P. Reidar Pettersen, M. S. Mohamed Salem, S. R. Svein Rotevatn, K. K. Karel Kuiper, T. L. Terje Larsen, 

P. B Pavol Bohov, R. B Rolf Berge, J. E. N. Jan Erik Nordrehaug. 

P486 tHE AGE-BNP SURVIVAl MODEl: PREDICtION OF SURVIVAl IN OlD (>75 yEARS) PAtIENtS 

WItH HEARt FAIlURE 

E. Shlyakhto, M. Sitnikova, T. Lelyavina. 

P487 INtERACtION BEtWEEN tHE ACE POlyMORPHISM GENES (INSERtION/DElEtION) AND 

tHE PARtICUlAR ClINICAl FEAtURES OF CONGEStIVE HEARt FAIlURE, StRUCtURAl AND 

FUNCtIONAl INDEXES OF tHE HEARt AND MORtAlIty 

M. Sitnikova, S. Ivanov, O. Krasnova, E. Shlyakhto. 



P488 IMPROVEMENt IN SIX-MINUtE WAlk tESt PERFORMANCE AFtER A SINGlE DOSE OF 

SIlDENAFIl IN CHRONIC HEARt FAIlURE PAtIENtS 

J. Curotto Grasiosi, A. Paragano, M. Pelliza, D. Cordero, R. Machado, A. Abdala, G. Bertelle, R. Perez, 

C. Magallanes, R. Esper. 

P489 SERUM MAtRIX MEtAllOPROtEINASE-9/tISSUE INHIBItOR OF MAtRIX 

MEtAllOPROtEINASE-1 AND lEFt VENRIClE PERFORMANCE IN PAtIENtS WItH AORtIC 

StENOSIS 

N. Goncharova, O. Moiseeva, G. Aleshina, E. Shlykhto. 

P490 HyPERtRIGlyCERIDEMIA: AN INDEPENDENt PREDICtOR StRONGly CORRElAtED WItH 

OtHER CARDIOVASCUlAR RISk FACtORS? 

A. Paragano, J. Curotto Grasiosi, R. Machado, D. Cordero, A. Abdala, P. Merlo, J. Lopez Diez, D. Alasia, 

C. Magallanes, R. Esper. 

P491 RIGHt CORONARy ARtERy MORPHOlOGy By 64-ROW MDCt IN PAtIENtS WItH lEFt 

DOMINANt SyStEM. 

P. Carrascosa, C. Capuñay, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa. 

P492 ClINICAl PERCEPtION OF MS VS. DIAGNOSIS ACCORDING tO AtPIII CRItERION. CARISMA 

(CHARACtERIzAtION AND RISk ANAlySIS OF INDIVIDUAlS WItH MEtABOlIC SyNDROME) 

StUDy GROUP. 

G. Cerezo, A. Vicario, N. Vainstein, E. Biasin, D. Ricon, D. Piskorz, I. Nocetti, C. Brommer, M. Miragaya. 

P493 EStROGEN-DEPENDENt GENE EXPRESSION IN HUMAN CARDIAC tISSUE 

G. Kararigas, E. Becher, V. Regitz-Zagrosek. 

P494 DOBUtAMINE DyNAMIC INtRAVENtRICUlAR GRADIENt AND HyPERtROPHIC 

CARDIOMyOPAtHy: MORPHOlOGIC AND FUNCtIONAl EVAlUAtION By CARDIAC MAGNEtIC 

RESONANCE 

M. Ferreira, P. Donato, S. Monteiro, T. Pereira, R. Martins, F. Caseiro-Alves, L. A. Providência. 

P495 CARDIAC MAGNEtIC RESONANCE IN tHE StUDy OF PAtIENtS WItH A DyNAMIC 

INtRAVENtRICUlAR GRADIENt DURING DOBUtAMINE StRESS ECHOCARDIOGRAPHy 

M. Ferreira, P. Donato, S. Monteiro, R. Martins, F. Caseiro-Alves, L. A. Providência. 

P496 tUMOR NECROSIS FACtOR AlPHA, INtERlEUkIN 1 AND INtERlEUkIN 1 RECEPtOR 

ANtAGONISt POlyMORPHISMS IN MEXICAN PAtIENtS WItH MyOCARDIAl INFARCtION. 

G. Vargas-Alarcón, J. M. Fragoso, J. M. Rodríguez-Pérez, N. Pérez-Hernández, D. Cruz-Robles, E. Chuquiure, 

C. Martínez, Marco A. Martínez Ríos, P. A. Reyes. 

P497 GENDER DIFFERENCES IN PRESENtAtION AND PROGNOSIS IN POPUlAtION WItH ACUtE 

CHESt PAIN SUSPECtED tO BE RElAtED WItH ACUtE CARDIAC ISCHEMIA 

M. Ferreira, V. Rodrigues, F. Santos, L. A. Providência.


P498 SUDDEN CARDIAC DEAtH AND DEFIBRIllAtORS IN lAtIN AMERICA. PRIMARy AND. 

SECONDARy PREVENtION. DAtA FROM tHE ICD REGIStRy lAtIN AMERICA. 

R. Keegan, R. Eloy Pereyra, F. Colombo, W. Uribe, J. Cordero Cabra, C. Tentori, V. Moraes, K. Griffith, J. Maloney, 

C. Muratore . 

P499 BENEFICIAl EFFECtS OF tRIMEtAzIDINE, GIVEN BEFORE PERCUtANEOUS CORONARy 

INtERVENtION, ON MyOCARIAl DAMAGE DURING tHE PROCEDURE 

A. Yilmaz, A. Erdem, K. Yalta, S. Sarikaya, M. B. Yilmaz, O. O. Turgut, I. Tandogan. 

P500 ABDOMINAl OBESIty: AN INDICAtOR OF EXtENSIVE CORONARy ARtERIAl DISEASE IN 

NStEMI PAtIENtS? 

A. Erdem, O. C. Yontar, S. Sarikaya, A. Yilmaz, K. Yalta, M. B. Yilmaz, I. Tandogan. 

P501 EFFECtS OF CHRONIC WAtER REStRICtION ON CARDIOVASCUlAR 

M.P. Da Rosa, P. Arza, A. Fellet, M. Toscani, C. Arranz, M. A Costa, A. M Balaszczuk. 

P502 tHE INtERlEUkIN 1B –511 POlyMORPHISM IS ASSOCIAtED WItH tHE RISk OF DEVElOPING 

REStENOSIS AFtER CORONARy StENtING IN MEXICAN PAtIENtS. 

G. Vargas-Alarcon, E. Malpica-Miranda, J. M. Fragoso, H. Delgadillo-Rodríguez, J. M. Rodríguez-Pérez, C. González- 

Quesada, N. Martínez-Rodríguez, M. A. Peña-Duque, Marco A. Martínez Ríos. 

P503 ENDOtHElIAl FUNCtION AND HORMONE REPlACEMENt WItH tIBOlONE IN MENOPAUSAl 

WOMEN 

J. Gomez-Mancebo, M. Navarrete, L. A. Sanchez, A. Pinzon. 

P504 CORONARy ARtERy ByPASS SURGERy IN DIABEtES 

E. Gabe, M. Santos, E. Dulbecco, J. Abud, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen, 

R. R. Favaloro. 

P505 RElAtIONSHIP BEtWEEN INFlAMMAtORy BIOMARkERS, OXIDAtIVE StRESS AND 

MORPHO-FUNCtIONAl MItOCHONDRIAl CHANGES IN EXPERIMENtAl AtHEROGENIC MODEl 

M. C. Baez, M. Tarán, V. Campana, P. Pons, J. C. Simes, D. F. Comay, J. A. Palma, M. Moya. 

P506 HyPERtROPHIC CARDIOMyOPAtHy AND PREGNANCy RElAtED COMPlICAtIONS. 

F. Landeta, A. Fernandez, J. H. Casabe, F. Vaisbuj, C. Lopez, R. Coronel, R. Bianco, E. Guevara. 

P507 EFFECtS OF A COX-2 ANtAGANONISt ON VASCUlAR INFlAMMAtION ASSOCIAtED 

tO A MODEl OF MEtABOlIC SyNDROME 

N. F. Renna, E. S. Gonzalez, M. C. Lama, R. M. Miatello. 

P508 CHARACtERIStICS OF HyPERtROPHIC CARDIOMyOPAtHy IN tHE ElDERly 

J. H. Casabe, A. Fernandez, F. Landeta, G. Fava, F. Vaisbuj, R. Peidro, R. Laguens, R. R. Favaloro, C. Lopez, 

E. Guevara. 



P509 EARly AND lAtE OUtCOME IN PAtIENtS WItH END StAGE RENAl FAIlURE UNDER CHRONIC 

DIAlySIS UNDERGOING CARDIAC VAlVE SURGERy: MECHANICAl VERSUS BIOlOGICAl 

PROStHEtIC VAlVE 

A. Hershson, M. Cabello, R. Coronel, G. Stampone, P. Roura, P. Raffaelle, J. Abud, E. Dulbecco, H. Raffaelli, 

R. Favaloro. 

P510 IS tHERE ANy DIFFERENCE At PRESENtAtION IN INFANtIlE DIlAtED CARDIOMyOPAtHy 

REGARDING tHE AGE? 

Vitor Manuel Pereira Azevedo, Marco Auré,lio Santos, Má,rcia Bueno Castier, Maria Cristina C. Kuschnir, José, 

Geraldo De Castro Amino, Maria Ourinda Mesquita Cunha, Rogé,rio Brant Martins Chaves, Bernardo Rangel Tura, 

Francisco M. Albanesi Filho, Regina Maria De Aquino Xavier. 

P511 INAPPROPRIAtE ICD SHOCkS: INCIDENCE, PREDICtORS AND PREVENtION OF RECURRENCE. 

COMPAS REGIStRy. 

N. Galizio, S. Schanz, L. Medesani, P. Montoya, M. Ramirez, L. Soriano, G. Fava, R. Raña, H. Fraguas, J.L. Gonzalez. 

P512 USE OF A SElECtIVE BEtA-BlOCkER IN PEDIAtRIC PAtIENtS WItH lONG Qt SyNDROME 

J. Moltedo, N. J Kertesz, M. S Abello, R. A Friedman, A. L Fenrich, B. C Cannon. 

P513 RADIOFREQUENCy ABlAtION IN PAtIENtS WItH CONGENItAl HEARt DISEASE 

J. Moltedo, M. Abello, A. Ithuralde, C. Seara, H. Grancelli, M. Campos, N. Fernandez, S. Waldman, M. Ithuralde. 

P514 PREDICtOR FACtORS FOR DEAtH IN CORONARy ARtERy ByPASS SURGERy PAtIENtS. 

WHICH COUlD BE MODIFIED BEFORE SURGERy? 

Renato Kaufman, Vitor Manuel Pereira Azevedo, Maria Cristina C. Kuschnir, José Geraldo De Castro Amino, Marco 

Aurelio Santos, Rogério Brant Martins Chaves, Carlos Alberto Moreira Magalhã, Arn Migowski Rocha Dos Santos, 

Bernardo Rangel Tura, Regina Maria De Aquino Xavier. 

P515 tHE RElAtIONSHIP BEtWEEN SERUM lIPIDS AND QUARtIlES OF tHE OMEGA-3 INDEX 

IN A BEEF EAtING POPUlAtION IN ARGENtINA AS COMPARED tO A FISH EAtING ACS 

POPUlAtION IN NORWAy. 

R. Leòn De La Fuente, H. Aarsetoey, P. Gallo, V. Pönitz, T. Aarsland, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, 

D. W. T. Nilsen. 

P517 EARly ARRHytHMIC EVENtS AND QUAlIty OF lIFE AFtER RADIOFREQUENCy CAtHEtER 

ABlAtION OF AtRIAl FIBRIllAtION 

T. Balabanski, V. Traykov, T. Shalganov, B. Dinov, M. Protich. 

P518 PREVAlENCE OF PROlONGED Qt INtERVAl IN lEFt VENtRICUlAR HyPERtROPHy. 

M. Orellana, P. Adriazola, F. Bello, P. Trejo, P. Gonzalez, E. Escobar. 

P519 StEPWISE AlGORItHM. DIAGNOStIC ACCURACy OF tHE SUPRAVENtRICUlAR tACHyCARDIA 

MECHANISM. 

P. Montoya, J. L. Gonzalez, N. Galizio, G. Fava, S. Schanz, L. Medesani, L. Soriano, R. Raña, M. Ramirez.


P520 tHE EFECt OF SIMVAStAtIN ON tHE DECREASE OF INtIMOMEDIAl COMPlEX OF CAROtIDAl 

ARtERIES IN PAtIENtS WItH ARtERIAl HyPERtENSION 

D. L. Lovic Dragan, B. L. Lovic Branko, M. L. Lovic Milan, D. D. J. Djordjevic Dragan, I.T. Tasic Ivan. 

P522 ASPIRIN RESIStANCE AND CARDIOVASCUlAR EVENtS AFtER PERCUtANEUS CORONARy 

INtERVENtION. 

I. Santos-Rodriguez, I. Gonzalez-Mendia, C. Alonso-Buron, V. Ramirez-Castro, M. J. Ruiz-Olgado, M. L. Lopez, 

M. Cascon-Bueno, J. Rodriguez-Collado, M. Diego-Dominguez, I. Alberca. 

P523 CARDIAC INVOlVEMENt IN SyStEMIC SClEROSIS 

M. E. Isasi Capelo, E. S. Isasi Capelo. 

P524 MAGNEtIC RESONANCE EVAlUAtION OF PUlMONARy REGURGItAtION 

R. Parra, F. Heusser, G. Urcelay, P. Becker, E. Villanueva, J. Otero, C. Toledo, C. Garcia. 

P526 EARly IDENtIFICAtION OF PRESERVED SyStOlIC FUNCtION IN ACUtE DECOMPENSAtED 

HEARt FAIlURE. 

E. Fairman, V. Mauro, A. Charask, Y. Castillo Costa, L. Rodriguez, M. Ferrer, C. Barrero. 

P527 IMPlANtABlE CARDIOVERtER DEFIBRIllAtOR IN HIGH RISk PAtIENtS WItH HyPERtROPHIC 

CARDIOMyOPAtHy. FOllOW-UP. 

G. Fava, N. Galizio, J. L Gonzalez, H. Casabe, A. Fernandez, E. Guevara, L. Medesani, P. Montoya, S. Schanz, 

F. Landeta. 

P528 tHE RElAtIONSHIP BEtWEEN BNP AND HSCRP AND QUARtIlES OF tHE OMEGA-3 INDEX 

IN A BEEF EAtING ACS POPUlAtION IN ARGENtINA AS COMPARED tO A COAStAl ACS 

POPUlAtION IN NORWAy. 

R. Leòn De La Fuente, H. Aarsetoey, T. Brügger-Andersen, V. Pönitz, S. A. Dib Ashur, S. T. Nilsen, L. Woie, 

H. Staines, W. S. Harris, D. W. T. Nilsen. 

P529 ASSESSMENt OF ANEMIA AND RENAl FUNCtION IN PAtIENtS WItH HEARt FAIlURE: 

A COMPARISON OF PAtIENtS WItH lEFt VENtRICUlAR SyStOlIC DySFUNCtION VERSUS 

PRESERVED SyStOlIC FUNCtION 

B. Sáenz, E. Barcellos, H. Villacorta, L. Costa Lima, . Soares, C. Wiefels, R. Steffen, A. Salles, E. Tinoco. 

P530 PROGNOStIC UtIlIty OF StRESS (99M)tC-SEStAMIBI SPECt IN RISk StRAtIFICAtION OF 

NON-St-SEGMENt ElEVAtION ACUtE CORONARy SyNDROMES 

A. Dos Santos, C. Cortes, M. Daicz, J. Peirano, O. Cendoya, G. Marrero, I. Merlo, E. Duronto, E. Gurfinkel. 

P531 GRAVItAtIONAl StRESS IN RAyNAUD’S PHENOMENON. 

M.E. Isasi Capelo, E.S. Isasi Capelo. 



P532 HEARt RAtE RECOVERy AFtER A CARDIOVASCUlAR REHABIlItAtION PROGRAM 

R. Peidro, P. Diaz uberti, G. Brión, A. Angelino, E. Navia, D. Motta, F. Peidro, M. Santa María, R. Lowenstein, 

R. Favaloro. 

P533 NON-PHARMACOlOGICAl PREVENtION OF AtRIAl FIBRIlAttION AFtER OFF-PUMP CABG: 

tEMPORARy AtRIAl EXtERNAl StIMUlAtION 

F. Silva, P. Brofman, R. Milani, D. Précoma, M. Guimarães, L. Barbosa, A. Sartori, J. Augusto Souza. 

P534 PREDICtING ElEVAtED C-REACtIVE PROtEIN lEVElS By BODy MASS INDEX AND WAISt 

CIRCUMFERENCE IN tyPE 2 DIABEtES PAtIENtS 

A. C. Cordeiro, I. Castro, C. C. Gonzaga, M. G. Sousa, F. O. Borelli, O. Passarelli Jr., L. Lotaif, L. S. Piegas, C. Amodeo. 

P535 NOCtURNAl BlOOD PRESSURE PAttERN IN OBESE PAtIENt WItH AND WItHOUt SlEEP 

APNEA 

G. Simonyi, J. R. Bedros, M. Medvegy. 

P536 GlUtAtHIONE PEROXIDASE, SUPEROXIDE DISMUtASE, tNF-AlPHA, CRP AND VCAM-1 ARE 

MARkERS OF MEtABOlIC SyNDROME 

T. Francuz, J. Gminski, K. Siemianowicz, M. Goss, J. Kopec. 

P537 lDl-C, HDl-C AND GlUCOSE OPtIMIzAtION USING PHytONUtRIENt COMBINAtION 

tHERAPy IN DIABEtES 

I. Martinez, B. Horne, P. Verdegem. 

P538 INFlUENCE OF MyOCARDIAl ISCHEMIA AND tHE NUMBER OF OBStRUCtED CORONARIES At 

MAJOR CORONARy EVENtS IN PAtIENtS SUBMIttED tO MEDICAl tREAtMENt ONly. 

T. Carvalho, M. Benetti, A. L. C. Hallal, A. J. Mansur. 

P539 ACUtE CORONARy SINDROMES WItHOUt SIGNIFICANt CORONARy lESSIONS: ClINICAl 

PROFIlE AND lONG tERM OUtCOME. 

C. Cabrera, D. Barranco, A. Spinelli, G. Vignolo, J. C. Hiriart. 

P540 SURGERy FOR COARCtAtION OF tHE AORtA IN PREMAtURES WEIGHtING lESS tHAN 1.900 kG. 

R. De Rossi, E. Juaneda, G. Campos. 

P541 DEtECtING SUBClINICAl AltERAtIONS IN EARly StAGES OF CHAGAS’S DISEASE 

tHROUGH HOltER 

D. S. Andres, I. M. Irurzun, M. M. Defeo, E. E. Mola, J. Mitelman, L. Gimenez, G. Ranchilio, P. Velazco, J. Armentano. 

P542 A NEW APPROACH FOR PERCUtANEOUS INtERVENtION OF OStIAl RIGHt CORONARy 

ARtERy lESIONS. FEASIBIlIty OF tHE FlOAtING WIRE tECHNIQUE 

G. Carvalho, V. Daher Vaz, J. M. Dias De Azeredo Bastos, S. Pontes Câmara, S. Rassi, A. Carvalho Leme Neto.


P543 ENHANCED BASAl AND EXERtIONAl ISOMEtRIC DIAStOlIC FUNCtION IN RESIStANCE 

tRAINING AtHlEtES 

E. Fisman, Y. Adler, N. Koren-Morag, D. Tanne, E Lasry, A. Tenenbaum. 

P544 tHE AtRIAl VUlNERABIlIty PARAMEtERS OF lONE AtRIAl FIBRIllAtION PAtIENtS WItH 

SUBClINICAl HyPOtHyROIDISM 

N. Komiya, S. Seto, S. Fukae. 

P545 INSUlIN RESIStANCE AND ClUStERING OF CARDIOMEtABOlIC RISk FACtORS IN BRAzIlIAN 

ADOlESCENtS: EFFECt OF BODy WEIGHt 

I. C. Guimaraes, A. M. Almeida, R. Rocha, A. G. Bittencourt, A. Guimaraes. 

P546 COMPlEX AORtIC COARtAtION ANGIOPlASty WItH PtFE-COVERED BAllOON EXPANDABlE 

StENt 

M. Granja, L. Trentacoste, J. Damsky Barbosa, V. Lucini, M. Rivarola. 

P547 A MEtA-ANAlySIS OF tRIAlS OF OMEGA-3 FAtty ACIDS SUPPlEMENtAtION IN 

CARDIOVASCUlAR DISEASES. 

A. Macchia, R. Marchioli, R. Marfisi, H. Doval, S. Varini, D. Nul, H. Grancelli, P. D. Comignani, J. J. Fuselli, G. Tognoni. 

P548 ANtIBODIES AGAINSt tRyPANOSOMA CRUzI RIBOSOMAl P PROtEINS INDUCE APOPtOSIS 

ON Hl-1 CARDIAC CEllS. 

G. Levy, M. J. Levin, K. Gomez. 

P549 CARDIAC REHABIlItAtION PROGRAM IN PEDIAtRIC PAtIENtS 

P. Quiroga, Hermes Ilarraza-Lomel, M. D. Rius Suárez, I. Miranda, C. Zamora, A. Buendía. 

P552 DEFINItIVE HIS BUNDlE PACING IN PAtIENtS WItH WIDE QRS 

R. Barba, P. Moriña, J. Venegas, J. M. Fernández, M. Herrera. 

P553 SERUM tRIGlyCERIDES MAy REFlECt tHE CONtENt OF CEllUlAR OMEGA-3 FAtty ACIDS 

IN CHD POPUlAtIONS WItH A lOW INtAkE OF FISH. 

R. Leòn De La Fuente, P. Gallo, S. A. Dib Ashur, E. Lovaglio, A. Torino, S. T. Nilsen, L. Woie, H. Staines, W. S. Harris, 

D. W. T. Nilsen. 

P554 RHEUMAtIC HEARt DISEASE DAtABASE AS A FRAMEWORk tO CONSOlIDAtE RHEUMAtIC 

FEVER SURVEIllANCE SyStEM IN BRAzIl. 

R. M. A. X. Regina Maria Aquino Xavier, M. C. C .K. Maria Cristina Caetno Kuschnir, V. M. P. A. Vitor Manuel Pereira 

Azevedo, R. E. M Regina Elizabeth Muller, M. C. P. Márcia Cristina Pnheiro, B. R. T. Bernardo Rangel Tura, 

D. V. Denizar Vianna, M. A. S. Marco Aurélio Santos, E. L. Eliane Lucas, M. F. P. L. Maria De Fátima Pereira Leite. 



P555 tHE StRONG RElAtIONSHIP BEtWEEN AGE OF PAtIENtS BUt NOt POlyMORPHISMS OF 

GENES ENCODING G-PROtEINS SyStEM COMPONENtS AND DOMINANt VASODEPRESSOR 

RESPONSE tO tIltING IN SyNCOPAl yOUNG AND MIDDlE-AGED PAtIENtS 

M. Lelonek, T. Pietrucha, M. Matyjaszczyk, J. H. Goch. 

P556 PRIMARy HyPERtENSION IN ADOlESCENtS – RIO DE JANEIRO, BRAzIl 

M. C. K. Maria Cristina Kuschnir, G. M. Gulnar Mendonça, R. M. A. X. Regina Maria Aquino Xavier, 

R. E. M. Regina Elisabeth Muller, H. D. Henrique D‘abreu, A. M. Arn. Migowski, R. B. C. Rogério Brant Chaves, 

M. C. P. Márcia Cristina Pinheiro, C. A. M. Carlos Alberto Magalhães, V. M.P. A. Vitor Manuel Pereira Azevedo. 

P557 COMPARAtIVE VAlUE OF Nt-BNP AND tEI INDEX IN tHE EStIMAtING OF tHE SEVERIty OF 

CONGEStIVE HEARt FAIlURE 

J. Celutkiene, V. Grabauskiene, R. Steponeniene, J. Misiura, A. Laucevicius. 

P558 NON INVASIVE DIAGNOStIC MEtHODS IN CONtROllING tHE EFFECtIVENESS OF 

CARDIOPROtECtIVE PROPERtIES OF CREAtINEPHOSPHAtE AND AGENtS ON tHE BASE OF 

NAtIVE DNA IN yOUNG AtHlEtES 

L. A. Balykova, L. M. Makarov, I. A. Markelova, I. A. Gorbunova, V. P. Balashov, S. A. Ivyanskij. 

P559 PREDICtORS OF ABNORMAl HEARt RAtE RESPONSE tO DIPyRIDAMOlE IN PAtIENtS 

UNDERGOING MyOCARDIAl PERFUSION SPECt 

R. S. L Lima, A. De Lorenzo, M. P. Pellini, L. M. B. Fonseca. 

P560 RISk MODEl FOR CARDIAC SURGERy IN ARGENtINA: A BEDSIDE GRAPHIC SCORE. 

V. Carosella, W. Rodriguez, M. Caceres, M. Sellanes, J. Bilbao, C. Cardenas, C. Pensa, H. Grancelli, C. Nojek. 

P561 GENDER DIFFERENCES IN tHE APPROACH OF CORONARy ARtERy HEARt DISEASE 

J. Erriest, M. Cornelli, G. Vigo, V. Arregui, M. L. Plastino, L. Cartasegna, J. Camilletti. 

P562 INFlUENCE OF CHRONIC RENAl FAIlURE ON tHE HEARt RAtE RESPONSE tO DIPyRIDAMOlE 

OF PAtIENtS UNDERGOING MyOCARDIAl PERFUSION SPECt 

A. De Lorenzo, R. S. L. Lima, M. P. Pellini, L. M. B. Fonseca. 

P563 DEFIBRIllAtION tHRESHOlD IN PAtIENtS OF lABOR REGIStRy 

L. Jurado, C. Martinengo, A. Martín, F. Colosia, R. Samaniego, C. Garillo, E. Valero. 

P564 ICD EXPERIENCE IN A lAtIN AMERICAN PEDIAtRIC POPUlAtION 

J. Scaglione, G. Fernandez, G. Maid, M. Senesi, R. Pesce, F. Dorticós, E. Valero, Icd-Labor Investigators. 

P565 RISk StRAtIFICAtION IN PAtIENtS POSt-CABG USING StRESS MyOCARDIAl 

PERFUSION SPECt 

J. Erriest, A. Mele, V. Severicha, P. Kociubinski, J. Camilletti.


P566 A NON-lINEAR HRV INDEX USED AS AN INDIRECt MEASURE OF lEFt VENtRICUlAR 

FUNCtION 

D. S. Andres, I. M. Irurzun, M. M. Defeo, E. E. Mola, J. Mitelman, L. Gimenez, C. De Luca, M. Marcia, P. Velazco. 

P567 ROlE OF BRAIN NAtRIUREtIC PEPtIDE AS A PREDICtOR OF RIGHt VENtRICUlAR 

DySFUNCtION IN PAtIENtS WItH PUlMONARy EMBOlISM 

B. Fabricio, K. Jose, S. Serafim, A. Flavio, P. P. Sampaio, N. Augusto, B. Alexandre, M. Joao. 

P568 INCREASE IN tHE EMBEDDING DIMENSION IN ElECtROCARDIOGRAMS OF ADUlt AND 

PEDIAtRIC PAtIENtS WItH VENtRICUlAR ARRHytHMIA AND CONGEStIVE HEARt FAIlURE 

D. S. Andres, I. M. Irurzun, M. M. Defeo, J. Bleiz, E. E. Mola, D. Perez Casal, J. Paul. 

P569 ARtERIAl StIFFNESS SURROGAtES IN BlACk-AFRICAN HUMAN IMMUNODEFICIENCy VIRUS- 

INFECtED PAtIENtS 

D. Lemogoum, C. Kouanfack, L. Van Bortel, M. Leeman, J. P. Degaute, P. H. Van De Borne. 

P570 RElAtIONSHIP BEtWEEN PlASMAtIC ACtIVIty OF tyPE 1 PlASMINOGEN ACtIVAtOR 

INHIBItOR AND tHE PRESENCE OF RISk FACtORS IN PAtIENtS WItH tyPE II DIABEtES. 

N. Crespi, A. Scicolone, V. Sanchez, G. Scicolone. 

P571 PREVAlENCE OF HyPERtENSION AND OtHER CARDIOVASCUlAR RISk FACtORS IN 

POStMENOPAUSAl WOMEN. DAtA FROM SEPHAR StUDy. 

M. Dorobantu, E. Badila, S. Ghiorghe, R. O. Darabont, G. Datcu, M. R. Luca. 

P572 INFlUENCE OF AN ADECUAtE zINC INtAkE DURING FEtAl AND POSNAtAl AND ADUlt lIFE 

ON ARtERIAl BlOOD PRESSURE AND CARDIOVASCUlAR NItRIC OXIDE SyStEM 

C. Arranz, A. Tomat, S. Finella, R. Elesgaray, L. Veiras, A. Balaszczuk, M. A. Costa. 

P573 CHRONIC CARBON MONOXIDE EXPOSURE IS ASSOCIAtED WItH INCREASED 

ElECtROCARDIOGRAPHIC P-WAVE AND Qt DISPERSION 

I. Sari, S. Zengin, O. Ozer, C. Yildirim, V. Davutoglu, M. Aksoy. 

P574 ASSOCIAtION OF CHANGES IN OXIDAtIVE AND PROINFlAMMAtORy StAtES WItH CHANGES 

IN VASCUlAR FUNCtION AFtER A lIFEStylE MODIFICAtION tRIAl AMONG OBESE 

ADOlESCENtS 

R. Kelishadi, M. Hashemi, N. Mohammadifard, S. Asgary, N. Khavarian. 

P575 CHARACtERIStICS OF HyPERtROPHIC CARDIOMyOPAtHy IN tHE ElDERly 

J. H. Casabe, A. Fernandez, F. Landeta, G. Fava, F. Vaisbuj, R. Peidro, R. Laguens, R. R. Favaloro, C. Lopez, 

E. Guevara. 

P576 ASSESSMENt OF RIGHt VENtRICUlAR FUNCtION IN INFERIOR MyOCARDIAl INFARCtION By 

tEI INDEX. 

M. Barranco, R. Migliore, M. E. Adaniya, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi. 



P577 A NEW tRANSGENIC lINE FOR IN VIVO ASSESSMENt OF BONE-MARROW CEll HOMING tO 

DAMAGED CARDIAC tISSUE 

G. Barila, D. L. Altschuler, J. A. Genovese. 

P579 IN-StENt REStENOSIS IN CORONARy ARtERIES EVAlUAtED WItH MUltISlICE COMPUtED 

tOMOGRAPHy OF 64 CHANNElS 

A. Bayol, J. Vallejos, R. Peloso, R. Obregon, M. Aguero, J. Baccaro, J. Mazucco, M. Romero, M. Vera, J. Parras. 

P580 IMPACt OF A SUPERVISED EXERCISE REHABIlItAtION PROGRAM ON SECONDARy 

PREVENtION GOAlS AFtER ACUtE CORONARy SyNDROMES. 

I. B. Ignacio Batista, H. F. Horacio Fernandez, M. B. Mariano Berro, F. L. Federico Lipszyc, J. B. Jose Bonorino, 

L. P. Luciano Pastori, S. B. Sergio Baratta, M. O. Martin O’Flaherty, G. I. Gilbert Iacometti, A. H. Alejandro Hita. 

P581 VAlUE OF ElECtROPHySIOlOGICAl tEStING AND CAtHEtER ABlAtION IN CHIlDREN AND 

ADOlESCENtS 

A. Stefani, O. Perez Mayo, G. Costa, R. Speranza, D. Deluso, C. Zuloaga. 

P582 CARDIOVASCUlAR RISk FACtORS IN RURAl MEXICO: RESUltS FROM tHE PROyECtO 

PUENtES DE SAlUD 

K. A. Olson, L. A . Temming, C. R. Clover, T. D. Snyder, A. D. Nanney, I. JvNelligan, A. L. Rollins, B. D. Skinner, 

P. Y. Frasier, M. G. Cohen. 

P583 INFlUENCE OF EMIGRAtION OF RURAl MEXICANS tO tHE UNItED StAtES AND 

CARDIOVASCUlAR RISk FACtORS IN ClOSE RElAtIVES WHO REMAIN IN MEXICO 

C. R. Clover, L. A. Temming, K. A. Olson, S. M. Skinner, P. Y Frasier, D. Reuland, B. D. Skinner, A. Krishnarao, 

M. G Cohen. 

P590 CORRElAtION BEtWEEN SERUM HIGH SENSItIVIty CRP lEVEl AND INHOSPItAl CARDIAC 

EVENtS IN tHE PAtIENtS WItH UNStABlE ANGINA 

H. Kazerani, A. Rai, V. Dehlaghi. 

P593 ANAlySIS OF RAtE-PRESSURE PRODUCt IN SOUtH BRAzIlIAN POPUlAtION 

K.C. Belli, T. Dipp, T.F. Panigas, C.F. Panigas, D.C. Bündchen, C.M. Richter, J.Z. Klafke, R. Killing, P.R.N. Viecili. 

P596 ANAlySIS OF MAXIMAl OXyGEN CONSUMPtION-VO2 MAX OF A BRAzIlIAN SPECIFIC 

POPUlAtION 

K. C. Belli, T. F. Panigas, T. Dipp, D. C. Bündchen, C. F. Paniga, C. M. Richter, J. Z. Klafke, M. A. Silva, J. L. C. Pippi, 

P. R. N. Viecili. 

P597 tHE ROlE OF ClINICAl lABORAtORy IN HIGH-RISk FOR DEAtH GROUPS SElECtION USING 

ClASSIFICAtION tREE ANAlySIS FOR INFANtIlE DIlAtED CARDIOMyOPAtHy. 

Vitor Manuel Pereira Azevedo, Marco Aurélio Santos, Márcia Bueno Castier, Maria Cristina C. Kuschnir, 

José Geraldo Castro Amino, Maria Ourinda M. Cunha, Rogério Brant Martins Chaves, Bernardo Rangel Tura, 

Francisco M. Albanesi Filho, Regina Maria De Aquino Xavier.


P598 JOB StRESS AND ARtERIAl HyPERtENSION IN PREGNANCy 

J. Marques Neto, S. A. G. Marques, M. S. Queroz, I. Fonseca, S. Moura, N. Oliveira, T. M. Araujo. 

P599 DIlAtED CARDIOMyOPAtHIES: tREAtMENt WItH StEM-CEllS : EXPERIENCE DURING 

30 MONtHS. 

O. T. Greco, J. L. B. Jacob, R. V. Ardito, M. R. Lago, A. Parro Junior, R. T. Takeda, F. V. Salis, L. P. Ruiz, M. A. Ruiz, 

A. C. Abreu. 

P600 INtRAHOSPItAl AND lONG tERM ClINIC OUtCOMES OF CORONARy ANGIOPlASty WItH 

DRUG ElUtING StENt, IN DIABEtIC PAtIENtS, COMPARED WItH tHE NO DIABEtIC ONES. 

F. F.O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A .C. Alberto Cristino, 

C. A. I. Carlos Alvarez Iorio. 

P601 ACAPCONFIRM: A NEW AlGORItHM BASED ON EVOkED-RESPONSE DEtECtION FOR AtRIAl 

CAPtURE CONtROl. A SHORt-tIME FOllOW-UP StUDy 

J. Olagüe, J. G. Martínez, J. J. García-Cuerrero, J. Fernández De La Concha, C. Llorente, F. Crespo, A. Ibañez, 

M. J. Sancho-Tello, O. Sanz. 

P602 NEW ECG PAttERN IN yOUNG PAtIENt WItH CAtECHOlAMINERGIC POlyMORPHIC 

VENtRICUlAR tACHyCARDIA 

L. Makarov, T. Kyryleva, S. Chuprova, V. Komoliatova. 

P603 INtRAHOSPItAl AND lAtE OUtCOMES A UNIQUE CENtRE OF tREAtMENt WItH 

DIFFERENt kINDS OF DRUG ElUtING StENtS, IN PAtIENtS WItH “OFF lABEl” CORONARy 

ANGIOPlASty INDICAtION. 

F. F. O. Fernando Fabian Ordonez, C. A. I. Carlos Alejandro Alvarez, A. C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio. 

P604 INtRAHOSPItAl AND lONG tERM ClINIC OUtCOMES OF tREAtMENt WItH DRUG ElUtING 

StENt, IN SMAll VESSEl WItH “OFF lABEl” CORONARy ANGIOPlASty INDICAtION. 

F. F. O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A. C. Alberto Cristino, C. A. I. Carlos Alvarez Iorio. 

P607 HEMODyNAMIC BEHAVIOR IN DIFFERENt PERIODS OF DAy IN A PHySICAl EXERCISE 

PROGRAM SUBJECtS 

T. Dipp, D. C. Bündchen, T. F. Panigas, K. C. Belli, C. F. Panigas, C. M. Richter, A. M. R. Pereira, J. Z. Klafke, R. Killing, 

P.R.N. Viecili. 

P608 COMMON MENtAl DISORDERS AND HyPERtENSION IN ADOlESCENtS – 

RIO DE JANEIRO, BRAzIl 

M. C. K. Maria Cristina Kuschnir, G. M. Gulnar Mendonça. 

P609 PROGNOStIC SIGNIFICANCE OF MICROAlBUMINURIA IN NON-DIABEtIC PAtIENtS WItH 

St-SEGMENt ElEVAtION MyOCARDIAl INFARCtION. 

A. Dominguez-Rodriguez, S. Samimi-Fard, M. J. Garcia-Gonzalez, G. Yanes-Bowden, A. Sanchez Grande-Flecha, 

I. Hernandez-Baldomero, P. Abreu-Gonzalez, F. Marrero-Rodriguez, J. C. Kaski. 



P610 CORRElAtION BEtWEEN OXIDAtIVE StRESS, ENDOtHElIAl INJURy AND COAGUlAtION 

ACtIVAtION IN ADVANCED CHRONIC HEARt FAIlURE 

O. Korzh, S. Krasnokutskiy. 

P611 tHE EFFECt OF AMBIENt tEMPERAtURE VARIABIlIty 0N BlOOD PRESSURE: tWO yEARS OF 

OBSERVAtION 

T. F. Panigas, T. Dipp, C. M. Richter, D. C. Bündchen, J. L. C. Pippi, C. F. Panigas, Z. Klafke, K. C. Belli, P. R. N. Viecili. 

P612 ANAlySIS OF CARDIORESPIRAtORy FItNESS IN A BRAzIlIAN SPECIFIC POPUlAtION 

K. C. Belli, T. Dipp, T. F. Panigas, C. F. Panigas, C. M. Richter, D. C. Bündchen, J. Z. Klafke, P. R. N. Viecili. 

P614 lEFt AtRIAl DOPPlER tISSUE IMAGING: CHANGES IN PAtIENtS WItH CORONARy ARtERy 

DISEASE. 

C. Killinger, G. Cabrejos, M. Del Campo, M. Sun, D. Lozano, S. Ferradas, R. Rosental, G. Mohamed, S. Zymerman, 

E. Beck. 

P615 REDUCtION OF EXAGGERAtED EXERCISE BlOOD PRESSURE lEVElS IN NORMOtENSIVE 

INDIVIDUAlS AFtER PHySICAl EXERCISE PROGRAM. 

C. M. Richter, C. F. Panigas, D.C. Bündchen, K. C. Belli, T. Dipp, T. F. Panigas, J. L. C. Pippi, J. Z. Klafke, 

R. M. F. Sampedro, P. R. N. Viecili. 

P616 AlzHEIMER’S tyPE DEMENtIA VERSUS VASCUlAR DEMENtIA IN HyPERtENSIVE PAtIENtS 

A. Vicario, C. D. Martinez, G. H. Cerezo. 

P617 SEVERE AORtIC StENOSIS AND NONCARDIAC SURGERy IN tHE ElDERly POPUlAtION. 

D. De Mollein, C. Dominguez, G. Lopez Soutric, S. Robert, S. Berensztein, M. Vazquez Blanco, J. Lerman. 

P618 RElAtION BEtWEEN DIABEtES, HEARt RAtE VARIABIlIty AND lEFt VENtRICUlAR 

FUNCtION IN PAtIENtS AFtER MyOCARDIAl INFARCtION 

V. Stoickov, S. Ilic, M. Deljanin Ilic. 

P619 StUDy OF tHE QUAlIty OF lIFE (QOl) OF CORONARy PAtIENtS, tREAtIES WItH AND 

WItHOUt CARDIAC REHABIlItAtION (CR). 

A. Gómez Monroy, A. Amarilla, R. Gonzalez, D. Marelli, C. Herrera, S. Macin, N. Mijailovsky. 

P620 CONtRIBUtION OF tHE AVl lEAD IN tHE ElECtROCARDIOGRAPHIC DIStINCtION BEtWEEN 

AV NODAl REENtRANt tACHyCARDIA AND AV REENtRANt tACHyCARDIA. 

C. Hadid, D. Di Toro, C. Lopez, L. Vidal, C. Labadet. 

P621 CEREBROVASCUlAR ACCIDENt PREVAlENCE AND PREDICtORS IN MyOCARDIAl 

REVASCUlARIzAtION SURGERy 

R. Marelli, I. Rifourcat, E. Serrano, R. Lolo, J. Como Birche, C. Salomón, L. Ponce, M. David, A. Gomez Monroy, L. Mancini.


P623 DIFFERENCES IN CARDIOVASCUlAR MORtAlIty AMONG MEN AND WOMEN IN tHE CIty OF 

RIO DE JANEIRO, BRAzIl, DURING tHE 1998 AND 2002 FIFA SOCCER WORlD CUP 

F. Braga, A. Bahia, J. Kezen, S. Gomes Jr., L. Armini, P. P. Sampaio, G. Oliveira, A. C. Neno, J. Mansur. 

P624 FREQUENCy OF COMMON VARIANtS OF ABCB1, CyP3A4 AND CyP3A5 GENES IN CHIlEAN 

SUBJECtS WItH PRIMARy HyPERCHOlEStEROMIA 

A. Rosales, A. Pacheco, N. Saavedra, F. Lanas, L. A. Salazar. 

P625 ENDOtHElIAl FUNCtION: RElAtIONSHIP BEtWEEN CORONARy GRAFtS AND BRACHIAl 

ARtERy IN PAtIENtS OF CORONARy ARtERy ByPASS SURGERy. 

V. Proto, C. Joo Turoni, R. Marañon, J. Salinas, J. Muntaner, M. Peral De Bruno. 

P626 FAMIly MyXOMAtOSIS. PRESENtAtION OF tHREE ClINICAl CASES. 

R. Marelli, A. Hauqui, M. Portis, D. Vazquez, C. Viscuso, C. Echeverria, V. Strada, J. Como Birche, F Hauqui, 

N. Baungartner. 

P627 SECONDARy ACUtE CORONARy SyNDROMES IN OlDER PEOPlE. 

G. F. López Soutric, A. Brignoli, S. Swieszkowski, A. Lakowsky, V. Brito, J. M. Caparrós, R. Perez De La Hoz, 

E. A. Sampó. 

P628 tAkAyASU DISEASE. PRESENtAtION OF A ClINICAl CASE 

R. Marelli, L. Bernardini, D. Braziunas, J. Di Siervi, C. Echeverria, C. Viscuso, N. Bangartner, R. Lagos, O. Pisano, 

O. Rastelli. 

P629 ASSOCIAtION BEtWEEN BIRtH WEIGHt AND CARDIOVASCUlAR RISk FACtORS 

IN BRAzIlIAN ADOlESCENtS 

M. A. C. Sousa, I. C. Guimarães, C. Daltro, A. C. Guimarães. 

P630 USEFUlNESS OF tHE RAPID tESt OF Nt-PROBNP AND NON-INVASIVE HAEMODyNAMIC 

ASSESSMENt WItH tISSUE DOPPlER FOR EARly DIAGNOSIS OF DECOMPENSAtED HEARt 

FAIlURE IN A CARDIOVASCUlAR EMERGENCy ROOM 

E. Perna, E Garcia, O. Querencio, E. Villegas, P. Pozzer, G. Pereira Zini, R. Sanchez De Coll, W. Garcia, E. Fernandez, 

J. Parras. 

P631 COMPARING DRUG ElUtED WItH BARE MEtAl StENtS: ARE WE tREAtING tHE SAME 

PAtIENtS IN tHE SAME WAy? 

F. Braga, L. Armini, J. Kezen, S. Gomes Jr., R. Guerreiro, A. Bahia, A. Neno, M. Batista, R. Villela, J. Mansur. 

P632 tRANSRADIAl PERCUtANEOUS CORONARy ANGIOGRAPHy AND INtERVENtIONS 

E. C. Eric J. Carro-Jiménez, H. Q. Humberto O. Quintana-Irazola, J. B. Jonathan Bonilla Díaz, C. A. Claudia Algaze, J. 

D. R. Juan M. Del Río, J. C. Joaquín Crespo, J. O. José Ortiz Betancourt, E. R. Ernesto Ruiz, M. A. Michelle Arrieta, I. 

P. Iris Parrilla Boria. 



P633 CONDUCt RElAtION COMPARISON BEtWEENt CARDIAC FREQUENCy AND WORk lOAD 

DURING StRESS tESt ON PAtIENtS WItH CARDIOPAtHy 

N. Pacheco, N. Ceron, J. Alonso, H. Ilarraza. 

P634 INCIDENCE OF CORONARy ARtERy StENt tHROMBOSIS IN tHE “REAl WORlD” EXPERIENCE 

OF A UNIVERSItARy COlOMBIAN HOSPItAl 

B. Lombo, C. Satizabal, I. Rendon, D. Sarmiento, C. Carvajal, J. Mor. 

P635 tHE RElAtIONSHIP OF lEFt AtRIAl SIzE AND StRESS ECHOCARDIOGRAPHy 

S. Enar. 

P636 EFFECtS OF AMARANtHUS CAUDAtUS l. HyDROAlCOHOlIC EXtRACt ON NEW RISk 

FACtORS OF CARDIOVASCUlAR DISEASES AND PREVENtION OF FAtty StREAk FORMAtION 

AND COMPARING ItS EFFECt WItH lOVAStAtINE 

S. Asgary, N. Kabiri, H. Madani, P. Mahzoni, N. Jafari Dinani. 

P637 EFFECt OF HyDROAlCOHOlIC EXtRACtS OF JUGUlANS REGIA ON BlOOD SUGAR IN 

DIABEtES-INDUCED RAtS 

S. Asgary, P. Rahimi, H. Madani, P. Mahzouni, N. Jafari Dinani. 

P638 DIEtARy SUPPlEMENtAtION WItH ARtEMISIA SIEBERI REDUCE AtHEROSClEROSIS IN 

HyPERCHOlEStEROlEMIC RABBItS 

S. Asgary, N. Jafari Dinani, P. Mahzouni. 

P639 tHE UtIlIty RAtES OF INtEGRAtED tREAtMENt StRAtEGIES FOR CHD SECONDARy 

PREVENtION AMONG HIGH RISk CHD PAtIENtS IN CHINA 

D. zhao, Q. Liu, M. Hunn, W. Wang, C. M. Yu, J. R. Zhu, J. Liu, S. Smith Jr. 

P640 ADIPOkINES IN CORONARy ARtERy DISEASE AND HEARt FAIlURE: RElAtIONSHIPS WItH 

lEFt VENtRIClE HEMODyNAMICS AND CACHEXIA 

C. Antoniades, D. Tousoulis, A. Antonopoulos, A. Drolias, N. Koumallos, K. Marinou, K. Bakoyiannis, C. Tentolouris, 

E. Vavouranakis, C. Stefanadis. 

P641 GENEtIC POlyMORPHISM ON ANGIOtENSIN RECEPtOR tyPE 2, MODIFIES PlASMA lEVElS OF 

ACUtE PHASE PROtEINS AND AFFECtS CARDIOVASCUlAR RISk IN HyPERtENSIVE SUBJECtS 

D. Tousoulis, N. Koumallos, C. Antoniades, A. Antonopoulos, D. Kardara, D. Mentzikof, C. Vasiliadou, C. Tentolouris, 

E. Stefanadi, C. Stefanadis. 

P642 tHE IMPACt OF ACUtE CONSUMPtION OF CORN OIl, lIVER OIl, OlIVE OIl OR SOyA OIl ON 

ENDOtHElIAl FUNCtION AND OXIDAtIVE StRESS StAtUS, IN HEAltHy ADUltS 

C. Tentolouris, D. Tousoulis, N. Papageorgiou, C. Antoniades, A. Giolis, E. Stefanadi, C. Tsioufis, G. Bouras, 

K. Marinou, C. Stefanadis.


P643 OXIDAtIVE StRESS IS NOt tHE MAIN REGUlAtOR OF ASyMMEtRICAl DIMEtHyl-ARGININE 

(ADMA) SyNtHESIS IN EXPERIMENtAl HOMOCyStEINEMIA 

C. Antoniades, D. Tousoulis, K. Marinou, G. Bouras, E. Stefanadi, C. Vasiliadou, C. Vlachopoulos, A. Antonopoulos, 

C. Tentolouris, C. Stefanadis. 

P644 GENDER DIFFERENCES IN A POPUlAtION SUSPECtED OF ISCHEMIC HEARt DISEASE: 

EXERCISE RESPONSE, PERFUSION ABNORMAlItIES AND PROGNOSIS 

M. Ferreira, A. Ferrer-Antunes, J. Lima, L. A. Providência. 

P645 tHE UNDERlyING DISEASE StAtE AS tHE MAIN MODIFIER OF tHE RElAtIONSHIP BEtWEEN 

INFlAMMAtORy StAtUS AND tHE RElEASE OF SCD40l IN CORONARy AtHEROSClEROSIS 

D. Tousoulis, C. Antoniades, C. Tentolouris, A. Nikolopoulou, K. Marinou, N. Koumallos, K. Koniari, C. Vasiliadou, 


P646 VAlUE OF MyOCARDIAl PERFORMANCE INDEX IN EVAlUAtION OF PAtIENtS WItH 

HEPAtOESPlENIC MANSONIC SCHIStOSOMIASIS 

V. T. Carvalho, M. M. Barbosa, L. C. S. Silva, J. R. Lambertucci. 

P647 lOW-DOSE AtORVAStAtIN tREAtMENt SUPPRESSES INFlAMMAtORy AND tHROMBOtIC 

PROCESSES DURING POSt- StEMI PERIOD 

C. Tentolouris, D. Tousoulis, C. Antoniades, V. Katsi, E Bosinakou, A. Antonopoulos, K. Marinou, P. Aggelopoulos, 


P648 HOMOCyStEINE VARIAtIONS INDUCE ENDOtHElIAl DySFUNCtION By ACtIVAtING 

ENDOtHElIN-1 PAtHWAy IN HyPERtENSIVE PAtIENtS 

D. Tousoulis, G. Bouras, C. Antoniades, K. Marinou, C. Tentolouris, C. Vasiliadou, A. Antonopoulos, E. Stefanadi, 

P. Aggelopoulos, C. Stefanadis. 

P649 ROlE OF tElEMEDICINE FOR tHE DEtECtION OF St-SEGMENt ElEVAtION ACUtE 

MyOCARDIAl INFARCtION 

F. C. Cura, Fernando, R. L. Levi, Regina, L. V. Verruna, Leticia, A. S. Szyszko, Ariel, M. F. Farias, Marcelo, 

F. O. Olejnik, Francisco, N. V. Navarro Victor, D. D. Drago, Daniel, J. E. Estrella, Javier. 

P650 PERCUtANEOUS CORONARy INtERVENtION IN PAtIENtS WItH AtRIAl FIBRIllAtION. 

ANtItHROMBOtIC tHERAPy AND BASElINE ClINICAl CHARACtERIStICS ANAlySIS. 

J. M. Ruiz-Nodar, T. A. Brouzet, J. Hurtado, J. Valencia, J. R. Jimeno, J. Pineda, M. Valdés, F. Sogorb, G.Y.H. Lip, 

F. Marín. 

P651 CASE REPORt: ASSOCIAtION OF 2 VERy UNCOMMON PAtHOlOGIES IN tHE SAME PAtIENt 

C. Stringi, S. Pereiro Gonzalez, M. Masuelli, A. Bordenave, A. Crespo, G. Sumay, B. Nadinic, C. Poliserpi, 

J. Modenesi, S Chekherdemian. 



P652 VAlUE OF tIMI RISk SCORE FOR PREDICtING MORtAlIty AND MAJOR ClINICAl EVENtS IN 

PAtIENtS WItH StEMI tHAt UNDERWENt PERCUtANEUS CORONARy INtERVENtION ON 

ADMISSION tO HOSPItAl. 

I. Santos-Rodriguez, M. J. Ruiz-Olgado, V. Ramirez-Castro, J. Rodriguez-Collado, M. Cascon-Bueno, A. Perez-Bueno, 

V. Leon-Arguero, I. Cruz-Gonzalez, F. Martin-Herrero, M. Diego-Dominguez. 

P653 POStGRADUAtE AND SyStEMAtIC DIStANCE lEARNING EXPERIENCE IN CARDIOlOGy 

R. Ortego, A. Pacher, S. Berman, T. Bertuzzi, A. Carli, B. Kennel, R. Lombardo, S. Nanfara. 

P654 EXPANDED ClINICAl INDICAtIONS FOR A tISSUE ENGINEERED BlOOD VESSEl 

L. M. De La Fuente, S. Garrido, A. Marini, J. Antonelli, A. Fiorillo, A. Kocher, I. Gasperovich, N. Dusserre, T. McAllister, 

N. L’heureux. 

P655 AMBUlAtORy BlOOD PRESSURE MONItORING IN HyPERtENSIVE OFFSPRINGS 

J. Knopfholz, A. Ribeiro Langowiski, E. Lima Junior, A. Reichert, M. Oliveira Nogueira, L. C. Guarita-Souza. 

P656 CONtINUOUS ACtIVIty IN tElEMEDICINE FOCUSED ON tEACHING CARDIOlOGy 

A. Pacher, R. Lombardo, R. Ortego, E. Schapachnik, S. Eskenazi, S. Nanfara, J. Sanagua, M. Heñin, S. Berman, 

Pcvc Group. 

P657 ENDOtHElIAl FUNCtION IN RESPONSE tO ORAl lIPIDS AND POStPRANDIAl lIPEMIA 

Carlos I. Ponte N., O. Sanchez, R. Melendez, J. Isea-P, J. Feijoo, J. Gomez-M. 

P658 ARE lAtERAl OR POStERO-lAtERAl VEINS tHE OPtIMAl SItE tO IMPlANt lEFt PACING 

lEADS? A StUDy OF 77 CONSECUtIVE RESyNCHRONIzED PAtIENtS 

C. D’Ivernois, J. Lesage, A. Lagrange, P. Blanc. 

P659 ECHOCARDIOGRAPHIC EVAlUAtION OF MyOCARDIAl CONtRACtIlIty IN HyPERtENSIVE 

lEFt VENtRICUlAR HyPERtROPHy By A lOAD-INDEPENDENt INDEX 

A. Tufare, E. Escudero. 

P660 DRUG-ElUtING-StENt-BASED PERCUtANEOUS CORONARy INtERVENtION FOR tREAtMENt 

OF ACUtE CORONARy SyNDROME WItH MUltIVESSEl DISEASE; COMPARISON OF ‘CUlPRIt- 

VESSEl-ONly’ AND COMPlEtE REVASCUlARIzAtION 

B. Hong, H. Kim, S. Yoon, M. Kim, H. Moon, Y. Yoon, P. Min, S. Rim, H. Kwon. 

P661 PROARRHytHMIC EFFECtS OF FlECAINIDE DURING EXERCISE StRESS tESt IN CORONARy 

ARtERy DISEASE DEtECtING 

K. G Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan. 

P662 ANtIOXIDANt SPECtRUM CHANGES DUE tO tRIMEtAzIDINE tREAtMENt IN PAtIENtS WItH 

CORONARy ARtERy DISEASE AND DIABEtES MEllItUS tyPE 2. EXPERIENCE IN 44 PAtIENtS 

K. G. Adamyan, A. V. Astvatsatryan, A. L. Chilingaryan.


P663 DIFFERENt EFFECt OF DM AND OtHER CARDIOVASCUlAR RISk FACtORS ON CIRCUlAtING 

MONOCytE COUNt IN PAtIENtS WItH StABlE CAD 

S. A. Kocaman, A. Sahinarslan, T. Timurkaynak. 

P664 tREAtMENtS AND OUtCOMES OF ACUtE MyOCARDIAl INFARCtION. A tHREE yEAR 

EXPERIENCE IN A PROGRESSIVE CARE UNIt. 

M. Perez, C. Martinez Sagasta, E. Brunel, E. Soloaga, G. Medina, J. Bori, C. Smith, A. Palazzo, M. Veltri, J. Ubaldini. 

P665 DRUG-ElUtING-StENt-BASED PERCUtANEOUS CORONARy INtERVENtION VERSUS 

CORONARy ARtERy ByPASS SURGERy FOR tREAtMENt OF PAtIENtS WItH MUltIVESSEl 

CORONARy ARtERy DISEASE 

B. Hong, H. Mun, N. Chon, M. Kim, C. Ahn, P. Min, Y. Yoon, S. Rim, H. Kwon. 

P666 lEFt VENtRICUlAR ROtAtION AND tORSION AFtER ANtERIOR AND INFERIOR MyOCARDIAl 

INFARCtION. 

M. Pinto. 

P667 DIFFERENt lEVElS tHAN PROPOSED IN ABDOMINAl WAISt CIRCUMFERENCE ON A 

lAtINOAMERICAN POPUlAtION 

Carlos I. Ponte N., N. Vargas, I. Brajkovich, L. Machado-H, J. Isea-Pérez, J. Gómez.M, C. Mendoza. 

P668 SOlItARy PAPIllARy MUSClE HyPERtROPHy CAN BE A PRECURSOR OF HyPERtROPHIC 

CARDIOMyOPAtHy 

T. F. Cianciulli, M. C. Saccheri, A. M. Bermann, J. A. Lax, I. V. Konopka, R. S. Acunzo, H. J. Redruello, H. A. Prezioso, 

M. V. Elizari, L. A. Vidal. 

P669 ACUtE EFFECtS OF NON INVASIVE VENtIlAtION WItH CONtINUOUS POSItIVE AIRWAy 

PRESSURE ON PUlSE PRESSURE IN CHRONIC HEARt FAIlURE 

M. Quintão, S. Chermont, N. N. Rocha, E. T. Mesquita, A. C. L. Da Nóbrega. 

P670 PERCUtANEOUS CORONARy INtERVENtIONS (PCI) FOR UNPROtECtED lEFt MAIN 

CORONARy ARtERy (UlCMA) 

M. Strozzi, D. Anic, B. Skoric. 

P671 IMPORtANtE OF REPERFUSION StRAtEGy AND HEARt FAIlURE IN tHE ACUtE MyOCARDIAl 

INFARCtION 

S. M. Macin, E. R. Perna, P. Barrios, J. Parra Moreno, P. Pozzer, E. Villegas, G. Zini, P. Liva, J. Baccaro, J. R. Badaraco. 

P672 HEPAtOPUlMONARy SyNDROME AND HEMODyNAMIC RESPONSE ON tHE lEFt SIzE 

OF tHE HEARt 

F. L. Weich Glogier, T. F. Cianciulli, J. Vilkas Anzorena, F. Spernanzoni, M. C. Saccheri, J. A. Lax, A. N. Dorelle, 

H. A. Prezioso, L. A. Vidal, O. C. Imventarza. 



P673 QUAlIty OF lIFE IMPROVEMENt IN StABlE ANGINA PECtORIS By COMBINING PHySICAl 

EXERCISE AND MEDICAl tREAtMENt 

L. Matos, M. Lengyel, J. Szlavov, L. Pál. 

P674 HAVE ADHERENCE tO GUIDElINES IN CHRONIC CORONARy ARtERy DISEASE? 

S. M Macin, J. Bono, H. Ramos, A. Romano, M. Balestra, G. Zapata, E. Hasbani, J. Mountaner, H. Luciardi. 

P676 DOPPlER tISSUE IMAGING IN PAtIENtS WItH HyPERtROPHIC CARDIOMyOPAtHy 

M. C. Saccheri, T. F. Cianciulli, S. E. Puga, I. V. Konopka, R. S. Acunzo, J. E. Guerra, D. F. Serans, H. A. Prezioso, 

M. V. Elizari, L. A. Vidal. 

P677 POSItIVE CORRElAtION BEtWEEN WAISt CIRCUMFERENCE, HDl-CHOlEStEROl AND 

tOtAl CHOlEStEROl IN CENtRAl AFRICANS WItH CONGEStIVE HEARt FAIlURE : REVERSE 

EPIDEMIOlOGy AND U-RElAtIONSHIP IN CARDIOVASCUlAR RISk 

B. Longo-Mbenza, H. F. Agongola Mambune, J. B. Kasiam On’Kin, E. Kintoki Vita, S. Mbungu Fuele, 

J. Nkondi Nsenga, L. Mabwa, V. Nzuzi. 

P678 HEARt RAtE VARIABIlIty AFtER DIFFERENt CARDIAC SURGERy PROCEDURES AND ItS 

PROGNOStIC VAlUE 

N. Lakusic, F. Baborski, J. Mirat, L. J. Pavelic, K. Fuckar, D. Cerovec, M. Majsec. 

P679 EARly DEtECtION OF MyOCARDIAl DAMAGE IN CHAGAS DISEASE. 

T. F. Cianciulli, J. A. Lax, M. C. Saccheri, A. Papantoniou, R. J. Mendez, N. G. Prado, A. N. Dorelle, A. R. Riarte, 


P680 ASSOCIAtION BEtWEEN CORONARy HEARt DISEASE, CERtAIN COMPONENtS OF MEtABOlIC 

SyNDROME AND tHE QtC INtERVAl IN HyPERtENSIVE CENtRAl AFRICANS 

B. Longo-Mbenza, J. C. Manzala Kumbi, G. Milongo Dipa, A. Nge Okwe, S. Mbungu Fuele. 

P681 EVAlUAtION OF CHESt PAIN WItH BNP: DO WE HAVE A NEW tOOl? 

F. Braga, L. Armine, P. P. Sampaio, A. Bahi, M. Simoes, J. Kezen, S. Gomes Jr., A. C. Neno, F. Alvim, J. Mansur. 

P682 USEFUlNESS OF tISSUE DOPPlER IMAGING AlONE AND WItH StRESS-DOBUtAMINE 

ECHOCARDIOGRAPHy IN CARDIOtRANSPlANtED PAtIENtS. 

F. S. Deketele, M. A. Morales Lezica, L. Ahualli, D. Radlovacky, V. Piccone, C. A. Rivas. 

P684 PREDICtION OF ECHOCARDIOGRAPHy RISk FACtORS OF tHROMBOEMBOlISM USING 

D-DIMMER IN NON-VAlVUlAR AtRIAl FIBRIllAtION 

F. Braga, P. Medeiros, F. Brasil, F. Nogueira, A. Godomiczer, M. Spelta, A. C. Neno, R. Salomao, R. H. Lins, B. Hellmuth. 

P685 EVAlUAtION OF PHySICIANS´ kNOWlEDGE ON REPERFUSION tHERAPy FOR ACUtE 

MyOCARDIAl INFARCtION IN ARGENtINA: A tOOl FOR QUAlIty IMPROVEMENt PROCESS. 

R. Iglesias, F. Rolandi, F. Di Tommaso, I. Chaves, M. Strumminger, P. Stuzbach, A. Pocovi.


P686 AORtOPUlMONARy FIStUlA AS AN UNUSUAl COMPlICAtION IN tHE FOllOW-UP OF AN 

ARtERIAl SWItCH OPERAtION (ASO) FOR tRANSPOSItION OF tHE GREAt ARtERIES. 

B. Chiostri, I. Lugones, M. Grippo, J. L. Simon, A. J. Schlichter. 

P687 tHE COMBINAtION OF AMlODIPINE 5 MG AND VAlSARtAN 160 MG lOWERS PUlSE 

PRESSURE EFFECtIVEly AND SAFEly IN ElDERly AND NON-ElDERly HyPERtENSIVE 

PAtIENtS NOt CONtROllED By MONOtHERAPy WItH CAlCIUM CHANNEl BlOCkERS 

J. Brachmann, R. Handrock, S. Klebs. 


PRESSURE EFFECtIVEly AND SAFEly IN OVERWEIGHt AND OBESE HyPERtENSIVE PAtIENtS 

NOt CONtROllED By MONOtHERAPy WItH CAlCIUM CHANNEl BlOCkERS 


P689 PREDICtIVE VAlUE OF PREOPERAtIVE BNP FOR ADVERSE OUtCOMES IN CORONARy ARtERy 

ByPASS GRAFtING 

L. Valtuille, L. Gomez, F. Rolandi, A. Domenech, R. De Miguel, D. Perez De Arenaza, A. Cagide, J. L. Navarro Estrada. 

P690 lEFt AtRIAl APPENDAGE FUNCtION AND RISk OF tHROMBOEMBOlISM IN MItRAl 

StENOSIS IN SINUS RHytHM 

T. F Cianciulli, M. C. Saccheri, J. A. Lax, F. L. Weich Glogier, J. J. Cirio, R. A. Sarmiento, M. L. Talavera, D. A. Kyle, 

O. Fustinoni (h), H. A. Prezioso. 

P691 BODy IMAGE ANAlySIS IN OBESES, OVERWEIGHt AND EUtROPHIC SUBJECtS 

K. C. Guidini, P. M. Lese, K. C. Belli, A. C. Côrrea, D. C. Bündchen, T. Dipp, T. F. Panigas, C. M. Richter, 

M.C. Romero, P. R. N. Viecili. 


PRESSURE EFFECtIVEly AND SAFEly IN HyPERtENSIVE PAtIENtS WItH MEtABOlIC RISk 

FACtORS NOt CONtROllED By MONOtHERAPy WItH CAlCIUM CHANNEl BlOCkERS 


P693 StUDy OF tHE PERIODIC AlIMENtARy COMPUlSION IN INDIVIDUAlS WItH DIFFERENt 

ANtHROPOMEtRICS INDEXES 

P. M. Lese, K. C. Guidini, K. C. Belli, C. M. Richter, A. C. Côrrea, D. C. Bündchen, T. Dipp, T. F. Panigas, M. C. Romero, 


P694 PROGRESS OF A CARDIAC tRANSPlANtAtION PROGRAM IN A PUBlIC PEDIAtRIC HOSPItAl 

IN ARGENtINA 

H. Vogelfang, G. Naiman, A. Villa, M. Disanto, A. Charroqui, G. Moreno, R. Magliola, L. Quiroga, G. Burlli, 

M. De La Riba. 



P695 CARDIOVERtER-DEFIBRIllAtOR tHERAPy AND ItS RElAtION WItH SyStOlIC AND 

DIAStOlIC FUNCtION IN PAtIENtS WItH CARDIOMyOPAtHIES 

C. Killinger, G. Ceconi, L. Shocron, M. Senesi, A. Cueto, M. Del Campo, C. Sun, G. Cabrejos, E. Beck, 

A. Papadopoulos. 

P696 ClOPIDOGREl RESPONSE IN ACUtE CORONARy SyNDROME PAtIENtS: COMPARING 

DIFFERENt lOADING DOSES 

F. Braga, G. Lavall, R. Guerreiro, A. Godomiczer, M. Spleta, C. Segadaes, A. C. Neno, G. Gouvea, R. Villela, R. H. Lins. 

P697 PlAtElEt AGGREGAtION AND POSt PERCUtANEOUS CORONARy INtERVENtION 

MyONECROSIS. 

F. Braga, E. Sophia, G. Lavall, R. Guerreiro, B. Zappa, R. Max, R. Villela, B. Hellmuth, P. Medeiros, R. H. Lins. 

P698 OBESIty IN A COHORt OF PUBlIC EMPlOyEES MEDICAl SERVICE OF MENDOzA - 

ARGENtINA. OPtIMAl SyStEMAtIC EVAlUAtION PROGRAM (OSEP StUDy) IN OBESIty 

S. Mortaloni, O. Arrieta, S. Zizzias, L. Cammi, J . Alvarez, A. Añó, S. Depine, S. Gimenez. 

P699 StRUCtURAl AND FUNtIONAl AltERAtIONS OF CARDIAC AND SkElEtAl MUSClE 

MItOCHONDRIA IN PAtIENtS WItH CONGEStIVE HEARt FAIlURE. 

G. Guzman Mentesana, R. Cordoba, A. Baez, R. Dominguez, D. Comay, S. Lo Presti, W. Rivarola, P. Pons, R. Fretes, 

P. Paglini. 

P700 INFlAMMAtION/lIPID SCORE MAy OUtPERFORM tIMI SCORE IN ACUtE MyOCARDIAl 

INFARCtION tREAtED By PRIMARy INtERVENtION. 

J. Kasprzak, K. Kolodziej, M. Wraga, J. Z. Peruga, M. Krzeminska-Pakula. 

P701 CONtRASt ENHANCEMENt SCORE: OPtIMAl PARAMEtER FOR PREDICtING lOCAl AND 

GlOBAl VIABIlIty AFtER MyOCARDIAl INFARCtION- A CONtRASt ECHOCARDIOGRAPHIC 

StUDy. 

J. Kasprzak, M. Ciesielczyk, J. Drozdz, M. Kurpesa, M. Kidawa, M. Krzeminska-Pakula. 

P702 CORONARy FlOW RESERVE IN INFARCt-RElAtED ARtERy.IS NOt AltERED By 

INtRACORONARy ADMINIStRAtION OF BONE MARROW StEM CEllS. 

J. Kasprzak, M. Plewka, P. Lipiec, K. Wierzbowska-Drabik, T. Robak, A. Korycka, T. Jezewski, J. Z. Peruga, 

M. Krzeminska-Pakula. 

P703 EFFECtS OF WEIGHt lOSS AFtER GAStRIC ByPASS ON lEFt VENtRICUlAR FUNCtION 

ASSESSED By tISSUE DOPPlER IMAGING 

T. F. Cianciulli, A. M. Bermann, J. A. Lax, M. C. Saccheri, B. E. Linetzky, L. A. Morita, J. A. Gagliardi, A. N. Dorelle, 


P704 ECONOMIC BENEFIt OF PHySICAl ACtIVIty PROGRAM FOR HyPERtENSIVE SUBJECtS: 

VARIAtION IN COSt-DOSE-MEDICAtION 

T. Dipp, D. C. Bündchen, T. F. Panigas, K. C. Belli, C. F. Panigas, C. M. Richter, A. M. R. Pereira, E. G. Barbosa, 

J. Z. Klafke, P. R. N. Viecili.


P705 EXERCISE-INDUCED ABNORMAl PUlMONARy ARtERIAl PRESSURE RESPONSE IN yOUNG 

AtHlEtES – NORMAl PHySIOlOGy OR PRECURSOR OF ENDOtHElIAl DAMAGE? 

T. Möller, K. Peersen, P. M. Fredriksen, H. Holmstrøm, E. Thaulow. 

P706 ECHOCARDIOGRAPHIC DEtECtION OF RENAl CEll CARCINOMA EXtENDING FROM INFERIOR 

VENA CAVA INtO RIGHt AtRIUM. 

T. F. Cianciulli, M. C. Saccheri, J. A. Lax, L. A. Morita, H. J. Altube, J. F. Codone, M. T. Lioy Lupis, A. N. Dorelle, 


P707 PERIPHERAl ARtERy DISEASE – StIll UNDEREStIMAtED IN DIAGNOStIC AND 

PHARMACOtHERAPy tREAtMENt 

L. J. Banfic, M. Vrkic Kirhmajer, E. Fucak, I. Sakic. 

P708 CAROtID ARtERy StENtING IMPROVES PARAMEtERS OF CEREBROVASCUlAR 

HAEMODyNAMICS 

D. Cerna, J. Veselka, P. Zimolova, P. Blasko, J. Fiedler, R. Duchonova, D. Zemanek, M. Maly, P. Hajek. 

P709 MODERAtE AltItUDE CONDItIONS MAy CAUSE HyPOXIA AND ABNORMAl PUlMONARy 

ARtERIAl PRESSURE RESPONSE At RESt AND DURING EXERCISE IN PAtIENtS WItH AtRIAl 

OR VENtRICUlAR SEPtAl DEFECt 

T. Möller, P. M. Fredriksen, H. Holmstrøm, J. Hallén, E. Thaulow. 

P710 ASPIRIN AND ClOPIDOGREl RESPONSE IN PAtIENtS WItH ACUtE CORONARy SyNDROME 

F. Braga, G. Lavall, A. Sterque, F. Albuquerque, G. Gouvea, A. C. Neno, J. Kezen, R. Max, E. Sophia, B. Hellmuth. 

P711 PARAMEtERS OF RIGHt VENtRICUlAR FUNCtION IN PREDICtING EXERCISE CAPACIty AS A 

DEtERMINANt OF VO2MAX IN PAtIENtS WItH DIlAtED CARDIOMyOPAtHy 

J. Vormbrock, G. Plehn, S. A. Machnick, C. Zuehlke, H. J. Trappe. 

P712 tHE DOSE-RESPONSE CURVE FOR EXERCISE AND BlOOD PRESSURE: HOW MANy SESSIONS 

ARE NEEDED? 

D. C. Bündchen, T. F. Panigas, C. M. Richter, T. Dipp, C. F. Panigas, K. C. Belli, J. L. C. Pippi, J. Z. Klafke, T. Carvalho, 


P713 ASSESSMENt OF PlANIMEtRIC MItRAl VAlVE AREA IN PAtIENtS WItH RHEUMAtIC MItRAl 

StENOSIS USING 16-ROW MUltIDEtECtOR COMPUtED tOMOGRAPHy:COMPARISON WItH 

tRANStHORACIC tWO-DIMENtIONAl ECHOCARDIOGRAPHy 

O. ucar, M. Vural, Z. Cetin, S. Gokaslan, T. Gursoy, B. Demircelik, A. Selvi, S. Aydogdu. 

P714 RADIAtION DOSE OF DUAl-SOURCE Ct IS MUCH HIGHER COMPARED tO INVASIVE 

CORONARy ANGIOGRAPHy 

R. Duchonova, T. Adla, J. Veselka, J. Neuwirth, L. Martinkovicova, V. Suchanek, P. Hajek, M. Maly, D. Zemanek, 

P. Blasko. 



P715 MANAGEMENt OF RESIStANt HyPERtENSION By ADDING A lOW DOSE SPIRONOlACtONE 

E. Badila, C. Tirziu, S. Ghiorghe, D. Bartos, M. Dorobantu. 

P716 INCREASED EXPRESSION OF tHE HOMOlOGUE ANGIOtENSIN I CONVERtING ENzyME (ACE2) 

INDUCED By BOtH CANDESARtAN AND FASUDIl IN RAtS WItH GENEtICAlly HIGH lEVElS 

OF ANGIOtENSIN II 

M. Ocaranza Jeraldino, P. Rivera, J. Jalil Milad. 

P717 ISCHEMIC OR NON-ISCHEMIC EtIOlOGy INFlUENCE ON ENDOtHElIAl FUNCtION IN 

PAtIENtS WItH CARDIAC FAIlURE 

E. Badila, S. Ghiorghe, C. Tirziu, D. Bartos, M. Dorobantu. 

P718 RISk FACtORS FOR tRyPANOSOMA CRUzI INFECtION REACtIVAtION IN CHAGAS’ HEARt 

tRANSPlANt RECIPIENtS. 

T. Theodoropoulos, A. Silva, R. Bestetti. 

P719 SINGlE CENtRE EXPERIENCE IN PAtIENtS WItH lEFt VENtRICUlAR NON-COMPACtION: 

ClINICAl CHARACtERIStICS AND EVOlUtION. 

M. Diez, R. Fernandez, A. Fernandez, J. Casabe, G. Arroyo, E. Guevara, M. Tettamanti, R. Gamboa, C. Rodriguez 

Correa, L. Favaloro. 

P720 REAl-tIME tHREE-DIMENSIONAl ECHOCARDIOGRAPHIC lEFt VENtRICUlAR SyStOlIC 

ASSESSMENt: SIDE-By-SIDE COMPARISON WItH CARDIAC COMPUtED tOMOGRAPHy 

M. L. C Vieira, C. H. Nomura, B. Tranchesi Jr., W. A. Oliveira, G. Naccarato, B. S. Serpa, R. B. D. Passos, 

M. B. G. Funari, C. H. Fischer, S. S. Morhy. 

P721 tHE ROlE OF HEMODyNAMIC AND NON-HEMODyNAMIC FACtORS OF lEFt VENtRICUlAR 

REMODElING IN PAtIENtS WItH ANkylOSING SPONDylItIS 

D.A. Poddubnyy, A. P. Rebrov. 

P722 PREVAlENCE AND RElEVANCE OF EXtREME DIPPING PAttERN OF BlOOD PRESSURE 

G. Simonyi, J. R. Bedros, M. Medvegy. 

P723 MORPHOlOGICAl StUDy OF tACHyARRHytHMIAS: tyPICAl FEAtURES ON CARDIAC MRI 

P. Donato, B. Graça, M. J. Ferreira, F. Caseiro-Alves, L. A. Providência. 

P724 INCIDENCE OF COCAINE USE IN PAtIENtS UNDER 45 yEARS PRESENtING tO AN EMERGENCy 

DEPARtMENt WItH ADVERSE CARDIOVASCUlAR EVENtS 

M. Colmenero, F. Manzano, A. Reina, R. Garcia, M. Rodriguez-Elvira, J. Roca. 

P725 CONtRIBUtION OF tHE DIAStOlIC WAVE tO tHE EVAlUAtION OF HyPERtENSIVE SUBJECtS 

F. C. Clara, Fernando, A. C. Casarini, Alfredo, A. T. Tufare, Ana, M. E. Echzu, María, A. S. Escandurra, Adriana, 

G. M. Meschino, Gustavo, L. C. Clara, Laurencia.


P726 lONG-tERM INFlUENCE OF CARDIOVASCUlAR RISk FACtORS IN tHE DEVElOPMENt OF 

tHROMBOEMBOlIC DISEASE. 

B. Roca, D. Bahamonde, M. Peris. 

P727 MASS IN tHE lEFt AtRIUM – A CHAllENGER OF DIAGNOSIS 

A. Soares, E. Marum, A. Silva, R. Russo, C. Chicanelli, H. Abensur. 

P728 StRESS DOPPlER ECHOCARDIOGRAPHy FOR SCREENING OF PAtIENtS At RISk FOR 

PUlMONARy ARtERIAl HyPERtENSION 

R. Maier, G. Kovacs, S. Scheidl, C. Hesse, W. Salmhofer, R. Stauber, M. Brodmann, E. Aberer, E. Gruenig, 

H. Olschewski. 

P729 CORONARy ANGIOPlASty OF BIFURCAtED lESIONS 

M. Albertal, F. Cura, L. Padilla, P. Perez Balino, A. Candiello, S. Jozami, J.. A. Belardi. 

P730 NURSING DIAGNOSES At RIO DE JANEIRO’S CHESt PAIN UNIt 

M. A. C. S Marluci Andrade Conceiçãostipp, K. B. A. Karla Biancha Silva De Andrade, 

V. Z. M. Valéria Zadra De Mattos, A. P. B. P. Ana Paula Brito Pinheiro, M. F. M. Maria De Fátima Muino, 

J. L. L. Josète Luzia Leite, R. S. S. Renata Silva Dos Santos, A. A. S. Alessandra Andrada De Souza, 

N. M. C. Natália Machado Da Cunha. 

P731 PAtCH CAROtID ENDARtERECtOMy. FOllOW UP RESUltS IN A SElECtED GROUP 

J. Cors, C. Schulte, A. Hershson, G. Peltz, M. Nallar, H. Raffaelli. 

P732 RANDOMIzED StUDy OF EVAlUAtION OF N-ACEtylCyStEINE AND SODIUM BICARBONAtE 

IN tHE PREVENtION OF CONtRASt-INDUCED NEPHROPAtHy 

A. Salvatierra Ruiz, G. Marchetti, A. Lagioia, M. Bodoira, D. Lavaggi, R. Ferreyra, A. Pocoví, A. Palacios, 

P733 DIFFERENtIAl tRENDS IN USE OF REVASCUlARIzAtION PROCEDURES IN MyOCARDIAl 

INFARCtION PAtIENtS ACCORDING tO SOCIOECONOMIC StAtUS 

M. G. Cohen, G. M. Holmes, T. S. Carey, S. B. Greene, K. A. Selzman, S. C. Smith Jr., C. Patterson. 

P734 INFlAMMAtION INFlUENCES lAtE PROGNOSIS OF PAtIENtS WItH StEMI tREAtED WItH 

PRIMARy PCI 

M. Pyda, M. Lanocha, K. Korybalska, K. Ksiazek, S. Grajek, M. Lesiak, M. Grygier, A. Katarzynska, W. Skorupski, 

J. Witowski. 

P735 A COMPARISON BEtWEEN MONOPHASIC AND BIPHASIC MUltIPUlSE BIOWAVE® PUlSES 

DURING 

E. Trendafilova, A. Alexandrov, E. Kostova, I. Toshev, A. Bankova, P. Tassovska, T. Andreeva, N. Gotcheva. 

P736 GENDER DIFFERENCES IN lEFt MAIN ARtERy DISEASE ASSESED By INtRAVASCUlAR 

UltRASOUND 

F. Kozak, L. Lasave, A. Abizaid, A. Damonte, M. Rossi, M. Gamen, F. Feres, E. Sousa, E. Picabea. 



P737 NEED tO REINFORCE tHE MEDICAl CONCERN FOR SMOkING CESSAtION. RESUltS FROM A 

SURVEy. 

J. Isea-Pérez, C. I. Ponte, B. Nuñez, J. L. Viloria, A. Reveron, J. Boscan, L. Hernandez, J. Pinto. 

P738 IMPORtANCE OF tHROMBUS ASPIRAtION IN INtRAHOSPItAl OUtCOMES FROM PRIMARy 

ANGIOPlASty 

F. F. O. Fernando Fabian Ordonez, C.A.A. Carlos Alejandro Alvarez, A. C. Aberto Cristino, V. H. Veronica Heredia, 


P739 DOES tHROMBUS ASPIRAtION WItH CAtHEtER EXPORt PROVIDE BENEFItS tO tHE 

INtRAHOSPItAl OUtCOMES OF PRIMARy ANGIOPlASty? 

F. F.O. Fernando Fabian Ordonez, C. A. A. Carlos Alejandro Alvarez, A. C. Alberto Cristino, V. H. Veronica Heredia, 


P741 MEtABOlIC SyNDROME AND HEPAtIC tRANSAMINASES lEVElS: ANAlySIS OF 

33 PAtIENtS 

J. Knopfholz, J. R. Faria Neto, A. Moser, B. A. Di Rico, G. Moreno Jardim, V. Bernardes, C. L. Pereira Da Cunha. 

P743 CIRCUIt WEIGHt tRAINING AND CARDIAC MORPHOlOGy: A tRIAl WItH MAGNEtIC 

RESONANCE IMAGING 

M. Camargo, R. Stein, J. Ribeiro, P. Schvartzman, M. Rizzatti, B. Schaan. 

P744 AN EMERGENCy DEPARtMENt OBSERVAtION UNIt PROtOCOl FOR AtRIAl FIBRIllAtION: 

PROCEEDINGS AND OUtCOMES 

M. D Tinetti Matias, M. D. Gonzalez Miguel, M. D. Castro Florencia, M. D. Costabel Juan Pablo, 

M. D. Fernando Botto, M. D. Albina Gaston, M. D. Jorge Thierer, M. D. Alberto Giniger, M. D. Marcelo Trivi. 

P745 SUPERIOR VENA CAVA tO PUlMONARy ARtERy OXyGEN GRADIENt IS A FUNCtION OF 

CORONARy SINUS OXyGEN SAtURAtION 

J. Giorgini, P. D Comignani, G. Ciambrone, S. Donato, J. Gambarte, C. Higa, A. Macchia, F. Novo. 

P746 EStIMAtING ACHIEVABlE BENEFIt FROM COMPONENtS OF A COMPREHENSIVE HEARt 

DISEASE PREVENtION AND tREAtMENt PROGRAM 

T. Kottke, D. Faith, C. Jordan. 

P747 lAtINO’S AttItUDES AND PREFERENCES REGARDING tREAtMENt 

OF HyPERtENSION 

M. G. Cohen, B. L. Sleath, S. Blalock, A. R. Cerna, D. E. Bender. 

P748 StUDy OF tHE ARtERIAl ByPASS IN DElAyED POStOOPERAtIVE OF MR (MIOCARDIAl 

REVASCUlARIzAtION) tHROUGH MUltI-DEtECtOR ROW 

Ct ANGIOGRAPHy 

A. Tangari, G.S. Fernandes, C. A. Cattani, L. Fonseca, R. Castro, A. A. Santos, J. F. Baungratz, J. H. Vila, 

J. C. Brigante, J. P. Silva.


P749 MID -tERM FOllOW UP IN A POPUlAtION WHO UNDERWENt PERCUtANEOUS RENAl 

ARtERy StENtING DUE tO UNCONtROllED HyPERtENSION 

C. Agatiello, H. Bassani Molinas, A. Pascua, D. Grinfeld, A. Fernandez, J. M. Gabay, C. Rojas Matas, D. Berrocal, L. Grinfeld. 

P751 lEFt VENtRICUlAR FUNCtION, EVAlUAtED By MEANS OF MyOCARDIAl PERFUSION GAtED- 

SPECt SCINtIGRAPHy IN A POPUlAtION OF lOW PROBABIlIty OF CORONARy HEARt 

DISEASE 

F. Otero, A. Salvati, R. Geronazzo, V. Crosa, G. Casella, G. Bozovich, S. Traverso, R. Campisi. 

P753 PREVAlENCE OF NOONAN SyNDROME IN ADUlt PAtIENtS WItH PRIMARy lEFt 

VENtRICUlAR HyPERtROPHy 

G. Pereiro, I. Masuda, H. Cola, A. Graziano, O. Serraiocco, O. Cravero, A. Pasca, R. Hoffman, R. Savanti, A. Leon. 

P755 EFFECtS OF OVEREXPANSION ON StENtS’ RECOIl, SyMMEtRIA-ASyMMEtRIA AND 

NEOINtIMAl HyPERPlASIA IN AORtAS OF HyPERCHOlEStEROlEMIC RABBItS 

G. E. González, D. H. Berrocal, A. Fernández, L. Wilensky, C. Morales, L. Grinfeld, R. J. Gelpi. 

P756 WHAt IS tHE PREVAlENCE OF ANEMIA IN ADHF? 

S. M. Martins, C. Medeiros, F. M.Oliveira, R. Cantarelli, C. Sarteschi. 

P757 ABSENCE OF ASSOCIAtION BEtWEEN FACtOR XII 46C>t GENE POlyMORPHISM AND 

CORONARy ARtERy DISEASE IN CHIlEAN SUBJECtS 

J. Caamaño, P. Jaramillo, C. Lanas, F. Lanas, L. A. Salazar. 

P758 ENzyME REPlACEMENt tHERAPy IN FABRy’S DISEASE: CARDIAC ANAlySIS 

A. Escobar, G. Ferrari, C. Kudrle, G. Doxastakis, O. Manuale, F. Casas, L. Dragonetti, S. Makhoul. 

P759 RHEUMAtIC CARDItIS – StIll A CHAllENGE IN BRAzIl! 

R. E. Müller, B. R. Tura, S. M. Lamy, M. C. C. Kuschnir, C. Weksler, R. M. A. Xavier, M. J. L. M. Silva, F. F. Nascimento. 

P760 HEMORRHAGIC COMPlICAtIONS OF COMBINED ANtIPlAtElEt AND ANtICOAGUlANt 

tHERAPy IN ElECtIVE PCI PAtIENtS 

F. Baraona. 

P761 UNAWARENESS OF PRESENCE FOR CARDIOVASCUlAR DISEASE RISk FACtORS 

IN A BRAzIlIAN REGIONAl POPUlAtION 

C. M. Richter, D. C. Bündchen, T. Dipp, K. C. Belli, T. F. Panigas, C. F. Panigas, J. Z. Klafke, M. A. Silva, P. R. N. Viecili. 

P762 GlyCEMIC CONtROl IN PAtIENtS WItH tyPE II DIABEtES MEllItUS AFtER AN ACUtE 

MyOCARDIAl INFARCtION – A RANDOMIzED CONtROllED PIlOt StUDy COMPARING 

GlARGINE INSUlIN PlUS REGUlAR INSUlIN VERSUS INSUlIN PUMP tHERAPy 

C. Sampaio, D. Franco, F Eliaschewitz. 



P763 ClINICAlS VARIABlES OF INtERRUPtION IN FOllOWING OF HyPERtENSIVE PAtIENtS 

R. Altamirano, J. O. Ibañez, J. Kriskovich, R. Perez Rey, B.G. Rovai, C. Martinez, J. Gomez, S. Ibañez. 

P764 BlOOD PRESSURE MEASUREMENt ACCORDING tO tHE V BRAzIlIAN HyPERtENSION 

GUIDElINE: DOES It MAkE DIFFERENCE? 

V. Guimarães Neto, S. Albuquerque, F. Souza, S. Lima, A. Feitosa, G. Falbo, D. Carvalho, J. Albuquerque. 

P765 HEARt RAtE RECOVERy AFtER MAXIMAl EXERCISE tEStING IN HEAltHy PHySICAlly 

ACtIVE OlDER WOMEN 

O. Tairova, D. R. S. De Lorenzi, P. E. G. Carvalho, A. Scariot, G. Cavalli, J. M. Baumgarten. 

P766 EARly VS lAtE lOSARtAN EFFECtS ON POSt-MyOCARDIAl INFARCtION VENtRICUlAR 

REMODEllING AND EARly INFlAMMAtORy INFIltRAtE IN RABItS 

G. E. González, L. Wilensky, L. Krieger, J. Palleiro, I. Seropian, M. Rodriguez, R. J. Gelpi, C. Morales. 

P767 CARDIOVASCUlAR EVENtS: 10 yEARS OF FOllOW-UP IN A ClOSED POPUlAtION 

J. Tartaglione, G. Grazioli, M. Sarmiento, L. Goldstraj. 

P768 FRACtION OF tHE lEFt VENtRIClE EJECtION AND AUtO DEClARED COlOR 

AND POlyMORPHISM OF tHE ENzyME GEN CONVERSER OF ANGIOtENSIN IN HEARt FAIlURE 

B. Cavalieri. 

P769 EFFECt OF REMOtE ISCHEMIC POSCONDItIONING ON ENDOtHElIAl FUNCtION AFtER ONE 

PERIOD OF SUStAINED ISCHEMIA. 

J. Álvarez- Gómez, Y. Coto Hernández, E. Roldos Cuza, L. Rodriguez Nandez, E. Rivas Stany, D. García Barreto. 

P770 tHE POSt MENOPAUSAl ClIMACtERIC WOMAN WItH HyPERtENSION: IMPlICAtIONS tO 

QUAlIty OF lIFE AND FUNCtIONAl CAPACIty. 

O. Tairova, D. R. S. De Lorenzi, P. E. G. Carvalho, G. Cavalli, A. Scariot. 

P771 ACUtE CORONARy SyNDROME IN tHE VERy ElDERly: DIFICUlt DIAGNOSIS, lAtE 

DIAGNOSIS, lESS GUIDElINES APPlICAtIONS AND WORSE PROGNOSIS. 

A. Lichter, A. L. P. Ribeiro, H. P. M. Pena, M. A. M Andrade. 

P772 AMBUlAtORy BlOOD PRESSURE (ABPM) IN HIGH RISk PAtIENtS. IMPROVEMENt OF 24 H 

PROFIlE WItH INtENSIVE tREAtMENt 

M. Baroni, C. Cruz, M. Gaute, SALA J, C. Balestrini, C. Serra, M. Bendersky. 

P773 IMPROVEMENt OF VASCUlAR RISk FACtORS MANAGEMENt tHROUGH A StROkE 

PREVENtION PROGRAM. PROGRAMA INtEGRAl GENERAl DE ACV (PROtEGE-ACV) 

M. Zurru, C. Alonzo, L. Brescacin, M. Romano, J. Rojas, MvPiaggio, M. Schneider, L. Camera, G. Waisman, E. Cristiano.


P775 ACUtE MyOCARDIAl INFARCtION IN A NON-PCI HOSPItAl 

AC Alberto Caccavo, CAA Carlos Alejandro Alvarez, RU Rogelio Urizar, AMC Alicia Maria Carrique, 

S. A. L. Sergio A. Lasdica, F. H. B. Facundo Horacio Bello, A. E. F. Adriana Elizabeth Ferrari. 

P776 ENDOtHElIAl FUNCtION IN A MODEl OF SyStEMIC INFlAMMAtION 

R. A. Sarmiento, A. Capuccio, R. Solerno, M. Fenucci, A. Perrone, F. Exposito, A. Videla Lynch, L. Balletti, 

A. Cherro, M. Larroude. 

P777 tHE CHADS 2 SCORE AS PREDICtOR OF StROkE RECURRENCE: GENDER COMPARISON 

M. zurru, J. Rojas, M. Romano, L. Patrucco, E. Cristiano. 

P779 RIGHt VENtRICUlAR HyPERtROPHy AlONE AS A NEW FORM OF PRESENtAtION OF 

HyPERtROPHIC CARDIOMyOPAtHy. 

M. C. Saccheri, T. F. Cianciulli, I. V. Konopka, R. S. Acunzo, R. J. Mendez, J. A. Gagliardi, L. A. Morita, 

H. A. Prezioso, M. V. Elizari, L. A. Vidal. 

P780 ClINICAl SIGNIFICANCE OF tISSUE DOPPlER IMAGING IN PAtIENtS WItH CHAGAS DISEASE. 

T. F. Cianciulli, J. A. Lax, M. C. Saccheri, M. A. Beck, L. A. Morita, N. G. Prado, A. R. Riarte, A. N. Dorelle, 


P781 lEFt VENtRICUlAR tACHyCARDIA IN “StRUCtURAlly NORMAl HEARtS”: 

IN SEARCH OF tHE lOSt SUBStRAtE. 

J. Petriz, O. Souza, A. Casarsa, A. Serra, A. Glavan, L. Pereira, L. Mendonça, J. Moll. 

P782 HIGH SENSItIVIty C - REACtIVE PROtEIN AND ASyMPtOMAtIC AtHEROSClEROSIS 

EVAlUAtED FOR ENDOtHElIAl DySFUNCtION AND CAROtID INtIMA MEDIA tHICkNESS 

D. E. Lopez, G. Scianca, C. Sturgeon, D. Morisse, D. Avayu. 

P783 BEtABlOCkERS IN ADMISSIONAl tREAtMENt OF ACUtE HEARt FAIlURE: SECURIty AND 

ClINICAl BENEFItS 

M. Montera, S. Bernardez, M. Scofano, V. Barzilai, A. Volschan, E. Mesquita. 

P784 NOCtURNAl BlOOD PRESSURE (BP) IN PAtIENtS WItH NO ANtIHyPERtENSIVE tREAtMENt 

M. Cruz, M. Baroni, J. Sala, C. Balestrini, C. Serra, M. Bendersky. 

P785 A QUAlItAtIVE SyStEMAtIC REVIEW INtO HElPSEEkING DURING HEARt FAIlURE : 

BARRIERS AND FACIlItAtORS tO PROMPt tREAtMENt 

A. M. Clark, L. Svard, S. Heath, F. McAlister, J. Spiers. 

P786 QUAlIty OF CARE: ACUtE CARDIAC FAIlURE tREAtMENt IN A CARDIAC FAIlURE UNIt 

M. Montera, S. Bernardez, V. Barzilai, A. Volshan, M. Scofano, E. Mesquita, A. Ribeiro. 

P787 COSt EVAlUAtION OF ACUtE CARDIAC FAIlURE tREAtMENt IN A CARDIAC FAIlURE UNIt 

M. Montera, S. Bernardez, I. Marques, E. Mesquita. 



P788 IMPACt OF GENDER ON CORONARy ARtERy ByPASS RESUltS.DIFFERENCES BEtWEEN MEN 

AND WOMEN. 

E. Gabe, M. Santos, J. Abud, E. Dulbecco, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen, 


P789 CORONARy ARtERy ByPASS SURGRy. ClINICAl RISk PREDICtORS OF IN-HOSPItAl 

MORtAlIty. 

E. Gabe, M. Santos, E. Dulbecco, J. Abud, H. Raffaelli, M. Rodriguez Acuña, A. Arnedo, F. Robles, R. Boughen, 


P790 ASPIRIN RESIStANCE RECOVERS IN tHE CHRONIC PHASE OF MyOCARDIAl INFARCtION 

B. Skoric, D. Lovric, K. Narancic Skoric, J. Sertic, D. Milicic. 

P792 lV REMODEllING FEAtURES IN AtHlEtES AND HyPERtENSIVE SUBJECtS 

N. Sharashidze, Z Pagava, G Mamaladze, T Kishmareia, G Saatashvili. 

P793 HEARt FAIlURE IN POPUlAtION OVER 50 yEARS IN BUlGARIA 

M. Grigorov, J. Uzunangelov, A. Velkova, M. Tsekova, S. Djambazov, V. Bratanova, A. Bajkova. 

P795 SHORt-tERM EFFECtS OF A lOW INtENSIty PHySICAl ACtIVIty 

PROGRAM ON CARDIOMEtABOlIC PROFIlE OF SEDENtARy PAtIENtS 

WItH MEtABOlIC SyNDROME 

C. M. Colombo, R. Macedo, A. M. Caporal, J. R. Faria Neto. 

P796 CENtRAlIzAtION OF INVASIVE CARDIAC CARE RESUltS IN lESS INVASIVE tREAtMENt IN 

AREAS WItH ONly REFERRAl HOSPItAlS 

A. Hvelplund, J. N. Rasmussen, S. Rasmussen, S. Z. Abildstrøm, M. Madsen, S. Galatius, J. K. Madsen. 

P797 CHARACtERIStICS AND DyNAMICS OF RESIStANCE tO ANtIPlAtElEt DRUGS IN 

PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION tREAtED WItH StANDARD DOSES OF 

ACEtylSAlICylIC ACID AND ClOPIDOGREl 

D. Milicic, B. Skoric, D. Lovric, K. Narancic Skoric, J. Sertic. 

P798 DISCRIMINAtING VAlUE OF CAROtID INtIMA-MEDIA tHICkNESS IN PRE- AND 

POStMENOPAUSAl WOMEN WItH SUSPECtED CORONARy ARtERy DISEASE 

A. Kablak-ziembicka, T. Przewlocki, W. Tracz, P. Pieniazek, P. Musialek, A. Sokolowski, D. Rzeznik, R. Drwila. 

P799 DOES AMBUlAtORy BlOOD PRESSURE PREDICt lEFt VENtRICUlAR DIAStOlIC 

DySFUNCtION INDEPENDENt OF CONVENtIONAl BlOOD PRESSURE IN GROUPS 

OF AFRICAN DESCENt? 

E. Libhaber, C. Libhaber, O. H. Majane, M. J. Maseko, M. R. Essop, P. Sareli, G. R. Norton, A. J. Woodiwiss. 

P800 AtHEROSClEROtIC PlAQUE INStABIlIty MAy NOt BE CONFINED tO CORONARy ARtERIES 

ONly, BUt MAy AlSO INVOlVE OtHER ARtERIAl DIStRICtS. 

A. Drzewiecka-Gerber, A. Rybicka-Musialik, J. Krauze, J. Myszor, M. Trusz-Gluza.


P802 lAtE GADOlINIUM ENHANCEMENt PREDICtS All CAUSE MORtAlIty IN PAtIENtS WItH 

HEARt FAIlURE AND SyStOlIC DySFUNCtION OF UNCERtAIN EtIOlOGy 

M. Nadal, A. Valle, J. Estornell, C. Soriano, N. Martinez, V. Jacas, A. Laynez, M Corbi, R. Paya, F. Ridocci-Soriano. 

P803 CORElAtION OF HyPONAtREMIA WItH SHORt tERM (30 DAyS) MORtAlIty AMONG tHE 

PAtIENtS OF ACUtE St ElEVAtION MyOCARDIAl INFARCtION. 

y. Varma, B. S. Yadav, T. Rajarajan, G. Singh, R. Gupta, R. K. Shrivastava, V. K. Sharma, R. S. Meena, 

T. N. Dube, R. K. Jain. 

P804 lAtE GADOlINIUM ENHANCEMENt CARDIOVASCUlAR MAGNEtIC RESONANCE IS USEFUl 

tO DIFERENCIAtE lEFt VENtRICUlAR SyStOlIC DySFUNCtION RElAtED tO CORONARy 

ARtERy DISEASE FROM DIlAtED CARDIOMyOPAtHy IN PAtIENtS WItH ACUtE NEW ONSEt 

CONGEStIVE HEARt FAIlURE. 

A. Valle, M. Nadal, J. Estornell, C. Soriano, N. Martinez, A. Trigo, R. Romaguera, J. Perez, R. Paya, F. Ridocci-Soriano. 

P805 tHE DIABEtES-CARDIOVASCUlAR RISk PARADOX: RESUltS FROM A FINNISH POPUlAtION- 

BASED PROSPECtIVE StUDy 

N. C. Barengo, S. Katoh, V. Moltchanov, N. Tajima, J. O. Tuomilehto. 

P806 EARly SURGICAl MANAGEMENt OF ANAtOMICAlly COMPlEtE VASCUlAR RINGS 

T. Tsai, F. Chen, J. Yu. 

P807 MICROAlBUMINURIA- CARDIOMEtABOlIC SyNDROME; INDEPENDENt MARkER OF 

CARDIOVASCUlAR RISk 

V. Raos, T. Katic, O. Jaksic, B. Vitunjski-Englert, M. Raguz, J. Sikic-Vagic, M. Bergovec. 

P808 AUtOlOGOUS INtRAMyOCARDIAl tRANSPlANtAtION OF BONE MARROW MONONUClEAR 

StEM-CEllS FOR DIlAtED CARDIOMyOPAtHy – tECNIQUE AND EARly RESUltS 

R. Kalil, D. Ott, R. Sant’Anna, E. Dias, J. Fracasso, A. Cañedo, N. Nardi, J. Sant’Anna, P. Prates, I. Nesralla. 

P809 EFFECtS OF HyDROXyMEtHylGlUtARyl COENzyME A REDUCtASE INHIBItORS IN 

REDUCtION OF INFlAMMAtORy RESPONSE tO CARDIOPUlMONARy ByPASS 

G. Teixeira, R. Kalil, P. Prates, J. Sant’Anna, L. Pellanda, A. Neto, I. Nesralla. 

P810 CORRElAtION OF FEMORAl AtHEROSClEROSIS AND SEVERIty OF CAD QUANtIFIED By 

GENSINI SCORE 

M. Vrkic Kirhmajer, L. J. Banfic, M. Vojkoviæ, M. Strozzi, J. Bulum, K. Putarek, T. Simoncek. 

P811 lEFt VENtRICUlAR tORSION DyNAMICS IN PAtIENtS WItH FABRy’S DISEASE 

y. zocalo, E. Guevara, D. Bia, A. Fernandez, J. Casabe, J. Politei, G. Cabrera, R. Armentano. 

P812 tHE CHANGE IN FRACtIONAl FlOW RESERVE CAN PREDICt lESION SEVERIty 

AND lONG tERM PROGNOSIS 

S. A. Kocaman, A. Sahinarslan, T. Timurkaynak. 



P813 PROGNOStIC VAlUE OF lEFt VENtRICUlAR DIAStOlIC DISFUNCtION FOR ADVERSE 

CARDIAC EVENtS 

A. Berger-Kucza, K. Wita, M. Turski, M. Trusz-Gluza. 

P814 DEtERMINANtS OF lEFt EARly AND lAtE VENtRICUlAR REMODElING IN PAtIENtS WItH 

ACUtE MI tREAtED WItH PRIMARy PCI 

A. Berger-Kucza, W. Wróbel, M. Nowak, M. Trusz-Gluza. 

P815 BIOFIElD (AURA) SCANNING FOR PREVENtIVE AND PRIMARy INVEStIGAtION 

OF HEARt PAtIENtS AND 

S. Vaidya, V Marathe. 

P816 tHROMBUS ASPIRAtION FOR MICROVASCUlAR PROtECtION IN PAtIENtS 

WItH ACUtE MI UNDERGOING EARly PRIMARy PCI. 

A. Berger-Kucza, M Lelek, K Wita, M Trusz-Gluza. 

P817 IMPAIRED MORNING ARtERIAl DIStENSIBIlIty ADJUStMENt IN 

HyPERtENSIVE PAtIENtS 

D. Bia, S. Lluberas, Y. Zocalo, M. Zabalza, R. Armentano. 

P818 PREVAlENCE OF MEtABOlIC SyNDROME IN ADOlESCENtS OF 

RIO DE JANEIRO CIty, BRAzIl 

D. G. Denise Giannini, M. S. Moysés Szklo, M. C. K. Maria Cristina Kuschnir. 

P819 tHE IMPACt OF DIFFUSE CORONARy ARtERy DISEASE ON FRACtIONAl 

FlOW RESERVE 

A. Sahinarslan, S. A. Kocaman, T. Timurkaynak. 

P820 SCREENING OF ISCHAEMIC HEARt DISEASE IN C HRONIC ARSENICOSIS PAtIENtS 

S. Kole, R. Dutta, S. K. Roy, S. K. Biswas, A. Ghosh, A. Kundu, S. Gupta, B. Sarkar. 

P821 CADIllAC RISk SCORE AND REGIONAl PERFUSION SCORE INDEX 

A. Berger-Kucza, M. Turski, K. Wita, M. Trusz-Gluza. 

P822 kISSING BAllON OVEREXPANSION IN PROVISIONAl t-StENtING: EXPERIENCES 

IN A BENCH MODEl 

M. zehetgruber, B. Pausa, B. Frey. 

P823 AMElIORAtING MORBIDIty AND ABOlISHING HOSPItAl MORtAlIty ASSOCIAtED tO ISOlAtED 

G. Gonzalez-Stawinski, L. Vargas, E. Nowicki, B. Lytle, J. Navia, G. Pettersson, L. Svensson, A. Gillinov, N. Smedira, 

J. Sabik. 

P825 WOMEN RECEIVE lESS INVASIVE tREAtMENt AFtER FIRSt ACUtE MyOCARDIAl INFARCtION 

A. Hvelplund, J. N. Rasmussen, S. Rasmussen, S. Z. Abildstrøm, M. Madsen, S. Galatius, J. K. Madsen.


P826 PROXIMAl NEUROPROtECtION AS tHE SyStEM OF CHOICE IN HIGH RISk CAROtID ARtERy 

StENtING: RESUltS FROM AN ACADEMIC CENtER REGIStRy OF 143 PROXIMAl– AND 412 

DIStAl–NEUROPROtECtED CAS 

P. Pieniazek, P. Musialek, A. Kablak-Ziembicka, L. Tekieli, T. Przewlocki, A. Lesniak-Sobelga, B. Biernacka, K. Zmudka, 

W. Tracz. 

P827 PSyCHOlOGy IN tHE CARDIAC tRANSPlANtAtION PROGRAM 

S. Bordignon, P. Ruschel, L. Lima, S. Wottrich, R. Machado, E. Vigueras, P. Cordeiro, V. Porto, S. Fonseca, I. Nesralla. 

P828 EARly MyOCARDIAl OXIDAtIVE StRESS PROFIlE At 48H POSt-EXPERIMENtAl INFARCtION 

IN RAtS AND tHE EFFECtS OF CEllUlAR tHERAPy 

A. M. V. Tavares, P. C. Schenkel, A. C. Taffarel, R. Dall’ Alba, G. Nicolaidis, G. Baldo, U. Matte, A. Belló-Klein, 

L. E. Rohde, N. Clausell. 

P829 HEARt RAtE RECOVERy ON tHE FIRSt MINUtE IN tHE SIX MINUtES WAlk tESt IN PAtIENtS 

WItH CHRONIC HEARt FAIlURE 

S. Chermont, S. Lindemberg Malfacini, M. Pena Quintão, M. De Rossi, S Guilhon, M. M. Veloso, P. L. C. Teixeira, 

S. Bernardez, A. C. Lucas Da Nobrega, E. T. Mesquita. 

P830 CHRONIC HEPAtItIS C INFECtION IS ASSOCIAtED WItH INCREASED CORONARy ARtERy 

AtHEROSClEROzIS DEFINED By MODIFIED REARDON SEVERIty SCORE 

F. Kacmaz, O. Alyan, B. Deveci, O. Ozdemir, R. Astan, A. S. Celebi, E. Ilkay. 

P831 SOCIAl INDICAtORS OF PAtIENtS IN CARDIAC tRANSPlANtAtION WAItING lISt ASSIStED 

By SOCIAl SERVICE OF IC/FUC 

S. Bordignon, V. Porto, S. Fonseca, L. Lima, J. Vieira, P. Ruschel, P. Cordeiro, I. Nesralla. 

P832 IMPACt OF ANGIOtENSIN-CONVERtING ENzyME INHIBItOR USE ON tHE INCIDENCE OF 

AtRIAl FIBRIllAtION IN tHE EARly POStOPERAtIVE PERIOD OF ElECtIVE CARDIAC SURGERy 

F. R. França, R. J. Alves, R. N. Campos, R. B. Piveta, N. Kenji. 

P833 INCREASED S100B SERUM lEVElS IN DIlAtED CARDIOMyOPAtHy PAtIENtS 

S. Bordignon, G. Mazzini, D. Schaf, E. Horowitz, F. Bacal, R. Bruch, C. Gonçalves, D. Souza, L. Portela. 

P834 lAtE RESUltS OF ENDOVENtRICUlAR PAtCH PlASty REPAIR IN AkINEtIC AND DySkINEtIC 

AREAS AFtER ACUtE MyOCARDIAl INFARCtION 

S. Bordignon, P. Prates, A. Homsi-Neto, L. Lovato, G. Teixeira Filho, J. Sant’Anna, L. Yordi, R. Kalil, I. Nesralla. 

P835 tHE EFFECt Ol VAlSARtAN IN PAtIENtS WItH PUlMONARy HyPERtENSION 

L. Koldas, F. Ayan, G. Bozkurt, I. Basar. 

P836 tHE ISCHEMIC RAt HEARt RElEASES S100B 

S. Bordignon, G. Mazzini, D. Schaf, A. Oliveira, C. Gonçalves, A. Belló-Klein, R. Bruch, G. Campos, D. Souza, 

L. Portella. 



P837 GENE EXPRESSION PROFIlING IN AtRIAl FIBRIllAtION PAtIENtS WItH StRUCtURAl HEARt 

DISEASES. 

M. Kharlap, L. Goryunova, A. Timofeeva, G. Smolyanova, G. Khaspekov, S. Dzemeshkevich, R. Akchurin, V. Ruskin, 

S. Golitsyn, R. Beabealashvilli. 

P838 ANGIOGRAPHIC PUlMONARy ANAtOMy IN PUlMONARy AtRESIA WItH VENtRICUlAR 

SEPtAl DEFECt. A USEFUl ClASSIFICAtION AND SURGICAl APPROACH. 

Marco Aurelio Santos, Vitor Manuel Pereira Azevedo, José Geraldo De Castro Amino, Maria Ourinda M. Da Cunha, 

Rogério Brant Martins Chaves, Maria Cristina C. Kuschnir, Renato Kaufman, Bernardo Rangel Tura, 

Regina Maria De Aquino Xavier. 

P839 REFlECtIONS ON StRAtEGIES OF PSyCHOSOCIAl REHABIlItAtION OF tHE tRANSPlANt 

PAtIENt, FROM My EXPERIENCE AS A VOlUNtEER IN A SUPPORtIVE HOUSE. 

M. Machado, C. Garcez, M. Tatsch, S. Macin, L. Rosa, N. Antunes, A. Alvim, J. Souza. 

P840 COMPARISON OF lEFt VENtRICUlAR EJECtION FRACtION EVAlUAtED By DUAl SOURCE Ct 

AND tWO-DIMENSIONAl ECHOCARDIOGRAPHy 

R. Duchonova, K. Linhartova, L. Martinkovicova, T. Adla, J. Neuwirth, J. Veselka. 

P842 ElECtIVE ElECtRICAl CARDIOVERSION PROtOCOl: QUAlIty INDICAtOR IN 

A CARDIAC EMERGENCy DEPARtMENt 

K. Andrade, A. Pinheiro, A. Volschan, M. F. Muiño, V. Mattos, C. Almeida, G. Trancoso, S. Simas. 

P843 ACUtE EFFECtS FROM WEANING OF MECHANICAl VENtIlAtION By HOltER ANAlySIS 

G. A. Tinoco, M. P. Quintão, C. L. Oliveira, A. Torrão, J. C. Pereira, J. M. Linhares, L. N. De Barros, R. Tinoco, 

E. T. Mesquita, S. Chermont. 

P845 SIzE OF MyOCARDIAl INFARCtION BUt NOt tRANSMURAlIty IS ASSOCIAtED WItH lOWER 

lEFt VENtRICUlAR EJECtION FRACtION AND HIGHER SPHERICIty INDEX 

D. Perez De Arenaza, M. Pietrani, M. Falconi, P. Pollono, J. Moon, FvAbramzon, P. Oberti, L. Grinfeld, 

R. Garcia-Monaco, A. Cagide. 

P846 PyRIDOStIGMINE INCREASES BAROREFlEX SENSItIVIty AND IMPROVES AUtONOMIC 

BAlANCE AFtER MyOCARDIAl INFARCtION IN RAtS 

R. N. De La Fuente, I. C. M. Silva, L. E. De Souza, G. O. Candido, R. A. Sirvente, B. Rodrigues, E. M. Krieger, 

S. Lacchini, M. C. Irigoyen. 

P847 COMPARISON BEtWEEN HIGH RESOlUtION MODEl AND tRADItIONAl HEAltH SyStEM 

MODEl IN AN OUtPAtIENt CONSUltAtION DEPARtMENt OF CARDIOlOGy. EXPERIENCE 

OF 5 yEARS 

G. A. Cortez Quiroga, C. Rus Mansilla, M. M. Martinez Quesada, G. Lopez Moyano, M. Delgado Moreno, 

E. Ruiz De Temiño De Andres, D. Sevilla Ruiz, M. Gavilan Perez, C. Recuerda Casado.


P848 CAlCIUM-DEPENDENt tyROSINE kINASE Pyk2 PlAyS CRUCIAl ROlE IN ANGIOtENSIN II- 

BUt NOt NOREPINEPRINE-MEDIAtED ACtIVAtION OF RAC/SUPEROXIDE PAtHWAy tHAt 

DIFFERENtIAlly REGUlAtES BlOOD PRESSURE AND VASOCONStRICtION 

A. Matsui, M. Okigaki, A. Katsume, H. Yamada, H. Matsubara. 

P849 ENDOMyOCARDIAl FIBROSIS – MISSED DIAGNOSIS 

V. Vaghela, K. Sliwa, R. Mvungi. 

P850 CRItICAl AORtIC StENOSIS IN INFANCy – HOW SMAll CAN lEFt VENtRIClE BE, AND StIll 

BE ADEQUAtE tO SUPPORt tHE CIRCUlAtION AFtER AN AORtIC VAlVOtOMy. 

Marco Aurelio Santos, Vitor Manuel Pereira Azevedo, José Geraldo De Castro Amino, Maria Ourinda Mesquita 

Cunha, Rogério Brant Martins Chaves, Renato Kaufman, Maria Cristina C. Kuschnir, Bernardo Rangel Tura, 

Regina Maria De Aquino Xavier. 

P853 CARDIOPROtECtIVE ACtION OF INtERlEUkIN-1BEtA IN ADAPtAtION tO CARDIAC PRESSURE 

OVERlOAD StRESS By ACtIVAtION OF IGF-1/Akt PAtHWAy 

S. Honsho, S. Nishikawa, M. Okigaki, A. Matsui, H. Matsubara. 

P855 EFFECtS OF CARVEDIlOl ON QUAlIty OF lIFE AND ClINICAl OUtCOMES IN ElDERly 

PAtIENtS WItH CHRONIC HEARt FAIlURE 

N. Ganugrava, I. Jashi, B. Kobulia, R. Abashidze, G. Tabidze. 

P857 ADHERENCE tO SElECtIVE CRItERIA FOR tHE USE OF DRUG-ElUtING StENtS RESUltS IN 

lOW RAtES OF tARGEt VESSEl REVASCUlARISAtION 

J. Gohil, K. Kadappu, Q. Lo, D. Tobing, S. Lo, A. P. Hopkins, D. Leung, C. P. Juergens, J. K. French. 

P858 ASSESSMENt OF MyOCARDIAl DySFUNCtION IN PAtIENtS WItH NON-St SEGMENt 

ElEVAtION MyOCARDIAl INFARCtION USING SERUM B-tyPE NAtRIUREtIC PEPtIDE lEVEl 

B. Kim, B. Lee, C. Goh, Y. Byun, K. Rhee. 

P859 COSt-EFFECtIVENESS OF 64- MUltISlICE SlICE CORONARy Ct ANGIOGRAPHy At 

EMERGENCy WARD COMPARED tO StANDARD MANAGEMENt IN lOW RISk PAtIENtS WItH 

ACUtE CHESt PAIN 

D. Perez De Arenaza, M . Falconi, F. Abramzon, P. Pollono, A. Fernandez, PvOberti, LvGrinfeld, R. Garcia’Monaco, 

J. Krauss, A Cagide. 

P860 CORRElAtION OF HEARt RAtE WItH CARDIOVASCUlAR RISk FACtORS 

A. Kalvelis, G. Bahs, I. Stukena, A. Lejnieks, U. Teibe. 

P862 HUMAN AORtA tRANSCRIPtOME PROFIlES OF DIFFERENt AtHEROSClEROtIC lESIONS 

tyPES. 

A. Timofeeva, L. Goryunova, G. Khaspekov, O. Ilyinskaya, V. Sirotkin, E. Tararak, R. Beabealashvilli. 



P863 tHE USE OF CONtRASt IN REAl-tIME AND IN BOlUS FOR QUANtIFICAtION AND 

QUAlIFICAtION OF MyOCARDIAl FlOW: COMPARISON WItH GAtED-SPECt AND 

ANGIOGRAPHy. 

A. Camarozano, A. Soares, D. Bastos, A. Cantisano, C. Oliveira, EvSanson, L. H. Weitzel. 

P864 MODUlAtION OF MONOCROtAlINE INDUCED COR PUlMONAlE By GRAPE JUICE 

A. Belló-Klein, A. R. Lenhenbauer-Lüdke, R. Caron-Lienert, F. Mosele, T. R. Fernandes, W. Partata, M.F. Ribeiro. 

P865 COSt EFFECtIVENESS ANAlySIS OF CAROtID DOPPlER UltRASOUND EXAMINAtIONS IN 

PAtIENtS WItH SIGNIFICANt lEFt MAIN CORONARy ARtERy StENOSIS 

A. L. V. Oliveira, M. S. Bittencourt, A. C. Pereira, L. A. M. Cesar, L. H. W. Gowdak. 

P866 99 tC-SEStAMIBI DIPyRIDAMOlE MyOCARDIAl PERFUSION SINGlE-PROtON EMISSION 

tOMOGRAPHy AND CORONARy COMPUtED tOMOGRAPHy ANGIOGRAPHy SCANNING IN 

DEtECtION OF AllOGRAFt CORONARy ARtERy DISEASE AFtER DEARt tRANSPlANttION 

A. Tangari, G. S. Fernandes, C. A. M. Cattani, J. P. Silva, J. C. Brigante, L. Fonseca, J. A. Bottega. 

P867 PREDICtORS OF MORtAlIty FROM MyOCARDIAl PERFUSION GAtED-SPECt IN PAtIENtS 

WItHOUt PREVIOUS MyOCARDIAl INFARCtION 

P. Pujol, G. Cuberas, G. De León, R. Falú, S. Aguedé-Bruix, J. Castell-Conesa, J. Candell-Riera. 

P868 VAlSAlVA MANEUVER PREDICtS EXERCISE lEFt VENtRICUlAR OUtFlOW tRACt 

OBStRUCtION IN PAtIENtS WItH HyPERtROPHIC CARDIOMIOPAtHy 

F. Vaisbuj, A. Fernandez, J. H. Casabe, M. Bustamante Labarta, G. Bozovich, F. Landeta, R. Peidro, G. Fava, E. Guevara. 

P869 CytOkINE NEtWORk GENES ARE ASSOCIAtED WItH SUSCEPtIBIlIty tO ESSENtIAl 

HyPERtENSION IN tAtARS FROM BASHkORtOStAN (RUSSIA) 

y. R. Timasheva, T. R. Nasibullin, A. N. Zakirova, O. E. Mustafina. 

P870 CARDIOVASCUlAR REHABIltACION POSt CARDIAC tRANSPlANtAtION 

G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, F. Bethencourt, M. Diez, L. Favaloro, R. Favaloro. 

P871 NUtRItIONAl PROFIlE OF PAtIENtS IN tHE WAItING lISt FOR HEARt tRANSPlANtAtION 

S. Bordignon, P. Cordeiro, P. Borges, V. Porto, S. Fonseca, E. Horowitz, L. Lima, J. Vieira, P. Ruschel, I. Nesralla. 

P872 PUlSE OXIMEtRIE IN SIX MINUtES WAlk tESt ASSOCIAtED WItH EXERCISE tOlERANCE IN 

OUtPAtIENtS WItH CHRONIC HEARt FAIlURE 

S. Chermont, S. Guilhon, M. P. Quintão, M. De Rossi, P. Teixeira, S. Lindemberg, S. Bernardez, D. A. Bastos, P. P. Soares, E. T. Mesquita. 

P873 QUANtIFICAtION OF SAVED MyOCARDIUM AFtER PRIMARy ANGIOPlASty WItH 

MyOCARDIAl PERFUSION GAtED-SPECt. PRElIMINARy RESUltS. 

P. Pujol, G. De León, S. Aguadé-Bruix, B. García Del Blanco, S. Rossi, R. Falú, J. Figueras, J. Castell-Conesa, 

J. Candell-Riera.


P875 ClINICAl CHARACtERIStICS OF PAIN IN MEN AND WOMEN ADMIttED tO A CHESt PAIN UNIt 

M. F. Larin, E. Ludueña Clos, C. Kudrle, G. M. Ferrari, H. Avaca, B. Lopez Ledesma, M. Gingins, EvBrunel, 

J. D. Humphreys, O. Manuale. 

P876 EFFICACy AND SAFEty OF DRUG ElUtING StENtS FOR tHE tREAtMENt 

OF DIFFUSE IN-StENt REStENOSIS. INFlUENCE OF DIABEtES ON lONG-tERM OUtCOME. 

G. Schipani, F. Azzari, D. Chambre, A. Fernandez, E. Torresani, S. Brieva, R, Nauwerk, Horacio Pomes Iparraguirre, 

C. Barrero, J. Leguizamon. 

P877 ENERGEtICS OF ISCHEMIA-REPERFUSION IN RAt NEONAtAl HEARtS: DIFFERENCES IN CA 

HOMEOStASIS 

A. E. Consolini, P. Bonazzola. 

P878 PROFESSIONAl DIVERS WItH HIStORy OF DECOMPRESSION SICkNESS HAVE MUCH 

MORE HIGHER PREVAlENCE OF RIGHt tO lEFt SHUNt tHAN IN tHOSE WItHOUt SUCH 

EVENt AND REAVEAl FAVOURABlE OUtCOME DURING MID-tERM FOllOW-UP AFtER tHE 

tRANSCAtHEtER ClOSURE 

J. Fiedler, T. Honìk, K. Linhartová, J. Veselka. 

P879 SUB-ClINICAl MIOCARDItIS DUE tO DENGUE INFECtION 

J. Galeano, J. Ortellado, M. Paniagua, I. Lovera, C. Rodriguez. 

P880 PROCAlCItONIN IS A MARkER OF INFECtION AFtER SURGERy FOR VAlVUlAR HEARt 

DISEASE IN A PREDOMINNAtly RHEUMAtIC POPUlAtION. 

G. Spina, F. Tarasoutchi, L.F. Moreira, R. O. Sampaio, F. Bertanha, V. M. Jonke, C. Strunz, M. Grinberg. 

P881 GENDER DIFFERENCES OF CARDIOVASCUlAR RISk PROFIlE IN lItHUANIA 

S. Kutkiene, Z. Petrulioniene, J. Badariene, V. Dzenkeviciute. 

P882 MISClASSIFICAtION OF ISCHAEMIC HEARt DISEASE MORtAlIty IN BRAzIl 

A. R. N. Migowski Rocha Dos Santos, BERNARDO Rangel Tura, CARLOS Alberto Moreira Magalhães, 

MÁRCIA Cristina C. Macedo Pinheiro, MARIA Cristina Kuschnir, REGINA Maria Aquino Xavier, ROGÉRIO Brant 

Chaves, VITOR Manuel Pereira Azevedo. 

P883 RElAtION BEtWEEN PAtIENtS BASElINE CHARACtERIStIC AND PRE-HOSPItAl tREAtMENt 

AND tHE OCCURRENCE OF NO-REFlOW AFtER PRIMARy PERCUtANEOUS INtERVENtION IN 

PAtIENtS WItH PRE-HOSPItAl DIAGNOSIS By MEANS OF ECG tElEtRANSMISSION 

L. Malek, M. Karcz, P. Bekta, M. Klopotowski, M. Skwarek, M. Dabrowski, K. Kukula, A. Witkowski,. W Ruzyllo. 

P884 A StUDy OF tHE PERCEPtION OF tHE HEARt tRANSPlANtAtION PAtIENt tHROUGH tHE 

FAMIly CAREtAkER. 

S. Bordignon, P. Ruschel, L. Lima, A. Souza, C. Thomas, C. Seelig, E. Vigueras, P. Cordeiro, S. Fonseca, I. Nesralla. 



P885 SPECt MyOCARDIAl PERFUSION AND PUlMONARy VENtIlAtION PERFUSION SCINtIGRAPHy 

FOR DIFFERENtIAl DIAGNOSIS BEtWEEN CORONARy ARtERy DISEASE VS. PUlMONARy 

EMBOlISM 

P. Pujol, S. Valdivielso, G. De León, R. Falú, S. Aiguadé-Bruix, J. Castell-Conesa, J. Candell-Riera. 

P886 IMPACt OF INSUlIN RESIStANCE AND NONAlCOHOlIC FAtty lIVER DISEASE ON lEFt 

VENtRICUlAR DIAStOlIC DySFUNCtION IN NON-OBESE PAtIENtS 

G. Roytberg, O. Sharkhun, T. Ushakova, D. Sobolev, O. Platonova. 

P887 MUltISlICE COMPUtED tOMOGRAPHIC CHARACtERIStICS OF CORONARy ARtERy lESIONS 

AND PAtHOPHySIOlOGy INSIGHtS tO tAkO-tSUBO lIkE lEFt VENtRICUlAR DySFUNCtION 

P. Avellana, C. Tajer, D. Santos, P. Carrascosa, A. Deviggiano, C. Capuñay, A. Pocoví, M. De Abreu, O. Santaera, 

L. Antonietti. 

P888 ANtIHyPERtENSIVE EFFICACy OF tHE DIRECt RENIN INHIBItOR AlISkIREN IN PAtIENtS 

WItH DIABEtES, MEtABOlIC SyNDROME OR OBESIty: A POOlED ANAlySIS OF 10 

RANDOMIzED tRIAlS 

M. R. Weir, M. F. Prescott, C. Bush, V. Arora, D. L. Keefe. 

P889 RHytHM CONtROl StRAtEGy IS NOt DIFFERENt OF RAtE CONtROl StRAtEGy: 

A lONG-tERM FOllOW UP COHORt StUDy 

M. Falconi, P. Oberti, R. Pizarro, A. Arias, F. Achilli, D. Perez De Arenaza, G. Jaimovich, S. Quevedo, J. Krauss, 

A. Cagide. 

P890 VISCERAl FAt IN HyPERtENSIVE AND PREHyPERtENSIVE OBESE PAtIENtS 

G. Simonyi, J. R. Bedros, M. Medvegy, L. Halmy. 

P891 CARDIOVASCUlAR REHABIlItAtION POSt CARDIAC tRANSPlANtAtION: FOllOW UP AND 

DROP OUt 

G. Brion, R. Peidro, A. Angelino, D. Motta, E. Navia, P. Diaz Uberti, M. Diez, L. Favaloro, R. Favaloro. 

P892 MAtERNAl HEARt DISEASE AND PREGNANCy OUtCOME: A SINGlE- 

V. Stangl, J. Schad, G. Gossing, A. Borges, G. Baumann, M. Laule, K. Stangl. 

P893 lONG tERM FOllOW-UP AFtER SURGICAl tREAtMENt FOR IDIOPAtHIC DIlAtAtION OF tHE 

RIGHt AtRIUM 

E. Mesquita, A. C. Rodrigues, V. Schubsky, H. Korkes, M. Barbero-Marcial, S. A. Oliveira, E. Lira, C. Fisher, M. Vieira, 

S. Morhy. 

P895 PROGNOStIC IMPORtANCE OF WEIGHt lOSS IN PAtIENtS WItH HEARt FAIlURE AND 

DIFFERENt PRE HEARt FAIlURE BODy MASS 

P. Rozentryt, J. U Nowak, S. Von Heahling, J. Sikora, A. John, U. Wilczek, L. Polonski, S. D Anker.


P896 ACE INHIBItION REVERtS CARDIAC DAMAGE IN EXPERIMENtAl DIABEtES: ROlE OF 

AUtONOMIC MODUlAtION 

C. Malfitano, R. B. Wichi, K. Rosa, C. Mostarda, K. De Angelis, M. C. Irigoyen. 

P897 SUCCESSFUl PERCUtANEOUS BAllOON FENEStRAtION FOR AORtIC DISSECtION 

PRESENtING AS ClAUDICAtION 

B. Kim, B. Lee, C. Goh. 

P900 tHE EFFECt OF lIVING IN tHE HIGH PlAtEAU ON CARDIOVASCUlAR SyStEM 

G. A. Gamez Aldo, C. N. Cellino Natalia. 

P901 PRIMARy ANGIOPlASty IN PAtIENtS PRESENtING lAtE AFtER ONSEt OF CHESt PAIN AND 

St ElEVAtION MyOCARDIAl INFARCtION – kAMI REGIStRy 

B. Kim, C. Goh, YvByun, M. H. Jeong, B. Lee. 

P902 CORRElAtION BEtWEEN PlASMA HOMOCyStEINE, CARDIOVASCUlAR RISk FACtORS AND 

CARDIOVASCUlAR DISEASE IN AN ADUlt POPUlAtION FROM BUENOS AIRES. 

L. Gariglio, O. Fridman, M. Potenzoni, D. Calcines, G. Perez Baztarrica, I. Bañes, L. Ferrero, J. Schnidt, A. Botbol, 

R. Porcile. 

P903 QUICkOPt®: A NEW AlGORItHM FOR AUtOMAtIC AtRIO-VENtRICUlAR DElAy 

OPtIMIzAtION IN PACEMAkERS. A SHORt-tIME FOllOW-UP StUDy 

J. García Guerrero, J. Fernández De La Concha, J. Olagüe, M. J. Sancho-Tello, J. G. Martínez, A. Ibáñez, C. Llorente, 

F. Crespo, O. Sanz. 

P904 MRI IN lEFt VENtRICUlAR NON-COMPACtION. OUR EXPERIENCE IN ElEVEN PAtIENtS. 

C. A. Rivas, L. Dragonetti, F. Corbella, F. S. Deketele, M. A. Morales Lezica, L. Ahualli. 

P905 PERMANENt SINUS RHytHM IS ASSOCIAtED WItH lESS HEARt FAIlURE HOSPItAlIzAtIONS 

IN PAtIENtS WItH HIStORy OF AtRIAl FIBRIllAtION 

M. Falconi, P. Oberti, R. Pizarro, F. Sosa, L. Lucas, G. Maid, D. Perez De Arenaza, G. Jaimovich, J. Krauss, A. Cagide. 

P906 INCIDENCE AND CHARACtERIStICS OF ISCHEMIC StROkE IN PAtIENtS WItH AtRIAl 

FIBRIllAtION 

M. Falconi, P. Oberti, R. Pizarro, G. Maid, D. Perez De Arenaza, S. Quevedo, A. Arias, F. Achilli, J. Krauss, A. Cagide. 

P907 tHE EFFECt OF tElMISARtAN ON lEFt VENtRICUlAR MASS AND RENAl FUNCtION 

T. Huang, H. Ezumi, Y. Kobayashi. 

P908 HOMOCyStEINE lEVElS AND MEtHylENtEtRAHyDROFOlAtE REDUCtASE GENE VARIANt 

(C677t) ARE ASSOCIAtED WItH INCREASED RISk OF HyPERtENSION IN A POPUlAtION OF 

tHE BUENOS AIRES CIty 

R. P. Porcile, L Gariglio, V. Vanasco, M. Junco, M. Potenzoni, I. Bañes, O. Fridman. 



P909 AtHEROGENIC INDEX OF PlASMA AS A DEtERMINANt OF OXIDIzED lDl IN SlOVAk NON- 

CHD SUBJECtS. 

B. Vohnout, P. Blazicek, A. Dukat, G. Fodor, J. Lietava. 

P910 StEM CEllS CARDIAC tRANSPlANtAtION 

F. Machado, E. Oliveira, F. Machado, V. Lisboa, B. Bessa, D. Gherardi, I. Pinto. 

P911 AtHEROSClEROtIC CAROtID PlAQUE IN PAtIENtS WItH ACUtE CORONARy SyNDROME (ACS). 

G. zampi, F. Fini, G. Illuminati, C. Torromeo, F. Barilla, V. Paravati. 

P912 RElAtION BEtWEEN PUlSE PRESSURE AND IN-HOSPItAl MORtAlIty, 30-DAy 

REHOSPItAlIzAtION AND COMBINED EVENtS, IN PAtIENtS WItH DECOMPENSAtED HEARt 

FAIlURE 

R. Cantarelli, F. L. Cantarelli, F. M. F. Oliveira, C. A. Medeiros, C. Sarteschi, S. Martins Marinho. 

P913 lONG-tERM OUtCOME OF CAROtID ARtERy StENtING WItH DIStAl EMBOlIC PROtECtION 

G. Andersen, F. Azzari, S. Ludueña, D. Chambre, G. Schipani, A. Fernandez, S. Brieva, E. Torresani, H. Bertoni, 

J. Leguizamon. 

P915 IS StRESS AND DEPRESSION A PROGNOStIC RISk FACtOR IN UNStABlE ANGINA PAtIENtS? 

N. Vita, A. Esquivel, D. Ostera, S. Bonetti, M. Gassmann, F. Diez. 

P916 CONSIStENCy OF tHE RESUltS WItH A NEW PERCUtANEOUS tREAtMENt FOR MItRAl 

REGURGItAtION AND HEARt FAIlURE tHROUGH tHE CORONARy SINUS (CARIllON-CDI). 

A. Ebner, S. Gallo, E. Alvarez, E. Silva, C. Oviedo. 

P917 OlDER PAtIENtS WItH HEARt FAIlURE ARE At HIGHER RISk OF HyPERkAlEMIA WItH 

SPIRONOlACtONE: RESUltS FROM A HEARt FAIlURE PROGRAMME 

C. Belziti, N. Vensentini, N. Vulcano, S. Fernandez, D. Perez De Arenaza. 

P920 GlOBAl MORtAlIty ON PAtIENtS WItH A PREVIOUS CARDIOVASCUlAR EVENt AND 

RElANtIOSHIP WItH CARDIOVASCUlAR RISk FACtORS IN A COHORt OF PUBlIC EMPlOyEES 

MEDICAl SERVICE MENDOzA ARGENtINA. OSEP StUDy (OPtIMAl SyStEMAtIC EVAlUAtION 

PROGRAM) 

O. Arrieta, S. Mortaloni, S. Zizzias, A. Añó, J. Alvarez, S. Depine, L. Cammi, S. Gimenez. 

P921 FUNCtIONAl CAPACIty IN CHIlDREN WItH CONGENItAl HEARt DISEASE 

C. Hossri, I. Jatene, G. Grecca, R. Meneghelo, H. Arakaki, A. Alves, B. Zaccara, S. Buglia, M. Tomazzi, J. Beutel. 

P922 ClINICAl AND MEtABOlIC CHARACtERIzAtION OF MEtABOlIC SyNDROME IN CHIlDREN 

AND ADOlESCENtS IN ARGENtINA 

C. Mazza, P. Evangelista, I. Kovalskys, A. Figueroa, P. Digon, S. Lopez, E. Scaiola, N. Perez, G. Dieuzeide.


P923 PROGNOSIS AND PREDICtORS OF lIFE tHREAtENING ARRHytHMIAS IN PAtIENtS WItH 

ACUtE CORONARy SINDROMES 

G. Maid, R. Perez Etchepare, F. Rolandi, J. Navarro Estrada, D. Perez De Arenaza, G. Elizalde, C. Moreno, 

A. Cagide, 

P924 lEFt MAIN CORONARy ARtERy ANGIOPlASty FOR StABlE ANGINA AND FOR ACUtE 

CORONARy SyNDROMES. ACUtE RESUltS AND lONG – tERM ClINICAl OUtCOME OF 73 

PAtIENtS. 

P. Tyczynski, A. Debski, Z. Chmielak, A. Witkowski, K. Cedro, J. Pregowski, W. Ruzyllo. 

P925 FREQUENCy AND DIStRIBUtION OF DEPRESSIVE SyMPtOMS At A CARDIOlOGy 

CONSUltING ROOM 

J. Tripolone, G. Santiago, R Barin. 

P927 BlOOD PRESSURE lEVEl, lIPIDS PROFIlE AND CARDIOVASCUlAR RISk FACtORS IN ADUltS 

RWANDAN HEAltH VOlUNtEERS. 

Twagirumukiza Marc, Karagirwa Alphonse, Umutesi Hassina, Seminega Benoit, Musafiri Sanctus, Nkeramihigo 

Emmanuel, Luc Van Bortel. 

P928 CARDIOVASCUlAR RISk REDUCtION WItH SINGlE-PIll AMlODIPINE/AtORVAStAtIN IN 

DIVERSE POPUlAtIONS 

R. Blank, S. Erdine, R. Feldman, P. Marques Da Silva, P. Chopra, H. Shi, R. A. Moller, M. Schou. 

P929 COMPlEX CAtHEtERISM PROCEDURES IN A PUBlIC HOSPItAl IN ARGENtINA. FEASIBIlIty 

AND RESUltS 

G. Feltes, M. De La Vega, A. Ittig, C. Leonardi, M. Giraudo, G. Pessah, L. Guzmán. 

P931 HIGHER AORtIC VAlVE RESIStANCE At RESt AND IN RESPONSE StRESS IN PAtIENtS WItH 

AORtIC VAlVE SClEROSIS 

M. Falconi, P. Oberti, R. Pizarro, A. Arias, L. Lucas, F. Sosa, M. Fernandez, D. Perez De Arenaza, J. Krauss, A. Cagide. 

P932 SHORt tERM RESUltS OF REPEAt VAlVE REPlACEMENt - PREDICtIVE FACtORS ANAlySIS 

S. Beurtheret, H. Feier, V. Gariboldi, D. Grisoli, A. Riberi, A. Mouly-Bandini, D. Metras, F. Collart. 

P934 tHE PROGNOStIC VAlUE OF DyPIRIDAMOl StRESS ECHOCARDIOGRAPHy IN WOMEN 

B. Markman-Filho, M.C. Almeida, M. Markman, M. Moreno, C. Barros, A. Chaves, I. Labanca, M. F. Lobo, W. Souza, 

S. Montenegro. 

P935 ROlE OF ADENOSINE tEStING IN SyNCOPE OF UNkNOWN ORIGIN 

M. Sammartino, G Albina, R Laiño, A Giniger. 

P936 VENtRICUlOARtERIAl COUPlING IN SEVERE AORtIC StENOSIS WItH HEARt FAIlURE 

R. Migliore, M. Adaniya, M. Bruzzece, M. Barranco, G. Miramont, F. Guerrero, H. Tamagusuku, A. Sinisi. 



P937 StUDy OF tHE DEPRESSIVE lOAD ON tHE CARDIOlOGIC PAtIENt 

J. Tripolone, G Santiago, J Gimenez, JM Tripolone. 

P938 PUlSE WAVE VElOCIty IN NORMOtENSIVE ADOlESCENtS 

M. Bracho, E. Silva, G. Bermudez, J. Villasmil, S. Briceño, C. Esis, J. Chacon. 

P939 HIStOPAtHOlOGICAl FEAtURES OF tHE RESECtED lEFt AtRIAl APPENDAGE IN 

PAROXySMAl AtRIAl FIBRIllAtION IN PAtIENtS WItHOUt VAlVUlAR HEARt DISEASE 

L. Antonietti, D. Santos, C. Tajer, M. Amat, A. Zapolanski, F. Mastrogiacomo, W. Astorino, E. Domenicchini, J. Lax. 

P940 ANAlySIS OF ClINICAl CHARACtERIStICS AND HEAD-UP tIlt tESt RESPONSES IN 

PAtIENtS SUFFERING FROM UNEXPlAINED SyNCOPE. 

K. Alonso, J. Escobar Calderon, R. Sansalone, J. Armentano, L Ferrer, R. Aguero, M. Leonardi, Horacio Pomes 

Iparraguirre. 

P941 EPItHElIOID HAEMANGIOENDOtHElIOMA OF tHE AORtA 

G. Feltes, M. Losano, N. Bustamante, G. Ghirardi, A Uribe, L. Guzmán. 

P942 PARtICUlARItIES OF tHE CARDIOVASCUlAR RISk IN OlD WOMEN IN AN URBAN ROMANIAN 

COMMUNIty 

D. Pop, D. Zdrenghea, A. Sitar-Tautu, M. Cebanu, D. Colcear, B. Borz. 

P943 HIStOPAtHOlOGIC EVAlUAtION OF PROPHylACtIC EFFECtS OF zOFENOPRIl, ENAlAPRIl 

AND VAlSARtAN AGAINSt DOXORUBICIN CARDIOtOXICIty IN RAtS 

E. Bozcali, V. Karpuz, D. B. Dedeoglu, O. Suzer, H. Karpuz. 

P944 FREQUENCy OF INCOMPlEtE StENt APPOSItION ASSESSED By StENtBOOSt: 

A NOVEl ANGIOGRAPHIC tECHNIQUE 

A. Candiello, M. Albertal, F. Cura, L. Padilla, P. Perez Baliño, S. Jozami, J. Thierer, J. Belardi. 

P945 ACUtE AORtIC REGURGItAtION DUE tO SPONtANEOUS RUPtURE OF A FENEStRAtED 

CUSP: REPORt IN SIX CASES. 

J. Goral, D. Avayu, J. Mitelman, D. Morisse, C. Froimovich, L. Rodas. 

P946 APPlICAtION OF HEAltH INFORMAtICS FOR GlOBAl EFFORtS: tHE CARE OF ADUlt 

CONGENItAl HEARt DEFECtS’ SURVEIllANCE 

A. Krishnaswamy, G. Mensah, W. Book, M. McConnell, T. Lyle, A. Correa. 

P947 BISOPROlOl FAVORABly AltERS DIAStOlIC FUNCtION AND REDUCES Nt-PRO-BNP lEVElS 

IN DIAStOlIC HEARt FAIlURE WItH REStRICtIVE tRANSMItRAl FlOW PAttERN. 

K. G. Adamyan, A. L. Chilingarian, A. V. Astvacatryan.


P948 EFFECtS OF SUPPlEMENtAtION WItH SAtURAtED, MONOUNSAtURAtED OR 

POlyUNSAtURAtED RICH-OIlS ON FUNCtIONAl ASPECtS OF HIGH-DENSIty lIPOPROtEIN 

(HDl) IN HAMStERS. 

F. Maniero, A. F. Padoveze, T. V. Oliveira, M. H. H. Santos, T. M. Seydell, M. L. Guzzo, C. H. Azevedo, R. C. Maranhão. 

P949 RElAtIONS OF Qt INtERVAlS WItH DIFFERENt DEFINItIONS AND COMPONENtS OF 

MEtABOlIC SyNDROME IN 

B. Longo-Mbenza, J. B Kasiam On’kin, J. C Manzala Kumbi, A. Nge Okwe, B. Buassa-Bu-Tsumbu, N. Kangola, 

D. Vangu Ngoma, S. Mbungu Fuele, I. Longo Phemba. 

P950 tHE EFFECt OF HOMOCyStEINE-lOWERING B-VItAMIN INtERVENtION ON ANGIOGRAPHIC 

CORONARy ARtERy DISEASE MAy BE ADVERSE - A WENBIt SUB-StUDy 

K. H. Løland, A. J. Blix, Ø. Bleie, E. Strand, P. M. Ueland, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. K. Nygård. 

P951 SINGlE AND DElAyED DEFIBRIllAtION tEStING tHE DAy AFtER FIRSt IMPlANtAtION OF 

CARDIOVERtER DEFIBRIllAtOR: A RElIABlE AND SAFE StRAtEGy 

H. Bader, N. Delarche, R. Lasserre, G. Flory, G. Estrade. 

P952 A NOVEl CORONARy HEARt DISEASE RISk EVAlUAtION AND COMMUNICAtION PROGRAM 

IMPROVES MODIFIABlE RISk FACtORS AND UNDERStANDING IN PAtIENtS WItH 

HyPERtENSION: tHE RISk EVAlUAtION AND COMMUNICAtION HEAltH OUtCOMES AND 

UtIlIzAtION tRIAl (REACH OUt) 

L. Erhardt, J. S. Benner, R. A. Moller, N. Rajicic, S. B. Cherry, Z. Gaciong, E. S. Johnson, M. C. J. M. Sturkenboom, 

J. Garcia-Puig, X. Girerd. 

P953 tOBACCO CONSUMPtION AND PREVAlENCy IN tHE PERSONNEl OF A HOSPItAl 

D. Morisse, D. Avayu, G. Lewy, J. Mitelman, J. Goral, C. Martorano, J. Gallo, C. Froimovich. 

P954 OBESIty AND HyPERtENSION 

z. Brankovic. 

P955 HEAltH CAMPAIGN: A MEtHOD OF SCREENING AND EDUCAtION IN CARDIOVASCUlAR 

HEAltH. 

A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, E. R. Suarez, 

C. Nagaoka, A. C. Santomauro, C. Ferreira. 

P956 PROGNOSIS INFlUENCE OF lEISURE-tIME PHySICAl ACtIVIty PRACtICE PRIOR tO 

CORONARy ARtERy ByPASS GRAFt SURGERy 

R. Nery, I. Mahmud, J. Barbisan, L. Smidt. 

P957 CORRElAtION BEtWEEN EPIDMIOlOGICS FACtORS AND DIABEtES MEllItUS IN PAtIENtS 

SUBMIttED tO MyOCARDIAl REVASCUlARIzAtION SURGERy 

A. C. Santomauro Jr., L .Z. P. Oliveira, M. R. Ugolini, I. A. B. Bincoleto, C. Nagaoka, W. A. Amorim, J. Albuquerque, 

A. C. Santomauro, A. T. Santomauro, F. Fraige Filho. 



P958 SECONDARy PREVENtION OF CARDIAC SUDDEN DEAtH WItH IMPlANtABlE CARDIOVERtER- 

DEFIBRIllAtOR IN PAtIENtS WItH CHRONIC CHAGASIC CARDIOMIOPAtHy AND PRESERVED 

lEFt VENtRICUlAR FUNCtION 

P. R. Salvador, D. D Nascimento, S. A Fakhouri, A. S Fakhouri, A. C Silva, E. S Resende, C. S Melo, F. R De Fazzio, 

F. H Silva, E. E Kanaan. 

P959 PRECISE FIltERED-QRS lIMItS tRACkING IN SIGNAl-AVERAGED ElECtROCARDIOGRAPHy: 

COMPARISON BEtWEEN ClASSICAl ESC VS. NEW DERIVAtIVE-BASED MEtHOD 

O. Nasario-Junior, P. R. Benchimol-Barbosa, J. Nadal, C. Miranda, G. N. Gobbi, F. P. Vilela, J. Barbosa-Filho, 

I. Cordovil. 

P960 ElECtROCARDIOGRAPHIC AltERAtIONS OF PREVAlENCE IN yOUNG SPORtMEN SOCCER 

AMAtEUR CAtEGORy, CORRElAtION WItH DOPPlER CARDIAC 

I. Diaz, D. Avayu, D. Morisse, C. Seidler, J. Fuse, J. Goral, L. Rodas, A. Cardozo, A. Cler Pereyra, C. Froimovich. 

P962 EXERCISE INDUCED ElEVAtION OF Nt-PRO-BNP IS ASSOCIAtED WItH SUBSEQUENt 

CORONARy EVENtS IN MEN WItH NEGAtIVE StRESS-tESt. 

K.G. Adamyan, A. L. Chilingarian, A. V. Astvatsatryan. 

P963 ARE CHANGES IN tHE ARtERIAl WAll RESPONSIBlE FOR tHE DEClINAtION OF MENtAl 

ACtIVIty IN lONGEVOUS INDIVIDUAlS ? 

E. Izcovich, A. Lescano, A. Izcovich, V. Daru, R. Izcovich, R. Ferreyra. 

P964 HyPERtROPHIC CARDIOMyOPAtHy: CASE REPORt 

E. R. F. L Moraes, F. S. V. Jardim, G. T. Gama, F. L. Vieira, F. J. B. Silva Filho, D. R. Almeida. 

P965 ASSESSMENt OF StENt EXPANSION By A NOVEl ANGIOGRAPHIC tECHNIQUE: StENtBOOSt 

M. Albertal, A. Candiello, F. Cura, L. Padilla, P. Perez Baliño, S. Jozami, J. Thierer, J. Belardi. 

P966 ClINICAl FEAtURES OF PAtIENtS UNDERGOING CABG WHO HAD PRIOR PERCUtANEUS 

CORONARy StENtING. 

A. Vizcarra Diaz, R. Marenchino, L. Diodato, V. Cesareo, A. Domenech, D. Bracco. 

P968 ASSESSMENt OF lEFt VENtRIClE SUBlINICAl DySFUNCtION AND SURGICAl OUtCOME IN 

ASyMPtOMAtIC SEVERE MItRAl REGURGItAtION. StUDy OF VECtOR VElOCIty IMAGING 

J. Moreno, M. A. Garcia, V. Celorrio, E. Perez, R. Pereira. 

P969 BASElINE PlASMA lEVElS OF NItRItES/NItRAtES IN PAtIENtS WItH VASOVAGAl SyNCOPE 

G. A Ruiz, S. Sinigaglia, R. Hermes, R. Chirife, M. Capula, H. Grancelli, M. Nogues, M. C. Tentori. 

P970 StUDy OF tHE HEARt RAtE VARIABIlIty IN tyPE 2 DIABEtES MEllItUS 

A. C. Santomauro Jr., C. Nagaoka, M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, 

W. A. Amorim, A. C. Santomauro, F. Fraige Filho.


P971 tHE COMBINAtION OF DIFFERENt IMAGING tECHNIQUES SEEMS tO BE RECOMMENDABlE IN 

tHE QUANtIFICAtION OF PUlMONARy VEIN OStIA SIzES. 

M. Christ, G. Plehn, M. Van Bracht, H. J. Trappe, A. Meissner. 

P972 CARDIOtOXIC EFFECtS OF PENtAVAlENt ANtIMONy IN GUINEA-PIG lEADING tO 

ARRHytHMIA AND CARDIOMyOPAtHy. 

A. C. A Carvalho, L. F. Rodrigues-Jr., C. C. Lores, M. O. Masuda, A. C. C Carvalho, J. H. M. Nascimento. 

P973 Nt-PROBNP IS NOt USEFUl IN EARly FOllOW-UP OF HEARt tRANSPlANt PAtIENtS 

D. Milicic, J. Ljubas, B. Pezo-Nikolic, B. Skoric. 

P974 EVAlUAtION OF tHE CARDIOPUlMONARy RESUSCItAtION tEACHING-lEARNING By tHE 

NURSING tEAM 

L. A. B. N. Sampaio, A. M. K. Miyadahira. 

P975 ASSOCIAtION BEtWEEN PRAVAStAtIN AND ENAlAPRIlAt IN tHE REVERSAl OF lEFt 

VENtRICUlAR HyPERtROPHy IN RAtS INDUCED By ISOPROtERENOl-PRElIMINARy RESUltS. 

I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, A. Meneghini, C. Ferreira Filho, T. R. Theodoro, 

E. R. Suarez, N. Murad, C. Ferreira. 

P976 tAkOtSUBO SyNDROME: A CAtHECOlAMINE CARDIOMyOPAtHy 

I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, F. M. B. Rossi, B. S. Santoro, J. F. Kelendjian, 

R. Alessi, A. R. P. Rieira, C. Ferreira. 

P977 PERCUtANEOUS tREAtMENt OF CHRONIC tOtAl OCClUSION IN ROUtINE ClINICAl 

PRACtICE 

S. Jozami, M. Albertal, F. Cura, L. Padilla, A. Candiello, P. Perez Baliño, J. Thierer, J. Belardi. 

P978 CARDIOPUlMONARy RESUSCItAtION (CPR) IN tHE POStOPERAtIVE ONE OF 

CARDIOVASCUlARy SURGERy: CHARACtERIzAtION OF tHE ACtIVItIES AND NECESSItIES OF 

tRAINING EVIDENCED By tHE PROFESSIONAlS OF NURSING. 

L. A. B. N. Sampaio, A. M. K. Miyadahira, D. V. Correa. 

P979 tGF-B1 MEDIAtES tHE HyPERtROPHIC CARDIOMyOCytE GROWtH INDUCED By 

ISOPROtERENOl IN RAtS. 

I. A. B. Bincoleto, A. C. Santomauro Jr., L. Z. P. Oliveira, M. R. Ugolini, C. Ferreira Filho, A. Meneghin I, T. R. 

Theodoro, E. R. Suarez, N. Murad, C. Ferreira. 

P980 CARDIAC PEPtIDES DURING EXERCISE IN HEARt FAIlURE PAtIENtS 

D. zdrenghea, M. Ilea, D. Pop, D. Petrovai. 

P981 ACtION OF MEMANtINE IN tHE MyOCItES OF RAtS SUBMIttED tO COlD StRESS. 

I. A. B. Bincoleto, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, C. Ferreira Filho, M. Ferriera, A. R. P. Rieira, 

A. Meneghini, C. Ferreira, N. Murad. 



P982 SUSPICION OF ACUtE CORONARy IllNESS IN DIABEtIC PAtIENtS. ClINICAl 

CHARACtERIStICS, tREAtMENt AND EVOlUtION At tHIRty DAyS 

P. Gallo, S. Saravia Toledo, R. Leon De La Fuente, C. Laspiur, S. Araujo, A. Farah, F. Marconetto, H. Velez, 

N. Barrientos. 

P984 tHE INFlUENCE OF GAStRIC ByPASS IN tHE IMPROVEMENt OF tHE MEtABOlIC SyNDROME 

FACtORS IN tHE lAtER POSt-OPERAtIVE (6 MONtHS) 

I. A. B. Bincoleto, F. M. B. Rossi, A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, W. A. Amorim, A. Serpa Neto, 

R. B. F. Silva, M. Rossi, E. Z. Chehter. 

P985 IS MAXIMAl EXERCISE CAPACIty RElAtED tO VENtRICUlAR DySSyNCHRONy IN 

ASyMPtOMAtIC AORtIC StENOSIS? 

M. Bustamante-Labarta, F. Vaisbuj, P. Roura, J. Casas, C. Lopez, M. Diaz, F. Salmo, C. Rodriguez-Correa, 

G. Marambio, E. Guevara. 

P986 CARDIAC OUtPUt MONItORING IN CRItICAl CARE: INFlUENCE OF tHE HEIGHt OF tHE 

HEADBOARD OF tHE BED IN tHE CARDIAC OUtPUt AND HEMODyNAMICS MEASUREMENtS. 

V. S. Bulgarelli, L. A. B. N. Sampaio. 

P987 INCIDENCE AND RISk FACtORS OF MAJOR BlEEDING IN ACUtE CORONARy SyNDROME 

PAtIENtS 

A. Reina, F. Manzano, M. Colmenero, P. Castan, M. Rodriguez-Elvira. 

P988 ClINICAl COURSE AND PROGNOSIS OF INFECtIVE ENDOCARDItIS IN tHE ElDERly 

C. M. Cortés, R. J. San Miguel, P. Roura, C. Nagel, C. Salvatori, A. Arlia Ciommo, E. Dulbecco, J. Abud, R. R. Favaloro, 

J. H. Casabe. 

P989 DRUG tREAtMENt OF HEARt FAIlURE PAtIENtS IN A ROMANIAN GENERAl HOSPItAl 

C. Talos, D. Zdrenghea, D. Pop. 

P990 VENtRICUlAR tACHyARRHytHMIAS AND tHE IMPACt OF ICD tHERAPy IN PAtIENtS WItH 

ARRHytHMOGENIC RIGHt VENtRICUlAR CARDIOMyOPAtHy 

F. Duru. 

P991 SUSPICION OF ACUtE CORONARy DISEASE IN PAtIENtS OVER 75 yEARS OlD. ClINICAl 

CHARACtERIStICS, tREAtMENt AND EVOlUtION At tHIRty DAyS 

P. Gallo, S. Saravia Toledo, R. Leon De La Fuente, S. Araujo, F. Wayar, C. Laspiur, F. Marconetto, C. Toldo, F. Rassi, 

E. Aramburu. 

P992 ADDItION OF IVABRADIN FURtHER IMPROVES ClINICAl StAtUS IN PAtIENtS WItH END 

StAGE HEARt FAIlURE AND INtOlERANCE tO SS-BlOCkERS. 

K. G. Adamyan, A. L. Chilingarian, A. V. Astvacatryan.


P993 SHOUlD NAtRIUREtIC PEPtIDE (BNP) BE CONSIDERED FOR A MARkER OF SyMPtOMAtIC 

StAtUS IN SEVERE AORtIC StENOSIS PAtIENtS? 

M. Katz, G. Spina, F. Tarasoutchi, C. Strunz, R. O. Sampaio, M. Grinberg. 

P994 INtAkE OF ISOFlAVONES-ENRICHED SOy PRODUCt FERMENtED WItH ENtEROCOCCUS 

FAECIUM DECREASE tOtAl AND NON-HDl CHOlEStEROl lEVElS IN RAtS 

D. C. u. Cavallini, E. A. Rossi, I. Z. Carlos, R. C. Vendramini, R. C Damaso, R. Bedani, G. F. Valdez. 

P995 lIPOPROtEIN (A) CONCENtRAtION IN tHREE AFRO-AMERICAN POPUlAtIONS IN zUlIA 

StAtE, VENEzUElA 

D. Aparicio, V. Bermúdez, E. Mengual, J. Faria, F. Finol, X. Guerra, D. Gotera, L. Acosta, E. Rojas, L. Sorell. 

P996 ASyMMEtRIC AND SyMMEtRIC DIMEtHylARGININE ARE WEAkER PREDICtORS tHAN 

HOMOCyStEINE OF lONG-tERM MORtAlIty IN BOtH MEN AND WOMEN WItH StABlE ANGINA 

G. Svingen, P. M. Ueland, Ø. Bleie, J. E. Nordrehaug, T. Folkestad, K. Kuiper, M. Ebbing, E. R. Pedersen, S. E. Vollset, 

O. Nygård. 

P997 DOES tHE FREQUENCy OF SyNCOPE PREDICt tHE RESPONSE tO HEAD-UP tIlt-tABlE 

tEStING IN ADOlESCENtS 

R. Andalaft, D. Moreira, R. Habib, L. Moraes, K. Tukamoto, G. Bellini, V. Cerutti, R. Hams, D. Serrano, 

C. Marques. 

P998 lONG tERM OUtCOME OF PAtIENtS WItH tyPE B AORtIC DISSECtION 

D. Bracco, R. Marenchino, A Domenech, V. Cesareo, L. Diodato. 

P999 B-tyPE NAtRIUREtIC PEPtIDE AND ANEMIA, ARE tHEy RElAtED? 

R. A. F. Gomes, L. M. Sena, J. L. Ferreira, C. Sarteschi, S. M. Martins, A. D. M. Feitosa. 

P1000 INCIDENCE OF tHE CARDIOVASCUlAR RISk FACtORS IN tHE PAtIENtS OF tHE HEAltH 

CAMPAIGN IN SANtO ANDRé, BRAzIl 

A. C. Santomauro Jr., M. R. Ugolini, L. Z. P. Oliveira, I. A. B. Bincoleto, F. M. B. Rossi, B. S. Santoro, C. Nagaoka, 

J. F. Kelendjian, E. R. Suarez, C. Ferreira. 

P1001 ASSESSMENt OF tHE ANAlGESIC EFFECtIVENESS OF GENERAl ANEStHESIA AND SPINAl 

ANEStHESIA USING MORPHINE AND ROPIVACAINE IN PAtIENtS SUBMIttED tO MIOCARDIAl 

REVASCUlARIzAtION SURGERy 

V. Pinheiro, R. Diniz, M. Ferreira, J. Costa, E. Pinheiro, M. Cascudo. 

P1002 SUSPICION OF ACUtE CORONARy DISEASE IN WOMEN, ClINICAl CHARACtERIStICS, 

tREAtMENt AND EVOlUtION At tHIRty DAyS 

R. Leon De La Fuente, S. Saravia Toledo, P. Gallo, S. Araujo, P. Kairuz, F. Wayar, N. Marquez, A. Lopez Facchin, 

M. Geronimo. 



P1003 ECOlOGIC MEtHODS FOR MEASURING HEAltH DISPARItIES AttRIBUtED tO 

SOCIOECONOMIC FACtORS: RISk OF PREMAtURE CVD MORtAlIty ACROSS GEO- 

DEMOGRAPHIC AREAS OF PORtO AlEGRE, BRAzIl 

S. L. Bassanesi, M. I. R. Azambuja, A. C. Achutti. 

P1004 SUSPICION OF ACUtE CORONARy DISEASES, ClINICAl CHARACtERIStICS, tREAtMENt AND 

EVOlUtION At tHIRty DAyS 

R. Leon De La Fuente, S. Saravia Toledo, P. Gallo, C. Laspiur, S. Araujo, C. Flores Borja, A. Farah, J. Gomez, J. Zapata, 

F. Rassi. 

P1005 MyOCARDIAl INFARCtION : StRAtEGy AND RESUltS IN HOSPItAlS WItH/WItHOUt PCI 

CHANCE. 

L. Herrera-Para, A. Reina-Toral, R. Diaz-Contreras, R. Lirola-Liebanas, G. Moratalla-Cecilia, F. Manzano-Manzano, 

I. Slimobich, J. Benitez-Parejo, E. Aguayo-De Hoyos, J. C. Luque-Moscoso. 

P1007 PAINFUl PROCEDURES IN tHE POSt-OPERAtORy OF CARDIAC SURGERy 

V. Pinheiro, C. Pimenta. 

P1008 ADDItIVE VAlUE OF tROPONINE t tO ADMISSION ElECtROCARDIOGRAM IN PAtIENtS WItH 

SUSPICION OF ACUtE CORONARy DISEASE 

S. Saravia Toledo, P. Gallo, R. Leon De La Fuente, F. Marconetto, C. Laspiur, C. Rodriguez, G. Castillo, 

F. Gomez Ortega, C. Swarzman. 

P1009 CARDIAC I tROPONIN AS A PREDICtOR OF NORMAl CORONARy ARtERIES IN ASSOCIAtION 

tO GENDER IN PAtIENtS WItH ACUtE CORONARy SyNDROME WItHOUt St SEGMENt 

ElEVAtION. 

D. Di Nanno, L. Lopez, M. Consoli, C. Pasinato, A. Bordenave, J. Tartaglione, S. Chekherdemian. 

P1010 lONG tERM FOllOW UP OF BIFURCAtION lESIONS ANGIOPlASty: OUR EXPERIENCE. 

D. Grinfeld, D. Berrocal, G. Cugat, J. Gabay, C. Agatiello, P. Pollono, F. Fuertes, A. Fernandez, J. L. Parmisano, L. Grinfeld. 

P1011 HOMEOStASIS MODEl ASSESSMENt (HOMA) AS SURROGAtE INSUlINIzAtION CRItERIA IN 

PAtIENtS WItH tyPE 2 DIABEtES 

F. Finol, V. Bermúdez, D. Aparicio, L. Acosta, R. Canelón, E. Rojas, E. Mengual, K. Acosta, R. Cano, M. Cabrera. 

P1012 tHE RAtIO OF APOlIPOPROtEINS APOB/APOA1 AS A PREDICtOR OF ANGIOGRAPHIC 

PROGRESSION OF AtHEROSClEROSIS IN PAtIENtS WItH CORONARy ARtERy DISEASE 

A. J. Blix, K. H. Loland, O. Bleie, E. Strand, P. M. Ueland, H. Refsum, M. Ebbing, J. E. Nordrehaug, O. K. Nygard. 

P1013 INCREMENtAl SHUttlE WAlk tESt IN tHE ASSESSMENt OF FUNCtIONAl CAPACIty IN 

CHRONIC HEARt FAIlURE 

C. Pulz, A. N. F. Alves, R. V. Z. Diniz, A.S. Tebexreni, A. C. C. Carvalho, A. A. V. De Paola, D. R. Almeida.


P1014 ANtIOXIDANt tHERAPy IMPROVES lEFt VENtRICUlAR DIAStOlIC FUNCtION 

AND AltERS REMODElING IN PAtIENtS WItH POStINFARCtION HEARt FAIlURE AND 

IMPAIRED RENAl FUNCtION. 

K. G. Adamyan, A. L. Chilingarian, A. V. Astvatsatryan. 

P1015 lOW FREQUENCy POWER OF HEARt RAtE VARIABIlIty ASSOCIAtED WItH BAROREFlEX 

IMPAIRMENt IN MyOCARDIAl INFARCtION IN RAtS 

C. Mostarda, E. D. Moreira, B. Rodrigues, M. Vane, K. T. Rosa, E. M. Krieger, K. De Angelis, M. C. Irigoyen. 

P1017 IS CARVEDIlOl USEFUl FOR SyMPtOMAtIC HEARt FAIlURE PAtIENtS WItH CHRONIC 

CARDIOMyOPAtHy DUE tO A CHAGA‘S DISEASE? 

R. V. z. Diniz, R. F. M Viegas, J. M. L Amorim, A. S. Tebexreni, A. C. C. Carvalho, A. A. V. Paola, D. R. Almeida. 

P1018 MINIMAlly-INVASIVE CARDIAC SURGICAl ABlAtION (WOlF MINI-MAzE) OF AtRIAl 

FIBRIllAtION IN PAtIENtS WItHOUt CONCOMItANt HEARt DISEASE. tHREE yEARS 

FOllOW UP. 

L. Antonietti, A. zapolanski, D. Santos, F. Mastrogiacomo, A. Villamil, N. Gastaldello, J. Lax, C. Tajer. 

P1020 HEARt RAtE VARIABIlIty ANAlySIS IN PAtIENtS WItH CONGENItAl GENERAlIzED 

lIPODyStROPHy (BERARDINEllI-SEIP SyNDROME) 

C. Faria, D. Sobral-Filho, J. Brandão-Neto, A. Rego, S. Egito, F. Baracho. 

P1022 PlASMA lEVElS OF NItRIC OXIDE MEtABOlItES AND VASCUlAR ENDOtHElIAl FUNCtION 

IN MAJOR DEPRESSION SUBJECtS. 

R. G Garcia, J. G. Zarruk-Serrano, W. Arenas-Borda, C. Barrera, E. Trillos, A. Pinzon, D. Quintero, C. Tomaz, 

P. Lopez-Jaramillo. 

P1024 ORANGE JUICE SyNERGIStIC EFFECtS ON GEMFIBROzIltREAtMENt IN HIGH FAt FED 

RABBItS 

M. Higuchi, J.J. Raposo, S. A. P. Palomino, M. H. H Santos, R. Ikegami, M. M Reis. 

P1025 B6 VItAMERS AND lONG tERM MORtAlIty IN PAtIENtS WItH StABlE ANGINA 

E. R. Pedersen, M. Ebbing, O. Midttun, P.M. Ueland, S.E. Vollset, O. Bleie, H. Schartum-Hansen, J. E. Nordrehaug, 

O. Nygard. 

P1027 ENDOtHElIUM DySFUNCtION AS CARDIOVASCUlAR EVENtS RISk FACtOR IN PAtIENtS 

WItH MEtABOlIC SyNDROME 

O. Savenko, V. Vikentyev. 

P1028 CHANGES IN MUltIFRACtAl PARAMEtERS OF HEARt RAtE FlUCtUAtIONS IN CORRElAtION 

WItH CIRCADIAN DIFFERENCES OF HEARt RAtE 

R. Galaska, D. Makowiec, A. Dudkowska, A. Koprowski, M. Fijalkowski, A. Rynkiewicz. 



P1030 MOlECUlAR IDENtIFICAtION OF t. CRUzI lINEAGES AND POPUlAtIONS IN END- 

StAGE CHAGAS HEARt DISEASE PAtIENtS UNDERGOING HEARt tRANSPlANtAtION: 

PREDOMINANCE OF lINEAGE I 

J. M. Burgos, M. Diez, C. Vigliano, M. Bisio, T. Duffy, L. Favaloro, R. Favaloro, M. J. Levin, A. G. Schijman. 

P1032 PERCUtANEOUS REVASCUlARIzAtION IN ElDERly WOMEN. DO tHEy HAVE WORSt 

PROGNOSIS? 

M. Monteverde, H. Caballero, S. Liotta, E. Barrera, H. Fernandez, S. Berenztein, M. Vazques Blanco, E. Sampo, 

J. Lerman. 

P1034 APICAl HyPERtROPHIC CARDIOMyOPAtHy AND APICAl CAlCIFIED tHROMBUS: 

A NEW COMPlICAtION?. 

M. C. Saccheri, T. F. Cianciulli, R. J. Mendez, I. V. Konopka, H. J. Redruello, G. E. Gigena, D. F. Serans, R. S. Acunzo, 


P1035 ROlE OF tHEOPHyllINE (ADENOSINE ANtAGONISt) OR N-ACEtylCyStEINE AlONE AND IN 

COMBINAtION FOR PREVENtION OF CONtRASt INDUCED NEPHROPAtHy 

S. Kumar, N. Sinha, K. Chawla, A. Kapoor, S. Tewari, N. Prasad, S. Gambhir, S. Barai. 

P1036 DOES tHE USE OF 600 MG ClOPIDOGREl lOADING DOSE BEFORE PERCUtANEOUS 

CORONARy INtERVENtION IN ACUtE CORONARy SyNDROMES INCREASE tHE RISk OF 

BlEEDING AFtER tHE PROCEDURE? 

R. Gusmao De Oliveira, A. Figueiredo, J. Petriz, A. Marques, M. Cardoso, A. Glavan, A. Brasileiro, B. Tura, 

P. Resende. 

P1038 BlEEDING COMPlICAtIONS IN ElDERly PAtIENtS WItH NON-St ElEVAtION ACUtE 

CORONARy SyNDROMES: PREDICtORS AND OUtCOMES 

C. Lourenço, R. Teixeira, A. Natália, S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, 

L. A. Providencia. 

P1039 ACUtE CARDIAC INSUFFICIENCy SECONDARy tO VIRAl MyOCARDItIS: A CASE StUDy 

C. L. Weksler, R. Alves, F. T. Oliveira, A. L. C. Marins, V. Z. Mattos, V. R. Souza. 

P1041 MAINtENANCE OF VENOUS ACCESS AS INDICAtOR OF QUAlIty OF CARE FOR NURSING 

A. L. C. Marins, R. Mourilhe Rocha, R. Esporcatte. 

P1042 tHE IMPACt OF CORONARy ARtERy ByPASS GRAFt SURGERy IN tHE ABANDON OF 

SMOkING 

R. Pietrobon, J. Barbisan, L. Smidt. 

P1043 MAlE GENDER AND MEtABOlIC SyNDROME IN yOUNG INDIVIDUAlS FOllOWED-UP FOR A 17 

yEARS-PERIOD. tHE RIO DE JANEIRO StUDy 

A. A. Brandao, M. E. C Magalhaes, E. G Campana, F. L Fonseca, O Pizzi, E. V Freitas, R Pozzan, A. P Brandao.


P1045 ANtI-StREPtOCCOCAl VACCINAtION INDUCES lOWERING OF ANtI-OXlDl ANtIBOtIES IN 

RESPONDING DIABEtIC PAtIENtS. 

E. Rzewuska, M. Karynski, K. Jankowski, M. Puchta, A. Lipinska, P. Grzesiowski, D. Liszewska-Pfejfer, P. Pruszczyk. 

P1047 IS ANklE-BRACHIAl INDEX ASSOCIAtED WItH ISCHEMIA ON MyOCARDIAl PERFUSION 

SCINtIGRAPHy IN ElDERly PAtIENtS? 

L. Machado, P. Smanio, C. Ferreira, J. Borges, M. Castillo, A. Thom, L. Piegas. 

P1048 PREVAlENCE OF ‘RESPONDERS’ AND ‘NON-RESPONDERS’ tO ANtIPlAtElEt DRUGS 

M. G. Gonzalez Achaval, S. Ghione, M. Hadad, S. Gomez, L. A. Del Val, C. Balestrini. 

P1049 HOMOCyStEINE AND MARkERS OF IMMUNE ACtIVAtION AS PREDICtORS 

OF MORtAlIty IN StABlE ANGINA PAtIENtS 

E. R. Pedersen, P. M. Ueland, S.E. Vollset, O. Midttun, G. Svingen, H. Schartum-Hansen, O. Bleie, M. Ebbing, 

J. E. Nordrehaug, O. Nygard. 

P1050 PREVAlENCE AND CHARACtERIStICS OF HIGH BlOOD PRESSURE AND ItS ASSOCIAtION 

tO CARDIOVASCUlAR RISk FACtORS IN SOUtH SERBIA 

I. Burazor, M. Burazor, N. Vukadinovic, B. Lovic, Z Burazor, G. Cvetanovic, N. Burazor. 

P1051 tISSUE SyNCHRONIzAtION IMAGING IN tHE lOCAlIzAtION OF tHE ACCESSORy 

AtRIOVENtRICUlAR PAtHWAyS 

M. Lanocha, A. Szyszka, K. Blaszyk, R. Ochotny, S. Grajek. 

P1052 ROlE OF PENtOXIFyllINE (NON-SPECIFIC ANtI-CytOkINE AGENt) ON lEFt VENtRICUlAR 

EJECtION FRACtION AND FUNCtIONAl ClASS IN PAtIENtS WItH lEFt VENtRICUlAR 

SyStOlIC DySFUNCtION 

S. Kumar, N. Sinha, A. Kapoor, S. Tewari, G. S. Gill, V. Agarwal, R. N. Mishra. 

P1053 HIGH BlOOD PRESSURE IN A COHORt OF PEOPlE JOINt tO PUBlIC EMPlOyEES MEDICAl 

SERVICE OF MENDOzA ARGENtINA 

A. Añó, S. Mortaloni, O. Arrieta, S. Zizzias, L. Cammi, G. Vega, S. DepineY, S. Gimenez. 

P1054 A COMPARAtIVE StUDy OF CAROtID INtIMA MEDIA tHICkNESS IN PAtIENt OF END StAGE 

RENAl DISEASE PAtIENtS ON PERItONEAl DIAlySIS 

S. Kumar, N. Sinha, N. Prasad, K. Chawla, A. Kapoor, S. Tewari. 

P1055 EFFECtS OF FlU VACCINAtION OF SENIOR CItIzENS (60+) ON SEASONAl tRENDS OF 

MORBI-MORtAlIty IN BRAzIlIAN HOSPItAlS. 

M. I. Azambuja, S. L. Bassanesi. 

P1056 INtIMAl PROlIFERAtION INDUCED By PERIVASCUlAR INFlAMMAtION IN MICE: 

COMPARISON BEtWEEN FEMORAl AND CAROtID ARtERIES 

S. Lacchini, L. F. Borges, J. P. F. Blini, B. S. Yasumura, J. E. Krieger. 



P1058 IMPACt OF BODy MASS INDEX IN tHE tARGEt ORGANS DAMAGE IN PAtIENtS WItH 

RESIStANt HyPERtENSION 

M. Barros, A.B. Lima, C. A. S. Nascimento, J. R. M. Pereira, F. D. Vilela, V. Verri, P.R. Benchimol-Barbosa, 

F. E. S. F. Cruz, I. Cordovil. 

P1059 CAN tHE PROGRESSION OF ENDOtHElIUM DySFUNCtION BE A PREDICtOR 

OF CARDIOVASCUlAR EVENtS IN PAtIENtS WItH MEtABOlIC SyNDROME? 

O. Savenko, V. Vikentyev. 

P1060 MyOCARDIAl INFARCtION WItH ANGIOGRAPHICAlly NORMAl CORONARy ARtERIES IN AN 

INFANt 

A. Sardella, H. Vazquez, I. Abella, C. Viegas, I. Torres, M. Grippo, M. Cazalas, A. Goldsman, A. Slichter, C. Kreutzer. 

P1061 ClINICAl IMPACt OF PROPHylACtIC USE OF APROtININ IN CARDIAC SURGERy. 

S. Olival, B. Santos, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa. 

P1063 CARDIOGENIC SHOCk WItHOUt ACUtE CARDIAC SyNDROME: ClINICAl PROFIlE OF 

PAtIENtS, MANAGEMENt StRAtEGIES AND PROGNOSIS. 

I. Wojtkowska, M. Banaszewski, A. Konopka, M. Marona, J. Stepinska. 

P1064 ACUtE HEARt FAIlURE WItH PRESERVED SyStOlIC FUNCtION IN ACUtE CORONARy 

SyNDROME PAtIENtS: ClINICAl RElEVANCE AND OUtCOMES 

C. Lourenço, R. Teixeira, S. Monteiro, N. António, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, 

L. Providência. 

P1065 AMBUlAtORy BlOOD-PRESSURE MONItORING IN PAtIENtS WItH SEVERE AORtIC 

REGURGItAtION, BEFORE AND AFtER tREAtMENt WItH NIFEDIPINE 

F. Gual-Capllonch, A. Evangelista, J. L. Tovar, T. Gonzalez-Alujas, M. Alvarez, P. Mahia, R. Aguilar, P. Tornos. 

P1066 tHE IMPACt OF HEAD-UP tIlt tESt (HUt) WItH NItROGlyCERINE (NtG) PROVOCAtION ON 

CHOSEN PARAMEtERS OF ASSESSMENt IN tHE HEAltHy HUMAN SUBJECt CIRCUlAtION 

K. Peczalski, P. Sionek, D. Wojciechowski. 

P1068 tyPE 2 DIABEtICS WItH HIGH lEVElS OF C-REACtIVE PROtEIN PRESENt A REDUCtION OF 

HEARt RAtE VARIABIlIty 

E. O. Fernandes, A. L. A. Branquinho, S. M. R. Castro, V. A. Leite, B. V. França, A.L.R.M. Freitas, L. C. Silva. 

P1069 ARtERIAl HyPERtENSION AND DySlIPIDEMIA: COMPARISON AMONG ANAMNESIS AND tHE 

RESUltS GOt FROM DIGItAl SPHyGMOMANOMEtER AND BIOCHEMICAl MEASUREMENt 

FROM PERIPHERAl BlOOD 

A. L. P. Arnaldo Lemos Porto, D. M. S. N. Douglas M. Silva Nascimento, J. P. H. R. João Paulo Hanel Rorato, 

E. C. A. R. Eliane Consuelo A. Rabelo, C. C. P. Celmo Celeno Porto.


P1070 tHE IMPACt OF NURSING CONSUltAtION ON tHE CONtROl OF INR 

F. Silva, A. Camara, R. Filho, C. Barros, S. Figueiredo, T. Guimaraes, I. Santos, I. Oliveira, M. Bosa, R. Silva. 

P1071 lOWER SERUM FEtUIN-A lEVElS ARE ASSOCIAtED WItH AORtIC SClEROSIS IN PAtIENtS 

WItH CORONARy ARtERy DISEASE AND PRESERVED RENAl FUNCtION 

K. Linhartova, J. Veselka, G. Sterbakova, O. Topolcan, R. Cerbak, J. Racek. 

P1072 SCIENtIFIC ANAlySIS OF PRODUCtION OF CARDIOVASCUlAR NURSING UNDER tHE 

PREVENtION tERtIARy 

A. Camara, C. Barros, D. Santoro, F. Silva, R. Barreiro Filho, R. Silva, S. Figueiredo, T. Guimarães, I. Santos, 

L. Campos. 

P1073 PERI-StENt REMODElING AFtER SIROlIMUS-ElUtING OR PAClItAXEl-ElUtING StENt 

IMPlANtAtION IN DIABEtIC PAtIENtS. A RANDOMIzED SERIAl INtRAVASCUlAR 

UltRASOUND StUDy. 

L. O. Jensen, M. Maeng, P. Thayssen, E. H. Christiansen, K. N. Hansen, A. Galloe, H. Kelbaek, J. F. Lassen, L. Thuesen. 

P1074 tHE MUltIDISCIPlINARy tEAM CARE tO SECONDARy PREVENtION IN A GROUP WItH 

RESIStANt HyPERtENSION tREAtED IN A PUBlIC INStItUtE OF CARDIOlOGy IN RIO DE 

JANEIRO, BRASIl. 

A. B. Lima, M. Barros, V. Verri, J. R. M. Pereira, C. A. S. Nascimento, F. D. Vilela, P. R. Benchhimol-Barbosa, 

F. E. S. F. Cruz, I. Cordovil. 

P1075 tHE RElAtIONSHIP BEtWEEN ANGIOtENSIN CONVERtING ENzyME GENE POlyMORPHISM 

AND COMORBIDItIES IN RURAl COMMUNIty PAtIENtS WItH CHRONIC HEARt FAIlURE. 

H. Balieiro, E. T. Mesquita, T. L. Balieiro, S. R. Brito, R. B. Moreira, R. K. Osugue, S. B. Pereira, A. M. Domingos, 

A. P. Moraes, G. Ribeiro. 

P1076 SUCCESSFUl tREAtMENt OF ENDOtENSION AND ANEURySM SAC ENlARGEMENt WItH 

ENDOVASCUlAR StENt GRAFt REINFORCEMENt. 

M. Ferreira, R. La Mura, E. Ruslender, J. C. Parodi. 

P1077 MEtHIONINE PRODUCED AN IMPAIRMENt OF CARDIOVASCUlAR AUtONOMIC MODUlAtION 

IN RAtS 

G. O. Candido, R. H. Mendes, R. N. De La Fuente, C. Mostarda, I. C. M. Silva, L. Jorge, M. C. Irigoyen, K. Rigatto. 

P1078 IMPACt OF A MANAGED ACUtE MyOCARDIAl INFARCtION (AMI) PROtOCOl IN tHE 

PRESCRIPtION RAtE OF ACE INHIBItORS OR ANGIOtENSIN RECEPtOR BlOCkER FOR 

HOSPItAlIzED PAtIENtS WItH ACUtE MyOCARDIAl INFARCtION AND lEFt VENtRICUlAR 

SyStOlIC DySFUNCtION 

M. R. P. Makdisse, A. Correa, S. Lagudis, S. S. Morhy, F. Bacal F, M. Knobel, C. H. Fischer, M. L. C. Vieira, 

P. V. Pires, E. Knobel. 



P1079 ANAlySIS OF POSSIBlE IPODS INtERFERENCE WItH PACEMAkERS 

M. Benassi, E. Valero, R. Pesce, L. Jurado. 

P1081 CONtEMPORARy MANAGEMENt OF CAROtID ARtERy StENOSIS: CAROtID 

ENDARtERECtOMy IS HERE tO StAy. SElECtION OF tHE APPROACH ACCORDING tO 

PAtIENt SURGICAl RISk. 

M. Ferreira, R. La Mura, E. Ruslender, J. C. Parodi. 

P1082 tHE RESIStANt HyPERtENSION GENOtyPES OF tHE POPUlAtION RESIDENt IN RIO DE 

JANEIRO 

F. D. Vilela, P. R. Benchimol-Barbosa, C. C. Zeno, A. B. Lima, M. Barros, F. V. Campos, C. S, Miranda, G. N. Gobbi, 

J. Barbosa-Filho, I Cordovil. 

P1083 GlyCAEMIA At ADMISSION ACCURAtEly PREDICtS IN-HOSPItAl OUtCOME IN ACUtE 

CORONARy SyNDROME PAtIENtS 

S. Monteiro, S. Costa, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, L. A. Providencia. 

P1084 USEFUlNESS OF MUltISlICE COMPUtED tOMOGRAPHy IN tHE DEtECtION 

OF NON-SUSPECtED CORONARy AND MyOCARDIAl DISEASES 

M. Falconi, D. Perez De Arenaza, P. Oberti, P. Pollono, A. Fernandez, F. Abramzon, L. Grinfeld, R. Garcia Monaco, 

J. Krauss, A. Cagide. 

P1085 ASSOCIAtION BEtWEEN PROGNOStIC FACtORS IN SEVERE IDIOPAtIC DIlAtED 

CARDIOMyOPAtHy AND FIBROSIS EVAlUAtED By CARDIOVASCUlAR MAGNEtIC 

RESONANCE 

M. L. O. Mugnaini, D. B. Précoma, P. R. Schvartzman, L. A. Z. Moura, S. H. Barberato, G. Lemke, P. R. Brofman. 

P1086 DOES SyMMEtRy OF tHE AORtIC OUtFlOW VElOCIty PROFIlE REFlECt CONtRACtIlE 

FUNCtION IN CORONARy ARtERy DISEASE ? AN AUtOMAtED ANAlySIS USING 

MAtHEMAtICAl MODEllING 

M. Cikes, H. Kalinic, A. Baltabaeva, S. Loncaric, C. Parsai, J. Separovic Hanzevacki, I. Cikes, G. Sutherland, B. Bijnens. 

P1087 ABSENCE OF ElECtROCADIOGRAPHIC ABNORMAlItIES IN CHIlDREN INFECtED WItH 

tRyPANOSOMA CRUzI FROM A RURAl AREA OF ARGENtINA. 

C. D. Lacunza, M. Gonzalez, A. Alberti, R. Cimino, V. Pereyra, R. Zacca, V. Orellana, M. A. Basombrío, J. Nasser, 

P. Diosque. 

P1088 HEMODyNAMIC AND AUtONOMIC RESPONSES tO A MENtAl StRESS tESt AND 

tO AN ISOMEtRIC EXERCISE tESt IN OFFSPRING OF HyPERtENSIVE PARENtS. 

J. V. Francica, M. V. Heeren, C. Mostarda, M. Sartori, M. Tubaldini, R. C. Araújo, M. C. Irigoyen, K. De Angelis. 

P1089 POPUlAtION AWARENESS ON CARDIOVASCUlAR RISk FACtORS: 

A DEVElOPING COUNtRy EXPERIENCE PREVENAçÃO 

A. Avezum, H. Guimarães, A. Brasileiro, P. Esteves, A. Neto, M. Bertolami, C. Serrano, L. Maia, A. Marco, F. Nobre.


P1090 264 DAyS ON BIVENtRICUlAR MECHANICAl ASSIStANt SUPPORt 

AS BRIDGE tO tRANSPlANtION IN A 31 MONtH OlD PAtIENt 

H. Vogelfang, G. Naiman, A. Villa, A. Charroqui, G. Moreno, R. Magliola, L. Quiroga, G. Burlli, D. Haag, M. De La Riba. 

P1091 NORMOtHERMIC CARDIOSURGERy. tHE COMPARAtIVE ANAlySIS 

OF HEMODyNAMIC IN AORtO-CORONARy ByPASS SURGERy 

R. S. Ovchinnikov, L. A. Bockeria, V. A. Lischouk, I. U. Sigaev, D. S. Gazizova, L. V. Sazukina, V. E. Volgushev. 

P1092 HyPERtENSION SCREENING WItH A NEW DIGItAl BlOOD PRESSURE DEVICE NAMED 

“RAStREOMEtER” 

A. D. M. Feitosa, V. R. Lafayette, L. B. N. C. Magalhaes, M. A. M. Gomes, R. D. Miranda. 

P1093 lAtVIAN BIFURCAtION lESION REGIStRy – IVUS RESUltS 

A. Erglis, I. Kumsars, I. Narbute, D. Sondore, S. Jegere, A. Dombrovskis, A. Lismanis, I. Olina. 

P1094 AMPlItUDE OF IN-HOSPItAl GlyCAEMIA VARIAtION: A NEW PROGNOStIC MARkER IN 

ACUtE CORONARy SyNDROMES? 

S. Monteiro, N. Antonio, S. Costa, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, 


P1095 tHE EFFECtS OF RESIStANCE EXERCISE ON PlASMA kINEtICS OF AN ARtIFICIAl 

NANOEMUlSION tHAt BINDS tO lOW-DENSIty lIPOPROtEIN RECEPtORS 

J. L. Silva, C. G. Vinagre, A. T. Morikawa, R. C. Maranhao. 

P1096 CARDIAC MAGNEtIC RESONANCE IN HEtEROzyGOtES FEMAlES WItH ANDERSON-FABRy 

DISEASE 

L. Dragonetti, C. Rivas, F. Corbella, E. Eyheremendy, Adellfa. 

P1097 EXERCISE tRAINING INDUCED AUtONOMIC IMPROVEMENt WAS ASSOCIAtED WItH 

MEtABOlIC AND RENAl DySFUNCtIONS AttENUAtION IN AN EXPERIMENtAl MODEl OF 

MEtABOlIC SyNDROME AND MENOPAUSE. 

K. Ponciano, J. Brito, I. Sanches, M. Heeren, M. C. Irigoyen, K. De Angelis. 

P1098 BODy MASS INDEX AND IN-HOSPItAl ACS OUtCOME: 

tHE MIDDlE IS tHE PlACE tO BE! 


P1099 ANAEMIA AND RENAl FAIlURE – A DEADly DUEt IN ACUtE CORONARy SyNDROMES 


P1100 USING A FIBER AND PHytONUtRIENt COMBINAtION tHERAPy tO CONtROl 

HyPERCHOlEStEROlEMIA IN AN AFRICAN AMERICAN COMMUNIty 

L. Njord, R. Njord, W. Cooper, P. J. E. Verdegem. 



P1101 CORONARy ACUtE SyNDROME IN PAtIENtS ADMIttED tO tHE EMERGENCy IN tHE CENtRAl 

HOSPytAl OF tHE SOCIAl INStItUtE PREVISIòN 

F. Fernandez Chamorro, C. Saldivar, L. Fatecha, M. Centurión, J. Paredes, L. Bell, A. Villamayor, V. Marmol, 

J. Gonzalez, S. Aguirre. 

P1102 PREDICtORS AND ClINICAl RElEVANCE OF tROPONIN ElEVAtION FOllOWING 

PERCUtANEOUS AORtIC VAlVE REPlACEMENt 

H. Jilaihawi, T. Spyt, E. Logtens, J. C. Laborde, D. Chin, J. Kovac. 

P1103 ENDOVASCUlAR RECONStRUCtION By MEANS OF StENtS OF SyMPtOMAtIC INtRACRANIAl 

StENOSIS 

P. Lylyk, C. Miranda, R. Ceratto, A. Ferrario, J. Vila, C. Ingino. 

P1104 DIABEtES: A CORONARy ARtERy DISEASE EQUIVAlENt REVISItED IN ACUtE CORONARy 

SyNDROME PAtIENtS 

S. Monteiro, N. Antonio, S. Costa, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, 

M. Freitas, L. A. Providencia. 

P1105 CARDIAC ABNORMAlItIES IN PAtIENtS WItH HIV-RElAtED MAlIGNANCIES 

IN SUB-SAHARAN AFRICA 

C. Onen. 

P1106 ANGIOPOIEtINS MEDIAtE MONOCytE ADHESION tO ENDOtHElIAl CEllS 

AND HAVE PRO-INFlAMMAtORy ACtIONS INDEPENDENt OF VEGF 

R. Potluri, T. Fujisawa, K. Chudasama, S. Ahmad, P. Hewett, M. Cudmore, A. Ahmed. 

P1107 HOW DO PARENtS AND RESPONSIBlE OF SCHOlARS DEAl WItH tONSIllItIS 

AND RHEUMAtIC FEVER IN RIO DE JANEIRO? 

R. Müller, M. F. M. P. Leite, D. L. Sampaio, M. C. C. Kuschnir, M. J. L. M. Silva, A. S. Souza, R. Thurler, R. Bedim, 

F. F. Nascimento, R. M. A. Xavier. 

P1108 lONG-tERM (UP tO FIVE yEARS) ClINICAl OUtCOMES OF ON-lABEl VERSUS OFF-lABEl 

PAtIENtS IN tHE DESIRE (DRUG ElUtING StENtS IN tHE REAl WORlD) REGIStRy 

J. Costa Jr., A. Sousa, R. Costa, A. Costa, M. Cano, G. Maldonado, O. Berwanger, R. Pavanello, M. Barbosa, 

J. Eduardo Sousa. 

P1109 ANGIOtENSIN-(1-7) INHIBItS ANGIOtENSIN II-StIMUlAtED PHOSPHORylAtION OF 

EXtRACEllUlAR SIGNAl-REGUlAtED kINASES (ERk) 1/2 IN RAt HEARt IN VIVO. 

J. F. Giani, M. M. Gironacci, M. C. Muñoz, D. Turyn, F. P. Dominici. 

P1110 MICROVASCUlAR DIABEtIC COMPlICAtIONS ARE MORE PREVAlENt IN INDIA COMPARED tO 

MAURItIUS AND tHE Uk DUE tO POORER DIABEtIC CONtROl 

R. Potluri, Y. Purmah, N. Sewpaul, M. Dowlut.


P1111 ElECtROCARDIOGRAPHIC PAttERNS AND CORONARIOGRAPHIC CORRElAtION IN PAtIENtS 

WItH StEMI tHAt UNDERWENt PERCUtANEOUS CORONARy INtERVENtION ON ADMISSION 

tO HOSPItAl. 

I. Santos-Rodriguez, M. J Ruiz-Olgado, V. Ramirez-Castro, J. Rodriguez-Collado, M. Cascon-Bueno, A. Perez-Bueno, 

V. Leon-Arguero, I. Cruz-Gonzalez, F. Martin-Herrero, M. Diego-Dominguez. 

P1113 “ASSESSMENt OF AtRIAl SyStOlE WItHIN tHE FIRSt 24 HOURS AFtER CARDIOVERSION IN 

PAtIENtS WItH ACUtE AtRIAl FIBRIllAtION” 

G. Rodriguez Botta, E. Escudero. 

P1114 OBESIty AS A PREDICtOR OF MAyOR CARDIOVASCUlAR RISk FACtORS- CHIlEAN 

POlICEMEN COHORt. 

F. Vilchez, P. Varleta, B. Clericus, P. Salvo. 

P1115 PREDICtIVE VAlUE OF CARDIAC I tROPONIN FOR HIGH RISk ANAtOMy IN ACUtE CORONARy 

SyNDROMES WItHOUt St SEGMENt ElEVAtION. 

D. Di Nanno, L. Lopez, A. Torterola, A. Bordenave, M. Consoli, C. Pasinato, R. La Greca, S. Chekherdemian. 

P1116 HEARt RAtE VARIAtION DIStURBANCE FOllOWED By RIGHt VENtRIClE ACUtE SyStOlIC 

StRAIN AFtER PUlMONARy EMBOlISMS 

M. Palinsky, J. Petrovicova, P. Mitro, M. Szakacs. 

P1117 EXCEllA FIRSt-IN-MAN StUDy : SAFEty AND EFFICACy OF ElIXIR NOVOlIMUS-ElUtING 

StENt IN tHE tREAtMENt OF PAtIENtS WItH DE NOVO CORONARy lESIONS 

A. Abizaid, J. Costa Jr., R. Costa, F. Feres, D. Siqueira, P. Fitzgeral, R. Staico, D. Siqueira, A. Sousa, J. Eduardo Sousa. 

P1118 ASSOCIAtION OF AlANINE AMINOtRANSFERASE WItH CARDIOVASCUlAR RISk FACtORS IN 

40 yEARS OlD SUBJECt FROM SlOVAk GENERAl POPUlAtION 

B. Vohnout, J. Gasparovic, Z. Basistova, S. Wsolova, L. Fabryova, K. Raslova. 

P1119 REStENOSIS OF DRUG-ElUtING StENtS: A CURRENtly UNSOlVED ISSUE? 

J. Costa Jr., A. Sousa, R. Costa, A. Moreira, G. Maldonado, M. Cano, E. Romano, C. Jardim, C. Campo, J. Eduardo Sousa. 

P1120 PRElIMINARy RESUltS OF tHE HyDROXyAPAtItE NON-POlyMER-BASED SIROlIMUS- 

ElUtING StENt FOR tHE tREAtMENt OF SINGlE DE NOVO CORONARy lESIONS – A FIRSt- 

IN-HUMAN ANAlySIS OF A tHIRD GENERAtION DRUG-ElUtING StENt (DES) SyStEM 

A. Abizaid, J. Costa Jr., R. Costa, F. Feres, R. Graebin, R. Staico, L. Fernando Tanajura, A. Abizaid, A. Sousa, 


P1123 tHE USE OF PICC IN INFECtIOUS ENDOCARDItIS tREAtMENt 

P. Silva, A. Silva, C. Barros, G. Carvalho, L. Campos, P. Mota, P. Marinho, R. Barreiro Filho, R. Silva, T. Guimarães. 



P1125 lONG-tERM RESUltS OF DRUG-ElUtING StENtS FOR tHE tREAtMENt OF SAPHENOUS 

VEIN GRAFtS: WHAt WE lEARNED FROM tHE DESIRE-SVG (DRUG-ElUtING StENtS IN REAl 

WORlD - SAPHENOUS VEIN GRAFt) REGIStRy 

J. Costa J., A. Sousa, A. Moreira, R. Costa, G. Maldonado, M. Cano, E. Egito, A. Cury, O. Berwanger, J. Eduardo Sousa. 

P1126 tIlt tESt IN tHE INVEStIGAtION OF EXERCISE-INDUCED SyNCOPE OF UNkNOWN ORIGIN 

A. Nobrega, R. Castro, A. Souza. 

P1127 DIFFERENtIAl INFlUENCES OF HIGH FAt DIEt ON CARDIAC REMODElING FROM 

NORMOtENSIVE AND SPONtANEOUSly HyPERtENSIVE RAtS 

S. A. Oliveira Júnior, A. P. Lima-Leopoldo, P. F. Martinez, D. H. S. Campos, M. M. Sugizaki, M. P. Okoshi, K. Okoshi, 

C. R. Padovani, M. Dal Pai-Silva, A. C. Cicogna. 

P1128 IMPACt OF INVASIVE StRAtEGy IN ElDERly PAtIENtS PRESENtING WItH 

NON-St ElEVAtION ACUtE CORONARy SyNDROMES 

C. Lourenço, R. Teixeira, N. António, S. Monteiro, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, 

L. A. Providência. 

P1129 NON St-SEGMENt ElEVAtION ACUtE CORONARy SyNDROMES. ANtECEDENtS, ClINICAl 

PRESENtAtION AND PREDICtORS OF PROGNOSIS By MUltIVARIAtE ANAlySIS 

H. Pomés Iparraguirre, G. Calderón, W. Santander, J. H. Leguizamón, O. Paredes, G. Kuhn, A. Arias Posada, L. Ferrer, 

R. Aguero, G. Valeriano. 

P1130 EXERCISE ANtIOXIDANt PROtECtIVE EFFECt IMPROVES CARDIOVASCUlAR AND RENAl 

FUNCtION IN DIABEtIC HyPERtENSIVE RAtS 

T. S. Cunha, R. H. Mendes, M. Bertagnolli, G. Cândido, J. P. Aguiar, K. Flues, K. De Angelis, F. K. Marcondes, 

A. Belló-Klein, M. C. Irigoyen. 

P1131 CHRONIC ClOPIDOGREl AND ASPIRIN tHERAPy FOR CORONARy ARtERy DISEASE: A 10 yEAR 

ClINICAl FOllOW-UP 

S. Krishna, R. Suneja, P. C. Chabot, N. Kleiman. 

P1132 ROlE OF M-MODE SEPtAl tO POStERIOR WAll MOtION DElAy AS PREDICtOR 

OF RESPONSE tO CARDIAC RESyNCHRONIzAtION tHERAPy 

N. António, L. Coelho, S. Costa, H. Vieira, R. Martins, M. Ventura, J. Cristóvão, L. Elvas, L. Gonçalves, 

L. A. Providência. 

P1133 IS AN INVASIVE StRAtEGy USEFUl IN WOMEN WItH NON-St ACUtE CORONARy 

SyNDROME? 

R. Teixeira, C. Lourenço, N. Antonio, S. Monteiro, S. Costa, F. Gonçalves, P. Monteiro, L. Gonçalves, M. Freitas, 

L. A. Providencia.


P1134 VERy lONG-tERM ClINICAl OUtCOMES OF A CONSECUtIVE HIGH-COMPlEXIty POPUlAtION 

tREAtED WItH DRUG-ElUtING StENtS: RESUltS OF tHE DESIRE (DRUG ElUtING StENtS 

IN tHE REAl WORlD) REGIStRy 

J. Costa Jr., A. Sousa, R. Costa, A. Moreira, M. Cano, G. Maldonado, C. Jardim, M. Helena Dib, C. Campos, 


P1135 VASCUlAR RISk FACtORS IN PERIMENOPAUSAl FEMAlE PHySICIANS IN ARGENtINA 

H. z. zylbersztejn, Horacio, A. M. Mulassi, Andres, A. C. Cardone, Alberto, A. P. Picarel, Anibal, A. R. Robilotte 

Analia, E. P. Pautasso, Enrique, S. K. Kusznier, Silvia, C. B. Belziti, Cesar. 

P1136 RISk OF HEMODIAlySIS AFtER HEARt SURGERy 

B. Santos, S. Olival, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa. 

P1137 SyNCOPE WItH INJURy. DIAGNOStIC AND OUtCOME 

N. Galizio, L. Soriano, G. Fava, J. L. Gonzalez, L. Medesani, P. Montoya, S. Schanz, R. Ramon, H. Ramirez. 

P1139 DIAGNOSIS OF tHE MEtABOlIC SyNDROME AND ItS RElAtION WItH INSUlIN RESIStANCE. 

G. Giunta, L. Cuniberti, C. Escarain, N. Pizzi, S. Lynch, A. Miranda, A. Christen, G. Yannarelli, R. Sanchez, H. Baglivo. 

P1140 C REACtIVE PROtEIN AND CARDIAC I tROPONIN. tWO SIDES OF tHE SAME MEDAl? 

D. Di Nanno, L. Lopez, M. Consoli, F. Petrolito, A. Costa, L. Saclietti, C. Pasinato, S. Chekherdemian. 

P1141 A NEW StRAtEGy FOR RHEUMAtIC FEVER PREVENtION tHROUGH HEAltH EDUCAtION – 

PREFERE PROGRAM, RIO DE JANEIRO, BRAzIl 

R. E. M. Regina Elizabeth Muller, M. C. K. Maria Cristina Kuschnir, B.R.T. Bernardo Rangel Tura, 

R. M. A. X. Regina Maria Aquino Xavier, M. J. L. S. Maria José Lucas M. Da Silva, A. L. S. Ana Lucia Schilke, 

F. F. N. Fabiana F. Nascimento, A. E. A. S. Anna Esther Araújo E Silva, A. B. L. Ana Beatriz Lima, 

M. F. C. Marcia Fernanda De Carvalho. 

P1142 ANGIOGRAPHIC AND UltRASONOGRAPHIC COMPARISON OF SIROlIMUS AND NOVOlIMUS- 

ElUtING StENtS FOR tHE tREAtMENt OF CORONARy lESIONS 

J. Maia, J. Costa Jr., A. Abizaid, D. Chamie, F. Feres, R. Costa, R. Staico, D. Siqueira, A. Sousa, J. Eduardo Sousa. 

P1144 MItOCHONDRIAl AtP-SENSItIVE POtASSIUM CHANNEl PARtICIPAtION 

IN SPIRONOlACtONE PRECONDItIONING 

C. C. Lores, L.F. Rodrigues Jr., A. C. A Carvalho, A. C. C. Carvalho, J. H. M. Nacimento. 

P1145 REStRICtIVE CARDIOMyOPAtHy: EtIOlOGIES AND OUtCOME IN A SINGlE CENtER 

EXPERIENCE 

V. Gregorietti, M. Peradejordi, A. Bertolotti, M. Diez, L. Favaloro, L. Talavera, C. Vigliano, R. Laguens, R. Favaloro. 

P1146 EQUIPlANARIty OF ECHOCARDIOGRAPHIC, SPECt AND CARDIAC MAGNEtIC RESONANCE 

IMAGING PlANES. tO WHAt EXtENt ARE tHE AHA StAtEMENtS FOR SEGMENtAtION AND 

NOMENClAtURE PRACtICABlE? 

R. Asbot, K. Sugar, I. Balogh. 



P1147 tHE GOOD SCORE´S QUAlIty OF lIFE IS A MARkER FOR tHE GOOD CONtROl 

ON BlOOD PRESSURE IN HyPERtENSION PAtIENt? 

G. M. Guerra, E. O. Freitas, P. L. Silva, D. M. A. Giorgi, E. M. Krieger, H. F. Lopes. 

P1148 RElAtIONSHIP BEtWEEN VENtRIClE-VASCUlAR COUPlING AND tHE VENtRICUlAR 

FUNCtION PARAMEtERS. CONCEPt OF VENtRIClE-VASCUlAR INtERACtION. 

J. Tripolone, G. Santiago, A. Schott, J. M. Tripolone. 

P1149 RACIAl DIStRIBUtION OF NItRIC OXIDE SyNtHASE POlyMORPHISM IN 

A MUltI-EtHNICAl POPUlAtION 

E. Mesquita, S. Bernardez, O. Tardin, L. Pessoa, S. Chermont, T. Alves, H. Balieiro, L. Amorim, G. Ribeiro, M. Velloso. 

P1152 AtHEROtHROMBOSIS IN ACUtE CORONARy SyNDROMES: ONE SIzE DOES NOt FIt All! 

S. Monteiro, N. Antonio, S. Costa, R. Teixeira, C. Negrier, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, 


P1153 StROkE AFtER CARDIOtHORACIC SURGERy: ANAlySIS OF ASSOCIAtED FACtORS 

S. Olival, B. Santos, R. Gomes, A. Rouge, L. Alves, M. Freitas, R. Vegni, W. Homena, J. O. R. Brito, O. N. Barbosa. 

P1154 EXPERIENCE WItH COVERED StENt IMPlANtAtION IN CONGENItAl HEARt DISEASE. 

A. Peirone, A. Guevara, A. Spillmann, E. Juaneda, G. Pessah, G. Guglieri, E. Banille, L. Alday. 

P1155 MyOGENIC REGUlAtORy FACtORS EXPRESSION IN SkElEtAl MUSClE CHANGES DURING 

VENtRICUlAR DySFUNCtION AND HEARt FAIlURE 

P. F. Martinez, K. Okoshi, L. A. M. Zornoff, R. F. Carvalho, S. A. Oliveira Jr, D. H. S. Campos, A. R. R. Lima, 

C. R. Nogueira, M. Dal Pai-Silva, M. P. Okoshi. 

P1156 PRECOMPEtItIVE ASSESSMENt IN yOUNG AtHlEtES 

J. Kriskovich, R. Rasmussen, E. Villegas, G. Pereira Zini, M. Avila, M. De La Rosa, E. Tassano. 

P1158 EMERGENCy SERVICE: ANAlySIS OF CHESt PAIN UNIty 

J. Silveyra, P. Bayol, O. Querencio, E. Fernandez, S. Manzolillo, R. Zoni, J. Parras, J. Kriskovich, J. Escalante, 

R. Peloso. 

P1159 EVAlUAtION OF AORtIC PAtHOlOGy By CARDIAC MAGNEtIC RESONANCE 

A. Ithuralde, C. Seara, J. Moltedo, J. P. Gallo, C. Nojek, P. Garcia De Lucis, M . Garcia Nani, A. De Elizari, M. Ithuralde. 

P1160 NON St-SEGMENt ElEVAtION ACUtE CORONARy SyNDROMES IN DIABEtIC PAtIENtS. 

ClINICAl CHARACtERIStICS, tHERAPEUtIC INtERVENtIONS AND INHOSPItAl OUtCOME 

H Pomés Iparraguirre-, G Kuhn, G Calderón, W Santander, JH Leguizamón, O Paredes, R Aguero, L Ferrer, 

J. Torres, A. Cejas.


P1161 EXERCISE tEStING ASSESSMENt IN ACtIVE MEN AND tHEIR RElAtIONSHIP WItH SMOkING 

J. Kriskovich, R. Rasmussen, E. Villegas, M. Avila, G. Pereira Zini, J. Sanagua, H. Martinez, E. Tassano. 

P1163 FAMIly HIStORy OF tOBACCO SMOkING AND AttItUDE tOWARDS tHE PAtIENt SMOkER IN 

FEMAlE PHySICIANS OF ARGENtINA 

H. z. zylbersztejn, Horacio, A. M. Mulassi, Andres, A. C. Cardone, Alberto, A. P. Picarel, Anibal, A. R. Robilotte, 

Analia, E. P. Pautasso, Enrique, S. K. Kusznier, Silvia, C. B. Belziti, Cesar. 

P1164 BlOOD PRESSURE CONtROl AND PREVAlENCE OF ARtERIAl HyPERtENSION IN 

ADOlESCENtS OF A RURAl POPUlAtION IN ARGENtINA. VElA PROJECt. 

Matias Tringler, Alejandro Diaz, Soledad Saravia, Maria Silvia Grenóvero. 

P1165 ANAlySIS OF RISk FACtORS FOR CARDIOVASCUlAR DISEASE AMONG WOMEN IN A CIty IN 

ARGENtINA 

M. Del Sueldo, Md, C. Serra, Md, Ph, G. Guerrero, Engineer, R. Rodrigo, Md. M. Carasa, Md. S. Castellino, 

Md. V. Giovinni, Md. I. Vigil Torres, Md. D. Barra, Biochemist, J. Zilberman, Md. 

P1166 ANtHROPOMEtRIC, MEtABOlIC AND CARDIORESPIRAtORy PROFIlE OF SUBJECtS OlDER 

tHAN 60 yEARS-OlD IN BRAzIl SOUtHERN POPUlAtION 

K. C. Belli, C. M. Richter, T. F. Panigas, D. C. Bündchen, T. Dipp, J. Z. Klafke, K. C. Guidini, C.F. Panigas, P. R. N. Viecili. 

P1167 ANGIOGRAPHIC AND UltRASONOGRAPHIC RESUltS OF tHE SISC (StENt IN SMAll 

CORONARIES) REGIStRy 

D. Chamie, J. Costa Jr., A. Abizaid, R. Costa, F. Feres, J. Maia, F. Devito, D. Siqueira, A. Sousa, J. Eduardo Sousa. 

P1168 RElAtIONSHIP BEtWEEN HEARt RAtE EQUAtIONS AND MAXIMUM OXyGEN CONSUMPtION 

FOR EXERCISE PROGRAM PRESCRIPtION 

J. L. C. Pippi, T. F. Panigas, T. Dipp, C. M. Richter, K. C. Belli, C. F. Panigas, D. C. Bündchen, J. Z. Klafke, P. R. N. Viecili. 

P1169 REHABIlItAtION IN CORONARy PAtIENt: FOllOW UP 

J. Kriskovich, R. Rasmussen, G. Amarilla, J. Vallejos, M. Avila, E. Villegas, J. Parra Moreno. 

P1170 DEtECtION OF CORONARy ARtERy DISEASE IN ASyMPtOMAtIC PAtIENtS WItH tyPE 

2 DIABEtES MEllItUS: PREVAlENCE OF PERFUSION DEFECtS DEtECtED By StRESS 

tECHNEtIUM-99M SEStAMIBI MyOCARDIAl PERFUSION SINGlE-PHOtON EMISSION 

COMPUtED tOMOGRAPHy. 

C. D. C Collaud Carlos, R. M. Redruello Marcela, B. J. Blanco Juan, P. O. Parysow Oscar, M. O. Masoli Osvaldo. 

P1171 ANAlySIS OF tHE REFlECtIVE VASOMOtOR CAROtID RESPONSE tO tHE 

HyPERVENtIlAtION tESt. COMPARAtIVE StUDy BEtWEEN NORMAl PAtIENtS WItH RISk 

FACtORS AND PAtIENtS WItH CAROtID AtHEROSClEROtIC OBStRUCCION 

J. Tripolone, G. Santiago, J. M. Tripolone. 



P1172 HEARt FAIlURE MORtAlIty IN tHREE BRAzIlIAN StAtES FROM 1999 tO 2004: AN ANAlySIS 

It´S ASSOCIAtION WItH OtHER CONDItIONS CHOSEN AS UNDERlyING CAUSE OF DEAtH. 

E. Gaui, G. Oliveira, C. Klein. 

P1173 lONG-tERM OUtCOMES IN PAtIENtS WItH UNStABlE ANGINA EVAlUAtED 

IN A CHESt PAIN UNIt 

T. G. Allison, G. S. Reeder, P. A. Smars. 

P1174 PREDICtORS OF MEDIAStINItIS AFtER HEARt SURGERy 

S. Olival, B. Santos, R. Gomes, M. Santos, K. Senna, A. Rouge, M. Freitas, R. Vegni, J. O. R. Brito, O. N. Barbosa. 

P1175 NUtRItIONAl PROFIlE IN OUtPAtIENtS WItH CHRONIC HEARt FAIlURE IN A 

HEARt FAIlURE ClINIC 

E. Britto, S. Chermont, E. T. Mesquita. 

P1176 tHE ROlE OF BAllOON StAtIC AtRIOSEPtOStOMy IN INtER AtRIAl EStABIlIzAtION OF 

INFANtS WItH COMPlEX CONGENItAl HEARt DISEASE 

L. Simões, P. R. Travancas, C. Lace, J. G. Athayde, W. Paiva, A. Inocenzi, M. Celente, F. Gurgel, A. H. Dorigo, C. C. Assef. 

P1178 VASCUlAR EFFECtS OF CANDESARtAN AND tEMPOl IN A MODEl OF MEtABOlIC SyNDROME 

N. F. Renna, E. S. Gonzalez, M. C. Lama, R. M. Miatello. 

P1179 DEtECtION, AWARENESS, COUNSElING AND CONtROl OF HyPERtENSION IN tHE US ADUlt 

AGE 18 yEARS OF MORE: A NHANES 1999-2004 StUDy. 

Sunil Kumar Agarwal, Samir Saba. 

P1180 CRItICAl PUlMONARy VAlVE StENOSIS OF tHE NEONAtE: tREAtMENt WItH BAllOON 

PERCUtANEOUS VAlVOPlASty.(BPV) 

L. Simões, C Lace, P. R. Travancas, P. S. Oliveira, F. Gurgel, W. Paiva, A. Inocenzi, M. Celente, J. G. Athayde, 

A. H. Lago Dorigo. 

P1181 AORtOPUlMONARy WINDOW—IMPACt OF ASSOCIAtED lESIONS ON NAtURAl HIStORy 

AND IN tHE SURGICAl RESUltS 

L. Simões, C. Gangana, J. Caliani, C. C. Assef, R. Minardi, A. H. Lago Dorigo, P. R. Travancas, C. Lace, M. Celente, F. Gurgel. 

P1182 PERSPECtIVA DE GéNERO EN tORNO A lA CARDIOPAtíA ISQUéMICA y lA SEXUAlIDAD DE 

lOS PACIENtES CORONARIOS. 

I. Brevis. 

P1183 ANGIOtENSIN-(1-7) DOWNREGUlAtES tyROSINE HyDROXylASE tHROUGH A PROtEASOME- 

DEPENDENt PAtHWAy 

M. A. Lopez Verrilli, M. M. Gironacci.


P1184 HOSPItAl COStS AND EFFECtS OF CONGENItAl HEARt SURGERy StRAtIFIED WItH 

ARIStOtlE SCORE 

E. Trindade, C. Tanamati, M. Barbero Marcial, R. Assad, M. Jatene, A. Riso, A. A. Lopes, L. Caneo, S. Fujii, 

C. Yukiko Osato. 

P1185 DIStRIBUtION OF BEtA–ADRENERGIC RECEPtORS POlyMORPHISMS IN A BRAzIlIAN HEARt 

FAIlURE ClINIC. 

S. Bernardez, O. Tardin, L. Pessoa, T. Alves, B. Cavaliere, R. Abdalah, S. Chermont, V. Navega, G. Ribeiro, 

E. Mesquita. 

P1186 ANklE BRACHIAl INDEX AND ItS ASSOCIAtED OBESIty CRItERIA 

T. Paes, D. Orlandi, F. Gazoni, H. Guimaraes, L. Vendrame, R. Lopes, A. C. Lopes. 

P1188 DIlAtED CARDIOMyOPAtHy REGIStRy IN CHRONIC HEMODIAlyS PAtIENtS (REMIDIAl) 

L. Gastaldi, M. Viso, C. Mascheroni, F. Acosta, D. Genova, A. Davila, S. Pezzotto, H. Lastiri, J. Beloscar. 

P1189 lIPOPROtEIN(A) PlASMAtIC lEVElS AND lIPIDIC PROFIlE ON INDIVIDUAlS OF tHE AñÚ 

tRIBE OF tHE PAEz MUNICIPAlIty, zUlIA StAtE, VENEzUElA 

L. Acosta, A. Siciliano, V. Bermúdez, E. Mengual, D. Aparicio, R. Canelón, F. Finol, E. Rojas, J. Faría, L. Sorell. 

P1190 ENAlAPRIl BUt NOt HyDRAlAzINE INCREASES ENDOCARDIAl tRANSIENt OUtWARD 

POtASSIUM CURRENt IN RAt CARDIOMIOCytES 

L. F. Rodrigues Jr., C. C. Lores, A. C. A. Carvalho, A. C. C. Carvalho, J. G. Mill, J. H. M. Nascimento. 

P1191 INCIDENCE OF DEPRESSIVE SyMPtOMS ON tHE lEFt VENtRICUlAR FUNCtION PARAMEtERS 

J. Tripolone, G. A. Santiago, J. M. Tripolone. 

P1192 WHICH IS tHE lAtE EVOlUtION OF SyMPtOMAtIC PAtIENtS WItH OBStRUCtIVE 

HyPERtROPHIC CARDIOMyOPAtHy SUBMIttED tO AlCOHOl SEPtAl ABlAtION? 

MANuEL Nicolas Cano, SILVIA Judith Fortunato De Cano, ADRIANA C Moreira, RICARDO Pavanello, 

JAIRO Alves Pinheiro Jr., AMANDA Gmr Sousa, JOSE Eduardo Mr Sousa, ADIB Domingos Jatene. 

P1194 EVAlUAtION OF ANtHROPOMEtRIC MEASURES, ClINICAl, NUtRItIONAl AND PHySICAl 

ACtIVIty lEVEl IN SUBJECt WItH DIFFERENt lEVElS OF CARDIOVASCUlAR RISk 

A. P. Q. Mello, I.T. Silva, C. A. Sanibal, A. S. Timm, R. D. S. Filho, R. C. Maranhao, N. R. T. Damasceno. 

P1195 DOES tHE tyPE OF StENt INFlUENCE IN-HOSPItAl OUtCOME IN 

ACUtE CORONARy SyNDROME PAtIENtS? 

S. Costa, S. Monteiro, N. Antonio, C. Negrier, R. Teixeira, F. Goncalves, P. Monteiro, L. Goncalves, M. Freitas, 




P1196 WHICH IS tHE BESt StRAtEGy tO tREAt CONCOMItANt CAROtID 

AND CORONARy ARtERy DISEASE? 

MANuEL Nicolas Cano, ANDRÉS Sanchez Esteva, ANTONIO M. Kambara, FAUSTO Feres, ALEXANDRE Abizaid, 

SAMUEL M. Martins, LEOPOLDO Soares Piegas, AMANDA Guerra Mr Sousa, JOSE Eduardo Mr Sousa, 

ADIB Domingos Jatene. 

P1197 NONINVASIVE MEtHOD FOR ASSESSMENt OF ENDOtHElIAl FUNCtION BASED ON 

REFlECtION INDEX OBtAINED WItH POSt-OCClUSIVE REACtIVE HyPEREMIA 

A. S. F. Ferreira, Arthur De Sá, J. B. F. Barbosa Filho, José, I. C. Cordovil, Ivan, M. N. S. Souza, Marcio Nogueira. 

P1198 AtRIAl FIBRIllAtION ANAlySIS ON tHE ABSENCE OF CARDIAC IllNESS tHROUGH tHE 

StROkE VOlUME AND ECHOCARDIOGRAM 

J. Morais, T. Diogenes, J. Paes Jr. 

P1199 MAIN PUlMONARy ARtERy PRESSURE WAVEFORM ANAlySIS: A tIME-DOMAIN APPROACH 

FOR COMPlEtE HEMODyNAMIC EVAlUAtION DURING PUlMONARy HyPERtENSION. 

J. Grignola, L. Devera, F. Ginés. 

P1200 tHE EFFECtS OF tHE BREAtH CONtROllED INCURSION ON tHE BlOOD PRESSURE SyStEM 

IN SUBJECtS WItH RESIStENt HIPERtENSIVE tO tHE tREAtMENt: IMPACt OF AUtONOMIC 

MODUlAtION ON RENIN-ANGIOtENSIN-AlDOStERONE SyStEM 

C. S. Miranda, P. R. Benchimol-Barbosa, G. N. Gobbi, J. Barbosa-Filho, M. V. Barros, A. B. R. Lima, F. Vilela, 

F. V. Campos, I. Cordovil. 

P1201 tHE VOlUMEtRIC INDEX OF tHE lEFt AtRIUM IS MORE PRECISE tHAN tHE lIMIAR MEASURE 

By tHE ECHOCARDIOGRAM 


P1202 CORRElAtION BEtWEEN tHE AVERAGE SPEED OF MItRAl RING EXCURSION By M-MODE AND 

tHE CONVENtIONAl DP / Dt OF tHE MItRAl REGURGItANt FlOW VAlUED By DOPPlER ECHO 


P1203 ROlE OF tHE CARDIOVASCUlAR MAGNEtIC RESONANCE IN PAtIENtS WItH VENtRICUlAR 

ARRHytHMIA OF UNkNOWN CAUSE 

D. Perez De Arenaza, G. Maid, M. Falconi, M. Pietrani, P. Pollono, F. Abramzon, R. Perez-Etchepare, 

R. Garcia Monaco, A. Cagide, G. Elizalde. 

P1204 NAtIVE INFECtIVE ENDOCARDItIS IN 111 CHIlDREN: CHANGING PAttERNS 

M. V. Lafuente, C. Villalba, G. Rossi, E. Lataza, H. Capelli. 

P1205 ANAlySIS OF DNA POlyMORPHISMS IN tHE ENDOtHElIN-1 AND SUPEROXIDE DISMUtASE- 

MN GENES AND tHEIR RElAtIONSHIP WItH tHE EVOlUtION OF 

tHE CHAGASIC CARDIOMyOPAtHy 

O. Lassen, F. Quintiero, S. Tabares, J. Herrera, A. Garutti, G. Dotto, R. Sosa, R. Galerano, A. Sembaj.


P1206 CONtROl OF RISk FACtORS tREAtMENt tHROUGH CAROtID INtIMA-MEDIA tHICkNESS 

AND ENDOtHElIUM-DEPENDENt BRACHIAl ARtERy VASODIlAtAtION FOR HIGH RISk 

PAtIENtS. 

C. Ingino, M. Kura, R. Machado, A. Cherro, E. Ricardo, P. Lylyk. 

P1207 EVAlUAtION OF tHE VOlUMEtRIC INDEX OF tHE lEFt AtRIUM ON DIABEtICS AND 

HyPERtENSIVE PAtIENtS 


P1208 PRElIMINARy REPORt AFtER A 7 yEAR FOllOW-UP IN WOMEN WItH A HIGH RISk SCORE 

EXERCISE tOlERANCE tESt AND A NORMAl CORONARy PERFUSION SPECt. 

G. Llamas-Esperon, S. Varela-Ortiz, S. Sandoval-Navarrete, R. Munoz-Sandoval, M. L. Fuantos-Delgado, 

U. Casas-Juarez, J. Albarran-Dominguez, A. Loera-Pinales, A. Zamora-Muciño. 

P1209 WAISt OBESIty - IMPORtANt RElAtIONSHIP WItH MEtABOlIC SyNDROME 

AND CARDIOVASCUlAR EVENtS 

I. A. B. Bincoleto, A. C. Santomauro Junior, M. R. Ugolini, L. Z. P. Oliveira, F. M. B. Rossi, C. Nagaoka, J. F. 

Kelendjian, A. C. Santomauro, E. R. Suarez, C. Ferreira. 

P1210 CHARACtERIStICS, tHERAPEUtIC INtERVENtIONS AND INHOSPItAl OUtCOME OF PAtIENtS 

WItH NON St-ElEVAtION ACUtE CORONARy SyNDROMES ACCORDING tO ClINICAl 

PRESENtAtION 

H. Pomés Iparraguirre, W. Santander, G. Calderón, J. Torres, O. Paredes, M. Leonardi, D. Chambre, J. C. Olmos, 

L. Ferrer, G. Guglieri. 

P1211 REACtIVE C PROtEIN, lIPID AND ANtHROPOMEtRIC PROFIlE IN ADOlESCENtS WItH 

DIFFERENt NUtRItIONAl StAtUS 

L. B. Sanches, I. T. Silva, A. F. S. Paz, M. Fisberg, I. P. Cintra, A. P. Q. Mello, N. R. T. Damasceno. 

P1212 tHE EFFECt OF CAMPOMANESIA XANtHOCARPA “GUABIROBA” IN HyPERCHOlEStEROlEMIC 

SUBJECtS 

J. Z. Klafke, T. F. Panigas, C. M. Richter, T. Dipp, K. C. Belli, D. C. Bündchen, M. A. Silva, J. C. H. Coracini, P. Bianchi, 


P1213 CORONARy FIStUlA: tREAtMENt By HEMODyNAMIC tECHNIQUES 

L. Simões, C. Lace, F. Gurgel, P. R. Travancas, J. G. Athayde, C. C. Assef, M. Celente, A. H Lago Dorigo, W. Paiva, 

M. S. Tagliari. 

P1214 ECHOCARDIOGRAPHIC EVAlUAtION OF tHE lEFt VENtRICUlAR HyPERtROPHy IN PAtIENtS 

WItH HyPERtENSION 

A. Martinez, A. Esper, D. Holownia, J. Tazar. 



P1215 EVAlUtION OF BlOOD PRESSURE lEVElS AMONG INDIAN POPUlAtION OF tHE UPPER RIO 

NEGRO BASIN 

L. M. Rodrigues, O. E. Soares, T. Dipp, T. F. Panigas, C. F. Panigas, D. C. Bündchen, K. C. Belli, C. M. Richter, 


P1216 RElAtIONSHIP BEtWEEN DEPRESSIVE SyMPtOMS AND SElF CEREBRAl 

FlOW REGUlAtION 


P1217 PREVAlENCE OF PERIPHERAl ARtERIAl DISEASE OF lOWER EXtREMItIES, IN PAtIENtS 

WItH CORONARy DISEASE. 

G. Llamas-Esperon, R. Muñoz-Sandoval, S. Sandoval-Navarrete, A. Zamora Muciño, M. L. Fuantos-Delgado, 

U. T. Casas Juarez, J. Albarran-Dominguez, S. Varela Ortiz. 

P1218 FUNCtIONAl AND StRUCtURAl AltERAtIONS ON AORtIC CAlCIFICAtIONS (AC) 


P1219 CARDIOPUlMONARy AND MEtABOlIC EFFECtS IN PAtIENtS SUBMIttED 

tO A CARDIOPUlMONARy AND MEtABOlIC REHABIlItAtION PROGRAM 

C. A. Hossri, M. C. Thomazi, R. Ceolin, G. Shinzato, E. C. Souza, H. Arakaki. 

P1220 ElECtROCARDIOGRAPHICAl EVIDENCES OF INtRA-CORONARy AUtOlOGOUS StEM 

CEllS IMPlANtAtION: INtRAVENtRICUlAR ElECtRICAl tRANSIENtS StUDy By SIGNAl- 

AVERAGED ElECtROCARDIOGRAM 

P. R. Benchimol-Barbosa, H. F. Martino, A. C. Campos-De-Carvalho, F. D. Vilela, C Miranda, R. N. Gobbi, 

P. S. De Oliveira, L. H. Weitzel, J. Barbosa-Filho, I. Cordovil,. 

P1221 REPRODUCIBIlIty OF REVERSIBlE MyOCARDIAl PERFUSION DEFECtS By COlD PRESSOR 

tESt MyOCARDIAl PERFUSION SPECt IMAGING. 

O. Masoli, M. Redruello, N. Maciel, J. Gagliardi, S. Traverso, L. Grynberg, L. Vidal, N. Perez Baliño. 

P1222 IS tHE RESt ECHOCARDIOGRAM IS ENOUGH tO EVAlUAtE tHE CONtRACtIlE RECOVERy 

AFtER CABG? 

L. H. Weitzel, A. C. Camarozano, F. J. M. Pitella, C. A. S. Nascimento, L. Belem, A. S. C. Rocha. 

P1223 PERCUtANEOUS SEPtAl ABlAtION WItH ABSORBABlE GElAtIN SPONGE IN HyPERtROPHIC 

OBStRUCtIVE CARDIOMIOPAtHy 

G. Llamas-Esperon, S. Sandoval-Navarrete, R. Muñoz-Sandoval, A. Loera Pinales, S. Varela Ortiz, 

E. Sandoval Rodriguez, M. L. Fuantos-Delgado, U. T. Casas Juarez, J. Albarran-Dominguez, A. Zamora Muciño. 

P1224 PREDICtION OF tHE INtRAOPERAtIVE IMPROVEMENt OF tHE RIGHt VENtRIClE StROkE 

WORk INDEX DURING PUlMONARy ENDARtERECtOMy 

A. Bertolotti, C. Gomez, J. Negroni, M. Diez, L. Favaloro, J. O. Caneva, R. Boughen, F. Klein, R. R. Favaloro.


P1225 PREDICtIVE VAlUE OF CAROtID INtIMA-MEDIA tHICkNESS, CAROtID PlAQUES AND 

ENDOtHElIUM-DEPENDENt VASODIlAtION FOR VASCUlAR EVENtS IN HIGH RISk PAtIENtS. 

C. Ingino, M. Kura, R. Machado, A. Cherro, E. Ricardo, P. Lylyk. 

P1226 HEARt FAIlURE IN A PUBlIC UNIVERSItARy HOSPItAl IN ARGENtINA. CHARACtERIStICS OF 

POPUlAtION AND CAUSES OF HOSPItAlIzAtION. 

V. Volberg, A. Pesantes, O. Grosso, J. Lerman, C. Berensztein, D. Pineiro. 

P1227 NON-INVASIVE EVAlUAtION OF lOCAl AND REGIONAl BIOMECHANICAl PROPERtIES OF 

POSt-IMPlANtED ARtERIAl CRyOPRESERVED HOMOGRAFtS 

D. Bia, S. Laza, H. Perez, Y. Zocalo, D. Craiem, S. Lluberas, A. Esperon, I. Alvarez, R. Armentano. 

P1228 tHE EFFECtS OF tHE BREAtH CONtROllED INCURSIONS ON tHE AUtONOMIC MODUlAtION 

OF tHE HEARt IN SUBJECtS WItH RESIStENt HIPERtENSIVE tO tHE tREAtMENt: IMPACt 

OF AUtONOMIC MODUlAtION ON RENIN-ANGIOtENSIN-AlDOStERONE SyStEM (SRAA) 

(CURUMIM StUDy II) 

G. N. Gobbi, P. R. Benchimol-Barbosa, C. S. Miranda, F. D. Vilela, A. F. P. Gondar, J. Barbosa-Filho, M. V. Barros, 

A. B. R. Lima, F. V. Campos, I. Cordovil. 

P1229 IS DECREASE OF lEFt VENtRICUlAR EJECtION FRACtION AFtER StRESS WItH NORMAl 

PERFUSION ASSOCIAtED WItH CARDIAC EVENtS? 

R. Berber, P. Nogueira, L. Ribeiro, D. Pareira, R. Lopes, F. Alves, M. Oliveira,. P Smanio. 

P1230 ClINICAl IMPlICAtIONS OF ANEMIA IN HEARt FAIlURE PAtIENtS 

M. Descalzo, M. Diez, L. Favaloro, M. Perea, R. Ratto, D. Puente, J. Barra, M. Peradejordi, L Feldman. 

P1231 ANAlySIS OF tHE RElAtIONSHIP OF tHE PRESENCE OF tHE RESIStANCE tO tHE INSUlIN 

AND DIAStOlIC DySFUNCtION IN SENIOR. 

R. F. M. Viégas, R. V. Z. Diniz, T. M. R. F. Viégas, A. M. R. R. Oliveira, A. C. Schimidt, D. R. Almeida. 

P1232 SOCIOECONOMIC StAtUS, HOSPItAl VOlUME AND ISCHEMIC StROkE MORtAlIty IN 

CANADA 

G. Saposnik, T. Jeerakathil, D. Selchen, V. Hachinski, M. K. Kapral. 

P1233 AORtIC INSUFFICIENCy AND VENtRICUlAR SEPtAl DEFECt – ANAlySIS OF SURGICAl 

tREAtMENt 

L. Simões, A. F. Malheiros, J. Caliani, L. C. Arongaus, F. Gurgel, F. Lino, J. A. T. Marinho, C. C. Assef, P. R. Travancas, W. Peixoto. 

P1234 HEARt FAIlURE IN A PUBlIC UNIVERSItARy HOSPItAl IN ARGENtINA. CAUSES OF ACUtE 

DECOMPENSAtION. 

V. Volberg, A. Pesantes, O. Grosso, J. Lerman, C. Berensztein, D. Pineiro. 



P1235 PRIMARy PERCUtANEOUS CORONARy INtERVENtION. A COMPARAtIVE ANAlISyS 

ACCORDING tO INFARCt lOCAlIzAtION IN A GENERAl HOSPItAl 

MANuEL Nicolas Cano, DINALDO Cavalcanti Oliveira, ANDRÉS Sanches Esteva, SILVIA Judith Fortunato De Cano, 

CLEBER Do Lago Mazzaro, EDUARDO Jaccoud, IGOR Alexander, MARIA Cristina Ferrari, PEDRO Augusto Abujamra, 

FLAVIO Antonio De Oliveira Borelli. 

P1236 ClINICAl AND ECHOCARDIOGRAPHyCAl FOllOW-UP AFtER ONE yEAR IN PAtIENtS WHO 

UNDERWENt MItRAl VAlVUlOPlASty WItH DOUBlE-BAllOON tECHNIQUE FOR SEVERE 

MItRAl StENOSIS 

S. Sandoval-Navarrete, G. Llamas-Esperon, R. Muñoz-Sandoval, S. Varela Ortiz, A. Rosas Cabral, F. J. Serna Vela, 

M. L. Fuantos Delgado, U. T. Casas Juarez, A. Zamora Muciño, J. Albarran Dominguez. 

P1237 tHE PREVAlENCE OF RISk FACtORS FOR CARDIOVASCUlAR DISEASE IN UNIVERSIty 

HOSPItAl 

T. Paes, D. Orlandi, F. Gazoni, H. Guimaraes, L. Vendrame, R. Lopes, A. C. Lopes. 

P1238 ABIlIty OF AORtIC AtHEROMAS tO PREDICt CORONARy AND CEREBRAl EVENtS. 

H. Deschle, A. Salazar, M. Fernandez, R. Pissinis, P. Carrascosa, J. Carrascosa. 

P1239 DOES MyOCARDIAl PERFUSION SCINtIGRAPHy HElP IN tHE DEFINItION OF tHERAPy tO 

ASSyMPtOMAtIC PAtIENtS WItH MyOCARDIAl ISCHEMIA? 

C. zukowski, R. Leite, C. Albertini, R. Kanthack, R. Lopes, M. Oliveira, FvAlves, P. Smanio. 

P1240 OBStEtRICAl AND ClINICAl FACtORS RElAtED tO tHE MODE OF DElIVERy IN PREGNANt 

WOMEN WItH HEARt DISEASE 

M. R. F. L. Bortolotto, M. Zugaib. 

P1241 ISCHEMIA ON RIGHt CORONARy tERRItORy DEMOStRAtED By MyOCARDIAl PERFUSION 

SPECt, CONDItIONED By A UNIQUE lEFt CORONARy ARtERy, CORROBORAtED By 

CORONARy Ct SCAN AND CORONARy ANGIOGRAPHy 

S. Sandoval-Navarrete, G. Llamas-Esperon, R. Muñoz-Sandoval, S. Varela Ortiz, A. Loera Pinales, 

E. Sandoval Rodriguez, M. L. Fuantos Delgado, U. T. Casas Juarez, J. Albarran Dominguez. 

P1242 FASCICUlAR tACHyCARDIA IN CHIlDREN AND ADOlESCENtS: IMPORtANt ASPECtS FOR 

tACHyARRHytHMIA APROACH 

R. Andalaft, D. Moreira, R. Habib, L. Moraes, K. Tukamoto, G. Bellini, R. Hams, V. Cerutti, A. Guimaraes, M. Juliano. 

P1243 BEHAVIOR OF tHE AtRIOVENtRICUlAR PRE-EXCItAtION DURING AN EXERCISE tEStING 

M. C. Thomazi, C. A. Hossri, N. Scarin, R. Meneghelo. 

P1244 lIPID PROFIlE RESPONSE tO RESIStED PHySICAl EXERCISE PROGRAM 

IN tyPE 2 DIABEtICS 

E. Fernandes, A. L. A. Branquinho, S. M. R. Castro, V. A. Leite, B. V. França, A.L.R.M. Freitas, L. C. Silva.


P1245 PlANIMEtRIC DEtERMINAtION OF lEFt VENtRICUlAR OUtFlOW tRACt: DIAGNOStIC 

IMPORtANCE ON PROStHESIS PAtIENt MISMAtCH 

E Castro, M. Cavazzi, A. Curcio, G. Converso, J. Quiroga, S. Chekerdemian. 

P1246 CASE FAtAlIty IN CORONARy ARtERy ByPASS GRAFt AlONG tHE FIRSt yEAR AFtER 

HOSPItAl DISCHARGE IN RIO DE JANEIRO StAtE, 1999 tO 2003 

P. Godoy, N. A. Souza E Silva, G. M. M Oliveira, C. H Klein. 

P1247 AMIODARONE AS A GOOD INtERVENtION FOR PAtIENtS WItH HEARt FAIlURE AND 

VENtRICUlAR ARRHytHMIAS 

L. P. Leopoldo Piegas, A. A. Alvaro Avezum, A. G. Aloyra Guimaraes, I. S. Italo Santos, H. G. Hélio Guimaraes, 

H. R. Helder Reis, E. S. Elizabeth Santos, A. M. A. Muniz. 

P1248 ABSENCE OF CORRElAtION BEtWEEN tHE ANtHROPOMEtRIC VARIABlES AND BlOOD 

PRESSURE IN HyPERtENSIVE OBESE SUBJECtS SUBMIttED tO AN EXERCISE PHySICAl 

PROGRAM 

C. F. Panigas, T. Dipp, T. F. Panigas, K. C. Belli, D. C. Bündchen, C. M. Richter, J. L.C. Pippi, P. R. N. Viecili. 

P1249 INFlUENCE OF DEPRESSIVE SyMPtOMS ON tHE PARAMEtERS OF lEFt VENtRICUlAR 

FUNCtION DURING ERGOMEtRIC tESt 

J. Tripolone, G. A. Santiago, J. M. Tripolone, P. Zuliani, M. Salguero. 

P1250 CARDIAC HyPERtROPHy AND OXIDAtIVE StRESS IN RAtS tREAtED WItH MEtHIONINE. 

R. Sirvente, R. H. Mendes, G. O. Candido, C. Mostarda, L. Jorge, A. Belló-Klein, K. Rigatto, M. C. Irigoyen,. 

P1251 EFFECt OF CHRONIC AtORVAStAtIN tHERAPy IN tHE MItOCHONDRIAl FUNCtION 

P. Monteiro, P. Matafome, A. Reis, S. Monteiro, R. Seiça, L. Goncalves, L. A. Providencia. 

P1252 MyOCARDIAl PERFUSION SCINtIGRAPHy IN PAtIENtS ASSESSED FOR RENAl 

OR RENOPANCREAtIC tRANSPlANtAtION. 

R. Ferrando, M. Lujambio, M. Kapitan, E. Moreira, J. Vilar, R. Hitateguy, C. Lecot, V. Selios, S. Miranda, 

P. Marichal. 

P1253 CASE FAtAlIty IN PERCUtANEOUS tRANSlUMINAl CORONARy ANGIOPlAStIES AlONG tHE 

FIRSt yEAR AFtER HOSPItAl DISCHARGE IN RIO DE JANEIRO StAtE, 1999 tO 2003 

P. Godoy, G. M. M. Oliveira, N. A. Souza E Silva, C. H Klein. 

P1254 PRIMARy PERCUtANEOUS CORONARy INtERVENtION DURING tHE ACUtE FASE OF 

MyOCARDIAl INFARCtION. ARE tHERE ANy DIFFERENCES IN tHE lAtE EVOlUtION OF 

ElDERly VS yOUNGER ADUlt PAtIENtS? 

MANuEL Nicolas Cano, DINALDO Cavalcanti Oliveira, ANDRÉS Sanches Esteva, SILVIA Judith Fortunato De Cano, 

CLEBER Lago Mazzaro, EDUARDO Jaccoud, IGOR Alexander, MARIA Cristina Ferrari, PEDRO Augusto Abujamra, 

FLAVIO Antonio Oliveira Borelli. 



P1255 RISk StRAtIFICAtION USING MyOCARDIAl PERFUSION SPECt IN tHE ASSESSMENt OF 

ISCHEMIC HEARt DISEASE IN SyMPtOMAtIC WOMEN. 

M. Lujambio, R. Ferrando, J. Vilar, M. Kapitan, V. Selios, C. Lecot, R. Hitateguy, G. Lago, R. Lluberas, J. Gaudiano. 

P1256 EFFECt OF SlEEP DEPRIVAtION PARtIAl OF tHE VASCUlAR REACtIVIty 

J.L. Dettoni, F. M. Consolim-Colombo, H. Moreno-Filho, M. C. Irigoyen, J. C. A. Ferreira-Filho, S. B. C. Souza, 

S. Borile, L. F. Drager, E. M. Krieger, G. Lorenzi-Filho. 

P1257 INFlUENCE OF PtCA ON MOBIlIzAtION OF BONE MARROW-CIRCUlAtING PROGENItOR 

CEllS IN PERIPHERAl BlOOD 

R. G. Turan, S. Yokus, M. Brehm, S. Steiner, T. Zeus, T. Bartsch, M. Koestering, C. M. Schannwell, B. E. Strauer. 

P1258 VAlUAtION OF tHE EXCURSION AND AVERAGE MItRAl RING SPEED AS lEFt VENtRICUlAR 

SyStOlIC FUNCtION INDEXES 


P1259 OPtIMIzAtION OF MEDICAl tHERAPy IN AFRICAN-AMERICAN PAtIENtS WItH HEARt 

FAIlURE REFERRED FOR CARDIAC RESyNCHRONIzAtION tHERAPy 

M. Sardar, J. Shin, A. Kezerashvili, S. Maybaum, M. Galvao, K. Trivedi. 

P1260 INCIDENCE OF HOStIlIty IN SUBJECtS FOllOWING A PROGRAM OF CARDIAC 

REHABIlItAtION POSt-MyOCARDIAl INFARCtION, PREDICtIVE FACtOR FOR POSSIBlE 

RElAPSES 

M. Alcocer, M. Rangel, E. Tirado, N. Pacheco, S. Leon, E. Castro, JvAlvarez De La Cadena, J. Rodriguez, E. Garcia, 

D. Arroyo. 

P1261 ACUtE EFFECtS OF ACUPUNCtURE ON HEMODyNAMICS VARIABlES IN OUtPAtIENtS WItH 

COMPENSAtED CHRONIC HEARt FAIlURE 

S. Chacon, S. Soares, M. Quintão, D. A. Bastos, L. Aragão, E. T. Mesquita, S. Chermont. 

P1262 EFFECt OF DAIly VERSUS AltERNAtE DAy tHERAPy WItH SIMVAStAtIN IN REDUCING 

lDl-CHOlEStEROl AMONG SOUtH ASIAN COHORt 

M. Sardar, S. Nadeem, A. Omer, R. Siddiqui. 

P1263 Ct ANGIOGRAM AS REPlACEMENt DIAGNOStIC INVEStIGAtION FOR ANGIOPlASty OF 

CORONARy ARtERIES 

M. C. L Lim, C. De Larrazabal, T. W. Wong. 

P1264 HOSPItAl MORtAlIty IN ACUtE StEMI IN GREAtER OF 70 yEARS 

M. Correa, M. Lopez, R. Codutti, M. Sanjurjo. 

P1265 lONG tERM RESUltS OF BAllOON DIlAtION OF tHE MItRAl VAlVE FOR PEDIAtRIC tyPICAl 

MItRAl VAlVE StENOSIS. 

A. Peirone, A. Guevara, A. Spillmann, B. Vega, E. Juaneda, E. Ruiz Lascano, E. Banille, L. Alday.


P1266 IN-HOSPItAl MANAGEMENt OF DECOMPENSAtED HEARt FAIlURE: INtERACtION AMONG 

Nt-PROBNP, RENAl FUNCtION AND DIUREtIC RESPONSE 

M. L Coronel, P. L. Pozzer, G. A. Pereira Zini, R. P. Laurino, G. V. Lepore, C. R. Zoni, G. D. Olivera, 

J. P. Cimbaro Canella, S. M. Macin, E Perna. 

P1267 PREVAlENCE AND tREAtMENt OF tHE ARtERIAl HyPERtENSION IN tHE CIty OF FORMOSA 

F. Sosa, C. Sosa, D. Hernandez. 

P1268 FINDS OF MIOCARDy PERFUSION IN DIABEtIC ASyMPtOMAtIC PAtIENtS WItHOUt 

PREVIOUS AMI. 

A. Pallares Farias, Abalsa Agustina, Joo Turoni Claudio, Rovaletti Federico, Castellanos Ramiro. 

P1269 PROGNOStIC VAlUE OF ADMISSION ECG IN NON-St ElEVAtION ACUtE CORONARy 

SyNDROMES 

H. Pomés Iparraguirre-, G Calderón, W. Santander, G. Guglieri, L. Ferrer, R. Aguero, O. Paredes, F. Brey, J. Torres, 

G. Guthmann. 

P1270 lACk OF lAtE ENHANCEMENt WItH GADOlINIUM IN NON COMPACtION CARDIOMyOPAtHy 

D. Perez De Arenaza, M. Falconi, M. Pietrani, P. Pollono, G. Maid, P. Oberti, C. Belziti, N. Vulcano, R. Garcia Monaco, 

A. Cagide. 

P1271 CARDIOVASCUlAR AND ElECtROCARDIOGRAPHIC ABNORMAlItIES OBSERVED IN PAtIENtS 

UNDERGOING CHRONIC DIAlySIS 

P. Nasca. 

P1272 REGUlAR AND CHRONIC USE OF StAtIN PREVENtS AtRIAl FIBRIllAtION IN tHE EARly 

POStOPERAtIVE PERIOD OF ElECtIVE CARDIAC SURGERy 

R. N. Campos, R. J. Alves, E. S. Hara, K. Nakiri. 

P1273 SIGNIFICANt PERCENtAGE OF PAtIENtS USING ANtIHyPERtENSIVE MEDICAtION ARE NOt 

PRESENtING ADEQUAtE lEVElS OF BlOOD PRESSURE IN tHE tWENty-FOUR HOURS RECORDING 

R. N. Campos, R. J. Alves, T. Inada, E. Florido, K. Nakiri. 

P1274 MORtAlIty IN tHE StEMI ACCORDING tO tHE AGE. EXPERIENCE IN CORDIS INStItUtE OF 

tHE HEARt. 

M. Correa, M. Sanjurjo, R. Codutti, M. Lopez. 

P1275 RISF FACtORS REDUCCION WItH IMPlEMENtAtION OF NUtRICIONAl AND EXERCISE PROGRAM 

M. Alcocer, A Nava, S. Leon, L. Robles, E. Castro, E. Tirado, E. Garcia, J. Alvarez De La Cadena, L. Mendoza, Y. Prior. 

P1276 DISCREPANCy BEtWEEN PERCEIVED OBESIty StAtUS, SElF-REPORtED, AND MEASURED 

BMI IN tHE US POPUlAtION; AND tHE StRAtEGIES EMPlOyED FOR WEIGHt lOSS OR 

MAINtENANCE: A NHANES 2003-2004 StUDy. 

Ruchika Goel, Sunil Kumar Agarwal, Nikhil Gupta. 



P1277 EVAlUAtION OF DIAStOlIC FUNCtION IN tHE ElDERly: COMPARISON OF ECHO DOPPlER 

PARAMEtERS IN PAtIENtS WItH AND WItHOUt HyPERtENSION. 

N. Allende, H. Deschle, A. Lakowsky, A. Miranda, D. Sanchez Lucero, R. Calviño, J. Carabajales. 

P1278 SERUM lEVElS OF INtERlEUkINS 1SS, 6, INtERlEUkIN 2 RECEPtOR AND C REACtIVE 

PROtEIN FOR DIAGNOStIC AND PROGNOStIC EVAlUAtION IN UNStABlE ANGINA. 

J. Petriz, A. Brasileiro, D. Albuquerque, R. Abtibol, R. Gusmão, A. Figueiredo, P. Resende, N. Souza E Silva, J. Moll, 

F. Albanesi. 

P1279 PERCUtANEOUS lEFt VENtRICUlAR ASSISt IN ISCHAEMIC CARDIAC ARRESt 

V. Tuseth, M. Salem, R. Pettersen, K. Grong, J. E. Nordrehaug. 

P1281 ASSOCIAtION OF CARDIOVASCUlAR EVENtS WItH GlyCOSylAtED HAEMOGlOBIN IN 

DIABEtIC PAtIENtS 

P. Karki, R. K. Deo, S. K. Sharma, P. Acharya. 

P1282 EFFECtS OF CIlNIDIPINE VERSUS AtENOlOl ON lEFt VENtRICUlAR DIAStOlIC FUNCtION 

AND HyPERtROPHy IN ESSENtIAl HyPERtENSION -CANDlE tRIAl 

W. J Chung, B. C. Oh, E. O. Shim, M. S. Shin, W. C. Kang, C. I. Moon, S. H. Han, K. K. Koh, T. H. Ahn, E. K. Shin. 

P1283 2-DIMENSIONAl StRAIN ECHOCARDIOGRAPHIC ASSESSMENt OF MyOCARDIAl FUNCtION IN 

PAtIENtS WItH MyOCARDIAl BRIDGE. 

C. Kyoung Im, L. Dong Won, L. Hyeon Gook, K. Tae Ik. 

P1284 COMPARISON OF CARDIAC StRUCtURE AND FUNCtION IN DIABEtES MEllItUS WItH AND 

WItHOUt SyStEMIC HyPERtENSION 

C. Kyoung Im, K. Bohyun, L. Donwon, L. Hyeongook, K. Taeik. 

P1285 10 - yEARS INVEStIGAtION OF INFlUENCE OF DEPRESSION ON MyOCARDIAl INFARCtION 

RISk At tHE POPUlAtION OF MEN OF 25-64 yEARS IN RUSSIA: EPIDEMIOlOGICAl VIEWS. 

V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova. 

P1286 OVERWEIGHt, OBESIty AND OtHER RISk FACtORS FOR ISCHEMIC HEARt DISEASE IN 10 tO 

18-yEAR OlD SCHOOlCHIlDREN 

S. Barbiero, L. Pellanda, C. Cesa, P. Campagnolo, F. Beltrami, C. Abrantes. 

P1287 tyPE OF StRESS FOR MyOCARDIUM PERFUSION StUDIES: 

REVISION OF tHE ADEQUACy OF INDICAtIONS. 

S. Armijo, B Morales, I Luksic, M Peña, J Jensen, P Canales. 

P1288 SEEkING MEDICAl ADVICE OF PAtIENtS WItH MyOCARDIAl INFARCtION 

V. Gafarov, A. Gafarova.


P1289 NAtIONWIDE tRENDS IN tHE UtIlIzAtION OF MUltI VESSEl PERCUtANEOUS CORONARy 

INtERVENtION (MPCI) IN tHE UNItED StAtES. 

M. R. Movahed, M. Hashemzadeh, M. M. Jamal. 

P1291 IN-VItRO AND IN VIVO PHARMACODyNAMIC PROPERtIES OF MEtOPROlOl 

IN FRUCtOSE HyPERtENSIVE RAtS 

C. Höcht, C. Di Verniero, E. Silberman, M. Mayer, J. A. W. Opezzo, F. Bertera, C. AvTaira. 

P1292 MODIFICAtION OF SOME COMPONENtS OF tHE CARDIAC BEtA-ADRENERGIC SyStEM AlONG 

tHE EXPERIMENtAl tRyPANOSOMA CRUzI INFECtION. 

M. S. Lo Presti, H. W. Rivarola, A. R. Fernández, J. E. Enders, G. Levin, D. F. Comay, P. A. Paglini-Oliva,. 

P1293 MOlECUlAR BASIS OF FAMIlIAl HyPERCHOlEStEROlEMIA IN URUGUAy 

M. Stoll, P. Esperón, V. Raggio, M. Lorenzo. 

P1294 AlDOStERONE SyNtHASE C344t POlyMORPHISMS DEtERMINE CIRCADIAN ARtERIAl BlOOD 

PRESSURE VARIAtION IN RESIStANt SyStEMIC ARtERIAl HyPERtENSION 

P. R. Benchimol-Barbosa, A. D. Varanda-Rosario, M. Rollin-Ornelas, F. D. Vilela, C. Miranda, G. N. Gobbi, 

J. Barbosa-Filho, I. Cordovil. 

P1295 CARDIOVASCUlAR DISEASE RISk AND ANAEMIA IN DIABEtES. WHAt’S tHE ASSOCIAtION? 

A. Silva, A. Baptista, A. Guedes, A. Cabrita, P. Neves. 

P1297 tACHyCARDIA-INDUCED CARDIOMyOPAtHy By FASCICUlAR VENtRICUlAR tACHyCARDIA 

IN A PAtIENt WItH lEFt VENtRICUlAR NONCOMPACtION/HyPERtRABECUlAtION: A CASE 

REPORt 

P. Pozzer, E. Perna, I. Reyes, L. Coronel, J. Silveyra, A. Bayol, R. Zoni, C. Babi. 

P1298 PROGNOStIC VAlUE FOR CA125 ANtIGEN IN NEWly DIAGNOSED, ADVANCED CONGEStIVE 

HEARt FAIlURE 

K. Filipiak, A. Folga, M. Grabowski, S. Szmit, R. Glowczynska, A. Budaj, M. Marchel, A. Serafin, B. Przybysz, G Opolski. 

P1299 ElECtROCARDIOGRAM (ECG) IN ACUtE CORONARy SyNDROMES - tHE SPECIFIC ECG 

FEAtURES tO PREDICt tOtAl MORtAlIty 

K. Filipiak, M. Grabowski, R. Glowczynska, A. Budaj, Z. Huczek, M. Marchel, A. Serafin, T. Imiela, F. Szymanski, 

G. Opolski. 

P1300 tHE CHANGE IN PREDICItIVE VAlUE OF DIFFERENt ElECtROCARDIOGRAM (ECG) FEAtURES 

IN FOllOW-UP OF ACUtE CORONARy SyNDROMES PAtIENtS 

K. Filipiak, M. Grabowski, R. Glowczynska, A. Budaj, A. Kaplon, B. Przybysz, A. Serafin, F. Szymanski, J. Olszewski, 

G Opolski. 

P1301 lONG-tERM FOllOW-UP OF PAtIENtS WItH HEARt FAIlURE AND INDICAtION FOR A 

DEFIBRIllAtOR FOR PRIMARy PREVENtION OF SUDDEN DEAtH. 

C. Hadid, P. Avellana, D. Di Toro, C. Fernandez Gomez, M. Visser, N. Prieto. 



P1302 INSUlIN POtENtIAtES tHE CENtRAl PRESSOR RESPONSE tO ANGIOtENSIN II IN RAtS 

M. Mayer, C. Höcht, J. Giani, F. Dominici, E. Silberman, J. A. W. Oppezzo, M. Gironacci, C. Taira, B. Fernández, 

A. M. Puyó. 

P1303 DISORDERS IN HEARt RHytHM AND DIStURBANCES IN INtRAVENtRICUlAR CONDUCtION 

SyStEM IN HEARt FAIlURE 

G. Vieyra, S. Folino, O. Agri, E. Pautasso, M. Koretzky, H. Bovero, J. Aiub, R. Montecchiesi. 

P1304 HEARt FAIlURE REGIStRy IN tHE NORtHERN AREA OF GREAtER BUENOS AIRES 

G. Vieyra, E. Pautasso, S. Folino, O. Agri, M. Koretzky, E. Pardo, M. Rey, M. Chiozza. 

P1305 CAN DIPyRIDAMOlE ACt AS A BRIDGE FOR DES PAtIENtS UNDERGOING NON CARDIAC 

SURGERy OFF ClOPIDOGREl 

A. Magd, H. Ragy, I. Attia, A. Zaki, N. Okasha. 

P1306 IS PlAtElEt AGGREGAtION ADEQUAtEly INHIBItED By CURRENt ClOPIDOGREl DOSING 

REGIMENS? 

A. Magd, M. Sawasany, A. Ramzy, S. Builtagy, A. Zaki, M. El Badry. 

P1307 EStIMAtION OF tHE lEVEl OF kNOWlEDGE AND ADHERENCE tO DIEtARy GUIDElINES 

DESIGNED FOR HyPERtENSION tREAtMENt IN A POPUlAtION OF PAtIENtS UNDER 

DIAlySIS 

I. M. Masuda, A. N. Aguirre , M. A. Marcozzi, F. M. Ferrero, z. C. ziella, H. A. Hansen , H. S. Hecker, 

C. M. Ciprés, R. A. Ríos. 

P1308 EXERCISE StRESS ECHOCARDIOGRAPHy PRIOR tO DISCHARGE FROM A CHESt PAIN UNIt IN 

PAtIENtS WItH DIABEtES MEllItUS 

B. Lopez Ledesma, E. Ludueña Clos, H. Avaca, G. M. Ferrari, C. Kudrle, M. Gingins, M. F. Larin, P. Pieroni, 

J. D. Humphreys, O. D. Manuale. 

P1309 AIR QUAlIty AND RESPIRAtORy AND CARDIOVASCUlAR DISEASES IN A SOUtHERNS 

BRAzIlIAN CIty FROM 1997 tO 2006 

E. O. Fernandes, R. Zumach, G. M. O. Fernandes, J. Müller, S. C. Faria. 

P1310 AtRIAl FIBRIllAtION IN PAtIENtS WItH AORtIC StENOSIS: ClINICAl SIGNIFICANCE OF 

tISSUE INHIBItOR OF MAtRIX MEtAllOPROtEINASE-1 

N. Goncharova, O. Moiseeva, G. Aleshina, E. Shlykhto. 

P1311 ARE tHERE ClINICAl AND OUtCOME DIFFERENCES IN PAtIENtS WItH AORtIC StENOSIS 

tREAtED WItH ANGIOtENSIN CONVERtING-ENzyME INHIBItORS? 

P. Oberti, R. Pizarro, M. Falconi, F. Achilli, A. Arias, F. Sosa, L. Lucas, J. Krauss, A. Cagide. 

P1312 kyMOGRAM - A NEW tOOl FOR tHE ASSESSMENt OF HEARt VAlVE PERFORMANCE 

M. Kondruweit, R. Cesnjevar, T. Wittenberg, S. Friedl, T. Strecker, M. Weyand.


P1313 COFFE CONSUMPtION AND AtRIAl FIBRIllAtION 

A. Mattioli, E. Tarabini Castellani, S. Bonatti, C. Miloro, D. Lodi, G. Mattioli. 

P1314 PUlMONARy VAlVUlOPlASty IN ADUltS USING tHE INOUE BAllOON CAtHEtER 

H.M. Pham, H.L. Nguyen, Q.N Ngoc, H.M Nguyen, H.N Khong, V.L Nguyen, L.D Do, K.G. Pham. 

P1315 PHySICAl AND SEDENtARy ACtIVItIES IN SOUtHERN BRAzIlIAN tEENAGERS: 

A POPUlAtION BASED CROSS-SECtIONAl StUDy 

C. Cesa, A. Andreola, T. Santos, R. Petkowics, S. Barbiero, P. Campagnolo, F. Beltrami, E. Vigueras, L. Pellanda. 

P1317 ADVANtAGES OF Ct ANGIOGRAPHy IN tHE PlANNING AND FOllOW UP OF ABDOMINAl 

AORtIC ANEURySM 

C Capuñay, P. Carrascosa, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa. 

P1318 MUltIDEtECtOR Ct FEAtURES IN tHE FOllOW UP OF PAtIENtS WItH ENDOVASCUlAR 

AORtIC ANEURySM tREAtMENt 

P. Carrascosa, C. Capuñay, A. Deviggiano, J. Vallejos, E. Martin Lopez, J. Carrascosa. 

P1319 Ct FEAtURES IN PUlMONARy EMBOlISM. IMPACt OF tHE MUltIDEtECtOR tECHNOlOGy 

C. Capuñay, P. Carrascosa, A. Deviggiano, E. Martin Lopez, J. Vallejos, J. Carrascosa. 

P1320 IVC-SCV FIltERS. A COMPREHENSIVE REVIEW OF tHE SPECtRUM OF COMPlICAtIONS. 

J. Tisnado, M. K. Sydnor, D. J. Komorowski, D. A. Leung. 

P1321 CHESt PAIN UNItS: ClINICAl FEAtURES OF tHE PAtIENtS 

J. Ibañez, J. Muntaner, V. Mansilla, R. Corbalan. 

P1322 IDIOPAtHIC VENtRICUlAR AND AtRIAl ARRHytHMIAS. RElAtIONSHIP WItH 

DEVElOPMENtAl DISMORPHOGENESIS OF tHEIR INVOlVED StRUCtURES. 

M. Elizari, S. Lupano, M. Ferreiro, M. Civetta, F. Lubenieki, S. Sicouri. 

P1324 PSEUDO INCOMPlEtE RIGHt BUNDlE BRANCH BlOCk. ItS RElAtIONSHIP WItH tHE 

EMBRyOlOGIC DEVElOPMENt OF tHE RIGHt VENtRICUlAR OUtFlOW tRACt. 

M. Elizari, M. F. Lambardi, M. Ferreiro, R. S. Acunzo, P. A. Chiale, M. M. Civetta, R. R. Bonato. 

P1326 INtRAMyOCARDIAl OR INtRACORONARy CEll DElIVERy: WHICH IS tHE BESt ROUtE FOR 

CEll tHERAPy IN IDIOPAtHIC DIlAtED CARDIOMyOPAtHy? 

A. C. Campos De Carvalho, F. B. Muccillo, P. C. S. Costa, S. N. S. Arvelo, E. Assunção E Silva, P. S. Oliveira, 

C. M. Gouvêa, C. T. Mesquita, H. F. Martino. 

P1327 EARly PROGNOSIS OF PAtIENtS WItH VAlVE PROStHESIS REGURGItAtION IMMEDIAtEly 

AFtER HEARt SURGERy. 

R. O. Sampaio, F. C. S. Silva Jr., I. S. Oliveira, G. S. Spina, F. Tarasoutchi, M. Grinberg. 



P1328 tHE tRyPANOSOMA CRUzI INFECtION WItH AN ISOlAtE OBtAINED FROM AN ENDEMIC 

AREA PRODUCES AltERAtIONS IN tHE COMPlEXES OF tHE CARDIAC MItOCHONDRIAl 

RESPIRAtORy CHAIN 

A. Baez, M. S. Lo Presti, H. W. Rivarola, G. Guzmán Mentesana, D. Comay, P. Paglini-Oliva. 

P1329 EFFECtIVENESS OF DIFFERENt ABlAtION MEtHODS FOR PAROXySMAl AtRIAl 

FIBRIllAtION IN RANDOMIzED StUDy 

D. Lebedev, E. Mikhaylov. 

P1330 P-WAVE ANAlySIS AS A ClUE FOR OPtIMIzAtION OF PAROXySMAl AtRIAl FIBRIllAtION 

ABlAtION 

D. Lebedev, E. Mikhaylov. 

P1331 MISlEADING INtERPOlAtED PREMAtURE AtRIAl CONtRACtIONS IN PAtIENtS WItH 

PAROXySMAl AtRIAl FIBRIllAtION: tHEIR MECHANISM AND ORIGINAtION 

E. Mikhaylov, D. Lebedev. 

P1332 ARIAl ARRHytHMIAS AND tHEIR ORIGINAtION IN PAtIENtS WItH PAROXySMAl AtRIAl 

FIBRIllAtION ACCORDING tO AMBUlAtORy OBSERVAtION 

E. Mikhaylov, D. Lebedev. 

P1333 ADVENtItIAl INFECtIOUS AGENtS IN HEARt tRANSPlANt ACCElERAtED GRAFt CORONARy 

AtHEROSClEROSIS (AGCA) 

N. V. Sambiase, M. L. Higuchi, M. M. Reis, E. Bocchi, N. Stolf. 

P1334 SERUM PARAOXONASE 1 ACtIVIty AND OXIDAtIVE MARkERS OF lDl IN PAtIENtS WItH 

CARDIAC SyNDROME-X 

M. Kayikcioglu, S. Saygi, E. Azarsiz, L. H. Can, H. Kultursay, E. Y. Sozmen. 

P1335 DOES MyOCARDIAl PERFUSION SCINtIGRAPHy USEFUl IN tHE DEtECtION 

OF ISCHEMIA AFtER SURGICAl REVASCUlARIzAtION? 

L. Cardenas, H. Herbas, R. Conti, Z. Fichino, A. Thom, R. Lopes, M. Oliveira, P. Smanio. 

P1336 COMBINAtION OF GENEtIC POlyMORPHISMS AND SMOkER StAtUS IN HIGH RISk FAMIlIES 

M. Stoll, P. Esperón, V. Raggio, M. Lorenzo, M.C. Artucio, F. Kuster. 

P1337 IMPORtANCE MEtABOlIC SyNDROME ON HyPERtENSIVE PAtIENtS WItH lEFt 

VENtRICUlAR HyPERtROPHy – AN 10 yEAR FOllOW-UP StUDy 

I. Tasic, D. Djordjevic, G. Lazarevic, D. Mijalkovic, M. Lovic, D. Lovic, N. Miladinovic Tasic. 

P1338 CAN EUStACHIAN VAlVE BE A RISk FACtOR FOR PUlMONARy EMBOlISM? 

I. Kurt.


P1340 NONINVASIVE ASSESSMENt OF CORONARy FlOW RESERVE AFtER PERCUtANEOUS 

CORONARy INtERVENtION IN PAtIENtS WItH PREVIOUS MyOCARDIAl INFARCtION: 

RElAtION tO FUNCtIONAl RECOVERy 

A. Djordjevic-Dikic, M. Ostojic, B. Beleslin, J. Stepanovic, V. Giga, B. Vujisic-Tesic, I. Nedeljkovic, M. Nedeljkovic, 

S. Stojkovic, Z. Petrasinovic. 

P1341 AN ANAlySIS OF lEFt AtRIAl EJECtION FRACtION IN tHE DIFFERENt tyPES OF lEFt 

VENtRIClE DIAStOlIC DySFUNCtION 

J. L. F. Jefferson Luís Vieira, T. V. B. Thaís Valenti Branchi, I. K. Ilmar Köhler, L. C. D. Luís Cláudio Danzmann, 

M. R. T. Marco R. Torres. 

P1342 ClINICAl OUtCOME AFtER MUltIlESION PERCUtANEOUS INtERVENtIONS: COMPARISON 

OF A SElECtIVE AND NON-SElECtIVE USE OF DRUG-ElUtING StENtS 

M. Albertal, F. Cura, L. T. Padilla, P. Perez Balino, A. Candiello, S. Jozami, J. A. Belardi. 

P1343 RESPONSES OF CORONARy FlOW IN POStMENOPAUSAl WOMEN WItHOUt EVIDENCES OF 

MyOCARDIAl ISCHEMIA EVAlUAtED By tRANSESOPHAGEAl DOBUtAMINE-StRESS-ECHO: 

A RANDOMIzED, DOUBlE BlIND, CROSSOVER ClINICAl ESSAy, WItH WASH OUt, DURING 

HORMONE REPlACEMENt AND RAlOX 

M. R. T. Marco R. Torres, J. C. T. João Carlos Tress, T. C. D. E. Tereza Cristina Duque Estrada, L. S. C. Lilian S. 

Costa, O. C. E. G. O. C. E. Gebara. 

P1344 PREVAlENCE OF CHAGAS DISEASE EVAlUAtED By 13 yEARS IN tHE HOSPItAl SAN 

FERNANDO OF BUENOS AIRES 

M. Galli, E. Alvarez, M. Boscaro, H. Deschle, M. Koretzky, J. Seresi, A. Rubinich. 

P1345 lONE AtRIAl FIBRIllAtION : COMPARAtION WItH AtRIAl FIBRIllAtION WItH HEARt 

DISEASE. OFFICE FA StUDy 

J. Gant Lopez, D. Di Toro, C. Muratore, J. Battista, A. Andina, A. Lucchini, C. Damico, R. Borracci. 

P1346 tItAN2® (HEXACAtH, FRANCE), A tItANIUM-NO COAtED StENt: A DRUG-ElUtING-lIkE 

BARE MEtAl StENt? 

L. Van Casteren, P. Debruyne, B. Vankelecom, J. Roosen, E. Raymenants, S. De Ridder, L. Janssens. 

P1347 INCOR-HCFMUSP’S CARDIOVASCUlAR EMERGENCy AND SIMUlAtION lABORAtORy AND 

AClS COURSES 

F. Marques, W. Nishizawa, M. Gonzalez, S. Timerman. 

P1348 RAtIONAlE FOR AN EVIDENCE-BASED INtERVENtION tO PREVENt RISk FACtORS FOR tHE 

DEVElOPMENt OF CHRONIC DISEASE 

C. Jordan, M. Slater, T. Kottke. 

P1349 REGRESSION OF CARDIAC lUPUS UNDER IMMUNOSUPPRESSIVE tHERAPy. 

E. Chammas, A. Hussein, A. Barbari, M. Abou Akl, O. Hamoui, L. Abouzahr. 



P1350 MUltIVESSEl CORONARy ARtERy DISEASE PAtIENtS UNDER MEDICAl tHERAPy: A 10 yEAR 

OBSERVAtIONAl StUDy 

E. Chammas, C. Elbacha, R. Kyrillos. 

P1351 tRADItIONAl RISk FACtORS ARE PREDICtIVE ON SEGMENtAl lOCAlIzAtION 

OF CORONARy ARtERy DISEASE 

G. Tacoy, S. Balcioglu, S. Akinci, G. Erdem, S. A. Kocaman, T. Timurkaynak, A. Cengel. 

P1352 EVOlUtION OF NO CUlPRIt COMPlEX CORONARy lESIONS 

R. Costantini, J. Telayna, F. Graziano. 

P1353 A SIMPlE ECHOCARDIOGRAPHIC MEtHOD FOR lEFt VENtRICUlAR EJECtION FRACtION 

CAlCUlAtION SPECIAlly USEFUl IN PAtIENtS WItH PRIOR MyOCARDIAl INFARCtION 

G. Liniado, J. Gagliardi, S. Schneck, S. Molteni. 

P1354 SUBACCUtE EFFECtS OF MAXIMAl EXERCISE ON ENDOtHElIAl FUNCtION 

IN PAtIENtS WItH CHRONIC HEARt FAIlURE 

P. Moreira, P. Soares, F. Das Neves, N. Rocha, A. Nobrega. 

P1355 PREDICtORS OF lEFt VENtRICUlAR REMODElING IN PAtIENtS AFtER SUCCESSFUl 

PRIMARy PERCUtANEOUS CORONARy INtERVENtION FOR ACUtE MyOCARDIAl 

INFARCtION: lONG tERM FOllOW-UP 

I. Nedeljkovic, B. Vujisic-Tesic, M. Ostojic, M. Petrovic, B. Beleslin, O. Petrovic, D. Zamaklar-Trifunovic, 

A. Djordjevic-Dikic, V. Giga, J. Stepanovic. 

P1356 PREDICtION OF ACUtE CORONARy EVENtS By MyOCARDIAl JEOPARDy SCORE: FIVE yEARS 

FOllOW-UP PAtIENtS WItH NAtURAl PROGRESSION OF CORONARy ARtERy DISEASE 

I. Nedeljkovic, M. Ostojic, B. Beleslin, A. Djordjevic-Dikic, V. Giga, J. Stepanovic, M. Nedeljkovic, S. Stojkovic, 

P. Mitrovic, B. Vujisic-Tesic. 

P1357 INFECtIOUS AGENtS, MMP-9 AND PPAR AlPHA ARE INCREASED IN tHE ADVENtItIA AND 

PERIADVENtItAl FAt OF AORtIC ANEURySMS 

A. Roggerio, M. L. Higuchi, N. V. Sambiase, N. Stolf. 

P1358 SlEEP-DISORDERED BREAtHING: RElAtION OF tREAtMENt COMPlIANCE AND tHE 

OCCURRENCE OF CARDIOVASCUlAR DISEASE IN SEVERE OBStRUCtIVE SlEEP APNEA 

PAtIENtS. 

J. Santos, B. Gonzales, J. Caneva, J. Oses, R. Boughen, F. Robles, E. Gabe. 

P1359 COStS AND EFFECtS: tHREE-yEARS FOllOW-UP OF tHE INCOR VAlVE REPlACEMENtS 

SURGERIES 

E. Trindade, P. Pomerantzeff, M. Grinberg, C.M. Brandão, S. Fujii.


P1360 ECHOCARDIOGRAPHIC CHARACtERItICS AND SURGICAl OUtCOME OF MItRAl VAlVE 

DISEASE IN MARFAN SyNDROME 

J. M Casas, C. E. Lopez, M. Segura, J. H. Casabe, P. Roura, H. Raffaelli, J. Abud, E. Dulbecco. 

P1361 SEVERE RHEUMAtIC tRICUSPID REGURGItAtION SEVERAl yEARS AFtER MItRAl VAlVE 

REPlACEMENt OR REPAIR 

H. Silva, A. Bartolomé, V. Picone, C. A. Bruno. 

P1362 EMERGENCy DEPARtMENt PREDICtORS OF MORtAlIty AND AORtIC INtERVENtION AMONG 

PAtIENtS WItH SyMPtOMAtIC ABDOMINAl AORtIC ANEURySM 

M. P. Marturano, G. Procopio, R. Merbilháa, G. A. Ontiveros, E. Dulbecco, F. Klein, M. J. Fosco. 

P1363 CARDIOPUlMONARy (VO2) EXERCISE tESt IN PAtIENtS WItH ASyMPtOMAtIC AND 

SyMPtOMAtIC SEVERE AORtIC StENOSIS 

H. Silva, J. Ale, C. A. Bruno, A. Bartolomé, V. Picone. 

P1365 lONG-tERM OUtCOME IN PAtIENtS WItH SyMPtOMAtIC SEVERE AORtIC StENOSIS 

H. Silva, A. Bartolomé, S. Belforte, V. Picone, C. A. Bruno. 

P1366 tHE EFFECt OF BODy MASS INDEX ON BlOOD PRESSURE RESPONSE DURING EXERCISE 

G. E. yazici, G. Tacoy, B. Alibazoglu. 

P1367 tIMI FRAME COUNt AND MyOCARDIAl BlUSH GRADE IN NORMAl CORONARy ARtERIES OF 

PAtIENtS 

G. Tacoy, G. E. Yazici, S. A. Kocaman, M. Ozdemir, A. Cengel. 

NOTE: FOR CONSISTENCY, CLARITY AND EASE OF INTERPRETATION, SOME ABSTRACT TITLES HAVE HAD THE FONT OF THEIR TEXT AMENDED AND 

MINOR SPELLING CHANGES MADE. 


industry sAteLLite syMPosiA And WorksHoP ACtivities 

Programme at a glace – satellite symposia table 

MONDAy, 19 MAy, 2008 TuESDAy, 20 MAy, 2008 

PAVILLION ROOM 12.30 - 13.30 (INTERSESSION) 18.00 - 19.30 (EVENING SESSION) 12.30 - 13.30 (INTERSESSION) 18.00 - 19.30 (EVENING SESSION) 

RED 

yELLOW 

GREEN 

Rio de 

la Plata 

Thames 

Danube SyMP 

(IS) 

Missouri SyMP 

(IS) 

Nile 

SyMP 

(IS) 

Pilcomayo SyMP 

(IS) 

Tiber 

Mississippi SyMP 

(IS) 

Tigris 

Niger 

Ganges 

Seine 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

Astra zeneca 

Optimising Outcomes in Acute 

Coronary Syndromes: Role of New 

Approaches to Platelet Inhibition 


Targeting multiple risk factors to 

optimise cardiovascular care 


Drug Eluting Stent Technology: a 

breakthrough in PTCA patient outcome 

IFPMA 

Transparency around clinical trials and 

data: are we on the right trajectory? 


Retinopathy associated with prevalent 

CHD in patients with T2D. What needs 

to be done? 


Acute Myocardial Infarction - 

Reperfusion Strategies in Real Life and 

their Potential Benefit for the Patient 


Acute Heart Failure Treatment: Doing 

what comes naturally? 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

Sanofi-aventis Latin America 

Intraabdominal Obesity and SyMP 

Cardiometabolic Risk Factors: present (IS) 

and future 

Arrhythmias 





Hypertension 



ONTARGET: New Evidence 

in Total Cardio & Vascular 

Protection 

Daiichi Sankyo Brazil 

Blood pressure and beyond 

- Ancillar effects by AT1 - 

Receptor blockade 


Diabetes, Cardiovascular 

disease and Thiazelidinediones 

Menarini International 

Operations Luxembourg S.A. 

From hypertension to heart 

failure: the developing role of 

vasodilating beta-blockers 


Strengthening the Chain 

of Survival: From bench to 

community 

Merck Sharp & Dohme 

ER Niacin/Laropiprant: A new 

Paradigm in Comprehensive 

Lipid Management 


Reshaping the future in the 

management of 

atrial fibrillation 

Pharmacology 

Basic science 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

WS 

(IS) 

SyMP 

(IS) 






Pfizer 

A Remarkable Change in 

Smoking Cessation: Approach 

and Treatment 


Management of right ventricular 

dysfunction in pulmonary arterial 

hypertension 


Emerging Data in the Treatment 

of Cardiovascular Disease 

Colgate 

Oral Health-Cardiovascular 

Health: Emerging Evidence of 

the Relationship 

Biotronik (12.45-13.30) 

New Trends in Catheter 

Ablation of Atrial Fibrillation 

Merck KGaA 

The weight of the evidence: 

setting the standard with betablockade 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP 

(IS) 

SyMP (IS) Symposium 

GlaxoSmithKiline 

Clinical evidence of fondaparinux in 

thrombosis: From VTE prevention to 

acute coronary syndrome treatment 


Building New Strategies in Acute 

Decompensated Heart Failure 


LMWHs Across the Spectrum of 

ACS: The Weight of the Evidence 

WS (IS) How-to and Workshop session

industry sAteLLite syMPosiA And WorksHoP ACtivities - intersession 



Symposium (IS) 


aCute myoCaRdial infaRCtion - RePeRfusion stRategies in Real life 

and theiR Potential benefit foR the Patient 

Chairs: Frans Van De Werf (BELGIUM), Rafael Diaz (ARGENTINA) 

12:30 Thrombolysis: a treatment option for rural areas only? 

Richard Arntz (GERMANY) 

12:45 Fibrinolysis or Primary PCI: are we living up to the guidelines? 

Rob Welsh (CANADA) 

13:00 The benefits of gaining time in the treatment of STEMI patients 

Freek Verheugt (NETHERLANDS) 

13:15 Panel Discussion with an outlook to a new trial (STREAM) 

Frans Van De Werf (BELGIUM) and Rafael Diaz (ARGENTINA) 




taRgeting multiPle Risk faCtoRs to oPtimise CaRdiovasCulaR CaRe 

Chairs: Smith Sidney (UNITED STATES), Alberto Villamil (ARGENTINA) 

12:30 The unique formulation determines the benefits of nifedipine GITS 

Peter A. Meredith (UNITED KINGDOM) 

12:50 Nifedipine GITS - combining intervention and evidence to create a standard in cardiovascular care 

Giuseppe Mancia (ITALY) 

13:10 Low-dose ASA - from secondary to primary prevention 




Astra zeneca 

oPtimising outComes in aCute CoRonaRy syndRomes: 

Role of neW aPPRoaChes to Platelet inhibition 

Chairs: Nicolau José (BRAZIL), Deepak Bhatt (UNITED STATES) 

12:30 Introduction 

Nicolau José (BRAZIL), Deepak Bhatt (UNITED STATES) 

12:40 Implications for Antiplatelet Therapy Post TRITON 

Nicolau José (BRAZIL) 

12:50 Bleeding Complications in Patients Receiving Oral Antiplatelet Therapy: Definitions, Prevalence, Consequences 

Sunil V. Rao (UNITED STATES) 

13:00 Novel Approaches to Platelet Inhibition: New Mechanisms 

Hans Van Giezen (SWEDEN) 

13:10 Novel Approaches to Platelet Inhibition: New Agents 

Steen Husted (DENMARK) 

13:20 Panel Discussion 

Deepak Bhatt (UNITED STATES) 







RetinoPathy assoCiated With PRevalent Chd in Patients With t2d. 

What needs to be done? 

Chairs: Alberto Zambon (ITALY), Anthony Keech (AUSTRALIA) 

12:30 The eye microvascular complications and the vascular residual risk 

Xavier Pintó (SPAIN) 

12:50 FIELD; Macro- and Microvascular Benefits and the Metabolic Syndrome Profile 

Anthony Keech (AUSTRALIA) 

13:10 Role of Fibrates in Vascular Events Reduction in T2D Patients 

Alberto Zambon (ITALY) 




aCute heaRt failuRe tReatment: doing What Comes natuRally? 

Chairs: Sergio Perrone (ARGENTINA), Fabio Vilas-Boas (BRAZIL) 

Welcome 

Sergio Perrone (ARGENTINA) 

ALARM-HF versus Euroheart II: What have we learnt? 

Ferenc Follath(SWITZERLAND) 

ALARM-HF: Factors which impact mortality 


Acute Heart Failure Hlobal Registry of Standard Treatment (ALARM-HF): Providing answers 

Ferenc Follath(SWITZERLAND) 

Q + A 

Faculty 



Sanofi-aventis Latin America 

intRaabdominal obesity and CaRdiometaboliC Risk faCtoRs: 

PResent and futuRe 

Chair: Maria Ines Sosa Liprandi (ARGENTINA) 

12:30 Reduction of Cardiometabolic Risk: is there room for improvement? 

Richard W. Nesto (UNITED STATES) 

13:00 ECS: New target for patients with multiple cardiometabolic risk factors 

Rafael Maldonado (SPAIN)





International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) 

tRansPaRenCy aRound CliniCal tRials and data: 

aRe We on the Right tRajeCtoRy? 

Chairs: Beat Widler (UNITED KINGDOM), Aurora Vila (ARGENTINA) 

12:30 Setting the scene 

Beat Widler (UNITED KINGDOM) 

12:50 What does transparency mean for patients in Latin America 

Aurora Vila (ARGENTINA) 

13:10 Appropriate use and communication of public domain data - a case study on meta-analysis 

Alexander Walker (UNITED STATES) 




dRug eluting stent teChnology: a bReakthRough in PtCa Patient outCome 

Chair: Jorge Belardi (ARGENTINA) 

12:30 PTCA current indications. PTCA alternative or complementary to surgery / medical treatment? 


12:50 DES benefits. On and off label indications 

Oscar Mendiz (ARGENTINA) 

13:10 DES in the daily practice. The influence of the technique, clinical data support and the use of new 

technology (IVuS) in the outcome. 

Jorge Belardi (ARGENTINA) 


industry sAteLLite syMPosiA And WorksHoP ACtivities - evening sessions 




Menarini International Operations Luxembourg S.A. 

fRom hyPeRtension to heaRt failuRe: the develoPing Role of 

vasodilating beta-bloCkeRs 

Chairs: Alberto Zanchetti (ITALY), Sanchez Ramiro (ARGENTINA) 

18:00 Targets and benefits of blood pressure lowering 

Brandão Ayrton (BRAZIL) 

18:22 Beta-blockers in hypertension: do we know it all? 

Gabriel D. Waisman (ARGENTINA) 

18:44 CHF: from clinical trials to clinical pratice 

Solon Navarrete (COLOMBIA) 

19:06 The road ahead with nebivolol in the treatment of elederly CHF patients: clinical outcomes from SENIORS trial 

Van Veldhuisen Dirk (NETHERLANDS) 




ontaRget: neW evidenCe in total CaRdio & vasCulaR PRoteCtion 

Chairs: Piegas Leopoldo (BRAZIL), Michael Böhm (GERMANY) 

18:00 Blood pressure lowering or cardio & vascular protection - what to aim for? 

Giuseppe Mancia (ITALY) 

18:22 Cardio & vascular protection - the value of combining an ARB and an ACE-inhibitor 

Thomas Unger (GERMANY) 

18:44 The ONTARGET results 


19:06 Translating ONTARGET into clinical practice 

Michael Böhm (GERMANY) 



American Heart Association (AHA) 

stRengthening the Chain of suRvival: fRom benCh to Community 

Chairs: Timerman Sergio (BRAZIL), Robert O’connor (UNITED STATES) 

18:00 ECC from bench to community to bench 

Robert O’connor (UNITED STATES) 

18:22 Progress and lessons learned from the «Take Heart America» project 

Ed Racht (UNITED STATES) 

18:44 International Perspective on the Strengthening the Chain of Survival 

Timerman Sergio (BRAZIL) 

19:06 A view from the future 

Graham Nichol (UNITED STATES)






ReshaPing the futuRe in the management of atRial fibRillation 

Chairs: John Camm (UNITED KINGDOM), Marcelo Elizari (ARGENTINA) 

18:00 Rationale for outcomes studies in atrial fibrillation 

Gerald Nacarelli (UNITED STATES) 

18:30 Impact of atrial fibrillation in the prognosis of cardiovascular disease 

Marcelo Elizari (ARGENTINA) 

19:00 ATHENA: a landmark study in atrial fibrillation 




Merck Sharp and Dohme 

eR niaCin/laRoPiPRant: a neW PaRadigm in ComPRehensive liPid management 

Chairs: Pedro Lipszyc (ARGENTINA), Ricardo Horacio Rey (ARGENTINA) 

18:00 Epidemiology in Latin America 

Ricardo Horacio Rey (ARGENTINA) 

18:22 The need for Comprehensive Lipid Management 

Anders G. Olsson (SWEDEN) 

18:44 New Insights into Niacin Biology 

Pedro Lipszyc (ARGENTINA) 

19:06 Laropiprant: unlocking the Therapeutic Potential of Niacin 

Moriguchi Emilio Hideyuki (BRAZIL) 




diabetes, CaRdiovasCulaR disease and thiazelidinediones 

Chairs: Isaac Sinay (ARGENTINA), Juan Rosas (MEXICO) 

18:00 Diabetes, Metabolic Syndrome & Cardiovascular disease 


18:22 Rosiglitazone the most widely studied Oral Antidiabetic Medicine 

Isaac Sinay (ARGENTINA) 

18:44 Rosiglitazone FDA final statement 

Juan Rosas (MEXICO) 

19:06 Rosiglitazone Cardiovascular Profile 

Nesto Richard W (UNITED STATES) 






Daiichi Sankyo Brazil 

blood PRessuRe and beyond - anCillaR effeCts by at1 - ReCePtoR bloCkade 

Chairs: Antonio Felipe Simão (BRAZIL), Antonio Chagas (BRAZIL) 

18:00 HTN in the LA Region 

Agustin Lara Esqueda (MEXICO) 

18:22 RAAS and Drugs 

Robson Santos (BRAZIL) 

18:44 OLM Activity and figures 

Arthur Ribeiro (BRAZIL) 

19:06 Vascular Protection 

Carlos Ferrario M. (ARGENTINA) 

danube - yelloW Pavillion - 18.00-19.30 

Symposium/Workshop 

St. Jude Medical 

fiRst latin ameRiCan symPosium/WoRkshoP on atRial fibRillation 

President: Oseroff Oscar (Argentina) 

Chairs: Andrea Natale (UNITED STATES), Arruda Mauricio (UNITED STATES), Morillo Carlos (CANADA) 

18:00 Opening remarks on AF "The New Epidemic"AF mechanisms and the role of neural network: Implications on 

current AF ablation strategies 


18:15 LA and PVs anatomy. The use of CT, MR and Echo to guide AF Ablation 

Jose Carlos Pachon Mateos (BRAZIL), Mauricio Scanavacca (BRAZIL) 

18:30 Current worldwide AF ablation approaches. Is image-guided remote navigation the future of AF ablation? 

Andrea Natale (UNITED STATES) 

18:45 Ablation of long-standing AF: Strategies beyond PV isolation. Future tools to minimize ablation collateral 

Arruda Mauricio (UNITED STATES) 

19:00 AF ablation "Guidelines and Clinical Trials "Are we ready for AF ablation as first line therapy" 

Morillo Carlos (CANADA) 

19:15 Open discussion on: What to do in front of the Atrial Fibrillation patient, with the participation of the 

Symposium Faculty and invited experts





Colgate 

oRal health-CaRdiovasCulaR health: emeRging evidenCe of the RelationshiP 

Chair: Nestor Lopez (CHILE) 

12:30 The Oral Cavity and Chronic Inflammation: What is periodontal disease and how might it affect 

cardiovascular health? 

David Paquette (UNITED STATES) 

12:45 The Global Epidemic of Cardiovascular Disease and Diabetes: What is the evidence of a relationship 

between periodontal disease and CVD and Diabetes? 


13:00 Discussion: Can the recognition and treatment of periodontal disease make a difference in 

cardiovascular outcomes? 

David Paquette (UNITED STATES) 

13:15 Discussion: What can a cardiologist do in his/her practice to assist in reducing the risk that 

periodontal disease might contribute to a patient’s risk for CVD? What’s next for cardiology? 





emeRging data in the tReatment of CaRdiovasCulaR disease 

Chair: Alberto Villamil (ARGENTINA) 

12:30 Welcome and Introduction: understanding the Burden of Hypertension 

Alberto Villamil (ARGENTINA) 

12:45 A New Look at the Cardiovascular Continuum with Valsartan 

Matthew Weir (UNITED STATES) 

13:00 Amlodipine-Valsartan: Changing the Landscape of Blood Pressure Management 

Kenneth Jamerson (UNITED STATES) 

13:15 Evolution in Renin Suppression: the New Frontier 

Matthew Weir (UNITED STATES) 


Workshop session (IS) 

Biotronik 

neW tRends in CatheteR ablation of atRial fibRillation 

12:45 Catheter ablation of atrial fibrillation: Where do we stand? 

Dubner Sergio (ARGENTINA) 

13:07 Catheter ablation of atrial fibrillation in patients with LV dysfunction 








management of Right ventRiCulaR dysfunCtion in 

PulmonaRy aRteRial hyPeRtension 

Chairs: Miguel Gomez Sanchez (SPAIN), Sergio Perrone (ARGENTINA) 

12:30 RV function in pulmonary hypertension 

Sandrine Huez (BELGIUM) 

12:45 How should we evaluate right ventricular function? 


13:00 Chronic adaptation of right ventricular function: Eisenmenger syndrome 

Julio Sandoval (ARGENTINA) 

13:15 Management of right ventricular dysfunction 

Stephan Rosenkranz (GERMANY) 



Merck KGaA 

the Weight of the evidenCe: setting the standaRd With beta-bloCkade 

Chair: Norberto Vulcano (ARGENTINA) 

12:30 Beta-blockade in chronic heart failure (CHF): past, presence and future of beta-blockers in CHF management 


12:42 Beta-blockade in chronic heart failure (CHF): CIBIS III - expanding the frontier 

Piotr Ponikowski (POLAND) 

12:54 Cardioprotection in non-cardiac surgery (NCS):perioperative management in NCS - current status 

Anai Durazzo (BRAZIL) 

13:06 Cardioprotection in non-cardiac surgery (NCS): recent advances with beta-blockade in NCS 

Don Poldermans (NETHERLANDS) 

13:18 Closing remarks 

Piotr Ponikowski (POLAND)






lmWhs aCRoss the sPeCtRum of aCs: the Weight of the evidenCe 

Chairs: José Luis López-Sendón (SPAIN), Grinfeld Liliana (ARGENTINA) 

18:00 Differentiating anticoagulants: Do pharmacologic differences lead to differences in clinical outcomes? 

Nicolau José (BRAZIL) 

18:22 Defining adjunctive anticoagulants therapy in ACS 


18:44 A decade of GRACE: The real world in STEMI and NSTE ACS 

P. Gabriel Steg (FRANCE) 

19:06 Panel discussion / Q & A 

Grinfeld Liliana (ARGENTINA) 




building neW stRategies in aCute deComPensated heaRt failuRe 

Chairs: Nadine Clausell (BRAZIL), Sergio Perrone (ARGENTINA) 

18:00 Focus on Latin America: unmet Needs in Acute Decompensated Heart Failure Management 

Nadine Clausell (BRAZIL) 

18:22 Current Treatment Options for Acute Decompensated Heart Failure 

Uri Elkayam (UNITED STATES) 

18:44 Nesiritide Therapy for the ADHF Patient 

J. Thomas Heywood (UNITED STATES) 

19:06 Case Presentation and Panel Discussion 

Uri Elkayam (UNITED STATES), Panelists: Nadine Clausell (BRAZIL), Heywood J Thomas (UNITED STATES), 

Sergio Perrone (ARGENTINA), Vilas-Boas Fábio (BRAZIL) 




CliniCal evidenCe of fondaPaRinux in thRombosis: fRom vte PRevention 

to aCute CoRonaRy syndRome tReatment 

Chairs: Rafael Diaz (ARGENTINA), Álvaro Avezum (BRAZIL) 

18:00 VTE Prevention in Surgical Patients: Fondaparinux benefits over Enoxaparin 

Alexander Turpie (CANADA) 

18:22 Factor Xa Inhibition across the spectrum of ACS: Improved anti-thrombin treatment with 

reduced bleeding risk 


18:44 Optimising Management of Acute coronary Syndromes from guidelines to clinical practice 


19:06 Introduction to Fondapariniux Clinical Role 



index 

Authors 

H. Aarsetoey ................................................... 75, 206-207 

T. Aarsland ........................................................... 199, 206 

A. Abalovich ................................................................. 106 

R. Abashidze ................................................................ 235 

S. Abbrederis ............................................................... 173 

A. Abdala ..................................................................... 204 

R. Abdalah ................................................................... 263 

M. Abdel-Salam ........................................................... 200 

J. Abe .......................................................................... 175 

S. Abe .......................................................................... 181 

I. Abella ........................................................................ 252 

M. S. Abello ................................................................. 206 

M. Abello ..................................................................... 206 

H. Abensur ........................................................... 144, 225 

E. Aberer ...................................................................... 225 

T. Abesadze ................................................................. 175 

S. Z. Abildstrøm ................................................... 230, 232 

L. Abouzahr .................................................................. 277 

F. Abramzon .................................................235, 254, 264 

C. Abrantes .................................................................. 272 

A. C. Abreu .................................................................. 213 

P. Abreu-Gonzalez ........................................167, 169, 213 

R. Abtibol ..................................................................... 272 

J. Abud ............................73, 107, 205-206, 230, 246, 279 

A. Abufhele .................................................................. 178 

E. Acarturk ................................................................... 105 

P. Acharya .................................................................... 272 

F. Achilli .........................................144, 202, 238-239, 274 

S. K. Açikgöz ................................................................ 186 

A. Acosta ..........................................................74, 80, 136 

F. Acosta ...................................................................... 263 

K. Acosta ..................................................................... 248 

Y. Acosta ..................................................................... 190 

N. Acuña ...................................................................... 168 

R. S. Acunzo ..................................219-220, 229, 250, 275 

K. Adalet .............................................................. 106, 191 

M. Adamczyk ....................................................... 172, 185 

K. G. Adamyan ...............................72, 103, 109, 136, 193, 

......................................................218, 242, 244, 246, 249 

M. E. Adaniya ............................................................... 211 

T. Adla ...........................................................141, 223, 234 

Y. Adler ........................................................................ 209 

A. Adriana .................................................................... 111 

P. Adriazola .................................................................. 206 

S. Affatato .................................................................... 132 

V. Agarwal ................................................................... 251 

P. Aggelopoulos ........................................................... 217 

M. Aglony .................................................................... 137 

U. Agrawal ................................................................... 198 

O. Agri ......................................................................... 274 

S. Aguadé-Bruix ................................................... 132, 236 

R. Aguayo .................................................................... 185 

S. Aguedé-Bruix ........................................................... 236 

M. Aguero .................................................................... 212 

R. Aguero ........................................69, 242, 258, 260, 271 

R. Agüero ..................................................................... 103 

J. P. Aguiar ................................................................... 258 

R. Aguilar ..................................................................... 252 

C. Aguilar-Salinas ......................................................... 108 

E. Aguilera ................................................................... 177 

L. Aguinaga .................................................................. 185 

S. Aguirre ..................................................................... 256 

A. N. Aguirre ................................................................ 274 

R. M. Ahmad .................................................................. 73 

S. Ahmad ..................................................................... 256 

A. Ahmed ..................................................................... 256 

S. Ahmed ....................................................................... 73 

C. Ahn .................................................................. 110, 219 

T. H. Ahn .............................................................. 111, 272 

R. Ahuad .............................................................. 171, 181 

L. Ahualli .............................................................. 220, 239 

M. Aiga ........................................................................ 167 

S. Aiguadé-Bruix .......................................................... 238 

J. Aiub .................................................................. 181, 274 

R. Akar ......................................................................... 111 

A. Akcay ............................................................... 185, 195 

R. Akchurin .................................................................. 234 

C. Akel ........................................................................... 73 

G. Akgun ...................................................................... 192 

S. Akinci ............................................................... 186, 278 

M. Aksoy ............................................................. 171, 211 

M. Aktoz ...................................................................... 182 

A. Akyol ....................................................................... 186 

H. Alanazi ..................................................................... 163 

D. Alasia ....................................................................... 204 

F. Albanesi ................................................................... 272 

J. Albarran-Dominguez ......................................... 265-266 

E. S. Albayrak ............................................................... 198 

J. P. Albenque .............................................................. 103 

I. Alberca ...................................................................... 207 

M. Albertal .......................71, 132, 225, 242, 244-245, 277 

A. Alberti ................................................................ 53, 254 

C. Albertini ................................................................... 268 

C. Alberto ......................................................109, 213, 226 

G. Albina ...................................................................... 241 

F. Albuquerque ............................................................ 223 

D. Albuquerque ............................................................ 272 

S. Albuquerque ............................................................ 228 

J. Albuquerque .................................................... 228, 243 

M. Alcocer ............................................................ 270-271 

G. Aldama-López ......................................................... 198 

K. Aldworth-Gaumond ................................................. 135 

J. Ale ............................................................................ 279 

G. Aleshina .......................................................... 204, 274 

R. Alessi ....................................................................... 245 

A. Alessi ................................................................. 77, 176 

G. Alexanderson .......................................................... 133 

B. Alexandre ................................................................ 211 

A. Alexandrescu ........................................................... 200 

A. Alexandrov .............................................................. 225 

A. Alfie ......................................................................... 102 

B. Alibazoglu ................................................................ 279 

V. Aliperti ....................................................................... 77 

T. Aliyeva ..................................................................... 196 

G. Allende ............................................................ 175, 178 

N. Allende .................................................................... 272 

M. Allievi ...................................................................... 109 

T. G. Allison .......................................................... 108, 262 

J. Almada ..................................................................... 133 

C. Almeida ........................................................... 234, 241 

D. R. Almeida .........................................244, 248-249, 267 

S. Almeida ........................................................... 111, 181 

B. Almeida ................................................................... 102 

A. M. Almeida .............................................................. 209 

M. C. Almeida .............................................................. 241 

K. Alonso ..................................................................... 242 

A. Alonso ..................................................................... 132 

M. Alonso .................................................................... 201 

J. Alonso ...................................................................... 216 

R. Alonso ..................................................................... 193 

C. Alonso-Buron ........................................................... 207 

C. Alonzo ..................................................................... 228 

A. Alper ........................................................................ 186 

R. Altamirano ............................................................... 228 

W. Altarche-Xifró ........................................................... 77 

T. Altin ......................................................................... 192 

P. A. Altman ................................................................. 140 

D. L. Altschuler ............................................................ 212 

H. J. Altube .................................................................. 223 

I. Altun ......................................................................... 106 

M. G. Alvarez ....................................................... 170, 201 

M. Alvarez .................................................................... 252 

E. Alvarez ............................................................. 240, 277 

F. Alvarez ..................................................................... 196 

I. Alvarez ...................................................................... 267 

J. Alvarez ......................................107, 202, 222, 240, 271 

R. J. Alves ............................................................ 233, 271 

C. N. Alves ............................................................. 74, 138 

A. N. F. Alves ............................................................... 248 

L. Alves ......................................................... 252, 259-260 

A. Alves ........................................................111, 179, 240 

T. Alves ................................................................ 260, 263 

F. Alves ................................................................ 248, 267 

E. O. Alves ................................................................... 111 

R. Alves ....................................................................... 250 

F. Alvim ................................................................ 136, 220 

A. Alvim ....................................................................... 234 

O. Alyan ............................................................... 110, 233 

A. Amanullah ....................................................... 166, 172 

A. Amarilla ................................................................... 214 

G. Amarilla ................................................................... 261 

M. Amat ....................................................................... 242 

J. M. Amatruda ............................................................ 166 

J. Amatruda ................................................................... 75 

G. Ambrosio ................................................................. 141 

A. Ambu ....................................................................... 186 

D. Ametrano .................................................................. 74 

K. Amitani .................................................................... 175 

M. Amoedo .................................................................. 144 

M. Amor .............................................................. 111, 189 

J. M. L. Amorim ........................................................... 249 

W. A. Amorim ............................................... 243-244, 246 

L. Amorim ............................................................ 249, 260 

M. Amorin .................................................................... 184

Authors 

R. Andalaft ........................................................... 247, 268 

G. Andersen ........................................................... 69, 240 

L. B. Andersen ............................................................. 168 

A. Andina ..................................................................... 277 

K. Andrade ................................................................... 234 

M. A. M. Andrade ........................................................ 228 

M. M. Andrade ............................................................... 79 

M. Andrade ............................................................ 79, 228 

T. Andreeva ................................................................. 225 

A. Andreola .................................................................. 275 

D. S. Andres ......................................................... 208, 211 

C. K. Ang ...................................................................... 201 

P. Angelani ..................................................................... 78 

A. Angelino ............................106-107, 201, 208, 236, 238 

D. Anic ......................................................................... 219 

F. D. Anjos-Andrade ..................................................... 111 

S. D. Anker ................................................................... 238 

A. Añó ...................................................107, 222, 240, 251 

A. A. Ansari ........................................................... 202-203 

D. Antonelli .................................................................. 186 

J. Antonelli ................................................................... 218 

M. Antonetti ................................................................ 190 

D. Antoni ........................................................................ 76 

C. Antoniades ................................................. 69, 216-217 

L. Antonietti ..................................................238, 242, 249 

N. Antonio ...........78-79, 101, 132, 255-256, 258, 260, 263 

N. António .......................................................70, 252, 258 

A. Antonopoulos ............................................. 69, 216-217 

N. Antunes ....................................................133, 166, 234 

D. Aparicio .................................................... 247-248, 263 

N. Apro ........................................................................ 137 

F. Apullan ..................................................................... 197 

L. Aragão ..................................................................... 270 

T. S. Aragão ................................................................. 111 

H. Arakaki ............................................................ 240, 266 

E. Aramburu ................................................................. 246 

A. Arandjelovic ............................................................... 71 

C. Aranis ...................................................................... 109 

R. L. Arantes ................................................................ 101 

A. Araujo ...................................................................... 178 

S. Araujo ............................................................... 246-248 

T. M. Araujo ................................................................. 213 

R. C. Araújo .................................................................. 254 

R. C. Araújo .................................................................. 254 

E. Arcani ...................................................................... 106 

P. Arce ........................................................................... 69 

N. Archvadze ............................................................... 164 

R. V. Ardito ................................................................... 213 

J. Areias ....................................................................... 109 

P. Arellano ................................................................... 178 

W. Arenas-Borda ......................................................... 249 

C. Argenta .................................................................... 108 

S. Argiró ......................................................................... 69 

E. Arias ........................................................................ 134 

A. Arias ..........................144, 202, 238-239, 241, 258, 274 

J. Aringoli ..................................................................... 197 

B. Armaro .................................................................... 186 

J. Armentano ....................................................... 208, 242 

R. Armentano ........................................194, 231-232, 267 

A. Armenti ........................................................... 170, 201 

S. Armijo ...................................................................... 272 

L. Armine ..................................................................... 220 

L. Armini .............................................................. 136, 215 

P. Armstrong ............................................................... 143 

A. M. Arn Migowski ..................................................... 210 

P. Arnaiz ....................................................................... 137 

F. Arnaldo .................................................................... 135 

A. Arnedo ............................................................. 205, 230 

L. C. Arongaus ............................................................. 267 

V. Arora ........................................................................ 238 

A. G. Aroutunov ........................................................... 164 

A. Arrastia .................................................................... 184 

O. Arrieta ..............................................107, 222, 240, 251 

G. Arroyo ..................................................................... 224 

D. Arroyo ..................................................................... 270 

G. M. Arroyo .......................................................... 76, 165 

R. Arroyo-Espliguero .................................................... 165 

U. Arslan .......................................................180, 186, 190 

M. Arslan ..................................................................... 163 

E. Arteaga .................................................................... 136 

V. Artiko ....................................................................... 171 

M. C. Artucio ................................................................ 276 

G. P. Arutyunov .......................................... 74-75, 104-105 

A. G. Arutyunov ............................................................. 74 

S. N. S. Arvelo .............................................................. 275 

H. Arý ........................................................................... 197 

P. Arza ......................................................................... 205 

Y. Arzani ....................................................................... 192 

M. Asanin .................................................................... 187 

R. Asbot ............................................................... 164, 259 

S. Asgary ............................................................. 211, 216 

O. Asghar ..................................................................... 179 

T. Ashikaga .......................................................... 188, 197 

T. Asmann ..................................................................... 72 

N. Aspromonte .............................................................. 70 

M. Assad ..................................................................... 201 

R. Assad ...................................................................... 263 

J. A. Assad ................................................................... 139 

A. R. Assali ........................................................... 110, 178 

C. Assef ........................................................262, 265, 267 

V. Assinnato ................................................................. 175 

R. Astan ....................................................................... 233 

W. Astorino .................................................................. 242 

A. V. Astvacatryan ................................................ 242, 246 

A. V. Astvatsatryan .........72, 103, 109, 193, 218, 244, 249 

R. Atak ......................................................................... 110 

J. G. Athayde ....................................................... 262, 265 

I. Attia .......................................................................... 274 

N. Augusto ................................................................... 211 

H. A. Avaca .................................................................. 133 

P. Avanzas .............................................165, 168, 196-197 

D. Avayu ..................................................80, 229, 242-244 

P. Avellana ........................................................... 238, 273 

P. J. Avery ...................................................................... 77 

M. Avila ................................................................. 260-261 

F. Ayala ........................................................................ 141 

F. Ayan ......................................................................... 233 

S. Aydogdu .................................................................. 223 

S. Ayub ........................................................................ 191 

M. I. R. Azambuja......................................................... 248 

I. Azar ............................................................................. 76 

S. Azarisman ................................................................ 184 

E. Azarsiz ..................................................................... 276 

R. Azevedo .................................................................... 72 

H. Azevedo ...........................................109, 191, 195, 243 

C. H. M. Azevedo ............................................77, 109, 191 

L. Azocar ...................................................................... 185 

F. Azzari ............................................................... 237, 240 

F. Azzato .............................................................. 109, 138 

C. Babi ......................................................................... 273 

T. Babic ........................................................................ 202 

F. Baborski ................................................................... 220 

J. Baccaro ............................................................ 212, 219 

O. Badak ...................................................................... 170 

J. R. Badaraco .............................................................. 219 

J. Badariene ......................................................... 184, 237 

H. Bader ....................................................................... 243 

A. Bader ....................................................................... 176 

J. Badie ........................................................................ 194 

Z. Badiei ......................................................................... 73 

E. Badila ........................................................106, 211, 224 

E. Badino ..................................................................... 169 

H. Badiola Villa ............................................................. 166 

S. H. Badruddin .............................................................. 73 

A. Baez ................................................................ 222, 276 

M. C. Baez ................................................................... 205 

R. Bagnati .................................................................... 169 

R. Bagur ....................................................................... 176 

D. Bahamonde ............................................................. 225 

A. Bahi ......................................................................... 220 

A. Bahia ....................................................................... 215 

V. K. Bahl ......................................................140, 164, 167 

G. Bahs ........................................................................ 235 

A. Bajkova .................................................................... 230 

K. Bakoyiannis ....................................................... 69, 216 

S. Bakshi ...................................................................... 179 

T. Balabanski ................................................................ 206 

J. M. Balaguer ................................................................ 73 

V. P. Balashov ...................................................... 135, 210 

N. Balasubramanian ..................................................... 111 

A. M. Balaszczuk .................................................. 169, 205 

Y. Balbay ...................................................................... 110 

S. Balcioglu ...........................................180, 186, 190, 278 

G. Baldo ....................................................................... 233 

M. Balestra .................................................................. 220 

A. Balestrini ................................................................. 102 

C. Balestrini .....................................78, 102, 228-229, 251 

M. Balevic .................................................................... 202 

H. Balieiro ............................................................ 253, 260 

T. L. Balieiro ................................................................. 253 

S. K. Ball ......................................................................... 73 

C. Ballantyne .................................................................. 75 

A. E. Ballestrini ............................................................... 71 

L. Balletti ...................................................................... 229 

index / 291

Authors 

S. Balmaceda ............................................................... 181 

I. Balogh ....................................................................... 259 

A. Baltabaeva ............................................................... 254 

L. A. Balykova ...................................................... 135, 210 

M. Banaszewski .......................................................... 252 

P. Bandosz ................................................................... 106 

I. Bañes ........................................................................ 239 

L. J. Banfic ........................................................... 223, 231 

N. Bangartner .............................................................. 215 

E. Banille .........................................................76, 260, 270 

A. Bankova ................................................................... 225 

A. Bantar ...................................................................... 168 

A. Baptista ........................................................... 183, 273 

K. Baqueiro .................................................................. 108 

F. Baracho .................................................................... 249 

S. Barai ........................................................................ 250 

K. Baranska .................................................................. 174 

F. Baraona .................................................................... 227 

R. Barba ....................................................................... 209 

A. Barbari ..................................................................... 277 

S. H. Barberato ............................................................ 254 

M. Barbero Marcial ...................................................... 263 

M. Barbero-Marcial ...................................................... 238 

E. Barbieri ...................................................................... 72 

G. F. Barbieri ................................................................ 100 

S. Barbiero ........................................................... 272, 275 

J. Barbisan ....................................................134, 243, 250 

L. Barbosa ............................................................ 135, 208 

M. M. Barbosa ....................................................... 74, 217 

M. Barbosa .....................................................74, 217, 256 

T. Barbosa ...................................................................... 76 

E. G. Barbosa ............................................................... 222 

M. A. O. Barbosa ........................................................... 76 

O. N. Barbosa ........................................252, 259-260, 262 

J. Barbosa-Filho ......191-192, 244, 254, 264, 266-267, 273 

E. Barcellos .................................................................. 207 

N. C. Barengo .............................................................. 231 

G. Barila ....................................................................... 212 

F. Barilla ....................................................................... 240 

R. Barin ........................................................................ 241 

J. L. Barisani ................................................................ 139 

J. C. Barisani ................................................................ 139 

L. Barja ................................................................. 102, 189 

L. D. Barja ...................................................................... 78 

S. Barja ........................................................................ 137 

L. Baroncini ............................................................ 77, 176 

L. A. V. Baroncini............................................................ 77 

M. Baroni .............................................................. 228-229 

J. Barra ........................................................................ 267 

M. Barra ......................................................................... 77 

D. Barra ........................................................................ 261 

M. Barranco ..............................................74, 79, 211, 241 

D. Barranco .................................................................. 208 

R. Barreiro Filho .....................................139-140, 253, 257 

J. Barrera Sarduy ......................................................... 202 

C. Barrera ..................................................................... 249 

E. Barrera ..................................................................... 250 

S. S. M. Barreto ........................................................... 142 

J. A. S. Barreto-Filho .................................................... 111 

N. Barrientos ................................................................ 246 

E. Barrionuevo ............................................................. 191 

P. Barrios ............................................................. 105, 219 

R. Barros Wanderley .................................................... 164 

C. Barros .......................................................241, 253, 257 

M. V. Barros ...........................................191-192, 264, 267 

M. Barros .............................................................. 252-254 

S. Barsamyan ............................................................... 181 

E. Bartha .............................................................. 197, 202 

A. Bartolomé ................................................................ 279 

J. Bartolucci ................................................................. 132 

D. Bartos ...................................................................... 224 

T. Bartsch ............................................................ 104, 270 

A. Barutcu .................................................................... 182 

V. Barzilai ..................................................................... 229 

I. Basar ......................................................................... 233 

G. Basile ...................................................................... 186 

Z. Basistova ................................................................. 257 

M. A. Basombrío .......................................................... 254 

S. L. Bassanesi .................................................... 248, 251 

H. Bassani Molinas ...................................................... 227 

T. Bassani .................................................................... 106 

S. L. Bassin .............................................................. 75, 79 

C. Basso ...................................................................... 134 

G. Basso ...................................................................... 190 

M. Bastos Fernandez ........................................... 187, 194 

J. C. Bastos .................................................................. 202 

V. L. F. C. Bastos ......................................................... 202 

D. Bastos ..................................................................... 236 

L. Batista ...................................................................... 185 

M. Batista .................................................................... 215 

G. Batsides .................................................................... 69 

L. Battaglia ................................................................... 140 

R. Battellini .......................................................... 173, 182 

R. R. Battellini .............................................................. 173 

J. Battista ..................................................................... 277 

M. Battiston ................................................................. 181 

A. Battler .............................................................. 110, 178 

T. Bauernfeind ............................................................. 164 

G. Baumann ....................................................75, 140, 238 

J. M. Baumgarten ........................................................ 228 

N. Baungartner ............................................................ 215 

J. F. Baungratz ............................................................. 226 

P. Bayazit ..................................................................... 191 

N. Baybek ............................................................ 185, 195 

M. Bayern .................................................................... 104 

A. Bayol ................................................134, 170, 212, 273 

P. Bayol ........................................................................ 260 

R. Bayrak ..................................................................... 195 

R. Beabealashvilli .................................................. 234-235 

M. Bechelli ................................................................... 137 

E. Becher ..................................................................... 204 

M. A. Beck ....................................................176, 178, 229 

E. Beck .........................................................100, 214, 222 

K. Beck ........................................................................ 111 

T. Becker ..................................................................... 203 

A. Becker .............................................................. 202-203 

A. C. Becker ................................................................. 203 

P. Becker ..................................................................... 207 

K. Beckey ....................................................................... 75 

R. Bedani ..................................................................... 247 

H. Bedi ......................................................................... 179 

R. Bedim ...................................................................... 256 

J. R. Bedros ..................................164, 199, 208, 224, 238 

R. J. Bedros ................................................................. 203 

G. Beffagna .................................................................. 134 

V. Begovic .................................................................... 193 

T. Behrens ................................................................... 109 

R. Beigelman ............................................................... 141 

P. Bekta ............................................................... 102, 237 

J. A. Belardi .....................................................71, 225, 277 

L. Belem ...................................................................... 266 

B. Beleslin ................................71, 110, 142, 171, 277-278 

S. Belforte .................................................................... 279 

L. Bell ........................................................................... 256 

N. Bellera ....................................................................... 69 

K. C. Belli .........212-214, 221-223, 227, 261, 265-266, 269 

S. Belli .......................................................................... 189 

K. C. Belli .........212-214, 221-223, 227, 261, 265-266, 269 

C. Bellido ............................................................. 106, 200 

C. A. Bellido ................................................................. 201 

G. Bellini .............................................................. 247, 268 

F. Bello ......................................................................... 206 

A. Belló-Klein ................................201, 233, 236, 258, 269 

M. Bellomo .................................................................. 137 

R. Bellomo ..................................................................... 80 

J. Beloscar ................................................................... 263 

F. Beltrami ........................................................... 272, 275 

O. Belzares .................................................................. 198 

M. Benassi ................................................................... 254 

P. R. Benchhimol-Barbosa ........................................... 253 

J. Benchimol ................................................................ 137 

P. R. Benchimol-Barbosa ......................191-192, 244, 252, 

.......................................................254, 264, 266-267, 273 

D. E. Bender ................................................................ 226 

M. Benderski ................................................................. 74 

I. Ben-Dor ............................................................ 110, 178 

A. Benetos ................................................................... 110 

M. Benetti .................................................................... 208 

J. Benitez ....................................................................... 70 

J. Benitez-Parejo .......................................................... 248 

A. M. Benjo .................................................................... 77 

J. S. Benner ................................................................. 243 

R. Berber ............................................................... 79, 267 

C. Berensztein ............................................................. 267 

S. Berensztein ............................................................. 214 

Z. Berente .................................................................... 197 

S. Berenztein ............................................................... 250 

A. Berez ......................................................................... 78 

A. Berger-Kucza ........................................................... 232 

D. Bergerot .................................................................. 169 

G. Berglund .................................................................... 75 

M. Bergovec ................................................................ 231 

D. Berkowitz .................................................................. 77 

S. Berliner .................................................................... 163

Authors 

C. O. Berlowitz Fo ........................................................ 102 

S. Berman .....................................................141, 187, 218 

D. S. Berman ............................................................... 141 

S. G. Berman ............................................................... 180 

A. M. Bermann ...............................................80, 219, 222 

G. Bermudez ................................................................ 242 

V. Bermúdez ................................................. 247-248, 263 

A. Bernabe-Ortiz .......................................................... 137 

V. Bernardes ................................................................ 226 

S. Bernardez .................................229, 233, 236, 260, 263 

D. Bernardez .................................................................. 79 

L. Bernardini ................................................................ 215 

X. Berrios ..................................................................... 137 

D. H. Berrocal .............................................................. 227 

M. Bertagnolli .............................................................. 258 

F. Bertanha .................................................................. 237 

M. P. Bertato ............................................................... 198 

G. Bertelle .................................................................... 204 

F. Bertera ..................................................................... 273 

G. Bertocchi ......................................................... 170, 201 

M. Bertolami ................................................................ 254 

M. Bertoli ..................................................................... 168 

A. Bertolotti ......................................................... 259, 266 

C. Bertoluci .................................................................. 106 

H. Bertoni .................................................................... 240 

T. Bertuzzi .................................................................... 218 

O. Berwanger ...................................................... 256, 258 

B. Bessa ...................................................................... 240 

I. Bessonov .................................................................. 202 

M. Bessonova ...................................................... 183, 202 

R. Bestetti .................................................................... 224 

F. Bethencourt ............................................................. 236 

A. Betriu ......................................................................... 69 

M. Bettinotti ................................................................ 141 

S. Beurtheret ............................................................... 241 

J. Beutel ...................................................................... 240 

P. R. Bhimashankar ...................................................... 167 

D. Bia ............................................................ 231-232, 267 

P. Bianchi ..................................................................... 265 

R. Bianco ............................................................. 107, 205 

E. Biasin ....................................................................... 204 

L. Biason ...................................................................... 134 

V. Bichara ..................................................................... 178 

L. Bicudo ...................................................................... 136 

B. Biernacka ........................................................... 78, 233 

B. Bijnens .................................................................... 254 

J. Bilbao ..........................................................79, 102, 210 

B. Bilchik .............................................................. 138, 182 

Z. T. Bilinska ................................................................. 175 

C. Bilos ........................................................................ 140 

I. A. B. Bincoleto ........................................... 243-247, 265 

C. Birka .......................................................................... 77 

M. Bisio ....................................................................... 250 

S. K. Biswas ................................................................. 232 

E. Bit Chacock ................................................................ 70 

H. N. S. Bittencourt ........................................................ 74 

A. G. Bittencourt .......................................................... 209 

M. S. Bittencourt ................................................. 193, 236 

H. B. Bittner ................................................................. 173 

S. Blalock ..................................................................... 226 

P. Blanc ................................................................ 135, 218 

N. Blanco ......................................111, 170, 181, 189, 196 

F. Blanco ....................................................69-70, 132, 188 

R. Blanco ........................................................70, 132, 142 

P. Blanco ...................................................................... 102 

G. Blanco ..................................................................... 139 

B. J. Blanco .................................................................. 261 

R. Blank ....................................................................... 241 

P. Blasko ...................................................................... 223 

K. Blaszyk .................................................................... 251 

P. Blazicek ................................................................... 240 

Ø. Bleie .................................................133, 142, 243, 247 

J. Bleiz ................................................................. 175, 211 

J. P. F. Blini .................................................................. 251 

A. Blinowska .................................................................. 80 

A. J. Blix ............................................................... 243, 248 

J. Bloch .................................................................. 75, 103 

A. Bloigu ........................................................................ 75 

M. H. S. L. Blotta ......................................................... 133 

I. Bluro ........................................................................... 77 

E. Bocchi ...................................................................... 276 

E. A. Bocchi ................................................................. 191 

G. Boccuzzi .................................................................. 171 

A. Bochoeyer ............................................................... 102 

L. A. Bockeria ............................................................... 255 

M. Bodoira ................................................................... 225 

L. Boero ....................................................................... 136 

G. Boerrigter ................................................................ 108 

J. Boggiano .................................................................. 168 

E. Bognar ............................................................. 197, 202 

K. Bohyun .................................................................... 272 

N. Bonaros ................................................................... 173 

R. R. Bonato ................................................................. 275 

J. Bonatti ..................................................................... 173 

S. Bonatti ..................................................................... 275 

P. Bonazzola ........................................................ 193, 237 

J. Bonelli ...................................................................... 182 

S. Bonetti ..................................................................... 240 

C. Bonini ...................................................................... 134 

J. Bono ........................................................................ 220 

W. Book ....................................................................... 242 

E. Borbas ............................................................. 196, 198 

A. Bordenave ................................................217, 248, 257 

S. Bordignon ............................................77, 233, 236-237 

J. Bordone ................................................................... 139 

F. O. Borelli ............................................................ 80, 208 

M. Borger .................................................................... 182 

A. Borges ..................................................................... 238 

M. Borges ...................................................................... 78 

P. Borges ..................................................................... 236 

J. Borges ..................................................................... 251 

L. F. Borges ................................................................. 251 

J. Bori .......................................................................... 219 

S. Borile ............................................................... 138, 270 

R. Borojevick ........................................................ 139, 184 

R. Borracci ........................................................... 181, 277 

C. Borrego ................................................................... 181 

M. R. F. L. Bortolotto ................................................... 268 

A. Bortone ................................................................... 103 

B. Borz ......................................................................... 242 

M. Bosa ....................................................................... 253 

J. Boscan ..................................................................... 226 

M. Boscaro .......................................................... 181, 277 

E. Bosch ...................................................................... 183 

E. Bosinakou ................................................................ 217 

A. Boskovic .................................................................. 167 

A. Bossi ....................................................................... 102 

A. Botbol ...............................................111, 170, 181, 239 

L. Botbol .............................................................. 189, 196 

G. Bottaro .................................................................... 186 

M. Bottcher ........................................................... 79, 110 

J. A. Bottega ................................................................ 236 

R. Boughen ...........................................205, 230, 266, 278 

J. Boullosa ................................................................... 170 

B. Bourahla .................................................................. 139 

G. Bouras .............................................................. 216-217 

M. Bourassa ................................................................ 197 

F. Bourdin ............................................................ 183, 197 

E. Bouskela .................................................................... 71 

K. Bousquet-Santos ..................................................... 138 

S. Boveda .................................................................... 103 

H. Bovero ..................................................................... 274 

G. Bowlin ..................................................................... 142 

T. Bozat ........................................................................ 197 

E. Bozcali ..................................................................... 242 

E. Bozçali ..................................................................... 180 

H. Bozkurt .................................................................... 170 

G. Bozkurt .................................................................... 233 

G. Bozovich .......................................................... 227, 236 

M. Bracho .................................................................... 242 

F. Braga .................................................215, 220, 222-223 

J. Braga ........................................................................ 132 

D. M. Braile .......................................................... 133, 166 

I. Brajkovich ................................................................. 219 

L. Brandani ................................................................... 179 

A. A. Brandao ............................................................... 250 

A. P. Brandão ............................................................... 201 

J. Brandão-Neto ........................................................... 249 

B. F. Branka Filipovic .................................................... 134 

Z. Brankovic ................................................................. 243 

R. J. Brashear ...................................................... 172, 185 

F. Brasil ........................................................................ 220 

A. Brasileiro ..................................................250, 254, 272 

F. Bravo ....................................................................... 197 

S. Bravo ....................................................................... 137 

D. Braziunas ................................................................. 215 

A. Breazna ................................................................... 183 

M. Brehm ............................................................ 104, 270 

A. Breitgand ................................................................. 141 

U. Brel .......................................................................... 175 

E. Brenna ..................................................................... 176 

L. Brescacin ................................................................. 228 

I. Brevis ........................................................................ 262 

F. Brey ......................................................................... 271 

index / 293

Authors 

S. Briceño .................................................................... 242 

D. Brieger .................................................................... 100 

S. Brieva .............................................................. 237, 240 

J. C. Brigante ....................................................... 226, 236 

M. Brignole .................................................................. 134 

A. Brignoli .................................................................... 215 

M. Brinckmann .............................................................. 77 

G. Brion ..................................................106-107, 236, 238 

G. Brión ................................................................ 201, 208 

F. Brites ............................................................74, 77, 136 

S. F. Brito Jr. ................................................................ 102 

S. R. Brito ..................................................................... 253 

V. Brito ......................................................................... 215 

J. O. R. Brito ..........................................252, 259-260, 262 

J. Brito ......................................................................... 255 

M. Brito ........................................................................ 189 

E. Britto ........................................................................ 262 

M. Brodmann ............................................................... 225 

P. R. Brofman ...................................................... 176, 254 

C. Brommer ................................................................. 204 

D. Bron ........................................................................ 188 

D. Brosh ............................................................... 110, 178 

T. A. Brouzet ................................................................ 217 

L. Browne .................................................................... 169 

R. Bruch ....................................................................... 233 

T. Brugger-Andersen ................................................... 178 

T. Brügger-Andersen ........................................... 178, 207 

E. Brunel ...................................................................... 219 

P. Brunel ...................................................................... 173 

D. Brunner ................................................................... 202 

C. A. Bruno .................................................................. 279 

J. Bruthans .................................................................. 166 

M. Bruzzece ........................................................... 74, 241 

L. B. Brydak ................................................................. 175 

B. Buassa-Bu-Tsumbu ........................................... 78, 243 

R. Buckley .................................................................... 166 

A. Budaj ....................................................................... 273 

S. Budelli ...................................................................... 197 

A. Buendía ................................................................... 209 

O. Bugarin .................................................................... 181 

S. Buglia ....................................................................... 240 

Z. Bugra ............................................................... 106, 191 

S. Builtagy .................................................................... 274 

G. Bulacio .................................................................... 168 

V. S. Bulgarelli .............................................................. 246 

J. Bulum ...................................................................... 231 

S. Bulur ................................................................. 198-199 

D. C. Bündchen ..............................212-214, 221-223, 227, 

...............................................................261, 265-266, 269 

J. Buono ...................................................................... 144 

I. Burazor ..................................................................... 251 

M. Burazor ................................................................... 251 

Z. Burazor .................................................................... 251 

N. Burazor .................................................................... 251 

S. Burger ...................................................................... 176 

J. M. Burgos ................................................................ 250 

G. Burke ....................................................................... 137 

G. Burlando .................................................................. 184 

G. Burlli .........................................................111, 221, 255 

J. C. Burnett ....................................................72, 108, 136 

C. Burnikoff .................................................................... 79 

S. Burtchaell ........................................................ 103, 105 

A. Busato ..................................................................... 109 

C. Bush ........................................................................ 238 

N. Bustamante ............................................................. 242 

M. Bustamante ...............................................73, 143, 236 

I. Butkuviene ................................................................ 184 

M. Buyuklu .................................................................. 182 

N. A. Bylova ........................................74-75, 104-105, 164 

J. G. Byrne ..................................................................... 73 

Y. Byun ........................................................................ 235 

J. Caamaño .................................................................. 227 

I. Caballe ...................................................................... 188 

H. Caballero ................................................................. 250 

E. Caballero .................................................................... 75 

M. Cabello ................................................................... 206 

S. Cabral ...................................................................... 191 

G. Cabrejos .......................................................... 214, 222 

C. Cabrera .................................................................... 208 

L. Cabrera .................................................................... 164 

M. Cabrera ........................................................... 174, 248 

G. Cabrera .................................................................... 231 

A. Cabrita ..................................................................... 273 

R. Cacchione ................................................................ 188 

R. Caccione .................................................................. 139 

M. Caceres .................................................................. 210 

M. Cáceres .................................................................. 192 

M. Cadeiras ................................................................. 104 

A. Cagide ................................77, 144, 202, 221, 234-235, 

.......................................238-239, 241, 254, 264, 271, 274 

A. M. Cagide ................................................................ 183 

E. Caguioa .................................................................... 181 

N. Cakmak ................................................................... 186 

D. Calcines ........................................................... 181, 239 

G. Calderon .................................................................. 103 

G. Calderón .....................................69, 258, 260, 265, 271 

L. Cali ........................................................................... 190 

J. Caliani .............................................................. 262, 267 

A. Califano ................................................................... 104 

R. Calviño ............................................................. 175, 272 

R. Calviño-Santos ......................................................... 198 

D. Calvo ....................................................................... 196 

V. A. Cama ................................................................... 164 

A. Camara ............................................................ 140, 253 

A. Câmara .................................................................... 139 

M. Camargo ................................................................. 226 

A. Camarozano ...................................................... 71, 236 

K. Camarozano ............................................................... 71 

A. C. Camarozano ........................................................ 266 

L. Camera .................................................................... 228 

L. Cámera .................................................................... 137 

J. Camilletti .................................................................. 210 

L. Cammi ..............................................107, 222, 240, 251 

P. Campagnolo .................................................... 272, 275 

V. Campana ................................................................. 205 

E. G. Campana ............................................................. 250 

P. Campana ................................................................. 175 

D. Campbell ......................................................... 135, 163 

C. Campo ..................................................................... 257 

C. Campoamor ............................................................. 188 

R. Campo-Pérez ........................................................... 198 

A. C. Campos De Carvalho ................................... 140, 275 

R. N. Campos ....................................................... 233, 271 

M. Campos .................................................................. 206 

G. Campos ........................................................... 208, 233 

D. H. S. Campos .................................................. 258, 260 

L. Campos .............................................139-140, 253, 257 

P. Campos ................................................................... 132 

C. Campos ....................................................140, 259, 275 

F. V. Campos .................................191-192, 254, 264, 267 

D. H. S. Campos .................................................. 258, 260 

A. C. Campos-De-Carvalho .......................................... 266 

L. H. Can ...................................................................... 276 

P. Canales .................................................................... 272 

J. Candell-Riera .............................................132, 236, 238 

B. Candemir ................................................................. 192 

G. O. Candido ...............................................234, 253, 269 

G. Cândido ................................................................... 258 

A. Candiello ..............................71, 225, 242, 244-245, 277 

A. Cañedo .................................................................... 231 

R. Canelón ........................................................... 248, 263 

L. Caneo ...................................................................... 263 

J. O. Caneva ................................................................ 266 

C. Caniffi ...................................................................... 169 

T. Canji ......................................................................... 190 

B. C. Cannon ................................................................ 206 

M. Cano ................................................................ 256-259 

R. Cano ........................................................................ 248 

R. Cantarelli ......................................................... 227, 240 

F. L. Cantarelli .............................................................. 240 

M. Cantarelli ................................................................ 190 

A. Cantisano ................................................................ 236 

M. Cantos .................................................................... 184 

C. Capano .................................................................... 107 

J. M. Caparrós ............................................................. 215 

D. Capdeferro ........................................................ 79, 201 

R. A. Capece ................................................................ 166 

G. Caponi ..................................................................... 192 

A. M. Caporal ............................................................... 230 

A. Capuccio .................................................................. 229 

M. Capula .................................................................... 244 

C. Capuñay ...................................141, 200, 204, 238, 275 

S. Carabajal .................................................................. 178 

J. Carabajales ............................................................... 272 

M. Carasa .................................................................... 261 

E. Carasca .................................................................... 134 

J. Carbajales ................................................................ 175 

C. Cardenas ................................................................. 210 

L. Cardenas .................................................................. 276 

M. Cardoso .................................................................. 250 

A. Cardozo ................................................................... 244 

T. S. Carey ........................................................... 138, 225 

O. Carlevaro ................................................................. 142 

A. Carli ......................................................................... 218

Authors 

F. Carlos ..........................................................78, 110, 143 

I. Z. Carlos .................................................................... 247 

M. R. Carmo ................................................................ 166 

E. Carmona .................................................................. 111 

R. Caron-Lienert ........................................................... 236 

V. Carosella .................................................................. 210 

A. F. Carpentier ............................................................ 172 

M. Carrageta ........................................................ 111, 181 

V. B. Carranza .................................................77, 140, 198 

E. Carrasco .................................................................. 178 

P. Carrascosa ........................141, 200, 204, 238, 268, 275 

J. Carrascosa ................................141, 200, 204, 268, 275 

A. Carro ........................................................................ 197 

S. Carson ....................................................................... 74 

L. Cartasegna ............................................................... 210 

C. Carvajal .................................................................... 216 

J. Carvajal .................................................................... 137 

A. C. A. Carvalho ...........................................245, 259, 263 

A. C. C. Carvalho ............................245, 248-249, 259, 263 

D. Carvalho .................................................................. 228 

R. F. Carvalho ............................................................... 260 

G. Carvalho ....................................139-140, 208, 228, 257 

A. C. A Carvalho ............................................245, 259, 263 

T. Carvalho ....................................................208, 217, 223 

P. E. G. Carvalho .......................................................... 228 

A. Carvalho ...................................110, 208, 245, 259, 263 

C. Carvalho ............................111, 245, 248-249, 259, 263 

J. J. Carvalho ............................................................... 198 

V. T. Carvalho ............................................................... 217 

H. Casabe .......................73, 205, 207, 211, 236, 246, 279 

J. Casabe ............................................................. 224, 231 

A. C. Casarini ............................................................... 224 

A. Casarsa .................................................................... 229 

J. Casas ....................................................................... 246 

F. Casas ....................................................................... 227 

J. M. Casas .................................................................. 279 

F. A. Casas ................................................................... 133 

U. Casas-Juarez ........................................................... 265 

M. Cascon-Bueno .........................................207, 218, 257 

M. Cascudo ................................................................. 247 

F. Caseiro-Alves ................................................... 204, 224 

C. B. Casella ..................................................172, 180, 192 

G. Casella ..................................................................... 227 

A. Casella-Filho .............................................172, 180, 192 

B. Cassis ...................................................................... 137 

P. Castan ..................................................................... 246 

S. Castelar ................................................................... 168 

A. Castellanos .............................................................. 169 

J. Castell-Conesa ..........................................132, 236, 238 

S. Castellino ................................................................. 261 

H. Castello ................................................................... 190 

G. Castillo .................................................................... 248 

V. Castillo ..................................................................... 106 

M. Castillo .................................................................... 251 

R. Castro .......................................137, 226, 252, 258, 268 

I. Castro ....................................................................... 208 

D. Castro .........................................................75, 107, 226 

E. Castro ............................................................... 269-271 

P. H. C. Castro ............................................................. 140 

S. M. R. Castro..................................................... 252, 268 

A. Castro-Beiras ........................................................... 198 

A. Cataliotti .....................................................72, 108, 136 

L. Catão ....................................................................... 108 

C. A. M. Cattani............................................................ 236 

B. Cavaliere .................................................................. 263 

B. Cavalieri ................................................................... 228 

G. Cavalli ...................................................................... 228 

D. C. U. Cavallini .......................................................... 247 

M. Cavazzi ................................................................... 269 

R. Cayre ....................................................................... 178 

M. Cazalas ............................................................. 76, 252 

M. Cebanu ................................................................... 242 

G. Ceconi ..................................................................... 222 

K. Cedro ....................................................................... 241 

A. Cejas ....................................................................... 260 

A. S. Celebi .................................................................. 233 

M. Celente ........................................................... 262, 265 

D. S. Celermajer ........................................................... 180 

A. Celestini .................................................................... 76 

V. Celorrio .................................................................... 244 

J. Celutkiene ................................................................ 210 

N. Cemerlic-Adjic ......................................................... 183 

M. Cenanovic ............................................................... 105 

O. Cendoya .................................................................. 207 

A. Cengel ...................................................... 185, 278-279 

A. Çengel ......................................................172, 180, 186 

M. Centemero ............................................................. 198 

S. Centeno ................................................................... 142 

R. Centurión ................................................................. 199 

M. Centurión ................................................................ 256 

R. Ceolin ...................................................................... 266 

R. Ceratto .............................................................. 78, 256 

R. Cerbak ..................................................................... 253 

G. H. Cerezo ................................................................ 214 

A. R. Cerna ................................................................... 226 

D. Cerna ....................................................................... 223 

D. ňerná ........................................................................ 169 

N. Ceron ...................................................................... 216 

M. Cerón .............................................................. 181, 193 

D. Cerovec ................................................................... 220 

E. Cerqueira ................................................................. 192 

V. Cerutti .............................................................. 247, 268 

C. Cesa ................................................................ 272, 275 

L. A. M. Cesar ...............................................101, 193, 236 

L. César ....................................................................... 179 

V. Cesareo ........................................................... 244, 247 

F. Y. Cesena ..................................................172, 180, 192 

R. Cesnjevar ................................................................ 274 

Z. Cetin ........................................................................ 223 

P. C. Chabot ................................................................. 258 

E. Chachques ....................................................... 139, 172 

J. Chacon ..................................................................... 242 

S. Chacon .................................................................... 270 

A. P. M. Chacra ............................................................ 198 

S. Chada ...................................................................... 139 

A. C. P. Chagas .............................................172, 180, 192 

A. Chaitoff .................................................................... 168 

T. Chalabi ..................................................................... 175 

T. Chaliabi .................................................................... 175 

D. Chambre ..................................................237, 240, 265 

D. Chamie ............................................................ 259, 261 

E. Chammas ......................................................... 277-278 

G. Chamorro ................................................. 109, 182-183 

H. C. Champion .............................................................. 77 

K. Chan ........................................................................ 135 

M. Chan ..........................................................73, 143, 179 

P. Chandra ................................................................... 132 

D. Chaparro .................................................................. 168 

A. Charalambous ........................................................... 77 

A. Charask ..............................................69, 100, 191, 207 

A. Charroqui ..................................................111, 221, 255 

S. S. Chauhan .............................................................. 140 

I. Chaves ...................................................................... 220 

H. Chaves .................................................................... 108 

A. Chaves .................................................................... 241 

A. Chávez ....................................................................... 76 

K. Chawla .............................................................. 250-251 

M. Chazan ...................................................................... 74 

T. Chazova ................................................................... 163 

E. Z. Chehter ................................................................ 246 

D. Chejtman ....................................................79, 106, 187 

S. Chekerdemian ......................................................... 269 

S. Chekherdemian ................................217, 248, 257, 259 

M. G. Chelu .................................................................. 103 

K. Chemello ................................................................. 109 

F. Chen ........................................................................ 231 

M. Chen ....................................................................... 107 

H. H. Chen ......................................................72, 108, 136 

Y. Cheng ...................................................................... 202 

N. Chepurina ................................................................ 175 

R. Cherhousky ............................................................. 193 

S. Chermont ...........219, 233-234, 236, 260, 262-263, 270 

Z. A. Chernaya ................................................ 74, 104-105 

T. K. Chernyavskaya ........................................ 74, 104-105 

A. Cherro ......................................................229, 265, 267 

S. B. Cherry .................................................................. 243 

R. Chervin .................................................................... 189 

P. A. Chiale .................................................................. 275 

G. R. Chiappa ......................................................... 74, 138 

C. Chicanelli ................................................................. 225 

T. Chikamori ................................................................. 167 

A. L. Chilingarian ...................................242, 244, 246, 249 

A. L. Chilingaryan ....................................72, 103, 193, 218 

D. Chin ................................................................... 73, 256 

W. M. Chin ................................................................... 201 

B. S. P. Chin ................................................................. 201 

B. Chiostri .................................................................... 221 

M. Chiozza ................................................................... 274 

R. Chirife ...................................................................... 244 

R. Chirino ..................................................................... 183 

M. Chiru ....................................................................... 200 

M. Chkhetia ................................................................. 164 

Z. Chmielak .................................................................. 241 

A. Chockalingam .......................................................... 138 

index / 295

Authors 

S. Chockalingam .......................................................... 138 

D. Choi ......................................................................... 110 

I. S. Choi ...................................................................... 111 

L. Chojnowska ............................................................. 136 

N. Chon ........................................................................ 219 

P. Chopra ............................................................. 108, 241 

J. B Choy ..................................................................... 165 

M. Christ .......................................................103, 194, 245 

G. Christ ....................................................................... 110 

A. Christen ........................................................... 139, 259 

E. H. Christiansen ...........................................71, 142, 253 

D. Chrysos ................................................................... 181 

P. H. Chu ...................................................................... 179 

K. Chudasama .............................................................. 256 

J. Chudek ..................................................................... 101 

S. Chugh ............................................................... 141-142 

W. J. Chung .......................................75-77, 111, 144, 272 

S. Chuprova ................................................................. 213 

E. Chuquiure ................................................................ 204 

G. Ciambrone ..................................................72, 200, 226 

T. F. Cianciulli ....................................79-80, 136, 142, 176, 

.......................................................178, 219-223, 229, 250 

L. Cicco .......................................................................... 73 

F. T. Cichelero .............................................................. 106 

A. C. Cicogna ............................................................... 258 

A. B. Cid Alvarez ................................................... 186-187 

M. Ciesielczyk .............................................................. 222 

R. Cífková ............................................................ 166, 173 

C. Cigalini ..................................................................... 182 

M. Cikes ...................................................................... 254 

I. Cikes ......................................................................... 254 

M. Cikirikcioglu ............................................................ 142 

L. Cimerman .................................................................. 80 

R. Cimino ..................................................................... 254 

H. E. Cingolani ..................................................... 140, 189 

I. P. Cintra .................................................................... 265 

M. Ciprés ..................................................................... 274 

J. J. Cirio .............................................................. 111, 221 

M. Cisterna .................................................................. 107 

M. Ciszewski ............................................................... 102 

A. Ciszewski ................................................................ 175 

L. Citta ......................................................................... 102 

N. Citta ......................................................................... 102 

M. M. Civetta ............................................................... 275 

K. Ckarke ..................................................................... 168 

D. Clark ........................................................................ 135 

A. M. Clark ........................................................... 143, 229 

S. C. Clark .................................................................... 138 

N. C. D. Clementino ....................................................... 74 

I. P. Clements .............................................................. 105 

B. Clericus ................................................................... 257 

C. R. Clover .......................................................... 138, 212 

M. R. Cobain .................................................................. 73 

J. F. Codone ................................................................. 223 

R. Codutti .............................................................. 270-271 

L. Coelho ..................................................................... 258 

F. Coelho ..................................................................... 191 

M. G. Cohen ..........................................138, 212, 225-226 

S. R. Coimbra ............................................................... 192 

A. Coimbra ................................................................... 137 

P. Cokkinos ........................................................... 181-182 

D. V. Cokkinos ..................................................... 177, 182 

H. Cola ......................................................................... 227 

S. Colangelo ................................................................. 171 

D. Colcear .................................................................... 242 

C. Coleman .................................................................. 182 

F. Collart ...................................................................... 241 

C. Collaud ............................................................ 139, 261 

C. Collet ....................................................................... 186 

T. Collier ..........................................................73, 107, 143 

M. Colmenero ...................................................... 224, 246 

F. Colombo .................................................................. 205 

C. M. Colombo ............................................................. 230 

F. Colosia ..................................................................... 210 

D. Comay ............................................................. 222, 276 

N. Combes ................................................................... 103 

P. Comignani ............................................................... 200 

C. Commes .................................................................. 179 

D. Comtesse ................................................................ 179 

M. Condori ................................................................... 192 

T. Conforti .................................................................... 190 

M. Conforto ................................................................. 100 

C. Conkbayir ................................................................ 180 

S. Connolly ......................................................73, 107, 143 

M. Consoli ....................................................248, 257, 259 

F. M. Consolim-Colombo ..................................... 138, 270 

A. E. Consolini .............................................................. 237 

D. Constantinescu ....................................................... 200 

R. Conti ........................................................................ 276 

A. Contreras ................................................................. 176 

L. Contreras ................................................................. 189 

H. Contreras ................................................................ 190 

G. Converso ................................................................. 269 

L. Cook ........................................................................ 176 

J. Cooke ....................................................................... 111 

W. Cooper ................................................................... 255 

J. C. H. Coracini ........................................................... 265 

S. Corali ....................................................................... 188 

S. Coralli ....................................................................... 188 

F. Corbella ............................................................ 239, 255 

M. Corbi ....................................................................... 231 

P. Cordeiro ...............................77, 111, 181, 233, 236-237 

V. Cordeiro ................................................................... 144 

A. C. Cordeiro ........................................................ 80, 208 

D. Cordero ................................................................... 204 

I. Cordovil .........191-192, 244, 252-254, 264, 266-267, 273 

D. Cornalo .................................................................... 189 

M. Cornelli ................................................................... 210 

M. L. Coronel ..................................................70, 105, 271 

R. Coronel ............................................................. 205-206 

L. Coronel ...............................................70, 105, 271, 273 

A. Correa ...............................................102, 132, 242, 253 

A. G. Correa ................................................................. 102 

M. Correa .............................................................. 270-271 

D. V. Correa ................................................................. 245 

A. C. Côrrea ................................................................. 221 

L. C. L. Correia ....................................................... 72, 107 

J. Cors ......................................................................... 225 

C. Cortes ...................................................................... 207 

C. M. Cortés ................................................................ 246 

R. Corvalan .................................................................. 132 

L. A. Cosarinsky ........................................................... 136 

G. Cosentino ................................................................ 186 

N. M. Cosgrove ............................................................ 144 

A. Costa ..................................72, 169, 205, 211, 256, 259 

G. Costa ............................................................... 102, 212 

E. Costa ....................................................................... 185 

S. Costa ..............................70, 78-79, 101, 132, 250, 252, 

.......................................254-256, 258, 260, 263, 275, 277 

L. Costa ........................................................189, 197, 207 

R. Costa ........................................................ 256-259, 261 

J. Costa ..................................................247, 256-259, 261 

M. A. Costa ...................................................169, 205, 211 

P. C. S. Costa ............................................................... 275 

J. Costa Jr. .............................................256-257, 259, 261 

R. Costantini ................................................................ 278 

R. Costello ........................................................... 102, 181 

L. C. Costello-Boerrigter .............................................. 108 

C. Cotrim ............................................................. 111, 181 

M. Coutinho ................................................................. 179 

L. A. Cozarinsky ........................................................... 178 

G. Cozzarin ................................................................... 197 

I. Craciunescu .............................................................. 134 

D. Craiem ..................................................................... 267 

O. Cravero ................................................................... 227 

N. Crespi ...................................................................... 211 

A. Crespo ..................................................................... 217 

F. Crespo ............................................................. 213, 239 

M. Crespo .................................................................... 188 

A. Cribier ........................................................................ 78 

E. Cristiano ........................................................... 228-229 

J. Cristóvão .................................................................. 258 

V. Crosa ....................................................................... 227 

N. Crozzoli .................................................................... 168 

C. N. Crudo Norma....................................................... 169 

A. Crusitu ..................................................................... 200 

H. Cruz ................................................................. 181, 193 

C. Cruz ......................................................................... 228 

M. Cruz ........................................................................ 229 

F. E. S. F. Cruz ...................................................... 252-253 

I. Cruz-Gonzalez ................................................... 218, 257 

D. Cruz-Robles ............................................................. 204 

T. Csatay ...................................................................... 199 

G. Cuberas ........................................................... 132, 236 

M. Cudmore ................................................................ 256 

F. Cuellar ...................................................................... 139 

R. Cuenca .................................................................... 188 

A. Cueto ....................................................................... 222 

A. Cuevas .................................................................... 163 

H. Cuezo ........................................................................ 78 

G. Cugat ....................................................................... 248 

C. Culebras .................................................................. 183 

S. Cunha .............................................................. 202, 258 

T. S. Cunha .................................................................. 258

Authors 

L. Cuniberti .................................................................. 259 

F. Cura .............................71, 132, 225, 242, 244-245, 277 

C. Curato ........................................................................ 77 

A. Curcio ...................................................................... 269 

A. Cury ................................................................... 79, 258 

G. Cvetanovic .............................................................. 251 

B. Cveticanin ................................................................ 174 

A. Cypiene ................................................................... 184 

F. Cyrino ........................................................................ 71 

E. Czarnowska ............................................................. 134 

A. Czerniczyniec .......................................................... 197 

R. Dágosto .................................................................. 168 

C. Dámico ................................................................... 138 

L. D’angelo .................................................................. 106 

K. Da Correggio ............................................................ 179 

P. Da Luz ...................................................................... 176 

M. P. Da Rosa .............................................................. 205 

M. Da Cunha ................................................................ 234 

M. Dabrowski ...............................................102, 136, 237 

J. Dadoniene ................................................................ 184 

M. D’Aglio .................................................................... 197 

R. B. D’Agostino ............................................................ 73 

V. Daher Vaz ................................................................ 208 

I. Dahlbom ..................................................................... 75 

M. Daicz ....................................................................... 207 

M. Dal Pai-Silva .................................................... 258, 260 

R. Dall’ Alba ................................................................. 233 

P. Dallágo .......................................................74, 138, 142 

P. Dall’Ago ......................................................74, 138, 142 

L. A. O. Dallan .............................................................. 193 

C. Daltro ....................................................................... 215 

P. Daluz ........................................................................ 111 

N. R. T. Damasceno ............................................. 263, 265 

R. C. Damaso ............................................................... 247 

C. Damico .................................................................... 277 

S. Damilano ................................................................. 189 

J. Damsky Barbosa ...................................................... 209 

L. D’Angelo .................................................................. 106 

G. A. Danieli ................................................................. 134 

R. O. Darabont ..................................................... 106, 211 

V. Daru ......................................................................... 244 

V. Darú ......................................................................... 111 

F. Das Neves ............................................................... 278 

J. Dassanayake ............................................................ 164 

G. Datcu ....................................................................... 211 

A. Dauria ...................................................................... 134 

G. Davey Smith ............................................................ 164 

Z. Davicevic ................................................................. 193 

F. David ........................................................................ 144 

M. David ...................................................................... 214 

A. R. Davies ................................................................. 164 

A. Davila ....................................................................... 263 

V. Davutoglu ........................................................ 171, 211 

M. De Abreu ...................................................70, 100, 238 

W. De Andrade ............................................................ 185 

K. De Angelis ...............................74, 76-77, 136-138, 239, 

...............................................................249, 254-255, 258 

G. De Backer ............................................73, 107-108, 143 

D. De Backer ................................................................ 107 

D. De Bacquer .........................................73, 107-108, 143 

G. De Bacquer ............................................................. 107 

L. N. De Barros ............................................................ 234 

L. De Candido .............................................................. 142 

F. De Cecco ................................................................. 181 

A. De Dios .................................................................... 178 

A. De Elizari .................................................................. 260 

U. De Faire ..................................................................... 75 

F. R. De Fazzio ............................................................. 244 

J. A. De Grazia ............................................................. 137 

M. De La Vega ............................................................. 241 

J. De La Hera ........................................................ 196-197 

M. De La Riba ...............................................111, 221, 255 

R. N. De La Fuente .................................76, 138, 234, 253 

M. De La Rosa ............................................................. 260 

M. E. De La Antonia ..................................................... 168 

L. M. De La Fuente .............................................. 140, 218 

R. N. De La Fuente .................................76, 138, 234, 253 

C. De Larrazabal ........................................................... 270 

G. De León ....................................................132, 236, 238 

J. J. G. De Lima ........................................................... 101 

D. R. S. De Lorenzi ....................................................... 228 

A. De Lorenzo ...............................................110, 142, 210 

C. De Luca ................................................................... 211 

R. De Miguel ................................................................ 221 

D. De Mollein ............................................................... 214 

L. De Noronha ................................................................ 77 

P. S. De Oliveira ........................................................... 266 

A. De Paola .................................................................. 110 

A. V. De Paola ........................................................ 72, 248 

F. J. De Paula ............................................................... 101 

J. De Paz ...................................................................... 139 

S. De Ridder ................................................................. 277 

R. De Rosa ................................................................... 178 

M. De Rossi ......................................................... 233, 236 

R. De Rossi ............................................................ 76, 208 

T. De Santo .................................................................... 72 

M. De Sena .................................................................. 143 

L. De Souza .................................................................. 137 

C. De Zuloaga .............................................................. 102 

P. Debruyne ................................................................. 277 

A. Debski ............................................................. 102, 241 

J. Decourcey ................................................................ 166 

D. B. Dedeoglu .................................................... 180, 242 

R. Dedrick .................................................................... 104 

M. M. Defeo ........................................................ 208, 211 

J. P. Degaute ............................................................... 211 

M. Degrange .........................................111, 170, 189, 196 

J. A. Degrazia ............................................................... 107 

V. Dehlaghi .......................................................... 142, 212 

F. Deketele .................................................................. 195 

M. Dekleva .................................................................. 174 

M. Del Campo ...................................................... 214, 222 

C. Del Mazo ..........................................111, 170, 189, 196 

M. Del Sueldo ........................................................ 78, 261 

L. A. Del Val ................................................................. 251 

A. Del Val ............................................................. 190, 251 

N. Delarche .................................................................. 243 

H. Delgadillo-Rodríguez ............................................... 205 

M. Delgado Moreno ..................................................... 234 

D. Delgado ..................................................................... 74 

E. Delgado ............................................................ 196-197 

J. Delgado .................................................................... 139 

M. Deljanin Ilic ..................................................... 166, 214 

R. Della Pasqua .............................................................. 72 

D. Deluso ............................................................. 102, 212 

D. Demicco .................................................................. 183 

A. D. Demir .................................................................. 110 

B. Demircelik ............................................................... 223 

M. Demkow .................................................. 101-102, 136 

M. Dencker .................................................................. 168 

M. C. Deng .................................................................. 104 

D. H. Denis Hamel ....................................................... 138 

D. V. Denizar Vianna..................................................... 209 

C. Dennison ................................................................. 196 

R. K. Deo ...................................................................... 272 

S. Depine ......................................................107, 222, 240 

M. Descalzo ................................................................. 267 

H. Deschle ............................................175, 268, 272, 277 

P. Dessen .............................................................. 75, 103 

M. Destro .................................................................... 173 

J. L. Dettoni ................................................................. 270 

A. Dettorre ................................................................... 103 

B. Deveci ..................................................................... 233 

L. Devera ..................................................................... 264 

A. Deviggiano ...............................141, 200, 204, 238, 275 

F. Devito ...................................................................... 261 

S. C. Dharmage ............................................................ 164 

G. Di Gesaro ................................................................ 106 

F. Di Giovanni ............................................................... 179 

D. Di Nanno ..................................................248, 257, 259 

B. A. Di Rico ................................................................. 226 

J. Di Siervi .................................................................... 215 

G. Di Tano ...................................................................... 70 

F. Di Tomaso ................................................................ 189 

F. Di Tommaso ............................................................ 220 

D. Di Toro ..............................................197, 214, 273, 277 

C. Di Verniero ............................................................... 273 

S. Di Yelsi ..................................................................... 179 

J. Diament ................................................................... 109 

S. Diangelo .................................................................. 185 

J. M. Dias De Azeredo Bastos ..................................... 208 

C. Dias ......................................................................... 108 

V. Dias ......................................................................... 191 

E. Dias ......................................................................... 231 

R. Dias ......................................................................... 176 

P. Diaz Uberti .........................106-107, 201, 208, 236, 238 

I. Diaz ..................................................................... 80, 244 

M. Diaz ........................................................................ 246 

C. Diaz ..................................................................... 73, 75 

A. Díaz Redondo .......................................................... 186 

R. Díaz ......................................................................... 137 

R. Diaz-Contreras ......................................................... 248 

S. A. Dib Ashur..................................................... 207, 209 

M. Dicugno .................................................................. 201 

index / 297

Authors 

M. Diego-Dominguez ....................................207, 218, 257 

A. Dieterle .................................................................... 176 

G. Dieuzeide ................................................................ 240 

F. Diez .................................................................. 105, 240 

M. Diez .......... 106, 186, 224, 236, 238, 250, 259, 266-267 

P. Digon ....................................................................... 240 

M. Dikic ......................................................................... 71 

C. H. Dina ..................................................................... 191 

A. Dini ............................................................................ 71 

R. V. Z. Diniz.................................................. 248-249, 267 

R. Diniz ........................................................................ 247 

M. Diniz ....................................................................... 201 

B. Dinov ....................................................................... 206 

L. Diodato ............................................................ 244, 247 

T. Diogenes .......................................................... 264-266 

P. Diosque ................................................................... 254 

T. Dipp .............212-214, 221-223, 227, 261, 265-266, 269 

M. Disanto ................................................................... 221 

F. Ditomaso ................................................................. 102 

C. D’Ivernois ........................................................ 135, 218 

C. Dizeo ....................................................................... 189 

W. Djaballah ................................................................. 110 

S. Djambazov ............................................................... 230 

D. Djordjevic ................................................................ 276 

A. Djordjevic-Dikic ..........................110, 142, 171, 277-278 

B. Djukanovic ............................................................... 202 

L. D. Do ................................................................ 143, 275 

D. Dobrev .................................................................... 103 

H. Dohmann ........................................................ 139, 184 

N. Doll .......................................................................... 182 

A. Dombrovskis ........................................................... 255 

E. Domenicchini ........................................................... 242 

A. M. Domingos ........................................................... 253 

R. Dominguez ...................................................... 168, 222 

C. Dominguez .............................................................. 214 

A. Dominguez-Rodriguez ..............................167, 169, 213 

M. Dominiak ................................................. 170-171, 188 

F. Dominici ................................................................... 274 

S. Donato ........................................................72, 200, 226 

P. Donato ............................................................. 204, 224 

L. Dong Won ................................................................ 272 

I. Donis ........................................................................ 190 

L. Donwon ................................................................... 272 

J. P. Donzeau ............................................................... 103 

A. N. Dorelle ........79-80, 176, 178, 219-220, 222-223, 229 

A. H. Dorigo ................................................................. 262 

M. Dorobantu .......................................106, 200, 211, 224 

D. Dorsey ..................................................................... 133 

F. Dorticós ................................................................... 210 

A. Dos Santos .............................................................. 207 

G. Dotto ....................................................................... 264 

R. Doughty ................................................................... 136 

P. Dourado ................................................................... 111 

H. Doval ..........................................................70, 100, 209 

M. Dowlut .................................................................... 256 

G. Doxastakis ............................................................... 227 

S. Dragnic .................................................................... 167 

D. D. Drago .................................................................. 217 

L. Dragonetti .................................................227, 239, 255 

M. Dragovic ................................................................. 169 

H. Dreger ..................................................................... 140 

A. Drolias ..................................................................... 216 

J. Drozdz .......................................................170, 188, 222 

R. Drwila ...................................................................... 230 

A. Drzewiecka-Gerber .................................................. 230 

M. Duarte ............................................................. 200-201 

D. Duarte ....................................................................... 79 

T. N. Dube ............................................................ 108, 231 

R. Duchonova ...............................................141, 223, 234 

R. Duchoňová ............................................................... 136 

A. Dudkowska ............................................................. 249 

T. Duffy ........................................................................ 250 

H. Duggirala ................................................................. 110 

A. Dukat ....................................................................... 240 

E. Dulbecco .....................73, 107, 205-206, 230, 246, 279 

L. Dumas ..................................................................... 176 

H. Duplain .............................................................. 75, 103 

J. Dupont ..................................................................... 139 

E. Duronto ........................................................... 100, 207 

F. Duru ......................................................................... 246 

G. Dussaillant ............................................................... 141 

N. Dusserre ................................................................. 218 

R. Dutta ....................................................................... 232 

H. Duygu ...................................................................... 188 

S. Dzemeshkevich ....................................................... 234 

V. Dzenkeviciute .................................................. 184, 237 

Z. Dzielinska ................................................................. 101 

S. S. Eagle ...................................................................... 73 

K. A. Eagle ................................................................... 100 

M. Ebbing ......................................142, 243, 247-249, 251 

A. Ebner ....................................................................... 240 

R. Ebrahimi .................................................................. 144 

C. Echeverria ................................................ 189-190, 215 

H. Ede .......................................................................... 192 

T. Eftestøl .................................................................... 199 

Z. Egileten .................................................................... 111 

E. Egito ........................................................................ 258 

E. T. Egito ...................................................................... 76 

S. Egito ........................................................................ 249 

Y. Ekimova ................................................................... 132 

A. Eksik ........................................................................ 186 

C. Elbacha .................................................................... 278 

R. Elesgaray ......................................................... 169, 211 

A. Elhendy ................................................................... 111 

F. Eliaschewitz ............................................................. 227 

G. Elizalde ............................................................ 241, 264 

A. Elizalde ...................................................................... 77 

M. V. Elizari ................................................... 219-220, 229 

R. El-Kik ....................................................................... 175 

S. Ellovitch ................................................................... 102 

I. Elmadbouh ................................................................ 139 

H. Eltchaninoff ............................................................... 78 

L. Elvas ........................................................................ 258 

W. T. Emery ................................................................. 165 

F. Emperador ............................................................... 190 

S. Enar ......................................................................... 216 

L. Enciso ...................................................................... 102 

J. E. Enders .................................................................. 273 

O. Epstein .................................................................... 175 

A. R. Erbay ................................................................... 110 

P. Erceg ................................................................. 74, 105 

A. Erdem .......................................................180, 194, 205 

G. Erdem ..................................................................... 278 

M. Erden ...................................................................... 186 

S. Erdine .............................................................. 108, 241 

I. Erdinler ..................................................................... 186 

E. Erdogan ................................................................... 197 

M. Eren ........................................................................ 171 

B. Erer .......................................................................... 171 

A. Erglis ....................................................................... 255 

L. Erhardt ..................................................................... 243 

C. M. Erley ................................................................... 141 

Z. Eroglu ........................................................................ 77 

C. Erol .......................................................................... 192 

N. Erondu ............................................................... 75, 166 

J. Erriest ...................................................................... 210 

S. Eryilmaz ................................................................... 111 

B. Eryonucu ................................................................. 185 

J. Escalante ................................................................. 260 

A. S. Escandurra .......................................................... 224 

C. Escarain ................................................................... 259 

A. Escobar ............................................................. 72, 227 

J. Escudero .................................................................. 185 

E. M. Escudero ...............................................77, 140, 198 

C. Esis .......................................................................... 242 

S. Eskenazi .................................................................. 218 

M. M. Esnaola ........................................................ 78, 111 

A. Esper ....................................................................... 265 

A. Esperon ................................................................... 267 

P. Esperón ........................................................... 273, 276 

G. Espersen ................................................................. 166 

R. Esporcatte ............................................................... 250 

A. Esquivel ................................................................... 240 

A. R. Essop .................................................................. 203 

M. R. Essop ......................................................... 203, 230 

J. P. Esteves .......................................................... 72, 107 

P. Esteves .......................................................72, 107, 254 

J. Estornell ................................................................... 231 

G. Estrade .................................................................... 243 

S. J. Eum ....................................................................... 79 

A. Evangelista .............................................................. 252 

P. Evangelista .............................................................. 240 

L. Evlampieva .............................................................. 183 

F. Exposito ................................................................... 229 

E. Eyheremendy .......................................................... 255 

H. Ezumi ...................................................................... 239 

J. N. Fabiani ................................................................. 179 

B. Fabricio ............................................................ 136, 211 

L. Fabryova .................................................................. 257 

G. Facin ........................................................................ 100 

S. Fadel ........................................................................ 179 

K. Fagnilli ..................................................................... 168 

G. E. Fagogenis ............................................................ 185 

B. Faillace .................................................................... 195

Authors 

I. Faillace ...................................................................... 195 

D. Faith ........................................................................ 226 

D. Faivovich ................................................................. 137 

S. A. Fakhouri ............................................................... 244 

A. S. Fakhouri ............................................................... 244 

G. Falbo ....................................................................... 228 

S. Falcão ...................................................................... 111 

F. Falcón ...................................................................... 137 

V. Falk .......................................................................... 182 

J. P. Faller .................................................................... 194 

V. Faltus ..........................................................72, 132, 200 

R. Falú ...........................................................132, 236, 238 

R. Falú, ..........................................................132, 236, 238 

S. Fandiño .............................................................. 70, 136 

M. Fanuele ................................................................... 181 

A. Farah ............................................................... 246, 248 

S. C. Faria ..................................................................... 274 

C. Faria ................................................................. 249, 274 

J. Faría ......................................................................... 263 

E. Farias ....................................................................... 141 

M. F. Farias .................................................................. 217 

M. Farnier ...................................................................... 75 

M. Farrall ........................................................................ 77 

H. Farras .............................................................. 171, 181 

J. Fassl ................................................................... 73, 182 

L. Fatecha .................................................................... 256 

A. Fauzi ........................................................................ 184 

G. Fava ...........................................205-207, 211, 236, 259 

C. Fava ............................................................78, 188, 193 

L. Favaloro ..... 106, 186, 224, 236, 238, 250, 259, 266-267 

R. R. Favaloro ........................186, 205, 211, 230, 246, 266 

D. Favarato .................................................................. 192 

D. Favaratto ................................................................. 172 

G. Fazio ........................................................................ 106 

C. Febres ..................................................................... 190 

M. Fechner .................................................................. 140 

R. A. Fedato ................................................................... 75 

F. L. Federico Lipszyc .................................................. 212 

B. Federico .................................................................. 132 

H. Feier ........................................................................ 241 

J. Feijoo ....................................................................... 218 

M. Feissel .................................................................... 194 

A. D. M. Feitosa ................................................... 247, 255 

A. Feitosa ..................................................................... 228 

G. S. Feitosa-Filho ........................................................ 109 

L. Feldman ................................................................... 267 

G. Feldman ...................................................141, 180, 187 

R. Feldman .......................................................... 187, 241 

A. Feldman .................................................................. 186 

M. S. Felix .................................................................... 142 

A. Fellet ....................................................................... 205 

G. Feltes ............................................................... 241-242 

H. Feng .......................................................................... 73 

C. Fenili ........................................................................ 189 

A. L. Fenrich ................................................................. 206 

M. Fenucci ................................................................... 229 

F. Feres .........................................198, 225, 257, 259, 261 

E. L. Ferlin .............................................................. 74, 106 

E. O. Fernandes ................................................... 252, 274 

T. R. Fernandes ............................................................ 236 

E. Fernandes ................................................................ 268 

G. S. Fernandes ................................................... 226, 236 

G. M. O. Fernandes ..................................................... 274 

F. Fernandez Chamorro ............................................... 256 

C. Fernandez Gomez ................................................... 273 

N. Fernandez ............................................................... 206 

G. Fernandez ............................................................... 210 

E. Fernandez ........................................................ 215, 260 

S. Fernandez ........................................................ 169, 240 

M. Fernandez ........................................178, 182, 241, 268 

A. Fernandez ........................102, 205, 207, 211, 224, 227, 

...............................................231, 235-237, 240, 248, 254 

R. Fernandez ................................................................ 224 

H. Fernandez ..........................................79, 176, 187, 250 

F. Fernandez ........................................................ 165, 256 

E. H. Fernandez ........................................................... 176 

J. Fernández De La Concha ................................. 213, 239 

A. Fernández Meseguer .............................................. 174 

J. M. Fernández ........................................................... 209 

A. Fernández .................................................174, 186, 227 

A. R. Fernández ........................................................... 273 

C. Fernández .................................................................. 69 

V. Fernández ................................................................ 188 

B. Fernández ................................................................ 274 

C. Fernández-Cimadevilla ............................................ 196 

C. Fernández-Labandera .............................................. 174 

J. M. Fernandez-Real ................................................... 188 

F. L. Fernando Lanas ................................................... 102 

L. Fernando Tanajura ................................................... 257 

S. Ferradas ................................................................... 214 

R. Ferrando ........................................................... 269-270 

D. Ferrante ................................................................... 137 

G. M. Ferrari ..................................................133, 237, 274 

G. Ferrari ...................................................................... 227 

A. Ferrario .............................................................. 78, 256 

C. Ferreira Filho .................................................... 195, 245 

J. L. Ferreira ................................................................. 247 

B. Ferreira .................................................................... 180 

C. Ferreira .............................195, 243, 245, 247, 251, 265 

M. Ferreira .....................110, 142, 204, 217, 247, 253-254 

G. M. Ferreira ............................................................... 142 

A. L. Ferreira ................................................................ 106 

M. A. P. Ferreira ........................................................... 108 

M. J. Ferreira ............................................................... 224 

J. C. A. Ferreira-Filho.................................................... 270 

M. Ferreiro ................................................................... 275 

C. R. Ferreiro .................................................................. 76 

L. Ferrer ..........................69, 103, 242, 258, 260, 265, 271 

M. Ferrer ................................................................ 69, 207 

A. Ferrer-Antunes ................................................ 110, 217 

F. M. Ferrero ................................................................ 274 

L. Ferrero ..................................................................... 239 

M. Ferrero .................................................................... 274 

R. Ferreyra ............................................102, 185, 225, 244 

M. Ferriera ................................................................... 245 

L. Ferro ........................................................................ 176 

A. Ferro ........................................................................ 166 

M. Fervenza ................................................................... 72 

G. Feuchtner ................................................................ 173 

Z. Fichino ..................................................................... 276 

J. Fiedler .............................................................. 223, 237 

J. Figal ......................................................................... 107 

L. Figiel ........................................................................ 170 

J. Figueira .................................................................... 190 

A. Figueiredo ................................................108, 250, 272 

J. Figueiredo ................................................................ 138 

S. Figueiredo ................................................................ 253 

J. Figueras ................................................................... 236 

J. Figueredo ................................................................. 190 

A. Figueroa .................................................................. 240 

M. Fijalkowski .............................................................. 249 

R. D. S. Filho ................................................................ 263 

R. Filho ......................................................................... 253 

I. Filibev ....................................................................... 194 

K. Filipiak ...................................................................... 273 

S. Finella ...................................................................... 211 

F. Fini ........................................................................... 240 

F. Finol .......................................................... 247-248, 263 

A. Fiorillo ...................................................................... 218 

M. Fisberg ................................................................... 265 

C. H. Fischer ...................................................79, 224, 253 

C. Fisher ...................................................................... 238 

E. Fisman ..................................................................... 209 

R. Fitaroni .................................................................... 144 

P. Fitzgeral ................................................................... 257 

G. Fitzgerald ................................................................. 100 

P. Flaherty .................................................................... 197 

A. Flavio ....................................................................... 211 

E. Fleck .................................................................. 75, 107 

E. Fleitas ...................................................................... 177 

P. Flondor .................................................................... 106 

C. Flores Borja ............................................................. 248 

E. Flores ....................................................................... 178 

D. Flores ...................................................................... 107 

M. Flores ..................................................................... 190 

X. Flores-Ríos ............................................................... 198 

J. Floridia ....................................................................... 78 

E. Florido ...................................................................... 271 

L. Florio ........................................................................ 199 

S. Florit ........................................................................ 142 

G. Flory ........................................................................ 243 

K. Flues ...............................................76-77, 137-138, 258 

B. Flynn ........................................................................ 176 

G. Fodor ....................................................................... 240 

A. Fogel ......................................................................... 76 

A. Folga ........................................................................ 273 

S. Folino ....................................................................... 274 

T. Folkestad ................................................................. 247 

A. Y. Y. Fong ................................................................ 201 

F. L. Fonseca ............................................................... 250 

S. Fonseca ...............................................77, 233, 236-237 

I. Fonseca .................................................................... 213 

L. M. B. Fonseca ...........................................110, 140, 210 

L. Fonseca ....................................................226, 236, 250 

index / 299

Authors 

L. H. Fonseca ............................................................... 201 

C. Fontana ................................................................... 179 

P. Forcada .....................................................106, 138, 187 

L. M. A. Forlenza .................................................. 102, 132 

M. Forrester ................................................................. 201 

O. Forster ............................................................. 202-203 

R. Y. Forte .................................................................... 100 

E. Forte ................................................................ 100, 111 

A. Fortier ...................................................................... 197 

M. J. Fosco .....................................................73, 100, 279 

J. Fourie ....................................................................... 196 

R. Fowler ..................................................................... 108 

R. Foye ........................................................................ 181 

J. Fracasso ................................................................... 231 

J. M. Fragoso ........................................................ 204-205 

H. Fraguas ................................................................... 206 

F. Fraige Filho ....................................................... 243-244 

R. Frajndlich ................................................................. 109 

O. França Neto ............................................................. 176 

O. R. França Neto .......................................................... 77 

F. R. França .................................................................. 233 

O. França ............................................................... 77, 176 

B. V. França .......................................................... 252, 268 

A. Francesia ........................................................... 74, 136 

J. V. Francica ................................................................ 254 

D. Franco ..................................................................... 227 

L. François ..................................................................... 78 

T. Francuz .................................................................... 208 

A. Frangi ................................................................ 79, 201 

R. Frank ....................................................................... 179 

P. Y. Frasier .................................................................. 212 

L. Frazin ....................................................................... 202 

P. M. Fredriksen .................................................. 103, 223 

N. A. Freedberg ........................................................... 186 

B. Freedman ................................................................ 100 

L. Freire ....................................................................... 195 

R. Freire ....................................................................... 195 

E. O. Freitas ................................................................. 260 

J. Freitas ........................................................................ 72 

M. Freitas ...................................70, 78-79, 101, 132, 250, 

.................................252, 254-256, 258-260, 262-263, 268 

E. V. Freitas .................................................................. 250 

A. L. R. M. Freitas ................................................ 252, 268 

L. Freitas ...................................................................... 186 

X. Freixa ......................................................................... 69 

J. French ...................................................................... 132 

R. Fretes ...................................................................... 222 

B. Frey ......................................................................... 232 

N. Freyberg .................................................................. 143 

O. Fridman ................................................................... 239 

S. Friedl ........................................................................ 274 

R. A. Friedman ............................................................. 206 

G. Friedrich .................................................................. 173 

C. Froimovich .................................................. 80, 242-244 

J. Frostegård .................................................................. 75 

A. G. Fruntelata ............................................................ 200 

M. L. Fuantos Delgado................................................. 268 

M. L. Fuantos-Delgado ......................................... 265-266 

E. Fucak ....................................................................... 223 

S. Fuchs ............................................................... 110, 178 

F. D. Fuchs ......................................................76, 106, 143 

S. C. Fuchs ......................................................76, 106, 143 

F. C. Fuchs ............................................................. 76, 106 

K. Fuckar ...................................................................... 220 

F. Fuertes .................................................................... 248 

S. Fujii .................................................................. 263, 278 

H. Fujii ...........................................................164, 188, 197 

T. Fujisawa ................................................................... 256 

S. Fukae ............................................................... 195, 209 

H. Fukuda .......................................................70, 185, 189 

K. Fukuyo ..................................................................... 195 

M. B. G. Funari ............................................................. 224 

E. Fung ........................................................................ 111 

T. Furuhashi ....................................................70, 185, 189 

S. Furuyama ................................................................. 181 

J. Fuse ................................................................... 80, 244 

S. Fuse ......................................................................... 167 

J. Fuselli ............................................................... 102, 209 

O. Fustinoni ......................................................... 111, 221 

O. Fustoni ...................................................................... 78 

J. Gabay ....................................................................... 248 

E. Gabbay .................................................................... 108 

E. Gabe .................................................142, 205, 230, 278 

A. Gacek ...................................................................... 171 

Z. Gaciong .................................................................... 243 

F. L. Gadaleta ............................................................... 168 

F. J. Gadea ................................................................... 178 

V. Gafarov .............................................108, 138, 177, 272 

A. Gafarova ...........................................108, 138, 177, 272 

J. Gagliardi ..............................70, 100, 102, 133, 266, 278 

I. Gagulin .............................................................. 138, 272 

E. Gainoiu .................................................................... 200 

D. Gainza ........................................................75, 107, 137 

M. Gaito ......................................................................... 69 

R. Galaska .................................................................... 249 

S. Galatius ............................................................ 230, 232 

R. Galerano .................................................................. 264 

A. Galindo .................................................................... 190 

M. Galli ........................................................................ 277 

S. Gallo ........................................................................ 240 

P. Gallo ..................................141, 206, 209, 246-248, 260 

J. Gallo ......................................................................... 243 

J. P. Gallo ............................................................. 141, 260 

A. Galloe .........................................................71, 142, 253 

M. Galovcová ............................................................... 166 

M. Galvao .................................................................... 270 

G. T. Gama ................................................................... 244 

J. Gambarte ....................................................72, 200, 226 

S. Gambhir ................................................................... 250 

R. Gamboa ......................................................76, 165, 224 

M. Gamen ............................................................ 134, 225 

C. Gangana .................................................................. 262 

I. Gantz .......................................................................... 75 

N. Ganugrava ............................................................... 235 

F. Ganzalez .................................................................. 193 

C. Garcez ..................................................................... 234 

E. A. Garcia Gras .......................................................... 191 

M. A. Garcia ................................................................. 244 

E. Garcia ....................................................... 215, 270-271 

W. Garcia ..................................................................... 215 

R. G. Garcia .................................................................. 249 

R. Garcia .......................................224, 235, 254, 264, 271 

A. Garcia ...............................111, 132, 184, 191, 195, 244 

M. Garcia ...............................141, 186-187, 192, 200, 260 

C. Garcia .............................................................. 177, 207 

S. Garcia ...................................................................... 141 

H. H. Garcia .................................................................. 164 

A. García .........................................................69, 174, 188 

J. J. García-Cuerrero .................................................... 213 

A. Garcia-Flores ........................................................... 188 

M. J. Garcia-Gonzalez ...................................167, 169, 213 

R. Garcia’Monaco .................................235, 254, 264, 271 

J. Garcia-Puig ............................................................... 243 

C. D. Garciarena ........................................................... 140 

L. García-Rojas ............................................................. 133 

J. García-Ruiz ........................................................ 196-197 

J. García-Seara ..................................................... 180, 194 

J. Gardin ................................................................ 73, 179 

N. Garg ........................................................................ 198 

V. Gariboldi .................................................................. 241 

L. Gariglio ......................................................181, 193, 239 

C. Garillo ...................................................................... 210 

S. Garrido ..................................................................... 218 

A. Garutti ..................................................................... 264 

J. Gasparovic ............................................................... 257 

I. Gasperovich .............................................................. 218 

M. Gassmann .............................................................. 240 

E. Gassner ................................................................... 173 

N. Gastaldello .............................................................. 249 

L. Gastaldi .................................................................... 263 

J. Gaudiano .................................................................. 270 

E. Gaui ................................................................. 106, 262 

M. Gaute ...................................................................... 228 

G. Gavrielatos .............................................................. 181 

M. Gayda ..................................................................... 197 

D. S. Gazizova .............................................................. 255 

F. Gazoni .............................................................. 263, 268 

O. C. E. Gebara ............................................................ 277 

S. Geidel ...................................................................... 103 

R. J. Gelpi ............................................................. 227-228 

D. Genova .................................................................... 263 

J. A. Genovese .................................................... 172, 212 

A. T. Germanos ............................................................ 185 

T. Gerntholtz ................................................................ 107 

R. Geronazzo ............................................................... 227 

L. Gerones ................................................................... 197 

L. Geronés ................................................................... 189 

M. Geronés .................................................................. 189 

C. Geronés ................................................................... 183 

M. Geronimo ............................................................... 247 

H. Ghandehari ................................................................ 79 

D. Gherardi .................................................................. 240 

M. Ghias ...................................................................... 163 

S. Ghione ............................................................. 190, 251

Authors 

S. Ghiorghe ...................................................106, 211, 224 

G. Ghirardi .................................................................... 242 

F. Ghizzoni ................................................................... 143 

A. Ghosh ...................................................................... 232 

M. Giacomo .......................................................... 189-190 

J. Giani ......................................................................... 274 

E. Giardina ............................................................. 75, 107 

A. Gibert ...................................................................... 188 

V. Giga ...................................................110, 142, 277-278 

G. Gigena ............................................................... 69, 132 

G. S. Gill ....................................................................... 251 

J. Gill ............................................................................ 179 

A. Gillinov ..................................................................... 232 

R. H. Gilman ......................................................... 137, 164 

V. M. L. Gimenes ........................................................... 79 

L. Gimenez .......................................................... 208, 211 

J. Gimenez ................................................................... 242 

S. Gimenez ...........................................107, 222, 240, 251 

F. Ginés ....................................................................... 264 

C. Ginghina .................................................................. 134 

M. Gingins ........................................................... 237, 274 

A. Giolis ....................................................................... 216 

S. Gioppato .................................................................. 190 

D. M. A. Giorgi ............................................................. 260 

J. Giorgini ..................................................................... 226 

V. Giovinni .................................................................... 261 

M. Giraudo ................................................................... 241 

X. Girerd ....................................................................... 243 

M. Gironacci .................................................256, 262, 274 

M. M. Gironacci ................................................... 256, 262 

P. Gitelman .................................................................... 70 

A. Giuca ....................................................................... 180 

G. Giunta .......................................................107, 179, 259 

E. Gkaliagkousi ............................................................ 166 

A. Gkouziouta .............................................................. 182 

A. Glavan ............................................................. 229, 250 

G. Gleim ......................................................................... 75 

D. Glogar .............................................................. 100, 110 

R. Glowczynska ........................................................... 273 

J. Gminski .................................................................... 208 

R. N. Gobbi .................................................................. 266 

G. N. Gobbi ....................191-192, 244, 254, 264, 267, 273 

J. H. Goch .................................................................... 210 

A. Godomiczer ..................................................... 220, 222 

L. Godoy .............................................................. 189, 197 

P. Godoy ...................................................................... 269 

G. Godoy ...................................................................... 183 

T. J. S. Goes ................................................................ 111 

C. Goh .................................................................. 235, 239 

Y. Goh .......................................................................... 192 

P. Goh .......................................................................... 192 

J. Gohil ......................................................................... 235 

S. Gokaslan .................................................................. 223 

R. J. Goldberg .............................................................. 100 

R. C. S. Goldenberg ..................................................... 140 

A. Goldsman ................................................................ 252 

A. Goldsmit .................................................................. 141 

L. Goldstraj .................................................................. 228 

S. Golitsyn ................................................................... 234 

T. Golitsyna .................................................................. 163 

A. M. Gomes ....................................................... 100, 255 

R. Gomes .......................................190, 252, 259-260, 262 

I. Gomes ...................................................................... 102 

G. B. Gomes .................................................................. 75 

M. A. M. Gomes .......................................................... 255 

C. Gomes ..................................................................... 191 

L. Gomes ..................................................................... 191 

R. A. F. Gomes ............................................................ 247 

S. Gomes Jr. .................................................136, 215, 220 

J. Gomez ................................................71, 139, 228, 248 

C. Gomez ............................................................... 73, 266 

K. Gomez ..................................................................... 209 

S. Gomez ............................................................. 190, 251 

L. Gomez ..................................................................... 221 

R. Gomez ............................................................. 106, 189 

J. Gómez ..................................................................... 219 

J. Gomez-Mancebo ..................................................... 205 

F. Goncalves ...... 70, 79, 101, 132, 250, 254-256, 260, 263 

L. Gonçalves .............................................70, 78, 252, 258 

F. Gonçalves ...................................................78, 252, 258 

C. Gonçalves ................................................................ 233 

R. Gonçalves .......................................................... 76, 190 

B. Gonçalves ................................................................ 143 

N. Goncharova ..................................................... 204, 274 

A. F. P. Gondar .............................................. 191-192, 267 

H. Gonna .............................................................. 103, 105 

C. C. Gonzaga ........................................................ 80, 208 

B. Gonzales .................................................................. 278 

D. Gonzales ................................................................... 77 

P. Gonzalez .................................................................. 206 

R. Gonzalez ............................134, 170, 186-187, 194, 214 

J. L. Gonzalez ................................................ 206-207, 259 

C. D. Gonzalez ............................................................. 166 

F. Gonzalez .................................................................. 181 

E. Gonzalez ............................171, 174, 186-187, 192, 194 

E. S. Gonzalez ...................................................... 205, 262 

J. Gonzalez ...................................................180, 190, 256 

S. Gonzalez ...................................................184, 205, 262 

C. Gonzalez .................................................................. 184 

G. E. González ....................................................... 227-228 

G. E. González ....................................................... 227-228 

T. Gonzalez-Alujas ........................................................ 252 

J. R. Gonzalez-Juanatey ............................................... 194 

I. Gonzalez-Mendia ...................................................... 207 

C. González-Quesada ................................................... 205 

G. Gonzalez-Stawinski ................................................. 232 

M. Good ....................................................................... 103 

J. Goral ........................................................... 80, 242-244 

E. Gorbatenko .............................................................. 183 

I. A. Gorbunova ............................................................ 210 

J. M. Gore .................................................................... 100 

T. Goren ....................................................................... 191 

S. Gorgulu .................................................................... 171 

L. Goryunova ........................................................ 234-235 

M. Goss ....................................................................... 208 

G. Gossing ................................................................... 238 

N. Gotcheva ................................................................. 225 

D. Gotera ..................................................................... 247 

I. Gotlib ........................................................................ 136 

C. Gottschall ................................................................ 138 

G. Gouvea ............................................................. 222-223 

C. M. Gouvêa ............................................................... 275 

L. H. W. Gowdak...........................................101, 193, 236 

V. Grabauskiene ........................................................... 210 

N. A. Grablina ....................................................... 174, 192 

M. Grabowski .............................................................. 273 

B. Graça ....................................................................... 224 

R. Graebin .................................................................... 257 

S. Graf .......................................................................... 194 

S. Grajek .............................................................. 225, 251 

N. Gramatnikovski ....................................................... 163 

D. R. Grana ...........................106, 109, 138, 141, 197, 201 

B. E. Grand ................................................................... 183 

H. Gransar .................................................................... 141 

I. Graziadei ................................................................... 173 

A. Graziano .................................................................. 227 

F. Graziano ................................................................... 278 

G. Grazioli .................................................................... 228 

L. Grazioli ..................................................................... 141 

G. Grecca ..................................................................... 240 

A. Greco ......................................................................... 79 

O. T. Greco .................................................................. 213 

J. P. Greelish .................................................................. 73 

S. B. Greene ........................................................ 138, 225 

S. B. Greene ........................................................ 138, 225 

V. Gregorietti ............................................................... 259 

A. Grentzinger .............................................................. 194 

K. Griffith ..................................................................... 205 

J. Grignola .................................................................... 264 

M. Grigorov .................................................................. 230 

V. Grigorov ................................................................... 191 

M. Grinberg ..................................132, 237, 247, 275, 278 

D. Grinfeld ........................................................... 227, 248 

M. Grippo ............................................................. 221, 252 

D. Grisoli ...................................................................... 241 

E. Gromova .......................................................... 138, 272 

K. Grong ............................................................... 143, 272 

H. Grönlund ................................................................... 75 

P. Grosse ....................................................................... 78 

O. Grosso .................................................................... 267 

E. Gruenig .................................................................... 225 

S. Grujic ....................................................................... 105 

H. Grundt ............................................................... 75, 178 

H. Grunfeldova ................................................72, 132, 200 

C. J. Grupi .................................................................... 193 

M. Grygier .................................................................... 225 

L. Grynberg ...........................................133, 139, 188, 266 

A. Grzesiak ..................................................................... 77 

P. Grzesiowski ............................................................. 251 

A. Guajardo .................................................................. 143 

F. Gual-Capllonch ......................................................... 252 

L. C. Guarita-Souza ...................................................... 218 

G. Guarraccino ............................................................. 175 

D. Guastavino .............................................................. 197 

index / 301

Authors 

A. Guedes .................................................................... 273 

F. Guerloy .................................................................... 100 

R. Guerra ..................................................................... 183 

G. M. Guerra ........................................................ 138, 260 

X. Guerra ...................................................................... 247 

F. Guerra ...................................................................... 190 

J. E. Guerra ............................................................ 80, 220 

G. M. Guerra ........................................................ 138, 260 

R. Guerreiro ......................................................... 215, 222 

F. Guerrero .....................................................74, 211, 241 

P. Guerrero .................................................................. 106 

J. Guerrieri ................................................................... 138 

E. Guevara ...... 73, 186, 205, 207, 211, 224, 231, 236, 246 

A. Guevara ........................................................... 260, 270 

R. Guglielmone ...................................................... 80, 111 

G. Guglieri .....................................................260, 265, 271 

D. Guidi ........................................................................ 143 

K. C. Guidini ......................................................... 221, 261 

R. Guidoin .................................................................... 178 

S. Guilhon ............................................................ 233, 236 

A. Guimaraes ....................................................... 209, 268 

T. Guimaraes ............................................................... 253 

M. Guimarães ...................................................... 135, 208 

T. Guimarães .........................................139-140, 253, 257 

J. B. Guimarães ........................................................... 190 

H. Guimarães ....................................................... 132, 254 

A. Guimarães ............................................................... 108 

I. C. Guimarães ............................................................ 215 

A. C. Guimarães ........................................................... 215 

R. Guindy ..................................................................... 108 

S. Guinjoan .................................................................. 138 

C. Gul ........................................................................... 182 

R. Guleria ..................................................................... 103 

G. M. Gulnar Mendonça....................................... 210, 213 

B. Gumbiner ................................................................ 166 

C. Gun ............................................................................ 79 

S. Guneri ...................................................................... 170 

S. Gupta ....................................................................... 232 

R. Gupta ............................................................... 108, 231 

E. P. Gurfinkel .............................................................. 100 

F. Gurgel .......................................................262, 265, 267 

L. Gurrin ....................................................................... 164 

T. Gursoy ..................................................................... 223 

M. Gus ......................................................................... 106 

R. Gusmão ................................................................... 272 

F. Gustafsson .............................................................. 104 

A. Gustavo ................................................................... 175 

B. Gutfilen .................................................................... 140 

G. Guthman ................................................................... 69 

G. Guthmann ............................................................... 271 

D. F. Gutierrez ........................................................ 76, 165 

L. A. Guzman ................................................................. 74 

B. Guzman ................................................................... 137 

M. L. Guzzo .................................................................. 243 

M. Gyongyosi ...................................................... 100, 110 

D. Haag ................................................................ 111, 255 

R. Habib ............................................................... 247, 268 

T. Habon ...................................................................... 202 

V. Hachinski ................................................................. 267 

M. Hadad ............................................................. 190, 251 

A. Haddad ............................................................ 139, 184 

C. Hadid ........................................................197, 214, 273 

M. P. Haefner .............................................................. 142 

L. Hagemann ............................................................... 109 

P. Hajek ....................................................................... 223 

A. Halabe ..................................................................... 107 

A. L. C. Hallal................................................................ 208 

J. Hallén ....................................................................... 223 

R. Halmosi ................................................................... 202 

L. Halmy .............................................................. 199, 238 

L. Hamity ..................................................................... 173 

O. Hamoui ................................................................... 277 

R. Hams ............................................................... 247, 268 

S. Han ............................................................... 75-77, 144 

R. Handrock ..........................................106, 196, 198, 221 

M. Hanna ..................................................................... 168 

K. N. Hansen ...................................................71, 142, 253 

A. Hansen .................................................................... 274 

M. Hara ........................................................................ 170 

E. S. Hara ..................................................................... 271 

S. Harb ......................................................................... 110 

C. Harden ..................................................................... 176 

G. E. Harders ......................................................... 72, 136 

J. M. Hare ...................................................................... 77 

W. S. Harris ..............................................75, 206-207, 209 

W. Harvey ............................................................ 134, 170 

C. Hasdemir ................................................................... 77 

H. Hasdemýr ................................................................ 186 

H. Hase ........................................................................ 189 

M. Hashemi ................................................................. 211 

M. Hashemzadeh .....................72, 79, 102, 106, 111, 273 

K. H. Hashemzadeh ..................................................... 176 

S. H. Hashemzadeh ..................................................... 176 

C. Hasikidis .................................................................. 181 

A. Hasslocher-Moreno ................................................. 140 

T. Hatano ..................................................................... 167 

G. Hatzigeorgiou .......................................................... 182 

A. Hauqui ..................................................................... 215 

F. Hauqui ..................................................................... 215 

K. Hayashi ............................................................ 137, 173 

S. Heath ....................................................................... 229 

J. L. Hebert .................................................................. 179 

T. G. Heck ...................................................................... 74 

S. Hecker ..................................................................... 274 

B. Hedblad ..................................................................... 75 

M. Heeren ......................................................77, 137, 255 

M. Heigert ................................................................... 110 

M. Helguera ................................................................. 135 

B. Hellmuth ................................................... 220, 222-223 

L. Helman .................................................................... 192 

R. Hemetsberger ......................................................... 100 

M. Heñin ...................................................................... 218 

R. L. Henn .............................................................. 76, 143 

R. Henquin ................................................................... 104 

H. S. Henrik .................................................................. 141 

H. D. Henrique Dàbreu................................................ 210 

G. Heper ........................................................................ 72 

H. Herbas ..................................................................... 276 

R. Hermes ................................................................... 244 

L. Hernandez ............................................................... 226 

D. Hernandez ............................................................... 271 

A. Hernandez ............................................................... 163 

E. Hernández ........................................................ 196-197 

I. Hernandez-Baldomero ...................................... 167, 213 

M. Herrera ................................................................... 209 

J. Herrera ..................................................................... 264 

C. Herrera .................................................................... 214 

D. Herrera .................................................................... 190 

R. N. Herrera ................................................................ 180 

L. Herrera-Para ............................................................. 248 

A. Hershon ................................................................... 179 

A. Hershson ......................................................... 206, 225 

C. Hesse ...................................................................... 225 

Ø. Hetland ................................................................... 199 

F. Heusser ................................................................... 207 

P. Hewett .................................................................... 256 

S. Heymsfield ................................................................ 75 

F. Hidden-Lucet ........................................................... 179 

K. Hideg ....................................................................... 202 

C. Higa ....................................................72, 102, 200, 226 

M. Higuchi ................................................................... 249 

D. Hilfiker-Kleiner ......................................................... 202 

M. N Hill ....................................................................... 196 

G. Hillis ........................................................................ 136 

M. S. Hiremath ............................................................ 132 

J. C. Hiriart ................................................................... 208 

A. Hita .....................................79, 102, 106, 138, 187, 189 

R. Hitateguy .......................................................... 269-270 

S. P. H. Hjortshoj.......................................................... 166 

M. Hlawaty ...........................................170, 173, 185, 193 

M. Hochleitner ............................................................. 176 

C. Höcht ................................................................ 273-274 

D. O. Hodge ................................................................. 105 

S. J. Hoff ........................................................................ 73 

P. Hoffman ...........................................109, 134, 171, 174 

R. Hoffman .................................................................. 227 

A. Holden ........................................................73, 107, 143 

R. Holloway ......................................................... 103, 105 

G. M. Holmes ...................................................... 138, 225 

G. M. Holmes ...................................................... 138, 225 

H. Holmstrøm ...................................................... 103, 223 

D. Holownia ................................................................. 265 

W. Homena .................................................. 252, 259-260 

A. Homsi-Neto ............................................................. 233 

B. Hong ......................................................... 110, 218-219 

T. Honìk ....................................................................... 237 

S. Honsho .................................................................... 235 

A. Hopkins ................................................................... 132 

W. Hopman ......................................................... 135, 163 

B. Horne ...................................................................... 208 

K. Horoba ..................................................................... 171 

E. Horowitz ................................................77-78, 233, 236 

C. Hossri ...................................................................... 240 

J. Hou ............................................................................ 73

Authors 

L. Howes ..................................................................... 108 

H. Hreybe .................................................................... 101 

K. Hristova ................................................................... 194 

V. Hsieh ....................................................................... 132 

X. R. Hu ........................................................................ 163 

C. X. Huang .................................................................. 163 

S. Huang ...................................................................... 135 

T. Huang ...................................................................... 239 

J. Huang ...................................................................... 202 

J. Huber ....................................................................... 109 

Z. Huczek ..................................................................... 273 

W. Hueb ...................................................................... 191 

M. Huguet ............................................................. 79, 201 

J. D. Humphreys .................................................. 237, 274 

M. Hunn ....................................................................... 216 

B. K. Huntley .......................................................... 72, 136 

J. Hurtado .................................................................... 217 

P. Huschnir .................................................................. 111 

A. Hussain ..................................................................... 69 

A. Hussein ................................................................... 277 

A. Hvelplund ........................................................ 230, 232 

L. Hyeongook .............................................................. 272 

G. Iacometti ................................................................. 106 

L. E. Ianhez .................................................................. 101 

O. Iavicoli ..................................................................... 200 

A. Ibañez ...................................................................... 213 

J. Ibañez ...................................................................... 275 

S. Ibañez ...................................................................... 228 

A. Ibáñez ...................................................................... 239 

J. Igland ....................................................................... 133 

D. Iglesias ...................................................................... 77 

M. Ignjatovic ................................................................ 105 

K. Ihara ................................................................. 188, 197 

R. Ikegami .................................................................... 249 

H. Ilarraza ..................................................................... 216 

M. Ildizli ......................................................................... 77 

M. Ilea .......................................................................... 245 

S. Ilic .................................................................... 166, 214 

M. Ilic ........................................................................... 187 

E. Ilkay ................................................................. 110, 233 

G. Illuminati .................................................................. 240 

O. Ilyinskaya ................................................................ 235 

T. Imiela ....................................................................... 273 

O. C. Imventarza .................................................... 79, 219 

T. Inada ........................................................................ 271 

B. Inan ......................................................................... 111 

A. Incarbone ................................................................ 168 

C. Ingino .................................................78, 256, 265, 267 

A. Innasimuthu ............................................................ 168 

A. Inocenzi ................................................................... 262 

J. Insua ........................................................................ 181 

D. D. Ionescu ............................................................... 180 

J. Iribarren .................................................................... 190 

M. C. Irigoyen ......................74, 76-77, 136-138, 234, 239, 

................................................249, 253-255, 258, 269-270 

M. Irurita ...................................................................... 183 

J. Irurita ........................................................................ 183 

I. M. Irurzun ......................................................... 208, 211 

M. Isa ........................................................................... 102 

M. E. Isasi Capelo ........................................................ 207 

J. Isea-P ....................................................................... 218 

J. Isea-Pérez ........................................................ 219, 226 

M. Ishikawa ................................................................. 175 

O. Istratoaie ................................................................. 180 

A. Ithuralde ...................................................141, 206, 260 

A. Ittig .......................................................................... 241 

S. Ivanov .......................................................174, 192, 203 

L. Ivaskeviciene ........................................................... 184 

S. A. Ivyanskij ............................................................... 210 

T. Iwao ......................................................................... 170 

Y. U. A. Izachik ..................................................... 174, 192 

A. Izaguirre ................................................................... 141 

E. Izcovich .................................................................... 244 

A. Izcovich ................................................................... 244 

R. Izcovich ................................................................... 244 

V. Jacas ....................................................................... 231 

S. Jacob ....................................................................... 103 

J. L. B. Jacob ............................................................... 213 

M. H. V. M. Jacob ........................................................ 201 

I. Jadavji ....................................................................... 165 

F. Jahan ......................................................................... 73 

F. Jaimes ..................................................................... 139 

G. Jaimovich ......................................................... 238-239 

R. K. Jain .............................................................. 108, 231 

O. Jaksic ...................................................................... 231 

M. M. Jamal ..............................72, 79, 102, 106, 111, 273 

A. Jamalludin ............................................................... 184 

M. A. James ........................................................ 103, 105 

K. D. James ................................................................. 108 

J. Janas ........................................................................ 172 

Y. Jang ......................................................................... 110 

K. Jankowski ................................................................ 251 

D. R. Janner ................................................................. 201 

P. Jansky ........................................................72, 132, 200 

L. Janssens .................................................................. 277 

A. Januszewicz ............................................................ 101 

P. Jaramillo .......................................................... 163, 227 

C. Jardim ............................................................. 257, 259 

F. S. V. Jardim .............................................................. 244 

M. R. Järvelin ................................................................. 75 

I. Jashi ......................................................................... 235 

I. Jatene ................................................................. 76, 240 

M. Jatene .................................................................... 263 

P. Y. Jayet .................................................................... 103 

T. Jeerakathil ............................................................... 267 

S. Jegere ..................................................................... 255 

M. Jelinek .................................................................... 100 

S. Jenkins .................................................................... 108 

A. J. W. Jenney ........................................................... 103 

C. S. Jennings .............................................................. 107 

L. O. Jensen .....................................71, 79, 110, 142, 253 

J. Jensen ..................................................................... 272 

D. Jeon ........................................................................ 110 

M. H. Jeong ................................................................. 239 

T. Jezewski .................................................................. 222 

J. Jezewski .................................................................. 171 

H. Jiang ........................................................................ 163 

X. Jiang ........................................................................ 202 

H. Jilaihawi ............................................................ 73, 256 

M. Jiménez .................................................................... 69 

J. R. Jimeno ................................................................. 217 

M. Joao ........................................................................ 211 

N. Jochmann ................................................................. 75 

S. Joekes ....................................................................... 78 

A. John ........................................................................ 238 

S. O. Johnsen .............................................................. 110 

S. P. Johnsen ................................................................. 79 

B. J. Johnson ............................................................... 108 

E. S. Johnson ............................................................... 243 

O. Johnson .................................................................. 178 

A. O. Johnson-Levonas .................................................. 75 

N. Joki .......................................................................... 189 

P. Jolivet ...................................................................... 110 

L. Joly .......................................................................... 110 

J. Jones ..........................................................73, 107, 143 

J. L. Jones ................................................................... 107 

V. M. Jonke .................................................................. 237 

C. Jordan ............................................................. 226, 277 

L. Jorge ...........................................................74, 253, 269 

K. Jose ......................................................................... 211 

G. Joseph ...................................................................... 77 

X. Jouven ..................................................................... 180 

A. Jovelic ..................................................................... 190 

Z. Jovic ........................................................................ 193 

L. J. Jovovic ......................................................... 187, 202 

S. Jozami .................................71, 225, 242, 244-245, 277 

T. Jozic ......................................................................... 187 

J. G. Juárez-Rojas ........................................................ 133 

C. Juergens ................................................................. 132 

M. Juliano .................................................................... 268 

M. Junco ...................................................................... 239 

S. M. Jung ................................................................... 179 

L. Jurado .............................................................. 210, 254 

S. H. Jurayeva .............................................................. 196 

A. Jussipov .................................................................. 174 

N. Kabiri ....................................................................... 216 

A. Kablak-Ziembicka ............76, 78, 80, 101, 141, 230, 233 

F. Kacmaz ............................................................ 110, 233 

K. Kadappu ................................................................... 235 

J. Kado ......................................................................... 103 

J. Kadziela .................................................................... 102 

L. I. Kafarskaya ........................................... 74-75, 104-105 

P. Kairuz ....................................................................... 247 

L. Kaklamanis ................................................................. 77 

T. Kálai ......................................................................... 202 

M. Kalaivani ................................................................. 167 

A. Kalangos .................................................................. 142 

C. Kalianos ................................................................... 177 

R. Kalil .................................................................. 231, 233 

H. Kalinic ...................................................................... 254 

M. Kalousova ............................................................... 200 

A. Kaltoft ................................................................ 79, 110 

A. Kalvelis .................................................................... 235 

S. Kamal-Bahl ................................................................. 79 

index / 303

Authors 

U. Kamilova .................................................................. 196 

E. E. Kanaan ................................................................. 244 

A. Kandra ..................................................................... 173 

J. Kang ......................................................................... 163 

W. C. Kang ........................................................... 111, 272 

N. Kangola ........................................................... 109, 243 

R. Kanthack .................................................................. 268 

T. Kapadohos ............................................................... 181 

M. Kapitan ............................................................ 269-270 

A. Kaplon ..................................................................... 273 

A. Kapoor ...................................................... 110, 250-251 

M. K. Kapral ................................................................. 267 

B. Karadag ................................................................... 187 

N. Karadag ................................................................... 187 

A. Karadzic ................................................................... 169 

A. Karanfýl ................................................................... 195 

G. Kararigas ................................................................. 204 

S. Karas ........................................................................ 201 

M. Karcz ............................................................... 102, 237 

D. Kardara .................................................................... 216 

P. Karki ......................................................................... 272 

M. K. Karlsson .............................................................. 168 

R. Karnik ...................................................................... 110 

N. A. Karoli ................................................................... 103 

H. Karpuz ............................................................. 180, 242 

V. Karpuz ...................................................................... 242 

G. Karthikeyan ............................................................. 167 

M. Karynski .................................................................. 251 

P. Karyofillis ................................................................. 177 

E. Kaschina .................................................................... 77 

J. C. Kaski ..............................................165, 168-169, 213 

R. Kasliwal ............................................................ 141-142 

J. Kasprzak .................................................... 170-171, 222 

A. Katarzynska ............................................................. 225 

R. E. Katholi ................................................................. 142 

T. Katic ......................................................................... 231 

S. Katoh ....................................................................... 231 

V. Katsi ......................................................................... 217 

A. Katsume .................................................................. 235 

M. Katz ........................................................................ 247 

A. Kavata .............................................................. 172, 185 

N. Kawaguchi ............................................................... 175 

H. Kawano ................................................................... 164 

A. Kaya .......................................................... 195, 198-199 

B. Kaya ......................................................................... 111 

M. Kayikcioglu ....................................................... 77, 276 

H. Kazerani ................................................................... 212 

K. Kazmi ......................................................................... 73 

C. Kchmelnitskaya ....................................................... 203 

A. Kearney-Schwartz ................................................... 110 

S. Keavey ..................................................................... 177 

B. Keavney ..................................................................... 77 

E. Keba ........................................................................ 187 

V. Kecskemeti .............................................................. 203 

D. L. Keefe ................................................................... 238 

R. Keegan .................................................................... 205 

H. Kelbaek ......................................................71, 142, 253 

J. F. Kelendjian ..............................................245, 247, 265 

I. Keles ......................................................................... 187 

J. Kempfert .................................................................. 182 

S. Kenan ...................................................................... 180 

M. Kenar .............................................................. 102, 189 

N. Kenji ........................................................................ 233 

B. Kennel ..................................................................... 218 

B. M. Kennelly ............................................................. 100 

C. Kepka ...................................................................... 175 

S. Kerbage ....................................................107, 138, 179 

N. J. Kertesz ................................................................ 206 

R. Kevorkian ................................................................. 142 

A. Kevorkov ................................................................. 196 

J. Kezen ................................................136, 215, 220, 223 

A. Kezerashvili ............................................................. 270 

K. Khairi ........................................................................ 184 

R. Khalaky .................................................................... 194 

M. Kharlap ................................................................... 234 

G. Khaspekov ........................................................ 234-235 

N. Khavarian ................................................................. 211 

K. A. Khmelnitskaya ..................................................... 192 

H. N. Khong ................................................................. 275 

R. Kiamco ...................................................................... 69 

M. Kidawa .................................................................... 222 

M. Kilickap ................................................................... 192 

R. Killing ................................................................ 212-213 

C. Killinger ............................................................ 214, 222 

B. Kim .................................................................. 235, 239 

H. Kim .......................................................................... 218 

M. Kim .................................................................. 218-219 

H. S. Kim ........................................................................ 79 

Y. Kinoshita .................................................................. 164 

A. Kirilmaz .................................................................... 163 

B. Kirilmaz .................................................................... 188 

S. Kiserud ...................................................................... 75 

Y. Kishi ......................................................................... 188 

T. Kishmareia ............................................................... 230 

G. Y. N. Kiss ................................................................. 197 

J. Z. Klafke ......................212-214, 222-223, 227, 261, 265 

S. Klebs .................................................106, 196, 198, 221 

T. Kleemann ................................................................. 203 

N. Kleiman ................................................................... 258 

S. Klein ......................................................................... 166 

F. Klein ............................................................73, 266, 279 

C. Klein ................................................................ 106, 262 

C. H. Klein .................................................................... 269 

M. Klopotowski .................................................... 136, 237 

M. Klosinska ................................................................ 188 

I. Kloszewska ............................................................... 188 

M. Knobel .....................................................102, 132, 253 

E. Knobel ......................................................102, 132, 253 

J. Knopfholz ......................................................... 218, 226 

Y. Kobayashi ................................................................ 239 

B. Kobulia ..................................................................... 235 

M. Koc ......................................................................... 105 

V. Koca ......................................................................... 197 

S. A. Kocaman ..............................172, 180, 185-186, 190, 

........................................................219, 231-232, 278-279 

E. Koch .................................................................... 73, 75 

A. Kocher ..................................................................... 218 

P. Kociubinski .............................................................. 210 

M. Koestering ...................................................... 104, 270 

K. Koh ................................................75-77, 111, 144, 272 

N. V. Kokosadze ............................................................. 74 

C. Kolbitsch .................................................................. 173 

L. Koldas ...................................................................... 233 

S. Kole ......................................................................... 232 

K. Kolodziej .................................................................. 222 

A. Kolosova .................................................................. 175 

G. Kolovou ................................................................... 182 

G. Kolunin ............................................................ 183, 202 

H. Kominsky ................................................................ 168 

N. Komiya ............................................................ 195, 209 

V. Komoliatova ............................................................. 213 

V. N. Komolyatova ....................................................... 135 

D. J. Komorowski ................................................ 179, 275 

M. Kondruweit ..................................................... 176, 274 

K. Koniari ...................................................................... 217 

M. Konka ............................................................. 136, 174 

A. Konopka .................................................................. 252 

I. V. Konopka ..........................................219-220, 229, 250 

F. O. Kontari ................................................................. 185 

D. Kontogianni ............................................................. 181 

G. Kopec ...................................................................... 101 

J. Kopec ....................................................................... 208 

S. Kopecky ................................................................... 107 

C. Kopp ........................................................................ 100 

A. Koprowski ............................................................... 249 

G. E. Kordosis .............................................................. 185 

N. Koren-Morag ........................................................... 209 

M. Koretzky ..................................................181, 274, 277 

H. Korkes ..................................................................... 238 

M. E. Korkmaz ............................................................... 72 

R. Kornowski ....................................................... 110, 178 

V. Korpelainen .............................................................. 143 

M. I. Korsunskaya .......................................................... 74 

K. Korybalska ............................................................... 225 

A. Korycka .................................................................... 222 

O. Korzh ............................................................... 186, 214 

C. Kosour ..................................................................... 133 

J. Kostic ......................................................................... 71 

J. B. Kostis ........................................................... 137, 144 

M. Kostkiewicz ........76, 101, 170, 173-174, 182, 185, 193 

E. Kostova .................................................................... 225 

G. Kotchuev ................................................................. 186 

C. Kotliar .......................................................106, 138, 187 

K. Kotlinski ................................................................... 171 

V. Kotowicz .................................................................. 189 

K. Kotseva ................................................73, 107-108, 143 

T. Kottke .............................................................. 226, 277 

C. Kouanfack ................................................................ 211 

S. Koulchitsky .............................................................. 176 

N. Koumallos .................................................. 69, 216-217 

A. P. Kourounakis ........................................................... 77 

P. N. Kourounakis .......................................................... 77 

P. A. Koustas ............................................................... 185 

J. Kovac ................................................................. 73, 256

Authors 

K. Kovacs ..................................................................... 202 

G. Kovacs ..................................................................... 225 

M. Kovaite ................................................................... 184 

I. Kowalik ..................................................................... 135 

E. Kowalik ............................................................ 109, 171 

M. Kowalski ......................................................... 109, 171 

I. Kowatsch .................................................................. 179 

M. Kowman ................................................................. 188 

F. Kozak ............................................................... 134, 225 

A. Kozanecki .............................................76, 80, 101, 141 

N. Kozarevic ................................................................. 171 

B. Koziner .................................................................... 140 

V. Krämer ...................................................... 143, 182-183 

S. Krasnokutskiy .................................................. 186, 214 

O. Krasnova ................................................................. 203 

J. Krauze ...................................................................... 230 

C. Kreutzer ............................................................. 76, 252 

E. M. Krieger .................................101, 234, 249, 260, 270 

L. Krieger ..................................................................... 228 

J. E. Krieger ......................................................... 193, 251 

E. Krieger ............................................................. 193, 251 

D. Krinochkin ....................................................... 183, 202 

S. Krishna ..................................................................... 258 

A. Krishnarao ....................................................... 138, 212 

A. Krishnaswamy ......................................................... 242 

J. Kriskovich .................................................. 228, 260-261 

G. Krljanac .................................................................... 169 

G. Krogh ....................................................................... 183 

N. Krstic ....................................................................... 170 

M. Kruk ........................................................................ 175 

H. Kruklis ..................................................................... 100 

M. Krzeminska-Pakula ................................................. 222 

K. Ksiazek .................................................................... 225 

M. Kuchta .................................................................... 137 

A. Kuchwaha ................................................................ 108 

K. H. Kuck .................................................................... 103 

N. Kucukarslan ............................................................. 163 

C. Kudrle .......................................................227, 237, 274 

G. Kuhn ................................................................ 258, 260 

K. Kuiper ...................................................................... 247 

K. Kukula .............................................................. 102, 237 

L. Kuller ........................................................................ 137 

H. Kultursay ........................................................... 77, 276 

S. Kumar ................................................110, 132, 250-251 

I. Kumsars .................................................................... 255 

A. Kundu ...................................................................... 232 

F. Kuniyoshi ................................................................. 107 

S. Kunstmann .................................................75, 107, 137 

B. Kuo .......................................................................... 135 

M. Kura ................................................................ 265, 267 

E. Kuralay ..................................................................... 163 

M. Kurpesa .................................................................. 222 

I. Kurt ........................................................................... 276 

T. Kurum ...................................................................... 182 

I. Kury Nunes ............................................................... 164 

P. Kuschnir ........................................................ 79-80, 201 

B. Kusmierczyk ............................................................ 136 

M. Kusmierczyk ........................................................... 109 

F. Kuster ...................................................................... 276 

S. Kutkiene .................................................................. 237 

W. Kuzmicz .................................................................... 80 

V. Kuznetsov ........................................................ 183, 202 

J. T. Kvaløy ........................................................... 135, 199 

H. Kwon ........................................................ 110, 218-219 

D. A. Kyle ..................................................................... 221 

R. Kyrillos ..................................................................... 278 

T. Kyryleva ................................................................... 213 

N. L’heureux ................................................................ 218 

G. Labakhua ................................................................. 164 

I. Labanca .................................................................... 241 

J. C. Laborde .......................................................... 73, 256 

S. Lacchini ........................................................... 234, 251 

C. Lace ................................................................. 262, 265 

N. Lachmann ............................................................... 182 

C. D. Lacunza ............................................................... 254 

V. R. Lafayette ............................................................. 255 

N. Laffaye .................................................................... 200 

M. V. Lafuente ............................................................. 264 

A. Lagioia ..................................................................... 225 

N. Lago ........................................................................ 139 

M. R. Lago ................................................................... 213 

G. Lago ........................................................................ 270 

R. Lagos ....................................................................... 215 

A. Lagrange ......................................................... 135, 218 

S. Lagudis .................................................................... 253 

R. Laguens ............................................186, 205, 211, 259 

R. Laiño ........................................................................ 241 

J. Laitinen ...................................................................... 75 

A. Lakowsky .................................................175, 215, 272 

T. Laks ......................................................................... 187 

N. Lakusic .................................................................... 220 

P. Lal ............................................................................ 104 

S. Lam ......................................................................... 176 

M. C. Lama .......................................................... 205, 262 

M. F. Lambardi ............................................................. 275 

J. R. Lambertucci ......................................................... 217 

P. A. Lamothe .............................................................. 133 

S. M. Lamy .................................................................. 227 

F. Lanas ................................................132, 163, 215, 227 

C. Lanas ............................................................... 163, 227 

M. C. Landermann ....................................................... 140 

F. Landeta .....................................186, 205, 207, 211, 236 

I. Lang .......................................................................... 110 

M. Lanocha .......................................................... 225, 251 

M. Lanzotti ................................................................... 185 

M. F. Larin ............................................................ 237, 274 

J. C. Larosa .................................................................. 183 

M. Larroude ................................................................. 229 

L. Lasave ............................................................. 134, 225 

R. Lasica ...................................................................... 187 

C. Laspiur ............................................................. 246, 248 

E. Lasry ........................................................................ 209 

M. Lass ........................................................................ 103 

O. Lassen .................................................................... 264 

J. F. Lassen ...............................................71, 79, 142, 253 

R. Lasserre .................................................................. 243 

E. Lataza ...................................................................... 264 

F. Latif .......................................................................... 104 

F. Latiff ........................................................................ 104 

G. Laufer ...................................................................... 173 

M. Laule ................................................................. 75, 238 

R. P. Laurino ................................................................ 271 

D. Lavaggi .................................................................... 225 

G. Lavall ................................................................ 222-223 

M. Lavalle .................................................................... 168 

T. Lavergne .................................................................. 179 

P. L. Lavitola ................................................................ 132 

R. A. Lawrance ............................................................ 165 

J. Lax ................................................................... 242, 249 

A. Laynez ..................................................................... 231 

S. Laza ......................................................................... 267 

G. Lazarevic ................................................................. 276 

M. Lazovic ................................................................... 170 

O. Lazzarín ..................................................................... 76 

V. Le .............................................................................. 79 

M. Leacche .................................................................... 73 

M. Leal ......................................................................... 189 

D. Lebedev .................................................................. 276 

Y. Lecarpentier ............................................................ 179 

D. Lecic-Tosevski ......................................................... 110 

C. Lecot ................................................................ 269-270 

P. Ledesma .................................................................. 169 

B. Lee .................................................................. 235, 239 

E. J. Lee ......................................................................... 79 

M. Leeman .................................................................. 211 

J. H. Leguizamon ......................................................... 176 

J. H. Leguizamón ......................................................... 258 

M. Leiner ..................................................................... 187 

F. Leisch ...................................................................... 110 

M. F. M. P. Leite .......................................................... 256 

R. Leite ........................................................................ 268 

M. Leite ....................................................................... 109 

V. A. Leite ............................................................ 252, 268 

A. Lejnieks ................................................................... 235 

M. Lelek ....................................................................... 232 

M. Lelonek ................................................................... 210 

T. Lelyavina .................................................................. 203 

M. Lemes .................................................................... 195 

G. Lemke ..................................................................... 254 

C. Lemos ..................................................................... 138 

M. Lengyel ................................................................... 220 

A. R. Lenhenbauer-Lüdke ............................................ 236 

A. Leon ........................................................................ 227 

S. Leon ................................................................. 270-271 

M. Leonardi ..................................................103, 242, 265 

C. Leonardi .................................................................. 241 

V. Leon-Arguero ................................................... 218, 257 

G. V. Lepore ................................................................. 271 

J. Lesage ............................................................. 135, 218 

A. Lescano ........................................................... 111, 244 

P. M. Lese ................................................................... 221 

M. Lesiak ..................................................................... 225 

A. Lesniak-Sobelga .........................78, 174, 182, 185, 233 

D. Leung .............................................................. 132, 235 

index / 305

Authors 

E. Lev ................................................................... 110, 178 

G. Lev .............................................78, 110, 143, 188, 193 

M. J. Levin ........................................................... 209, 250 

G. Levin ....................................................................... 273 

N. Levitt ....................................................................... 196 

G. Levy ........................................................................ 209 

M. Lewandowski ..............................................76, 80, 135 

G. Lewy ....................................................................... 243 

C. Lezon ......................................................................... 77 

Q. Li ............................................................................... 73 

J. Li ........................................................................ 77, 202 

E. Libhaber ........................................................... 203, 230 

C. Libhaber .................................................................. 230 

A. Lichter ..................................................................... 228 

J. Lietava ..................................................................... 240 

C. K. Liew .................................................................... 201 

H. B. Liew .................................................................... 201 

G. Ligorio ....................................................................... 72 

W. K. Lim ..................................................................... 104 

M. C. L. Lim ................................................................. 270 

A. R. R. Lima ................................................................ 260 

J. Lima ................................................................. 110, 217 

A. B. R. Lima ..........................................191-192, 264, 267 

S. Lima ......................................................................... 228 

A. B. Lima ............................................................. 252-254 

L. Lima .............................77, 110, 140, 210, 233, 236-237 

R. S. L. Lima .................................................110, 140, 210 

V. Lima .................................................................. 139-140 

A. P. Lima-Leopoldo ..................................................... 258 

D. Lindefjeld ................................................................ 109 

S. Lindemberg ..................................................... 233, 236 

C. Linden ..................................................................... 168 

B. Lindsay .................................................................... 179 

B. Linetzky ............................................................ 137-138 

J. M. Linhares .............................................................. 234 

K. Linhartova ........................................................ 234, 253 

K. Linhartová ........................................................ 136, 237 

G. Liniado ..................................................................... 278 

A. Linke .................................................................. 73, 182 

F. Lino .......................................................................... 267 

R. H. Lins ............................................................. 220, 222 

A. Liœniak-Sobelga ...................................................... 193 

S. Liotta ....................................................................... 250 

M. T. Lioy Lupis ........................................................... 223 

G. Y. H. Lip ................................................................... 217 

P. Lipiec ....................................................................... 222 

A. Lipinska ................................................................... 251 

E. Lira ........................................................................... 238 

R. Lirola-Liebanas ........................................................ 248 

V. Lisboa ...................................................................... 240 

L. F. Lisboa .................................................................. 132 

V. A. Lischouk .............................................................. 255 

A. Lismanis .................................................................. 255 

D. Liszewska-Pfejfer .................................................... 251 

N. Liu ............................................................................. 75 

Q. Liu ........................................................................... 216 

J. Liu ............................................................................ 216 

P. Liva .......................................................................... 219 

T. Livieratos ................................................................. 185 

T. H. Livieratos ............................................................. 185 

J. Ljubas .............................................................. 104, 245 

G. Llamas-Esperon ....................................... 265-266, 268 

J. M. Llaneza ................................................................ 165 

S. C. Llois ..................................................................... 168 

C. Llorente ........................................................... 213, 239 

J. Lloveras ..................................................................... 79 

S. Lluberas ........................................................... 232, 267 

R. Lluberas ................................................................... 270 

A. C. Lo Prete ...................................................... 109, 191 

Q. Lo .................................................................... 132, 235 

S. Lo .............................................132, 222, 235, 273, 276 

M. F. Lobo ................................................................... 241 

B. Lococo ............................................................. 170, 201 

D. Lodi ......................................................................... 275 

A. Loera-Pinales ........................................................... 265 

E. Logtens ............................................................. 73, 256 

K. H. Loland ................................................................. 248 

K. H. Løland ......................................................... 142, 243 

R. Lolo ......................................................................... 214 

R. Lombardo ................................................................ 218 

F. Lombi ....................................................................... 201 

B. Lombo ..................................................................... 216 

S. Loncar ...................................................................... 182 

S. Loncaric ................................................................... 254 

G. Longo ...................................................................... 179 

B. Longo-Mbenza .............................76, 78, 109, 220, 243 

R. Lopes ........................................186, 263, 267-268, 276 

A. C. Lopes .......................................................... 263, 268 

A. A. Lopes .................................................................. 263 

H. F. Lopes .................................................................. 260 

M. A. Lopez Verrilli ....................................................... 262 

C. Lopez ..........................73, 138, 197, 205, 211, 214, 246 

M. L. Lopez .................................................................. 207 

L. Lopez ........................................183, 207, 248, 257, 259 

M. Lopez ............................................................... 270-271 

V. A. Lopez ................................................................... 137 

V. Lopez ......................................................................... 75 

S. Lopez ............................................................... 176, 240 

C. E. Lopez ................................................................... 279 

D. E. Lopez .................................................................. 229 

J. Lopez ............................................................... 183, 204 

E. Lopez ........................................................184, 229, 279 

G. F. López Soutric....................................................... 215 

A. López ....................................................................... 107 

P. Lopez-Jaramillo ........................................................ 249 

F. López-Jiménez ......................................................... 107 

M. Lorenz ...................................................................... 75 

G. Lorenzi-Filho ............................................................ 270 

M. Lorenzo .......................................................... 273, 276 

C. C. Lores ....................................................245, 259, 263 

M. Losano .................................................................... 242 

L. Lotaif .................................................................. 80, 208 

M. J. Loureiro ...................................................... 111, 181 

C. Lourenco ....................................................79, 101, 132 

C. Lourenço ......................................70, 78, 250, 252, 258 

E. Lovaglio ............................................................. 75, 209 

L. Lovato ...................................................................... 233 

I. Lovera ....................................................................... 237 

D. L. Lovic Dragan........................................................ 207 

B. Lovic ........................................................................ 251 

M. Lovic ....................................................................... 276 

D. Lovic ........................................................................ 276 

D. Lovric ...................................................................... 230 

D. Lowenstein ............................................................. 142 

R. Lowenstein ............................................................. 208 

J. Lowenstein .............................................................. 111 

I. Lozano ....................................................... 165, 196-197 

D. Lozano ..................................................................... 214 

Z. B. Lu ........................................................................ 163 

K. Lu ............................................................................ 166 

F. Lubenieki ................................................................. 275 

B. Lubiszewska ............................................................ 174 

M. R. Luca ................................................................... 211 

L. Lucas ................................................144, 239, 241, 274 

A. Lucchini ................................................................... 277 

S. Luchese ................................................................... 109 

H. Luciardi .....................................................141, 187, 220 

V. Lucini ....................................................................... 209 

M. Luduena ................................................................. 182 

S. Ludueña ................................................................... 240 

I. Lugones .............................................................. 76, 221 

L. Luis .......................................................................... 169 

M. Lujambio .......................................................... 269-270 

I. Luksic ....................................................................... 272 

A. Luongo .................................................................... 184 

S. Lupano ..................................................................... 275 

S. Lupi .......................................................................... 189 

J. C. Luque-Moscoso ................................................... 248 

A. Luz ........................................................................... 191 

T. Lyle .......................................................................... 242 

S. Lynch ....................................................................... 259 

B. Lytle ........................................................................ 232 

P. Maagh ............................................................. 103, 194 

L. Mabwa ..................................................................... 220 

A. Macedo ..................................................................... 72 

R. Macedo ................................................................... 230 

R. Machado ..........................................204, 233, 265, 267 

P. Machado .................................................................... 78 

M. Machado ................................................................ 234 

F. Machado .................................................................. 240 

L. Machado .................................................................. 251 

L. Machado-H .............................................................. 219 

S. A. Machnick ............................................................. 223 

A. Maciag ....................................................................... 76 

N. Maciel ............................................................. 133, 266 

S. M. Macin .............................................70, 219-220, 271 

S. Macin ............................................................... 214, 234 

O. Macz ....................................................................... 185 

R. Maczynska .............................................................. 136 

H. Madani .................................................................... 216 

O. Maden ..................................................................... 110 

M. Madsen .......................................................... 230, 232 

J. K. Madsen ........................................................ 230, 232 

C. Mady ....................................................................... 136

Authors 

S. Maeda ............................................................. 188, 197 

M. Maeng .........................................71, 79, 110, 142, 253 

H. Maffeo .................................................................... 142 

R. B. Magaldi ............................................................... 132 

M. Magalhaes .............................................................. 137 

M. E. C. Magalhaes...................................................... 250 

L. B. N. C. Magalhaes .................................................. 255 

E. Magalhães ............................................................... 201 

M. A. Magalhães .......................................................... 102 

C. Magallanes .............................................................. 204 

A. Magd ....................................................................... 274 

R. Maggi ...................................................................... 134 

S. Maggi ...................................................................... 137 

L. Maggio ..................................................................... 178 

A. P. Maggioni ............................................................. 103 

R. Magliola ........................................................... 221, 255 

P. Mahia ....................................................................... 252 

I. Mahmud ................................................................... 243 

P. Mahzoni ................................................................... 216 

P. Mahzouni ................................................................. 216 

J. Maia ................................................................. 259, 261 

F. Maia ......................................................................... 198 

L. Maia ......................................................................... 254 

A. Maiato ..................................................................... 108 

G. Maid .........................185, 195, 210, 239, 241, 264, 271 

R. Maier ....................................................................... 225 

A. Maiorana ................................................................. 108 

O. H. Majane ................................................................ 230 

M. Majsec .................................................................... 220 

C. R. Majul ................................................................... 133 

L. Makarov ................................................................... 213 

M. Makdisse ........................................................ 102, 132 

S. Makhoul ................................................................... 227 

D. Makowiec ............................................................... 249 

M. Makowiecka-Ciesla ................................................ 101 

A. Malan ...................................................................... 185 

G. Maldonado ....................................................... 256-259 

L. Malek ....................................................................... 237 

M. Maletin ................................................................... 183 

C. Malfitano ................................................................. 239 

A. F Malheiros .............................................................. 267 

A. Mallouhi ................................................................... 173 

J. Maloney ........................................................... 185, 205 

E. Malpica-Miranda ...................................................... 205 

M. Maly ....................................................................... 223 

G. Mamaladze .............................................................. 230 

S. C. Manchanda .......................................................... 140 

D. M. Mancini .............................................................. 104 

L. Mancini .................................................................... 214 

C. A. Mandarim-De-Lacerda ................................. 198, 202 

N. Mangani .....................................................78, 102, 189 

A. Manginas ................................................................. 177 

J. Manica ..................................................................... 109 

F. Maniero ........................................................... 109, 243 

V. G. Manolopoulos ....................................................... 77 

L. Manriquez ............................................................ 73, 75 

V. Mansilla ................................................................... 275 

J. Mansur ..............................................136, 208, 215, 220 

A. J. Mansur ................................................................ 208 

J. Manterola ................................................................... 78 

O. Manuale .......................................................... 227, 237 

O. D. Manuale ...................................................... 133, 274 

F. Manzano .......................................................... 224, 246 

S. Manzolillo ................................................................ 260 

G. Marambio ........................................................ 178, 246 

R. C. Maranhao .............................109, 180, 191, 255, 263 

L. Marani ...................................................................... 173 

R. Marañon .................................................................. 215 

V. Marasa ..................................................................... 189 

V. Marathe ........................................................... 195, 232 

V. Maravic .................................................................... 202 

C. C. Marboe ................................................................ 104 

M. Marchel .................................................................. 273 

G. Marchetti ................................................................. 225 

R. Marchioli .................................................................. 209 

M. Marcia .................................................................... 211 

A. Marco ...................................................................... 254 

M. S. Marcolino ............................................................. 74 

F. K. Marcondes ........................................................... 258 

F. Marconetto ...................................................... 246, 248 

M. A. Marcozzi ............................................................. 274 

R. Marelli ................................183, 189-190, 197, 214-215 

D. Marelli ..................................................................... 214 

R. Marenchino ..................................................... 244, 247 

R. Marfisi ..................................................................... 209 

L. Mari ................................................................... 78, 102 

J. Mariani ............................................................... 78, 100 

P. Marichal ................................................................... 269 

P. Y. Marie ................................................................... 110 

E. Marijon ............................................................ 103, 180 

F. Marín ....................................................................... 217 

P. Marinho ................................................................... 257 

J. A. T. Marinho............................................................ 267 

A. Marini ...................................................................... 218 

J. Marinkovic ............................................................... 182 

K. Marinou ...................................................... 69, 216-217 

A. L. C. Marins ............................................................. 250 

I. A. Markelova ............................................................. 210 

M. Markman ................................................................ 241 

B. Markman-Filho ........................................................ 241 

V. Marmol .................................................................... 256 

M. Marona ................................................................... 252 

E. Marques .................................................................... 72 

C. Marques .................................................................. 247 

I. Marques ................................................................... 229 

A. Marques .................................................................. 250 

S. A. G. Marques.......................................................... 213 

N. Marquez .................................................................. 247 

H. Marrero ................................................................... 183 

G. Marrero ................................................................... 207 

F. Marrero-Rodriguez ........................................... 167, 213 

N. A. Marsan ................................................................ 136 

M. Martin ..................................................................... 165 

F. L. Martin .....................................................72, 108, 136 

A. Martín ...................................................................... 210 

C. Martinengo .............................................................. 210 

J. Martinez ............................................................. 74, 108 

F. Martinez ..............................................74, 108, 258, 260 

R. Martinez .................................................................. 197 

A. Martinez .......................................................... 144, 265 

L. Martinez .................................................... 185-186, 194 

C. Martinez .......................................................... 219, 228 

M. Martinez ......................................................... 189, 234 

C. D. Martinez .............................................................. 214 

I. Martinez .................................................................... 208 

N. Martinez .................................................................. 231 

H. Martinez .................................................................. 261 

P. F. Martinez ....................................................... 258, 260 

J. G. Martínez ...................................................... 213, 239 

C. Martínez .................................................................. 204 

N. Martínez-Rodríguez ................................................. 205 

L. Martinez-Sande ................................................ 180, 194 

F. Martin-Herrero ................................................. 218, 257 

L. Martinkovicova .........................................141, 223, 234 

H. F. Martino ........................................................ 266, 275 

R. Martins ............................................................ 204, 258 

S. M. Martins ....................................................... 227, 247 

V. M. Martins ............................................................... 106 

S. Martins ............................................................ 141, 240 

V. Martire .............................................................. 184-185 

B. Martire ..................................................................... 172 

C. Martorano ................................................................ 243 

M. P. Marturano ..............................................73, 100, 279 

E. Marum ............................................................. 144, 225 

E. Marusic .................................................................... 137 

R. Marzoa-Rivas ........................................................... 198 

C. Mascheroni ............................................................. 263 

M. J. Maseko ............................................................... 230 

G. Masina .................................................................... 175 

M. Masotti ..................................................................... 69 

R. Massa ...................................................................... 188 

J. Massa ...................................................................... 188 

J. Massaro ..................................................................... 73 

H. Massetti .................................................................. 181 

W. M. Masson ............................................................. 183 

L. Mastrocolla ....................................................... 110-111 

F. Mastrogiacomo ................................................ 242, 249 

M. O. Masuda .............................................................. 245 

I. Masuda ............................................................. 190, 227 

M. Masuelli .................................................................. 217 

P. Matafome ........................................................ 100, 269 

R. S. Math .................................................................... 167 

A. Mathavan ................................................................ 138 

N. Mathew ................................................................... 167 

W. Mathias Jr. ..................................................... 111, 179 

C. Mathieu ............................................................. 75, 103 

G. Matic ..........................................................74, 105, 169 

M. Matic ...................................................................... 187 

I. Matko ....................................................................... 203 

A. Matonia ................................................................... 171 

L. Matos ...................................................................... 220 

H. Matsubara ............................................................... 235 

A. Matsui ..................................................................... 235 

U. Matte ...................................................................... 233 

index / 307

Authors 

P. G. Mattingly ..................................................... 172, 185 

A. Mattioli .................................................................... 275 

G. Mattioli .................................................................... 275 

M. J. Mattioli ................................................................ 183 

V. Mattos ..................................................................... 234 

L. A. Mattos ................................................................. 198 

V. Z. Mattos ................................................................. 250 

R. Matunovic ............................................................... 193 

M. Matyjaszczyk .......................................................... 210 

S. K. Maulik .................................................................. 140 

S. Mavrogeni ............................................................... 182 

R. Max .................................................................. 222-223 

T. Maximova ................................................................ 203 

S. Maybaum ................................................................ 270 

O. Mayer .............................................................. 166, 173 

R. Mayer ...................................................................... 179 

M. Mayer .............................................................. 273-274 

O. Mayer Jr. ................................................................. 166 

G. Mazina ..................................................................... 175 

J. Mazucco ...................................................134, 170, 212 

C. Mazza ...................................................................... 240 

G. Mazzini .................................................................... 233 

P. Mbuilu ....................................................................... 78 

F. McAlister ................................................................. 229 

T. McAllister ................................................................ 218 

M. McConnell .............................................................. 242 

N. McHado .................................................................... 74 

E. McKay ..................................................................... 179 

J. McMillan .................................................................. 135 

A. Mead ..........................................................73, 107, 143 

A. Meave ..................................................................... 133 

P. Medeiros ......................................................... 220, 222 

A. Medeiros ......................................................... 136, 240 

C. Medeiros ......................................................... 141, 227 

L. Medesani .................................................. 206-207, 259 

M. Medina ................................................................... 168 

G. Medina .................................................................... 219 

M. Medvegy .........................164, 199, 203, 208, 224, 238 

R. S. Meena ......................................................... 108, 231 

A. Mehra ........................................................................ 69 

A. B. Mehta .................................................................. 132 

O. Meilhac ................................................................... 139 

F. Meiller ...................................................................... 195 

S. Meiners ................................................................... 140 

A. Meissner ..................................................103, 194, 245 

H. Mejias ..................................................................... 190 

S. Melamed ................................................................. 163 

A. Mele ........................................................................ 210 

R. Melendez ................................................................ 218 

P. Mello ....................................................................... 138 

A. P. Q. Mello....................................................... 263, 265 

C. S. Melo .................................................................... 244 

P. Melor ....................................................................... 184 

J. Meltzer ..................................................................... 176 

R. H. Mendes ................................................253, 258, 269 

R. J. Mendez .................................................220, 229, 250 

O. A. Mendiz .................................................................. 76 

L. Mendonça ................................................................ 229 

C. Mendoza ......................................................... 107, 219 

L. Mendoza .................................................................. 271 

R. Meneghelo ........................................110-111, 240, 268 

A. Meneghin I. ............................................................. 245 

H. Menezes ................................................................. 109 

E. Mengual ................................................... 247-248, 263 

D. Mentzikof ................................................................ 216 

R. Merbilhaa ................................................................ 102 

E. Merilind ................................................................... 187 

P. Merlo ....................................................................... 204 

I. Merlo ........................................................................ 207 

A. Mesples .................................................................... 80 

E. Mesquita ..........................191, 201, 229, 238, 260, 263 

E. T. Mesquita ................219, 233-234, 236, 253, 262, 270 

K. Messlinger ............................................................... 176 

P. Meszaros ................................................................. 183 

D. Metras ..................................................................... 241 

V. Mezzalira ......................................................74, 80, 111 

D. Mezzano .................................................................. 109 

J. Miano ....................................................................... 140 

R. M. Miatello ...................................................... 205, 262 

V. Micevski .................................................................. 104 

L. Michea ..................................................................... 137 

J. B. Michel .................................................................. 139 

O. Midttun ........................................................... 249, 251 

Z. Mijailovic .................................................................. 193 

N. Mijailovsky .............................................................. 214 

D. Mijalkovic ................................................................ 276 

E. Mikhaylov ................................................................ 276 

R. Milani ............................................................... 135, 208 

L. Milani ......................................................................... 70 

S. Milanov .................................................................... 194 

D. Milic ........................................................................ 170 

D. Milicic .......................................................104, 230, 245 

C. Militaru .................................................................... 180 

J. G. Mill ....................................................................... 263 

G. Millet ....................................................................... 138 

M. Milli ........................................................................... 70 

J. Mills ......................................................................... 177 

V. Milman .................................................................... 196 

C. Miloro ...................................................................... 275 

P. Milosavljevic ............................................................ 166 

A. Milosevic ................................................................. 169 

P. Min ........................................................... 110, 218-219 

R. Minardi .................................................................... 262 

M. Minelli ..................................................................... 171 

G. S. Mintz ................................................................... 142 

M. Miragaya ................................................................. 204 

G. Miramont ...................................................74, 211, 241 

C. Miranda ......................................78, 244, 256, 266, 273 

V. Miranda ................................................................... 191 

R. Miranda ................................................................... 181 

C. S. Miranda .................................191-192, 254, 264, 267 

I. Miranda ..................................................................... 209 

A. Miranda ....................................................175, 259, 272 

S. Miranda .............................191-192, 254, 264, 267, 269 

R. D. Miranda ............................................................... 255 

J. J. Miranda ........................................................ 137, 164 

L. Miranda-Peats .......................................................... 141 

J. Mirat ........................................................................ 220 

R. Miret ........................................................................ 168 

R. N. Mishra ................................................................. 251 

S. Mishra ............................................................. 140, 164 

J. Misiura ..................................................................... 210 

P. Mitro ........................................................................ 257 

P. Mitrovic ..............................................74, 105, 169, 278 

S. I. Miura .................................................................... 181 

A. M. K. Miyadahira...................................................... 245 

S. Möbius-Winkler ......................................................... 73 

A. O. Mocumbi ............................................................ 180 

J. Modenesi ................................................................. 217 

P. Moffa ......................................................................... 72 

G. Mohamed ................................................................ 214 

N. Mohammadifard ...................................................... 211 

A. Mohan ..................................................................... 103 

J. Mohan ........................................................................ 79 

F. Mohr .......................................................................... 73 

O. Moiseeva ........................................................ 204, 274 

V. Moitra ...................................................................... 176 

E. E. Mola ............................................................ 208, 211 

J. C. Molina ............................................................ 75, 107 

J. Moll .................................................................. 229, 272 

R. A. Moller ...................................................108, 241, 243 

T. Möller .............................................................. 103, 223 

P. Mollon ..........................................76, 78, 110, 143, 165 

A. Mollon ............................................................. 188, 193 

F. P. Mollon ............................................................ 76, 165 

G. Molon ........................................................................ 72 

V. Moltchanov .............................................................. 231 

S. Molteni .................................................................... 278 

H. Mon ........................................................................... 76 

M. Mongitore ............................................................... 201 

Z. Monhart ......................................................72, 132, 200 

A. Monney ............................................................. 75, 103 

O. Montaña .......................................................... 111, 138 

S. Monte ...................................................................... 103 

R. Montecchiesi ........................................................... 274 

S. Monteiro ..........................70, 78-79, 100-101, 132, 204, 

...............................250, 252, 254-256, 258, 260, 263, 269 

P. Monteiro ..........................70, 78-79, 100-101, 132, 250, 

.......................................252, 254-256, 258, 260, 263, 269 

G. Monteiro ................................................................. 110 

S. Montenegro ............................................................. 241 

I. Montero .................................................................... 107 

A. Montero-Gómez ...................................................... 107 

C. Montes ...................................................................... 76 

M. Monteverde ............................................................ 250 

P. Montoya ................................................... 206-207, 259 

H. Moon ....................................................................... 218 

C. I. Moon ............................................................ 111, 272 

J. Moon ............................................................... 141, 234 

J. Mor .......................................................................... 216 

L. Moraes .....................................................244, 247, 268 

V. Moraes .................................................................... 205 

A. P. Moraes ................................................................ 253 

R. S. Moraes ........................................................ 106, 138

Authors 

N. Moraes .................................................................... 176 

M. Moraes ................................................................... 109 

E. R. F. L. Moraes ........................................................ 244 

J. Morais ............................................................... 264-266 

M. Morais ............................................................ 109, 134 

M. A. Morales Lezica ........................................... 220, 239 

C. Morales ............................................................ 227-228 

B. Morales ................................................................... 272 

G. Moratalla-Cecilia ...................................................... 248 

S. K. Morcos ................................................................ 141 

G. Moré ......................................................................... 74 

D. Moreira ..................................76-77, 110, 247, 249, 268 

E. D. Moreira ..................................................... 76-77, 249 

R. B. Moreira ................................................................ 253 

L. F. Moreira ................................................................ 237 

P. Moreira ............................................................ 108, 278 

A. Moreira ............................................................. 257-259 

L. B. Moreira ...................................................76, 106, 143 

M. B. Moreira ....................................................... 106, 143 

C. M. Moreira ............................................................... 106 

E. Moreira ............................................................ 137, 269 

L. Moreira .................................................................... 108 

R. C. Moreira ........................................................ 139, 184 

J. Moreno .................................................................... 244 

C. Moreno .................................................................... 241 

M. Moreno ......................................................75, 137, 241 

G. Moreno ............................................111, 221, 226, 255 

H. Moreno-Filho ........................................................... 270 

A. Moreyra ..................................................................... 69 

A. E. Moreyra ....................................................... 142, 144 

S. Morhy .................................................79, 224, 238, 253 

A. T. Morikawa ............................................................. 255 

D. Morillo ..................................................................... 176 

P. Moriña ..................................................................... 209 

C. Moris ....................................................................... 165 

C. Morís ................................................................ 196-197 

T. Morishima ................................................................ 167 

D. Morisse ...............................................80, 229, 242-244 

L. A. Morita ................................................... 222-223, 229 

M. Moroi .........................................................70, 185, 189 

S. Mortaloni ..........................................107, 222, 240, 251 

G. Moscardi ................................................................. 110 

F. Mosele ..................................................................... 236 

A. Moser ...................................................................... 226 

C. Mostarda .........76-77, 137-138, 239, 249, 253-254, 269 

P. Mota ......................................................... 139-140, 257 

A. Mota ........................................................................ 186 

D. Motta ................................106-107, 201, 208, 236, 238 

A. Mouly-Bandini ......................................................... 241 

J. Mountaner ............................................................... 220 

S. Moura ...................................................................... 213 

L. A. Z. Moura .............................................................. 254 

J. Mouras ..................................................................... 139 

M. Moutinho ................................................................ 191 

M. R. Movahed .................72, 79, 102, 106, 111, 144, 273 

M. Moya ...................................................................... 205 

E. Moya ....................................................................... 168 

A. Moyano ................................................................... 173 

M. S. Moysés Szklo ..................................................... 232 

I. Mrdovic ..................................................................... 187 

F. B. Muccillo ............................................................... 275 

D. Mugnai .................................................................... 142 

M. L. O. Mugnaini ........................................................ 254 

M. F. Muiño ................................................................. 234 

E. K. Mulholland ........................................................... 103 

R. E. Müller .................................................................. 227 

R. Müller ...................................................................... 256 

M. A. Müller ................................................................. 106 

J. Müller ....................................................................... 274 

H. Mun ......................................................................... 219 

K. Munakata ................................................................. 175 

A. Muniz .............................................................. 132, 269 

A. Muñoz ..................................................................... 183 

M. C. Muñoz ................................................................ 256 

R. Munoz-Sandoval ...................................................... 265 

N. Murad ...................................................................... 245 

N. Murai ............................................................... 188, 197 

C. Muratore ..................................................185, 205, 277 

P. Murray ....................................................................... 73 

A. Muryan .................................................................... 201 

A. Musacchio ................................................................. 78 

P. Musialek .......................................78, 80, 141, 230, 233 

L. Music ....................................................................... 167 

B. Musser .............................................................. 75, 166 

O. E. Mustafina ............................................................ 236 

R. Mvungi .................................................................... 235 

B. Myasnik ................................................................... 196 

J. Myszor ..................................................................... 230 

G. Naccarato .......................................................... 79, 224 

J. H. M. Nacimento ...................................................... 259 

J. Nadal ........................................................................ 244 

M. Nadal ...................................................................... 231 

S. Nadeem ................................................................... 270 

B. Nadinic .................................................................... 217 

C. Nagaoka ............................................243-244, 247, 265 

Y. Nagayoshi ................................................................ 164 

C. Nagel ....................................................................... 246 

M. Nahin ...................................................................... 197 

G. Naiman .....................................................111, 221, 255 

S. Najarian .................................................................... 142 

J. Najjar ........................................................................ 103 

Y. Naka ........................................................................ 104 

S. Nakayama ................................................................ 164 

M. Nakayama ............................................................... 167 

R. Nakazato .....................................................70, 185, 189 

K. Nakiri ....................................................................... 271 

M. Nallar ...................................................................... 225 

S. Nanfara .................................................................... 218 

A. Nanhay .................................................................... 172 

A. D. Nanney ................................................................ 212 

N. Napoli ...................................................................... 189 

R. Narang ..................................................................... 103 

A. Naranjo .................................................................... 174 

I. Narbute ..................................................................... 255 

J. Nardi ........................................................................ 190 

N. Nardi ........................................................................ 231 

A. B. Nargizyan ............................................................ 136 

B. Naronha ................................................................... 168 

J. Narula ....................................................................... 141 

O. Nasario-Junior ......................................................... 244 

P. Nasca ....................................................................... 271 

D. D. Nascimento ........................................................ 244 

F. F. Nascimento .................................................. 227, 256 

C. A. S. Nascimento ...................................... 252-253, 266 

B. C. G. Nascimento ............................................ 172, 180 

J. H. M. Nascimento ............................................ 245, 263 

A. L. R Nascimento ...................................................... 198 

C. Nascimento ............................................................. 102 

F. Nascimento ..............................................227, 256, 259 

T. R. Nasibullin ............................................................. 236 

J. Nasser ...................................................................... 254 

A. Natália ..................................................................... 250 

R. Nauwerk .................................................................. 237 

A. Nava ........................................................................ 271 

M. Navarrete ................................................................ 205 

V. Navarro .................................................................... 217 

C. Navas ...................................................................... 139 

V. Navega .................................................................... 263 

D. Navia ....................................................................... 142 

E. Navia ..................................106-107, 201, 208, 236, 238 

H. Nawawi ........................................................... 133, 201 

J. Nayee ......................................................................... 75 

C. Nazzal ...................................................................... 132 

I. Nedeljkovic ................................................ 110, 277-278 

M. Nedeljkovic .................................71, 110, 142, 277-278 

J. A. Neder ................................................................... 187 

S. Nedogoda ................................................................ 175 

C. E. Negrao ..................................................172, 180, 192 

C. E. Negrão ................................................................. 138 

C. Negrier ..............................................255-256, 260, 263 

J. Negroni .................................................................... 266 

M. J. Nel ...................................................................... 203 

K. Nelson ....................................................................... 78 

R. Neme ................................................................ 69, 132 

A. Neno ........................................................................ 215 

R. Nery ......................................................................... 243 

I. Nesralla .........................................77, 231, 233, 236-237 

A. Neto ................................................................ 231, 254 

R. Neto-Ferreira ........................................................... 198 

W. Neuhuber ............................................................... 176 

A. Neujahr .................................................................... 175 

J. Neumann ................................................................. 166 

J. Neuwirth ...................................................141, 223, 234 

F. Neves ................................................................ 76, 108 

P. Neves .............................................................. 183, 273 

J. L. Neyeloff ............................................................... 106 

D. Nezic ....................................................................... 167 

Q. N. Ngoc ................................................................... 275 

H. Ngow ...................................................................... 184 

H. L. Nguyen ........................................................ 143, 275 

Q. N. Nguyen ............................................................... 143 

V. L. Nguyen ........................................................ 143, 275 

H. M. Nguyen .............................................................. 275 

Z. Ni ............................................................................. 141 

index / 309

Authors 

P. Nicod ......................................................................... 75 

G. Nicolaidis ................................................................. 233 

C. Nicoletti ................................................................... 134 

L. Nicoloso ................................................................... 109 

V. Nieto ........................................................................ 183 

A. Nigam ...................................................................... 197 

S. Niki .................................................................. 188, 197 

N. Nikolaou .................................................................. 181 

L. Nikolic ...................................................................... 166 

A. Nikolic .............................................................. 187, 202 

D. Nikolic ..................................................................... 187 

A. Nikolopoulou ........................................................... 217 

D. T. W. Nilsen ..................................................... 178, 199 

S. T. Nilsen ...............................................75, 206-207, 209 

Y. Nisanci ............................................................. 106, 191 

S. Nishikawa ................................................................ 235 

M. Nishizaki ......................................................... 188, 197 

W. Nishizawa ............................................................... 277 

L. Njord ........................................................................ 255 

R. Njord ........................................................................ 255 

F. Nobre ....................................................................... 254 

A. Nobrega ...............................76, 108, 137-138, 258, 278 

I. Nocetti ...................................................................... 204 

R. Noe ............................................................................ 71 

M. Nofal ....................................................................... 189 

G. Nogiene ................................................................... 184 

F. Nogueira .................................................................. 220 

C. R. Nogueira .............................................................. 260 

P. Nogueira ............................................................ 79, 267 

M. Nogues ................................................................... 244 

C. Nojec ....................................................................... 141 

M. B. Nolly ................................................................... 140 

C. H. Nomura ............................................................... 224 

S. Noorfaizan ............................................................... 184 

M. Nordaby .................................................................. 181 

J. E. Nordrehaug .....133, 142-143, 243, 247-249, 251, 272 

T. Norgaz ..................................................................... 186 

L. Noronha ................................................................... 176 

G. R. Norton ................................................................. 230 

A. Novakovic ................................................................ 167 

L. P. Novaretto ............................................................. 189 

F. Novo ...........................................................72, 200, 226 

G. Novo ........................................................................ 106 

S. Novo ........................................................................ 106 

L. Novotny ................................................................... 200 

M. Nowak .................................................................... 232 

J. U. Nowak ................................................................. 238 

E. Nowicki .................................................................... 232 

N. Nranyan ................................................................... 136 

L. Ntyintyane ............................................................... 107 

R. B. Nunes .................................................................... 74 

M. C. P. Nunes............................................................... 74 

B. Nuñez ...................................................................... 226 

B. Nuta ......................................................................... 103 

O. Nygard ............................................................ 249, 251 

O. Nygård .....................................................133, 142, 247 

D. Nyhan ........................................................................ 77 

V. Nzuzi ........................................................................ 220 

V. Obradovic ................................................................ 171 

R. Obregon ...................................................134, 170, 212 

S. Obregon .......................................................... 106, 138 

M. Ocaranza ...................................................77, 137, 224 

J. Ochoa ...................................................................... 141 

R. Ochotny ................................................................... 251 

M. Odaira ..................................................................... 167 

G. O’Driscoll ................................................................ 108 

H. Ogawa ..................................................................... 164 

H. Oh ........................................................................... 192 

B. Oh ................................................................ 75-77, 144 

N. Okasha .................................................................... 274 

M. Okigaki ................................................................... 235 

K. Okoshi ............................................................. 258, 260 

M. P. Okoshi ........................................................ 258, 260 

J. Olagüe ............................................................. 213, 239 

T. Olcer ........................................................................ 110 

F. O. Olejnik ................................................................. 217 

J. Olin .......................................................................... 111 

I. Olina ......................................................................... 255 

S. Olival ..................................................252, 259-260, 262 

A. Olive ........................................................................ 178 

S. A. Oliveira Júnior...................................................... 258 

A. M. R. R. Oliveira ...................................................... 267 

A. Oliveira .......................79, 193, 224, 233, 238, 258, 260 

F. M. F. Oliveira............................................................ 240 

I. S. Oliveira .................................................................. 275 

L. Z. P. Oliveira .............................................. 243-247, 265 

P. P. M. Oliveira ................................................... 133, 166 

V. Oliveira .............................................102, 193, 236, 243 

G. Oliveira .....................................................106, 215, 262 

T. V. Oliveira ................................................................. 243 

C. P. Oliveira ................................................................ 198 

N. Oliveira .................................................................... 213 

F. Oliveira ......................................................132, 191, 240 

S. A. Oliveira .........................................193, 238, 258, 260 

P. S. Oliveira ........................................................ 262, 275 

E. Oliveira .................................................................... 240 

M. Oliveira ..... 111, 133, 166, 186, 218, 227, 267-269, 276 

C. Oliveira .................................................................... 236 

J. L. M. Oliveira ............................................................ 111 

S. Oliveira .....................................................176, 262, 275 

F. T. Oliveira ................................................................. 250 

I. Oliveira ...................................................................... 253 

S. A. Oliveira Jr. ........................................................... 260 

W. Oliveira Jr. .............................................................. 141 

W. A. Oliveira ......................................................... 79, 224 

S. A. Oliveira .........................................193, 238, 258, 260 

V. F. Oliveira ................................................................. 132 

C. L. Oliveira ................................................................ 234 

A. L. V. Oliveira .................................................... 193, 236 

F. M. Oliveira ............................................................... 227 

P. S. Oliveira ........................................................ 262, 275 

G. D. Olivera ................................................................ 271 

P. Olivier ...................................................................... 110 

G. Oller ........................................................................ 201 

J. Ollitrault ..................................................................... 80 

J. C. Olmos ............................................................ 69, 265 

H. Olschewski ............................................................. 225 

K. A. Olson ........................................................... 138, 212 

J. Olszewski ................................................................ 273 

M. Olszowska .......................................170, 173, 185, 193 

M. Olteanu ................................................................... 106 

A. Omer ....................................................................... 270 

A. Oncul ............................................................... 106, 191 

T. K. Ong ...................................................................... 201 

Z. Ongen ...................................................................... 187 

G. A. Ontiveros .................................................... 100, 279 

R. Onut ........................................................................ 200 

T. Ooie ......................................................................... 170 

J. A. W. Opezzo ........................................................... 273 

G. Opolski .................................................................... 273 

J. Oporto ...................................................................... 109 

K. Orban ....................................................................... 134 

G. Ordoñez .................................................................. 144 

S. Ordu ................................................................. 198-199 

M. Orellana .................................................................. 206 

V. Orellana ................................................................... 254 

L. Orellana ................................................................... 182 

R. Oren ........................................................................ 163 

D. Orlandi ............................................................. 263, 268 

D. Orlic ................................................................... 71, 142 

D. Ortega ............................................................. 102, 189 

D. F. Ortega ................................................................... 78 

F. Ortega ........................................................................ 78 

Y. R. Ortega ................................................................. 164 

R. Ortego ..................................................................... 218 

J. Ortellado .................................................................. 237 

C. Ortiz ......................................................................... 168 

L. Ose ............................................................................ 75 

J. Oses ........................................................................ 278 

A. Osório ...................................................................... 179 

D. Ostera ..................................................................... 240 

J. Ostermeyer .............................................................. 103 

M. Ostojic .......... 71, 74, 105, 110, 142, 171, 182, 277-278 

R. K. Osugue ................................................................ 253 

M. Oteh ....................................................................... 184 

F. Otero ....................................................................... 227 

J. Otero ........................................................................ 207 

D. Ott ........................................................................... 231 

G. Ottaviano ................................................................. 106 

K. Otter ........................................................................ 187 

R. S. Ovchinnikov ......................................................... 255 

C. Oviedo ..................................................................... 240 

D. Oz ............................................................................ 186 

B. Oz ............................................................................ 163 

E. Ozal ......................................................................... 163 

E. Ozcinar .................................................................... 111 

A. O. Ozdemir .............................................................. 192 

O. Ozdemir .......................................................... 192, 233 

M. Ozdemir .................................................................. 279 

O. Ozer ................................................................ 171, 211 

F. Ozerkan ................................................................... 188 

H. Ozhan ...................................................................... 198 

H. Özhan ...................................................................... 199 

J. Ozores ..................................................................... 177

Authors 

U. Ozyurda ................................................................... 111 

G. Pacheco ............................................................ 78, 102 

N. Pacheco .......................................................... 216, 270 

A. Pacheco ................................................................... 215 

O. Pachinger ................................................................ 173 

L. Padilla ........................................132, 225, 242, 244-245 

C. R. Padovani .............................................................. 258 

A. F. Padoveze ............................................................. 243 

T. Paes ................................................................. 263, 268 

J. Paes Jr. ............................................................. 264-266 

Z. Pagava ..................................................................... 230 

N. Paglia ....................................................................... 138 

P. Paglini ...................................................................... 222 

P. Paglini-Oliva ............................................................. 276 

J. Paiva ........................................................................ 134 

W. Paiva ............................................................... 262, 265 

L. Pál ............................................................................ 220 

C. Paladino ................................................................... 189 

C. Palaniswamy ........................................................... 103 

A. Palazzo .................................................................... 219 

P. Palazzolo .................................................................. 106 

M. Palinsky .................................................................. 257 

J. Palleiro ..................................................................... 228 

J. A. Palma ................................................................... 205 

M. Palmeira ................................................................. 195 

T. Palomero ................................................................. 104 

S. A. P. Palomino ......................................................... 249 

G. Paluzie ..................................................................... 188 

G. Paluzuie ................................................................... 188 

A. Panaro ............................................................. 111, 201 

O. Panes ...................................................................... 109 

G. Panic ....................................................................... 190 

C. F. Paniga .................................................................. 212 

T. F. Panigas ....212-214, 221-223, 227, 261, 265-266, 269 

C. F. Panigas ...........212-214, 222-223, 227, 261, 266, 269 

J. Panini ....................................................................... 181 

A. A. V. Paola ............................................................... 249 

F. Paoletti ..................................................................... 185 

J. F. Paolini ..................................................................... 75 

A. Papadopoulos .......................................................... 222 

E. Papadopoulou .......................................................... 182 

T. Papafanis ................................................................. 181 

N. Papageorgiou .......................................................... 216 

A. Papantoniou ............................................................ 220 

A. Paragano ................................................................. 204 

A. C. Parameswaran ............................................ 166, 172 

V. Paravati .................................................................... 240 

E. Pardes ..................................................................... 189 

E. Pardo ....................................................................... 274 

O. Paredes ......................................69, 258, 260, 265, 271 

J. Paredes .................................................................... 256 

M. Paredes .............................................................. 73, 75 

D. Pareira ..................................................................... 267 

K. Parikh ....................................................................... 132 

C. Parisi .......................................................................... 70 

C. E. Parisi .................................................................... 136 

J. L. Parmisano ............................................................ 248 

J. C. Parodi ............................................................ 253-254 

E. Parra ........................................................................ 190 

R. Parra ........................................................................ 207 

J. Parras ........................................134, 170, 212, 215, 260 

C. Parsai ....................................................................... 254 

W. Partata .................................................................... 236 

O. Parysow .................................................................. 261 

A. Pasca ....................................................................... 227 

A. Pascua ..................................................................... 227 

C. Pasinato ....................................................248, 257, 259 

M. Pasowicz .................................................101, 173, 193 

M. Pasquale ................................................................. 178 

O. Passarelli Jr. ...................................................... 80, 208 

M. Passauer ................................................................. 195 

R. B. D. Passos ............................................................ 224 

T. Patel ......................................................................... 132 

M. Patricio ................................................................... 144 

L. Patrucco ................................................................... 229 

A. L. Patsilinakos .......................................................... 185 

S. Patsilinakos .............................................................. 177 

C. Patterson ......................................................... 138, 225 

J. Paul .......................................................................... 211 

J. Paulini ......................................................74, 76-77, 137 

B. Pausa ....................................................................... 232 

E. Pautasso .......................................................... 181, 274 

R. Pavanello ................................................................. 256 

L. J. Pavelic .................................................................. 220 

G. Pavlides ................................................................... 177 

M. Pavlovic .................................................................. 170 

K. Pavlovic ................................................................... 183 

S. Pavlovic ................................................................... 171 

N. Pavo ........................................................................ 100 

I. Pavo Jr. ..................................................................... 100 

R. Paya ......................................................................... 231 

W. R. Payne ................................................................. 164 

S. Payzin ........................................................................ 77 

N. Paz .......................................................................... 189 

A. F. S. Paz ................................................................... 265 

K. Peczalski .................................................................. 252 

E. R. Pedersen ..............................................247, 249, 251 

K. E. Pedersen ............................................................. 110 

L. Pedersen ........................................................... 79, 110 

E. R. Pedersen ..............................................247, 249, 251 

S. F. Pedra ..................................................................... 76 

S. Pedrosa ................................................................... 137 

R. C. Pedrosa ............................................................... 140 

N. Peer ......................................................................... 196 

K. Peersen ........................................................... 103, 223 

J. Pei .............................................................................. 73 

F. Peidro ...................................................................... 208 

J. Peirano ..................................................................... 207 

L. Peixoto ....................................................................... 72 

R. Peixoto .................................................................... 143 

W. Peixoto ................................................................... 267 

C. Peixoto .................................................................... 184 

N. Pejcic ....................................................................... 105 

E. Pektok ..................................................................... 142 

L. Pellanda ....................................................231, 272, 275 

F. Pellegrini .................................................................. 103 

C. Pellegrini .................................................................. 100 

G. M. M. Pellegrino .........................................78, 102, 189 

M. P. Pellini .......................................................... 110, 210 

M. Pelliza ..................................................................... 204 

R. Peloso ..............................................134, 170, 212, 260 

G. Peltz ........................................................................ 225 

H. P. M. Pena ............................................................... 228 

M. Peña ....................................................................... 272 

M. A. Peña-Duque ....................................................... 205 

E. Peñaloza .................................................................. 140 

G. Peñaloza .................................................................. 111 

F. Penhalves ................................................................ 186 

C. Pensa .............................................................. 192, 210 

M. Peradejordi ..................................................... 259, 267 

M. Perazzoli ................................................................. 137 

I. Perdomo ................................................................... 168 

M. Perea ...................................................................... 267 

F. Pereda ..................................................................... 190 

L. Pereira ............................................................. 226, 229 

R. Pereira ......................................................213, 222, 244 

S. B. Pereira ................................................................. 253 

A. M. R. Pereira.................................................... 213, 222 

J. R. M. Pereira ..................................................... 252-253 

J. B. Pereira ................................................................. 110 

T. Pereira ..................................................................... 204 

A. C. Pereira ......................................................... 193, 236 

G. Pereiro ..................................................................... 227 

V. Pereyra .................................................................... 254 

H. Pereyra .................................................................... 201 

E. Perez ....................................................................... 244 

R. Perez ................................178, 195, 204, 215, 228, 241 

H. Perez ....................................................................... 267 

A. Perez ............................................................73, 75, 179 

N. Perez ........................................133, 139, 188, 240, 266 

J. Perez ........................................................................ 231 

M. Perez .............................................................. 178, 219 

R. Pérez ....................................................................... 191 

A. Perez-Bueno .................................................... 218, 257 

R. Perez-Etchepare ...................................................... 264 

N. Pérez-Hernández ..................................................... 204 

M. Peric ....................................................................... 167 

M. Perin ....................................................................... 102 

C. A. Perings ........................................................ 103, 194 

M. Peris ....................................................................... 225 

Z. Perisic ...................................................................... 170 

E. Perna ..........................................70, 105, 215, 271, 273 

D. Peroni ...................................................................... 176 

A. Perrone .................................................................... 229 

B. Pertiné ....................................................................... 80 

J. Z. Peruga .................................................................. 222 

J. Perunicic .................................................................. 187 

A. Pesantes ................................................................. 267 

C. Pesce ........................................................................ 77 

G. Pessah ............................................................ 241, 260 

L. Pessoa ............................................................. 260, 263 

A. B. Pestova ....................................................... 174, 192 

M. Peterson ................................................................. 187 

M. Petit .................................................................. 79, 201 

index / 311

Authors 

R. Petkowics ................................................................ 275 

Ö. Petnehazy ............................................................... 100 

M. R. Petracek ............................................................... 73 

Z. Petrasi ...................................................................... 100 

Z. Petrasinovic ..................................................... 171, 277 

J. Petriz .........................................................229, 250, 272 

F. Petrolito ................................................................... 259 

D. Petrov ...................................................................... 194 

V. Petrov ...................................................................... 175 

D. Petrovai ................................................................... 245 

M. Petrovic .......................................................... 190, 278 

D. Petrovic ............................................................ 187-188 

O. Petrovic ................................................................... 278 

J. Petrovicova .............................................................. 257 

D. Petroviè ................................................................... 136 

O. Petrucci ........................................................... 133, 166 

Z. Petrulioniene .................................................... 184, 237 

R. Pettersen ......................................................... 143, 272 

E. Pettersen ................................................................. 103 

G. Pettersson ............................................................... 232 

M. Petti ................................................................ 170, 201 

B. Pezo-Nikolic ..................................................... 104, 245 

S. Pezzotto ................................................................... 263 

A. Pfeferman ............................................................... 102 

L. Pfister ...................................................................... 100 

H. M. Pham .......................................................... 143, 275 

O. N. Pham .................................................................. 143 

K. G. Pham ........................................................... 143, 275 

E. Picabea ............................................................ 134, 225 

F. Piccinini .................................................................... 142 

A. Piccoli Jr. ................................................................. 109 

V. Piccone .................................................................... 220 

R. Picon ....................................................................... 106 

V. Picone ...................................................................... 279 

L. S. Piegas ............................................................ 80, 208 

P. Pieniazek ......................................78, 80, 141, 230, 233 

P. Pieroni ..................................................................... 274 

M. Pietrani ....................................................234, 264, 271 

R. Pietrobon ................................................................. 250 

T. Pietrucha .................................................................. 210 

M. Pilan .......................................................................... 73 

M. Pilato ...................................................................... 184 

S. Pilato ........................................................................ 184 

K. Pilichou .................................................................... 134 

C. Pimenta ................................................................... 248 

J. Pineda ...................................................................... 217 

D. Pineiro ..................................................................... 267 

A. Pinheiro ................................................................... 234 

V. Pinheiro ............................................................ 247-248 

E. Pinheiro ................................................................... 247 

J. Pinheiro Jr. ................................................................. 79 

O. A. Pinilla .....................................................77, 140, 198 

B. Pinto ........................................................................ 132 

I. Pinto ................................................................. 198, 240 

J. Pinto ................................................................. 179, 226 

A. Pinzon .............................................................. 205, 249 

D. Piotrowska-Kownacka ............................................. 174 

W. Piotrowski .............................................................. 175 

S. Pipitone ................................................................... 106 

J. L. C. Pippi ..................................212, 214, 223, 261, 269 

M. Piraino .................................................................... 100 

P. V. Pires .................................................................... 253 

J. Pirkola ........................................................................ 75 

O. Pisano ...................................................... 189-190, 215 

D. Pisano ....................................................................... 79 

A. Pisarevsky ............................................................... 106 

R. Pissinis .................................................................... 268 

J. Pitanga ..................................................................... 108 

F. J. M. Pitella .............................................................. 266 

B. Pitt ........................................................................... 108 

F. J. M. Pittela .............................................................. 142 

R. B. Piveta .................................................................. 233 

O. Pizzi ......................................................................... 250 

M. Plášková ................................................................. 173 

M. L. Plastino ............................................................... 210 

J. Plate ........................................................................... 69 

L. Platica ...................................................................... 200 

O. Platonova ................................................................ 238 

G. Plehn ................................................103, 194, 223, 245 

A. Pleskovic .......................................................... 187-188 

A. Pleskoviè ................................................................. 136 

M. Plewka .................................................................... 222 

J. Poch ........................................................................... 79 

A. Pocoví .............................................................. 225, 238 

Y. A. Pocrovskiy ........................................................... 105 

D. A. Poddubnyy .................................................. 103, 224 

C. Podoleanu ............................................................... 134 

D. Podoleanu ............................................................... 134 

P. Podolec .............................................170, 173, 185, 193 

E. Podolskaya .............................................................. 175 

G. Podosyan ................................................................ 181 

J. Poeys ....................................................................... 110 

P. Pogonza ................................................................... 176 

Y. A. Pokrovskiy ............................................................. 74 

E. Polanco .................................................................... 201 

N. Polat ........................................................................ 106 

C. Poliserpi ................................................................... 217 

J. Politei ....................................................................... 231 

D. Polk ......................................................................... 141 

J. Pollan ....................................................................... 137 

P. Pollono .......................182, 234-235, 248, 254, 264, 271 

L. Polonski ................................................................... 238 

P. Pomerantzeff ........................................................... 278 

L. Ponce ....................................................................... 214 

K. Ponciano .................................................................. 255 

V. Pönitz .................................................166, 178, 206-207 

P. Pons ................................................................ 205, 222 

C. I. Ponte .................................................................... 226 

D. Pop ........................................................... 242, 245-246 

S. Popovic .................................................................... 105 

K. Poppe ...................................................................... 136 

R. P. Porcile ................................................................. 239 

L. Portela ..................................................................... 233 

L. Portella ..................................................................... 233 

D. Portillo .............................................................. 184-185 

M. Portis .............................................................. 183, 215 

V. Porto ...........................................................77, 233, 236 

A. Posa ........................................................................ 100 

J. Postley ........................................................73, 137, 179 

M. Potenzoni ............................................................... 239 

S. Potic ........................................................................ 105 

R. Potluri ...................................................................... 256 

L. Potocnakova ............................................................ 137 

A. Potosyan ................................................................. 181 

J. Pouso ....................................................................... 199 

A. Pouta ......................................................................... 75 

C. Poy .......................................................................... 105 

R. Pozzan ............................................................. 201, 250 

P. Pozzer .......................................................215, 219, 273 

P. L. Pozzer .................................................................. 271 

F. S. Pozzi .................................................................... 199 

N. G. Prado .......................................................... 220, 229 

N. Prasad .............................................................. 250-251 

P. Prates .............................................................. 231, 233 

S. Prates ...................................................................... 175 

P. Pratesi ....................................................................... 79 

D. Précoma .....................................................77, 135, 208 

I. Préda ........................................................................ 164 

J. Pregowski ................................................................ 241 

A. Prejbisz .................................................................... 101 

M. F. Prescott .............................................................. 238 

H. A. Prezioso .....79-80, 142, 176, 178, 219-223, 229, 250 

J. C. Prieto ................................................................... 132 

N. Prieto ....................................................................... 273 

C. Prim ................................................................... 77, 176 

C. R. Prim ....................................................................... 77 

L. Principe .................................................................... 174 

D. Prior ......................................................................... 136 

J. O. Prior ..................................................................... 133 

Y. Prior ................................................................. 107, 271 

D. Pritchard .................................................................. 178 

G. F. Procopio .............................................................. 100 

G. Procopio ............................................................ 73, 279 

Z. Prohaszka ................................................................ 203 

L. Protasio .................................................................... 138 

M. Protich .................................................................... 206 

V. Proto ........................................................................ 215 

L. A. Providencia ........................78-79, 100-101, 132, 250, 

...............................................254-256, 258, 260, 263, 269 

L. Providência ........................................................ 70, 252 

P. Pruszczyk ................................................................. 251 

T. Przewlocki .............. 76, 78, 80, 101, 141, 170, 230, 233 

A. Przybylski ............................................................ 76, 80 

B. Przybysz .................................................................. 273 

B. Psaty ....................................................................... 137 

M. Puchta .................................................................... 251 

D. Puente ..................................................................... 267 

S. E. Puga .................................................................... 220 

P. Pujol ..........................................................132, 236, 238 

C. G. Puk .............................................................. 109, 191 

C. Pulz .......................................................................... 248 

Y. Purmah .................................................................... 256 

K. Putarek .................................................................... 231 

A. M. Puyó ................................................................... 274

Authors 

M. Pyda ....................................................................... 225 

O. Querencio ....................................................... 215, 260 

M. S. Queroz ................................................................ 213 

S. Quevedo ........................................................... 238-239 

J. Quiles ....................................................................... 165 

M. Quintão ........................................................... 219, 270 

M. P. Quintão ....................................................... 234, 236 

D. Quintero .................................................................. 249 

F. Quintiero .................................................................. 264 

C. Quiroga .................................................................... 102 

L. Quiroga .....................................................111, 221, 255 

P. Quiroga ............................................................ 107, 209 

J. Quiroga .................................................................... 269 

C. Quiroz ...................................................................... 111 

M. Quon ........................................................... 75-77, 144 

M. Rabrenovic ............................................................. 193 

J. Racek ....................................................................... 253 

L. J. Radevic ................................................................ 170 

D. Radlovacky .............................................................. 220 

N. Radovanoviæ ........................................................... 136 

M. Radovanovic ..............................................74, 105, 169 

N. Radovanovic ................................74, 105, 169, 187-188 

S. Rafajlovski ............................................................... 193 

P. Raffaelle .................................................................. 206 

H. Raffaelli .......................73, 107, 205-206, 225, 230, 279 

A. Rafie ........................................................................ 111 

V. Raggio ............................................................. 273, 276 

M. Raguz ..................................................................... 231 

H. Ragy ........................................................................ 274 

P. Rahimi ..................................................................... 216 

R. Rahmonov ............................................................... 196 

A. Rai ................................................................... 142, 212 

H. Rai ........................................................................... 110 

H. Raich ....................................................................... 142 

F. Raineri ...................................................................... 186 

T. Rajarajan .................................................................. 231 

D. Rajic .................................................................. 74, 105 

N. Rajicic ...................................................................... 243 

S. Ramamurthy ............................................................ 103 

F. Ramello .................................................................... 173 

J. Ramires ............................................................ 111, 179 

M. Ramirez .......................................................... 181, 206 

H. Ramirez ................................................................... 259 

A. Ramirez ................................................................... 141 

V. Ramirez-Castro .........................................207, 218, 257 

J. C. Ramiro Novoa ...................................................... 177 

R. C. Ramon Corbalan .................................................. 102 

R. Ramon ..................................................................... 259 

R. Ramos ....................................................................... 79 

A. Rampazzo ................................................................ 134 

K. A. Ramsdale ............................................................ 179 

D. R. Ramsdale ............................................................ 179 

A. Ramzy ..................................................................... 274 

R. Raña ........................................................................ 206 

G. Ranchilio .................................................................. 208 

C. Rando ........................................................................ 71 

M. Rangel .................................................................... 270 

A. Rao .......................................................................... 179 

G. Rao .......................................................................... 168 

V. Raos ........................................................................ 231 

A. Rapaee ............................................................ 133, 201 

C. Rapallo ..................................................................... 133 

J. J. Raposo ................................................................. 249 

K. Raslova .................................................................... 257 

J. N. Rasmussen .................................................. 230, 232 

R. Rasmussen ...................................................... 260-261 

S. Rasmussen ...................................................... 230, 232 

S. Rassi ........................................................................ 208 

F. Rassi ................................................................ 246, 248 

A. Rastan ..................................................................... 182 

A. J. Rastan .................................................................. 173 

O. Rastelli ............................................................ 189, 215 

R. Ratto ........................................................................ 267 

J. Ravkilde ................................................................... 166 

E. Ravussin .................................................................. 166 

R. Ray .......................................................................... 140 

E. Raymenants ............................................................ 277 

A. P. Rebrov ......................................................... 103, 224 

C. Recuerda Casado .................................................... 234 

D. P. Redfearn ..................................................... 135, 163 

H. J. Redruello ......................................136, 142, 219, 250 

M. Redruello .........................................133, 139, 261, 266 

G. S. Reeder ................................................................ 262 

H. Refsum ............................................133, 142, 243, 248 

V. Regitz-Zagrosek ....................................................... 204 

A. Rego ........................................................................ 249 

A. Reichert ................................................................... 218 

R. P. Reidar Pettersen.................................................. 203 

A. Reina ..........................................................70, 224, 246 

A. Reina-Toral .............................................................. 248 

J. Reiner ...................................................................... 142 

S. Reinmets ................................................................. 187 

R. Reinoso ................................................................... 166 

A. Reis ................................................................. 100, 269 

H. Reis ......................................................................... 132 

M. M. Reis ........................................................... 249, 276 

L. S. R Reis .................................................................. 198 

D. Reisner .................................................................... 166 

A. Rekhviashvili .................................................... 164, 175 

I. Rendon ..................................................................... 216 

J. Rengel ...................................................................... 190 

N. F. Renna .......................................................... 205, 262 

E. S. Resende .............................................................. 244 

P. Resende .......................................................... 250, 272 

M. Resnik .................................................................... 178 

D. Reuland ................................................................... 212 

A. Reveron ................................................................... 226 

M. Rey ......................................................................... 274 

G. Rey .......................................................................... 189 

I. Reyes ........................................................................ 273 

P. A. Reyes .................................................................. 204 

J. Reynolds .................................................................. 169 

K. Rhee ........................................................................ 235 

A. R. Riarte ........................................................... 220, 229 

A. Ribeiro Langowiski .................................................. 218 

J. P. Ribeiro .....................................................74, 106, 138 

M. F. Ribeiro ................................................................ 236 

A. L. P. Ribeiro ....................................................... 74, 228 

A. Ribeiro ............................................................. 218, 229 

G. Ribeiro ......................................................253, 260, 263 

E. P. Ribeiro ................................................................. 190 

J. Ribeiro ...................................................................... 226 

L. Ribeiro ............................................................... 79, 267 

M. F. M. Ribeiro ........................................................... 201 

M. Ribeiro .................................................................... 201 

C. Ribeiro ..................................................................... 141 

A. Riberi ....................................................................... 241 

R. Ricardo ...................................................................... 77 

E. Ricardo ............................................................ 265, 267 

M. Riccitelli ............................................................ 70, 139 

C. M. Richter ....212-214, 221-223, 227, 261, 265-266, 269 

D. Ricon ....................................................................... 204 

F. Ridocci-Soriano ........................................................ 231 

I. Riecansky ................................................................. 137 

E. Riedemann .............................................................. 109 

A. R. P. Rieira ............................................................... 245 

A. Riera .......................................................................... 72 

M. A. Rieth ................................................................... 143 

I. Rifourcat ........................................................... 183, 214 

K. Rigatto ............................................................. 253, 269 

A. Righetti ...................................................................... 78 

P. Rigueiro Veloso ................................................ 186, 194 

S. Rim ........................................................... 110, 218-219 

S. J. Rim ........................................................................ 79 

R. E. Rios Mendez ................................................. 76, 165 

A. Ríos ......................................................................... 274 

A. V. Risnenko ............................................................... 74 

A. Riso ......................................................................... 263 

L. Ritt ........................................................................... 132 

J. Ritter ........................................................................ 166 

W. Rivarola ...................................................222, 273, 276 

H. W. Rivarola ...................................................... 273, 276 

M. Rivarola ................................................................... 209 

E. Rivas Stany .............................................................. 228 

C. Rivas ................................................................ 195, 255 

C. A. Rivas ........................................................... 220, 239 

A. Rivera ...................................................................... 188 

P. Rivera .........................................................77, 137, 224 

M. Rizzatti .................................................................... 226 

N. Rizzo ........................................................................ 200 

Y. Ro ............................................................................ 108 

T. Robak ....................................................................... 222 

S. Robert .............................................................. 200, 214 

C. Roberts .................................................................... 137 

F. Robles .......................................................205, 230, 278 

L. Robles ...................................................................... 271 

G. Robles ..................................................................... 194 

M. Robles .................................................................... 141 

B. Roca ........................................................................ 225 

J. Roca ......................................................................... 224 

G. Rocca ...................................................................... 175 

L. Rocha Lopes .................................................... 111, 181 

R. Rocha ...................................................................... 209 

N. Rocha .........................................76, 108, 198, 219, 278 

index / 313

Authors 

M. S. Rocha ........................................................... 72, 107 

A. S. C. Rocha ...................................................... 142, 266 

V. N. Rocha .................................................................. 198 

C. Rochitte ........................................................... 136, 141 

L. Rodas ..........................................................80, 242, 244 

R. Rodrigo .................................................................... 261 

L. F. Rodrigues Jr. ................................................ 259, 263 

L. F. Rodrigues Jr. ................................................ 259, 263 

B. Rodrigues ...........................................74, 136, 234, 249 

L. M. Rodrigues ........................................................... 266 

A. C. Rodrigues ............................................................ 238 

V. Rodrigues ........................................................ 110, 204 

M. Rodriguez Acuña ............................................ 205, 230 

G. Rodriguez Botta ....................................................... 257 

C. Rodriguez Correa ............................................... 73, 224 

L. Rodriguez Nande ..................................................... 202 

L. Rodriguez Nandez .................................................... 228 

A. Rodriguez Saavedra ................................................. 181 

L. Rodriguez ............................................69, 202, 207, 228 

C. Rodriguez ...........................................73, 224, 237, 248 

A. Rodriguez ........................................................ 132, 181 

M. Rodriguez ................................................205, 228, 230 

W. Rodriguez ....................................................... 192, 210 

J. Rodriguez ......................................................... 175, 270 

D. Rodríguez Ierace ..................................................... 169 

M. Rodríguez ............................................................... 133 

L. Rodríguez ................................................................. 191 

J. Rodriguez-Collado .....................................207, 218, 257 

C. Rodriguez-Correa ..................................................... 246 

M. Rodriguez-Elvira .............................................. 224, 246 

J. M. Rodríguez-Pérez ........................................... 204-205 

H. Rodríguez-Zanella .................................................... 133 

J. Roesch ..................................................................... 176 

D. Roganovic ............................................................... 182 

A. Roggerio .................................................................. 278 

O. Rogowski ................................................................ 163 

L. E. Rohde .................................................................. 233 

C. Rojas Matas ....................................................... 78, 227 

J. Rojas ................................................................. 228-229 

E. Rojas ......................................................... 247-248, 263 

E. Roldos Cuza ............................................................. 228 

R. B. Rolf Berge ........................................................... 203 

C. Rollan ...................................................................... 195 

M. Rollin-Ornelas ......................................................... 273 

A. L. Rollins .................................................................. 212 

R. Romaguera .............................................................. 231 

C. Roman ................................................................. 73, 75 

M. I. Roman ................................................................... 76 

J. Román García ........................................................... 174 

A. Romano ................................................................... 220 

E. Romano ................................................................... 257 

M. Romano ........................................................... 228-229 

E. R. Romano ................................................................. 76 

L. Romano ................................................................... 141 

M. Romanowska ......................................................... 175 

L. Romeo ....................................................................... 70 

M. Romero ...........................................103, 134, 170, 212 

I. Romero ..................................................................... 185 

R. Romero ............................................................. 78, 179 

T. Romero ................................................................ 73, 75 

M. C. Romero .............................................................. 221 

M. U. Rondon .............................................................. 172 

J. Roosen ..................................................................... 277 

M. Rosa ....................................................................... 191 

K. Rosa .................................................................. 74, 239 

K. T. Rosa ..................................................................... 249 

D. Rosa ........................................................................ 133 

F. Rosa ......................................................................... 108 

L. Rosa ......................................................................... 234 

G. Rosadiez .................................................................... 77 

A. Rosales .................................................................... 215 

A. Rosas Cabral ............................................................ 268 

B. T. Roseguini ............................................................... 74 

R. Rosental .................................................................. 214 

P. Rosique ................................................................... 183 

A. Roslawiecka ...................................................... 76, 141 

E. Rosner ..................................................................... 186 

H. Ross .......................................................................... 74 

H. J. Ross .................................................................... 104 

J. Ross ......................................................................... 104 

M. Rossi .......................................................134, 225, 246 

A. Rossi ............................................................... 136, 247 

G. Rossi ....................................................................... 264 

F. M. B. Rossi ............................................... 243-247, 265 

S. Rossi ........................................................................ 236 

R. Rossi ......................................................................... 78 

E. A. Rossi ................................................................... 247 

N. Rossi ......................................................................... 76 

P. Rossi ........................................................................ 189 

L. Rosso ......................................................................... 77 

F. Rotemberg ............................................................... 168 

S. Rotevatn .................................................................. 143 

A. Rouge ................................................252, 259-260, 262 

P. Roura ..................................................73, 206, 246, 279 

B. G. Rovai ................................................................... 228 

S. K Roy ....................................................................... 232 

G. Roytberg ................................................................. 238 

J. Rozanski ........................................................... 109, 171 

P. Rozentryt ................................................................. 238 

A. Rozga ...................................................................... 170 

A. Rózga ...................................................................... 171 

A. Rubinich .................................................................. 277 

P. Rubis ....................................................................... 101 

Y. Rückert .................................................................... 182 

H. Ruda Vega ............................................................... 109 

M. Ruffa ....................................................................... 178 

G. Ruibal ...................................................................... 189 

E. Ruiz De Temiño De Andres...................................... 234 

G. Ruiz Deza ................................................................ 139 

E. Ruiz Lascano ............................................................ 270 

M. Ruiz Moraga ........................................................... 174 

M. L. Ruiz Morosini ...................................................... 184 

E. Ruiz .................................................................. 234, 270 

G. A. Ruiz ..................................................................... 244 

L. P. Ruiz ...................................................................... 213 

M. Ruiz ................................................................ 174, 184 

A. Ruiz ................................................................. 213, 244 

J. M. Ruiz-Nodar .......................................................... 217 

M. J. Ruiz-Olgado .........................................207, 218, 257 

A. Ruokonen .................................................................. 75 

C. Rus Mansilla ............................................................ 234 

E. Rusak ....................................................................... 200 

P. Ruschel ..................................................... 233, 236-237 

P. Ruschell ..................................................................... 77 

U. Rushentsova ........................................................... 132 

V. Ruskin ...................................................................... 234 

E. Ruslender ......................................................... 253-254 

R. Russo .............................................................. 144, 225 

M. Russo ..................................................................... 178 

C. M. Rutherford .......................................................... 139 

O. Ruyer ...................................................................... 194 

W. Ruzyllo .......................101-102, 136, 174-175, 237, 241 

A. Rybicka-Musialik ...................................................... 230 

L. Ryliskyte .................................................................. 184 

A. Rynkiewicz .............................................................. 249 

E. Rzewuska ................................................................ 251 

D. Rzeznik .......................................................76, 141, 230 

A. Sa ............................................................................ 201 

A. K. Sá ........................................................................ 201 

G. Saatashvili ............................................................... 230 

L. Saavedra .................................................................. 107 

N. Saavedra ................................................................. 215 

A. Sabanov ................................................................... 175 

J. Sabik ........................................................................ 232 

M. C. Saccheri ..................................79-80, 136, 142, 176, 

.......................................................178, 219-223, 229, 250 

L. Saclietti .................................................................... 259 

B. Sáenz ....................................................................... 207 

D. Y. Sahin ................................................................... 105 

M. Sahin ...................................................................... 163 

A. Sahinarslan ................................172, 185, 219, 231-232 

S. Sahýn ....................................................................... 195 

T. Saikawa ................................................................... 170 

V. Saini ......................................................................... 138 

B. Saiz .......................................................................... 183 

S. Sakalli ...................................................................... 186 

I. Sakic ......................................................................... 223 

K. Saku ......................................................................... 181 

J. P. Sala ...................................................................... 190 

A. Salacata ................................................................... 177 

H. Salazar ....................................................................... 69 

L. A. Salazar ..................................................163, 215, 227 

A. Salazar ..............................................163, 215, 227, 268 

C. Salazar ..................................................................... 169 

C. Saldarriaga ............................................................... 139 

C. Saldivar .................................................................... 256 

M. Salem ............................................................. 143, 272 

A. Sales .......................................................................... 76 

J. Salgado-Fernández ................................................... 198 

M. Salguero ......................................................... 195, 269 

J. Saligova .................................................................... 137 

J. Salinas ...................................................................... 215 

S. Salinger .................................................................... 170 

F. V. Salis ..................................................................... 213

Authors 

F. Saliva ......................................................................... 74 

A. Salles ....................................................................... 207 

J. B. Salles ................................................................... 202 

W. Salmhofer ............................................................... 225 

F. Salmo ................................................................. 73, 246 

R. Salomao .................................................................. 220 

C. Salomón .................................................................. 214 

P. R. Salvador ............................................................... 244 

F. Salvaggio ......................................................... 181, 193 

F. Salvagio ............................................111, 170, 189, 196 

C. Salvatori ............................................................. 73, 246 

P. Salvo ........................................................................ 257 

S. Salzberg ..................................................................... 70 

G. Samaja .................................................................... 181 

R. Samaniego .............................................................. 210 

J. Samardzic ................................................................ 193 

N. V. Sambiase .................................................... 276, 278 

S. Samimi-Fard .............................................167, 169, 213 

S. Samir ....................................................................... 101 

M. Sammartino ............................................................ 241 

P. P. Sampaio ........................................136, 211, 215, 220 

R. O. Sampaio .......................................132, 237, 247, 275 

D. L. Sampaio .............................................................. 256 

C. Sampaio .................................................................. 227 

R. M. F. Sampedro ....................................................... 214 

F. Sampedro ................................................................ 214 

E. A. Sampó ................................................................. 215 

H. Sanabria .......................................................... 142, 179 

J. Sanagua ........................................................... 218, 261 

P. Sanches ..................................................................... 72 

L. B. Sanches ............................................................... 265 

I. Sanches .................................................................... 255 

F. Sanchez ........................................................... 181, 193 

O. Sanchez .................................................................. 218 

R. Sanchez ....................................................183, 215, 259 

V. Sanchez ................................................................... 211 

L. Sanchez ................................................................... 183 

S. Sanchez ................................................................... 190 

A. Sanchez ....................................................190, 205, 213 

L. A. Sanchez ............................................................... 205 

M. A. Sánchez Chaparro .............................................. 174 

A. Sanchez-Grande ...................................................... 167 

M. J. Sancho-Tello ............................................... 213, 239 

A. Sancineti .................................................................. 103 

M. Sancineti ................................................................. 103 

S. Sandoval-Navarrete .................................. 265-266, 268 

M. Sani ........................................................................ 178 

C. A. Sanibal ................................................................. 263 

M. Sanjurjo ........................................................... 270-271 

R. Sankaranarayanan ........................................... 103, 105 

R. Sansalone ................................................................ 242 

M. Santa ...................................................................... 208 

R. Santa ....................................................................... 179 

W. Santander ..................................69, 258, 260, 265, 271 

P. Santander .................................................................. 69 

J. Sant’Anna ........................................................ 231, 233 

R. Sant’Anna ................................................................ 231 

G. Santiago .............................192, 195, 241-242, 260-261 

G. A. Santiago .................................263-264, 266, 269-270 

A. C. Santomauro .......................................... 243-247, 265 

A. T. Santomauro ......................................................... 243 

A. C. Santomauro Jr. ............................................. 243-247 

B. S. Santoro ................................................. 243-245, 247 

D. Santoro ..................................................... 139-140, 253 

D. Santos ......................................................238, 242, 249 

E. Santos ..................................................................... 132 

I. Santos ............................................................... 132, 253 

M. Santos .....................................142, 201, 205, 230, 262 

B. Santos .......................................175, 252, 259-260, 262 

T. Santos ...................................................................... 275 

F. Santos .......................................................110, 175, 204 

M. H. H. Santos ................................................... 243, 249 

J. Santos ...................................................................... 278 

A. A. Santos ................................................................. 226 

I. Santos-Rodriguez .......................................207, 218, 257 

O. Sanz ................................................................ 213, 239 

S. Sapari ....................................................................... 184 

G. Saposnik .....................................................78, 111, 267 

D. J. Saranovic ............................................................. 171 

S. Saravia .............................................................. 246-248 

M. Sardar ..................................................................... 270 

A. Sardella .............................................................. 76, 252 

P. Sareli ........................................................................ 230 

I. Sari .................................................................... 171, 211 

S. Sarikaya ................................................................... 205 

R. Sarjanovich ................................................................ 74 

B. Sarkar ...................................................................... 232 

R. A. Sarmiento .........................................70, 80, 221, 229 

R. Sarmiento ...................................................69, 102, 132 

D. Sarmiento ................................................................ 216 

M. Sarmiento ............................................................... 228 

Z. S. Sarszegi ............................................................... 197 

C. Sarteschi ..................................................227, 240, 247 

A. Sartori .............................................................. 135, 208 

C. Sartori ................................................................ 75, 103 

M. Sartori ..................................................................... 254 

J. Sasaki ....................................................................... 195 

C. Satizabal .................................................................. 216 

L. Satlin ........................................................................ 173 

R. Savanti ..................................................................... 227 

N. A. Savelov ................................................................. 74 

O. Savenko ...................................................141, 249, 252 

M. Sawasany ............................................................... 274 

S. Saygi ........................................................................ 276 

B. Saygi .......................................................................... 77 

T. Sayin ........................................................................ 192 

L. V. Sazukina ............................................................... 255 

A. Scafa-Udriste ........................................................... 200 

J. Scaglia .........................................78, 110, 143, 188, 193 

J. Scaglione ................................................................. 210 

E. Scaiola ..................................................................... 240 

N. Scarin ...................................................................... 268 

A. Scariot ..................................................................... 228 

G. B. Scaro ..................................................................... 74 

B. Schaan ..................................................................... 226 

T. Schachner ................................................................ 173 

J. Schad ....................................................................... 238 

R. Schaetzl ........................................................... 196, 198 

D. Schaf ....................................................................... 233 

C. M. Schannwell ................................................. 104, 270 

S. Schanz ...................................................... 206-207, 259 

E. Schapachnik .................................................... 195, 218 

M. Schapira .................................................................. 137 

H. Schartum-Hansen ........................................... 249, 251 

N. Schechtmann .......................................................... 201 

S. Scheidl ..................................................................... 225 

P. C. Schenkel .............................................................. 233 

U. Scherrer ............................................................ 75, 103 

I. T. Schettert ............................................................... 193 

A. G. Schijman ............................................................. 250 

A. C. Schimidt .............................................................. 267 

N. Schimidt .................................................................. 175 

T. H. Schindler ............................................................. 133 

G. Schipani ........................................................... 237, 240 

J. A. Schirger ............................................................... 108 

A. J. Schlichter ....................................................... 76, 221 

S. Schneck ................................................................... 278 

M. Schneider ............................................................... 228 

C. Schneider ................................................................ 106 

J. Schnidt ..................................................................... 239 

A. Schott ...................................................................... 260 

M. Schou ............................................................. 108, 241 

I. M. Schou .................................................................. 108 

P. Schreib .................................................................... 200 

V. Schubsky ................................................................. 238 

G. Schuler .............................................................. 73, 182 

C. Schulte ............................................................ 138, 225 

R. Schumiachkin ............................................................ 76 

I. Schusterova .............................................................. 137 

P. Schvartzman ............................................................ 226 

M. Schwab ............................................................ 75, 103 

O. A. Schwint ............................................................... 142 

P. Schygiel ................................................................... 171 

R. Sciacca .............................................................. 75, 107 

G. Scianca .................................................................... 229 

A. Scicolone ................................................................. 211 

G. Scicolone ................................................................. 211 

S. Sclarovsky ................................................102, 167, 178 

E. Sclarovsky ......................................................... 72, 143 

M. Scofano .................................................................. 229 

C. G. Scott ................................................................... 105 

E. Scrivano ..................................................................... 78 

C. Seara ........................................................141, 206, 260 

C. Seelig ...................................................................... 237 

C. Segadaes ................................................................. 222 

E. V. Segura ................................................................. 189 

M. Segura .................................................................... 279 

R. Seiça ................................................................ 100, 269 

K. Seidl ......................................................................... 203 

C. Seidler ............................................................... 80, 244 

D. Seinhart ................................................................... 137 

D. Selchen ................................................................... 267 

Y. Selcoki ............................................................. 185, 195 

V. Selios ................................................................ 269-270 

index / 315

Authors 

M. Sellanes .......................................................... 192, 210 

A. Selvi ......................................................................... 223 

K. A. Selzman ....................................................... 138, 225 

A. Sembaj .................................................................... 264 

M. Semukhin ............................................................... 202 

O. Sen .......................................................................... 105 

L. M. Sena ................................................................... 247 

M. Senesi ............................................................ 210, 222 

K. Senna ...................................................................... 262 

D. Sepulveda ............................................................... 137 

S. Serafim .................................................................... 211 

A. Serafin ..................................................................... 273 

D. F. Serans ......................................................... 220, 250 

J. Seresi ....................................................................... 277 

P. Seron ....................................................................... 132 

I. Seropian .................................................................... 228 

B. S. Serpa ................................................................... 224 

A. Serra ........................................................................ 229 

S. Serra .......................................................................... 76 

O. Serraiocco ............................................................... 227 

D. Serrano .................................................................... 247 

E. Serrano .................................................................... 214 

C. Serrano .................................................................... 254 

J. Sertic ........................................................................ 230 

A. Seth ......................................................................... 132 

K. K. Sethi .................................................................... 132 

S. Seto ................................................................. 195, 209 

V. Severicha ................................................................. 210 

L. J. Sevic .................................................................... 174 

N. Sewpaul .................................................................. 256 

T. M. Seydell .................................................109, 191, 243 

A. Shah ........................................................................ 166 

T. P. Shah ..................................................................... 172 

T. Shalganov ................................................................ 206 

I. Shapira ...................................................................... 163 

N. Sharashidze ............................................................. 230 

O. Sharkhun ................................................................. 238 

V. K. Sharma ........................................................ 108, 231 

S. K. Sharma ........................................................ 142, 272 

S. Sharma .................................................................... 140 

C. Shaw ....................................................................... 163 

L. J. Shaw .................................................................... 141 

C. Shekhar ..................................................................... 79 

H. Sheng ...................................................................... 202 

J. Shepherd ................................................................. 183 

H. Shi ........................................................................... 241 

S. Shigematsu ............................................................. 170 

L. S. Shigueoka .............................................................. 75 

E. O. Shim ............................................................ 111, 272 

K. Shimomura .............................................................. 195 

J. Shin .......................................................................... 270 

E. Shin .............................................................. 75-77, 144 

M. S. Shin ............................................................ 111, 272 

E. K. Shin ............................................................. 111, 272 

T. Shingo ...................................................................... 175 

G. Shinzato .................................................................. 266 

A. Shiozaki ................................................................... 136 

J. Shiraishi ................................................................... 192 

A. Shirom ..................................................................... 163 

E. Shlyakhto ................................................................. 203 

E. Shlykhto ........................................................... 204, 274 

Z. Shoalimova .............................................................. 196 

L. Shocron ................................................................... 222 

N. Shor ................................................................. 110, 178 

A. A. Shoukas ................................................................ 77 

R. K. Shrivastava .................................................. 108, 231 

S. Shukurjanova ........................................................... 196 

A. Shurman .................................................................. 186 

A. Siciliano ................................................................... 263 

S. Sicouri ...................................................................... 275 

R. Siddiqui .................................................................... 270 

D. Sidi .......................................................................... 180 

K. Siemianowicz .......................................................... 208 

I. U. Sigaev ................................................................... 255 

J. Sikic-Vagic ................................................................ 231 

J. Sikora ............................................................... 171, 238 

E. Silberman ......................................................... 273-274 

F. J. B. Silva Filho ......................................................... 244 

E. Silva ..........................138, 240, 242, 259, 269, 272, 275 

J. Silva ..............................................................72, 78, 109 

F. Silva ..................................................135, 208, 246, 253 

A. C. Silva ..................................................................... 244 

F. H. Silva ..................................................................... 244 

M. C. C. Silva ............................................................... 202 

H. Silva ................................................................. 244, 279 

P. Silva ...................................137, 139-140, 226, 236, 257 

A. Silva ...................................139-141, 164, 183-184, 212, 

...............................................224-225, 227, 257, 265, 273 

R. Silva ................................................................. 253, 257 

M. J. L. M. Silva ................................................... 227, 256 

L. C. S. Silva ................................................................. 217 

I. T. Silva .............................................................. 263, 265 

M. A. Silva .....................................................212, 227, 265 

B. Silva ................................................................... 76, 244 

I. C. M. Silva ............................................76, 138, 234, 253 

V. M. Silva ............................................................ 180, 198 

R. B. F. Silva ................................................................. 246 

S. A. Silva ............................................................. 139, 184 

J. P. Silva ............................................................. 226, 236 

M. Silva ..................................76, 109, 138, 180, 198, 227, 

...............................................................234, 252-253, 256 

F. C. S Silva Jr. ............................................................. 275 

I. C. M. Silva ............................................76, 138, 234, 253 

C. Silva ..................................................202, 244, 252, 268 

J. L. Silva ...................................................................... 255 

P. L. Silva ..................................................................... 260 

V. M. Silva ............................................................ 180, 198 

J. P. Silva ............................................................. 226, 236 

M. Silvero ............................................................. 169-170 

J. Silveyra ............................................................ 260, 273 

K. H. Sim ...................................................................... 201 

S. Simas ....................................................................... 234 

J. C. Simes ................................................................... 205 

M. Simoes ................................................................... 220 

O. Simoes ............................................................ 111, 181 

L. Simões ......................................................262, 265, 267 

J. L. Simon ............................................................. 76, 221 

J. Šimon ............................................................... 166, 173 

T. Simoncek ................................................................. 231 

G. Simonyi ............................164, 199, 203, 208, 224, 238 

C. S. Simpson ...................................................... 135, 163 

S. Singh ....................................................................... 167 

G. Singh ............................................................... 108, 231 

N. Singh ....................................................................... 110 

I. Singla ........................................................................ 101 

N. Sinha .........................................110, 132, 198, 250-251 

A. Sinha ....................................................................... 104 

D. A. Siniawski ............................................................. 183 

S. Sinigaglia ................................................................. 244 

A. Sinisi .............................................74, 79, 201, 211, 241 

P. Sionek ...................................................................... 252 

P. Siostrzonek .............................................................. 110 

D. Siqueira ....................................................257, 259, 261 

A. Siqueira-Filho ............................................................. 71 

M. Sirlak ....................................................................... 111 

V. Sirotkin .................................................................... 235 

R. Sirvente ................................................................... 269 

A. Sitar-Tautu ............................................................... 242 

M. Sitnikova ................................................................. 203 

B. Sjöberg ...................................................................... 75 

D. Skapura ................................................................... 103 

B. D. Skinner ........................................................ 138, 212 

S. M. Skinner ....................................................... 138, 212 

B. Skoric ...............................................104, 219, 230, 245 

W. Skorupski ............................................................... 225 

M. Skwarek ......................................................... 102, 237 

M. Slater ...................................................................... 277 

B. L. Sleath .................................................................. 226 

J. Sleigh ......................................................................... 71 

A. Slichter .................................................................... 252 

I. Slimobich ............................................................ 70, 248 

E. Slywitch ................................................................... 199 

P. Smanio .......................110-111, 186, 251, 267-268, 276 

P. A. Smars .................................................................. 262 

N. Smedira ................................................................... 232 

L. Smeeth ............................................................ 137, 164 

L. Smidt ................................................134, 138, 243, 250 

C. Smith ............................................................4, 219, 225 

G. Smolyanova ............................................................. 234 

T. D. Snyder ................................................................. 212 

P. Soares ........................................76, 108, 138, 236, 278 

S. Soares ..................................................................... 270 

A. Soares ......................................................144, 225, 236 

C. E. Soares ................................................................. 198 

O. E. Soares ................................................................. 266 

F. Soares ...................................................................... 191 

P. P. Soares ................................................................. 236 

D. Sobic-Saranovic ....................................................... 171 

D. Sobolev ................................................................... 238 

T. Sobow ..................................................................... 188 

D. Sobral-Filho ............................................................. 249 

M. Socorro ................................................................... 144 

H. Soejima ................................................................... 164 

F. Sogorb ..................................................................... 217

Authors 

A. Sokolowski ...................................................... 101, 230 

G. Solari ....................................................................... 169 

R. Solerno .................................................................... 229 

E. Z. Soliman ................................................................ 200 

E. Soloaga .................................................................... 219 

R. J. Solomon .............................................................. 142 

H. Solomon .................................................................. 137 

I. Solti ................................................................... 197, 202 

M. Somera ................................................................... 181 

D. Sondore ................................................................... 255 

S. Sood ........................................................................ 103 

T. Sööt ......................................................................... 187 

E. Sophia ............................................................... 222-223 

L. Sorell ................................................................ 247, 263 

T. Soria ......................................................................... 181 

L. Soriano ............................................................. 206, 259 

C. Soriano .................................................................... 231 

P. Sorroche .................................................................. 183 

F. Sosa ..................................144, 172, 239, 241, 271, 274 

E. Sosa ......................................................................... 102 

R. Sosa ........................................................................ 264 

C. Sosa ........................................................................ 271 

J. E. Sousa ............................................................. 76, 198 

E. Sousa ..........................................................76, 198, 225 

A. Sousa ....................................................... 256-259, 261 

A. G. M. R. Sousa ........................................................ 198 

J. E. Sousa ............................................................. 76, 198 

M. G. Sousa ........................................................... 80, 208 

A. C. S Sousa ............................................................... 111 

M. A. C. Sousa ............................................................. 215 

I. Souto ........................................................................ 175 

N. A. Souza E. Silva ...................................................... 269 

O. Souza ...................................................................... 229 

A. Souza ........................................................237, 258, 269 

D. Souza ...................................................................... 233 

A. S. Souza ....................................................139, 184, 256 

S. B. C. Souza .............................................................. 270 

F. Souza ....................................................................... 228 

M. Souza ...................................................................... 138 

E. C. Souza ................................................................... 266 

J. Souza ....................................................................... 234 

L. C. B. Souza ................................................................ 76 

W. Souza ..................................................................... 241 

V. R. Souza ................................................................... 250 

S. Soydinc .................................................................... 171 

O. Soylu ....................................................................... 186 

E. Y. Sozmen ......................................................... 77, 276 

C. Spargias ................................................................... 177 

R. Spasic ...................................................................... 193 

M. Spelta ..................................................................... 220 

R. Speranza .......................................................... 102, 212 

F. Spernanzoni ....................................................... 79, 219 

J. Spiers ....................................................................... 229 

A. Spillmann ......................................................... 260, 270 

G. Spina ........................................................132, 237, 247 

A. Spinelli ..................................................................... 208 

M. Spleta ..................................................................... 222 

L. A. Sposato ......................................................... 78, 111 

T. Spyt ................................................................... 73, 256 

R. Squires .................................................................... 107 

M. Šrámek ................................................................... 169 

M. Šramko ................................................................... 169 

I. Srdanovic .................................................................. 190 

M. Srdic ....................................................................... 187 

A. Srinivas .................................................................... 132 

R. Staico .......................................................198, 257, 259 

H. Staines ........................................75, 178, 206-207, 209 

G. Stampone ................................................................ 206 

V. Stangl ................................................................ 75, 140 

K. Stangl .........................................................75, 140, 238 

C. Staniloae .................................................................. 142 

B. Stankova .................................................................. 200 

S. Stankovic ................................................................. 187 

G. Stankovic ........................................................... 71, 142 

J. Stanley ..................................................................... 176 

S. Stanojevic ................................................................ 137 

R. Stauber .................................................................... 225 

A. C. Steer ................................................................... 103 

E. Stefanadi .................................................... 69, 216-217 

C. Stefanadis .................................................. 69, 216-217 

A. Stefani ............................................................. 102, 212 

B. Stefanovic ..................................................74, 105, 169 

R. Steffen .................................................................... 207 

M. Stefuriac ................................................................. 200 

R. Stein ...........................................74, 106, 138, 187, 226 

S. Steiner ............................................................. 104, 270 

S. Steiner-Boker ........................................................... 100 

V. Stelet ......................................................................... 76 

J. Stepanovic .........................................110, 142, 277-278 

J. Stepinska ......................................................... 172, 252 

R. Steponeniene .......................................................... 210 

G. Sterbakova .............................................................. 253 

M. Sterlinski ................................................................... 76 

A. Sterque .................................................................... 223 

J. Stertzer .................................................................... 140 

S. H. Stertzer ............................................................... 140 

A. Stevanovic ............................................................... 174 

S. Stewart ............................................................ 107, 203 

C. Stipp ........................................................................ 201 

V. Stoickov ........................................................... 166, 214 

S. Stojkovic ..............................................71, 142, 277-278 

A. Stojkovic .................................................................. 170 

N. Stolf ................................................................. 276, 278 

M. Stoll ................................................................ 273, 276 

P. Stoll ......................................................................... 143 

T. Stompor ................................................................... 101 

I. Stopa .................................................................. 80, 141 

V. Strada ...................................................................... 215 

L. Strain ....................................................................... 143 

E. Strand ...............................................133, 142, 243, 248 

B. E. Strauer ......................................................... 104, 270 

M. Strauß ..................................................................... 203 

P. Strebelas ................................................................. 181 

T. Strecker ........................................................... 176, 274 

C. Stringi ...................................................................... 217 

M. Strozzi ............................................................. 219, 231 

M. Strumminger .......................................................... 220 

C. Strunz .............................................................. 237, 247 

K. Stuart ....................................................................... 135 

I. Stukena ..................................................................... 235 

C. Sturgeon .................................................................. 229 

A. Sturich ....................................................................... 76 

M. C. J. M. Sturkenboom ............................................ 243 

A. Stuto ........................................................................ 186 

P. Stuzbach .................................................................. 220 

J. Su ............................................................................... 75 

L. Suarez ...................................................................... 183 

E. R. Suarez ..........................................243, 245, 247, 265 

R. Suarez-Arias ..................................................... 196-197 

V. Suchanek ......................................................... 141, 223 

M. Sucu ....................................................................... 171 

K. Sugar ....................................................................... 259 

J. Sugawara ......................................................... 137, 173 

K. Sugi ................................................................... 70, 185 

M. M. Sugizaki ............................................................. 258 

M. Sultan ..................................................................... 136 

M. Sultán ............................................................... 80, 111 

G. Sumay ..................................................................... 217 

B. Sumegi ............................................................ 197, 202 

V. Sumodi .................................................................... 168 

Y. Sun .......................................................................... 135 

C. Sun .......................................................................... 222 

M. Sun ......................................................................... 214 

V. Sundararajan ............................................................ 164 

J. B. Sundstrom .................................................... 202-203 

R. Suneja ..................................................................... 258 

A. Sunil ........................................................................ 101 

S. Suryawanshi .............................................................. 75 

L. Sutera ...................................................................... 106 

G. Sutherland ............................................................... 254 

M. Sutton ............................................................... 74, 136 

O. Suzer ....................................................................... 242 

O. Süzer ....................................................................... 180 

L. Svard ........................................................................ 229 

L. Svensson ................................................................. 232 

G. Svingen ........................................................... 247, 251 

C. Swarzman ............................................................... 248 

S. Swieszkowski .......................................................... 215 

M. K. Sydnor ........................................................ 179, 275 

P. Syska ......................................................................... 76 

A. Sýsman ................................................................... 170 

Z. Szabolcs ................................................................... 203 

M. Szakacs .................................................................. 257 

K. Szakolczai ........................................................ 164, 199 

J. Szarfer .................................................69, 132, 139, 188 

A. Szebeni .................................................................... 203 

J. Szlavov ..................................................................... 220 

S. Szmit ....................................................................... 273 

E. Szûcs ....................................................................... 164 

H. Szwed ..........................................................76, 80, 135 

F. Szymanski ................................................................ 273 

A. Szyszka .................................................................... 251 

E. Tabak ....................................................................... 104 

S. Tabares .................................................................... 264 

index / 317

Authors 

G. Tabidze .................................................................... 235 

G. Tacoy ................................................................ 278-279 

G. Taçoy ............................................................... 172, 186 

K. Taeik ........................................................................ 272 

M. Tafazzoli-Shadpour ................................................. 142 

A. C. Taffarel ................................................................ 233 

R. Tagle ........................................................................ 182 

M. S. Tagliari ................................................................ 265 

C. Taira ......................................................................... 274 

O. Tairova .................................................................... 228 

N. Tajima ...................................................................... 231 

N. Takahashi ................................................................ 175 

T. Takakura .................................................................. 170 

D. Takara ...................................................................... 193 

K. Takazawa ................................................................. 167 

R. T. Takeda ................................................................. 213 

K. Takeishi ................................................................... 167 

L. Talavera ....................................................142, 221, 259 

M. L. Talavera ...................................................... 142, 221 

J. A. Talayero ............................................................... 133 

C. Talos ........................................................................ 246 

H. Tamagusuku .........................................74, 79, 211, 241 

G. Tamashiro ................................................................. 71 

A. Tamashiro .................................................................. 71 

T. Tammelin ................................................................... 75 

Y. Tanaka ..................................................................... 164 

H. Tanaka ............................................................. 137, 173 

C. Tanamati .................................................................. 263 

R. Tandler .................................................................... 176 

I. Tandogan ...................................................180, 194, 205 

Q. Z. Tang .................................................................... 163 

A. Tangari ............................................................. 226, 236 

D. Tanne ...................................................................... 209 

E. Tanus ................................................111, 170, 189, 196 

P. Tapanainen ................................................................ 75 

M. Tarán ...................................................................... 205 

E. Tararak ..................................................................... 235 

F. Tarasoutchi .......................................132, 237, 247, 275 

S. Tarasov .................................................................... 175 

J. C. Tardif .................................................................... 197 

O. Tardin .............................................................. 260, 263 

J. Tartaglione ....................................................... 228, 248 

I. Tasic ......................................................................... 276 

A. Tasouli ..................................................................... 181 

R. Tasoz ....................................................................... 111 

E. Tassano ............................................................ 260-261 

P. Tassovska ................................................................ 225 

C. P. Tastan .................................................................. 191 

H. Tatar ........................................................................ 163 

R. Tataradze ................................................................. 175 

E. Tatli .......................................................................... 182 

M. Tatsch ..................................................................... 234 

S. Taurozzi ................................................................... 178 

A. Tavares ...................................................................... 74 

L. Tavares .................................................................... 191 

A. M. V. Tavares........................................................... 233 

D. Tavciovski ................................................................ 193 

A. Tavridou ..................................................................... 77 

A. Taylor ................................................................... 73, 75 

Y. Tayyareci ......................................................... 106, 191 

J. Tazar ................................................................ 178, 265 

A. S. Tebexreni ..................................................... 248-249 

A. Tedeschi .................................................................. 143 

B. Tedeschi .................................................................. 143 

U. Teibe ....................................................................... 235 

R. Teixeira ...................................70, 78-79, 101, 110, 132, 

.......................................250, 252, 255-256, 258, 260, 263 

P. Teixeira .................................................................... 236 

G. Teixeira ............................................................ 231, 233 

E. Tekbas ..................................................................... 171 

L. Tekieli ................................................................ 78, 233 

J. Telayna ..................................................................... 278 

L. A. Temming ..................................................... 138, 212 

P. L. Temporelli ............................................................ 136 

A. Tenenbaum ............................................................. 209 

C. Tentolouris ................................................. 69, 216-217 

M. C. Tentori ................................................................ 244 

C. Tentori ............................................................. 205, 244 

I. Teplitsky ........................................................... 110, 178 

I. Ternouth ............................................................. 71, 179 

C. Terzic ....................................................................... 107 

M. Tettamanti .............................................................. 224 

S. Tewari ....................................................... 110, 250-251 

S. Tewell ...................................................................... 144 

S. Tezuka ..................................................................... 175 

E. Thaulow ........................................................... 103, 223 

P. Thayssen ......................................71, 79, 110, 142, 253 

T. R. Theodoro ............................................................. 245 

T. Theodoropoulos ....................................................... 224 

G. Thiene ..................................................................... 134 

A. Thom .........................................110-111, 186, 251, 276 

M. Thomas .................................................................. 108 

R. Thomas ................................................................... 107 

C. Thomas ................................................................... 237 

M. C. Thomazi ...................................................... 266, 268 

S. Thomopoulou .......................................................... 177 

S. Thompson-Bell .......................................................... 75 

O. Thorsson ................................................................. 168 

L. Thuesen ........................................71, 79, 110, 142, 253 

R. Thurler ..................................................................... 256 

K. Tibazarwa ................................................................ 107 

C. Tibbatts ..................................................................... 71 

J. C. Tille ...................................................................... 142 

H. Tilsted ............................................................... 79, 110 

Y. R. Timasheva ........................................................... 236 

A. S. Timm ................................................................... 263 

M. Timm ........................................................................ 77 

A. Timofeeva ........................................................ 234-235 

T. Timurkaynak 172, 180, 185-186, 190, 219, 231-232, 278 

E. Tinoco ...................................................................... 207 

R. Tinoco ...................................................................... 234 

G. A. Tinoco ................................................................. 234 

E. Tirado ................................................................ 270-271 

C. Tirziu ........................................................................ 224 

G. C. Tiscornia .............................................................. 191 

J. Tisnado ............................................................ 179, 275 

K. Tjelta ........................................................................ 199 

M. Tobar ...................................................................... 178 

D. Tobing ............................................................. 132, 235 

J. E. Toblli .................................................................... 138 

C. Tobon ........................................................................ 79 

M. Todorovic-Tirnanic .................................................. 171 

S. Toker ....................................................................... 163 

C. Toldo ....................................................................... 246 

C. Toledo ..................................................................... 207 

I. Tolj ............................................................................ 190 

J. F. Tolsa ..................................................................... 103 

D. Tomar ........................................................................ 79 

P. Tomašov .................................................................. 136 

A. Tomat ...................................................................... 211 

C. Tomaz ...................................................................... 249 

M. Tomazzi .................................................................. 240 

A. Tomek ..................................................................... 169 

S. Tomic ............................................................... 187, 202 

H. Tomiyama ............................................................... 187 

M. Tonetto ..................................................................... 74 

O. Topolcan ................................................................. 253 

A. Torino ...................................................................... 209 

P. Tornos ..................................................................... 252 

A. Torrão ...................................................................... 234 

I. Torres ....................................................................... 252 

J. Torres ........................................................260, 265, 271 

F. Torres ...................................................................... 196 

E. Torresani .......................................................... 237, 240 

C. Torromeo ................................................................. 240 

A. Tors ........................................................................... 72 

A. Torterola .................................................................. 257 

M. Toscani ................................................................... 205 

A. Toscano ................................................................... 201 

I. Toshev ...................................................................... 225 

K. Toth ......................................................................... 202 

J. L. Tovar .................................................................... 252 

R. Tracy ........................................................................ 137 

W. Tracz .....................................76, 78, 80, 101, 141, 170, 

.......................................173-174, 182, 185, 193, 230, 233 

J. Trainini ..................................................................... 139 

J. C. Trainini ................................................................. 139 

F. Tramontini ................................................................ 187 

B. Tranchesi Jr. ............................................................ 224 

G. Trancoso ................................................................. 234 

D. Trapaidze ................................................................. 175 

H. J. Trappe ..........................................103, 194, 223, 245 

P. R. Travancas .............................................262, 265, 267 

S. Traverso ............................................133, 139, 227, 266 

V. Traykov .................................................................... 206 

N. Trehan .............................................................. 141-142 

P. Trejo ........................................................................ 206 

E. Trendafilova ............................................................. 225 

P. Trenkwalder ..................................................... 196, 198 

L. Trentacoste .............................................................. 209 

M. Trevisan .................................................................. 100 

A. Trigo ........................................................................ 231 

E. Trillos ....................................................................... 249 

H. Trimarchi ................................................................. 201

Authors 

E. Trindade ........................................................... 263, 278 

J. Tripolone ............................192, 195, 241-242, 260-261, 

........................................................263-264, 266, 269-270 

K. Trivedi ...................................................................... 270 

L. J. Trkulja ................................................................... 202 

I. C. Trombetta ..............................................172, 180, 192 

C. Tron ........................................................................... 78 

J. Tronge ...................................................................... 171 

E. Trucco ...................................................................... 185 

T. Tsai .................................................................. 135, 231 

S. Tsao ......................................................................... 135 

H. F. Tse ...................................................................... 108 

M. Tsekova .................................................................. 230 

W. Tshani .............................................................. 202-203 

B. Tsinamdzgvrishvili ........................................... 164, 175 

C. Tsioufis .................................................................... 216 

A. Tsiskaridze ............................................................... 164 

V. Tsoma ...................................................................... 175 

J. Tsutsui ..............................................111, 136, 176, 179 

R. Tsuyuki .................................................................... 143 

M. Tubaldini ................................................................. 254 

F. A. Tuche ........................................................... 139, 184 

A. Tufare ...................................................................... 218 

T. Tuiketei .................................................................... 103 

K. Tukamoto ........................................................ 247, 268 

L. R. Tumasyan ............................................................ 136 

M. Tundybaeva ............................................................ 174 

L. Tunyan ..................................................................... 134 

J. O. Tuomilehto .......................................................... 231 

B. Tura ......................................................................... 250 

R. G. Turan ........................................................... 104, 270 

Y. Turgeman ................................................................ 186 

O. O. Turgut ................................................................. 205 

F. H. Turgut .................................................................. 195 

S. Turhan ..................................................................... 192 

U. Turk ......................................................................... 188 

C. Turkoglu .................................................................. 188 

S. Türkoglu ........................................................... 186, 190 

C. Turner ...................................................................... 104 

D. Turri ....................................79, 102, 106, 138, 187, 189 

M. Turski ...................................................................... 232 

D. Turyn ....................................................................... 256 

V. Tuseth ............................................................. 143, 272 

P. Tyczynski ......................................................... 101, 241 

A. Tziovas .................................................................... 185 

V. Tzoma ...................................................................... 175 

O. Ucar ........................................................................ 223 

E. Ucer ......................................................................... 171 

O. N. Uchevatkina ........................................................ 135 

T. Uchida ...................................................................... 175 

A. H. Uchida ................................................................. 195 

A. Uchida ..................................................................... 176 

M. Uder ....................................................................... 176 

Y. Uehara ..................................................................... 181 

P. M. Ueland ..........................133, 142, 243, 247-249, 251 

M. Uellendahl .............................................................. 141 

K. Ueng ........................................................................ 135 

H. Ugalde ..................................................................... 141 

D. Ugalde ..................................................................... 141 

M. R. Ugolini ................................................. 243-247, 265 

M. Uhlemann ............................................................... 182 

E. Ulusoy ..................................................................... 163 

R. Umakanthan .............................................................. 73 

B. Umman ........................................................... 106, 191 

S. Umman .................................................................... 191 

D. Umpierre ................................................................. 106 

A. Unzueta ................................................................... 144 

J. Urban ......................................................................... 75 

G. Urcelay .................................................................... 207 

P. Uriarte ...................................................................... 178 

W. Uribe ...................................................................... 205 

A. Uribe ........................................................................ 242 

F. Urinovsky ................................................................. 176 

T. Ushakova ................................................................. 238 

H. Uyarel ...................................................................... 171 

B. Uz .................................................................... 185, 195 

E. Uz ............................................................................ 195 

J. Uzunangelov ............................................................ 230 

M. Vääräsmäki ............................................................... 75 

M. Vaccari .................................................................... 178 

G. Vaccarino ................................................................. 142 

V. Vaghela .................................................................... 235 

M. Vaidotas .......................................................... 102, 132 

S. Vaidya .............................................................. 195, 232 

N. Vainstein ..............................................74, 77, 136, 204 

F. Vaisbuj ........................................73, 205, 211, 236, 246 

H. Vaknin Assa ..................................................... 110, 178 

A. M. Valderrama ......................................................... 109 

H. Valdes Pino .............................................................. 177 

M. Valdés ..................................................................... 217 

G. F. Valdez .................................................................. 247 

S. Valdivielso ................................................................ 238 

L. R. Valdivieso Cedeño ................................................. 76 

L. Valdivieso ....................................78, 110, 143, 188, 193 

J. Valencia .................................................................... 217 

G. Valenzuela ............................................................... 176 

G. Valeriano ................................................................. 258 

E. Valero .............................................................. 210, 254 

S. Väli ........................................................................... 187 

J. M. Valle .................................................................... 165 

A. Valle ......................................................................... 231 

R. Valle ........................................................................... 70 

R. Vallejo ...................................................................... 169 

J. Vallejos .............. 107, 134, 170, 200, 204, 212, 261, 275 

G. Vallejos .................................................................... 106 

L. Valtuille .................................................................... 221 

L. Van Bortel ................................................................ 211 

M. Van Bracht .............................................................. 245 

L. Van Casteren ........................................................... 277 

P. H. Van De Borne ...................................................... 211 

R. Van Der Vijver .......................................................... 132 

R. Van Manen .............................................................. 110 

R. Van Oort .................................................................. 103 

V. Vanasco ................................................................... 239 

M. Vane ....................................................................... 249 

A. Vanella ....................................................................... 74 

D. Vangu Ngoma ...............................................76, 78, 243 

B. Vankelecom ............................................................. 277 

A. D. Varanda-Rosario .................................................. 273 

S. Varela Ortiz ...................................................... 266, 268 

M. Varela Otero ........................................................... 192 

A. Varela Roman .......................................................... 194 

J. S. Varela ................................................................... 106 

C. Varela ...................................................................... 137 

S. Varela-Ortiz .............................................................. 265 

E. Varella ...................................................................... 179 

L. Vargas ...................................................................... 232 

N. Vargas ..................................................................... 219 

G. Vargas-Alarcon ........................................................ 205 

G. Vargas-Alarcón ........................................................ 204 

P. Varleta ..................................................................... 257 

Y. Varma .............................................................. 108, 231 

A. Vasile ....................................................................... 200 

C. Vasiliadou ................................................... 69, 216-217 

Z. Vasiljevic .............................................74, 105, 169, 187 

B. Vatan ....................................................................... 187 

E. Vavouranakis ........................................................... 216 

M. Vazques Blanco ...................................................... 250 

M. Vazquez Blanco .............................................. 109, 214 

G. Vazquez ................................................................... 188 

H. Vazquez ................................................................... 252 

S. Vazquez ................................................................... 200 

D. Vazquez ................................................................... 215 

C. Vazquez ................................................................... 178 

N. Vázquez-González ................................................... 198 

J. M. Vázquez-Rodríguez ............................................. 198 

H. Vefring ..................................................................... 135 

M. Vega Fernandez ...................................................... 194 

F. Vega ......................................................................... 165 

G. Vega ........................................................................ 251 

B. Vega .................................................................. 76, 270 

J. Vega ......................................................................... 169 

J. Vegas ................................................................ 196-197 

R. Vegni .................................................252, 259-260, 262 

A. B. G. Veiga ................................................................. 74 

L. Veiras ....................................................................... 211 

E. Veitenheimer ........................................................... 175 

O. Velásquez ................................................................ 139 

J. Velayo ...................................................................... 183 

P. Velazco ............................................................ 208, 211 

H. Velez ....................................................................... 246 

A. Velkova .................................................................... 230 

M. Velloso .................................................................... 260 

H. H. Veloso ................................................................... 72 

M. M. Veloso ............................................................... 233 

M. Veltri ....................................................................... 219 

A. Venalis ..................................................................... 184 

L. Vendrame ........................................................ 263, 268 

R. C. Vendramini .......................................................... 247 

J. Venegas ................................................................... 209 

M. Venere .................................................................... 175 

N. Vensentini ............................................................... 240 

M. Ventura ................................................................... 258 

M. J. Vera Janavel.......................................................... 70 

index / 319

Authors 

M. Vera ................................................................ 201, 212 

V. Vera ......................................................................... 178 

P. J. E. Verdegem ........................................................ 255 

P. Verdegem ................................................................ 208 

R. Verney ............................................................. 139, 184 

V. H. Veronica Heredia ................................................. 226 

V. Verri .................................................................. 252-253 

J. Veselka .....................136, 141, 169, 223, 234, 237, 253 

V. B. Vesna Bisenic ...................................................... 134 

F. F. Vianna .................................................................. 106 

A. Vicario .............................................................. 204, 214 

R. Vidal Perez .........................................180, 186-187, 194 

L. A. Vidal ..........................................79-80, 136, 176, 178, 

........................................188, 219-220, 222-223, 229, 250 

L. Vidal ........................69-70, 132-133, 139, 197, 214, 266 

M. Vidal ........................................................................ 178 

L. A. Vidal ..................................79-80, 136, 176, 178, 188, 

................................................219-220, 222-223, 229, 250 

A. Videla Lynch ............................................................ 229 

P. R. N. Viecili.................................212-214, 221-223, 227, 

...............................................................261, 265-266, 269 

C. Viegas ...................................................................... 252 

R. F. M. Viegas............................................................. 249 

T. M. R. F. Viégas ......................................................... 267 

F. L. Vieira .................................................................... 244 

H. Vieira ....................................................................... 258 

P. J. C. Vieira ...................................................74, 106, 138 

R. W. Vieira .......................................................... 133, 166 

J. Vieira ...........................................................77, 233, 236 

C. Vietti ........................................................................ 184 

G. Vieyra ...................................................................... 274 

I. Vigil Torres ................................................................ 261 

C. Vigliano ...............................70, 170, 186, 201, 250, 259 

G. Vignolo ............................................................ 199, 208 

G. Vigo ......................................................................... 210 

E. Vigueras ....................................................233, 237, 275 

V. Vikentyev ..................................................141, 249, 252 

J. H. Vila ....................................................................... 226 

J. Vila ..................................................................... 78, 256 

J. Vilar ................................................................... 269-270 

M. Vilaseca .................................................................. 188 

F. Vilchez ..................................................................... 257 

F. D. Vilela ........................191-192, 252-254, 266-267, 273 

F. P. Vilela .................................................................... 244 

F. D. Vilela ........................191-192, 252-254, 266-267, 273 

F. Vilela ........................................................................ 264 

J. Vilkas Anzorena .................................................. 79, 219 

A. Villa ...........................................................111, 221, 255 

D. M. Villa .................................................................... 165 

H. Villacorta .................................................................. 207 

L. Villagra ........................................78, 110, 143, 188, 193 

C. Villalba ..................................................................... 264 

A. Villamayor ................................................................ 256 

L. Villano ...................................................................... 172 

E. Villanueva ................................................................ 207 

M. A. Villasis ................................................................ 144 

J. Villasmil .................................................................... 242 

R. Villavicencio ............................................................. 134 

E. Villegas ..............................................215, 219, 260-261 

M. Villegas ..................................................................... 71 

R. Villela ............................................................... 215, 222 

J. L. Viloria ................................................................... 226 

C. G. C. Vinagre............................................................ 198 

J. C. M. Vinagre ........................................................... 199 

C. G. Vinagre ........................................................ 199, 255 

R. Vinueza .................................................................... 109 

R. Viotti ................................................................ 170, 201 

M. Virgolini ................................................................... 137 

A. Virgos Lamela .......................................................... 186 

C. Viscuso .....................................................183, 190, 215 

M. F. Visintini Jaime..................................................... 169 

M. Viso ........................................................................ 263 

J. Visperas ................................................................... 181 

M. Visser ..................................................................... 273 

N. Vita .......................................................................... 240 

L. Vitek ......................................................................... 200 

B. Vitunjski-Englert ...................................................... 231 

R. Vivacqua .................................................................... 76 

A. Vizcarra Diaz ............................................................ 244 

G. Vizcarra .................................................................... 197 

C. Vlachopoulos ........................................................... 217 

W. Vogel ...................................................................... 173 

S. Vogogna .................................................................. 184 

B. Vohnout ........................................................... 240, 257 

M. Vojkoviæ ................................................................. 231 

V. Volberg ............................................................ 103, 267 

V. E. Volgushev ............................................................ 255 

A. L. Volkova .......................................................... 74, 164 

S. E. Vollset ...................................133, 142, 247, 249, 251 

J. A. Volmink ................................................................ 165 

A. Volschan ...................................................201, 229, 234 

A. Volshan .................................................................... 229 

M. Von Bracht ...................................................... 103, 194 

S. Von Heahling ........................................................... 238 

I. Vondermuhl .............................................................. 165 

M. Voos ............................................................... 171, 181 

J. Vormbrock ............................................................... 223 

L. S. Voto ..................................................................... 183 

G. N. Voto .................................................................... 183 

V. Voudris ............................................................ 177, 182 

J. M. Vrancic ................................................................ 142 

O. Vraspir Porenta ................................................. 187-188 

M. Vrkic Kirhmajer ............................................... 223, 231 

Z. Vucinic ..................................................................... 193 

B. Vujisic-Tesic .......................................171, 174, 277-278 

N. Vukadinovic ............................................................. 251 

V. Vukcevic ...............................................71, 74, 105, 142 

M. Vukovic ........................................................... 187, 202 

O. Vukovic ................................................................... 110 

A. Vukusich .................................................................. 137 

D. Vulic ........................................................................ 182 

B. Vulic ......................................................................... 182 

V. A. Vural .................................................................... 187 

M. Vural ....................................................................... 223 

K. Wahab ..................................................................... 178 

E. Walczak ................................................................... 174 

S. Waldman ..................................................138, 192, 206 

M. Walker ...................................................................... 74 

B. Walpoth ................................................................... 142 

T. Walther .............................................................. 73, 182 

W. Wang ...................................................................... 216 

T. Wang ......................................................................... 73 

S. Wang ....................................................................... 176 

L. Waqatakirewa .......................................................... 103 

D. D. Waters ................................................................ 183 

H. Watkins ..................................................................... 77 

F. Wayar ............................................................... 246-247 

T. Wcis£o ..................................................................... 171 

T. Wcislo ...................................................................... 170 

L. Wee ......................................................................... 135 

X. H. Wehrens ............................................................. 103 

F. L. Weich Glogier .........................................79, 219, 221 

M. R. Weir ................................................................... 238 

L. H. Weitzel ........................................................ 236, 266 

C. Weksler ................................................................... 227 

H. Z. Wen ..................................................................... 163 

M. Weyand .......................................................... 176, 274 

G. Whalley ................................................................... 136 

R. B. Wichi ................................................................... 239 

A. Wiecek .................................................................... 101 

C. Wiefels .................................................................... 207 

K. Wierzbowska-Drabik ................................................ 222 

U. Wilczek .................................................................... 238 

L. Wilensky ........................................................... 227-228 

D. Wilkinson ................................................................ 107 

A. Wilson ............................................................... 69, 111 

N. Wilson ..................................................................... 103 

E. R. Winkelmann .......................................................... 74 

K. Wita ......................................................................... 232 

R. Witjes ...................................................................... 135 

A. Witkowski ................................................136, 237, 241 

J. Witowski .................................................................. 225 

T. Wittenberg ............................................................... 274 

E. Wittke ...................................................................... 106 

E. K. Wlodarska .................................................... 134, 174 

L. Woie ....................................75, 135, 199, 206-207, 209 

D. Wojciechowski ........................................................ 252 

I. Wojtkowska .............................................................. 252 

P. Wollmer ................................................................... 168 

H. Wong ...................................................................... 135 

N. D. Wong .................................73, 75, 79, 137, 141, 179 

T. W. Wong .................................................................. 270 

D. A. Wood .................................................................. 107 

A. J. Woodiwiss ........................................................... 230 

S. Wottrich ................................................................... 233 

N. Wouters .................................................................. 132 

O. Wozniak .......................................................... 134, 174 

M. Wraga ..................................................................... 222 

J. Wrobel ..................................................................... 171 

W. Wróbel ................................................................... 232 

S. Wsolova ................................................................... 257 

Y. Wu ........................................................................... 135 

V. F. Xavier ..................................................................... 74 

R. M. A. Xavier ..................................................... 227, 256

Authors 

S. Xavier ................................................................. 76, 140 

S. S. Xavier ................................................................... 140 

H. Xiao ......................................................................... 202 

B. Xu .............................................................................. 73 

S. Xue .......................................................................... 136 

P. Xun .......................................................................... 202 

B. S. Yadav ........................................................... 108, 231 

S. M. Yala ..................................................................... 104 

S. Yala .................................................................... 75, 107 

K. Yalta ..........................................................180, 194, 205 

H. Yamabe ................................................................... 164 

H. Yamada ................................................................... 235 

T. Yamaguchi ............................................................... 175 

M. Yamamoto .............................................................. 181 

A. Yamamoto ............................................................... 175 

A. Yamashina ....................................................... 167, 187 

N. Yamawake ...................................................... 188, 197 

G. Yanes-Bowden ................................................ 167, 213 

D. Yanez ...................................................................... 137 

F. Yañez ....................................................................... 143 

X. Yang ........................................................................ 110 

J. Yang ......................................................................... 110 

G. Yannarelli ................................................................. 259 

B. S. Yasumura ............................................................ 251 

G. E. Yazici ................................................................... 279 

M. Yazici ............................................................... 198-199 

L. Yazicioglu ................................................................. 111 

G. Yentzen ................................................................... 137 

T. Yildiran ..................................................................... 105 

V. Yildirim ..................................................................... 163 

C. Yildirim .................................................................... 211 

A. Yilmaz ...................................................................... 205 

M. B. Yilmaz ..................................................180, 194, 205 

A. Yip ........................................................................... 202 

T. Yokoi ................................................................ 137, 173 

S. Yokus ............................................................... 104, 270 

M. Yokusoglu ............................................................... 163 

O. C. Yontar ..................................................180, 194, 205 

S. Yoon ........................................................................ 218 

Y. Yoon ......................................................... 110, 218-219 

S. B. Yoon ...................................................................... 79 

Y. W. Yoon ..................................................................... 79 

L. Yordi ........................................................................ 233 

N. Ysturiz ..................................................................... 190 

J. Yu ..................................................................... 135, 231 

C. Yu ............................................................................ 136 

C. Yukiko Osato ........................................................... 263 

S. Yurdakul ................................................................... 106 

K. Yusoff .............................................................. 133, 201 

B. Yusuf ....................................................................... 178 

F. Zaanad ..................................................................... 108 

M. Zabalza ................................................................... 232 

R. Zacca ....................................................................... 254 

B. Zaccara .................................................................... 240 

A. Zak ........................................................................... 200 

A. Zaki .......................................................................... 274 

A. N. Zakirova ............................................................... 236 

D. Zakrzewski .............................................................. 172 

D. Zamaklar-Trifunovic ................................................. 278 

A. Zamora Muciño ............................................... 266, 268 

A. Zamora .....................................................188, 266, 268 

R. Zamora .............................................................. 78, 111 

C. Zamora .................................................................... 209 

A. Zamora-Muciño ....................................................... 265 

N. Zamorano ................................................................ 144 

M. Zampach ................................................................. 178 

G. Zampi ...................................................................... 240 

G. Zapata ..................................................................... 220 

J. Zapata ...................................................................... 248 

A. Zapolanski ....................................................... 242, 249 

B. Zappa ....................................................................... 222 

R. Zarate ...................................................................... 183 

D. Zaremba .................................................................. 175 

B. Zarlenga ................................................................... 178 

J. G. Zarruk-Serrano ..................................................... 249 

A. Zarza ................................................................ 134, 170 

A. D. Zazula ............................................................ 75, 100 

D. Zdrenghea ................................................ 242, 245-246 

T. Zdrojewski ............................................................... 106 

M. Zehetgruber ............................................................ 232 

F. Zelaya ...................................................................... 102 

D. Zeltser ..................................................................... 163 

P. Zelveian ................................................................... 181 

D. Zemanek ................................................................. 223 

D. Zemánek ................................................................. 136 

S. Zengin ...................................................................... 211 

G. Zenker ..................................................................... 110 

C. C. Zeno ............................................................ 142, 254 

A. Zervoudaki ............................................................... 110 

T. Zeus ................................................................. 104, 270 

Y. Zhan ......................................................................... 202 

X. L. Zhang ................................................................... 133 

L. Zhang ..........................................................73, 133, 195 

B. Zhang ...................................................................... 181 

D. Zhao ................................................................ 163, 216 

J. R. Zhu ....................................................................... 216 

A. Zichert ..................................................................... 168 

J. Zidanaviciute ............................................................ 184 

Z. C. Ziella .................................................................... 274 

J. Zietek ....................................................................... 171 

A. Zillo .......................................................................... 197 

T. Zima ......................................................................... 200 

J. Zimmermann ............................................................. 69 

P. Zimolova .................................................................. 223 

P. Zimolová .................................................................. 169 

G. Zini .......................................................................... 219 

S. Zizzias ...............................................107, 222, 240, 251 

M. Zlatanovic ............................................................... 202 

K. Zmudka .......................................................78, 141, 233 

Y. Zocalo ....................................................... 231-232, 267 

C. R. Zoni ..................................................................... 271 

R. Zoni ..........................................................260, 271, 273 

R. Zorc Pleskovic .................................................. 187-188 

M. Zorc ..........................................105, 136, 174, 187-188 

R. Zorc-Pleskoviè ......................................................... 136 

L. A. M. Zornoff............................................................ 260 

E. Zuanich .................................................................... 100 

C. Zuehlke .................................................................... 223 

M. Zugaib ..................................................................... 268 

C. Zukowski ................................................................. 268 

P. Zuliani ...................................................................... 269 

C. Zuloaga .................................................................... 212 

R. Zumach ................................................................... 274 

M. Zurru ................................................................ 228-229 

K. Zykov ....................................................................... 163 

S. Zymerman ............................................................... 214 

index / 321

index 

Faculty 

Sharaf Abd El Rahman Abd El Gawad .......................... 141 

Alia Abdelfattah ................................................... 113, 122 

Pasquale Abete .............................................................. 91 

Alexander Abizaid .............................89, 92, 142, 154, 160 

Mónica Acevedo .............................................................. 4 

Aloyzio Achutti ............................................................. 126 

Gustavo Acosta ........................................................... 125 

Luis Acosta .................................................................. 123 

Susan Acosta Castillo .................................................. 154 

Harry Acquatella .................................................... 93, 126 

David Adams ....................................................... 113, 121 

Miguel Adorno ....................................................... 88, 106 

Carla Agatiello ................................................................ 64 

Fernando Aguirre ................................................... 84, 157 

Luis Alcocer ....................................................87, 115, 135 

Luis Alday .................................................................. 4, 64 

Erick Alexanderson ........................................................ 83 

Adel Allam ............................................................. 83, 128 

Angeles Alonso Garcia ............................97, 108, 114, 162 

Oscar Alvarado C ......................................................... 117 

Marcelo Alvarez ........................................................... 148 

Giuseppe Ambrosio ............................................. 116, 120 

Sebastián Ameriso ....................................................... 130 

Albert Amoah ................................................................... 8 

Celso Amodeo ............................................................. 123 

Ezra Amsterdam .......................................................... 146 

Marcos Amuchastegui ................................................. 158 

Luis María Amuchástegui ................................................ 4 

Claudia Anchique ......................................................... 162 

Rosana Andreoli ........................................................... 157 

Octavio Aparicio ........................................................... 150 

José Luis Araya ............................................................ 153 

Daniel Areco ................................................................ 126 

Julio Argentieri ............................................................... 96 

Virginia Argibay Pitlyk ................................................... 157 

Dagnovar Aristizabal ............................................ 106, 145 

Pilar Arnaiz ............................................................. 82, 116 

Richard Arntz ............................................................... 281 

Cristina Arranz ............................................................... 76 

Víctor Arregui ............................................................... 119 

Arturo Arribada ............................................................ 152 

Pablo Aschner ................................................................ 86 

Rene Asenjo ........................................................ 144, 156 

Ademar Atik ........................................................... 82, 118 

T. P. Aufderheide ........................................................... 91 

Gustavo Avegliano ....................................................... 147 

Álvaro Avezum ..............................................129, 285, 289 

Fernando Bacal ...................................................... 93, 116 

Ricardo Baeza .............................................................. 147 

Hugo Baglivo ................................................................. 85 

Noel Bairey Merz ..........................................114, 128, 152 

Victor Balestrini ............................................................ 125 

Miguel Ballarino ........................................................... 160 

Adrian Baranchuk ..............................81, 85, 102, 145, 157 

Alejandro Barbagelata ............................................ 85, 322 

Miguel L Barbero Marcial ............................................... 82 

Marcia Barbosa ............................................................ 113 

José Luis Barisani .................................................. 93, 119 

Joaquín Barnoya .................................................. 118, 121 

Carlos Barrero ................................................................ 64 

Antoni Bayés De Luna ......................................... 149, 162 

Oscar BAzzino ............................................................... 84 

Craig T Beam ................................................................ 8-9 

Jorge Belardi ........................................................ 154, 283 

George Beller ...........................................86, 113, 124-125 

Cesar Belziti ................................................................... 88 

Mario Bendersky ......................................................... 161 

Francisco Benítez ...........................................99, 122, 125 

Daniel Berman ............................................................... 95 

Daniel Berrocal .......................................92, 114, 142, 283 

Mario Bey Lombana ......................................107, 126, 149 

Deepak Bhatt ....................................................... 146, 281 

Eduardo Bianco ............................................................ 121 

Roberto Blandon Calderon ............................................. 84 

Jorge Bluguerman ................................................. 78, 123 

José Antonio Boggiano ................................................ 143 

Michael Böhm ............................................................. 284 

Carlos Boissonet ............................................................ 69 

Robert Bonow ..................................................92, 95, 123 

Jeffrey Borer ...................................................95, 147, 161 

Guillermo Bortman ...................................................... 158 

Xavier Bosch ................................................................ 129 

Bernardo Boskis .......................................................... 128 

Fernando Botto .................................................... 129, 226 

Daniel Bracco ............................................................... 129 

Johannes Brachmann .....................................82, 144, 287 

Jorge Braguinsky ......................................................... 152 

Ayrton Brandão .......................................................... 4, 64 

Andrea Brandão ............................................................. 85 

Nancy Bravo ................................................................ 148 

Günter Breithardt ....................................4, 64, 80, 87, 155 

Raúl Bretal ............................................................... 71, 84 

Nancy Brown ............................................................... 130 

William J Bryant ........................................................... 322 

AlfonsO Buendia-Hernandez ........................129, 148, 156 

Enio Buffolo ........................................................... 94, 129 

Matthew Burg ............................................................. 128 

Javier Bustamante ............................................... 118, 152 

Miguel Bustamante-Labarta ........................................ 155 

Jorge Cachero ............................................................. 155 

Andres Caeiro .............................................................. 150 

Arturo Cagide ........................................................4, 34, 68 

Jaime Calderón Herrer ................................................. 121 

Robert Califf ..................................................116, 127, 151 

John Camm ...............................................87, 93, 285-286 

Roxana Campisi ................................................... 141, 152 

Horacio Capelli ............................................................... 64 

Riccardo Cappato ............................................93, 112, 150 

Alessandro Capucci ....................................................... 98 

Jonathan Carapetis .......................................................... 4 

Oscar Carretero ........................................82, 90, 115, 155 

José Horacio Casabé ................................................... 120 

Marcelo Casey ............................................................. 130 

Ricardo Castro ............................................................. 155 

Christopher Cates ...........................................92, 117, 120 

Manuel Cerqueira ................................................ 113, 124 

Juan Carlos Chachques ......................................... 96, 140 

Antonio Chagas ....................115, 131, 149, 152, 161, 286 

Sergio Chain .................................................................. 19 

Beatriz Champagne ..................................................... 121 

Victoria Chaparro Cristaldo ........................................... 131 

Hilton Chaves .............................................................. 162 

John Cheatham ..................................................76, 90, 96 

Shih-Ann Chen ......................................................... 81, 87 

Pablo ChiAle .................................................................. 93 

Miguel Chiape .............................................................. 123 

Tomás Cianciulli ............................................................. 95 

Juan Cimbaro Canella .................................................. 157 

Horacio F. Cingolani ............................................... 77, 151 

Nadine Clausell .................................................... 158, 289 

John Cleland .....................................................81, 94, 112 

Antonio Coca ..................................................85, 115, 126 

Mauricio Cohen ..................................................... 85, 127 

Hernán Cohen Arazi ..................................................... 119 

William E. Cohn ........................................................... 113 

Jay Cohn .........................................94, 112, 119, 126, 162 

Roberto Colque ............................................................ 151 

I. Coma-Canella .............................................................. 90 

Eduardo Conci ............................................................... 19 

Jose Condado .................................................89, 113, 150 

Ramon Corbalan .................................................. 102, 313 

Roque Cordoba ............................................................ 114 

Pedro Cossio ................................................................. 18 

Costantino Costantini ...................................110, 120, 160 

Ronald Cuellar .............................................................. 156 

Ada Cuevas .....................................................86, 153, 160 

Carlos Cuneo ........................................................... 75, 98

Faculty 

Fernando Cura ....................................................... 78, 123 

Donald Cutlip ................................................................. 84 

Protasio Da Luz .....................................125, 137, 159, 161 

Anibal Damonte ............................................................. 91 

Adolfo De Bold ............................................................. 151 

Luis De La Fuente .................................................... 77, 96 

Fernando De La Serna ................................................. 128 

Robert J. De Souza ...................................................... 128 

Radu Deac ................................................................... 155 

Diego Delgado ........................................88, 117, 151, 159 

Hector Delgado OsoriO ................................120, 136, 158 

Hernán Delmonte ........................................................ 121 

Gabriel D’empaire Yanes ............................................... 99 

Milind Desai ........................................................... 95, 125 

Richard Devereux .........................................115, 123, 151 

Rafael Diaz ..............................................84, 281, 284, 289 

Mirta Diez ...................................................................... 18 

Horacio Dinunzio ............................................................ 91 

Van Veldhuisen Dirk ..................................................... 284 

Alberto Domenech ...................................................... 121 

Wistremundo Dones ....................................117, 137, 149 

Hernan Doval ......................................................... 87, 145 

Luciano Drager ............................................................ 161 

José Drago Silva .......................................................... 131 

Saúl Drajer ..................................................................... 93 

Sergio Dubner ................................................................ 64 

Carlos Dumont ............................................................. 158 

Anai Durazzo ................................................................ 288 

Shah Ebrahim .............................................................. 160 

Denise Eldemire Shearer ..................................... 128, 143 

Marcelo Elizari ....................................................... 93, 285 

Uri Elkayam .................................................................. 289 

Nabil El-Sheriff ................................................87, 118, 134 

Ladislao Endrei ............................................................ 150 

Irene Ennis ..................................................................... 64 

Sabine Ernst ........................................................ 150, 157 

Diego Esandi .................................................................. 97 

Edgardo Escobar ........................................................ 4, 64 

Eduardo Escudero ............................................... 154, 191 

Roberto César Esper .................................................... 145 

Ricardo Esper .......................................................... 75, 89 

Jaime Espinosa ............................................................ 126 

Agustin Lara Esqueda .................................................. 286 

GuilleRmo Fabregues .......................................... 155, 162 

Horacio Faella ..............................................3-4, 34, 64, 68 

Robert Fagard .......................................................... 86, 95 

Enrique Fairman ........................................................... 127 

Mariano Falconi ............................................................. 64 

Roberto Favaloro ......................................................... 129 

Gilson Feitosa ...................................................87, 95, 125 

J. Fernandes .......................................................... 75, 153 

Manoel Fernandes Canesin ........................................... 98 

Alberto Fernández ....................................................... 157 

Waldo Fernández Durand .............................................. 93 

Marcela Ferrada ........................................................... 148 

Carlos Ferrario ..........................................82, 90, 151, 286 

Mariano Ferreira .......................................................... 123 

Ernesto Ferreiro ........................................................... 100 

John Field .................................................................... 129 

Bartolome Finizola ......................................................... 87 

Scott Flamm ................................................................ 147 

Ferenc Follath .............................................................. 282 

Francisco Fonseca ....................................................... 153 

Guy Fontaine ....................................................... 119, 157 

Valmir Fontes ............................................................... 115 

Patricia Frangini ........................................................... 148 

Erika S Froelicher ........................................................... 83 

Jean Charles Fruchart .................................................... 86 

Juan José Fuselli ......................................................... 116 

Valentin Fuster ...............................................4, 8-9, 16, 64 

José Gabay ............................................................ 98, 111 

Juan Gagliardi ................................................................ 72 

Javier Galeano ............................................................. 156 

Nestor Galizio ................................................................ 93 

Runlin GaO ...................................................................... 4 

Mario Garcia .....................................................92, 95, 122 

Ernest Garcia ......................................................... 91, 113 

Carlos García .................................................................. 81 

Santiago García Egüez ......................................... 131, 146 

Mario Garcia-Palmieri ............................................... 91, 98 

Timothy Gardner ............................................................ 89 

Jorge Garguichevich .................................................... 150 

Fabián Gelpi ................................................................... 98 

Ricardo Gelpi ............................................................... 151 

Gerald Nacarelli ............................................................ 285 

Mihai Gheorghiade ...................................81, 94, 112, 151 

Federico Giachello ....................................................... 121 

Alberto Giniger ..........................................72, 80, 156, 226 

Mariano Giorgi ............................................................... 91 

Alan Goble ..................................................................... 83 

Jaime Goich ................................................................... 87 

Michael Gold .......................................................81, 88, 93 

Marcelo Goldstein ......................................83, 91, 95, 141 

Alejandro Gómez Monroy ............................................ 160 

Miguel Gomez Sanchez ................................120, 146, 288 

Gilberto Gonzalez ................................................. 130, 146 

Rolando Gonzalez ........................................................ 150 

Miguel Gonzalez ....................................................... 93-94 

Oscar González ............................................................ 124 

Graciela González Bogado ............................................. 93 

Antonio Gonzalez Hermosillo ....................................... 112 

Juan Gonzalez Juanatey ................................................ 83 

Juan Gonzalez Moreno ................................................ 150 

Jorge Gonzalez ZUelgaray ..................................... 88, 135 

John Gorcsan III ................................................81, 93, 146 

Hugo Grancelli ......................................................4, 64, 68 

Miguel Granja ................................................................ 90 

Liliana Grinfeld ........................................................... 4, 64 

Scott Grundy ...................................................86, 117, 152 

Jose Fernando Guadalajara ............................................ 79 

Eduardo Guevara ................................................... 79, 161 

Luiza Guilherme ........................................................... 126 

Victor Gura ................................................................... 151 

Enrique Gurfinkel ................................................. 147, 161 

Pedro Gutierrez Fajardo ............................................... 126 

Tj. Guzik ....................................................................... 151 

Luis Guzman ........................................................ 111, 114 

Laksmiati A. Hanafiah ...................................................... 8 

Eduardo Hasbani ............................................................ 85 

Trevor Hassell ......................................................4, 8-9, 64 

Sergio Hauad ............................................................... 146 

Laura Hayman .............................................................. 131 

Felipe Heusser Risopatró ............................................. 113 

J. Thomas Heywood .................................................... 289 

Ziyad Hijazi ..................................................82, 92, 96, 115 

Shirish Hiremath .............................................96, 116, 128 

Alejandro Hita .............................................................. 212 

Sun Yee Ho .................................................................. 130 

Peter Hollins .................................................................... 8 

Nancy Houston Miller ...................................131, 148, 157 

Sandrine Huez ............................................................. 288 

Steen Husted ............................................................... 281 

Ricardo Iglesias .............................................................. 18 

Hermes Ilarraza-Lomeli ...................................83, 108, 159 

Manuel IrarrazAbal ............................................... 100, 129 

Daniel Isaza .................................................................... 99 

Mitsuaki Isobe ............................................................. 158 

Mariano Ithuralde ........................................................... 96 

Jorge Jalil ............................................................. 155, 161 

Kenneth Jamerson ...................................................... 287 

Loreta Jara ..................................................................... 90 

Alex Javois ............................................................. 82, 129 

Catriona Jennings ........................................................ 131 

Daniel W. Jones ................................................... 121, 123 

Soon Joo Wang .................................................. 91, 97-98 

Ernesto Juaneda ............................................................ 97 

Luis Juncos .................................................................. 115 

index / 323

Faculty 

Juan Justiniano Encina .......................................... 84, 114 

Edward L. Kaplan ......................................................... 126 

Wahida Karmally .................................................. 145, 159 

Juan Kaski .....................................................127, 145, 151 

Anthony Keech ............................................................ 282 

Ulrich Keil ..................................................................... 121 

Roya Kelishadi ............................................................. 116 

David T. Kelly ........................................................... 92, 96 

Karl B. Kern ............................................................ 91, 122 

Bjoy Khandheria .................................................... 154-155 

Spencer King III .............................................117, 147, 160 

Sverre E. Kjeldsen ........................................................ 126 

Kwang Koh .....................................................82, 140, 148 

Marvin Konstam .......................................83, 94, 119, 162 

Irina Kovalskys ............................................................. 129 

Veronica Kramer .................................................. 131, 153 

Juan Krauss ............................................................... 4, 64 

Christian Kreutzer .......................................................... 82 

Guillermo Kreutzer ....................................................... 115 

Henry Krum ..................................................112, 119, 147 

Anil Kumar ....................................................................... 8 

Paola Kuschnir ............................................................... 64 

EmiliO Kuschnir ............................................................. 64 

Rodolfo Daniel La Greca ...................................... 107, 116 

Carlos Labadet ................................................81, 102, 195 

Mario Lado .......................................................... 122, 131 

Michael Landzberg .......................................115, 129, 148 

Hugo Lastiri ..................................................................... 4 

Aleksandras Laucevicius ................................................ 88 

Aina Lauga ................................................................... 153 

Jorge Lax ..................................................................... 110 

Trong Phi Le ................................................................... 96 

Jorge Leguizamon ............................................... 102, 130 

Daniel Lemogoum ......................................................... 97 

Jorge Lemus ................................................................ 124 

Jorge Lerman ............................................................ 4, 64 

Ricardo Levin ................................................................. 88 

Jack Lewin ..................................................................... 86 

Peter Libby ................................................... 124, 145-146 

Michael Lim ................................................................. 149 

J. C. Linares-Casas ...................................................... 156 

Lars Lindholm .......................................................... 82, 95 

Pedro Lipszyc ...................................................... 122, 285 

Maria Teresa Lira ....................................75, 107, 137, 306 

Peter Liu .......................................................120, 127, 158 

Shay Livschiz ............................................................... 111 

Ricardo Lluberas ...........................................114, 125, 132 

Hugo Londero ................................................................ 98 

Beatriz Londoño ............................................................. 97 

Nestor Lopez ............................................................... 287 

Ricardo López Santi ..................................................... 127 

Jorge Lopez Sosa .......................................................... 95 

José Luis López-Sendón ...................87, 89, 112, 125, 289 

Alberto Lorenzatti ................................................ 137, 153 

Jorge A. Lowenstein .................................................... 154 

Hector LUciardi ............................................................ 155 

Sergio Lupo ................................................................... 97 

Pedro Lylyk .................................................................... 64 

Carlos Macaya ................................................84, 130, 143 

Alejandro Macchia ......................................................... 88 

Daniel Maggio .............................................................. 157 

John Mahmarian .......................................................... 124 

Stella Maimone ............................................................ 148 

A. A. Shafi Majumder ................................................... 113 

Rafael Maldonado ........................................................ 282 

Giuseppe Mancia ............................................90, 281, 284 

Fernando Manzur Jattin ............................73, 92, 155, 162 

Mário Maranhão .............................................................. 4 

Pablo Marantz ........................................................ 90, 109 

V. Mareev ............................................................ 119, 145 

Alvaro Margoglis .......................................................... 156 

José Antônio Marin-Neto ............................................. 152 

Javier Marino ............................................................... 158 

Flavio Marques .............................................................. 91 

Ricardo Martellotto ...................................................... 146 

Felipe Martínez .....................................................4, 34, 68 

Marco A. Martínez Ríos ................................ 204-205, 307 

Jose Alejandro Martinez Sepulveda ....................... 96, 154 

Carlos Martinez-Sanchez ............................................. 116 

Hori Masatsugu ........................................................... 112 

Osvaldo Masoli ........................................................ 18, 64 

Mònica Masotti ........................................................ 72, 90 

Barry Massie .................................112, 125, 136, 151, 158 

Wilson Mathias ...................................................... 95, 154 

Akira Matsumori ..................................................4, 8-9, 64 

Alicia MattiazzI ............................................................... 82 

Luiz Piva Mattos .......................................................... 161 

Victor Mauro ................................................................ 116 

Branco Mautner .................................................... 118-119 

Bongani Mayosi ............................................................... 4 

Jean-Rene M’buyamba .................................................. 97 

Mabel Medina .............................................................. 153 

Felix Medina ................................................................ 162 

Roxana Mehran ................................71, 98, 120, 130, 147 

Anibal Mele .................................................................... 83 

Eduardo Mele ...............................................18, 34, 64, 68 

Nedina Mendez ............................................................. 91 

Shanthi Mendis .................................................... 121, 128 

Carlos Mendiz .................................................92, 117, 142 

Oscar Mendiz .............................................................. 283 

Ivan Mendoza ...................................................72, 80, 157 

Claudio Meneghetti ....................................................... 83 

George A. Mensah ................................................. 86, 149 

Luis Mercado ....................................................... 127, 145 

Peter A. Meredith ........................................................ 281 

Ricardo Miglino .............................................................. 81 

Ricardo Migliore ................................................... 103, 152 

Jose Milei ...................................................................... 84 

Santiago Miriuka ............................................................ 88 

Jorge Mitelman ............................................................. 84 

Kyoichi Mizuno ............................................................ 145 

Luis Molina .............................................93, 118, 145, 150 

Luis Molinary ................................................101, 115, 152 

Jose Moltedo ............................................................... 148 

Marcelo Montera ................................................... 74, 158 

Lorenzo Montserrat ............................................... 95, 127 

James Moon ................................................................ 147 

Rosalia Morais Torres .................................................... 84 

Eduardo Morales Briceño ...................................... 69, 149 

Eduardo Moreyra ..........................................127, 136, 151 

Abel Moreyra ............................................................... 155 

Carlos A Morillo ................................................... 112, 118 

Luis Moya .................................................................... 150 

Bernhard Mumm ................................................. 113, 161 

Juan Muntaner .............................................................. 19 

Francisco Nacinovich ................................................... 120 

Juan Carlos Nadalich .................................................... 124 

M Nahir ................................................................ 129, 146 

Takeshi Nakatani .................................................... 92, 154 

Navin Nanda .......................................................86, 92, 99 

Andrea Natale ...................................................81, 87, 286 

Solon Navarrete ................................................... 157, 284 

Jose Navarro Estrada ..................................................... 90 

José Luis Navia ...................................................... 94, 121 

Daniel Navia ................................................................. 114 

Jose Navia ................................................................... 160 

Jorge Neira .................................................................... 85 

Rodolfo Neirotti ........................................................... 118 

Deborah Nercolini .............................................78, 89, 113 

Richard W. Nesto ......................................................... 282 

David Newby ............................................................... 159 

Graham Nichol ............................................................. 284 

Jose Nicolau .............................................90, 99, 116, 160 

Carlos Nijensohn .......................................................... 160 

Sania Nishtar .............................................................. 4, 64 

Carlos Nojek ................................................................ 113 

Daniel Nul ............................................................ 136, 151

Faculty 

Ismael N. Nuno ............................................................ 324 

Pablo Oberti ................................................................. 116 

Graciela Ocaña ............................................................. 124 

Robert O’connor .......................................................... 284 

Jose Andres Octavio .................................................... 156 

Mario Oliveira .............................................................. 324 

Anders G. OlssOn ........................................................ 285 

T. Omland .................................................................... 159 

Churchill Onen ........................................................... 4, 64 

Marcelo Orias ................................................................ 82 

Cesare Orlandi ............................................................... 83 

Andres Orlandini .......................................................... 127 

Enrique Oropeza .......................................................... 157 

Oscar Oseroff ................................................................ 64 

Ali Oto ...........................................................144, 150, 159 

Armando Pacher .......................................................... 156 

Jose Carlos Pachon Mateos ...........................81, 103, 286 

S. R. K. Padmavati........................................................ 324 

Dev Pahlajani ............................................................. 4, 64 

Igor Palacios .........................................121, 142, 147, 154 

Alejandro Palacios ................................................ 113, 143 

Norberto Pallavicini ...................................................... 152 

Julio Palmaz ........................................................... 84, 121 

Maria Paniagua ............................................................ 117 

Ernesto Paolasso ......................................................... 122 

David Paquette ............................................................ 287 

Gianfranco Parati ..........................................145, 151, 161 

Manish Parikh ................................................................ 92 

Carlos Pedra .................................................................. 96 

Jairo Pedraza ............................................................... 126 

Roberto Peidro ..............................................108, 126, 138 

Amparo Peiró ....................................................... 143, 148 

Alejandro Peirone ........................................................ 156 

Fernando Peliche ......................................................... 161 

Imelda Perdomo .......................................................... 153 

Alfonso Perez ................................................................ 97 

Néstor Gustavo Pérez .................................................. 148 

Néstor Pérez Baliño ................................................... 4, 64 

Diego Pérez De Arenaza ................................................ 64 

Eduardo Perna ............................................................. 158 

Sergio Perrone .......................................146, 282, 288-289 

Ricardo Pesce .............................................................. 144 

Leopoldo Piegas .......................................................... 269 

Mario Pieroni ............................................................... 117 

Ileana Piña ....................................................105, 125, 158 

Daniel Piñeiro ................................................................. 64 

Sergio Pinski .......................................................... 87, 145 

Manuel Pinto ............................................................... 154 

Xavier Pintó .................................................................. 282 

Alfredo Piombo .................................................... 122, 169 

Rubén Piraino ................................................................ 89 

Raul Pisabarro ........................................................ 79, 128 

Daniel Piskorz ........................................................ 95, 155 

Rodolfo Pizarro ...................................................... 85, 133 

Nelson Pizzano ...................................................... 99, 154 

Juan Carlos Plana ..............................................92, 99, 155 

Juan A. Plastino ............................................................... 4 

Antonio Pocovi ............................................................. 117 

Don Poldermans .................................................. 119, 288 

Horacio Pomes Iparraguirre ....................70, 103, 237, 242 

Piotr Ponikowski .......................................................... 288 

Carlos I. Ponte N. .................................................. 218-219 

Philip A Poole-Wilson ..................................83, 88, 94, 112 

Barry Popkin ................................................................ 117 

Rafael Porcile ............................................................... 105 

Edgar Pozo Valdivia .............................................. 119, 125 

Domingo Pozzer ............................................................ 19 

Palmira Pramparo .........................................107, 117, 152 

Pekka Puska ............................................................. 4, 8-9 

Qing Qiao ..................................................................... 128 

Ramón Quesada .................................................... 89, 114 

Miguel Quiñones ..........................................117, 119, 154 

MiGuel Quintana .................................................... 99, 125 

Fernán Quirós .............................................................. 156 

Rafael Rabinovich ........................................................ 112 

Ed Racht ...................................................................... 284 

P. Radke .............................................................. 114, 127 

Jose Antonio Francisco Ramires.......................85, 95, 122 

Sanchez Ramiro ........................................................... 284 

Hugo Ramos ................................................................ 146 

José Luis Ramos ........................................................... 64 

Sunil V. Rao .................................................................. 281 

Anis Rassi Jr. ............................................................... 152 

Alberto Re ...................................................................... 90 

Patricia Rebaza ............................................................ 125 

Srinath Reddy ........................................................... 4, 8-9 

Zeljko Reiner ...................................................77, 121, 159 

Willem Remme ...........................................83, 89, 94, 112 

Jorge Resk ................................................................... 106 

Gustavo Restrepo ................................................ 150, 154 

Enrique Retyk .............................................................. 144 

Ricardo Horacio Rey ............................................ 145, 285 

Karina Rey García ................................................... 96, 144 

Walter Reyes Caorsi ................................................ 82, 93 

Expedito Ribeiro ...........................................117, 129, 154 

Arthur Ribeiro .............................................................. 286 

Leonardo Ribeiro ......................................................... 145 

Roberto Ricca .......................................................... 74, 94 

Eduardo Rivas Estany .............................83, 138, 149, 153 

Lyn Roberts ..................................................................... 8 

Rose Marie Robertson ......................................... 114, 159 

Alfredo Rodriguez ........................................................ 129 

Pablo Rodriguez ........................................................... 123 

José Antonio Rodríguez ............................................... 147 

Marco Roffi .......................................................... 116, 128 

Florencia Rolandi ......................................................... 130 

Carlos Romero ................................................................. 4 

Ricardo Ronderos ...................................................... 4, 64 

Juan Rosas .................................................................. 285 

Stephan Rosenkranz .................................................... 288 

Diego Rosso ................................................................ 147 

Rodolfo Rothlin .............................................................. 64 

Eduardo Roura ..................................................81, 85, 118 

Miguel Rubio ............................................................... 120 

Luis Ruilope ....................................................82, 123, 126 

Frank Thomas Ruschitzka .................................... 115, 147 

Joseph F. Sabik III ........................................................ 123 

Masood Sadiq .............................................................. 118 

Lawrence B. Sadwin .................................................... 325 

David Sahn ............................................................... 82, 90 

Jose Sala ..................................................................... 160 

Oscar Salomone .......................................................... 152 

Ana Salvati ..................................................................... 98 

Eduardo Sampo ............................................................. 74 

Ramiro Sánchez ..................................................... 95, 161 

María José Sancho Tello ........................................ 88, 150 

Fabio Sandoli De Brito.................................................. 114 

Julio Sandoval .............................................................. 288 

Edgardo Sandoya ........................................................... 87 

Angel Sandrin .............................................................. 113 

Patricia Sangenis ......................................................... 116 

Patricio Sanhueza ........................................................ 102 

Masao Sano ......................................................75, 98, 162 

Omar Santaera ..................................................... 110, 130 

Robson Santos ............................................................ 286 

Gines Sanz ............................................................. 89, 116 

Ricardo Sarmiento ....................................................... 154 

Nizal SarrAf-Zadegan ................................................. 4, 64 

Shigetake Sasayama ............................................ 112, 158 

Anita Saxena ...................................................97, 118, 129 

Mauricio Scanavacca ........................................... 150, 286 

Herman Schargrodsky ......................................... 143, 160 

Heinrich Schelbert ........................................120, 125, 146 

Angelique Schiffer ............................................... 128, 138 

Andrés Schlichter ........................................................ 115 

Joanne D Schuijf ............................................................ 95 

Alberto Sciegata .................................................... 76, 118 

index / 325

Faculty 

Ernesto Sebrie ............................................................. 121 

Martin Seoane ............................................................... 97 

José Luis Serra ............................................................ 157 

César Serra .................................................................. 122 

Satyavan Sharma ......................................85, 89, 114, 159 

Leslee Shaw .........................................124, 127, 152, 156 

Shahryar A. Sheikh ......................................................... 94 

Rafael Shuchleib .............................................................. 8 

Joanna Sikkema ........................................................... 131 

Galvao Silas ................................................................... 81 

Antonio Felipe Simão ................................................... 286 

Isaac Sinay ........................................................... 128, 285 

Victor Sinisi ............................................................ 80, 119 

Karen Sliwa .......................................................86, 97, 158 

Sidney Smith .....................................................8-9, 34, 68 

Dario Sobral ....................................................80, 112, 156 

Fernando Sokn ............................................................... 18 

Jane Somerville ................................................... 103, 148 

Maria Inés Somoza ...................................................... 159 

Maria Ines Sosa Liprandi ........................................ 97, 282 

Álvaro Sosa Liprandi .................................................... 153 

Monica Soto Vertchert ................................................. 157 

Howard Spencer .......................................................... 149 

José Spolidoro ............................................................. 138 

Peter Spooner .............................................................. 119 

Andrew Steer .............................................................. 126 

P. Gabriel Steg ..............................................127, 132, 289 

George Steiner ............................................................ 153 

Krisela Steyn .......................................................... 86, 130 

Walter Stoermann ....................................................... 122 

Noedir Groppo Stolf ............................................... 94, 118 

Carlos Eduardo Suaide Silva......................................... 155 

Hisayoshi Suma ....................................................... 92, 94 

Robert Superko ............................................................ 147 

Carlos Tajer .....................................................99, 138, 149 

Ana Tambussi .............................................................. 121 

Teruhisa Tanabe .................................................. 150, 157 

Chuwa Tei .................................................................... 158 

Jacques Theron ............................................................. 98 

Jorge Thierer ......................................................... 94, 226 

Ari Timerman ........................................................... 85, 91 

Sergio Timerman ............................................................. 4 

Gianni Tognoni .......................................................... 97-98 

Andrew Tonkin .......................................................... 4, 64 

Martín Toranzo ............................................................. 153 

Adam Torbicki ...............................................120, 146, 288 

Guillermo Torre Amione ....................................81, 88, 112 

Dimitri Tousoulis ...........................................120, 124, 145 

Jorge Trainini ......................................................... 96, 139 

Marcelo Trivi .......................................................... 92, 226 

Tak-Fu Tse ................................................................... 159 

Paolo Tucci .................................................................. 148 

Gioia Turitto ........................................................... 87, 118 

Alexander Turpie .......................................................... 289 

Jorge UbaldiNi ............................................................. 146 

Gerardo Uceda ............................................................. 152 

Thomas Unger ............................................................. 284 

Tudor Vagaonescu ....................................................... 155 

Gloria S Valdes ............................................................... 85 

Andre Ricardo Valle ...................................................... 147 

Frans Van De Werf................................................. 84, 281 

Hans Van Giezen .......................................................... 281 

Diego Vanegas ............................................................... 88 

Gabriel Vanerio ............................................................ 119 

Mani Vannan .....................................................92, 99, 154 

Jesus Vargas Baron ..................................................... 161 

Sergio Varini ........................................................... 80, 112 

Richard Vaughan-Jones ............................................... 148 

Horacio Vazquez .......................................................... 154 

Manuel Vazquez-Blanco ....................................... 106, 122 

Hector Ventura ...........................................86, 88, 94, 104 

Freek Verheugt ............................................................ 281 

David Vetcher ................................................................ 91 

René Vicuña Mariño ..................................................... 156 

Luis Vidal ......................................................115, 169, 195 

Aurora Vila ................................................................... 283 

Jorge Vilarino ......................................................... 73, 145 

Fabio Vilas-Boas ..............................................81, 157, 282 

Alberto Villamil ................................................82, 281, 287 

Fernando Vinuela ................................................... 78, 130 

Néstor Alejandro Vita ........................................... 124, 128 

Joao Vitola ............................................................. 83, 113 

Veronica Ines Volberg .................................................. 116 

Janet Voûte .............................................................. 4, 8-9 

C. Vozzi ........................................................................ 160 

Jose Luis Vukasovic ....................................................... 89 

Norberto VUlcano .................................................. 88, 288 

Gabriel D. Waisman ............................................. 149, 284 

Mauricio Wajngarten ......................................91, 107, 129 

Nicholas Wald .......................................................... 90, 97 

Alexander Walker ........................................................ 283 

W. Douglas Weaver ....................................................... 86 

Bonnie Weiner ......................................................... 84, 92 

Ernesto Weinschelbaum ............................................... 94 

Matthew Weir ............................................................. 287 

Rob Welsh ................................................................... 281 

Nanette Wenger .........................................9, 89, 114, 122 

Beat Widler .................................................................. 283 

Andy Wielgosz ........................................................... 8, 16 

William Wijns ..........................................................4, 8, 64 

Silvia Wikinski .............................................................. 147 

Neil Wilson .....................................................96, 113, 115 

Christian Wolpert ..................................................... 82, 93 

David Wood ................................................................. 153 

Marian Worcester .......................................................... 83 

Yunlong Xia ............................................................ 81, 119 

Cheuk-Man Yu ..........................................81, 92, 158, 161 

Salim Yusuf ...................................................................... 4 

Carlos Zabal ................................................................. 156 

Patricio Zaefferer ......................................................... 123 

Alberto Zambon ........................................................... 282 

A. Zampelas ................................................................. 159 

Alberto Zanchetti ....................................90, 123, 126, 284 

Faiez Zannad .......................................................81, 84, 91 

Barry Zaret ......................................................83, 113, 124 

Susana Zeffiro .............................................................. 152 

Paulo Zielinsky ............................................................... 90 

Judith Zilberman .......................................................... 152 

Claudio Zin ........................................................... 124, 152 

Horacio Zylbersztejn .................................................... 129

FROM PATIENTS TO POPULATIONS 

“See you in 

Beijing 2010” 

www.worldcardiocongress.org

More control. 

Less risk. 

St. Jude Medical is focused on reducing risk by continuously 

fi nding ways to put more control into the hands of those who save lives. 

Experience Control. WCC booth 310 

©2008 St. Jude Medical. All Rights Reserved. 

The ST. JUDE MEDICAL logo is a trademark of St. Jude Medical, Inc. 

Every option considered. 

Every move confi dent. 

Every outcome critical.

Final Programme - World Heart Federation

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?